snps_index,snps,genes,trait,cui,significance,status
0,NM_198576.4(AGRN):c.226G>A (p.Gly76Ser),LOC126805576|AGRN,congenital myasthenic syndrome 8,C3808739,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1,NM_080605.4(B3GALT6):c.1A>G (p.Met1Val),B3GALT6,"ehlers-danlos syndrome, spondylodysplastic type, 2",C3809210,"pathogenic(last reviewed: jan 7, 2023)","criteria provided, multiple submitters, no conflicts"
1,NM_080605.4(B3GALT6):c.1A>G (p.Met1Val),B3GALT6,spondyloepimetaphyseal dysplasia with joint laxity,C0432243,"pathogenic(last reviewed: jan 7, 2023)","criteria provided, multiple submitters, no conflicts"
2,NM_080605.4(B3GALT6):c.2T>C (p.Met1Thr),B3GALT6,spondyloepimetaphyseal dysplasia with joint laxity,C0432243,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
2,NM_080605.4(B3GALT6):c.2T>C (p.Met1Thr),B3GALT6,"ehlers-danlos syndrome, spondylodysplastic type, 2",C3809210,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
3,NM_080605.4(B3GALT6):c.2T>A (p.Met1Lys),B3GALT6,spondyloepimetaphyseal dysplasia with joint laxity,C0432243,"likely pathogenic(last reviewed: jun 15, 2022)","criteria provided, single submitter"
3,NM_080605.4(B3GALT6):c.2T>A (p.Met1Lys),B3GALT6,"ehlers-danlos syndrome, spondylodysplastic type, 2",C3809210,"likely pathogenic(last reviewed: jun 15, 2022)","criteria provided, single submitter"
4,NM_080605.4(B3GALT6):c.3G>A (p.Met1Ile),B3GALT6,spondyloepimetaphyseal dysplasia with joint laxity,C0432243,"pathogenic(last reviewed: may 16, 2022)","criteria provided, single submitter"
4,NM_080605.4(B3GALT6):c.3G>A (p.Met1Ile),B3GALT6,"ehlers-danlos syndrome, spondylodysplastic type, 2",C3809210,"pathogenic(last reviewed: may 16, 2022)","criteria provided, single submitter"
5,NM_080605.4(B3GALT6):c.200C>T (p.Pro67Leu),B3GALT6,spondyloepimetaphyseal dysplasia with joint laxity,C0432243,"pathogenic(last reviewed: nov 30, 2021)","criteria provided, single submitter"
5,NM_080605.4(B3GALT6):c.200C>T (p.Pro67Leu),B3GALT6,"ehlers-danlos syndrome, spondylodysplastic type, 2",C3809210,"pathogenic(last reviewed: nov 30, 2021)","criteria provided, single submitter"
6,NM_080605.4(B3GALT6):c.766C>T (p.Arg256Trp),B3GALT6,"ehlers-danlos syndrome, spondylodysplastic type, 2",C3809210,pathogenic,"criteria provided, single submitter"
7,NM_032348.4(MXRA8):c.1238T>A (p.Ile413Asn),MXRA8,abnormality of brain morphology,C4021085,likely pathogenic,"criteria provided, single submitter"
8,NM_001170535.3(ATAD3A):c.1217T>G (p.Leu406Arg),ATAD3A,congenital cerebellar hypoplasia,C0266470,"pathogenic(last reviewed: may 30, 2019)","criteria provided, single submitter"
9,NM_001170535.3(ATAD3A):c.1361A>G (p.Asn454Ser),ATAD3A,harel-yoon syndrome,C4310677,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
10,NM_001170535.3(ATAD3A):c.1582C>T (p.Arg528Trp),ATAD3A,harel-yoon syndrome,C4310677,"pathogenic/likely pathogenic(last reviewed: may 22, 2022)","criteria provided, multiple submitters, no conflicts"
11,NM_001170535.3(ATAD3A):c.1583G>A (p.Arg528Gln),ATAD3A,harel-yoon syndrome,C4310677,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
12,NM_001114748.2(TMEM240):c.509C>T (p.Pro170Leu),TMEM240,spinocerebellar ataxia type 21,C1843891,"pathogenic/likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
13,NM_001114748.2(TMEM240):c.419T>A (p.Leu140Gln),TMEM240,spinocerebellar ataxia type 21,C1843891,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
14,NM_001114748.2(TMEM240):c.239C>T (p.Thr80Met),TMEM240,spinocerebellar ataxia type 21,C1843891,"pathogenic(last reviewed: jan 4, 2021)","criteria provided, single submitter"
15,NM_002074.5(GNB1):c.976G>A (p.Ala326Thr),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
16,NM_002074.5(GNB1):c.388G>A (p.Glu130Lys),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: may 6, 2021)","criteria provided, multiple submitters, no conflicts"
17,NM_002074.5(GNB1):c.301A>G (p.Met101Val),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: jul 16, 2022)","criteria provided, multiple submitters, no conflicts"
18,NM_002074.5(GNB1):c.284T>C (p.Leu95Pro),GNB1,hypotonia,C1858120,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
18,NM_002074.5(GNB1):c.284T>C (p.Leu95Pro),GNB1,microcephaly,C4551563,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
19,NM_002074.5(GNB1):c.274G>A (p.Ala92Thr),GNB1,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: may 16, 2022)","criteria provided, multiple submitters, no conflicts"
19,NM_002074.5(GNB1):c.274G>A (p.Ala92Thr),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: may 16, 2022)","criteria provided, multiple submitters, no conflicts"
20,NM_002074.5(GNB1):c.239T>G (p.Ile80Ser),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
21,NM_002074.5(GNB1):c.239T>A (p.Ile80Asn),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
21,NM_002074.5(GNB1):c.239T>A (p.Ile80Asn),GNB1,acute lymphoid leukemia,C0023449,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
22,NM_002074.5(GNB1):c.239T>C (p.Ile80Thr),GNB1,global developmental delay,C0557874,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
22,NM_002074.5(GNB1):c.239T>C (p.Ile80Thr),GNB1,cerebral palsy,C0007789,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
22,NM_002074.5(GNB1):c.239T>C (p.Ile80Thr),GNB1,neurodevelopmental delay,C4022738,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
22,NM_002074.5(GNB1):c.239T>C (p.Ile80Thr),GNB1,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
22,NM_002074.5(GNB1):c.239T>C (p.Ile80Thr),GNB1,neurodevelopmental disorder,C1535926,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
22,NM_002074.5(GNB1):c.239T>C (p.Ile80Thr),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
23,NM_002074.5(GNB1):c.233A>G (p.Lys78Arg),GNB1,global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,Cumapped80,"pathogenic/likely pathogenic(last reviewed: feb 27, 2023)","criteria provided, multiple submitters, no conflicts"
23,NM_002074.5(GNB1):c.233A>G (p.Lys78Arg),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 27, 2023)","criteria provided, multiple submitters, no conflicts"
24,NM_002074.5(GNB1):c.230G>A (p.Gly77Asp),GNB1,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
25,NM_002074.5(GNB1):c.229G>T (p.Gly77Cys),GNB1,neurodevelopmental delay,C4022738,pathogenic,"criteria provided, single submitter"
26,NM_002074.5(GNB1):c.229G>A (p.Gly77Ser),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
27,NM_002074.5(GNB1):c.228T>A (p.Asp76Glu),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic(last reviewed: jun 24, 2022)","criteria provided, single submitter"
28,NM_002074.5(GNB1):c.226G>A (p.Asp76Asn),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
29,NM_002074.5(GNB1):c.217G>A (p.Ala73Thr),GNB1,global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome,Cumapped80,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, single submitter"
30,NM_002074.5(GNB1):c.183G>T (p.Met61Ile),GNB1,"intellectual disability, autosomal dominant 42",C3276355,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
31,NM_000815.5(GABRD):c.778C>G (p.Leu260Val),GABRD,"epilepsy, idiopathic generalized, susceptibility to, 10",C2751603,"pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
32,NM_003036.4(SKI):c.59C>T (p.Thr20Met),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: jan 14, 2022)","criteria provided, single submitter"
33,NM_003036.4(SKI):c.62T>G (p.Leu21Arg),SKI,shprintzen-goldberg syndrome,C1321551,pathogenic,"criteria provided, single submitter"
34,NM_003036.4(SKI):c.68A>C (p.Gln23Pro),SKI,shprintzen-goldberg syndrome,C1321551,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
35,NM_003036.4(SKI):c.82T>A (p.Ser28Thr),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: mar 14, 2022)","criteria provided, single submitter"
36,NM_003036.4(SKI):c.91T>C (p.Ser31Pro),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: nov 29, 2018)","criteria provided, single submitter"
37,NM_003036.4(SKI):c.94C>G (p.Leu32Val),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: dec 20, 2018)","criteria provided, multiple submitters, no conflicts"
38,NM_003036.4(SKI):c.100G>T (p.Gly34Cys),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
39,NM_003036.4(SKI):c.100G>A (p.Gly34Ser),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic/likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
40,NM_003036.4(SKI):c.101G>T (p.Gly34Val),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: nov 15, 2019)","criteria provided, single submitter"
41,NM_003036.4(SKI):c.101G>A (p.Gly34Asp),SKI,shprintzen-goldberg syndrome,C1321551,pathogenic,"criteria provided, single submitter"
42,NM_003036.4(SKI):c.103C>G (p.Pro35Ala),SKI,shprintzen-goldberg syndrome,C1321551,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
43,NM_003036.4(SKI):c.103C>T (p.Pro35Ser),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
44,NM_003036.4(SKI):c.104C>A (p.Pro35Gln),SKI,shprintzen-goldberg syndrome,C1321551,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
45,NM_003036.4(SKI):c.106G>C (p.Ala36Pro),SKI,shprintzen-goldberg syndrome,C1321551,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
46,NM_003036.4(SKI):c.265C>T (p.Pro89Ser),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic(last reviewed: oct 11, 2021)","criteria provided, single submitter"
47,NM_003036.4(SKI):c.347G>A (p.Gly116Glu),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
48,NM_003036.4(SKI):c.349G>C (p.Gly117Arg),SKI,shprintzen-goldberg syndrome,C1321551,"pathogenic/likely pathogenic(last reviewed: jun 2, 2017)","criteria provided, multiple submitters, no conflicts"
49,NM_003036.4(SKI):c.539C>A (p.Thr180Lys),SKI,disproportionate tall stature,C1836996,"likely pathogenic(last reviewed: jun 12, 2017)","criteria provided, single submitter"
50,NM_002617.4(PEX10):c.827G>C (p.Cys276Ser),PEX10,peroxisome biogenesis disorder 6a (zellweger),C3553947,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
51,NM_002617.4(PEX10):c.2T>C (p.Met1Thr),PEX10,peroxisome biogenesis disorder 6a (zellweger),C3553947,"pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
51,NM_002617.4(PEX10):c.2T>C (p.Met1Thr),PEX10,peroxisome biogenesis disorder 6b,C3553948,"pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
51,NM_002617.4(PEX10):c.2T>C (p.Met1Thr),PEX10,"peroxisome biogenesis disorder, complementation group 7",C1864399,"pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
51,NM_002617.4(PEX10):c.2T>C (p.Met1Thr),PEX10,peroxisome biogenesis disorder,C1832200,"pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
52,NM_002617.4(PEX10):c.1A>T (p.Met1Leu),PEX10,"peroxisome biogenesis disorder, complementation group 7",C1864399,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
53,NM_002617.4(PEX10):c.1A>G (p.Met1Val),PEX10,"peroxisome biogenesis disorder, complementation group 7",C1864399,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
53,NM_002617.4(PEX10):c.1A>G (p.Met1Val),PEX10,peroxisome biogenesis disorder 6a (zellweger),C3553947,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
53,NM_002617.4(PEX10):c.1A>G (p.Met1Val),PEX10,peroxisome biogenesis disorder 6b,C3553948,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
54,NM_015557.3(CHD5):c.2735C>T (p.Ser912Phe),CHD5,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
54,NM_015557.3(CHD5):c.2735C>T (p.Ser912Phe),CHD5,global developmental delay,C0557874,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
55,NM_015557.3(CHD5):c.1279G>A (p.Glu427Lys),CHD5,global developmental delay,C0557874,"likely pathogenic(last reviewed: jan 18, 2021)","criteria provided, single submitter"
56,NM_015557.3(CHD5):c.577C>T (p.Arg193Trp),CHD5,global developmental delay,C0557874,"likely pathogenic(last reviewed: jan 18, 2021)","criteria provided, single submitter"
57,NM_207370.4(GPR153):c.217C>T (p.Arg73Cys),GPR153,childhood-onset schizophrenia,C0036346,"likely pathogenic(last reviewed: jan 1, 2014)","criteria provided, single submitter"
58,NM_031475.3(ESPN):c.1972G>A (p.Glu658Lys),ESPN,autosomal recessive nonsyndromic hearing loss 36,C3711374,"likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, single submitter"
59,NM_020631.6(PLEKHG5):c.1889C>A (p.Pro630His),PLEKHG5,juvenile amyotrophic lateral sclerosis,C3468114,"likely pathogenic(last reviewed: mar 31, 2020)","criteria provided, single submitter"
60,NM_015215.4(CAMTA1):c.2863C>T (p.Arg955Trp),CAMTA1,nonprogressive cerebellar atxia with intellectual disability,Cumapped176,"likely pathogenic(last reviewed: jan 6, 2017)","criteria provided, single submitter"
61,NM_001377275.1(PER3):c.1243C>G (p.Pro415Ala),PER3,advanced sleep phase syndrome 3,C4225169,"pathogenic(last reviewed: jun 23, 2017)","criteria provided, single submitter"
62,NM_001377275.1(PER3):c.1250A>G (p.His417Arg),PER3,advanced sleep phase syndrome 3,C4225169,"pathogenic(last reviewed: jun 23, 2017)","criteria provided, single submitter"
63,NM_007262.5(PARK7):c.302T>C (p.Leu101Pro),PARK7,autosomal recessive early-onset parkinson disease 7,C1853445,"likely pathogenic(last reviewed: jan 5, 2022)","criteria provided, single submitter"
64,NM_007262.5(PARK7):c.322G>A (p.Gly108Ser),PARK7,autosomal recessive early-onset parkinson disease 7,C1853445,"pathogenic(last reviewed: jan 7, 2022)","criteria provided, single submitter"
65,NM_007262.5(PARK7):c.460A>G (p.Thr154Ala),PARK7,young-onset parkinson disease,C4275179,"likely pathogenic(last reviewed: may 3, 2021)","criteria provided, single submitter"
66,NM_001080397.3(SLC45A1):c.629C>T (p.Ala210Val),SLC45A1,intellectual developmental disorder with neuropsychiatric features,C4479636,"likely pathogenic(last reviewed: jun 28, 2021)","criteria provided, single submitter"
67,NM_005026.5(PIK3CD):c.1570T>A (p.Tyr524Asn),PIK3CD,immunodeficiency 14,C0021051,"pathogenic(last reviewed: nov 11, 2021)","criteria provided, single submitter"
68,NM_005026.5(PIK3CD):c.1571A>C (p.Tyr524Ser),PIK3CD,immunodeficiency 14,C0021051,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
69,NM_005026.5(PIK3CD):c.1573G>A (p.Glu525Lys),PIK3CD,immunodeficiency 14,C0021051,"pathogenic/likely pathogenic(last reviewed: mar 7, 2022)","criteria provided, multiple submitters, no conflicts"
70,NM_005026.5(PIK3CD):c.3061G>A (p.Glu1021Lys),PIK3CD,inherited immunodeficiency diseases,C5197805,"pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
70,NM_005026.5(PIK3CD):c.3061G>A (p.Glu1021Lys),PIK3CD,not specified,Cumapped182,"pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
70,NM_005026.5(PIK3CD):c.3061G>A (p.Glu1021Lys),PIK3CD,immunodeficiency 14,C0021051,"pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
71,NM_022787.4(NMNAT1):c.25G>A (p.Val9Met),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: dec 19, 2021)","criteria provided, single submitter"
72,NM_022787.4(NMNAT1):c.53A>G (p.Asn18Ser),NMNAT1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
72,NM_022787.4(NMNAT1):c.53A>G (p.Asn18Ser),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic/likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
73,NM_022787.4(NMNAT1):c.104T>C (p.Met35Thr),NMNAT1,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jul 9, 2018)","criteria provided, single submitter"
74,NM_022787.4(NMNAT1):c.196C>T (p.Arg66Trp),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: sep 21, 2022)","criteria provided, single submitter"
75,NM_022787.4(NMNAT1):c.205A>G (p.Met69Val),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: mar 10, 2022)","criteria provided, single submitter"
76,NM_022787.4(NMNAT1):c.293T>G (p.Val98Gly),NMNAT1,"spondyloepiphyseal dysplasia, sensorineural hearing loss, impaired intellectual development, and leber congenital amaurosis",Cumapped301,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
76,NM_022787.4(NMNAT1):c.293T>G (p.Val98Gly),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
76,NM_022787.4(NMNAT1):c.293T>G (p.Val98Gly),NMNAT1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
77,NM_022787.4(NMNAT1):c.500A>G (p.Asn167Ser),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
78,NM_022787.4(NMNAT1):c.619C>T (p.Arg207Trp),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
79,NM_022787.4(NMNAT1):c.629T>C (p.Ile210Thr),NMNAT1,leber congenital amaurosis,C0339527,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
80,NM_022787.4(NMNAT1):c.709C>T (p.Arg237Cys),NMNAT1,retinal dystrophy,C4229674,"pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
80,NM_022787.4(NMNAT1):c.709C>T (p.Arg237Cys),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
81,NM_022787.4(NMNAT1):c.716T>C (p.Leu239Ser),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: oct 29, 2021)","criteria provided, single submitter"
82,NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys),NMNAT1,retinal dystrophy,C4229674,"pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
82,NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys),NMNAT1,leber congenital amaurosis,C0339527,"pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
82,NM_022787.4(NMNAT1):c.769G>A (p.Glu257Lys),NMNAT1,leber congenital amaurosis 9,C1837873,"pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
83,NM_007375.4(TARDBP):c.881G>T (p.Gly294Val),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
83,NM_007375.4(TARDBP):c.881G>T (p.Gly294Val),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
84,NM_007375.4(TARDBP):c.892G>A (p.Gly298Ser),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: apr 6, 2022)","criteria provided, multiple submitters, no conflicts"
85,NM_007375.4(TARDBP):c.931A>G (p.Met311Val),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
86,NM_007375.4(TARDBP):c.943G>A (p.Ala315Thr),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
86,NM_007375.4(TARDBP):c.943G>A (p.Ala315Thr),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
87,NM_007375.4(TARDBP):c.962C>A (p.Ala321Asp),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
88,NM_007375.4(TARDBP):c.1009A>G (p.Met337Val),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: feb 24, 2022)","criteria provided, multiple submitters, no conflicts"
89,NM_007375.4(TARDBP):c.1035C>A (p.Asn345Lys),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, single submitter"
90,NM_007375.4(TARDBP):c.1042G>T (p.Gly348Cys),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, multiple submitters, no conflicts"
90,NM_007375.4(TARDBP):c.1042G>T (p.Gly348Cys),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, multiple submitters, no conflicts"
91,NM_007375.4(TARDBP):c.1043G>T (p.Gly348Val),TARDBP,motor neuron disease,C0085084,"pathogenic(last reviewed: aug 31, 2016)","criteria provided, single submitter"
92,NM_007375.4(TARDBP):c.1055A>G (p.Asn352Ser),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
92,NM_007375.4(TARDBP):c.1055A>G (p.Asn352Ser),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
93,NM_007375.4(TARDBP):c.1060C>G (p.Gln354Glu),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"likely pathogenic(last reviewed: mar 31, 2020)","criteria provided, single submitter"
94,NM_007375.4(TARDBP):c.1123A>G (p.Ser375Gly),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"likely pathogenic(last reviewed: may 18, 2022)","criteria provided, single submitter"
95,NM_007375.4(TARDBP):c.1129T>C (p.Ser377Pro),TARDBP,frontotemporal dementia,C0338451,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
96,NM_007375.4(TARDBP):c.1144G>A (p.Ala382Thr),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
96,NM_007375.4(TARDBP):c.1144G>A (p.Ala382Thr),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
97,NM_007375.4(TARDBP):c.1147A>G (p.Ile383Val),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
97,NM_007375.4(TARDBP):c.1147A>G (p.Ile383Val),TARDBP,amyotrophic lateral sclerosis type 10,C2677565,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
97,NM_007375.4(TARDBP):c.1147A>G (p.Ile383Val),TARDBP,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
98,NM_004958.4(MTOR):c.3026G>A (p.Arg1009Gln),MTOR,papillary renal cell carcinoma type 1,C1336839,"pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
99,NM_004958.4(MTOR):c.1816T>C (p.Cys606Arg),MTOR,macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,C4225259,"likely pathogenic(last reviewed: sep 23, 2020)","criteria provided, single submitter"
100,NM_004958.4(MTOR):c.1078C>T (p.Arg360Trp),MTOR,macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome,C4225259,"likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, single submitter"
101,NM_013319.3(UBIAD1):c.718G>A (p.Asp240Asn),UBIAD1,schnyder crystalline corneal dystrophy,C0271287,"likely pathogenic(last reviewed: sep 28, 2021)","criteria provided, single submitter"
102,NM_005957.5(MTHFR):c.1793T>G (p.Leu598Arg),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
103,NM_005957.5(MTHFR):c.1715C>T (p.Pro572Leu),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: may 7, 2022)","criteria provided, single submitter"
104,NM_005957.5(MTHFR):c.1516T>G (p.Tyr506Asp),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: nov 5, 2021)","criteria provided, single submitter"
105,NM_005957.5(MTHFR):c.1316T>C (p.Leu439Pro),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, multiple submitters, no conflicts"
106,NM_005957.5(MTHFR):c.1262G>C (p.Trp421Ser),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
107,NM_005957.5(MTHFR):c.1130G>A (p.Arg377His),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: sep 17, 2022)","criteria provided, single submitter"
108,NM_005957.5(MTHFR):c.1070G>A (p.Arg357His),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
109,NM_005957.5(MTHFR):c.1069C>T (p.Arg357Cys),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: mar 2, 2022)","criteria provided, single submitter"
110,NM_005957.5(MTHFR):c.1033C>T (p.Arg345Cys),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: jul 22, 2021)","criteria provided, multiple submitters, no conflicts"
111,NM_005957.5(MTHFR):c.1015T>G (p.Trp339Gly),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
112,NM_005957.5(MTHFR):c.1013T>C (p.Met338Thr),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
113,NM_005957.5(MTHFR):c.1003C>T (p.Arg335Cys),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, single submitter"
114,NM_005957.5(MTHFR):c.971A>G (p.Asn324Ser),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: apr 22, 2022)","criteria provided, single submitter"
115,NM_005957.5(MTHFR):c.968T>C (p.Leu323Pro),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, single submitter"
116,NM_005957.5(MTHFR):c.584C>T (p.Ala195Val),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: mar 16, 2022)","criteria provided, multiple submitters, no conflicts"
117,NM_005957.5(MTHFR):c.548G>A (p.Arg183Gln),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
118,NM_005957.5(MTHFR):c.523G>A (p.Ala175Thr),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: feb 20, 2022)","criteria provided, single submitter"
119,NM_005957.5(MTHFR):c.476A>G (p.Asp159Gly),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: aug 24, 2020)","criteria provided, single submitter"
120,NM_005957.5(MTHFR):c.470G>A (p.Arg157Gln),MTHFR,thrombophilia due to thrombin defect,C3160733,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
120,NM_005957.5(MTHFR):c.470G>A (p.Arg157Gln),MTHFR,"neural tube defects, folate-sensitive",C1866558,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
120,NM_005957.5(MTHFR):c.470G>A (p.Arg157Gln),MTHFR,schizophrenia,C0036341,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
120,NM_005957.5(MTHFR):c.470G>A (p.Arg157Gln),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
120,NM_005957.5(MTHFR):c.470G>A (p.Arg157Gln),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
121,NM_005957.5(MTHFR):c.459C>G (p.Ile153Met),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
121,NM_005957.5(MTHFR):c.459C>G (p.Ile153Met),MTHFR,thrombophilia due to thrombin defect,C3160733,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
121,NM_005957.5(MTHFR):c.459C>G (p.Ile153Met),MTHFR,"neural tube defects, folate-sensitive",C1866558,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
121,NM_005957.5(MTHFR):c.459C>G (p.Ile153Met),MTHFR,schizophrenia,C0036341,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
121,NM_005957.5(MTHFR):c.459C>G (p.Ile153Met),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
122,NM_005957.5(MTHFR):c.379C>T (p.His127Tyr),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: may 3, 2020)","criteria provided, single submitter"
123,NM_005957.5(MTHFR):c.337G>T (p.Ala113Ser),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,likely pathogenic,"criteria provided, single submitter"
124,NM_005957.5(MTHFR):c.337G>A (p.Ala113Thr),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, single submitter"
125,NM_005957.5(MTHFR):c.237G>T (p.Arg79Ser),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: dec 3, 2017)","criteria provided, single submitter"
126,NM_005957.5(MTHFR):c.202C>G (p.Arg68Gly),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
127,NM_005957.5(MTHFR):c.155G>A (p.Arg52Gln),MTHFR,schizophrenia,C0036341,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
127,NM_005957.5(MTHFR):c.155G>A (p.Arg52Gln),MTHFR,thrombophilia due to thrombin defect,C3160733,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
127,NM_005957.5(MTHFR):c.155G>A (p.Arg52Gln),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
127,NM_005957.5(MTHFR):c.155G>A (p.Arg52Gln),MTHFR,"neural tube defects, folate-sensitive",C1866558,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
127,NM_005957.5(MTHFR):c.155G>A (p.Arg52Gln),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
128,NM_005957.5(MTHFR):c.137G>A (p.Arg46Gln),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"likely pathogenic(last reviewed: may 13, 2022)","criteria provided, single submitter"
129,NM_005957.5(MTHFR):c.2T>A (p.Met1Lys),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, single submitter"
130,NM_005957.5(MTHFR):c.2T>C (p.Met1Thr),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, single submitter"
131,NM_005957.5(MTHFR):c.1A>G (p.Met1Val),MTHFR,homocystinuria due to methylene tetrahydrofolate reductase deficiency,C1856058,"pathogenic/likely pathogenic(last reviewed: jul 22, 2022)","criteria provided, multiple submitters, no conflicts"
132,NM_000302.4(PLOD1):c.2032G>A (p.Gly678Arg),PLOD1,"ehlers-danlos syndrome, kyphoscoliotic type 1",C0013720,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
133,NM_014874.4(MFN2):c.145T>G (p.Tyr49Asp),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
134,NM_014874.4(MFN2):c.227T>C (p.Leu76Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
135,NM_014874.4(MFN2):c.262A>C (p.Ile88Leu),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
136,NM_014874.4(MFN2):c.262A>T (p.Ile88Phe),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
137,NM_014874.4(MFN2):c.263T>C (p.Ile88Thr),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jun 23, 2022)","criteria provided, multiple submitters, no conflicts"
138,NM_014874.4(MFN2):c.275T>C (p.Leu92Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
139,NM_014874.4(MFN2):c.280C>G (p.Arg94Gly),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,scarring,C2004491,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,hyperpigmentation of the skin,C0162834,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,abnormal blistering of the skin,C2132198,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,emg abnormality,C0476403,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,distal muscle weakness,C0427065,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,alopecia of scalp,C0574769,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,abnormal dental enamel morphology,C4021800,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,abnormality of the dentition,C0262444,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,microcephaly,C4551563,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,decreased body weight,C1262477,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,scarring alopecia of scalp,C3806301,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,short stature,C2919142,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,failure to thrive,C0015544,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
140,NM_014874.4(MFN2):c.280C>T (p.Arg94Trp),MFN2,nail dystrophy,C0221260,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
141,NM_014874.4(MFN2):c.281G>A (p.Arg94Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
141,NM_014874.4(MFN2):c.281G>A (p.Arg94Gln),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
142,NM_014874.4(MFN2):c.283A>G (p.Arg95Gly),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jun 2, 2022)","criteria provided, multiple submitters, no conflicts"
143,NM_014874.4(MFN2):c.285G>T (p.Arg95Ser),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
144,NM_014874.4(MFN2):c.285G>C (p.Arg95Ser),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,"charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b;",C0007959,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
145,NM_014874.4(MFN2):c.310C>T (p.Arg104Trp),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
146,NM_014874.4(MFN2):c.313A>G (p.Thr105Ala),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
147,NM_014874.4(MFN2):c.314C>T (p.Thr105Met),MFN2,cerebellar ataxia,C0007758,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
147,NM_014874.4(MFN2):c.314C>T (p.Thr105Met),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
147,NM_014874.4(MFN2):c.314C>T (p.Thr105Met),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
148,NM_014874.4(MFN2):c.318C>G (p.Ser106Arg),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: feb 4, 2022)","criteria provided, single submitter"
149,NM_014874.4(MFN2):c.326A>G (p.Lys109Arg),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 27, 2021)","criteria provided, single submitter"
150,NM_014874.4(MFN2):c.382C>T (p.His128Tyr),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
151,NM_014874.4(MFN2):c.395G>A (p.Cys132Tyr),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: dec 10, 2021)","criteria provided, single submitter"
152,NM_014874.4(MFN2):c.401T>A (p.Leu134Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, single submitter"
153,NM_014874.4(MFN2):c.436C>T (p.Leu146Phe),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
153,NM_014874.4(MFN2):c.436C>T (p.Leu146Phe),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
154,NM_014874.4(MFN2):c.479T>G (p.Val160Gly),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: aug 18, 2015)","criteria provided, single submitter"
155,NM_014874.4(MFN2):c.493C>T (p.His165Tyr),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
155,NM_014874.4(MFN2):c.493C>T (p.His165Tyr),MFN2,not specified,Cumapped182,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
156,NM_014874.4(MFN2):c.493C>G (p.His165Asp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
157,NM_014874.4(MFN2):c.494A>C (p.His165Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: mar 29, 2022)","criteria provided, single submitter"
158,NM_014874.4(MFN2):c.494A>G (p.His165Arg),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
158,NM_014874.4(MFN2):c.494A>G (p.His165Arg),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
159,NM_014874.4(MFN2):c.495T>A (p.His165Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
160,NM_014874.4(MFN2):c.495T>G (p.His165Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
161,NM_014874.4(MFN2):c.497C>T (p.Ala166Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: feb 6, 2022)","criteria provided, multiple submitters, no conflicts"
161,NM_014874.4(MFN2):c.497C>T (p.Ala166Val),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: feb 6, 2022)","criteria provided, multiple submitters, no conflicts"
162,NM_014874.4(MFN2):c.526G>A (p.Gly176Ser),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: aug 18, 2015)","criteria provided, single submitter"
163,NM_014874.4(MFN2):c.616A>G (p.Thr206Ala),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
164,NM_014874.4(MFN2):c.629A>G (p.Asp210Gly),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
165,NM_014874.4(MFN2):c.638T>A (p.Ile213Asn),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
166,NM_014874.4(MFN2):c.638T>C (p.Ile213Thr),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
167,NM_014874.4(MFN2):c.647T>C (p.Phe216Ser),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
168,NM_014874.4(MFN2):c.656A>G (p.Asp219Gly),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
169,NM_014874.4(MFN2):c.658G>A (p.Ala220Thr),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 12, 2022)","criteria provided, multiple submitters, no conflicts"
169,NM_014874.4(MFN2):c.658G>A (p.Ala220Thr),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: oct 12, 2022)","criteria provided, multiple submitters, no conflicts"
170,NM_014874.4(MFN2):c.664G>C (p.Val222Leu),MFN2,tip-toe gait,C1843570,"likely pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
171,NM_014874.4(MFN2):c.688G>A (p.Glu230Lys),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
172,NM_014874.4(MFN2):c.692C>T (p.Ser231Phe),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
173,NM_014874.4(MFN2):c.694A>C (p.Thr232Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
174,NM_014874.4(MFN2):c.695C>G (p.Thr232Ser),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: oct 26, 2021)","criteria provided, single submitter"
175,NM_014874.4(MFN2):c.701T>A (p.Met234Lys),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: oct 17, 2018)","criteria provided, single submitter"
176,NM_014874.4(MFN2):c.705G>C (p.Gln235His),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
177,NM_014874.4(MFN2):c.718T>C (p.Phe240Leu),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
178,NM_014874.4(MFN2):c.718T>G (p.Phe240Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
179,NM_014874.4(MFN2):c.720C>G (p.Phe240Leu),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"likely pathogenic(last reviewed: dec 6, 2016)","criteria provided, single submitter"
180,NM_014874.4(MFN2):c.720C>A (p.Phe240Leu),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
181,NM_014874.4(MFN2):c.730G>A (p.Val244Met),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
181,NM_014874.4(MFN2):c.730G>A (p.Val244Met),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
182,NM_014874.4(MFN2):c.730G>T (p.Val244Leu),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: sep 17, 2015)","criteria provided, single submitter"
183,NM_014874.4(MFN2):c.731T>G (p.Val244Gly),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
184,NM_014874.4(MFN2):c.742C>G (p.Leu248Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
185,NM_014874.4(MFN2):c.746C>G (p.Ser249Cys),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: dec 28, 2021)","criteria provided, multiple submitters, no conflicts"
185,NM_014874.4(MFN2):c.746C>G (p.Ser249Cys),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: dec 28, 2021)","criteria provided, multiple submitters, no conflicts"
186,NM_014874.4(MFN2):c.746C>T (p.Ser249Phe),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
186,NM_014874.4(MFN2):c.746C>T (p.Ser249Phe),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
187,NM_014874.4(MFN2):c.748C>T (p.Arg250Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
188,NM_014874.4(MFN2):c.751C>G (p.Pro251Ala),MFN2,charcot-marie-tooth disease,C0007959,pathogenic,"criteria provided, single submitter"
189,NM_014874.4(MFN2):c.752C>T (p.Pro251Leu),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
190,NM_014874.4(MFN2):c.752C>G (p.Pro251Arg),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
191,NM_014874.4(MFN2):c.775C>T (p.Arg259Cys),MFN2,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
191,NM_014874.4(MFN2):c.775C>T (p.Arg259Cys),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
192,NM_014874.4(MFN2):c.776G>T (p.Arg259Leu),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
193,NM_014874.4(MFN2):c.818T>G (p.Val273Gly),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
194,NM_014874.4(MFN2):c.820C>T (p.Arg274Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 16, 2022)","criteria provided, single submitter"
195,NM_014874.4(MFN2):c.821G>A (p.Arg274Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, single submitter"
196,NM_014874.4(MFN2):c.828G>T (p.Gln276His),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
197,NM_014874.4(MFN2):c.838C>T (p.Arg280Cys),MFN2,"multiple system atrophy, cerebellar type",C4295283,"likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
198,NM_014874.4(MFN2):c.839G>C (p.Arg280Pro),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
199,NM_014874.4(MFN2):c.839G>A (p.Arg280His),MFN2,"neuropathy, hereditary motor and sensory, type 6a",C0393807,"pathogenic(last reviewed: mar 27, 2023)","criteria provided, multiple submitters, no conflicts"
199,NM_014874.4(MFN2):c.839G>A (p.Arg280His),MFN2,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: mar 27, 2023)","criteria provided, multiple submitters, no conflicts"
199,NM_014874.4(MFN2):c.839G>A (p.Arg280His),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: mar 27, 2023)","criteria provided, multiple submitters, no conflicts"
199,NM_014874.4(MFN2):c.839G>A (p.Arg280His),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: mar 27, 2023)","criteria provided, multiple submitters, no conflicts"
199,NM_014874.4(MFN2):c.839G>A (p.Arg280His),MFN2,peripheral neuropathy,C4721453,"pathogenic(last reviewed: mar 27, 2023)","criteria provided, multiple submitters, no conflicts"
200,NM_014874.4(MFN2):c.1069A>G (p.Lys357Glu),MFN2,severe early-onset axonal neuropathy due to mfn2 deficiency,C4707897,pathogenic,"criteria provided, single submitter"
201,NM_014874.4(MFN2):c.1070A>C (p.Lys357Thr),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, single submitter"
202,NM_014874.4(MFN2):c.1071G>C (p.Lys357Asn),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
203,NM_014874.4(MFN2):c.1081C>T (p.His361Tyr),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
204,NM_014874.4(MFN2):c.1082A>C (p.His361Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: nov 12, 2021)","criteria provided, single submitter"
205,NM_014874.4(MFN2):c.1083C>G (p.His361Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
206,NM_014874.4(MFN2):c.1085C>T (p.Thr362Met),MFN2,"charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b;",C0007959,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
206,NM_014874.4(MFN2):c.1085C>T (p.Thr362Met),MFN2,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
206,NM_014874.4(MFN2):c.1085C>T (p.Thr362Met),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
206,NM_014874.4(MFN2):c.1085C>T (p.Thr362Met),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
206,NM_014874.4(MFN2):c.1085C>T (p.Thr362Met),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
207,NM_014874.4(MFN2):c.1090C>T (p.Arg364Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
207,NM_014874.4(MFN2):c.1090C>T (p.Arg364Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
207,NM_014874.4(MFN2):c.1090C>T (p.Arg364Trp),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
208,NM_014874.4(MFN2):c.1091G>T (p.Arg364Leu),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
208,NM_014874.4(MFN2):c.1091G>T (p.Arg364Leu),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
209,NM_014874.4(MFN2):c.1091G>C (p.Arg364Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
209,NM_014874.4(MFN2):c.1091G>C (p.Arg364Pro),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
210,NM_014874.4(MFN2):c.1091G>A (p.Arg364Gln),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: apr 24, 2022)","criteria provided, multiple submitters, no conflicts"
211,NM_014874.4(MFN2):c.1100A>C (p.Gln367Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
212,NM_014874.4(MFN2):c.1126A>G (p.Met376Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jul 4, 2022)","criteria provided, multiple submitters, no conflicts"
212,NM_014874.4(MFN2):c.1126A>G (p.Met376Val),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: jul 4, 2022)","criteria provided, multiple submitters, no conflicts"
213,NM_014874.4(MFN2):c.1127T>G (p.Met376Arg),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
214,NM_014874.4(MFN2):c.1144G>C (p.Ala382Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
215,NM_014874.4(MFN2):c.1145C>T (p.Ala382Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 22, 2022)","criteria provided, single submitter"
216,NM_014874.4(MFN2):c.1148C>T (p.Ala383Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: feb 22, 2022)","criteria provided, multiple submitters, no conflicts"
217,NM_014874.4(MFN2):c.1426C>G (p.Arg476Gly),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: dec 18, 2017)","criteria provided, single submitter"
218,NM_014874.4(MFN2):c.1946G>C (p.Arg649Pro),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"likely pathogenic(last reviewed: aug 18, 2015)","criteria provided, single submitter"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,"neuropathy, hereditary motor and sensory, type 6a",C0393807,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,"charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b;",C0007959,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,"charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b;",C0007959,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,"neuropathy, hereditary motor and sensory, type 6a",C0393807,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,"charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b;",C0007959,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
219,NM_014874.4(MFN2):c.2119C>T (p.Arg707Trp),MFN2,peripheral axonal neuropathy,C1263857,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
220,NM_014874.4(MFN2):c.2120G>C (p.Arg707Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
221,NM_014874.4(MFN2):c.2129T>C (p.Leu710Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
221,NM_014874.4(MFN2):c.2129T>C (p.Leu710Pro),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
222,NM_014874.4(MFN2):c.2171T>C (p.Leu724Pro),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
223,NM_014874.4(MFN2):c.2212G>A (p.Ala738Thr),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
224,NM_014874.4(MFN2):c.2213C>T (p.Ala738Val),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic(last reviewed: aug 11, 2021)","criteria provided, multiple submitters, no conflicts"
224,NM_014874.4(MFN2):c.2213C>T (p.Ala738Val),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 11, 2021)","criteria provided, multiple submitters, no conflicts"
225,NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser),MFN2,"charcot-marie-tooth disease, axonal, autosomal recessive, type 2a2b;",C0007959,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
225,NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser),MFN2,hereditary motor and sensory neuropathy with optic atrophy,C0393807,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
225,NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
225,NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
225,NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser),MFN2,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
225,NM_014874.4(MFN2):c.2219G>C (p.Trp740Ser),MFN2,charcot-marie-tooth disease type 2a2,C4721887,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
226,NM_014874.4(MFN2):c.2220G>T (p.Trp740Cys),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: may 26, 2016)","criteria provided, single submitter"
227,NM_014874.4(MFN2):c.2222T>G (p.Leu741Trp),MFN2,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
228,NM_014874.4(MFN2):c.2232G>C (p.Glu744Asp),MFN2,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, single submitter"
229,NM_007272.3(CTRC):c.2T>C (p.Met1Thr),CTRC,hereditary pancreatitis,C0238339,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
230,NM_007272.3(CTRC):c.464G>A (p.Cys155Tyr),CTRC,hereditary pancreatitis,C0238339,"likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, single submitter"
231,NM_033440.3(CELA2A):c.209C>T (p.Thr70Met),CELA2A,abdominal obesity-metabolic syndrome 4,C5231430,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
232,NM_000085.5(CLCNKB):c.274C>T (p.Arg92Trp),CLCNKB|LOC106501713,bartter disease type 3,C0341700,"pathogenic(last reviewed: jun 30, 2021)","criteria provided, single submitter"
232,NM_000085.5(CLCNKB):c.274C>T (p.Arg92Trp),CLCNKB|LOC106501713,bartter disease type 4b,C0341700,"pathogenic(last reviewed: jun 30, 2021)","criteria provided, single submitter"
233,NM_000085.5(CLCNKB):c.508G>A (p.Val170Met),CLCNKB|LOC106501713,bartter disease type 3,C0341700,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
233,NM_000085.5(CLCNKB):c.508G>A (p.Val170Met),CLCNKB|LOC106501713,bartter disease type 4b,C0341700,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
234,NM_000085.5(CLCNKB):c.610G>A (p.Ala204Thr),LOC106501713|CLCNKB,bartter disease type 4b,C0341700,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
234,NM_000085.5(CLCNKB):c.610G>A (p.Ala204Thr),LOC106501713|CLCNKB,bartter disease type 3,C0341700,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
234,NM_000085.5(CLCNKB):c.610G>A (p.Ala204Thr),LOC106501713|CLCNKB,bartter disease type 3,C0341700,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
235,NM_000085.5(CLCNKB):c.1270G>A (p.Gly424Arg),LOC106501713|CLCNKB,bartter disease type 3,C0341700,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
236,NM_000085.5(CLCNKB):c.1309G>A (p.Gly437Arg),CLCNKB|LOC106501713,bartter disease type 3,C0341700,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
237,NM_000085.5(CLCNKB):c.1325A>G (p.Glu442Gly),CLCNKB|LOC106501713,bartter disease type 3,C0341700,"pathogenic/likely pathogenic(last reviewed: aug 11, 2021)","criteria provided, multiple submitters, no conflicts"
238,NM_000085.5(CLCNKB):c.1400C>T (p.Ala467Val),CLCNKB|LOC106501713,bartter disease type 3,C0341700,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
239,NM_004431.5(EPHA2):c.2353G>A (p.Ala785Thr),EPHA2,cataract 6 multiple types,C1861825,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
240,NM_003000.3(SDHB):c.758G>A (p.Cys253Tyr),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
240,NM_003000.3(SDHB):c.758G>A (p.Cys253Tyr),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
240,NM_003000.3(SDHB):c.758G>A (p.Cys253Tyr),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
240,NM_003000.3(SDHB):c.758G>A (p.Cys253Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
241,NM_003000.3(SDHB):c.744C>G (p.Asn248Lys),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
241,NM_003000.3(SDHB):c.744C>G (p.Asn248Lys),SDHB,paraganglioma,C0030421,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
241,NM_003000.3(SDHB):c.744C>G (p.Asn248Lys),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
241,NM_003000.3(SDHB):c.744C>G (p.Asn248Lys),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
241,NM_003000.3(SDHB):c.744C>G (p.Asn248Lys),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
242,NM_003000.3(SDHB):c.729C>G (p.Cys243Trp),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
242,NM_003000.3(SDHB):c.729C>G (p.Cys243Trp),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
242,NM_003000.3(SDHB):c.729C>G (p.Cys243Trp),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
243,NM_003000.3(SDHB):c.728G>T (p.Cys243Phe),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 29, 2019)","criteria provided, single submitter"
244,NM_003000.3(SDHB):c.727T>C (p.Cys243Arg),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jan 18, 2022)","criteria provided, single submitter"
245,NM_003000.3(SDHB):c.725G>A (p.Arg242His),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jan 27, 2023)","criteria provided, multiple submitters, no conflicts"
245,NM_003000.3(SDHB):c.725G>A (p.Arg242His),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jan 27, 2023)","criteria provided, multiple submitters, no conflicts"
245,NM_003000.3(SDHB):c.725G>A (p.Arg242His),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jan 27, 2023)","criteria provided, multiple submitters, no conflicts"
245,NM_003000.3(SDHB):c.725G>A (p.Arg242His),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 27, 2023)","criteria provided, multiple submitters, no conflicts"
245,NM_003000.3(SDHB):c.725G>A (p.Arg242His),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: jan 27, 2023)","criteria provided, multiple submitters, no conflicts"
245,NM_003000.3(SDHB):c.725G>A (p.Arg242His),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jan 27, 2023)","criteria provided, multiple submitters, no conflicts"
246,NM_003000.3(SDHB):c.724C>A (p.Arg242Ser),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
246,NM_003000.3(SDHB):c.724C>A (p.Arg242Ser),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
246,NM_003000.3(SDHB):c.724C>A (p.Arg242Ser),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
246,NM_003000.3(SDHB):c.724C>A (p.Arg242Ser),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
247,NM_003000.3(SDHB):c.724C>T (p.Arg242Cys),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: mar 15, 2022)","criteria provided, multiple submitters, no conflicts"
247,NM_003000.3(SDHB):c.724C>T (p.Arg242Cys),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: mar 15, 2022)","criteria provided, multiple submitters, no conflicts"
247,NM_003000.3(SDHB):c.724C>T (p.Arg242Cys),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: mar 15, 2022)","criteria provided, multiple submitters, no conflicts"
247,NM_003000.3(SDHB):c.724C>T (p.Arg242Cys),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: mar 15, 2022)","criteria provided, multiple submitters, no conflicts"
248,NM_003000.3(SDHB):c.689G>T (p.Arg230Leu),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
248,NM_003000.3(SDHB):c.689G>T (p.Arg230Leu),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
248,NM_003000.3(SDHB):c.689G>T (p.Arg230Leu),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
248,NM_003000.3(SDHB):c.689G>T (p.Arg230Leu),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,carney-stratakis syndrome,C1847319,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
249,NM_003000.3(SDHB):c.689G>A (p.Arg230His),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
250,NM_003000.3(SDHB):c.688C>G (p.Arg230Gly),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 24, 2015)","criteria provided, single submitter"
251,NM_003000.3(SDHB):c.688C>T (p.Arg230Cys),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
251,NM_003000.3(SDHB):c.688C>T (p.Arg230Cys),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
251,NM_003000.3(SDHB):c.688C>T (p.Arg230Cys),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
251,NM_003000.3(SDHB):c.688C>T (p.Arg230Cys),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
251,NM_003000.3(SDHB):c.688C>T (p.Arg230Cys),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
252,NM_003000.3(SDHB):c.653G>C (p.Trp218Ser),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: feb 9, 2017)","criteria provided, single submitter"
253,NM_003000.3(SDHB):c.650G>T (p.Arg217Leu),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: mar 29, 2022)","criteria provided, single submitter"
253,NM_003000.3(SDHB):c.650G>T (p.Arg217Leu),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: mar 29, 2022)","criteria provided, single submitter"
253,NM_003000.3(SDHB):c.650G>T (p.Arg217Leu),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: mar 29, 2022)","criteria provided, single submitter"
254,NM_003000.3(SDHB):c.650G>A (p.Arg217His),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
254,NM_003000.3(SDHB):c.650G>A (p.Arg217His),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
254,NM_003000.3(SDHB):c.650G>A (p.Arg217His),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
254,NM_003000.3(SDHB):c.650G>A (p.Arg217His),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
254,NM_003000.3(SDHB):c.650G>A (p.Arg217His),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
255,NM_003000.3(SDHB):c.649C>G (p.Arg217Gly),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
255,NM_003000.3(SDHB):c.649C>G (p.Arg217Gly),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
255,NM_003000.3(SDHB):c.649C>G (p.Arg217Gly),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
256,NM_003000.3(SDHB):c.649C>T (p.Arg217Cys),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
256,NM_003000.3(SDHB):c.649C>T (p.Arg217Cys),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
256,NM_003000.3(SDHB):c.649C>T (p.Arg217Cys),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
256,NM_003000.3(SDHB):c.649C>T (p.Arg217Cys),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
256,NM_003000.3(SDHB):c.649C>T (p.Arg217Cys),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
256,NM_003000.3(SDHB):c.649C>T (p.Arg217Cys),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
257,NM_003000.3(SDHB):c.642G>T (p.Gln214His),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 4, 2022)","criteria provided, multiple submitters, no conflicts"
258,NM_003000.3(SDHB):c.623G>A (p.Gly208Glu),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
258,NM_003000.3(SDHB):c.623G>A (p.Gly208Glu),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
258,NM_003000.3(SDHB):c.623G>A (p.Gly208Glu),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
258,NM_003000.3(SDHB):c.623G>A (p.Gly208Glu),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
259,NM_003000.3(SDHB):c.622G>A (p.Gly208Arg),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 3, 2022)","criteria provided, single submitter"
260,NM_003000.3(SDHB):c.600G>T (p.Trp200Cys),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
260,NM_003000.3(SDHB):c.600G>T (p.Trp200Cys),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
260,NM_003000.3(SDHB):c.600G>T (p.Trp200Cys),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
260,NM_003000.3(SDHB):c.600G>T (p.Trp200Cys),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
260,NM_003000.3(SDHB):c.600G>T (p.Trp200Cys),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
260,NM_003000.3(SDHB):c.600G>T (p.Trp200Cys),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
261,NM_003000.3(SDHB):c.598T>C (p.Trp200Arg),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
261,NM_003000.3(SDHB):c.598T>C (p.Trp200Arg),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
261,NM_003000.3(SDHB):c.598T>C (p.Trp200Arg),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
261,NM_003000.3(SDHB):c.598T>C (p.Trp200Arg),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
262,NM_003000.3(SDHB):c.590C>G (p.Pro197Arg),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
262,NM_003000.3(SDHB):c.590C>G (p.Pro197Arg),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
262,NM_003000.3(SDHB):c.590C>G (p.Pro197Arg),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
262,NM_003000.3(SDHB):c.590C>G (p.Pro197Arg),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
263,NM_003000.3(SDHB):c.589C>T (p.Pro197Ser),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
263,NM_003000.3(SDHB):c.589C>T (p.Pro197Ser),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
263,NM_003000.3(SDHB):c.589C>T (p.Pro197Ser),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
264,NM_003000.3(SDHB):c.587G>A (p.Cys196Tyr),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
264,NM_003000.3(SDHB):c.587G>A (p.Cys196Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
264,NM_003000.3(SDHB):c.587G>A (p.Cys196Tyr),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
264,NM_003000.3(SDHB):c.587G>A (p.Cys196Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
264,NM_003000.3(SDHB):c.587G>A (p.Cys196Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
265,NM_003000.3(SDHB):c.586T>C (p.Cys196Arg),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
265,NM_003000.3(SDHB):c.586T>C (p.Cys196Arg),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
265,NM_003000.3(SDHB):c.586T>C (p.Cys196Arg),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
266,NM_003000.3(SDHB):c.575G>A (p.Cys192Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
266,NM_003000.3(SDHB):c.575G>A (p.Cys192Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
266,NM_003000.3(SDHB):c.575G>A (p.Cys192Tyr),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
266,NM_003000.3(SDHB):c.575G>A (p.Cys192Tyr),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
267,NM_003000.3(SDHB):c.574T>C (p.Cys192Arg),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
267,NM_003000.3(SDHB):c.574T>C (p.Cys192Arg),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
267,NM_003000.3(SDHB):c.574T>C (p.Cys192Arg),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
267,NM_003000.3(SDHB):c.574T>C (p.Cys192Arg),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
268,NM_003000.3(SDHB):c.572G>A (p.Cys191Tyr),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
268,NM_003000.3(SDHB):c.572G>A (p.Cys191Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
268,NM_003000.3(SDHB):c.572G>A (p.Cys191Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
268,NM_003000.3(SDHB):c.572G>A (p.Cys191Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
268,NM_003000.3(SDHB):c.572G>A (p.Cys191Tyr),SDHB,renal neoplasm,C0022665,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
269,NM_003000.3(SDHB):c.567T>G (p.Cys189Trp),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
269,NM_003000.3(SDHB):c.567T>G (p.Cys189Trp),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
269,NM_003000.3(SDHB):c.567T>G (p.Cys189Trp),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
270,NM_003000.3(SDHB):c.566G>A (p.Cys189Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, single submitter"
270,NM_003000.3(SDHB):c.566G>A (p.Cys189Tyr),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, single submitter"
270,NM_003000.3(SDHB):c.566G>A (p.Cys189Tyr),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, single submitter"
271,NM_003000.3(SDHB):c.566G>T (p.Cys189Phe),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
271,NM_003000.3(SDHB):c.566G>T (p.Cys189Phe),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
271,NM_003000.3(SDHB):c.566G>T (p.Cys189Phe),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
271,NM_003000.3(SDHB):c.566G>T (p.Cys189Phe),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
272,NM_003000.3(SDHB):c.557G>A (p.Cys186Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
272,NM_003000.3(SDHB):c.557G>A (p.Cys186Tyr),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
272,NM_003000.3(SDHB):c.557G>A (p.Cys186Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
273,NM_003000.3(SDHB):c.539T>C (p.Leu180Pro),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
274,NM_003000.3(SDHB):c.418G>T (p.Val140Phe),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
274,NM_003000.3(SDHB):c.418G>T (p.Val140Phe),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
274,NM_003000.3(SDHB):c.418G>T (p.Val140Phe),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
274,NM_003000.3(SDHB):c.418G>T (p.Val140Phe),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
274,NM_003000.3(SDHB):c.418G>T (p.Val140Phe),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
274,NM_003000.3(SDHB):c.418G>T (p.Val140Phe),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
275,NM_003000.3(SDHB):c.413A>G (p.Asp138Gly),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
275,NM_003000.3(SDHB):c.413A>G (p.Asp138Gly),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
275,NM_003000.3(SDHB):c.413A>G (p.Asp138Gly),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
276,NM_003000.3(SDHB):c.412G>T (p.Asp138Tyr),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
276,NM_003000.3(SDHB):c.412G>T (p.Asp138Tyr),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
276,NM_003000.3(SDHB):c.412G>T (p.Asp138Tyr),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
276,NM_003000.3(SDHB):c.412G>T (p.Asp138Tyr),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
276,NM_003000.3(SDHB):c.412G>T (p.Asp138Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
277,NM_003000.3(SDHB):c.395A>C (p.His132Pro),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 24, 2021)","criteria provided, multiple submitters, no conflicts"
277,NM_003000.3(SDHB):c.395A>C (p.His132Pro),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 24, 2021)","criteria provided, multiple submitters, no conflicts"
277,NM_003000.3(SDHB):c.395A>C (p.His132Pro),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 24, 2021)","criteria provided, multiple submitters, no conflicts"
277,NM_003000.3(SDHB):c.395A>C (p.His132Pro),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 24, 2021)","criteria provided, multiple submitters, no conflicts"
278,NM_003000.3(SDHB):c.386C>G (p.Pro129Arg),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: apr 10, 2019)","criteria provided, single submitter"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
279,NM_003000.3(SDHB):c.380T>G (p.Ile127Ser),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
280,NM_003000.3(SDHB):c.379A>G (p.Ile127Val),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
280,NM_003000.3(SDHB):c.379A>G (p.Ile127Val),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
280,NM_003000.3(SDHB):c.379A>G (p.Ile127Val),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
281,NM_003000.3(SDHB):c.338G>A (p.Cys113Tyr),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
281,NM_003000.3(SDHB):c.338G>A (p.Cys113Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
281,NM_003000.3(SDHB):c.338G>A (p.Cys113Tyr),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
282,NM_003000.3(SDHB):c.338G>C (p.Cys113Ser),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: jun 26, 2022)","criteria provided, single submitter"
282,NM_003000.3(SDHB):c.338G>C (p.Cys113Ser),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: jun 26, 2022)","criteria provided, single submitter"
282,NM_003000.3(SDHB):c.338G>C (p.Cys113Ser),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: jun 26, 2022)","criteria provided, single submitter"
283,NM_003000.3(SDHB):c.296G>A (p.Gly99Asp),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
283,NM_003000.3(SDHB):c.296G>A (p.Gly99Asp),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
283,NM_003000.3(SDHB):c.296G>A (p.Gly99Asp),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
283,NM_003000.3(SDHB):c.296G>A (p.Gly99Asp),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
283,NM_003000.3(SDHB):c.296G>A (p.Gly99Asp),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
284,NM_003000.3(SDHB):c.293G>A (p.Cys98Tyr),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: mar 16, 2023)","criteria provided, multiple submitters, no conflicts"
284,NM_003000.3(SDHB):c.293G>A (p.Cys98Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: mar 16, 2023)","criteria provided, multiple submitters, no conflicts"
284,NM_003000.3(SDHB):c.293G>A (p.Cys98Tyr),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: mar 16, 2023)","criteria provided, multiple submitters, no conflicts"
285,NM_003000.3(SDHB):c.289A>T (p.Ile97Phe),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
285,NM_003000.3(SDHB):c.289A>T (p.Ile97Phe),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
285,NM_003000.3(SDHB):c.289A>T (p.Ile97Phe),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
285,NM_003000.3(SDHB):c.289A>T (p.Ile97Phe),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
286,NM_003000.3(SDHB):c.287G>A (p.Gly96Asp),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
286,NM_003000.3(SDHB):c.287G>A (p.Gly96Asp),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
286,NM_003000.3(SDHB):c.287G>A (p.Gly96Asp),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
286,NM_003000.3(SDHB):c.287G>A (p.Gly96Asp),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
286,NM_003000.3(SDHB):c.287G>A (p.Gly96Asp),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
287,NM_003000.3(SDHB):c.286G>T (p.Gly96Cys),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
287,NM_003000.3(SDHB):c.286G>T (p.Gly96Cys),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
287,NM_003000.3(SDHB):c.286G>T (p.Gly96Cys),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
288,NM_003000.3(SDHB):c.286G>A (p.Gly96Ser),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
288,NM_003000.3(SDHB):c.286G>A (p.Gly96Ser),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
288,NM_003000.3(SDHB):c.286G>A (p.Gly96Ser),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
288,NM_003000.3(SDHB):c.286G>A (p.Gly96Ser),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
289,NM_003000.3(SDHB):c.278G>A (p.Cys93Tyr),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: apr 6, 2022)","criteria provided, single submitter"
290,NM_003000.3(SDHB):c.278G>T (p.Cys93Phe),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 13, 2013)","criteria provided, single submitter"
291,NM_003000.3(SDHB):c.269G>T (p.Arg90Leu),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
291,NM_003000.3(SDHB):c.269G>T (p.Arg90Leu),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
291,NM_003000.3(SDHB):c.269G>T (p.Arg90Leu),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
292,NM_003000.3(SDHB):c.260T>C (p.Leu87Ser),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, multiple submitters, no conflicts"
292,NM_003000.3(SDHB):c.260T>C (p.Leu87Ser),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, multiple submitters, no conflicts"
292,NM_003000.3(SDHB):c.260T>C (p.Leu87Ser),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, multiple submitters, no conflicts"
292,NM_003000.3(SDHB):c.260T>C (p.Leu87Ser),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, multiple submitters, no conflicts"
292,NM_003000.3(SDHB):c.260T>C (p.Leu87Ser),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, multiple submitters, no conflicts"
293,NM_003000.3(SDHB):c.259T>G (p.Leu87Val),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, single submitter"
293,NM_003000.3(SDHB):c.259T>G (p.Leu87Val),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, single submitter"
293,NM_003000.3(SDHB):c.259T>G (p.Leu87Val),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, single submitter"
294,NM_003000.3(SDHB):c.221A>G (p.Asp74Gly),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
294,NM_003000.3(SDHB):c.221A>G (p.Asp74Gly),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
294,NM_003000.3(SDHB):c.221A>G (p.Asp74Gly),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
295,NM_003000.3(SDHB):c.221A>T (p.Asp74Val),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 10, 2019)","criteria provided, single submitter"
296,NM_003000.3(SDHB):c.221A>C (p.Asp74Ala),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
296,NM_003000.3(SDHB):c.221A>C (p.Asp74Ala),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
296,NM_003000.3(SDHB):c.221A>C (p.Asp74Ala),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
296,NM_003000.3(SDHB):c.221A>C (p.Asp74Ala),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
297,NM_003000.3(SDHB):c.206G>T (p.Gly69Val),SDHB,paraganglioma,C0030421,"pathogenic(last reviewed: mar 11, 2022)","criteria provided, single submitter"
298,NM_003000.3(SDHB):c.203G>A (p.Cys68Tyr),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
298,NM_003000.3(SDHB):c.203G>A (p.Cys68Tyr),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
298,NM_003000.3(SDHB):c.203G>A (p.Cys68Tyr),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
298,NM_003000.3(SDHB):c.203G>A (p.Cys68Tyr),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
299,NM_003000.3(SDHB):c.194T>C (p.Leu65Pro),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: jun 7, 2022)","criteria provided, single submitter"
299,NM_003000.3(SDHB):c.194T>C (p.Leu65Pro),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: jun 7, 2022)","criteria provided, single submitter"
299,NM_003000.3(SDHB):c.194T>C (p.Leu65Pro),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: jun 7, 2022)","criteria provided, single submitter"
300,NM_003000.3(SDHB):c.194T>A (p.Leu65His),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: apr 20, 2021)","criteria provided, single submitter"
301,NM_003000.3(SDHB):c.143A>T (p.Asp48Val),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
301,NM_003000.3(SDHB):c.143A>T (p.Asp48Val),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
301,NM_003000.3(SDHB):c.143A>T (p.Asp48Val),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
301,NM_003000.3(SDHB):c.143A>T (p.Asp48Val),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
302,NM_003000.3(SDHB):c.137G>T (p.Arg46Leu),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
302,NM_003000.3(SDHB):c.137G>T (p.Arg46Leu),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
302,NM_003000.3(SDHB):c.137G>T (p.Arg46Leu),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
302,NM_003000.3(SDHB):c.137G>T (p.Arg46Leu),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,carney-stratakis syndrome,C1847319,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
303,NM_003000.3(SDHB):c.137G>A (p.Arg46Gln),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
304,NM_003000.3(SDHB):c.136C>G (p.Arg46Gly),SDHB,paragangliomas 4,C1861848,"pathogenic(last reviewed: apr 27, 2022)","criteria provided, multiple submitters, no conflicts"
304,NM_003000.3(SDHB):c.136C>G (p.Arg46Gly),SDHB,pheochromocytoma,C4551683,"pathogenic(last reviewed: apr 27, 2022)","criteria provided, multiple submitters, no conflicts"
304,NM_003000.3(SDHB):c.136C>G (p.Arg46Gly),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: apr 27, 2022)","criteria provided, multiple submitters, no conflicts"
304,NM_003000.3(SDHB):c.136C>G (p.Arg46Gly),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: apr 27, 2022)","criteria provided, multiple submitters, no conflicts"
305,NM_003000.3(SDHB):c.127G>C (p.Ala43Pro),SDHB,pheochromocytoma,C4551683,"likely pathogenic(last reviewed: mar 27, 2022)","criteria provided, multiple submitters, no conflicts"
305,NM_003000.3(SDHB):c.127G>C (p.Ala43Pro),SDHB,paragangliomas 4,C1861848,"likely pathogenic(last reviewed: mar 27, 2022)","criteria provided, multiple submitters, no conflicts"
305,NM_003000.3(SDHB):c.127G>C (p.Ala43Pro),SDHB,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: mar 27, 2022)","criteria provided, multiple submitters, no conflicts"
305,NM_003000.3(SDHB):c.127G>C (p.Ala43Pro),SDHB,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 27, 2022)","criteria provided, multiple submitters, no conflicts"
306,NM_003000.3(SDHB):c.3G>A (p.Met1Ile),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
306,NM_003000.3(SDHB):c.3G>A (p.Met1Ile),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
306,NM_003000.3(SDHB):c.3G>A (p.Met1Ile),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
306,NM_003000.3(SDHB):c.3G>A (p.Met1Ile),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
306,NM_003000.3(SDHB):c.3G>A (p.Met1Ile),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
306,NM_003000.3(SDHB):c.3G>A (p.Met1Ile),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
307,NM_003000.3(SDHB):c.1A>T (p.Met1Leu),SDHB,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
307,NM_003000.3(SDHB):c.1A>T (p.Met1Leu),SDHB,paragangliomas 4,C1861848,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
307,NM_003000.3(SDHB):c.1A>T (p.Met1Leu),SDHB,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
307,NM_003000.3(SDHB):c.1A>T (p.Met1Leu),SDHB,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
308,NM_016233.2(PADI3):c.335T>A (p.Leu112His),PADI3,uncombable hair syndrome 1,C4551573,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
309,NM_016233.2(PADI3):c.628C>T (p.Arg210Trp),PADI3,central centrifugal cicatricial alopecia,C1274708,"pathogenic(last reviewed: jul 1, 2018)","criteria provided, single submitter"
310,NM_016233.2(PADI3):c.1669C>T (p.Arg557Trp),PADI3,central centrifugal cicatricial alopecia,C1274708,"pathogenic(last reviewed: jul 1, 2018)","criteria provided, single submitter"
311,NM_016233.2(PADI3):c.1955G>A (p.Arg652Lys),PADI3,central centrifugal cicatricial alopecia,C1274708,"pathogenic(last reviewed: jul 1, 2018)","criteria provided, single submitter"
312,NM_207421.4(PADI6):c.633T>A (p.His211Gln),LOC126805634|PADI6,preimplantation embryonic lethality 2,C4310659,"pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
313,NM_207421.4(PADI6):c.659C>A (p.Ala220Glu),LOC126805634|PADI6,preimplantation embryonic lethality 2,C4310659,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
314,NM_207421.4(PADI6):c.1054C>T (p.Arg352Cys),PADI6,preimplantation embryonic lethality 2,C4310659,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
315,NM_207421.4(PADI6):c.1247T>C (p.Ile416Thr),LOC126805635|PADI6,preimplantation embryonic lethality 2,C4310659,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
316,NM_207421.4(PADI6):c.1298C>T (p.Pro433Leu),LOC126805635|PADI6,preimplantation embryonic lethality 2,C4310659,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
317,NM_207421.4(PADI6):c.1618G>A (p.Gly540Arg),PADI6,preimplantation embryonic lethality 2,C4310659,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
318,NM_207421.4(PADI6):c.1894C>A (p.Pro632Thr),PADI6,preimplantation embryonic lethality 2,C4310659,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
319,NM_015047.3(EMC1):c.1754C>A (p.Pro585Gln),EMC1-AS1|EMC1,"cerebellar atrophy, visual impairment, and psychomotor retardation;",Cumapped43,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
320,NM_015047.3(EMC1):c.1751C>G (p.Pro584Arg),EMC1|EMC1-AS1,"cerebellar atrophy, visual impairment, and psychomotor retardation;",Cumapped43,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
321,NM_015047.3(EMC1):c.2T>G (p.Met1Arg),EMC1,"cerebellar atrophy, visual impairment, and psychomotor retardation;",Cumapped43,"pathogenic/likely pathogenic(last reviewed: oct 3, 2021)","criteria provided, multiple submitters, no conflicts"
322,NM_032409.3(PINK1):c.377A>C (p.Gln126Pro),PINK1,autosomal recessive early-onset parkinson disease 6,C1853833,"likely pathogenic(last reviewed: mar 25, 2022)","criteria provided, single submitter"
323,NM_032409.3(PINK1):c.502G>C (p.Ala168Pro),PINK1,autosomal recessive early-onset parkinson disease 6,C1853833,"pathogenic/likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
324,NM_032409.3(PINK1):c.938C>T (p.Thr313Met),PINK1|PINK1-AS,autosomal recessive early-onset parkinson disease 6,C1853833,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
325,NM_032409.3(PINK1):c.1040T>C (p.Leu347Pro),PINK1-AS|PINK1,autosomal recessive early-onset parkinson disease 6,C1853833,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
326,NM_005216.5(DDOST):c.645G>C (p.Gln215His),DDOST,congenital disorder of glycosylation type ir,C3281084,"likely pathogenic(last reviewed: may 3, 2020)","criteria provided, single submitter"
327,NM_001397.3(ECE1):c.1966G>A (p.Gly656Arg),ECE1,"hirschsprung disease, cardiac defects, and autonomic dysfunction",C3151237,"likely pathogenic(last reviewed: mar 6, 2021)","criteria provided, single submitter"
328,NM_000478.6(ALPL):c.41T>C (p.Leu14Pro),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: dec 16, 2021)","criteria provided, single submitter"
329,NM_000478.6(ALPL):c.106A>C (p.Thr36Pro),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: dec 16, 2021)","criteria provided, single submitter"
330,NM_000478.6(ALPL):c.119C>T (p.Ala40Val),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 17, 2022)","criteria provided, multiple submitters, no conflicts"
330,NM_000478.6(ALPL):c.119C>T (p.Ala40Val),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: nov 17, 2022)","criteria provided, multiple submitters, no conflicts"
331,NM_000478.6(ALPL):c.140A>T (p.Asn47Ile),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: dec 13, 2021)","criteria provided, single submitter"
332,NM_000478.6(ALPL):c.146A>T (p.Asn49Ile),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: nov 15, 2021)","criteria provided, single submitter"
333,NM_000478.6(ALPL):c.194C>A (p.Ser65Tyr),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: dec 16, 2021)","criteria provided, single submitter"
334,NM_000478.6(ALPL):c.203C>T (p.Thr68Met),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
334,NM_000478.6(ALPL):c.203C>T (p.Thr68Met),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
334,NM_000478.6(ALPL):c.203C>T (p.Thr68Met),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
335,NM_000478.6(ALPL):c.211C>T (p.Arg71Cys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: aug 30, 2022)","criteria provided, multiple submitters, no conflicts"
336,NM_000478.6(ALPL):c.214A>G (p.Ile72Val),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: apr 6, 2022)","criteria provided, multiple submitters, no conflicts"
337,NM_000478.6(ALPL):c.215T>C (p.Ile72Thr),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jun 23, 2022)","criteria provided, multiple submitters, no conflicts"
338,NM_000478.6(ALPL):c.299C>T (p.Thr100Met),ALPL,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
339,NM_000478.6(ALPL):c.302A>G (p.Tyr101Cys),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, single submitter"
340,NM_000478.6(ALPL):c.346G>A (p.Ala116Thr),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
340,NM_000478.6(ALPL):c.346G>A (p.Ala116Thr),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
341,NM_000478.6(ALPL):c.361G>A (p.Val121Met),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: dec 13, 2021)","criteria provided, single submitter"
342,NM_000478.6(ALPL):c.386G>A (p.Gly129Glu),ALPL,childhood hypophosphatasia,C0220743,"likely pathogenic(last reviewed: nov 11, 2022)","criteria provided, single submitter"
343,NM_000478.6(ALPL):c.394G>A (p.Ala132Thr),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, multiple submitters, no conflicts"
344,NM_000478.6(ALPL):c.395C>T (p.Ala132Val),ALPL,childhood hypophosphatasia,C0220743,"likely pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
344,NM_000478.6(ALPL):c.395C>T (p.Ala132Val),ALPL,adult hypophosphatasia,C0268413,"likely pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
344,NM_000478.6(ALPL):c.395C>T (p.Ala132Val),ALPL,infantile hypophosphatasia,C0268412,"likely pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
345,NM_000478.6(ALPL):c.407G>A (p.Arg136His),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
346,NM_000478.6(ALPL):c.484G>A (p.Gly162Ser),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: jul 28, 2022)","criteria provided, multiple submitters, no conflicts"
347,NM_000478.6(ALPL):c.500C>T (p.Thr167Met),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
348,NM_000478.6(ALPL):c.500C>A (p.Thr167Lys),ALPL,adult hypophosphatasia,C0268413,"likely pathogenic(last reviewed: aug 14, 2018)","criteria provided, single submitter"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
349,NM_000478.6(ALPL):c.526G>A (p.Ala176Thr),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
350,NM_000478.6(ALPL):c.532T>C (p.Tyr178His),ALPL,micromelia,C0025995,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
351,NM_000478.6(ALPL):c.535G>A (p.Ala179Thr),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, multiple submitters, no conflicts"
351,NM_000478.6(ALPL):c.535G>A (p.Ala179Thr),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, multiple submitters, no conflicts"
351,NM_000478.6(ALPL):c.535G>A (p.Ala179Thr),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, multiple submitters, no conflicts"
351,NM_000478.6(ALPL):c.535G>A (p.Ala179Thr),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, multiple submitters, no conflicts"
351,NM_000478.6(ALPL):c.535G>A (p.Ala179Thr),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, multiple submitters, no conflicts"
352,NM_000478.6(ALPL):c.542C>T (p.Ser181Leu),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 30, 2022)","criteria provided, multiple submitters, no conflicts"
352,NM_000478.6(ALPL):c.542C>T (p.Ser181Leu),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 30, 2022)","criteria provided, multiple submitters, no conflicts"
352,NM_000478.6(ALPL):c.542C>T (p.Ser181Leu),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 30, 2022)","criteria provided, multiple submitters, no conflicts"
352,NM_000478.6(ALPL):c.542C>T (p.Ser181Leu),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: oct 30, 2022)","criteria provided, multiple submitters, no conflicts"
352,NM_000478.6(ALPL):c.542C>T (p.Ser181Leu),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 30, 2022)","criteria provided, multiple submitters, no conflicts"
352,NM_000478.6(ALPL):c.542C>T (p.Ser181Leu),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 30, 2022)","criteria provided, multiple submitters, no conflicts"
353,NM_000478.6(ALPL):c.551G>A (p.Arg184Gln),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
353,NM_000478.6(ALPL):c.551G>A (p.Arg184Gln),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
353,NM_000478.6(ALPL):c.551G>A (p.Arg184Gln),ALPL,infantile hypophosphatasia,C0268412,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,odontohypophosphatasia,C1840322,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
354,NM_000478.6(ALPL):c.571G>A (p.Glu191Lys),ALPL,delayed skeletal maturation,C0541764,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
355,NM_000478.6(ALPL):c.601T>C (p.Cys201Arg),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: dec 16, 2021)","criteria provided, single submitter"
356,NM_000478.6(ALPL):c.620A>C (p.Gln207Pro),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
357,NM_000478.6(ALPL):c.667C>T (p.Arg223Trp),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
357,NM_000478.6(ALPL):c.667C>T (p.Arg223Trp),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
358,NM_000478.6(ALPL):c.668G>A (p.Arg223Gln),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
358,NM_000478.6(ALPL):c.668G>A (p.Arg223Gln),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
358,NM_000478.6(ALPL):c.668G>A (p.Arg223Gln),ALPL,infantile hypophosphatasia,C0268412,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
359,NM_000478.6(ALPL):c.705G>T (p.Glu235Asp),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, single submitter"
360,NM_000478.6(ALPL):c.738G>T (p.Arg246Ser),ALPL,hypophosphatasia,C0020630,"pathogenic(last reviewed: oct 26, 2020)","criteria provided, single submitter"
361,NM_000478.6(ALPL):c.791A>G (p.Lys264Arg),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
361,NM_000478.6(ALPL):c.791A>G (p.Lys264Arg),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
361,NM_000478.6(ALPL):c.791A>G (p.Lys264Arg),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
361,NM_000478.6(ALPL):c.791A>G (p.Lys264Arg),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
361,NM_000478.6(ALPL):c.791A>G (p.Lys264Arg),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
362,NM_000478.6(ALPL):c.814C>T (p.Arg272Cys),ALPL,hypophosphatasia,C0020630,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
363,NM_000478.6(ALPL):c.815G>A (p.Arg272His),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
363,NM_000478.6(ALPL):c.815G>A (p.Arg272His),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
364,NM_000478.6(ALPL):c.871G>A (p.Glu291Lys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
365,NM_000478.6(ALPL):c.881A>C (p.Asp294Ala),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
365,NM_000478.6(ALPL):c.881A>C (p.Asp294Ala),ALPL,infantile hypophosphatasia,C0268412,"pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
365,NM_000478.6(ALPL):c.881A>C (p.Asp294Ala),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
365,NM_000478.6(ALPL):c.881A>C (p.Asp294Ala),ALPL,hypophosphatasia,C0020630,"pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
365,NM_000478.6(ALPL):c.881A>C (p.Asp294Ala),ALPL,osteogenesis imperfecta,C0029434,"pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
366,NM_000478.6(ALPL):c.892G>A (p.Glu298Lys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
366,NM_000478.6(ALPL):c.892G>A (p.Glu298Lys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
366,NM_000478.6(ALPL):c.892G>A (p.Glu298Lys),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
366,NM_000478.6(ALPL):c.892G>A (p.Glu298Lys),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
367,NM_000478.6(ALPL):c.896T>C (p.Leu299Pro),ALPL,hypophosphatasia,C0020630,"pathogenic(last reviewed: jul 29, 2022)","criteria provided, multiple submitters, no conflicts"
368,NM_000478.6(ALPL):c.931G>A (p.Glu311Lys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
369,NM_000478.6(ALPL):c.979T>C (p.Phe327Leu),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
369,NM_000478.6(ALPL):c.979T>C (p.Phe327Leu),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
369,NM_000478.6(ALPL):c.979T>C (p.Phe327Leu),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
369,NM_000478.6(ALPL):c.979T>C (p.Phe327Leu),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
369,NM_000478.6(ALPL):c.979T>C (p.Phe327Leu),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
369,NM_000478.6(ALPL):c.979T>C (p.Phe327Leu),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
370,NM_000478.6(ALPL):c.980T>G (p.Phe327Cys),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: jul 8, 2022)","criteria provided, multiple submitters, no conflicts"
371,NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
371,NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
371,NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
371,NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
371,NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
372,NM_000478.6(ALPL):c.1077C>G (p.Ile359Met),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
372,NM_000478.6(ALPL):c.1077C>G (p.Ile359Met),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
372,NM_000478.6(ALPL):c.1077C>G (p.Ile359Met),ALPL,infantile hypophosphatasia,C0268412,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
373,NM_000478.6(ALPL):c.1120G>A (p.Val374Met),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
373,NM_000478.6(ALPL):c.1120G>A (p.Val374Met),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
373,NM_000478.6(ALPL):c.1120G>A (p.Val374Met),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
374,NM_000478.6(ALPL):c.1130C>T (p.Ala377Val),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
374,NM_000478.6(ALPL):c.1130C>T (p.Ala377Val),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
374,NM_000478.6(ALPL):c.1130C>T (p.Ala377Val),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
375,NM_000478.6(ALPL):c.1133A>T (p.Asp378Val),ALPL,infantile hypophosphatasia,C0268412,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
375,NM_000478.6(ALPL):c.1133A>T (p.Asp378Val),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
375,NM_000478.6(ALPL):c.1133A>T (p.Asp378Val),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
375,NM_000478.6(ALPL):c.1133A>T (p.Asp378Val),ALPL,hypophosphatasia,C0020630,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
375,NM_000478.6(ALPL):c.1133A>T (p.Asp378Val),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
376,NM_000478.6(ALPL):c.1142A>G (p.His381Arg),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
377,NM_000478.6(ALPL):c.1144G>A (p.Val382Ile),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
378,NM_000478.6(ALPL):c.1166C>A (p.Thr389Asn),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
379,NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
379,NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
379,NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
379,NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys),ALPL,osteogenesis imperfecta,C0029434,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
379,NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
379,NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
380,NM_000478.6(ALPL):c.1183A>G (p.Ile395Val),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
380,NM_000478.6(ALPL):c.1183A>G (p.Ile395Val),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
380,NM_000478.6(ALPL):c.1183A>G (p.Ile395Val),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
381,NM_000478.6(ALPL):c.1243T>G (p.Tyr415Asp),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: mar 4, 2022)","criteria provided, single submitter"
382,NM_000478.6(ALPL):c.1250A>G (p.Asn417Ser),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
382,NM_000478.6(ALPL):c.1250A>G (p.Asn417Ser),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
383,NM_000478.6(ALPL):c.1328C>T (p.Ala443Val),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: dec 24, 2022)","criteria provided, multiple submitters, no conflicts"
383,NM_000478.6(ALPL):c.1328C>T (p.Ala443Val),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: dec 24, 2022)","criteria provided, multiple submitters, no conflicts"
384,NM_000478.6(ALPL):c.1348C>T (p.Arg450Cys),ALPL,adult hypophosphatasia,C0268413,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
384,NM_000478.6(ALPL):c.1348C>T (p.Arg450Cys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
384,NM_000478.6(ALPL):c.1348C>T (p.Arg450Cys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
385,NM_000478.6(ALPL):c.1354G>A (p.Glu452Lys),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
386,NM_000478.6(ALPL):c.1363G>A (p.Gly455Ser),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
386,NM_000478.6(ALPL):c.1363G>A (p.Gly455Ser),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
386,NM_000478.6(ALPL):c.1363G>A (p.Gly455Ser),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: jan 30, 2023)","criteria provided, multiple submitters, no conflicts"
387,NM_000478.6(ALPL):c.1403C>T (p.Ala468Val),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
387,NM_000478.6(ALPL):c.1403C>T (p.Ala468Val),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
388,NM_000478.6(ALPL):c.1418G>A (p.Gly473Asp),ALPL,hypophosphatasia,C0020630,"likely pathogenic(last reviewed: mar 4, 2022)","criteria provided, single submitter"
389,NM_000478.6(ALPL):c.1426G>A (p.Glu476Lys),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: may 21, 2022)","criteria provided, multiple submitters, no conflicts"
389,NM_000478.6(ALPL):c.1426G>A (p.Glu476Lys),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: may 21, 2022)","criteria provided, multiple submitters, no conflicts"
389,NM_000478.6(ALPL):c.1426G>A (p.Glu476Lys),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: may 21, 2022)","criteria provided, multiple submitters, no conflicts"
390,NM_000478.6(ALPL):c.1427A>C (p.Glu476Ala),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: mar 3, 2023)","criteria provided, multiple submitters, no conflicts"
390,NM_000478.6(ALPL):c.1427A>C (p.Glu476Ala),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: mar 3, 2023)","criteria provided, multiple submitters, no conflicts"
390,NM_000478.6(ALPL):c.1427A>C (p.Glu476Ala),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: mar 3, 2023)","criteria provided, multiple submitters, no conflicts"
390,NM_000478.6(ALPL):c.1427A>C (p.Glu476Ala),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: mar 3, 2023)","criteria provided, multiple submitters, no conflicts"
391,NM_000478.6(ALPL):c.1471G>A (p.Gly491Arg),ALPL,hypophosphatasia,C0020630,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
391,NM_000478.6(ALPL):c.1471G>A (p.Gly491Arg),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
391,NM_000478.6(ALPL):c.1471G>A (p.Gly491Arg),ALPL,adult hypophosphatasia,C0268413,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
391,NM_000478.6(ALPL):c.1471G>A (p.Gly491Arg),ALPL,childhood hypophosphatasia,C0220743,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
391,NM_000478.6(ALPL):c.1471G>A (p.Gly491Arg),ALPL,infantile hypophosphatasia,C0268412,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
392,NM_000478.6(ALPL):c.1479C>A (p.Asn493Lys),ALPL,childhood hypophosphatasia,C0220743,pathogenic,"criteria provided, single submitter"
393,NM_005529.7(HSPG2):c.1125C>G (p.Cys375Trp),HSPG2,schwartz-jampel syndrome,C0036391,"likely pathogenic(last reviewed: oct 1, 2019)","criteria provided, single submitter"
394,NM_001791.4(CDC42):c.68A>G (p.Tyr23Cys),CDC42,neurodevelopmental disorder,C1535926,"pathogenic(last reviewed: dec 15, 2022)","criteria provided, multiple submitters, no conflicts"
394,NM_001791.4(CDC42):c.68A>G (p.Tyr23Cys),CDC42,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,C4225222,"pathogenic(last reviewed: dec 15, 2022)","criteria provided, multiple submitters, no conflicts"
395,NM_001791.4(CDC42):c.137T>C (p.Ile46Thr),CDC42,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,C4225222,"likely pathogenic(last reviewed: jun 12, 2018)","criteria provided, single submitter"
396,NM_001791.4(CDC42):c.191A>G (p.Tyr64Cys),CDC42,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,C4225222,"pathogenic/likely pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
397,NM_001791.4(CDC42):c.203G>A (p.Arg68Gln),CDC42,macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome,C4225222,"pathogenic/likely pathogenic(last reviewed: nov 22, 2021)","criteria provided, multiple submitters, no conflicts"
398,NM_001791.4(CDC42):c.509A>G (p.Asp170Gly),CDC42,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
399,NM_001791.4(CDC42):c.511G>A (p.Glu171Lys),CDC42,noonan-like syndrome,C1834120,"pathogenic(last reviewed: nov 1, 2017)","criteria provided, single submitter"
400,NM_172369.5(C1QC):c.100G>A (p.Gly34Arg),C1QC,c1q deficiency,C3150902,"pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
401,NM_001009999.3(KDM1A):c.1196A>G (p.Asp399Gly),KDM1A,intellectual disability,C3714756,"likely pathogenic(last reviewed: jun 22, 2021)","criteria provided, multiple submitters, no conflicts"
402,NM_001009999.3(KDM1A):c.1207G>A (p.Glu403Lys),KDM1A,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,CL1776232,"pathogenic(last reviewed: sep 30, 2015)","criteria provided, single submitter"
403,NM_001009999.3(KDM1A):c.1733A>G (p.Gln578Arg),KDM1A,neurodevelopmental delay,C4022738,likely pathogenic,"criteria provided, single submitter"
404,NM_001009999.3(KDM1A):c.1739A>G (p.Asp580Gly),KDM1A,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,CL1776232,"pathogenic(last reviewed: sep 30, 2015)","criteria provided, single submitter"
405,NM_001009999.3(KDM1A):c.2353T>C (p.Tyr785His),KDM1A,palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome,CL1776232,"pathogenic(last reviewed: sep 30, 2015)","criteria provided, single submitter"
406,NM_001008216.2(GALE):c.715C>T (p.Arg239Trp),GALE,udpglucose-4-epimerase deficiency,C0751161,"likely pathogenic(last reviewed: mar 18, 2016)","criteria provided, single submitter"
407,NM_001008216.2(GALE):c.505C>T (p.Arg169Trp),GALE,udpglucose-4-epimerase deficiency,C0751161,"pathogenic/likely pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
407,NM_001008216.2(GALE):c.505C>T (p.Arg169Trp),GALE,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
408,NM_001008216.2(GALE):c.280G>A (p.Val94Met),GALE,udpglucose-4-epimerase deficiency,C0751161,"pathogenic/likely pathogenic(last reviewed: dec 31, 2022)","criteria provided, multiple submitters, no conflicts"
409,NM_001008216.2(GALE):c.207C>A (p.Asp69Glu),GALE,udpglucose-4-epimerase deficiency,C0751161,"likely pathogenic(last reviewed: oct 8, 2021)","criteria provided, single submitter"
410,NM_000191.3(HMGCL):c.698A>G (p.His233Arg),HMGCL,deficiency of hydroxymethylglutaryl-coa lyase,C0268601,"pathogenic/likely pathogenic(last reviewed: may 25, 2022)","criteria provided, multiple submitters, no conflicts"
411,NM_000191.3(HMGCL):c.602C>A (p.Ser201Tyr),HMGCL,deficiency of hydroxymethylglutaryl-coa lyase,C0268601,"pathogenic(last reviewed: dec 30, 2022)","criteria provided, multiple submitters, no conflicts"
412,NM_000191.3(HMGCL):c.499T>A (p.Tyr167Asn),HMGCL,deficiency of hydroxymethylglutaryl-coa lyase,C0268601,"pathogenic(last reviewed: dec 18, 2017)","criteria provided, single submitter"
413,NM_000191.3(HMGCL):c.122G>A (p.Arg41Gln),HMGCL,deficiency of hydroxymethylglutaryl-coa lyase,C0268601,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
414,NM_000191.3(HMGCL):c.3G>T (p.Met1Ile),HMGCL,deficiency of hydroxymethylglutaryl-coa lyase,C0268601,"likely pathogenic(last reviewed: nov 1, 2017)","criteria provided, single submitter"
415,NM_000147.5(FUCA1):c.691G>A (p.Gly231Arg),FUCA1,fucosidosis,C0016788,likely pathogenic,"criteria provided, single submitter"
416,NM_000147.5(FUCA1):c.422G>T (p.Gly141Val),FUCA1|LOC126805661,fucosidosis,C0016788,"likely pathogenic(last reviewed: jul 5, 2019)","criteria provided, multiple submitters, no conflicts"
417,NM_000147.5(FUCA1):c.194G>A (p.Gly65Asp),FUCA1,fucosidosis,C0016788,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, single submitter"
418,NM_198173.3(GRHL3):c.1171C>T (p.Arg391Cys),GRHL3,van der woude syndrome 2,C1847604,"likely pathogenic(last reviewed: nov 28, 2021)","criteria provided, single submitter"
419,NM_015627.3(LDLRAP1):c.1A>G (p.Met1Val),LDLRAP1,"hypercholesterolemia, familial, 4",C1863512,"likely pathogenic(last reviewed: nov 15, 2022)","criteria provided, single submitter"
420,NM_020451.3(SELENON):c.1A>G (p.Met1Val),SELENON,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
420,NM_020451.3(SELENON):c.1A>G (p.Met1Val),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
420,NM_020451.3(SELENON):c.1A>G (p.Met1Val),SELENON,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
420,NM_020451.3(SELENON):c.1A>G (p.Met1Val),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
421,NM_020451.3(SELENON):c.2T>C (p.Met1Thr),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
422,NM_020451.3(SELENON):c.2T>G (p.Met1Arg),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
423,NM_020451.3(SELENON):c.802C>T (p.Arg268Cys),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
424,NM_020451.3(SELENON):c.817G>A (p.Gly273Arg),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jun 7, 2022)","criteria provided, multiple submitters, no conflicts"
425,NM_020451.3(SELENON):c.872G>A (p.Arg291Gln),SELENON,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
425,NM_020451.3(SELENON):c.872G>A (p.Arg291Gln),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
425,NM_020451.3(SELENON):c.872G>A (p.Arg291Gln),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
426,NM_020451.3(SELENON):c.943G>A (p.Gly315Ser),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: feb 7, 2023)","criteria provided, multiple submitters, no conflicts"
426,NM_020451.3(SELENON):c.943G>A (p.Gly315Ser),SELENON,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: feb 7, 2023)","criteria provided, multiple submitters, no conflicts"
426,NM_020451.3(SELENON):c.943G>A (p.Gly315Ser),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: feb 7, 2023)","criteria provided, multiple submitters, no conflicts"
426,NM_020451.3(SELENON):c.943G>A (p.Gly315Ser),SELENON,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: feb 7, 2023)","criteria provided, multiple submitters, no conflicts"
427,NM_020451.3(SELENON):c.1358G>C (p.Trp453Ser),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, single submitter"
428,NM_020451.3(SELENON):c.1396C>T (p.Arg466Trp),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
429,NM_020451.3(SELENON):c.1397G>A (p.Arg466Gln),SELENON,muscular dystrophy,C0026850,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
429,NM_020451.3(SELENON):c.1397G>A (p.Arg466Gln),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
430,NM_020451.3(SELENON):c.1405C>T (p.Arg469Trp),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
431,NM_020451.3(SELENON):c.1406G>A (p.Arg469Gln),SELENON,eichsfeld type congenital muscular dystrophy,C0410180,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
432,NM_032588.4(TRIM63):c.390C>G (p.Ile130Met),TRIM63,hypertrophic cardiomyopathy,C3278959,pathogenic,"criteria provided, single submitter"
433,NM_205861.3(DHDDS):c.104G>A (p.Gly35Glu),DHDDS,retinitis pigmentosa 59,Cumapped250,"likely pathogenic(last reviewed: dec 23, 2021)","criteria provided, multiple submitters, no conflicts"
434,NM_205861.3(DHDDS):c.109C>T (p.Arg37Cys),DHDDS,retinitis pigmentosa 59,Cumapped250,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
435,NM_205861.3(DHDDS):c.113G>A (p.Arg38His),DHDDS,developmental delay and seizures with or without movement abnormalities,C4693376,"pathogenic(last reviewed: mar 8, 2018)","criteria provided, single submitter"
436,NM_205861.3(DHDDS):c.124A>G (p.Lys42Glu),DHDDS,developmental delay and seizures with or without movement abnormalities,C4693376,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
436,NM_205861.3(DHDDS):c.124A>G (p.Lys42Glu),DHDDS,retinitis pigmentosa 59,Cumapped250,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
436,NM_205861.3(DHDDS):c.124A>G (p.Lys42Glu),DHDDS,retinitis pigmentosa 59,Cumapped250,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
436,NM_205861.3(DHDDS):c.124A>G (p.Lys42Glu),DHDDS,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
437,NM_205861.3(DHDDS):c.614G>A (p.Arg205Gln),DHDDS,developmental delay and seizures with or without movement abnormalities,C4693376,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
437,NM_205861.3(DHDDS):c.614G>A (p.Arg205Gln),DHDDS,retinitis pigmentosa 59,Cumapped250,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
438,NM_205861.3(DHDDS):c.616A>G (p.Thr206Ala),DHDDS,retinitis pigmentosa 59,Cumapped250,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
438,NM_205861.3(DHDDS):c.616A>G (p.Thr206Ala),DHDDS,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
439,NM_205861.3(DHDDS):c.632G>A (p.Arg211Gln),DHDDS,retinitis pigmentosa 59,Cumapped250,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
439,NM_205861.3(DHDDS):c.632G>A (p.Arg211Gln),DHDDS,developmental delay and seizures with or without movement abnormalities,C4693376,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
440,NM_006015.6(ARID1A):c.3058A>T (p.Arg1020Trp),ARID1A,"intellectual disability, autosomal dominant 14",C3276355,"pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
441,NM_006015.6(ARID1A):c.3067T>G (p.Trp1023Gly),ARID1A,"intellectual disability, autosomal dominant 14",C3276355,"likely pathogenic(last reviewed: feb 25, 2021)","criteria provided, single submitter"
442,NM_006015.6(ARID1A):c.3067T>C (p.Trp1023Arg),ARID1A,"intellectual disability, autosomal dominant 14",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 21, 2021)","criteria provided, multiple submitters, no conflicts"
443,NM_017837.4(PIGV):c.55C>T (p.Arg19Cys),PIGV,hyperphosphatasia with intellectual disability syndrome 1,Cumapped91,"likely pathogenic(last reviewed: jan 27, 2017)","criteria provided, single submitter"
444,NM_017837.4(PIGV):c.607C>T (p.Arg203Cys),PIGV,hyperphosphatasia with intellectual disability syndrome 1,Cumapped91,"pathogenic/likely pathogenic(last reviewed: nov 26, 2021)","criteria provided, multiple submitters, no conflicts"
445,NM_017837.4(PIGV):c.1022C>A (p.Ala341Glu),PIGV,hyperphosphatasia-intellectual disability syndrome,C1855923,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
445,NM_017837.4(PIGV):c.1022C>A (p.Ala341Glu),PIGV,hyperphosphatasia with intellectual disability syndrome 1,Cumapped91,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
446,NM_001371928.1(AHDC1):c.3025C>G (p.Pro1009Ala),AHDC1,ahdc1-related intellectual disability - obstructive sleep apnea - mild dysmorphism syndrome,C4014419,"likely pathogenic(last reviewed: nov 29, 2022)","criteria provided, single submitter"
447,NM_016011.4(MECR):c.772C>T (p.Arg258Trp),MECR,"dystonia, childhood-onset, with optic atrophy and basal ganglia abnormalities",C4310634,"pathogenic(last reviewed: jun 4, 2022)","criteria provided, multiple submitters, no conflicts"
448,NM_001020658.2(PUM1):c.221G>A (p.Arg74His),PUM1,spastic ataxia,Cumapped289,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
449,NM_001020658.2(PUM1):c.46G>T (p.Asp16Tyr),PUM1,spinocerebellar ataxia 47,C4693672,"likely pathogenic(last reviewed: feb 27, 2020)","criteria provided, single submitter"
450,NM_006559.3(KHDRBS1):c.1262C>T (p.Pro421Leu),KHDRBS1,premature ovarian failure,C0085215,"likely pathogenic(last reviewed: mar 2, 2020)","criteria provided, single submitter"
451,NM_003680.4(YARS1):c.586G>C (p.Glu196Gln),YARS1,charcot-marie-tooth disease dominant intermediate c,C1842237,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
452,NM_003680.4(YARS1):c.586G>A (p.Glu196Lys),YARS1,charcot-marie-tooth disease dominant intermediate c,C1842237,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
453,NM_003680.4(YARS1):c.485G>C (p.Ser162Thr),YARS1,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset",C4015728,likely pathogenic,"criteria provided, single submitter"
454,NM_003680.4(YARS1):c.121G>A (p.Gly41Arg),YARS1,charcot-marie-tooth disease dominant intermediate c,C1842237,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
455,NM_003680.4(YARS1):c.46C>T (p.Arg16Trp),S100PBP|YARS1,"neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset",C4015728,likely pathogenic,"criteria provided, single submitter"
456,NM_001625.4(AK2):c.556C>T (p.Arg186Cys),AK2,severe combined immunodeficiency disease,C0085110,"likely pathogenic(last reviewed: aug 4, 2022)","criteria provided, single submitter"
457,NM_001625.4(AK2):c.545C>A (p.Ala182Asp),AK2,reticular dysgenesis,C0272167,"pathogenic/likely pathogenic(last reviewed: nov 27, 2019)","criteria provided, multiple submitters, no conflicts"
458,NM_001625.4(AK2):c.524G>C (p.Arg175Pro),AK2,reticular dysgenesis,C0272167,"likely pathogenic(last reviewed: dec 15, 2019)","criteria provided, single submitter"
459,NM_001625.4(AK2):c.307C>T (p.Arg103Trp),AK2,reticular dysgenesis,C0272167,"likely pathogenic(last reviewed: sep 26, 2018)","criteria provided, single submitter"
460,NM_014284.3(NCDN):c.1297G>C (p.Glu433Gln),NCDN,intellectual disability,C3714756,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
460,NM_014284.3(NCDN):c.1297G>C (p.Glu433Gln),NCDN,seizure,C0036572,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
460,NM_014284.3(NCDN):c.1297G>C (p.Glu433Gln),NCDN,neurodevelopmental delay,C4022738,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
461,NM_014284.3(NCDN):c.1433G>A (p.Arg478Gln),NCDN,cerebellar ataxia,C0007758,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
461,NM_014284.3(NCDN):c.1433G>A (p.Arg478Gln),NCDN,intellectual disability,C3714756,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
461,NM_014284.3(NCDN):c.1433G>A (p.Arg478Gln),NCDN,neurodevelopmental delay,C4022738,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
462,NM_014284.3(NCDN):c.1492T>C (p.Trp498Arg),NCDN,intellectual disability,C3714756,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
462,NM_014284.3(NCDN):c.1492T>C (p.Trp498Arg),NCDN,neurodevelopmental delay,C4022738,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
463,NM_014284.3(NCDN):c.1955C>T (p.Pro652Leu),NCDN,cerebellar ataxia,C0007758,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
463,NM_014284.3(NCDN):c.1955C>T (p.Pro652Leu),NCDN,intellectual disability,C3714756,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
463,NM_014284.3(NCDN):c.1955C>T (p.Pro652Leu),NCDN,neurodevelopmental delay,C4022738,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
464,NM_017825.3(ADPRS):c.235A>C (p.Thr79Pro),ADPRS,"neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures",C4748527,"pathogenic(last reviewed: sep 30, 2020)","criteria provided, single submitter"
465,NM_017825.3(ADPRS):c.485T>C (p.Leu162Pro),ADPRS,"neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures",C4748527,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
466,NM_017825.3(ADPRS):c.530C>T (p.Ser177Leu),ADPRS,"neurodegeneration, childhood-onset, stress-induced, with variable ataxia and seizures",C4748527,"likely pathogenic(last reviewed: oct 7, 2019)","criteria provided, single submitter"
467,NM_000760.4(CSF3R):c.1853C>T (p.Thr618Ile),CSF3R,autosomal recessive severe congenital neutropenia due to csf3r deficiency,C5190863,"pathogenic/likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, multiple submitters, no conflicts"
468,NM_000760.4(CSF3R):c.922C>T (p.Arg308Cys),CSF3R,severe congenital neutropenia,C0340970,"pathogenic(last reviewed: jun 1, 2013)","criteria provided, single submitter"
469,NM_022157.4(RRAGC):c.343T>C (p.Trp115Arg),RRAGC,see cases,Cumapped260,"likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
470,NM_017646.6(TRIT1):c.968G>A (p.Arg323Gln),TRIT1,combined oxidative phosphorylation deficiency 35,C4693466,"pathogenic(last reviewed: oct 15, 2018)","criteria provided, multiple submitters, no conflicts"
471,NM_017646.6(TRIT1):c.967C>T (p.Arg323Trp),TRIT1,combined oxidative phosphorylation deficiency 35,C4693466,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
472,NM_000310.4(PPT1):c.749G>A (p.Gly250Asp),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
473,NM_000310.4(PPT1):c.748G>A (p.Gly250Ser),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: aug 30, 2022)","criteria provided, single submitter"
474,NM_000310.4(PPT1):c.740A>G (p.Tyr247Cys),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
475,NM_000310.4(PPT1):c.739T>C (p.Tyr247His),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
476,NM_000310.4(PPT1):c.733G>A (p.Gly245Arg),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: jul 2, 2022)","criteria provided, single submitter"
477,NM_000310.4(PPT1):c.713C>T (p.Pro238Leu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
478,NM_000310.4(PPT1):c.707T>A (p.Val236Glu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
479,NM_000310.4(PPT1):c.665T>C (p.Leu222Pro),PPT1,spastic ataxia,Cumapped289,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
479,NM_000310.4(PPT1):c.665T>C (p.Leu222Pro),PPT1,neuronal ceroid lipofuscinosis,C0027877,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
479,NM_000310.4(PPT1):c.665T>C (p.Leu222Pro),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
480,NM_000310.4(PPT1):c.551A>T (p.Glu184Val),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
481,NM_000310.4(PPT1):c.550G>A (p.Glu184Lys),PPT1,neuronal ceroid lipofuscinosis,C0027877,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
481,NM_000310.4(PPT1):c.550G>A (p.Glu184Lys),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
482,NM_000310.4(PPT1):c.541G>C (p.Val181Leu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
483,NM_000310.4(PPT1):c.541G>A (p.Val181Met),PPT1,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
483,NM_000310.4(PPT1):c.541G>A (p.Val181Met),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
484,NM_000310.4(PPT1):c.541G>T (p.Val181Leu),PPT1,global developmental delay,C0557874,"pathogenic/likely pathogenic(last reviewed: mar 13, 2023)","criteria provided, multiple submitters, no conflicts"
484,NM_000310.4(PPT1):c.541G>T (p.Val181Leu),PPT1,neuronal ceroid lipofuscinosis,C0027877,"pathogenic/likely pathogenic(last reviewed: mar 13, 2023)","criteria provided, multiple submitters, no conflicts"
484,NM_000310.4(PPT1):c.541G>T (p.Val181Leu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: mar 13, 2023)","criteria provided, multiple submitters, no conflicts"
485,NM_000310.4(PPT1):c.533A>T (p.Glu178Val),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: jul 10, 2022)","criteria provided, single submitter"
486,NM_000310.4(PPT1):c.529C>G (p.Gln177Glu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
487,NM_000310.4(PPT1):c.364A>T (p.Arg122Trp),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic(last reviewed: sep 14, 2022)","criteria provided, multiple submitters, no conflicts"
488,NM_000310.4(PPT1):c.353G>A (p.Gly118Asp),PPT1,neuronal ceroid lipofuscinosis,C0027877,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
488,NM_000310.4(PPT1):c.353G>A (p.Gly118Asp),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
489,NM_000310.4(PPT1):c.326A>G (p.Tyr109Cys),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
490,NM_000310.4(PPT1):c.325T>G (p.Tyr109Asp),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
491,NM_000310.4(PPT1):c.223A>C (p.Thr75Pro),PPT1,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
491,NM_000310.4(PPT1):c.223A>C (p.Thr75Pro),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
492,NM_000310.4(PPT1):c.218G>A (p.Gly73Glu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
493,NM_000310.4(PPT1):c.218G>C (p.Gly73Ala),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
494,NM_000310.4(PPT1):c.3G>A (p.Met1Ile),PPT1,neuronal ceroid lipofuscinosis,C0027877,"pathogenic/likely pathogenic(last reviewed: mar 28, 2022)","criteria provided, multiple submitters, no conflicts"
494,NM_000310.4(PPT1):c.3G>A (p.Met1Ile),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: mar 28, 2022)","criteria provided, multiple submitters, no conflicts"
495,NM_000310.4(PPT1):c.2T>A (p.Met1Lys),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic(last reviewed: jul 27, 2021)","criteria provided, single submitter"
496,NM_000310.4(PPT1):c.2T>C (p.Met1Thr),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
497,NM_000310.4(PPT1):c.1A>C (p.Met1Leu),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
498,NM_000310.4(PPT1):c.1A>G (p.Met1Val),PPT1,neuronal ceroid lipofuscinosis 1,C1850451,"likely pathogenic(last reviewed: mar 18, 2016)","criteria provided, single submitter"
499,NM_001852.4(COL9A2):c.1145G>T (p.Gly382Val),COL9A2,intellectual disability,C3714756,"likely pathogenic(last reviewed: oct 16, 2020)","criteria provided, single submitter"
500,NM_004700.4(KCNQ4):c.140T>C (p.Leu47Pro),KCNQ4,autosomal dominant nonsyndromic hearing loss 2a,C3711374,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
501,NM_004700.4(KCNQ4):c.701A>T (p.His234Leu),KCNQ4,bilateral sensorineural hearing impairment,C0452138,pathogenic,"criteria provided, single submitter"
502,NM_004700.4(KCNQ4):c.825G>C (p.Trp275Cys),KCNQ4,nonsyndromic genetic hearing loss,Cumapped178,"likely pathogenic(last reviewed: sep 10, 2018)",reviewed by expert panel
503,NM_004700.4(KCNQ4):c.826T>C (p.Trp276Arg),KCNQ4,autosomal dominant nonsyndromic hearing loss 2a,C3711374,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
504,NM_004700.4(KCNQ4):c.827G>C (p.Trp276Ser),KCNQ4,rare genetic deafness,Cumapped240,"pathogenic(last reviewed: jun 24, 2014)","criteria provided, single submitter"
505,NM_004700.4(KCNQ4):c.842T>C (p.Leu281Ser),KCNQ4,autosomal dominant nonsyndromic hearing loss 2a,C3711374,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
506,NM_004700.4(KCNQ4):c.853G>A (p.Gly285Ser),KCNQ4,nonsyndromic genetic hearing loss,Cumapped178,"pathogenic(last reviewed: sep 11, 2018)",reviewed by expert panel
507,NM_004700.4(KCNQ4):c.859G>A (p.Gly287Ser),KCNQ4,autosomal dominant nonsyndromic hearing loss 2a,C3711374,"likely pathogenic(last reviewed: aug 3, 2020)","criteria provided, single submitter"
508,NM_004700.4(KCNQ4):c.961G>A (p.Gly321Ser),KCNQ4,rare genetic deafness,Cumapped240,"likely pathogenic(last reviewed: jan 5, 2022)","criteria provided, multiple submitters, no conflicts"
509,NM_148960.3(CLDN19):c.535G>A (p.Gly179Ser),CLDN19,renal hypomagnesemia 5 with ocular involvement,Cumapped245,"likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
510,NM_148960.3(CLDN19):c.530T>G (p.Leu177Arg),CLDN19,renal hypomagnesemia 5 with ocular involvement,Cumapped245,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
511,NM_148960.3(CLDN19):c.269T>G (p.Leu90Arg),CLDN19,renal hypomagnesemia 5 with ocular involvement,Cumapped245,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
512,NM_148960.3(CLDN19):c.83C>T (p.Pro28Leu),CLDN19,renal hypomagnesemia 5 with ocular involvement,Cumapped245,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
513,NM_148960.3(CLDN19):c.59G>A (p.Gly20Asp),CLDN19,renal hypomagnesemia 5 with ocular involvement,Cumapped245,"pathogenic/likely pathogenic(last reviewed: may 26, 2022)","criteria provided, multiple submitters, no conflicts"
514,NM_006516.4(SLC2A1):c.1454C>T (p.Pro485Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: jan 23, 2022)","criteria provided, multiple submitters, no conflicts"
515,NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
515,NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
515,NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp),SLC2A1,hereditary cryohydrocytosis with reduced stomatin,C5190707,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
515,NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp),SLC2A1,"epilepsy, idiopathic generalized, susceptibility to, 12",C3553859,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
515,NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp),SLC2A1,dystonia 9,C1832855,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
515,NM_006516.4(SLC2A1):c.1372C>T (p.Arg458Trp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
516,NM_006516.4(SLC2A1):c.1266C>A (p.Phe422Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: oct 29, 2021)","criteria provided, single submitter"
517,NM_006516.4(SLC2A1):c.1264T>C (p.Phe422Leu),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
517,NM_006516.4(SLC2A1):c.1264T>C (p.Phe422Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
518,NM_006516.4(SLC2A1):c.1261T>C (p.Cys421Arg),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: sep 26, 2018)","criteria provided, single submitter"
519,NM_006516.4(SLC2A1):c.1259T>C (p.Met420Thr),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: oct 13, 2021)","criteria provided, single submitter"
520,NM_006516.4(SLC2A1):c.1256G>A (p.Gly419Asp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: may 6, 2022)","criteria provided, single submitter"
521,NM_006516.4(SLC2A1):c.1234T>G (p.Trp412Gly),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"likely pathogenic(last reviewed: jun 7, 2019)","criteria provided, single submitter"
522,NM_006516.4(SLC2A1):c.1208C>T (p.Ala403Val),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
523,NM_006516.4(SLC2A1):c.1199G>T (p.Arg400Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
524,NM_006516.4(SLC2A1):c.1199G>A (p.Arg400His),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: aug 2, 2022)","criteria provided, multiple submitters, no conflicts"
524,NM_006516.4(SLC2A1):c.1199G>A (p.Arg400His),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: aug 2, 2022)","criteria provided, multiple submitters, no conflicts"
525,NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
525,NM_006516.4(SLC2A1):c.1198C>T (p.Arg400Cys),SLC2A1,dystonia 9,C1832855,"pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
526,NM_006516.4(SLC2A1):c.998G>A (p.Arg333Gln),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
526,NM_006516.4(SLC2A1):c.998G>A (p.Arg333Gln),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
526,NM_006516.4(SLC2A1):c.998G>A (p.Arg333Gln),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
526,NM_006516.4(SLC2A1):c.998G>A (p.Arg333Gln),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
526,NM_006516.4(SLC2A1):c.998G>A (p.Arg333Gln),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,glut1 deficiency syndrome,C1847501,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,hereditary cryohydrocytosis with reduced stomatin,C5190707,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,"epilepsy, idiopathic generalized, susceptibility to, 12",C3553859,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,dystonia 9,C1832855,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
527,NM_006516.4(SLC2A1):c.997C>T (p.Arg333Trp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
528,NM_006516.4(SLC2A1):c.985G>C (p.Glu329Gln),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: feb 25, 2022)","criteria provided, single submitter"
529,NM_006516.4(SLC2A1):c.971C>T (p.Ser324Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
529,NM_006516.4(SLC2A1):c.971C>T (p.Ser324Leu),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
530,NM_006516.4(SLC2A1):c.950A>C (p.Asn317Thr),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: jul 14, 2022)","criteria provided, single submitter"
531,NM_006516.4(SLC2A1):c.941G>A (p.Gly314Asp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, single submitter"
532,NM_006516.4(SLC2A1):c.940G>A (p.Gly314Ser),SLC2A1,dystonia 9,C1832855,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
532,NM_006516.4(SLC2A1):c.940G>A (p.Gly314Ser),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
532,NM_006516.4(SLC2A1):c.940G>A (p.Gly314Ser),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
533,NM_006516.4(SLC2A1):c.938C>T (p.Ser313Phe),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"likely pathogenic(last reviewed: dec 11, 2014)","criteria provided, single submitter"
534,NM_006516.4(SLC2A1):c.929C>T (p.Thr310Ile),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
535,NM_006516.4(SLC2A1):c.884C>T (p.Thr295Met),SLC2A1,glut1 deficiency syndrome,C1847501,"pathogenic(last reviewed: aug 8, 2022)","criteria provided, multiple submitters, no conflicts"
535,NM_006516.4(SLC2A1):c.884C>T (p.Thr295Met),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: aug 8, 2022)","criteria provided, multiple submitters, no conflicts"
535,NM_006516.4(SLC2A1):c.884C>T (p.Thr295Met),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: aug 8, 2022)","criteria provided, multiple submitters, no conflicts"
536,NM_006516.4(SLC2A1):c.880T>G (p.Ser294Ala),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: jan 15, 2022)","criteria provided, single submitter"
537,NM_006516.4(SLC2A1):c.878A>C (p.Tyr293Ser),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, single submitter"
538,NM_006516.4(SLC2A1):c.859A>C (p.Ile287Leu),SLC2A1,intellectual disability,C3714756,"pathogenic(last reviewed: feb 13, 2019)","criteria provided, single submitter"
539,NM_006516.4(SLC2A1):c.833T>C (p.Leu278Pro),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
540,NM_006516.4(SLC2A1):c.823G>A (p.Ala275Thr),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
540,NM_006516.4(SLC2A1):c.823G>A (p.Ala275Thr),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
541,NM_006516.4(SLC2A1):c.728A>T (p.Glu243Val),SLC2A1,glut1 deficiency syndrome,C1847501,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
542,NM_006516.4(SLC2A1):c.694C>T (p.Arg232Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
543,NM_006516.4(SLC2A1):c.692T>C (p.Leu231Pro),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"likely pathogenic(last reviewed: may 19, 2021)","criteria provided, single submitter"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,hereditary cryohydrocytosis with reduced stomatin,C5190707,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,"epilepsy, idiopathic generalized, susceptibility to, 12",C3553859,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,dystonia 9,C1832855,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
544,NM_006516.4(SLC2A1):c.667C>T (p.Arg223Trp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
545,NM_006516.4(SLC2A1):c.635G>A (p.Arg212His),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
545,NM_006516.4(SLC2A1):c.635G>A (p.Arg212His),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
546,NM_006516.4(SLC2A1):c.634C>T (p.Arg212Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: feb 1, 2022)","criteria provided, multiple submitters, no conflicts"
547,NM_006516.4(SLC2A1):c.539T>A (p.Met180Lys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: may 8, 2022)","criteria provided, single submitter"
548,NM_006516.4(SLC2A1):c.524G>T (p.Gly175Val),SLC2A1,dystonia 9,C1832855,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
549,NM_006516.4(SLC2A1):c.499G>C (p.Gly167Arg),SLC2A1,intellectual disability,C3714756,"likely pathogenic(last reviewed: aug 3, 2020)","criteria provided, single submitter"
549,NM_006516.4(SLC2A1):c.499G>C (p.Gly167Arg),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"likely pathogenic(last reviewed: aug 3, 2020)","criteria provided, single submitter"
550,NM_006516.4(SLC2A1):c.493G>A (p.Val165Ile),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
550,NM_006516.4(SLC2A1):c.493G>A (p.Val165Ile),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
551,NM_006516.4(SLC2A1):c.458G>C (p.Arg153Pro),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: may 24, 2022)","criteria provided, multiple submitters, no conflicts"
552,NM_006516.4(SLC2A1):c.458G>T (p.Arg153Leu),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: dec 8, 2020)","criteria provided, multiple submitters, no conflicts"
552,NM_006516.4(SLC2A1):c.458G>T (p.Arg153Leu),SLC2A1,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: dec 8, 2020)","criteria provided, multiple submitters, no conflicts"
553,NM_006516.4(SLC2A1):c.457C>T (p.Arg153Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
554,NM_006516.4(SLC2A1):c.418G>C (p.Val140Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: feb 8, 2022)","criteria provided, single submitter"
555,NM_006516.4(SLC2A1):c.418G>A (p.Val140Met),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: jul 23, 2022)","criteria provided, multiple submitters, no conflicts"
556,NM_006516.4(SLC2A1):c.400G>T (p.Gly134Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: oct 27, 2021)","criteria provided, single submitter"
557,NM_006516.4(SLC2A1):c.400G>A (p.Gly134Ser),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
557,NM_006516.4(SLC2A1):c.400G>A (p.Gly134Ser),SLC2A1,paroxysmal dystonia,C0393588,"pathogenic/likely pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
558,NM_006516.4(SLC2A1):c.388G>T (p.Gly130Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
559,NM_006516.4(SLC2A1):c.388G>A (p.Gly130Ser),SLC2A1,glut1 deficiency syndrome,C1847501,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
559,NM_006516.4(SLC2A1):c.388G>A (p.Gly130Ser),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
560,NM_006516.4(SLC2A1):c.377G>A (p.Arg126His),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
560,NM_006516.4(SLC2A1):c.377G>A (p.Arg126His),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
560,NM_006516.4(SLC2A1):c.377G>A (p.Arg126His),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
561,NM_006516.4(SLC2A1):c.376C>T (p.Arg126Cys),SLC2A1,hereditary cryohydrocytosis with reduced stomatin,C5190707,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
561,NM_006516.4(SLC2A1):c.376C>T (p.Arg126Cys),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
561,NM_006516.4(SLC2A1):c.376C>T (p.Arg126Cys),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
562,NM_006516.4(SLC2A1):c.287T>C (p.Met96Thr),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
562,NM_006516.4(SLC2A1):c.287T>C (p.Met96Thr),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
563,NM_006516.4(SLC2A1):c.286A>G (p.Met96Val),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
564,NM_006516.4(SLC2A1):c.277C>T (p.Arg93Trp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: jan 12, 2022)","criteria provided, multiple submitters, no conflicts"
564,NM_006516.4(SLC2A1):c.277C>T (p.Arg93Trp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: jan 12, 2022)","criteria provided, multiple submitters, no conflicts"
564,NM_006516.4(SLC2A1):c.277C>T (p.Arg93Trp),SLC2A1,seizure,C0036572,"pathogenic(last reviewed: jan 12, 2022)","criteria provided, multiple submitters, no conflicts"
565,NM_006516.4(SLC2A1):c.274C>T (p.Arg92Trp),SLC2A1,developmental disorder,C0008073,"pathogenic/likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
565,NM_006516.4(SLC2A1):c.274C>T (p.Arg92Trp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
565,NM_006516.4(SLC2A1):c.274C>T (p.Arg92Trp),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic/likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
565,NM_006516.4(SLC2A1):c.274C>T (p.Arg92Trp),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic/likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
565,NM_006516.4(SLC2A1):c.274C>T (p.Arg92Trp),SLC2A1,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
566,NM_006516.4(SLC2A1):c.227G>T (p.Gly76Val),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, single submitter"
567,NM_006516.4(SLC2A1):c.216T>G (p.Phe72Leu),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: aug 29, 2022)","criteria provided, single submitter"
568,NM_006516.4(SLC2A1):c.209C>T (p.Ala70Val),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"likely pathogenic(last reviewed: may 18, 2022)","criteria provided, single submitter"
569,NM_006516.4(SLC2A1):c.107C>T (p.Pro36Leu),SLC2A1,intellectual disability,C3714756,"likely pathogenic(last reviewed: feb 13, 2019)","criteria provided, single submitter"
570,NM_006516.4(SLC2A1):c.102T>G (p.Asn34Lys),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"likely pathogenic(last reviewed: jan 1, 2014)","criteria provided, single submitter"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,dystonia 9,C1832855,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,hereditary cryohydrocytosis with reduced stomatin,C5190707,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,childhood onset glut1 deficiency syndrome 2,CL1634609,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,"epilepsy, idiopathic generalized, susceptibility to, 12",C3553859,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
571,NM_006516.4(SLC2A1):c.101A>G (p.Asn34Ser),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
572,NM_006516.4(SLC2A1):c.100A>G (p.Asn34Asp),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic/likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, multiple submitters, no conflicts"
573,NM_006516.4(SLC2A1):c.49G>A (p.Gly17Arg),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
574,NM_006516.4(SLC2A1):c.2T>C (p.Met1Thr),SLC2A1,"glut1 deficiency syndrome 1, autosomal recessive",C3149117,"pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
575,NM_006516.4(SLC2A1):c.1A>G (p.Met1Val),SLC2A1,dystonia 9,C1832855,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
575,NM_006516.4(SLC2A1):c.1A>G (p.Met1Val),SLC2A1,encephalopathy due to glut1 deficiency,C1847501,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
576,NM_005373.3(MPL):c.205T>C (p.Tyr69His),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,pathogenic,"criteria provided, single submitter"
577,NM_005373.3(MPL):c.263G>A (p.Gly88Glu),MPL,thrombocytopenia,C0040034,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
578,NM_005373.3(MPL):c.304C>T (p.Arg102Cys),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
578,NM_005373.3(MPL):c.304C>T (p.Arg102Cys),MPL,essential thrombocythemia,C0040028,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
579,NM_005373.3(MPL):c.305G>A (p.Arg102His),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: mar 28, 2022)","criteria provided, single submitter"
579,NM_005373.3(MPL):c.305G>A (p.Arg102His),MPL,essential thrombocythemia,C0040028,"likely pathogenic(last reviewed: mar 28, 2022)","criteria provided, single submitter"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,primary myelofibrosis,C0001815,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,thrombocythemia 2,C3275998,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,essential thrombocythemia,C0040028,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
580,NM_005373.3(MPL):c.305G>C (p.Arg102Pro),MPL,thrombocytopenia,C0040034,"pathogenic(last reviewed: jan 11, 2023)","criteria provided, multiple submitters, no conflicts"
581,NM_005373.3(MPL):c.311T>C (p.Phe104Ser),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
581,NM_005373.3(MPL):c.311T>C (p.Phe104Ser),MPL,essential thrombocythemia,C0040028,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,essential thrombocythemia,C0040028,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,thrombocythemia 2,C3275998,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,primary myelofibrosis,C0001815,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,thrombocythemia 2,C3275998,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
582,NM_005373.3(MPL):c.317C>T (p.Pro106Leu),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
583,NM_005373.3(MPL):c.407C>G (p.Pro136Arg),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,likely pathogenic,"criteria provided, single submitter"
584,NM_005373.3(MPL):c.407C>A (p.Pro136His),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
584,NM_005373.3(MPL):c.407C>A (p.Pro136His),MPL,essential thrombocythemia,C0040028,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
585,NM_005373.3(MPL):c.460T>C (p.Trp154Arg),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
585,NM_005373.3(MPL):c.460T>C (p.Trp154Arg),MPL,essential thrombocythemia,C0040028,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
585,NM_005373.3(MPL):c.460T>C (p.Trp154Arg),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
585,NM_005373.3(MPL):c.460T>C (p.Trp154Arg),MPL,primary myelofibrosis,C0001815,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
585,NM_005373.3(MPL):c.460T>C (p.Trp154Arg),MPL,thrombocythemia 2,C3275998,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
586,NM_005373.3(MPL):c.761T>C (p.Leu254Pro),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,likely pathogenic,"criteria provided, single submitter"
587,NM_005373.3(MPL):c.769C>T (p.Arg257Cys),MPL,essential thrombocythemia,C0040028,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
587,NM_005373.3(MPL):c.769C>T (p.Arg257Cys),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
587,NM_005373.3(MPL):c.769C>T (p.Arg257Cys),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
588,NM_005373.3(MPL):c.1277G>C (p.Arg426Pro),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,pathogenic,"criteria provided, single submitter"
589,NM_005373.3(MPL):c.1303T>A (p.Trp435Arg),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: apr 25, 2017)","criteria provided, single submitter"
590,NM_005373.3(MPL):c.1305G>C (p.Trp435Cys),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"likely pathogenic(last reviewed: may 26, 2022)","criteria provided, single submitter"
590,NM_005373.3(MPL):c.1305G>C (p.Trp435Cys),MPL,essential thrombocythemia,C0040028,"likely pathogenic(last reviewed: may 26, 2022)","criteria provided, single submitter"
591,NM_005373.3(MPL):c.1589C>T (p.Pro530Leu),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,likely pathogenic,"criteria provided, single submitter"
592,NM_005373.3(MPL):c.1904C>T (p.Pro635Leu),MPL,congenital amegakaryocytic thrombocytopenia,C1327915,"pathogenic(last reviewed: feb 4, 2022)","criteria provided, single submitter"
592,NM_005373.3(MPL):c.1904C>T (p.Pro635Leu),MPL,essential thrombocythemia,C0040028,"pathogenic(last reviewed: feb 4, 2022)","criteria provided, single submitter"
593,NM_006279.5(ST3GAL3):c.1046C>T (p.Thr349Met),ST3GAL3,"intellectual disability, autosomal recessive 12",C1970200,"likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, single submitter"
594,NM_001024845.3(SLC6A9):c.235C>T (p.Pro79Ser),SLC6A9,atypical glycine encephalopathy,C0751748,likely pathogenic,"criteria provided, single submitter"
595,NM_020365.5(EIF2B3):c.674G>C (p.Arg225Pro),EIF2B3,vanishing white matter disease,C2960129,"pathogenic(last reviewed: aug 10, 2021)","criteria provided, single submitter"
596,NM_020365.5(EIF2B3):c.503T>C (p.Leu168Pro),EIF2B3,vanishing white matter disease,C2960129,"likely pathogenic(last reviewed: jun 4, 2020)","criteria provided, single submitter"
597,NM_020365.5(EIF2B3):c.272G>A (p.Arg91His),EIF2B3,vanishing white matter disease,C2960129,"likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
598,NM_020365.5(EIF2B3):c.89T>C (p.Val30Ala),EIF2B3,vanishing white matter disease,C2960129,"likely pathogenic(last reviewed: jun 4, 2020)","criteria provided, single submitter"
599,NM_000374.5(UROD):c.138T>A (p.Phe46Leu),UROD,familial porphyria cutanea tarda,C0268323,"likely pathogenic(last reviewed: oct 6, 2021)","criteria provided, single submitter"
600,NM_032756.4(HPDL):c.149G>A (p.Gly50Asp),HPDL,spastic ataxia,Cumapped289,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
600,NM_032756.4(HPDL):c.149G>A (p.Gly50Asp),HPDL,"spastic paraplegia 83, autosomal recessive",CL1660188,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
601,NM_032756.4(HPDL):c.788C>T (p.Thr263Met),HPDL,neurodevelopmental disorder with progressive spasticity and brain white matter abnormalities,Cumapped162,"likely pathogenic(last reviewed: sep 29, 2020)","criteria provided, single submitter"
602,NM_001048174.2(MUTYH):c.1393G>T (p.Val465Phe),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
602,NM_001048174.2(MUTYH):c.1393G>T (p.Val465Phe),MUTYH,gastric cancer,C0699791,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
602,NM_001048174.2(MUTYH):c.1393G>T (p.Val465Phe),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
602,NM_001048174.2(MUTYH):c.1393G>T (p.Val465Phe),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
603,NM_001048174.2(MUTYH):c.1130C>T (p.Pro377Leu),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
603,NM_001048174.2(MUTYH):c.1130C>T (p.Pro377Leu),MUTYH,gastric cancer,C0699791,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
603,NM_001048174.2(MUTYH):c.1130C>T (p.Pro377Leu),MUTYH,"b lymphoblastic leukemia lymphoma, no icd-o subtype",C3472624,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
603,NM_001048174.2(MUTYH):c.1130C>T (p.Pro377Leu),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
603,NM_001048174.2(MUTYH):c.1130C>T (p.Pro377Leu),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,neoplasm of stomach,C0038356,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,pilomatrixoma,C0206711,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,familial colorectal cancer,CL495361,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,"colorectal adenomatous polyposis, autosomal recessive, with pilomatricomas",C1837991,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,li-fraumeni syndrome 2,C1836482,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,lynch syndrome 1,C2936783,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
604,NM_001048174.2(MUTYH):c.1103G>A (p.Gly368Asp),MUTYH,ovarian carcinoma,C1140680,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
605,NM_001048174.2(MUTYH):c.1079T>C (p.Leu360Pro),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
605,NM_001048174.2(MUTYH):c.1079T>C (p.Leu360Pro),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
606,NM_001048174.2(MUTYH):c.800C>T (p.Pro267Leu),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 26, 2023)","criteria provided, multiple submitters, no conflicts"
606,NM_001048174.2(MUTYH):c.800C>T (p.Pro267Leu),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: jan 26, 2023)","criteria provided, multiple submitters, no conflicts"
607,NM_001048174.2(MUTYH):c.773G>A (p.Gly258Glu),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
607,NM_001048174.2(MUTYH):c.773G>A (p.Gly258Glu),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
608,NM_001048174.2(MUTYH):c.763A>G (p.Met255Val),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
608,NM_001048174.2(MUTYH):c.763A>G (p.Met255Val),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
609,NM_001048174.2(MUTYH):c.736C>T (p.Arg246Trp),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
609,NM_001048174.2(MUTYH):c.736C>T (p.Arg246Trp),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
610,NM_001048174.2(MUTYH):c.704G>C (p.Trp235Ser),MUTYH,familial adenomatous polyposis 2,C1837991,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
611,NM_001048174.2(MUTYH):c.649C>T (p.Arg217Cys),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
611,NM_001048174.2(MUTYH):c.649C>T (p.Arg217Cys),MUTYH,gastric cancer,C0699791,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
611,NM_001048174.2(MUTYH):c.649C>T (p.Arg217Cys),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
611,NM_001048174.2(MUTYH):c.649C>T (p.Arg217Cys),MUTYH,familial colorectal cancer,CL495361,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
611,NM_001048174.2(MUTYH):c.649C>T (p.Arg217Cys),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
612,NM_001048174.2(MUTYH):c.638G>A (p.Arg213Gln),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
612,NM_001048174.2(MUTYH):c.638G>A (p.Arg213Gln),MUTYH,familial adenomatous polyposis 2,C1837991,"likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
613,NM_001048174.2(MUTYH):c.637C>T (p.Arg213Trp),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
613,NM_001048174.2(MUTYH):c.637C>T (p.Arg213Trp),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
614,NM_001048174.2(MUTYH):c.622G>A (p.Asp208Asn),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: dec 10, 2019)","criteria provided, single submitter"
615,NM_001048174.2(MUTYH):c.606G>C (p.Gln202His),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 20, 2019)","criteria provided, single submitter"
616,NM_001048174.2(MUTYH):c.461G>A (p.Arg154His),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
616,NM_001048174.2(MUTYH):c.461G>A (p.Arg154His),MUTYH,gastric cancer,C0699791,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
616,NM_001048174.2(MUTYH):c.461G>A (p.Arg154His),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
616,NM_001048174.2(MUTYH):c.461G>A (p.Arg154His),MUTYH,not specified,Cumapped182,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
616,NM_001048174.2(MUTYH):c.461G>A (p.Arg154His),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,gastric cancer,C0699791,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,lowry-maclean syndrome,C0796020,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,paragangliomas 1,C0030421,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
617,NM_001048174.2(MUTYH):c.452A>G (p.Tyr151Cys),MUTYH,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
618,NM_001048174.2(MUTYH):c.323T>C (p.Met108Thr),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
619,NM_001048174.2(MUTYH):c.307T>A (p.Trp103Arg),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
619,NM_001048174.2(MUTYH):c.307T>A (p.Trp103Arg),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
620,NM_001048174.2(MUTYH):c.300T>A (p.Tyr100Ter),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
620,NM_001048174.2(MUTYH):c.300T>A (p.Tyr100Ter),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
621,NM_001048174.2(MUTYH):c.248T>C (p.Leu83Pro),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
621,NM_001048174.2(MUTYH):c.248T>C (p.Leu83Pro),MUTYH,familial adenomatous polyposis 2,C1837991,"likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
622,NM_001048174.2(MUTYH):c.247C>G (p.Leu83Val),MUTYH,familial adenomatous polyposis 2,C1837991,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
623,NM_001048174.2(MUTYH):c.241C>G (p.Arg81Gly),MUTYH,familial adenomatous polyposis 2,C1837991,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
624,NM_001048174.2(MUTYH):c.241C>T (p.Arg81Trp),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
624,NM_001048174.2(MUTYH):c.241C>T (p.Arg81Trp),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
625,NM_001048174.2(MUTYH):c.169C>G (p.His57Asp),MUTYH,familial adenomatous polyposis 2,C1837991,"likely pathogenic(last reviewed: feb 18, 2021)","criteria provided, single submitter"
626,NM_001048174.2(MUTYH):c.1A>G (p.Met1Val),MUTYH,familial adenomatous polyposis 2,C1837991,"pathogenic/likely pathogenic(last reviewed: oct 5, 2021)","criteria provided, multiple submitters, no conflicts"
626,NM_001048174.2(MUTYH):c.1A>G (p.Met1Val),MUTYH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 5, 2021)","criteria provided, multiple submitters, no conflicts"
627,NM_025077.4(TOE1):c.551G>T (p.Arg184Leu),TOE1,pontocerebellar hypoplasia type 7,C3554226,"likely pathogenic(last reviewed: sep 19, 2021)","criteria provided, single submitter"
628,NM_015506.3(MMACHC):c.1A>G (p.Met1Val),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
629,NM_015506.3(MMACHC):c.2T>G (p.Met1Arg),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: jul 31, 2021)","criteria provided, multiple submitters, no conflicts"
630,NM_015506.3(MMACHC):c.2T>C (p.Met1Thr),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: nov 7, 2019)","criteria provided, multiple submitters, no conflicts"
631,NM_015506.3(MMACHC):c.3G>A (p.Met1Ile),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
632,NM_015506.3(MMACHC):c.80A>G (p.Gln27Arg),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: aug 30, 2022)","criteria provided, multiple submitters, no conflicts"
633,NM_015506.3(MMACHC):c.182G>C (p.Arg61Pro),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
634,NM_015506.3(MMACHC):c.276G>T (p.Glu92Asp),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
635,NM_015506.3(MMACHC):c.346C>G (p.Leu116Val),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, single submitter"
636,NM_015506.3(MMACHC):c.346C>A (p.Leu116Met),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: aug 14, 2021)","criteria provided, single submitter"
637,NM_015506.3(MMACHC):c.347T>C (p.Leu116Pro),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
638,NM_015506.3(MMACHC):c.366T>A (p.His122Gln),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
639,NM_015506.3(MMACHC):c.366T>G (p.His122Gln),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
640,NM_015506.3(MMACHC):c.388T>C (p.Tyr130His),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
641,NM_015506.3(MMACHC):c.439G>C (p.Gly147Arg),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: jul 2, 2022)","criteria provided, single submitter"
642,NM_015506.3(MMACHC):c.439G>A (p.Gly147Ser),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
643,NM_015506.3(MMACHC):c.440G>A (p.Gly147Asp),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
644,NM_015506.3(MMACHC):c.440G>C (p.Gly147Ala),MMACHC,disorders of intracellular cobalamin metabolism,Cumapped62,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
644,NM_015506.3(MMACHC):c.440G>C (p.Gly147Ala),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
645,NM_015506.3(MMACHC):c.449T>A (p.Ile150Lys),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
646,NM_015506.3(MMACHC):c.463G>C (p.Gly155Arg),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, single submitter"
647,NM_015506.3(MMACHC):c.466G>A (p.Gly156Ser),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: nov 14, 2021)","criteria provided, single submitter"
648,NM_015506.3(MMACHC):c.471G>C (p.Trp157Cys),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: jun 21, 2021)","criteria provided, multiple submitters, no conflicts"
649,NM_015506.3(MMACHC):c.481C>G (p.Arg161Gly),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
650,NM_015506.3(MMACHC):c.482G>T (p.Arg161Leu),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: jul 13, 2022)","criteria provided, single submitter"
651,NM_015506.3(MMACHC):c.565C>A (p.Arg189Ser),MMACHC,cobalamin c disease,C1848561,"pathogenic/likely pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
652,NM_015506.3(MMACHC):c.566G>T (p.Arg189Leu),MMACHC,cobalamin c disease,C1848561,"likely pathogenic(last reviewed: may 19, 2022)","criteria provided, single submitter"
653,NM_015506.3(MMACHC):c.578T>C (p.Leu193Pro),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
654,NM_015506.3(MMACHC):c.643T>C (p.Tyr215His),MMACHC,cobalamin c disease,C1848561,"pathogenic(last reviewed: may 25, 2022)","criteria provided, single submitter"
655,NM_017739.4(POMGNT1):c.1814G>T (p.Arg605Leu),TSPAN1|POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
655,NM_017739.4(POMGNT1):c.1814G>T (p.Arg605Leu),TSPAN1|POMGNT1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
656,NM_017739.4(POMGNT1):c.1814G>A (p.Arg605His),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
656,NM_017739.4(POMGNT1):c.1814G>A (p.Arg605His),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
656,NM_017739.4(POMGNT1):c.1814G>A (p.Arg605His),POMGNT1|TSPAN1,muscular dystrophy-dystroglycanopathy,Cumapped135,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
656,NM_017739.4(POMGNT1):c.1814G>A (p.Arg605His),POMGNT1|TSPAN1,muscle eye brain disease,C0457133,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
657,NM_017739.4(POMGNT1):c.1814G>C (p.Arg605Pro),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
657,NM_017739.4(POMGNT1):c.1814G>C (p.Arg605Pro),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
657,NM_017739.4(POMGNT1):c.1814G>C (p.Arg605Pro),POMGNT1|TSPAN1,muscular dystrophy-dystroglycanopathy,Cumapped135,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
657,NM_017739.4(POMGNT1):c.1814G>C (p.Arg605Pro),POMGNT1|TSPAN1,muscle eye brain disease,C0457133,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
657,NM_017739.4(POMGNT1):c.1814G>C (p.Arg605Pro),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
658,NM_017739.4(POMGNT1):c.1813C>A (p.Arg605Ser),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"likely pathogenic(last reviewed: nov 24, 2021)","criteria provided, single submitter"
658,NM_017739.4(POMGNT1):c.1813C>A (p.Arg605Ser),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"likely pathogenic(last reviewed: nov 24, 2021)","criteria provided, single submitter"
659,NM_017739.4(POMGNT1):c.1649G>A (p.Ser550Asn),POMGNT1|TSPAN1,muscle eye brain disease,C0457133,"likely pathogenic(last reviewed: jun 25, 2014)","criteria provided, single submitter"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,retinitis pigmentosa 76,C4310704,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a3",C3151519,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,muscular dystrophy-dystroglycanopathy,Cumapped135,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
660,NM_017739.4(POMGNT1):c.1469G>A (p.Cys490Tyr),POMGNT1|TSPAN1,muscle eye brain disease,C0457133,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
661,NM_017739.4(POMGNT1):c.1468T>G (p.Cys490Gly),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"likely pathogenic(last reviewed: jan 23, 2022)","criteria provided, single submitter"
661,NM_017739.4(POMGNT1):c.1468T>G (p.Cys490Gly),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"likely pathogenic(last reviewed: jan 23, 2022)","criteria provided, single submitter"
662,NM_017739.4(POMGNT1):c.1343G>A (p.Gly448Glu),TSPAN1|POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"likely pathogenic(last reviewed: jun 17, 2022)","criteria provided, single submitter"
662,NM_017739.4(POMGNT1):c.1343G>A (p.Gly448Glu),TSPAN1|POMGNT1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"likely pathogenic(last reviewed: jun 17, 2022)","criteria provided, single submitter"
663,NM_017739.4(POMGNT1):c.1325G>A (p.Arg442His),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
663,NM_017739.4(POMGNT1):c.1325G>A (p.Arg442His),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
663,NM_017739.4(POMGNT1):c.1325G>A (p.Arg442His),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a3",C3151519,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
663,NM_017739.4(POMGNT1):c.1325G>A (p.Arg442His),POMGNT1|TSPAN1,muscular dystrophy-dystroglycanopathy,Cumapped135,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
663,NM_017739.4(POMGNT1):c.1325G>A (p.Arg442His),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy,C0686353,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
664,NM_017739.4(POMGNT1):c.1324C>T (p.Arg442Cys),POMGNT1|TSPAN1,muscular dystrophy-dystroglycanopathy,Cumapped135,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
664,NM_017739.4(POMGNT1):c.1324C>T (p.Arg442Cys),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
664,NM_017739.4(POMGNT1):c.1324C>T (p.Arg442Cys),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
664,NM_017739.4(POMGNT1):c.1324C>T (p.Arg442Cys),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy,C0686353,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
664,NM_017739.4(POMGNT1):c.1324C>T (p.Arg442Cys),POMGNT1|TSPAN1,muscle eye brain disease,C0457133,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
665,NM_017739.4(POMGNT1):c.1286G>T (p.Gly429Val),TSPAN1|POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a3",C3151519,likely pathogenic,"criteria provided, single submitter"
666,NM_017739.4(POMGNT1):c.1268C>T (p.Ser423Phe),TSPAN1|POMGNT1,muscle eye brain disease,C0457133,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
667,NM_017739.4(POMGNT1):c.932G>A (p.Arg311Gln),POMGNT1|TSPAN1,muscular dystrophy-dystroglycanopathy,Cumapped135,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
667,NM_017739.4(POMGNT1):c.932G>A (p.Arg311Gln),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
667,NM_017739.4(POMGNT1):c.932G>A (p.Arg311Gln),POMGNT1|TSPAN1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
667,NM_017739.4(POMGNT1):c.932G>A (p.Arg311Gln),POMGNT1|TSPAN1,autosomal recessive limb-girdle muscular dystrophy,C0686353,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
667,NM_017739.4(POMGNT1):c.932G>A (p.Arg311Gln),POMGNT1|TSPAN1,muscle eye brain disease,C0457133,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
668,NM_017739.4(POMGNT1):c.931C>G (p.Arg311Gly),TSPAN1|POMGNT1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"likely pathogenic(last reviewed: oct 6, 2022)","criteria provided, single submitter"
668,NM_017739.4(POMGNT1):c.931C>G (p.Arg311Gly),TSPAN1|POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"likely pathogenic(last reviewed: oct 6, 2022)","criteria provided, single submitter"
669,NM_017739.4(POMGNT1):c.316A>C (p.Ser106Arg),POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type a3",C3151519,likely pathogenic,"criteria provided, single submitter"
670,NM_017739.4(POMGNT1):c.3G>A (p.Met1Ile),POMGNT1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic(last reviewed: jan 13, 2022)","criteria provided, single submitter"
670,NM_017739.4(POMGNT1):c.3G>A (p.Met1Ile),POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic(last reviewed: jan 13, 2022)","criteria provided, single submitter"
671,NM_017739.4(POMGNT1):c.1A>G (p.Met1Val),POMGNT1,autosomal recessive limb-girdle muscular dystrophy type 2o,C4510742,"pathogenic(last reviewed: jul 9, 2022)","criteria provided, single submitter"
671,NM_017739.4(POMGNT1):c.1A>G (p.Met1Val),POMGNT1,"muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type b3",C3150412,"pathogenic(last reviewed: jul 9, 2022)","criteria provided, single submitter"
672,NM_003579.4(RAD54L):c.1883A>C (p.Glu628Ala),LRRC41|RAD54L,premature ovarian failure,C0085215,"likely pathogenic(last reviewed: mar 2, 2020)","criteria provided, single submitter"
673,NM_003579.4(RAD54L):c.1900C>T (p.Arg634Cys),LRRC41|RAD54L,premature ovarian failure,C0085215,"likely pathogenic(last reviewed: mar 2, 2020)","criteria provided, single submitter"
674,NM_001048166.1(STIL):c.1226G>C (p.Ser409Thr),STIL,abnormality of brain morphology,C4021085,likely pathogenic,"criteria provided, single submitter"
675,NM_001048166.1(STIL):c.895T>A (p.Phe299Ile),STIL,"microcephaly 7, primary, autosomal recessive",C2675187,"likely pathogenic(last reviewed: feb 8, 2013)","criteria provided, single submitter"
676,NM_012186.3(FOXE3):c.244A>G (p.Met82Val),FOXE3|LINC01389,congenital primary aphakia,C1853230,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
676,NM_012186.3(FOXE3):c.244A>G (p.Met82Val),FOXE3|LINC01389,congenital primary aphakia,C1853230,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
676,NM_012186.3(FOXE3):c.244A>G (p.Met82Val),FOXE3|LINC01389,anterior segment dysgenesis,C3552341,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
677,NM_012186.3(FOXE3):c.289A>G (p.Ile97Val),FOXE3|LINC01389,congenital primary aphakia,C1853230,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
678,NM_012186.3(FOXE3):c.291C>G (p.Ile97Met),FOXE3|LINC01389,congenital primary aphakia,C1853230,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
678,NM_012186.3(FOXE3):c.291C>G (p.Ile97Met),FOXE3|LINC01389,anterior segment dysgenesis,C3552341,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
679,NM_012186.3(FOXE3):c.310C>T (p.Arg104Cys),FOXE3|LINC01389,congenital primary aphakia,C1853230,"likely pathogenic(last reviewed: jun 1, 2017)","criteria provided, single submitter"
680,NM_012186.3(FOXE3):c.387C>G (p.Phe129Leu),FOXE3|LINC01389,congenital primary aphakia,C1853230,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
680,NM_012186.3(FOXE3):c.387C>G (p.Phe129Leu),FOXE3|LINC01389,anterior segment dysgenesis,C3552341,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
681,NM_004153.4(ORC1):c.1865T>C (p.Leu622Pro),ORC1,meier-gorlin syndrome 1,C4552001,pathogenic,"criteria provided, single submitter"
682,NM_004153.4(ORC1):c.314G>A (p.Arg105Gln),ORC1,meier-gorlin syndrome,C1868684,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
682,NM_004153.4(ORC1):c.314G>A (p.Arg105Gln),ORC1,meier-gorlin syndrome 1,C4552001,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
683,NM_004153.4(ORC1):c.313C>T (p.Arg105Trp),ORC1,meier-gorlin syndrome 1,C4552001,likely pathogenic,"criteria provided, single submitter"
684,NM_004153.4(ORC1):c.217G>A (p.Glu73Lys),ORC1,meier-gorlin syndrome 1,C4552001,pathogenic,"criteria provided, single submitter"
685,NM_000098.3(CPT2):c.148C>T (p.Pro50Ser),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,pancytopenia,C0030312,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,sinus tachycardia,C2108109,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,inappropriate sinus tachycardia,C4048808,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,polyarticular arthritis,C0162323,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,abnormal autonomic nervous system physiology,C0013363,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,gastrointestinal dysmotility,C1836923,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,chronic pain,C0150055,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
686,NM_000098.3(CPT2):c.149C>A (p.Pro50His),CPT2,arthritis,C4552845,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
687,NM_000098.3(CPT2):c.188G>T (p.Arg63Ile),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
688,NM_000098.3(CPT2):c.200C>G (p.Ala67Gly),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
689,NM_000098.3(CPT2):c.251G>A (p.Cys84Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
690,NM_000098.3(CPT2):c.359A>G (p.Tyr120Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
691,NM_000098.3(CPT2):c.451C>T (p.Arg151Trp),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
692,NM_000098.3(CPT2):c.452G>A (p.Arg151Gln),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
692,NM_000098.3(CPT2):c.452G>A (p.Arg151Gln),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
692,NM_000098.3(CPT2):c.452G>A (p.Arg151Gln),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
692,NM_000098.3(CPT2):c.452G>A (p.Arg151Gln),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
692,NM_000098.3(CPT2):c.452G>A (p.Arg151Gln),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
693,NM_000098.3(CPT2):c.520G>A (p.Glu174Lys),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
693,NM_000098.3(CPT2):c.520G>A (p.Glu174Lys),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
694,NM_000098.3(CPT2):c.680C>T (p.Pro227Leu),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, multiple submitters, no conflicts"
694,NM_000098.3(CPT2):c.680C>T (p.Pro227Leu),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic/likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, multiple submitters, no conflicts"
694,NM_000098.3(CPT2):c.680C>T (p.Pro227Leu),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, multiple submitters, no conflicts"
694,NM_000098.3(CPT2):c.680C>T (p.Pro227Leu),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, multiple submitters, no conflicts"
694,NM_000098.3(CPT2):c.680C>T (p.Pro227Leu),CPT2,aldosterone-producing adenoma with seizures and neurological abnormalities,Cumapped6,"pathogenic/likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, multiple submitters, no conflicts"
694,NM_000098.3(CPT2):c.680C>T (p.Pro227Leu),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, multiple submitters, no conflicts"
695,NM_000098.3(CPT2):c.764A>G (p.Asp255Gly),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"likely pathogenic(last reviewed: may 10, 2019)","criteria provided, single submitter"
696,NM_000098.3(CPT2):c.886C>G (p.Arg296Gly),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: may 31, 2022)","criteria provided, single submitter"
697,NM_000098.3(CPT2):c.887G>C (p.Arg296Pro),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
698,NM_000098.3(CPT2):c.1033G>A (p.Gly345Arg),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"likely pathogenic(last reviewed: may 10, 2019)","criteria provided, single submitter"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,seizure,C0036572,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
699,NM_000098.3(CPT2):c.1148T>A (p.Phe383Tyr),CPT2,abnormality of the nervous system,C0497552,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
700,NM_000098.3(CPT2):c.1436A>G (p.Tyr479Cys),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, single submitter"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
701,NM_000098.3(CPT2):c.1507C>T (p.Arg503Cys),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
702,NM_000098.3(CPT2):c.1511C>T (p.Pro504Leu),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
703,NM_000098.3(CPT2):c.1665C>G (p.His555Gln),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
704,NM_000098.3(CPT2):c.1798G>A (p.Gly600Arg),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic(last reviewed: may 5, 2022)","criteria provided, single submitter"
705,NM_000098.3(CPT2):c.1799G>A (p.Gly600Glu),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
706,NM_000098.3(CPT2):c.1813G>C (p.Val605Leu),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"likely pathogenic(last reviewed: apr 22, 2022)","criteria provided, single submitter"
707,NM_000098.3(CPT2):c.1883A>C (p.Tyr628Ser),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic/likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
708,NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys),CPT2,carnitine palmitoyltransferase ii deficiency,C0342790,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
708,NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, neonatal form",C1833518,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
708,NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys),CPT2,"encephalopathy, acute, infection-induced, susceptibility to, 4",C3280160,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
708,NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, myopathic form",C1850734,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
708,NM_000098.3(CPT2):c.1891C>T (p.Arg631Cys),CPT2,"carnitine palmitoyl transferase ii deficiency, severe infantile form",C1850734,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
709,NM_014762.4(DHCR24):c.1532G>A (p.Cys511Tyr),DHCR24,desmosterolosis,C1865596,"likely pathogenic(last reviewed: sep 13, 2018)","criteria provided, single submitter"
710,NM_014762.4(DHCR24):c.1504G>A (p.Ala502Thr),DHCR24,desmosterolosis,C1865596,"likely pathogenic(last reviewed: sep 13, 2018)","criteria provided, single submitter"
711,NM_014762.4(DHCR24):c.571G>A (p.Glu191Lys),DHCR24,desmosterolosis,C1865596,"likely pathogenic(last reviewed: mar 8, 2022)","criteria provided, multiple submitters, no conflicts"
712,NM_014762.4(DHCR24):c.281G>A (p.Arg94His),DHCR24,desmosterolosis,C1865596,"likely pathogenic(last reviewed: nov 7, 2019)","criteria provided, single submitter"
713,NM_057176.3(BSND):c.1A>T (p.Met1Leu),BSND,bartter disease type 4a,C1865270,"pathogenic(last reviewed: sep 5, 2022)","criteria provided, multiple submitters, no conflicts"
714,NM_057176.3(BSND):c.3G>A (p.Met1Ile),BSND,bartter disease type 4a,C1865270,"pathogenic/likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
715,NM_057176.3(BSND):c.22C>T (p.Arg8Trp),BSND,bartter syndrome,C0004775,"pathogenic/likely pathogenic(last reviewed: nov 7, 2022)","criteria provided, multiple submitters, no conflicts"
716,NM_057176.3(BSND):c.28G>A (p.Gly10Ser),BSND,bartter syndrome,C0004775,"likely pathogenic(last reviewed: jun 7, 2022)","criteria provided, single submitter"
717,NM_057176.3(BSND):c.97G>C (p.Val33Leu),BSND,bartter disease type 4a,C1865270,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
717,NM_057176.3(BSND):c.97G>C (p.Val33Leu),BSND,bartter syndrome,C0004775,"pathogenic/likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, multiple submitters, no conflicts"
718,NM_057176.3(BSND):c.139G>A (p.Gly47Arg),BSND,bartter disease type 4a,C1865270,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
719,NM_174936.4(PCSK9):c.381T>G (p.Ser127Arg),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"pathogenic(last reviewed: aug 30, 2022)","criteria provided, single submitter"
720,NM_174936.4(PCSK9):c.381T>A (p.Ser127Arg),PCSK9,"hypercholesterolemia, familial, 1",C0745103,"pathogenic/likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, multiple submitters, no conflicts"
720,NM_174936.4(PCSK9):c.381T>A (p.Ser127Arg),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"pathogenic/likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, multiple submitters, no conflicts"
721,NM_174936.4(PCSK9):c.386A>G (p.Asp129Gly),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
721,NM_174936.4(PCSK9):c.386A>G (p.Asp129Gly),PCSK9,"hypercholesterolemia, familial, 1",C0745103,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
722,NM_174936.4(PCSK9):c.652A>G (p.Arg218Gly),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, single submitter"
723,NM_174936.4(PCSK9):c.653G>C (p.Arg218Thr),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
724,NM_174936.4(PCSK9):c.1061A>T (p.Asn354Ile),PCSK9,"hypercholesterolemia, familial, 1",C0745103,"likely pathogenic(last reviewed: mar 1, 2016)","criteria provided, single submitter"
725,NM_174936.4(PCSK9):c.1120G>C (p.Asp374His),PCSK9,"hypercholesterolemia, familial, 1",C0745103,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
725,NM_174936.4(PCSK9):c.1120G>C (p.Asp374His),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
726,NM_174936.4(PCSK9):c.1120G>T (p.Asp374Tyr),PCSK9,"hypercholesterolemia, familial, 1",C0745103,"pathogenic/likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
726,NM_174936.4(PCSK9):c.1120G>T (p.Asp374Tyr),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"pathogenic/likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
727,NM_174936.4(PCSK9):c.1394C>G (p.Ser465Trp),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
728,NM_174936.4(PCSK9):c.1906A>C (p.Ser636Arg),PCSK9,"hypercholesterolemia, autosomal dominant, 3",C1863551,"likely pathogenic(last reviewed: may 24, 2021)","criteria provided, single submitter"
729,NM_001365792.1(DAB1):c.763C>T (p.Pro255Ser),DAB1,spastic ataxia,Cumapped289,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
730,NM_001367561.1(DOCK7):c.2977T>C (p.Trp993Arg),DOCK7,"developmental and epileptic encephalopathy, 23",C4014492,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
731,NM_013339.4(ALG6):c.2T>C (p.Met1Thr),ALG6,alg6-congenital disorder of glycosylation 1c,Cumapped8,"likely pathogenic(last reviewed: apr 25, 2018)","criteria provided, single submitter"
732,NM_013339.4(ALG6):c.250G>A (p.Ala84Thr),ALG6,alg6-congenital disorder of glycosylation 1c,Cumapped8,"likely pathogenic(last reviewed: nov 18, 2021)","criteria provided, multiple submitters, no conflicts"
733,NM_013339.4(ALG6):c.337C>T (p.Arg113Cys),ALG6,alg6-congenital disorder of glycosylation 1c,Cumapped8,"likely pathogenic(last reviewed: jun 7, 2022)","criteria provided, single submitter"
734,NM_013339.4(ALG6):c.998C>T (p.Ala333Val),ALG6,alg6-congenital disorder of glycosylation 1c,Cumapped8,"pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
735,NM_002633.3(PGM1):c.112A>T (p.Asn38Tyr),PGM1,pgm1-congenital disorder of glycosylation,C2752015,"pathogenic(last reviewed: apr 26, 2022)","criteria provided, single submitter"
736,NM_002633.3(PGM1):c.787G>T (p.Asp263Tyr),PGM1,pgm1-congenital disorder of glycosylation,C2752015,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
737,NM_002633.3(PGM1):c.871G>A (p.Gly291Arg),PGM1,pgm1-congenital disorder of glycosylation,C2752015,"likely pathogenic(last reviewed: dec 31, 2021)","criteria provided, single submitter"
738,NM_002633.3(PGM1):c.988G>C (p.Gly330Arg),PGM1,pgm1-congenital disorder of glycosylation,C2752015,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
739,NM_002633.3(PGM1):c.1544G>A (p.Arg515Gln),PGM1,pgm1-congenital disorder of glycosylation,C2752015,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
740,NM_002227.4(JAK1):c.2347C>T (p.Leu783Phe),JAK1,acute megakaryoblastic leukemia in down syndrome,C0023462,"likely pathogenic(last reviewed: sep 1, 2020)","criteria provided, single submitter"
741,NM_002303.6(LEPR):c.2880C>G (p.Asn960Lys),LEPR,obesity,C1963185,"likely pathogenic(last reviewed: aug 18, 2011)","criteria provided, single submitter"
742,NM_024911.7(WLS):c.1606C>T (p.Arg536Cys),WLS|GNG12-AS1,wls syndrome,Cumapped352,"likely pathogenic(last reviewed: apr 21, 2021)","criteria provided, single submitter"
743,NM_024911.7(WLS):c.1592T>C (p.Ile531Thr),GNG12-AS1|WLS,wls syndrome,Cumapped352,"likely pathogenic(last reviewed: apr 21, 2021)","criteria provided, single submitter"
744,NM_024911.7(WLS):c.1433A>G (p.Tyr478Cys),GNG12-AS1|WLS,wls syndrome,Cumapped352,"pathogenic(last reviewed: apr 21, 2021)","criteria provided, single submitter"
745,NM_024911.7(WLS):c.1175A>G (p.Tyr392Cys),GNG12-AS1|WLS,wls syndrome,Cumapped352,"pathogenic(last reviewed: apr 21, 2021)","criteria provided, single submitter"
746,NM_000329.3(RPE65):c.1590C>A (p.Phe530Leu),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
746,NM_000329.3(RPE65):c.1590C>A (p.Phe530Leu),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
747,NM_000329.3(RPE65):c.1583G>T (p.Gly528Val),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
748,NM_000329.3(RPE65):c.1543C>T (p.Arg515Trp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
748,NM_000329.3(RPE65):c.1543C>T (p.Arg515Trp),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
749,NM_000329.3(RPE65):c.1451G>T (p.Gly484Val),RPE65,leber congenital amaurosis,C0339527,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
750,NM_000329.3(RPE65):c.1451G>A (p.Gly484Asp),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
750,NM_000329.3(RPE65):c.1451G>A (p.Gly484Asp),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
750,NM_000329.3(RPE65):c.1451G>A (p.Gly484Asp),RPE65,leber congenital amaurosis,C0339527,"likely pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
751,NM_000329.3(RPE65):c.1430A>G (p.Asp477Gly),RPE65,neurodevelopmental disorder,C1535926,"pathogenic/likely pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
751,NM_000329.3(RPE65):c.1430A>G (p.Asp477Gly),RPE65,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
751,NM_000329.3(RPE65):c.1430A>G (p.Asp477Gly),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
751,NM_000329.3(RPE65):c.1430A>G (p.Asp477Gly),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
751,NM_000329.3(RPE65):c.1430A>G (p.Asp477Gly),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: feb 2, 2023)","criteria provided, multiple submitters, no conflicts"
752,NM_000329.3(RPE65):c.1418T>A (p.Val473Asp),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: aug 20, 2020)","criteria provided, single submitter"
752,NM_000329.3(RPE65):c.1418T>A (p.Val473Asp),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: aug 20, 2020)","criteria provided, single submitter"
753,NM_000329.3(RPE65):c.1409C>T (p.Pro470Leu),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
753,NM_000329.3(RPE65):c.1409C>T (p.Pro470Leu),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
754,NM_000329.3(RPE65):c.1399C>A (p.Pro467Thr),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: jan 23, 2022)","criteria provided, single submitter"
754,NM_000329.3(RPE65):c.1399C>A (p.Pro467Thr),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: jan 23, 2022)","criteria provided, single submitter"
755,NM_000329.3(RPE65):c.1399C>G (p.Pro467Ala),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
755,NM_000329.3(RPE65):c.1399C>G (p.Pro467Ala),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
756,NM_000329.3(RPE65):c.1399C>T (p.Pro467Ser),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
756,NM_000329.3(RPE65):c.1399C>T (p.Pro467Ser),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
757,NM_000329.3(RPE65):c.1338G>T (p.Arg446Ser),RPE65,leber congenital amaurosis,C0339527,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
757,NM_000329.3(RPE65):c.1338G>T (p.Arg446Ser),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
757,NM_000329.3(RPE65):c.1338G>T (p.Arg446Ser),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
758,NM_000329.3(RPE65):c.1309C>T (p.Leu437Phe),RPE65,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: aug 16, 2019)","criteria provided, single submitter"
759,NM_000329.3(RPE65):c.1292A>G (p.Tyr431Cys),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
759,NM_000329.3(RPE65):c.1292A>G (p.Tyr431Cys),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
760,NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln),RPE65,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
760,NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
760,NM_000329.3(RPE65):c.1249G>C (p.Glu417Gln),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
761,NM_000329.3(RPE65):c.1243G>A (p.Ala415Thr),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
761,NM_000329.3(RPE65):c.1243G>A (p.Ala415Thr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
761,NM_000329.3(RPE65):c.1243G>A (p.Ala415Thr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
762,NM_000329.3(RPE65):c.1223T>C (p.Leu408Pro),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: dec 23, 2022)","criteria provided, multiple submitters, no conflicts"
762,NM_000329.3(RPE65):c.1223T>C (p.Leu408Pro),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: dec 23, 2022)","criteria provided, multiple submitters, no conflicts"
762,NM_000329.3(RPE65):c.1223T>C (p.Leu408Pro),RPE65,leber congenital amaurosis,C0339527,"pathogenic/likely pathogenic(last reviewed: dec 23, 2022)","criteria provided, multiple submitters, no conflicts"
762,NM_000329.3(RPE65):c.1223T>C (p.Leu408Pro),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: dec 23, 2022)","criteria provided, multiple submitters, no conflicts"
763,NM_000329.3(RPE65):c.1102T>C (p.Tyr368His),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
763,NM_000329.3(RPE65):c.1102T>C (p.Tyr368His),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
763,NM_000329.3(RPE65):c.1102T>C (p.Tyr368His),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
764,NM_000329.3(RPE65):c.1087C>A (p.Pro363Thr),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: may 17, 2022)","criteria provided, multiple submitters, no conflicts"
764,NM_000329.3(RPE65):c.1087C>A (p.Pro363Thr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: may 17, 2022)","criteria provided, multiple submitters, no conflicts"
764,NM_000329.3(RPE65):c.1087C>A (p.Pro363Thr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: may 17, 2022)","criteria provided, multiple submitters, no conflicts"
765,NM_000329.3(RPE65):c.1078G>C (p.Ala360Pro),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
765,NM_000329.3(RPE65):c.1078G>C (p.Ala360Pro),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
766,NM_000329.3(RPE65):c.1039C>T (p.Arg347Cys),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: dec 2, 2021)","criteria provided, single submitter"
766,NM_000329.3(RPE65):c.1039C>T (p.Arg347Cys),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: dec 2, 2021)","criteria provided, single submitter"
767,NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
767,NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
767,NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser),RPE65,retinitis pigmentosa 87 with choroidal involvement,C5231465,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
767,NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
767,NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
767,NM_000329.3(RPE65):c.1022T>C (p.Leu341Ser),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
768,NM_000329.3(RPE65):c.1004A>T (p.Glu335Val),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
769,NM_000329.3(RPE65):c.989G>A (p.Cys330Tyr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
769,NM_000329.3(RPE65):c.989G>A (p.Cys330Tyr),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
770,NM_000329.3(RPE65):c.952T>A (p.Tyr318Asn),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
770,NM_000329.3(RPE65):c.952T>A (p.Tyr318Asn),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
770,NM_000329.3(RPE65):c.952T>A (p.Tyr318Asn),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
771,NM_000329.3(RPE65):c.938A>C (p.His313Pro),RPE65,abnormality of the eye,C4316870,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
772,NM_000329.3(RPE65):c.917C>T (p.Thr306Ile),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
772,NM_000329.3(RPE65):c.917C>T (p.Thr306Ile),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
773,NM_000329.3(RPE65):c.859G>T (p.Val287Phe),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: apr 21, 2022)","criteria provided, single submitter"
774,NM_000329.3(RPE65):c.746A>G (p.Tyr249Cys),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
774,NM_000329.3(RPE65):c.746A>G (p.Tyr249Cys),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
775,NM_000329.3(RPE65):c.718G>T (p.Val240Phe),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
775,NM_000329.3(RPE65):c.718G>T (p.Val240Phe),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
775,NM_000329.3(RPE65):c.718G>T (p.Val240Phe),RPE65,leber congenital amaurosis,C0339527,"likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
776,NM_000329.3(RPE65):c.715T>G (p.Tyr239Asp),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
776,NM_000329.3(RPE65):c.715T>G (p.Tyr239Asp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
777,NM_000329.3(RPE65):c.617T>C (p.Ile206Thr),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
777,NM_000329.3(RPE65):c.617T>C (p.Ile206Thr),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
777,NM_000329.3(RPE65):c.617T>C (p.Ile206Thr),RPE65,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
778,NM_000329.3(RPE65):c.556G>A (p.Asp186Asn),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: dec 18, 2017)","criteria provided, single submitter"
779,NM_000329.3(RPE65):c.545A>G (p.His182Arg),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: feb 20, 2022)","criteria provided, single submitter"
779,NM_000329.3(RPE65):c.545A>G (p.His182Arg),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: feb 20, 2022)","criteria provided, single submitter"
780,NM_000329.3(RPE65):c.544C>T (p.His182Tyr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
780,NM_000329.3(RPE65):c.544C>T (p.His182Tyr),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
781,NM_000329.3(RPE65):c.499G>T (p.Asp167Tyr),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
781,NM_000329.3(RPE65):c.499G>T (p.Asp167Tyr),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
781,NM_000329.3(RPE65):c.499G>T (p.Asp167Tyr),RPE65,leber congenital amaurosis,C0339527,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
782,NM_000329.3(RPE65):c.430T>G (p.Tyr144Asp),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: aug 19, 2021)","criteria provided, single submitter"
782,NM_000329.3(RPE65):c.430T>G (p.Tyr144Asp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: aug 19, 2021)","criteria provided, single submitter"
783,NM_000329.3(RPE65):c.419G>A (p.Gly140Glu),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
783,NM_000329.3(RPE65):c.419G>A (p.Gly140Glu),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
783,NM_000329.3(RPE65):c.419G>A (p.Gly140Glu),RPE65,leber congenital amaurosis,C0339527,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
784,NM_000329.3(RPE65):c.405T>A (p.Asn135Lys),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, single submitter"
784,NM_000329.3(RPE65):c.405T>A (p.Asn135Lys),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, single submitter"
785,NM_000329.3(RPE65):c.344T>C (p.Ile115Thr),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
785,NM_000329.3(RPE65):c.344T>C (p.Ile115Thr),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
786,NM_000329.3(RPE65):c.329A>G (p.Asp110Gly),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
786,NM_000329.3(RPE65):c.329A>G (p.Asp110Gly),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
787,NM_000329.3(RPE65):c.311G>A (p.Gly104Asp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, single submitter"
787,NM_000329.3(RPE65):c.311G>A (p.Gly104Asp),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, single submitter"
788,NM_000329.3(RPE65):c.311G>T (p.Gly104Val),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: jun 22, 2021)","criteria provided, single submitter"
789,NM_000329.3(RPE65):c.310G>A (p.Gly104Ser),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: may 6, 2022)","criteria provided, single submitter"
789,NM_000329.3(RPE65):c.310G>A (p.Gly104Ser),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: may 6, 2022)","criteria provided, single submitter"
790,NM_000329.3(RPE65):c.272G>A (p.Arg91Gln),RPE65,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
790,NM_000329.3(RPE65):c.272G>A (p.Arg91Gln),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
790,NM_000329.3(RPE65):c.272G>A (p.Arg91Gln),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
790,NM_000329.3(RPE65):c.272G>A (p.Arg91Gln),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,leber congenital amaurosis,C0339527,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,retinal dystrophy,C4229674,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
791,NM_000329.3(RPE65):c.271C>T (p.Arg91Trp),RPE65,abnormality of the eye,C4316870,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
792,NM_000329.3(RPE65):c.247T>C (p.Phe83Leu),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: may 31, 2022)","criteria provided, single submitter"
792,NM_000329.3(RPE65):c.247T>C (p.Phe83Leu),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: may 31, 2022)","criteria provided, single submitter"
793,NM_000329.3(RPE65):c.200T>G (p.Leu67Arg),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
793,NM_000329.3(RPE65):c.200T>G (p.Leu67Arg),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
794,NM_000329.3(RPE65):c.170T>C (p.Phe57Ser),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: apr 9, 2018)","criteria provided, single submitter"
795,NM_000329.3(RPE65):c.131G>C (p.Arg44Pro),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, single submitter"
795,NM_000329.3(RPE65):c.131G>C (p.Arg44Pro),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, single submitter"
796,NM_000329.3(RPE65):c.131G>A (p.Arg44Gln),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
796,NM_000329.3(RPE65):c.131G>A (p.Arg44Gln),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
796,NM_000329.3(RPE65):c.131G>A (p.Arg44Gln),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
797,NM_000329.3(RPE65):c.118G>A (p.Gly40Ser),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
797,NM_000329.3(RPE65):c.118G>A (p.Gly40Ser),RPE65,retinitis pigmentosa 87 with choroidal involvement,C5231465,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
797,NM_000329.3(RPE65):c.118G>A (p.Gly40Ser),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
797,NM_000329.3(RPE65):c.118G>A (p.Gly40Ser),RPE65,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
797,NM_000329.3(RPE65):c.118G>A (p.Gly40Ser),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
797,NM_000329.3(RPE65):c.118G>A (p.Gly40Ser),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
798,NM_000329.3(RPE65):c.94G>T (p.Gly32Cys),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: jul 22, 2021)","criteria provided, single submitter"
798,NM_000329.3(RPE65):c.94G>T (p.Gly32Cys),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: jul 22, 2021)","criteria provided, single submitter"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,retinitis pigmentosa 87 with choroidal involvement,C5231465,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
799,NM_000329.3(RPE65):c.74C>T (p.Pro25Leu),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
800,NM_000329.3(RPE65):c.65T>C (p.Leu22Pro),RPE65,leber congenital amaurosis 2,C1859844,"pathogenic(last reviewed: oct 11, 2022)","criteria provided, multiple submitters, no conflicts"
800,NM_000329.3(RPE65):c.65T>C (p.Leu22Pro),RPE65,retinitis pigmentosa 20,C3151086,"pathogenic(last reviewed: oct 11, 2022)","criteria provided, multiple submitters, no conflicts"
800,NM_000329.3(RPE65):c.65T>C (p.Leu22Pro),RPE65,leber congenital amaurosis,C0339527,"pathogenic(last reviewed: oct 11, 2022)","criteria provided, multiple submitters, no conflicts"
801,NM_000329.3(RPE65):c.3G>A (p.Met1Ile),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, single submitter"
801,NM_000329.3(RPE65):c.3G>A (p.Met1Ile),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, single submitter"
802,NM_000329.3(RPE65):c.2T>C (p.Met1Thr),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: oct 23, 2021)","criteria provided, multiple submitters, no conflicts"
802,NM_000329.3(RPE65):c.2T>C (p.Met1Thr),RPE65,leber congenital amaurosis 2,C1859844,"likely pathogenic(last reviewed: oct 23, 2021)","criteria provided, multiple submitters, no conflicts"
802,NM_000329.3(RPE65):c.2T>C (p.Met1Thr),RPE65,retinitis pigmentosa 20,C3151086,"likely pathogenic(last reviewed: oct 23, 2021)","criteria provided, multiple submitters, no conflicts"
803,NM_015978.3(TNNI3K):c.1538T>C (p.Leu513Pro),FPGT-TNNI3K|TNNI3K,arrhythmogenic right ventricular dysplasia 2,C1832931,"likely pathogenic(last reviewed: oct 20, 2021)","criteria provided, single submitter"
804,NM_015978.3(TNNI3K):c.2302G>A (p.Glu768Lys),FPGT-TNNI3K|LRRC53|TNNI3K,atrial conduction disease,Cumapped18,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
805,NM_000016.6(ACADM):c.1A>T (p.Met1Leu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
806,NM_000016.6(ACADM):c.1A>G (p.Met1Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
807,NM_000016.6(ACADM):c.3G>C (p.Met1Ile),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
808,NM_000016.6(ACADM):c.24C>A (p.Cys8Ter),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: oct 3, 2021)","criteria provided, single submitter"
809,NM_000016.6(ACADM):c.86G>T (p.Arg29Leu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, single submitter"
810,NM_000016.6(ACADM):c.135G>C (p.Gln45His),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
811,NM_000016.6(ACADM):c.157C>T (p.Arg53Cys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: jun 8, 2022)","criteria provided, multiple submitters, no conflicts"
812,NM_000016.6(ACADM):c.199T>C (p.Tyr67His),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
813,NM_000016.6(ACADM):c.221C>T (p.Pro74Leu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
814,NM_000016.6(ACADM):c.232A>G (p.Ile78Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
815,NM_000016.6(ACADM):c.233T>C (p.Ile78Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
816,NM_000016.6(ACADM):c.234T>G (p.Ile78Met),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
817,NM_000016.6(ACADM):c.241G>A (p.Ala81Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
818,NM_000016.6(ACADM):c.250C>T (p.Leu84Phe),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
819,NM_000016.6(ACADM):c.253G>C (p.Gly85Arg),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: jan 17, 2022)","criteria provided, single submitter"
820,NM_000016.6(ACADM):c.260T>C (p.Met87Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
821,NM_000016.6(ACADM):c.310G>A (p.Asp104Asn),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
822,NM_000016.6(ACADM):c.311A>G (p.Asp104Gly),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
823,NM_000016.6(ACADM):c.321A>C (p.Leu107Phe),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
824,NM_000016.6(ACADM):c.337G>A (p.Ala113Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
825,NM_000016.6(ACADM):c.338C>A (p.Ala113Asp),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
826,NM_000016.6(ACADM):c.341A>G (p.Tyr114Cys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,likely pathogenic,"criteria provided, single submitter"
827,NM_000016.6(ACADM):c.347G>A (p.Cys116Tyr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
828,NM_000016.6(ACADM):c.353G>C (p.Gly118Ala),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
829,NM_000016.6(ACADM):c.395C>A (p.Pro132His),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: dec 12, 2021)","criteria provided, single submitter"
830,NM_000016.6(ACADM):c.407C>T (p.Ala136Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: may 3, 2022)","criteria provided, single submitter"
831,NM_000016.6(ACADM):c.443G>T (p.Arg148Ile),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: apr 16, 2022)","criteria provided, single submitter"
832,NM_000016.6(ACADM):c.443G>A (p.Arg148Lys),ACADM,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
832,NM_000016.6(ACADM):c.443G>A (p.Arg148Lys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
833,NM_000016.6(ACADM):c.447G>A (p.Met149Ile),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: dec 31, 2021)","criteria provided, multiple submitters, no conflicts"
834,NM_000016.6(ACADM):c.464T>C (p.Met155Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
835,NM_000016.6(ACADM):c.472T>C (p.Tyr158His),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: oct 30, 2018)","criteria provided, single submitter"
836,NM_000016.6(ACADM):c.493G>A (p.Ala165Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, single submitter"
837,NM_000016.6(ACADM):c.503A>G (p.Asp168Gly),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
838,NM_000016.6(ACADM):c.554T>C (p.Ile185Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
839,NM_000016.6(ACADM):c.555T>G (p.Ile185Met),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
840,NM_000016.6(ACADM):c.577A>G (p.Thr193Ala),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
841,NM_000016.6(ACADM):c.583G>A (p.Gly195Arg),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
842,NM_000016.6(ACADM):c.584G>A (p.Gly195Glu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: mar 15, 2022)","criteria provided, single submitter"
843,NM_000016.6(ACADM):c.589A>G (p.Lys197Glu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, single submitter"
844,NM_000016.6(ACADM):c.609A>C (p.Leu203Phe),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
845,NM_000016.6(ACADM):c.613G>C (p.Ala205Pro),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
846,NM_000016.6(ACADM):c.614C>T (p.Ala205Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 11, 2022)","criteria provided, single submitter"
847,NM_000016.6(ACADM):c.616C>T (p.Arg206Cys),ACADM,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
847,NM_000016.6(ACADM):c.616C>T (p.Arg206Cys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
848,NM_000016.6(ACADM):c.617G>A (p.Arg206His),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
849,NM_000016.6(ACADM):c.622G>T (p.Asp208Tyr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
850,NM_000016.6(ACADM):c.653C>G (p.Ala218Gly),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: jul 2, 2022)","criteria provided, single submitter"
851,NM_000016.6(ACADM):c.659C>G (p.Thr220Ser),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
852,NM_000016.6(ACADM):c.667A>G (p.Ile223Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
853,NM_000016.6(ACADM):c.668T>C (p.Ile223Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: nov 17, 2021)","criteria provided, single submitter"
854,NM_000016.6(ACADM):c.683C>T (p.Thr228Ile),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
855,NM_000016.6(ACADM):c.698T>C (p.Ile233Thr),ACADM,"hydrocephalus, nonsyndromic, autosomal recessive 2",C4228466,"pathogenic/likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, multiple submitters, no conflicts"
855,NM_000016.6(ACADM):c.698T>C (p.Ile233Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, multiple submitters, no conflicts"
856,NM_000016.6(ACADM):c.708G>C (p.Lys236Asn),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
857,NM_000016.6(ACADM):c.717C>G (p.Asn239Lys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
858,NM_000016.6(ACADM):c.721G>A (p.Gly241Ser),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
859,NM_000016.6(ACADM):c.734C>T (p.Ser245Leu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
860,NM_000016.6(ACADM):c.742A>G (p.Arg248Gly),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: feb 20, 2015)","criteria provided, single submitter"
861,NM_000016.6(ACADM):c.744A>C (p.Arg248Ser),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
862,NM_000016.6(ACADM):c.757G>A (p.Glu253Lys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 6, 2022)","criteria provided, multiple submitters, no conflicts"
863,NM_000016.6(ACADM):c.799G>A (p.Gly267Arg),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
864,NM_000016.6(ACADM):c.820A>G (p.Met274Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 10, 2022)","criteria provided, single submitter"
865,NM_000016.6(ACADM):c.843A>T (p.Arg281Ser),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: jun 16, 2022)","criteria provided, multiple submitters, no conflicts"
866,NM_000016.6(ACADM):c.859G>C (p.Gly287Arg),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, single submitter"
867,NM_000016.6(ACADM):c.881G>C (p.Arg294Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
868,NM_000016.6(ACADM):c.949C>G (p.Gln317Glu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: mar 27, 2022)","criteria provided, single submitter"
869,NM_000016.6(ACADM):c.950A>T (p.Gln317Leu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
870,NM_000016.6(ACADM):c.977T>C (p.Met326Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
870,NM_000016.6(ACADM):c.977T>C (p.Met326Thr),ACADM,medium chain dicarboxylic aciduria,C1860081,"pathogenic/likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
871,NM_000016.6(ACADM):c.982A>G (p.Met328Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: feb 28, 2022)","criteria provided, single submitter"
872,NM_000016.6(ACADM):c.983T>C (p.Met328Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
873,NM_000016.6(ACADM):c.985A>C (p.Lys329Gln),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: feb 20, 2015)","criteria provided, single submitter"
874,NM_000016.6(ACADM):c.1010A>C (p.Tyr337Ser),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
875,NM_000016.6(ACADM):c.1034A>T (p.Asp345Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, single submitter"
876,NM_000016.6(ACADM):c.1042C>T (p.Arg348Cys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: mar 23, 2023)","criteria provided, multiple submitters, no conflicts"
877,NM_000016.6(ACADM):c.1045C>G (p.Arg349Gly),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
878,NM_000016.6(ACADM):c.1046G>A (p.Arg349Gln),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
879,NM_000016.6(ACADM):c.1052C>T (p.Thr351Ile),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
880,NM_000016.6(ACADM):c.1055A>G (p.Tyr352Cys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
881,NM_000016.6(ACADM):c.1066A>G (p.Ile356Val),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jun 17, 2022)","criteria provided, single submitter"
882,NM_000016.6(ACADM):c.1067T>C (p.Ile356Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
883,NM_000016.6(ACADM):c.1085G>A (p.Gly362Glu),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: jul 8, 2022)","criteria provided, single submitter"
884,NM_000016.6(ACADM):c.1118T>C (p.Val373Ala),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
885,NM_000016.6(ACADM):c.1124T>C (p.Ile375Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, single submitter"
886,NM_000016.6(ACADM):c.1175G>A (p.Arg392Lys),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
887,NM_000016.6(ACADM):c.1189T>A (p.Tyr397Asn),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
888,NM_000016.6(ACADM):c.1190A>C (p.Tyr397Ser),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
889,NM_000016.6(ACADM):c.1205G>A (p.Gly402Asp),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"likely pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
890,NM_000016.6(ACADM):c.1207A>G (p.Thr403Ala),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic/likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
891,NM_000016.6(ACADM):c.1229T>C (p.Ile410Thr),ACADM,medium-chain acyl-coenzyme a dehydrogenase deficiency,C0220710,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
892,NM_002440.4(MSH4):c.2261C>T (p.Ser754Leu),MSH4,oligospermia,C0868910,"pathogenic/likely pathogenic(last reviewed: may 24, 2021)","criteria provided, multiple submitters, no conflicts"
892,NM_002440.4(MSH4):c.2261C>T (p.Ser754Leu),MSH4,non-obstructive azoospermia,C4021107,"pathogenic/likely pathogenic(last reviewed: may 24, 2021)","criteria provided, multiple submitters, no conflicts"
892,NM_002440.4(MSH4):c.2261C>T (p.Ser754Leu),MSH4,premature ovarian insufficiency,C0025322,"pathogenic/likely pathogenic(last reviewed: may 24, 2021)","criteria provided, multiple submitters, no conflicts"
893,NM_182948.4(PRKACB):c.404A>T (p.His135Leu),PRKACB,cardioacrofacial dysplasia 2,CL1660773,"pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
894,NM_000969.5(RPL5):c.1A>C (p.Met1Leu),RPL5,diamond-blackfan anemia,C1260899,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
895,NM_000969.5(RPL5):c.2T>G (p.Met1Arg),RPL5,diamond-blackfan anemia,C1260899,"pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
896,NM_000969.5(RPL5):c.3G>A (p.Met1Ile),RPL5,diamond-blackfan anemia,C1260899,"pathogenic(last reviewed: jul 9, 2015)","criteria provided, single submitter"
897,NM_000969.5(RPL5):c.326T>C (p.Leu109Pro),RPL5|DIPK1A,diamond-blackfan anemia,C1260899,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
898,NM_000350.3(ABCA4):c.3064G>A (p.Glu1022Lys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: feb 4, 2022)","criteria provided, multiple submitters, no conflicts"
899,NM_000350.3(ABCA4):c.3056C>T (p.Thr1019Met),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
900,NM_000350.3(ABCA4):c.2947A>G (p.Thr983Ala),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
901,NM_000350.3(ABCA4):c.2932G>A (p.Gly978Ser),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: may 29, 2022)","criteria provided, multiple submitters, no conflicts"
902,NM_000350.3(ABCA4):c.2915C>A (p.Thr972Asn),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
902,NM_000350.3(ABCA4):c.2915C>A (p.Thr972Asn),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
902,NM_000350.3(ABCA4):c.2915C>A (p.Thr972Asn),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
902,NM_000350.3(ABCA4):c.2915C>A (p.Thr972Asn),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
902,NM_000350.3(ABCA4):c.2915C>A (p.Thr972Asn),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
902,NM_000350.3(ABCA4):c.2915C>A (p.Thr972Asn),ABCA4,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
903,NM_000350.3(ABCA4):c.2912C>A (p.Thr971Asn),ABCA4,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
903,NM_000350.3(ABCA4):c.2912C>A (p.Thr971Asn),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
904,NM_000350.3(ABCA4):c.2895T>G (p.Asn965Lys),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jan 24, 2019)","criteria provided, single submitter"
905,NM_000350.3(ABCA4):c.2894A>G (p.Asn965Ser),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
905,NM_000350.3(ABCA4):c.2894A>G (p.Asn965Ser),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
906,NM_000350.3(ABCA4):c.2893A>G (p.Asn965Asp),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: may 24, 2018)","criteria provided, single submitter"
907,NM_000350.3(ABCA4):c.2873T>A (p.Ile958Asn),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: may 31, 2021)","criteria provided, single submitter"
908,NM_000350.3(ABCA4):c.2870A>G (p.Gln957Arg),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: may 10, 2019)","criteria provided, multiple submitters, no conflicts"
909,NM_000350.3(ABCA4):c.2791G>T (p.Val931Leu),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: feb 27, 2019)","criteria provided, single submitter"
910,NM_000350.3(ABCA4):c.2609C>T (p.Pro870Leu),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
910,NM_000350.3(ABCA4):c.2609C>T (p.Pro870Leu),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
911,NM_000350.3(ABCA4):c.2579T>C (p.Val860Ala),ABCA4,isolated macular dystrophy,C4231166,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
912,NM_000350.3(ABCA4):c.2537A>G (p.Asp846Gly),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
913,NM_000350.3(ABCA4):c.2537A>T (p.Asp846Val),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
914,NM_000350.3(ABCA4):c.2461T>A (p.Trp821Arg),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
915,NM_000350.3(ABCA4):c.2453G>A (p.Gly818Glu),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
915,NM_000350.3(ABCA4):c.2453G>A (p.Gly818Glu),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
916,NM_000350.3(ABCA4):c.2385C>G (p.Ser795Arg),ABCA4,generalized choriocapillaris dystrophy,Cumapped78,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
917,NM_000350.3(ABCA4):c.2300T>A (p.Val767Asp),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
917,NM_000350.3(ABCA4):c.2300T>A (p.Val767Asp),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
918,NM_000350.3(ABCA4):c.2294G>C (p.Ser765Thr),ABCA4,isolated macular dystrophy,C4231166,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
919,NM_000350.3(ABCA4):c.2291G>A (p.Cys764Tyr),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
919,NM_000350.3(ABCA4):c.2291G>A (p.Cys764Tyr),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
920,NM_000350.3(ABCA4):c.1964T>G (p.Phe655Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
921,NM_000350.3(ABCA4):c.1958G>A (p.Arg653His),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
922,NM_000350.3(ABCA4):c.1957C>T (p.Arg653Cys),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
922,NM_000350.3(ABCA4):c.1957C>T (p.Arg653Cys),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
922,NM_000350.3(ABCA4):c.1957C>T (p.Arg653Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
922,NM_000350.3(ABCA4):c.1957C>T (p.Arg653Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
922,NM_000350.3(ABCA4):c.1957C>T (p.Arg653Cys),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
922,NM_000350.3(ABCA4):c.1957C>T (p.Arg653Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
923,NM_000350.3(ABCA4):c.1933G>A (p.Asp645Asn),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
924,NM_000350.3(ABCA4):c.1919C>T (p.Pro640Leu),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
925,NM_000350.3(ABCA4):c.1918C>G (p.Pro640Ala),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
926,NM_000350.3(ABCA4):c.1912C>T (p.Pro638Ser),ABCA4,isolated macular dystrophy,C4231166,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
927,NM_000350.3(ABCA4):c.1903C>A (p.Gln635Lys),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: feb 6, 2018)","criteria provided, single submitter"
928,NM_000350.3(ABCA4):c.1891G>A (p.Gly631Arg),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
929,NM_000350.3(ABCA4):c.1852G>A (p.Gly618Arg),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
930,NM_000350.3(ABCA4):c.1846G>A (p.Glu616Lys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
931,NM_000350.3(ABCA4):c.1822T>A (p.Phe608Ile),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
931,NM_000350.3(ABCA4):c.1822T>A (p.Phe608Ile),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
931,NM_000350.3(ABCA4):c.1822T>A (p.Phe608Ile),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
932,NM_000350.3(ABCA4):c.1819G>C (p.Gly607Arg),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
933,NM_000350.3(ABCA4):c.1804C>T (p.Arg602Trp),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
934,NM_000350.3(ABCA4):c.1789C>T (p.Pro597Ser),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
935,NM_000350.3(ABCA4):c.1742C>A (p.Thr581Asn),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 30, 2021)","criteria provided, single submitter"
936,NM_000350.3(ABCA4):c.1726G>C (p.Asp576His),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
937,NM_000350.3(ABCA4):c.1719G>A (p.Met573Ile),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
938,NM_000350.3(ABCA4):c.1715G>C (p.Arg572Pro),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
939,NM_000350.3(ABCA4):c.1698C>G (p.His566Gln),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic(last reviewed: jan 23, 2019)","criteria provided, single submitter"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
940,NM_000350.3(ABCA4):c.1648G>A (p.Gly550Arg),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
941,NM_000350.3(ABCA4):c.1609C>T (p.Arg537Cys),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
941,NM_000350.3(ABCA4):c.1609C>T (p.Arg537Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
942,NM_000350.3(ABCA4):c.1531C>T (p.Arg511Cys),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
942,NM_000350.3(ABCA4):c.1531C>T (p.Arg511Cys),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
942,NM_000350.3(ABCA4):c.1531C>T (p.Arg511Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
943,NM_000350.3(ABCA4):c.1508T>C (p.Phe503Ser),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
944,NM_000350.3(ABCA4):c.1364T>A (p.Leu455Gln),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
945,NM_000350.3(ABCA4):c.1335C>G (p.Ser445Arg),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
946,NM_000350.3(ABCA4):c.1253T>C (p.Phe418Ser),ABCA4,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
947,NM_000350.3(ABCA4):c.1007C>G (p.Ser336Cys),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 17, 2021)","criteria provided, multiple submitters, no conflicts"
948,NM_000350.3(ABCA4):c.926C>G (p.Pro309Arg),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
949,NM_000350.3(ABCA4):c.758T>A (p.Leu253His),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: may 31, 2021)","criteria provided, single submitter"
950,NM_000350.3(ABCA4):c.731T>C (p.Leu244Pro),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
951,NM_000350.3(ABCA4):c.688T>A (p.Cys230Ser),ABCA4,age related macular degeneration 2,C4230251,"pathogenic(last reviewed: jun 15, 2022)","criteria provided, multiple submitters, no conflicts"
952,NM_000350.3(ABCA4):c.658C>T (p.Arg220Cys),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
952,NM_000350.3(ABCA4):c.658C>T (p.Arg220Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
952,NM_000350.3(ABCA4):c.658C>T (p.Arg220Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
952,NM_000350.3(ABCA4):c.658C>T (p.Arg220Cys),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
952,NM_000350.3(ABCA4):c.658C>T (p.Arg220Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
953,NM_000350.3(ABCA4):c.634C>T (p.Arg212Cys),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
954,NM_000350.3(ABCA4):c.428C>T (p.Pro143Leu),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
955,NM_000350.3(ABCA4):c.298T>C (p.Ser100Pro),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
956,NM_000350.3(ABCA4):c.286A>G (p.Asn96Asp),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
957,NM_000350.3(ABCA4):c.214G>A (p.Gly72Arg),ABCA4,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
957,NM_000350.3(ABCA4):c.214G>A (p.Gly72Arg),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
957,NM_000350.3(ABCA4):c.214G>A (p.Gly72Arg),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
958,NM_000350.3(ABCA4):c.203C>G (p.Pro68Arg),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
958,NM_000350.3(ABCA4):c.203C>G (p.Pro68Arg),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
959,NM_000350.3(ABCA4):c.194G>A (p.Gly65Glu),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, multiple submitters, no conflicts"
959,NM_000350.3(ABCA4):c.194G>A (p.Gly65Glu),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, multiple submitters, no conflicts"
959,NM_000350.3(ABCA4):c.194G>A (p.Gly65Glu),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, multiple submitters, no conflicts"
959,NM_000350.3(ABCA4):c.194G>A (p.Gly65Glu),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, multiple submitters, no conflicts"
959,NM_000350.3(ABCA4):c.194G>A (p.Gly65Glu),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, multiple submitters, no conflicts"
959,NM_000350.3(ABCA4):c.194G>A (p.Gly65Glu),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, multiple submitters, no conflicts"
960,NM_000350.3(ABCA4):c.184C>T (p.Pro62Ser),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 30, 2021)","criteria provided, single submitter"
961,NM_000350.3(ABCA4):c.179C>T (p.Ala60Val),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
961,NM_000350.3(ABCA4):c.179C>T (p.Ala60Val),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
961,NM_000350.3(ABCA4):c.179C>T (p.Ala60Val),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
961,NM_000350.3(ABCA4):c.179C>T (p.Ala60Val),ABCA4,cone-rod dystrophy 3,C1858806,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
961,NM_000350.3(ABCA4):c.179C>T (p.Ala60Val),ABCA4,retinitis pigmentosa 19,C1866422,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
961,NM_000350.3(ABCA4):c.179C>T (p.Ala60Val),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
962,NM_000350.3(ABCA4):c.161G>A (p.Cys54Tyr),ABCA4,stargardt disease,C1412063,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
962,NM_000350.3(ABCA4):c.161G>A (p.Cys54Tyr),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
963,NM_000350.3(ABCA4):c.160T>G (p.Cys54Gly),ABCA4,cone-rod dystrophy 3,C1858806,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, multiple submitters, no conflicts"
963,NM_000350.3(ABCA4):c.160T>G (p.Cys54Gly),ABCA4,age related macular degeneration 2,C4230251,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, multiple submitters, no conflicts"
963,NM_000350.3(ABCA4):c.160T>G (p.Cys54Gly),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, multiple submitters, no conflicts"
963,NM_000350.3(ABCA4):c.160T>G (p.Cys54Gly),ABCA4,retinitis pigmentosa 19,C1866422,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, multiple submitters, no conflicts"
963,NM_000350.3(ABCA4):c.160T>G (p.Cys54Gly),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, multiple submitters, no conflicts"
964,NM_000350.3(ABCA4):c.86T>G (p.Leu29Arg),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
965,NM_000350.3(ABCA4):c.53G>C (p.Arg18Pro),ABCA4,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: feb 21, 2019)","criteria provided, single submitter"
966,NM_000350.3(ABCA4):c.52C>T (p.Arg18Trp),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
966,NM_000350.3(ABCA4):c.52C>T (p.Arg18Trp),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
967,NM_000350.3(ABCA4):c.32T>C (p.Leu11Pro),ABCA4,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
967,NM_000350.3(ABCA4):c.32T>C (p.Leu11Pro),ABCA4,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
967,NM_000350.3(ABCA4):c.32T>C (p.Leu11Pro),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
967,NM_000350.3(ABCA4):c.32T>C (p.Leu11Pro),ABCA4,age related macular degeneration 2,C4230251,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
968,NM_000350.3(ABCA4):c.1A>G (p.Met1Val),ABCA4,severe early-childhood-onset retinal dystrophy,C4274354,"pathogenic/likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
968,NM_000350.3(ABCA4):c.1A>G (p.Met1Val),ABCA4,abnormality of the eye,C4316870,"pathogenic/likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
969,NM_000110.4(DPYD):c.257C>T (p.Pro86Leu),DPYD,dihydropyrimidine dehydrogenase deficiency,C1959620,"pathogenic/likely pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
970,NM_000110.4(DPYD):c.3G>A (p.Met1Ile),DPYD,dihydropyrimidine dehydrogenase deficiency,C1959620,"likely pathogenic(last reviewed: jun 11, 2021)","criteria provided, multiple submitters, no conflicts"
971,NM_000642.3(AGL):c.3G>C (p.Met1Ile),AGL,glycogen storage disease type iii,C0017922,"likely pathogenic(last reviewed: may 8, 2017)","criteria provided, single submitter"
972,NM_000642.3(AGL):c.1078C>T (p.His360Tyr),AGL,glycogen storage disease type iii,C0017922,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
973,NM_000642.3(AGL):c.1571G>A (p.Arg524His),AGL,glycogen storage disease type iii,C0017922,"pathogenic(last reviewed: may 3, 2022)","criteria provided, multiple submitters, no conflicts"
974,NM_000642.3(AGL):c.1734A>T (p.Arg578Ser),AGL,glycogen storage disease type iii,C0017922,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
975,NM_000642.3(AGL):c.1859T>C (p.Leu620Pro),AGL,glycogen storage disease type iii,C0017922,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
976,NM_012243.3(SLC35A3):c.886A>G (p.Ser296Gly),SLC35A3,autism spectrum disorder - epilepsy - arthrogryposis syndrome,C4518080,"pathogenic(last reviewed: mar 27, 2023)","criteria provided, multiple submitters, no conflicts"
977,NM_001918.5(DBT):c.1385G>C (p.Arg462Pro),DBT,maple syrup urine disease,C0024776,"pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
978,NM_001918.5(DBT):c.1384C>T (p.Arg462Cys),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: sep 14, 2021)","criteria provided, single submitter"
979,NM_001918.5(DBT):c.1259T>C (p.Ile420Thr),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, single submitter"
980,NM_001918.5(DBT):c.1232C>T (p.Pro411Leu),DBT,maple syrup urine disease,C0024776,"pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
981,NM_001918.5(DBT):c.1196C>G (p.Ser399Cys),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
982,NM_001918.5(DBT):c.1184C>T (p.Thr395Ile),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: jun 2, 2020)","criteria provided, single submitter"
983,NM_001918.5(DBT):c.1033G>A (p.Gly345Arg),DBT,maple syrup urine disease,C0024776,"pathogenic(last reviewed: jan 1, 2013)","criteria provided, single submitter"
984,NM_001918.5(DBT):c.939G>C (p.Lys313Asn),DBT,maple syrup urine disease type 2,C1855371,"pathogenic/likely pathogenic(last reviewed: nov 7, 2021)","criteria provided, multiple submitters, no conflicts"
984,NM_001918.5(DBT):c.939G>C (p.Lys313Asn),DBT,maple syrup urine disease,C0024776,"pathogenic/likely pathogenic(last reviewed: nov 7, 2021)","criteria provided, multiple submitters, no conflicts"
985,NM_001918.5(DBT):c.901C>T (p.Arg301Cys),DBT,maple syrup urine disease,C0024776,"pathogenic/likely pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
986,NM_001918.5(DBT):c.872G>A (p.Arg291Gln),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, single submitter"
987,NM_001918.5(DBT):c.827T>G (p.Phe276Cys),DBT,maple syrup urine disease,C0024776,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
987,NM_001918.5(DBT):c.827T>G (p.Phe276Cys),DBT,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
988,NM_001918.5(DBT):c.820C>A (p.Pro274Thr),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, single submitter"
989,NM_001918.5(DBT):c.311A>T (p.Asp104Val),DBT,maple syrup urine disease,C0024776,"likely pathogenic(last reviewed: oct 27, 2021)","criteria provided, single submitter"
990,NM_001918.5(DBT):c.311A>G (p.Asp104Gly),DBT,maple syrup urine disease,C0024776,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
991,NM_001918.5(DBT):c.252G>T (p.Trp84Cys),DBT,maple syrup urine disease,C0024776,"pathogenic(last reviewed: jun 2, 2020)","criteria provided, single submitter"
992,NM_001918.5(DBT):c.206T>C (p.Leu69Pro),DBT,maple syrup urine disease,C0024776,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
993,NM_001918.5(DBT):c.1A>G (p.Met1Val),DBT,maple syrup urine disease,C0024776,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
994,NM_003672.4(CDC14A):c.934C>G (p.Arg312Gly),CDC14A,autosomal recessive nonsyndromic hearing loss 32,C3711374,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
995,NM_003672.4(CDC14A):c.935G>A (p.Arg312Gln),CDC14A,autosomal recessive nonsyndromic hearing loss 32,C3711374,"likely pathogenic(last reviewed: nov 5, 2018)","criteria provided, single submitter"
996,NM_003672.4(CDC14A):c.959A>C (p.Gln320Pro),CDC14A,autosomal recessive nonsyndromic hearing loss 32,C3711374,"likely pathogenic(last reviewed: nov 5, 2018)","criteria provided, single submitter"
997,NM_015958.3(DPH5):c.779A>G (p.His260Arg),DPH5|SLC30A7,"neurodevelopmental disorder with short stature, prominent forehead, and feeding difficulties",Cumapped166,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
998,NM_001854.4(COL11A1):c.2972G>A (p.Gly991Asp),COL11A1,stickler syndrome type 2,C1858084,"likely pathogenic(last reviewed: apr 20, 2017)","criteria provided, single submitter"
999,NM_001854.4(COL11A1):c.2752A>G (p.Arg918Gly),COL11A1,autism,C0004352,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
999,NM_001854.4(COL11A1):c.2752A>G (p.Arg918Gly),COL11A1,neurodevelopmental delay,C4022738,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
1000,NM_013386.5(SLC25A24):c.758G>C (p.Gly253Ala),SLC25A24,generalized tonic-clonic seizures,C0494475,"likely pathogenic(last reviewed: sep 6, 2019)","criteria provided, single submitter"
1000,NM_013386.5(SLC25A24):c.758G>C (p.Gly253Ala),SLC25A24,dementia,C0011265,"likely pathogenic(last reviewed: sep 6, 2019)","criteria provided, single submitter"
1001,NM_013386.5(SLC25A24):c.650G>A (p.Arg217His),SLC25A24,fontaine progeroid syndrome,C2676780,"pathogenic(last reviewed: jan 26, 2022)","criteria provided, multiple submitters, no conflicts"
1002,NM_013386.5(SLC25A24):c.649C>T (p.Arg217Cys),SLC25A24,fontaine progeroid syndrome,C2676780,pathogenic,"criteria provided, single submitter"
1003,NM_005645.4(TAF13):c.119T>A (p.Met40Lys),TAF13,"intellectual disability, autosomal recessive 60",C4479476,"pathogenic(last reviewed: mar 2, 2017)","criteria provided, single submitter"
1004,NM_005645.4(TAF13):c.92T>A (p.Leu31His),TAF13,"intellectual disability, autosomal recessive 60",C4479476,"pathogenic(last reviewed: mar 2, 2017)","criteria provided, single submitter"
1005,NM_006513.4(SARS1):c.638G>T (p.Arg213Leu),SARS1,"neurodevelopmental disorder with microcephaly, ataxia, and seizures",CL786474,likely pathogenic,"criteria provided, single submitter"
1006,NM_006513.4(SARS1):c.971T>C (p.Ile324Thr),SARS1,cerebral arteriovenous malformation,C0917804,"pathogenic(last reviewed: feb 14, 2018)","criteria provided, single submitter"
1007,NM_006496.4(GNAI3):c.118G>C (p.Gly40Arg),GNAI3,auriculocondylar syndrome 1,C4551996,"pathogenic(last reviewed: sep 17, 2012)","criteria provided, single submitter"
1008,NM_001377295.2(GNAT2):c.620A>T (p.Glu207Val),GNAT2,cone dystrophy,C3665342,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
1009,NM_001377295.2(GNAT2):c.605G>A (p.Gly202Glu),GNAT2,achromatopsia 4,C1841721,"pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1010,NM_001368809.2(AMPD2):c.971G>T (p.Arg324Leu),LOC126805822|AMPD2,pontocerebellar hypoplasia type 9,Cumapped209,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1010,NM_001368809.2(AMPD2):c.971G>T (p.Arg324Leu),LOC126805822|AMPD2,hereditary spastic paraplegia 63,C0037773,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1011,NM_001368809.2(AMPD2):c.1859G>T (p.Arg620Leu),AMPD2,pontocerebellar hypoplasia type 9,Cumapped209,"likely pathogenic(last reviewed: may 13, 2021)","criteria provided, single submitter"
1012,NM_001368809.2(AMPD2):c.1859G>A (p.Arg620His),AMPD2,hereditary spastic paraplegia 63,C0037773,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1012,NM_001368809.2(AMPD2):c.1859G>A (p.Arg620His),AMPD2,pontocerebellar hypoplasia type 9,Cumapped209,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1012,NM_001368809.2(AMPD2):c.1859G>A (p.Arg620His),AMPD2,pontocerebellar hypoplasia type 9,Cumapped209,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1013,NM_001368809.2(AMPD2):c.2165T>G (p.Leu722Arg),AMPD2,pontocerebellar hypoplasia type 9,Cumapped209,"pathogenic(last reviewed: sep 8, 2017)","criteria provided, single submitter"
1014,NM_001368809.2(AMPD2):c.2366G>A (p.Arg789His),AMPD2,pontocerebellar hypoplasia type 9,Cumapped209,"likely pathogenic(last reviewed: mar 2, 2017)","criteria provided, single submitter"
1015,NM_004974.4(KCNA2):c.1223T>G (p.Val408Gly),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, single submitter"
1016,NM_004974.4(KCNA2):c.1223T>C (p.Val408Ala),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: jan 1, 2014)","criteria provided, single submitter"
1017,NM_004974.4(KCNA2):c.1220C>T (p.Pro407Leu),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: oct 11, 2022)","criteria provided, single submitter"
1018,NM_004974.4(KCNA2):c.1220C>G (p.Pro407Arg),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, single submitter"
1019,NM_004974.4(KCNA2):c.1219C>T (p.Pro407Ser),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, single submitter"
1020,NM_004974.4(KCNA2):c.1219C>G (p.Pro407Ala),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic/likely pathogenic(last reviewed: jan 31, 2022)","criteria provided, multiple submitters, no conflicts"
1021,NM_004974.4(KCNA2):c.1216G>T (p.Val406Phe),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: jun 20, 2022)","criteria provided, single submitter"
1022,NM_004974.4(KCNA2):c.1214C>T (p.Pro405Leu),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic/likely pathogenic(last reviewed: jan 10, 2023)","criteria provided, multiple submitters, no conflicts"
1023,NM_004974.4(KCNA2):c.1210T>A (p.Leu404Ile),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1024,NM_004974.4(KCNA2):c.1130A>G (p.Tyr377Cys),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
1025,NM_004974.4(KCNA2):c.1120A>G (p.Thr374Ala),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
1026,NM_004974.4(KCNA2):c.1013G>A (p.Gly338Glu),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1027,NM_004974.4(KCNA2):c.959C>T (p.Thr320Ile),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: jan 1, 2018)","criteria provided, single submitter"
1028,NM_004974.4(KCNA2):c.928C>G (p.His310Asp),KCNA2,global developmental delay,C0557874,"likely pathogenic(last reviewed: feb 17, 2022)","criteria provided, single submitter"
1029,NM_004974.4(KCNA2):c.900A>C (p.Arg300Ser),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: jun 28, 2022)","criteria provided, single submitter"
1030,NM_004974.4(KCNA2):c.900A>T (p.Arg300Ser),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
1031,NM_004974.4(KCNA2):c.890G>A (p.Arg297Gln),KCNA2,neurodevelopmental disorder,C1535926,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
1031,NM_004974.4(KCNA2):c.890G>A (p.Arg297Gln),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
1032,NM_004974.4(KCNA2):c.889C>T (p.Arg297Trp),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1033,NM_004974.4(KCNA2):c.881G>C (p.Arg294Pro),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
1034,NM_004974.4(KCNA2):c.881G>A (p.Arg294His),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
1035,NM_004974.4(KCNA2):c.788T>C (p.Ile263Thr),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1036,NM_004974.4(KCNA2):c.785C>T (p.Ala262Val),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
1037,NM_004974.4(KCNA2):c.730T>C (p.Cys244Arg),KCNA2,"developmental and epileptic encephalopathy, 32",C4225350,"pathogenic(last reviewed: aug 2, 2022)","criteria provided, single submitter"
1038,NM_001349884.2(DRAM2):c.362A>T (p.His121Leu),DRAM2,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 1, 2014)","criteria provided, single submitter"
1039,NM_001349884.2(DRAM2):c.131G>A (p.Ser44Asn),DRAM2,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 1, 2014)","criteria provided, single submitter"
1040,NM_001349884.2(DRAM2):c.79T>C (p.Tyr27His),DRAM2,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 1, 2014)","criteria provided, single submitter"
1041,NM_001378969.1(KCND3):c.1138G>T (p.Gly380Trp),KCND3,spinocerebellar ataxia type 19/22,CL495137,"likely pathogenic(last reviewed: aug 30, 2022)","criteria provided, single submitter"
1042,NM_001378969.1(KCND3):c.1130C>T (p.Thr377Met),KCND3,spinocerebellar ataxia type 19/22,CL495137,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1043,NM_001378969.1(KCND3):c.1123C>T (p.Pro375Ser),KCND3,spinocerebellar ataxia type 19/22,CL495137,"pathogenic(last reviewed: apr 20, 2019)","criteria provided, single submitter"
1044,NM_001378969.1(KCND3):c.1111G>A (p.Gly371Arg),KCND3,spinocerebellar ataxia type 19/22,CL495137,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
1044,NM_001378969.1(KCND3):c.1111G>A (p.Gly371Arg),KCND3,brugada syndrome 9,C4225340,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
1045,NM_001378969.1(KCND3):c.1076G>T (p.Trp359Leu),KCND3,intellectual disability,C3714756,likely pathogenic,"criteria provided, single submitter"
1045,NM_001378969.1(KCND3):c.1076G>T (p.Trp359Leu),KCND3,seizure,C0036572,likely pathogenic,"criteria provided, single submitter"
1046,NM_001378969.1(KCND3):c.1034G>T (p.Gly345Val),KCND3,spinocerebellar ataxia type 19/22,CL495137,"pathogenic(last reviewed: jun 27, 2014)","criteria provided, single submitter"
1047,NM_001378969.1(KCND3):c.1013T>A (p.Val338Glu),KCND3,spinocerebellar ataxia type 19/22,CL495137,"pathogenic(last reviewed: apr 20, 2019)","criteria provided, single submitter"
1048,NM_001378969.1(KCND3):c.950G>A (p.Cys317Tyr),KCND3,spinocerebellar ataxia type 19/22,CL495137,"pathogenic(last reviewed: apr 20, 2019)","criteria provided, single submitter"
1049,NM_001378969.1(KCND3):c.911C>T (p.Ser304Phe),KCND3,spinocerebellar ataxia type 19/22,CL495137,"likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
1050,NM_001378969.1(KCND3):c.905G>C (p.Arg302Pro),KCND3,spinocerebellar ataxia type 19/22,CL495137,"likely pathogenic(last reviewed: may 21, 2020)","criteria provided, single submitter"
1051,NM_001378969.1(KCND3):c.869G>A (p.Arg290Gln),KCND3,spinocerebellar ataxia type 19/22,CL495137,"likely pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
1052,NM_001253852.3(AP4B1):c.955T>C (p.Phe319Leu),AP4B1|AP4B1-AS1,abnormality of brain morphology,C4021085,likely pathogenic,"criteria provided, single submitter"
1053,NM_002524.5(NRAS):c.449A>G (p.Gln150Arg),NRAS,noonan syndrome 6,C2750732,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
1054,NM_002524.5(NRAS):c.182A>G (p.Gln61Arg),NRAS,non-small cell lung carcinoma,C0007131,"pathogenic(last reviewed: sep 3, 2021)","criteria provided, multiple submitters, no conflicts"
1055,NM_002524.5(NRAS):c.179G>T (p.Gly60Val),NRAS,noonan syndrome and noonan-related syndrome,Cumapped100,"likely pathogenic(last reviewed: apr 27, 2017)","criteria provided, single submitter"
1056,NM_002524.5(NRAS):c.179G>A (p.Gly60Glu),NRAS,rasopathy,CL1662414,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1056,NM_002524.5(NRAS):c.179G>A (p.Gly60Glu),NRAS,noonan syndrome 6,C2750732,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1057,NM_002524.5(NRAS):c.175G>A (p.Ala59Thr),NRAS,noonan syndrome 6,C2750732,"pathogenic/likely pathogenic(last reviewed: may 21, 2020)","criteria provided, multiple submitters, no conflicts"
1058,NM_002524.5(NRAS):c.173C>T (p.Thr58Ile),NRAS,colorectal cancer,C0009404,"pathogenic/likely pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1058,NM_002524.5(NRAS):c.173C>T (p.Thr58Ile),NRAS,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1058,NM_002524.5(NRAS):c.173C>T (p.Thr58Ile),NRAS,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1059,NM_002524.5(NRAS):c.149C>T (p.Thr50Ile),NRAS,rasopathy,CL1662414,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1059,NM_002524.5(NRAS):c.149C>T (p.Thr50Ile),NRAS,noonan syndrome,C0028326,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1060,NM_002524.5(NRAS):c.108A>G (p.Ile36Met),NRAS,noonan syndrome 6,C2750732,"likely pathogenic(last reviewed: jan 27, 2022)","criteria provided, single submitter"
1061,NM_002524.5(NRAS):c.38G>A (p.Gly13Asp),NRAS,acute megakaryoblastic leukemia in down syndrome,C0023462,"pathogenic/likely pathogenic(last reviewed: jan 3, 2023)","criteria provided, multiple submitters, no conflicts"
1061,NM_002524.5(NRAS):c.38G>A (p.Gly13Asp),NRAS,autoimmune lymphoproliferative syndrome type 4,C2674723,"pathogenic/likely pathogenic(last reviewed: jan 3, 2023)","criteria provided, multiple submitters, no conflicts"
1062,NM_002524.5(NRAS):c.37G>C (p.Gly13Arg),NRAS,noonan syndrome 6,C2750732,"likely pathogenic(last reviewed: jul 8, 2019)","criteria provided, single submitter"
1063,NM_002524.5(NRAS):c.35G>C (p.Gly12Ala),NRAS,myelodysplastic syndrome progressed to acute myeloid leukemia,Cumapped140,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1063,NM_002524.5(NRAS):c.35G>C (p.Gly12Ala),NRAS,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1063,NM_002524.5(NRAS):c.35G>C (p.Gly12Ala),NRAS,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1064,NM_002524.5(NRAS):c.35G>T (p.Gly12Val),NRAS,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1064,NM_002524.5(NRAS):c.35G>T (p.Gly12Val),NRAS,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1065,NM_002524.5(NRAS):c.35G>A (p.Gly12Asp),NRAS,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
1065,NM_002524.5(NRAS):c.35G>A (p.Gly12Asp),NRAS,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
1065,NM_002524.5(NRAS):c.35G>A (p.Gly12Asp),NRAS,noonan syndrome 6,C2750732,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
1066,NM_002524.5(NRAS):c.34G>A (p.Gly12Ser),NRAS,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: feb 3, 2022)","criteria provided, multiple submitters, no conflicts"
1066,NM_002524.5(NRAS):c.34G>A (p.Gly12Ser),NRAS,rasopathy,CL1662414,"pathogenic(last reviewed: feb 3, 2022)","criteria provided, multiple submitters, no conflicts"
1067,NM_002524.5(NRAS):c.34G>C (p.Gly12Arg),NRAS,noonan syndrome 6,C2750732,"pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
1067,NM_002524.5(NRAS):c.34G>C (p.Gly12Arg),NRAS,increased nuchal translucency,C4023676,"pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
1068,NM_001232.4(CASQ2):c.1097T>C (p.Leu366Pro),CASQ2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
1068,NM_001232.4(CASQ2):c.1097T>C (p.Leu366Pro),CASQ2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
1069,NM_001232.4(CASQ2):c.923C>T (p.Pro308Leu),CASQ2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1069,NM_001232.4(CASQ2):c.923C>T (p.Pro308Leu),CASQ2,catecholaminergic polymorphic ventricular tachycardia 2,CL550942,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1069,NM_001232.4(CASQ2):c.923C>T (p.Pro308Leu),CASQ2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1069,NM_001232.4(CASQ2):c.923C>T (p.Pro308Leu),CASQ2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1070,NM_001232.4(CASQ2):c.164A>G (p.Tyr55Cys),CASQ2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
1070,NM_001232.4(CASQ2):c.164A>G (p.Tyr55Cys),CASQ2,catecholaminergic polymorphic ventricular tachycardia 2,CL550942,"likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
1070,NM_001232.4(CASQ2):c.164A>G (p.Tyr55Cys),CASQ2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
1071,NM_001232.4(CASQ2):c.98G>A (p.Arg33Gln),CASQ2,catecholaminergic polymorphic ventricular tachycardia 2,CL550942,"pathogenic/likely pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
1071,NM_001232.4(CASQ2):c.98G>A (p.Arg33Gln),CASQ2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic/likely pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
1071,NM_001232.4(CASQ2):c.98G>A (p.Arg33Gln),CASQ2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic/likely pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
1072,NM_000701.8(ATP1A1):c.905T>G (p.Leu302Arg),ATP1A1,"hypomagnesemia, seizures, and intellectual disability 2",Cumapped98,"pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
1073,NM_000701.8(ATP1A1):c.998C>G (p.Pro333Arg),ATP1A1,marfanoid habitus and intellectual disability,CL536965,likely pathogenic,"criteria provided, single submitter"
1074,NM_000701.8(ATP1A1):c.1798C>G (p.Pro600Ala),ATP1A1|ATP1A1-AS1,"charcot-marie-tooth disease, axonal, type 2dd",C4747974,"pathogenic(last reviewed: apr 22, 2022)","criteria provided, multiple submitters, no conflicts"
1075,NM_000701.8(ATP1A1):c.1799C>G (p.Pro600Arg),ATP1A1|ATP1A1-AS1,"charcot-marie-tooth disease, axonal, type 2dd",C4747974,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1076,NM_000701.8(ATP1A1):c.2531T>C (p.Leu844Pro),ATP1A1|ATP1A1-AS1,intellectual disability,C3714756,"likely pathogenic(last reviewed: dec 29, 2021)","criteria provided, multiple submitters, no conflicts"
1076,NM_000701.8(ATP1A1):c.2531T>C (p.Leu844Pro),ATP1A1|ATP1A1-AS1,"charcot-marie-tooth disease, axonal, type 2dd",C4747974,"likely pathogenic(last reviewed: dec 29, 2021)","criteria provided, multiple submitters, no conflicts"
1077,NM_206996.4(SPAG17):c.1069G>C (p.Asp357His),SPAG17,cranioectodermal dysplasia 2,C3150874,"likely pathogenic(last reviewed: aug 27, 2017)","criteria provided, single submitter"
1078,NM_015836.4(WARS2):c.680T>C (p.Met227Thr),WARS2,"neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures",C4540192,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1079,NM_015836.4(WARS2):c.622G>T (p.Glu208Ter),WARS2,"neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures",C4540192,"pathogenic(last reviewed: feb 28, 2020)","criteria provided, single submitter"
1080,NM_015836.4(WARS2):c.532G>C (p.Val178Leu),WARS2,"neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures",C4540192,"pathogenic(last reviewed: feb 15, 2019)","criteria provided, single submitter"
1081,NM_015836.4(WARS2):c.526G>T (p.Val176Phe),WARS2,"neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures",C4540192,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1082,NM_015836.4(WARS2):c.149G>A (p.Gly50Asp),WARS2,"neurodevelopmental disorder, mitochondrial, with abnormal movements and lactic acidosis, with or without seizures",C4540192,"likely pathogenic(last reviewed: apr 18, 2018)","criteria provided, single submitter"
1083,NM_015836.4(WARS2):c.148G>T (p.Gly50Cys),WARS2,"parkinsonism-dystonia 3, childhood-onset",CL1899265,"likely pathogenic(last reviewed: apr 20, 2021)","criteria provided, single submitter"
1084,NM_000198.4(HSD3B2):c.29C>A (p.Ala10Glu),HSD3B2|LOC109029530,3 beta-hydroxysteroid dehydrogenase deficiency,C0342471,"likely pathogenic(last reviewed: may 14, 2022)","criteria provided, single submitter"
1085,NM_000198.4(HSD3B2):c.244G>A (p.Ala82Thr),HSD3B2,3 beta-hydroxysteroid dehydrogenase deficiency,C0342471,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
1086,NM_000198.4(HSD3B2):c.518T>G (p.Leu173Arg),HSD3B2,congenital adrenal hyperplasia,C0001627,"pathogenic/likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1086,NM_000198.4(HSD3B2):c.518T>G (p.Leu173Arg),HSD3B2,3 beta-hydroxysteroid dehydrogenase deficiency,C0342471,"pathogenic/likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1087,NM_000198.4(HSD3B2):c.664C>A (p.Pro222Thr),HSD3B2,congenital adrenal hyperplasia,C0001627,"pathogenic(last reviewed: jun 29, 2022)","criteria provided, multiple submitters, no conflicts"
1087,NM_000198.4(HSD3B2):c.664C>A (p.Pro222Thr),HSD3B2,3 beta-hydroxysteroid dehydrogenase deficiency,C0342471,"pathogenic(last reviewed: jun 29, 2022)","criteria provided, multiple submitters, no conflicts"
1088,NM_000198.4(HSD3B2):c.665C>A (p.Pro222Gln),HSD3B2,congenital adrenal hyperplasia,C0001627,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
1089,NM_000198.4(HSD3B2):c.776C>T (p.Thr259Met),HSD3B2,congenital adrenal hyperplasia,C0001627,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1089,NM_000198.4(HSD3B2):c.776C>T (p.Thr259Met),HSD3B2,3 beta-hydroxysteroid dehydrogenase deficiency,C0342471,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1090,NM_006623.4(PHGDH):c.1A>C (p.Met1Leu),PHGDH,phgdh deficiency,C1866174,"pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
1091,NM_006623.4(PHGDH):c.1A>G (p.Met1Val),PHGDH,phgdh deficiency,C1866174,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
1092,NM_006623.4(PHGDH):c.2T>C (p.Met1Thr),PHGDH,phgdh deficiency,C1866174,"pathogenic/likely pathogenic(last reviewed: feb 1, 2022)","criteria provided, multiple submitters, no conflicts"
1093,NM_006623.4(PHGDH):c.797C>T (p.Pro266Leu),PHGDH,phgdh deficiency,C1866174,"likely pathogenic(last reviewed: may 3, 2020)","criteria provided, single submitter"
1094,NM_006623.4(PHGDH):c.1129G>A (p.Gly377Ser),PHGDH,phgdh deficiency,C1866174,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1094,NM_006623.4(PHGDH):c.1129G>A (p.Gly377Ser),PHGDH,neu-laxova syndrome 1,C4551478,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1094,NM_006623.4(PHGDH):c.1129G>A (p.Gly377Ser),PHGDH,phgdh deficiency,C1866174,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1095,NM_006623.4(PHGDH):c.1468G>A (p.Val490Met),PHGDH,phgdh deficiency,C1866174,"pathogenic/likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1095,NM_006623.4(PHGDH):c.1468G>A (p.Val490Met),PHGDH,neu-laxova syndrome 1,C4551478,"pathogenic/likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1095,NM_006623.4(PHGDH):c.1468G>A (p.Val490Met),PHGDH,phgdh deficiency,C1866174,"pathogenic/likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1095,NM_006623.4(PHGDH):c.1468G>A (p.Val490Met),PHGDH,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1096,NM_005518.4(HMGCS2):c.1499G>A (p.Arg500His),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
1097,NM_005518.4(HMGCS2):c.1162G>A (p.Gly388Arg),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,"pathogenic(last reviewed: may 8, 2022)","criteria provided, multiple submitters, no conflicts"
1098,NM_005518.4(HMGCS2):c.1090T>A (p.Phe364Ile),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
1099,NM_005518.4(HMGCS2):c.905C>T (p.Thr302Ile),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,"likely pathogenic(last reviewed: jan 7, 2019)","criteria provided, single submitter"
1100,NM_005518.4(HMGCS2):c.821G>A (p.Arg274His),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,likely pathogenic,"criteria provided, single submitter"
1101,NM_005518.4(HMGCS2):c.719A>C (p.Asp240Ala),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,likely pathogenic,"criteria provided, single submitter"
1102,NM_005518.4(HMGCS2):c.634G>A (p.Gly212Arg),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1103,NM_005518.4(HMGCS2):c.512C>T (p.Ala171Val),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,"likely pathogenic(last reviewed: jan 7, 2019)","criteria provided, single submitter"
1104,NM_005518.4(HMGCS2):c.422T>A (p.Val141Asp),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,likely pathogenic,"criteria provided, single submitter"
1105,NM_005518.4(HMGCS2):c.407A>G (p.Asp136Gly),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,likely pathogenic,"criteria provided, single submitter"
1106,NM_005518.4(HMGCS2):c.220G>A (p.Glu74Lys),HMGCS2,3-hydroxy-3-methylglutaryl-coa synthase deficiency,C4510940,likely pathogenic,"criteria provided, single submitter"
1107,NM_024408.4(NOTCH2):c.2587C>T (p.Pro863Ser),NOTCH2,alagille syndrome due to a notch2 point mutation,C0085280,"likely pathogenic(last reviewed: may 2, 2018)","criteria provided, single submitter"
1108,NM_003846.3(PEX11B):c.1A>G (p.Met1Val),PEX11B,peroxisome biogenesis disorder 14b,C3554055,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1109,NM_213653.4(HJV):c.959G>T (p.Gly320Val),HJV,hemochromatosis type 2a,C1865614,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
1110,NM_213653.4(HJV):c.572G>C (p.Trp191Ser),HJV,hemochromatosis type 2a,C1865614,likely pathogenic,"criteria provided, single submitter"
1111,NM_016361.5(ACP6):c.379G>A (p.Val127Met),ACP6,cerebral visual impairment and intellectual disability,Cumapped44,"likely pathogenic(last reviewed: sep 9, 2015)","criteria provided, single submitter"
1112,NM_005267.5(GJA8):c.130G>A (p.Val44Met),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: mar 4, 2022)","criteria provided, multiple submitters, no conflicts"
1113,NM_005267.5(GJA8):c.134G>T (p.Trp45Leu),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
1114,NM_005267.5(GJA8):c.134G>C (p.Trp45Ser),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
1115,NM_005267.5(GJA8):c.135G>T (p.Trp45Cys),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
1116,NM_005267.5(GJA8):c.136G>A (p.Gly46Arg),GJA8,cataract 1 multiple types,C1861828,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1117,NM_005267.5(GJA8):c.137G>A (p.Gly46Glu),GJA8,cataract 1 multiple types,C1861828,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1118,NM_005267.5(GJA8):c.143A>G (p.Glu48Gly),GJA8,cataract 1 multiple types,C1861828,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1119,NM_005267.5(GJA8):c.151G>A (p.Asp51Asn),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1120,NM_005267.5(GJA8):c.153C>G (p.Asp51Glu),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
1121,NM_005267.5(GJA8):c.175C>T (p.Pro59Ser),GJA8,microphthalmia,C0026010,"likely pathogenic(last reviewed: oct 15, 2022)","criteria provided, single submitter"
1122,NM_005267.5(GJA8):c.176C>T (p.Pro59Leu),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1123,NM_005267.5(GJA8):c.196T>C (p.Tyr66His),GJA8,cataract 1 multiple types,C1861828,"likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, single submitter"
1124,NM_005267.5(GJA8):c.197A>G (p.Tyr66Cys),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1125,NM_005267.5(GJA8):c.197A>C (p.Tyr66Ser),GJA8,cataract 1 multiple types,C1861828,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1126,NM_005267.5(GJA8):c.200A>G (p.Asp67Gly),GJA8,cataract 1 multiple types,C1861828,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1127,NM_005267.5(GJA8):c.226C>T (p.Arg76Cys),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: aug 14, 2021)","criteria provided, single submitter"
1128,NM_005267.5(GJA8):c.262C>G (p.Pro88Ala),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1129,NM_005267.5(GJA8):c.262C>T (p.Pro88Ser),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1130,NM_005267.5(GJA8):c.263C>A (p.Pro88Gln),GJA8,cataract 1 multiple types,C1861828,"likely pathogenic(last reviewed: may 20, 2022)","criteria provided, single submitter"
1131,NM_005267.5(GJA8):c.593G>A (p.Arg198Gln),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: oct 6, 2022)","criteria provided, single submitter"
1132,NM_005267.5(GJA8):c.595C>T (p.Pro199Ser),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1133,NM_005267.5(GJA8):c.602A>G (p.Glu201Gly),GJA8,cataract 1 multiple types,C1861828,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1134,NM_005850.5(SF3B4):c.2T>C (p.Met1Thr),SF3B4,nager syndrome,C0265245,"pathogenic(last reviewed: mar 19, 2020)","criteria provided, single submitter"
1135,NM_007259.5(VPS45):c.671C>A (p.Thr224Asn),VPS45,congenital neutropenia-myelofibrosis-nephromegaly syndrome,C4755251,"pathogenic(last reviewed: may 8, 2022)","criteria provided, single submitter"
1136,NM_007259.5(VPS45):c.712G>A (p.Glu238Lys),VPS45,congenital neutropenia-myelofibrosis-nephromegaly syndrome,C4755251,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
1137,NM_004698.4(PRPF3):c.1285G>T (p.Asp429Tyr),PRPF3,retinitis pigmentosa 18,C1832378,"pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1138,NM_004698.4(PRPF3):c.1345C>G (p.Arg449Gly),PRPF3,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
1139,NM_004698.4(PRPF3):c.1496A>C (p.His499Pro),PRPF3,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
1140,NM_004698.4(PRPF3):c.1504G>C (p.Ala502Pro),PRPF3,retinitis pigmentosa 18,C1832378,"likely pathogenic(last reviewed: sep 17, 2020)","criteria provided, single submitter"
1141,NM_004698.4(PRPF3):c.1532A>C (p.His511Pro),PRPF3,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: dec 11, 2017)","criteria provided, single submitter"
1142,NM_025150.5(TARS2):c.845C>T (p.Pro282Leu),TARS2,combined oxidative phosphorylation defect type 21,C4706316,"likely pathogenic(last reviewed: may 8, 2021)","criteria provided, single submitter"
1143,NM_004425.4(ECM1):c.499T>A (p.Phe167Ile),ECM1,lipid proteinosis,C0023795,"likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, single submitter"
1144,NM_004425.4(ECM1):c.806G>A (p.Cys269Tyr),ECM1,lipid proteinosis,C0023795,"pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
1145,NM_019032.6(ADAMTSL4):c.2594G>A (p.Arg865His),ADAMTSL4,ectopia lentis et pupillae,C1644196,"pathogenic/likely pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
1145,NM_019032.6(ADAMTSL4):c.2594G>A (p.Arg865His),ADAMTSL4,"ectopia lentis 2, isolated, autosomal recessive",C3541474,"pathogenic/likely pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
1146,NM_000396.4(CTSK):c.953G>A (p.Cys318Tyr),CTSK,pyknodysostosis,C0238402,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
1146,NM_000396.4(CTSK):c.953G>A (p.Cys318Tyr),CTSK,abnormality of the skeletal system,C4021790,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
1147,NM_000396.4(CTSK):c.934C>G (p.Arg312Gly),CTSK,pyknodysostosis,C0238402,"likely pathogenic(last reviewed: may 24, 2016)","criteria provided, single submitter"
1148,NM_000396.4(CTSK):c.926T>C (p.Leu309Pro),CTSK,pyknodysostosis,C0238402,"pathogenic/likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
1149,NM_000396.4(CTSK):c.907G>A (p.Gly303Arg),CTSK,pyknodysostosis,C0238402,pathogenic,"criteria provided, single submitter"
1150,NM_000396.4(CTSK):c.830C>T (p.Ala277Val),CTSK,pyknodysostosis,C0238402,"likely pathogenic(last reviewed: may 30, 2014)","criteria provided, single submitter"
1151,NM_000396.4(CTSK):c.827A>G (p.His276Arg),CTSK,pyknodysostosis,C0238402,likely pathogenic,"criteria provided, single submitter"
1152,NM_000396.4(CTSK):c.826C>T (p.His276Tyr),CTSK,pyknodysostosis,C0238402,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1153,NM_000396.4(CTSK):c.746T>A (p.Ile249Asn),CTSK,pyknodysostosis,C0238402,"likely pathogenic(last reviewed: oct 28, 2021)","criteria provided, single submitter"
1154,NM_000396.4(CTSK):c.746T>C (p.Ile249Thr),CTSK,pyknodysostosis,C0238402,"pathogenic/likely pathogenic(last reviewed: sep 4, 2022)","criteria provided, multiple submitters, no conflicts"
1155,NM_000396.4(CTSK):c.556T>C (p.Phe186Leu),CTSK,pyknodysostosis,C0238402,likely pathogenic,"criteria provided, single submitter"
1156,NM_000396.4(CTSK):c.436G>C (p.Gly146Arg),CTSK,pyknodysostosis,C0238402,"pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1157,NM_000396.4(CTSK):c.148T>G (p.Trp50Gly),CTSK,pyknodysostosis,C0238402,likely pathogenic,"criteria provided, single submitter"
1158,NM_000396.4(CTSK):c.136C>T (p.Arg46Trp),CTSK,pyknodysostosis,C0238402,"pathogenic/likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
1159,NM_000396.4(CTSK):c.26T>C (p.Leu9Pro),CTSK,pyknodysostosis,C0238402,"likely pathogenic(last reviewed: sep 19, 2016)","criteria provided, single submitter"
1160,NM_000396.4(CTSK):c.3G>A (p.Met1Ile),CTSK,pyknodysostosis,C0238402,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1161,NM_000396.4(CTSK):c.3G>T (p.Met1Ile),CTSK,pyknodysostosis,C0238402,"likely pathogenic(last reviewed: aug 4, 2016)","criteria provided, single submitter"
1162,NM_021222.3(PRUNE1):c.88G>A (p.Asp30Asn),PRUNE1,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",C4479566,"pathogenic/likely pathogenic(last reviewed: oct 13, 2020)","criteria provided, multiple submitters, no conflicts"
1162,NM_021222.3(PRUNE1):c.88G>A (p.Asp30Asn),PRUNE1,abnormality of brain morphology,C4021085,"pathogenic/likely pathogenic(last reviewed: oct 13, 2020)","criteria provided, multiple submitters, no conflicts"
1163,NM_021222.3(PRUNE1):c.316G>A (p.Asp106Asn),PRUNE1,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",C4479566,"pathogenic/likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
1163,NM_021222.3(PRUNE1):c.316G>A (p.Asp106Asn),PRUNE1,abnormality of brain morphology,C4021085,"pathogenic/likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
1164,NM_021222.3(PRUNE1):c.383G>A (p.Arg128Gln),PRUNE1,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",C4479566,"pathogenic/likely pathogenic(last reviewed: nov 9, 2020)","criteria provided, multiple submitters, no conflicts"
1164,NM_021222.3(PRUNE1):c.383G>A (p.Arg128Gln),PRUNE1,abnormality of brain morphology,C4021085,"pathogenic/likely pathogenic(last reviewed: nov 9, 2020)","criteria provided, multiple submitters, no conflicts"
1165,NM_003944.4(SELENBP1):c.985C>T (p.His329Tyr),SELENBP1,extra oral halitosis,C4746844,"likely pathogenic(last reviewed: apr 16, 2018)","criteria provided, single submitter"
1166,NM_003944.4(SELENBP1):c.673G>T (p.Gly225Trp),SELENBP1,extra oral halitosis,C4746844,"likely pathogenic(last reviewed: apr 16, 2018)","criteria provided, single submitter"
1167,NM_015100.4(POGZ):c.2569A>G (p.Arg857Gly),POGZ,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,Cumapped111,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1168,NM_015100.4(POGZ):c.1748A>G (p.His583Arg),POGZ,intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome,Cumapped111,"likely pathogenic(last reviewed: jun 8, 2017)","criteria provided, single submitter"
1169,NM_015100.4(POGZ):c.1418A>G (p.Tyr473Cys),POGZ,autism spectrum disorder,C1510586,"likely pathogenic(last reviewed: apr 12, 2022)","criteria provided, single submitter"
1170,NM_001330723.2(SNX27):c.989G>A (p.Arg330His),SNX27,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
1171,NM_012437.6(SNAPIN):c.163C>T (p.Arg55Trp),SNAPIN,abnormality of brain morphology,C4021085,likely pathogenic,"criteria provided, single submitter"
1172,NM_020699.4(GATAD2B):c.1446G>T (p.Gln482His),GATAD2B,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,Cumapped265,"likely pathogenic(last reviewed: jul 1, 2019)","criteria provided, single submitter"
1173,NM_020699.4(GATAD2B):c.1241G>A (p.Arg414Gln),GATAD2B,severe intellectual disability-poor language-strabismus-grimacing face-long fingers syndrome,Cumapped265,"pathogenic/likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
1174,NM_152263.4(TPM3):c.758C>A (p.Thr253Lys),TPM3,congenital myopathy with fiber type disproportion,C0546264,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
1174,NM_152263.4(TPM3):c.758C>A (p.Thr253Lys),TPM3,nemaline myopathy 1,C1836448,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
1175,NM_152263.4(TPM3):c.734G>T (p.Arg245Ile),TPM3,myopathy,C0026848,"likely pathogenic(last reviewed: dec 29, 2014)","criteria provided, single submitter"
1176,NM_152263.4(TPM3):c.535C>T (p.Arg179Cys),TPM3,congenital myopathy with fiber type disproportion,C0546264,"likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, single submitter"
1177,NM_152263.4(TPM3):c.503G>A (p.Arg168His),TPM3,congenital myopathy with fiber type disproportion,C0546264,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
1177,NM_152263.4(TPM3):c.503G>A (p.Arg168His),TPM3,nemaline myopathy 1,C1836448,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
1177,NM_152263.4(TPM3):c.503G>A (p.Arg168His),TPM3,nemaline myopathy 1,C1836448,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
1177,NM_152263.4(TPM3):c.503G>A (p.Arg168His),TPM3,see cases,Cumapped260,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
1178,NM_152263.4(TPM3):c.502C>T (p.Arg168Cys),TPM3,congenital myopathy with fiber type disproportion,C0546264,"pathogenic(last reviewed: dec 28, 2022)","criteria provided, multiple submitters, no conflicts"
1178,NM_152263.4(TPM3):c.502C>T (p.Arg168Cys),TPM3,nemaline myopathy 1,C1836448,"pathogenic(last reviewed: dec 28, 2022)","criteria provided, multiple submitters, no conflicts"
1179,NM_152263.4(TPM3):c.502C>G (p.Arg168Gly),TPM3,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1179,NM_152263.4(TPM3):c.502C>G (p.Arg168Gly),TPM3,nemaline myopathy 1,C1836448,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1179,NM_152263.4(TPM3):c.502C>G (p.Arg168Gly),TPM3,nemaline myopathy 1,C1836448,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1180,NM_152263.4(TPM3):c.455C>T (p.Ala152Val),TPM3,nemaline myopathy 1,C1836448,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
1180,NM_152263.4(TPM3):c.455C>T (p.Ala152Val),TPM3,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
1181,NM_152263.4(TPM3):c.298C>G (p.Leu100Val),TPM3,nemaline myopathy 1,C1836448,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1181,NM_152263.4(TPM3):c.298C>G (p.Leu100Val),TPM3,congenital myopathy with fiber type disproportion,C0546264,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1182,NM_152263.4(TPM3):c.272G>A (p.Arg91His),TPM3,nemaline myopathy 1,C1836448,"likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, single submitter"
1182,NM_152263.4(TPM3):c.272G>A (p.Arg91His),TPM3,congenital myopathy with fiber type disproportion,C0546264,"likely pathogenic(last reviewed: jul 3, 2022)","criteria provided, single submitter"
1183,NM_152263.4(TPM3):c.271C>G (p.Arg91Gly),TPM3,nemaline myopathy 1,C1836448,"likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, single submitter"
1183,NM_152263.4(TPM3):c.271C>G (p.Arg91Gly),TPM3,congenital myopathy with fiber type disproportion,C0546264,"likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, single submitter"
1184,NM_152263.4(TPM3):c.271C>T (p.Arg91Cys),TPM3,nemaline myopathy 1,C1836448,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
1184,NM_152263.4(TPM3):c.271C>T (p.Arg91Cys),TPM3,congenital myopathy with fiber type disproportion,C0546264,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
1185,NM_152263.4(TPM3):c.44A>T (p.Asp15Val),TPM3,nemaline myopathy 1,C1836448,"likely pathogenic(last reviewed: oct 11, 2021)","criteria provided, single submitter"
1185,NM_152263.4(TPM3):c.44A>T (p.Asp15Val),TPM3,congenital myopathy with fiber type disproportion,C0546264,"likely pathogenic(last reviewed: oct 11, 2021)","criteria provided, single submitter"
1186,NM_152263.4(TPM3):c.43G>A (p.Asp15Asn),TPM3,nemaline myopathy 1,C1836448,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1187,NM_152263.4(TPM3):c.7G>C (p.Glu3Gln),TPM3,nemaline myopathy 1,C1836448,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1188,NM_000748.3(CHRNB2):c.845T>A (p.Leu282His),CHRNB2,autosomal dominant nocturnal frontal lobe epilepsy 3,Cumapped26,"likely pathogenic(last reviewed: dec 4, 2019)","criteria provided, single submitter"
1189,NM_000748.3(CHRNB2):c.859G>T (p.Val287Leu),CHRNB2,autosomal dominant nocturnal frontal lobe epilepsy,C3696898,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
1189,NM_000748.3(CHRNB2):c.859G>T (p.Val287Leu),CHRNB2,autosomal dominant nocturnal frontal lobe epilepsy 3,Cumapped26,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
1190,NM_000748.3(CHRNB2):c.859G>A (p.Val287Met),CHRNB2,autosomal dominant nocturnal frontal lobe epilepsy,C3696898,"pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
1190,NM_000748.3(CHRNB2):c.859G>A (p.Val287Met),CHRNB2,autosomal dominant nocturnal frontal lobe epilepsy 3,Cumapped26,"pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
1191,NM_000748.3(CHRNB2):c.923T>C (p.Val308Ala),CHRNB2,autosomal dominant nocturnal frontal lobe epilepsy,C3696898,"pathogenic/likely pathogenic(last reviewed: jul 28, 2022)","criteria provided, multiple submitters, no conflicts"
1192,NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg),ADAR,symmetrical dyschromatosis of extremities,C0406775,"pathogenic/likely pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
1192,NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg),ADAR,aicardi-goutieres syndrome 6,C3539013,"pathogenic/likely pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
1192,NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg),ADAR,aicardi-goutieres syndrome 6,C3539013,"pathogenic/likely pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
1192,NM_001111.5(ADAR):c.3019G>A (p.Gly1007Arg),ADAR,symmetrical dyschromatosis of extremities,C0406775,"pathogenic/likely pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
1193,NM_001111.5(ADAR):c.2729A>G (p.His910Arg),ADAR|LOC126805874,symmetrical dyschromatosis of extremities,C0406775,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1194,NM_002249.6(KCNN3):c.1606G>A (p.Ala536Thr),KCNN3,zimmermann-laband syndrome 3,C5231447,"pathogenic(last reviewed: nov 18, 2020)","criteria provided, single submitter"
1195,NM_025207.5(FLAD1):c.1588C>T (p.Arg530Cys),FLAD1,multiple acyl-coa dehydrogenase deficiency,C0268596,"pathogenic(last reviewed: sep 8, 2017)","criteria provided, multiple submitters, no conflicts"
1196,NM_153741.2(DPM3):c.137T>A (p.Leu46Gln),DPM3,cardiomyopathy,C0878544,"likely pathogenic(last reviewed: jan 15, 2015)","criteria provided, single submitter"
1196,NM_153741.2(DPM3):c.137T>A (p.Leu46Gln),DPM3,emg: myopathic abnormalities,C4021726,"likely pathogenic(last reviewed: jan 15, 2015)","criteria provided, single submitter"
1196,NM_153741.2(DPM3):c.137T>A (p.Leu46Gln),DPM3,myopathy,C0026848,"likely pathogenic(last reviewed: jan 15, 2015)","criteria provided, single submitter"
1197,NM_153741.2(DPM3):c.41T>C (p.Leu14Pro),DPM3,dpm3-congenital disorder of glycosylation,Cumapped64,"pathogenic(last reviewed: may 15, 2022)","criteria provided, single submitter"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1198,NM_000157.4(GBA1):c.1604G>A (p.Arg535His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1199,NM_000157.4(GBA1):c.1505G>A (p.Arg502His),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
1199,NM_000157.4(GBA1):c.1505G>A (p.Arg502His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
1199,NM_000157.4(GBA1):c.1505G>A (p.Arg502His),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
1199,NM_000157.4(GBA1):c.1505G>A (p.Arg502His),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
1199,NM_000157.4(GBA1):c.1505G>A (p.Arg502His),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
1199,NM_000157.4(GBA1):c.1505G>A (p.Arg502His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1200,NM_000157.4(GBA1):c.1504C>T (p.Arg502Cys),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
1201,NM_000157.4(GBA1):c.1503C>G (p.Asn501Lys),LOC106627981|GBA1,gaucher disease type ii,C0268250,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1202,NM_000157.4(GBA1):c.1448T>G (p.Leu483Arg),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: oct 7, 2022)","criteria provided, multiple submitters, no conflicts"
1203,NM_000157.4(GBA1):c.1343A>T (p.Asp448Val),GBA1|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: dec 21, 2015)","criteria provided, single submitter"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1204,NM_000157.4(GBA1):c.1342G>C (p.Asp448His),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1205,NM_000157.4(GBA1):c.1312G>A (p.Asp438Asn),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: jul 15, 2022)","criteria provided, multiple submitters, no conflicts"
1206,NM_000157.4(GBA1):c.1300C>T (p.Arg434Cys),GBA1|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: jan 31, 2023)","criteria provided, single submitter"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1207,NM_000157.4(GBA1):c.1297G>T (p.Val433Leu),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1208,NM_000157.4(GBA1):c.1289C>T (p.Pro430Leu),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1209,NM_000157.4(GBA):c.1271T>C (p.Leu424Pro),GBA|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: feb 20, 2017)","criteria provided, single submitter"
1210,NM_000157.4(GBA):c.1255G>A (p.Asp419Asn),GBA|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: dec 6, 2019)","criteria provided, single submitter"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1211,NM_000157.4(GBA1):c.1249T>G (p.Trp417Gly),LOC106627981|GBA1,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1212,NM_000157.4(GBA1):c.1246G>A (p.Gly416Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1213,NM_000157.4(GBA1):c.1240G>T (p.Val414Leu),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: jan 30, 2020)","criteria provided, multiple submitters, no conflicts"
1213,NM_000157.4(GBA1):c.1240G>T (p.Val414Leu),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: jan 30, 2020)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,parkinson disease,C0030567,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,akinesia,C0085623,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1214,NM_000157.4(GBA1):c.1226A>G (p.Asn409Ser),GBA1|LOC106627981,rigidity,C0700109,"pathogenic/likely pathogenic; risk factor(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1215,NM_000157.4(GBA1):c.1208G>C (p.Ser403Thr),LOC106627981|GBA1,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: mar 2, 2022)","criteria provided, multiple submitters, no conflicts"
1216,NM_000157.4(GBA1):c.1184C>T (p.Ser395Phe),LOC106627981|GBA1,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
1217,NM_000157.4(GBA):c.1174C>T (p.Arg392Trp),GBA|LOC106627981,gaucher disease type i,C0017205,pathogenic,"criteria provided, single submitter"
1217,NM_000157.4(GBA):c.1174C>T (p.Arg392Trp),GBA|LOC106627981,gaucher disease type ii,C0268250,pathogenic,"criteria provided, single submitter"
1217,NM_000157.4(GBA):c.1174C>T (p.Arg392Trp),GBA|LOC106627981,gaucher disease type iii,C0268251,pathogenic,"criteria provided, single submitter"
1217,NM_000157.4(GBA):c.1174C>T (p.Arg392Trp),GBA|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,pathogenic,"criteria provided, single submitter"
1218,NM_000157.4(GBA1):c.1171G>C (p.Val391Leu),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
1218,NM_000157.4(GBA1):c.1171G>C (p.Val391Leu),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
1218,NM_000157.4(GBA1):c.1171G>C (p.Val391Leu),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
1218,NM_000157.4(GBA1):c.1171G>C (p.Val391Leu),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
1218,NM_000157.4(GBA1):c.1171G>C (p.Val391Leu),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease type ii,C0268250,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,lewy body dementia,C0752347,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease type iii,C0268251,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1219,NM_000157.4(GBA1):c.1090G>A (p.Gly364Arg),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1220,NM_000157.4(GBA1):c.1085C>T (p.Thr362Ile),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,lewy body dementia,C0752347,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,gaucher disease type ii,C0268250,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,gaucher disease perinatal lethal,C1842704,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,"parkinson disease, late-onset",C3160718,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,gaucher disease type iii,C0268251,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1221,NM_000157.4(GBA1):c.1052G>C (p.Trp351Ser),LOC106627981|GBA1,gaucher disease,C0017205,"likely pathogenic(last reviewed: nov 19, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1222,NM_000157.4(GBA1):c.928A>G (p.Ser310Gly),LOC106627981|GBA1,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1223,NM_000157.4(GBA):c.914C>T (p.Pro305Leu),GBA|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: mar 10, 2020)","criteria provided, single submitter"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,gaucher disease type iii,C0268251,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,lewy body dementia,C0752347,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,gaucher disease type ii,C0268250,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1224,NM_000157.4(GBA1):c.896T>C (p.Ile299Thr),GBA1|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
1225,NM_000157.4(GBA):c.894C>A (p.Phe298Leu),GBA|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: may 17, 2020)","criteria provided, single submitter"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1226,NM_000157.4(GBA1):c.887G>A (p.Arg296Gln),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1227,NM_000157.4(GBA1):c.764T>A (p.Phe255Tyr),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1228,NM_000157.4(GBA1):c.754T>A (p.Phe252Ile),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1229,NM_000157.4(GBA1):c.721G>A (p.Gly241Arg),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1229,NM_000157.4(GBA1):c.721G>A (p.Gly241Arg),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1229,NM_000157.4(GBA1):c.721G>A (p.Gly241Arg),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1229,NM_000157.4(GBA1):c.721G>A (p.Gly241Arg),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1229,NM_000157.4(GBA1):c.721G>A (p.Gly241Arg),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1229,NM_000157.4(GBA1):c.721G>A (p.Gly241Arg),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1230,NM_000157.4(GBA1):c.709A>G (p.Lys237Glu),LOC106627981|GBA1,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1231,NM_000157.4(GBA1):c.703T>C (p.Ser235Pro),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
1232,NM_000157.4(GBA1):c.681T>G (p.Asn227Lys),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
1232,NM_000157.4(GBA1):c.681T>G (p.Asn227Lys),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
1232,NM_000157.4(GBA1):c.681T>G (p.Asn227Lys),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
1232,NM_000157.4(GBA1):c.681T>G (p.Asn227Lys),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
1232,NM_000157.4(GBA1):c.681T>G (p.Asn227Lys),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: feb 13, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1233,NM_000157.4(GBA1):c.680A>G (p.Asn227Ser),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,lewy body dementia,C0752347,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,"parkinson disease, late-onset",C3160718,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1234,NM_000157.4(GBA1):c.661C>A (p.Pro221Thr),LOC106627981|GBA1,gaucher disease perinatal lethal,C1842704,"pathogenic/likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, multiple submitters, no conflicts"
1235,NM_000157.4(GBA1):c.625C>T (p.Arg209Cys),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: dec 23, 2020)","criteria provided, multiple submitters, no conflicts"
1235,NM_000157.4(GBA1):c.625C>T (p.Arg209Cys),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: dec 23, 2020)","criteria provided, multiple submitters, no conflicts"
1235,NM_000157.4(GBA1):c.625C>T (p.Arg209Cys),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: dec 23, 2020)","criteria provided, multiple submitters, no conflicts"
1235,NM_000157.4(GBA1):c.625C>T (p.Arg209Cys),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: dec 23, 2020)","criteria provided, multiple submitters, no conflicts"
1235,NM_000157.4(GBA1):c.625C>T (p.Arg209Cys),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: dec 23, 2020)","criteria provided, multiple submitters, no conflicts"
1236,NM_000157.4(GBA1):c.509G>T (p.Arg170Leu),GBA1|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: jan 13, 2020)","criteria provided, single submitter"
1237,NM_000157.4(GBA1):c.508C>T (p.Arg170Cys),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: jan 14, 2020)","criteria provided, multiple submitters, no conflicts"
1237,NM_000157.4(GBA1):c.508C>T (p.Arg170Cys),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: jan 14, 2020)","criteria provided, multiple submitters, no conflicts"
1237,NM_000157.4(GBA1):c.508C>T (p.Arg170Cys),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: jan 14, 2020)","criteria provided, multiple submitters, no conflicts"
1237,NM_000157.4(GBA1):c.508C>T (p.Arg170Cys),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: jan 14, 2020)","criteria provided, multiple submitters, no conflicts"
1237,NM_000157.4(GBA1):c.508C>T (p.Arg170Cys),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: jan 14, 2020)","criteria provided, multiple submitters, no conflicts"
1238,NM_000157.4(GBA):c.497A>T (p.Asp166Val),GBA|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: apr 16, 2021)","criteria provided, single submitter"
1239,NM_000157.4(GBA1):c.492C>G (p.Ser164Arg),GBA1|LOC106627981,gaucher disease,C0017205,"likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
1239,NM_000157.4(GBA1):c.492C>G (p.Ser164Arg),GBA1|LOC106627981,gaucher disease type i,C0017205,"likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
1240,NM_000157.4(GBA1):c.476G>A (p.Arg159Gln),LOC106627981|GBA1,gaucher disease type i,C0017205,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1240,NM_000157.4(GBA1):c.476G>A (p.Arg159Gln),LOC106627981|GBA1,gaucher disease type ii,C0268250,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1240,NM_000157.4(GBA1):c.476G>A (p.Arg159Gln),LOC106627981|GBA1,gaucher disease type iii,C0268251,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1240,NM_000157.4(GBA1):c.476G>A (p.Arg159Gln),LOC106627981|GBA1,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1240,NM_000157.4(GBA1):c.476G>A (p.Arg159Gln),LOC106627981|GBA1,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
1241,NM_000157.4(GBA1):c.475C>T (p.Arg159Trp),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: jan 25, 2023)","criteria provided, multiple submitters, no conflicts"
1242,NM_000157.4(GBA1):c.354G>C (p.Lys118Asn),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic/likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,gaucher disease perinatal lethal,C1842704,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,gaucher disease type ii,C0268250,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,gaucher disease type iii,C0268251,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome,Cumapped77,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,gaucher disease type i,C0017205,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,lewy body dementia,C0752347,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1243,NM_000157.4(GBA1):c.259C>T (p.Arg87Trp),GBA1|LOC106627981,see cases,Cumapped260,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1244,NM_000157.4(GBA1):c.254G>A (p.Gly85Glu),GBA1|LOC106627981,gaucher disease,C0017205,"pathogenic(last reviewed: jan 15, 2020)","criteria provided, multiple submitters, no conflicts"
1245,NM_000298.6(PKLR):c.1594C>T (p.Arg532Trp),PKLR,pyruvate kinase deficiency of red cells,C0340968,"pathogenic(last reviewed: jan 18, 2023)","criteria provided, multiple submitters, no conflicts"
1246,NM_000298.6(PKLR):c.1591C>A (p.Arg531Ser),PKLR,pyruvate kinase deficiency of red cells,C0340968,"likely pathogenic(last reviewed: nov 28, 2018)","criteria provided, single submitter"
1247,NM_000298.6(PKLR):c.1529G>A (p.Arg510Gln),PKLR,pyruvate kinase deficiency of red cells,C0340968,"pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
1248,NM_000298.6(PKLR):c.1511G>T (p.Arg504Leu),PKLR,pyruvate kinase deficiency of red cells,C0340968,"likely pathogenic(last reviewed: jan 19, 2023)","criteria provided, single submitter"
1249,NM_000298.6(PKLR):c.1511G>A (p.Arg504His),PKLR,pyruvate kinase deficiency of red cells,C0340968,"likely pathogenic(last reviewed: aug 7, 2018)","criteria provided, single submitter"
1250,NM_000298.6(PKLR):c.1456C>T (p.Arg486Trp),PKLR,pyruvate kinase deficiency of red cells,C0340968,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1250,NM_000298.6(PKLR):c.1456C>T (p.Arg486Trp),PKLR,pyruvate kinase hyperactivity,C1863224,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1250,NM_000298.6(PKLR):c.1456C>T (p.Arg486Trp),PKLR,pyruvate kinase deficiency of red cells,C0340968,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1250,NM_000298.6(PKLR):c.1456C>T (p.Arg486Trp),PKLR,pyruvate kinase hyperactivity,C1863224,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1250,NM_000298.6(PKLR):c.1456C>T (p.Arg486Trp),PKLR,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1251,NM_000298.6(PKLR):c.1436G>A (p.Arg479His),PKLR,pyruvate kinase deficiency of red cells,C0340968,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1252,NM_000298.6(PKLR):c.1178A>G (p.Asn393Ser),PKLR,pyruvate kinase deficiency of red cells,C0340968,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, multiple submitters, no conflicts"
1252,NM_000298.6(PKLR):c.1178A>G (p.Asn393Ser),PKLR,pyruvate kinase hyperactivity,C1863224,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, multiple submitters, no conflicts"
1253,NM_000298.6(PKLR):c.331G>A (p.Gly111Arg),PKLR,pyruvate kinase deficiency of red cells,C0340968,"pathogenic(last reviewed: dec 3, 2017)","criteria provided, single submitter"
1254,NM_000298.6(PKLR):c.224T>C (p.Leu75Pro),PKLR,pyruvate kinase deficiency of red cells,C0340968,"likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, single submitter"
1255,NM_018116.4(MSTO1):c.706G>C (p.Asp236His),MSTO1,mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,Cumapped129,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
1256,NM_018116.4(MSTO1):c.767G>A (p.Arg256Gln),MSTO1,mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome,Cumapped129,"likely pathogenic(last reviewed: dec 8, 2021)","criteria provided, single submitter"
1257,NM_006912.6(RIT1):c.284G>C (p.Gly95Ala),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1257,NM_006912.6(RIT1):c.284G>C (p.Gly95Ala),RIT1,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1257,NM_006912.6(RIT1):c.284G>C (p.Gly95Ala),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1257,NM_006912.6(RIT1):c.284G>C (p.Gly95Ala),RIT1,rasopathy,CL1662414,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1257,NM_006912.6(RIT1):c.284G>C (p.Gly95Ala),RIT1,noonan syndrome,C0028326,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1258,NM_006912.6(RIT1):c.270G>T (p.Met90Ile),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1259,NM_006912.6(RIT1):c.270G>C (p.Met90Ile),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1259,NM_006912.6(RIT1):c.270G>C (p.Met90Ile),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1260,NM_006912.6(RIT1):c.270G>A (p.Met90Ile),RIT1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, multiple submitters, no conflicts"
1260,NM_006912.6(RIT1):c.270G>A (p.Met90Ile),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, multiple submitters, no conflicts"
1260,NM_006912.6(RIT1):c.270G>A (p.Met90Ile),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, multiple submitters, no conflicts"
1260,NM_006912.6(RIT1):c.270G>A (p.Met90Ile),RIT1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, multiple submitters, no conflicts"
1261,NM_006912.6(RIT1):c.268A>C (p.Met90Leu),RIT1,noonan syndrome 8,C3809233,"likely pathogenic(last reviewed: nov 22, 2019)","criteria provided, single submitter"
1262,NM_006912.6(RIT1):c.268A>G (p.Met90Val),RIT1,rasopathy,CL1662414,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
1262,NM_006912.6(RIT1):c.268A>G (p.Met90Val),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
1262,NM_006912.6(RIT1):c.268A>G (p.Met90Val),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
1263,NM_006912.6(RIT1):c.265T>C (p.Tyr89His),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: aug 1, 2022)","criteria provided, multiple submitters, no conflicts"
1263,NM_006912.6(RIT1):c.265T>C (p.Tyr89His),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: aug 1, 2022)","criteria provided, multiple submitters, no conflicts"
1264,NM_006912.6(RIT1):c.251C>T (p.Ala84Val),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: sep 10, 2022)","criteria provided, multiple submitters, no conflicts"
1264,NM_006912.6(RIT1):c.251C>T (p.Ala84Val),RIT1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: sep 10, 2022)","criteria provided, multiple submitters, no conflicts"
1265,NM_006912.6(RIT1):c.247A>C (p.Thr83Pro),RIT1,rasopathy,CL1662414,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1265,NM_006912.6(RIT1):c.247A>C (p.Thr83Pro),RIT1,noonan syndrome 1,C4551602,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1265,NM_006912.6(RIT1):c.247A>C (p.Thr83Pro),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1266,NM_006912.6(RIT1):c.246T>A (p.Phe82Leu),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1266,NM_006912.6(RIT1):c.246T>A (p.Phe82Leu),RIT1,noonan syndrome 1,C4551602,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1267,NM_006912.6(RIT1):c.246T>G (p.Phe82Leu),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
1267,NM_006912.6(RIT1):c.246T>G (p.Phe82Leu),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
1267,NM_006912.6(RIT1):c.246T>G (p.Phe82Leu),RIT1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
1267,NM_006912.6(RIT1):c.246T>G (p.Phe82Leu),RIT1,non-immune hydrops fetalis,C0455988,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
1268,NM_006912.6(RIT1):c.245T>C (p.Phe82Ser),RIT1,noonan syndrome 1,C4551602,pathogenic,"criteria provided, single submitter"
1269,NM_006912.6(RIT1):c.245T>G (p.Phe82Cys),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: sep 22, 2021)","criteria provided, multiple submitters, no conflicts"
1270,NM_006912.6(RIT1):c.244T>G (p.Phe82Val),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
1270,NM_006912.6(RIT1):c.244T>G (p.Phe82Val),RIT1,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
1270,NM_006912.6(RIT1):c.244T>G (p.Phe82Val),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
1270,NM_006912.6(RIT1):c.244T>G (p.Phe82Val),RIT1,rasopathy,CL1662414,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
1271,NM_006912.6(RIT1):c.244T>C (p.Phe82Leu),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1271,NM_006912.6(RIT1):c.244T>C (p.Phe82Leu),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
1272,NM_006912.6(RIT1):c.244T>A (p.Phe82Ile),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: dec 7, 2021)","criteria provided, multiple submitters, no conflicts"
1273,NM_006912.6(RIT1):c.242A>G (p.Glu81Gly),RIT1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1273,NM_006912.6(RIT1):c.242A>G (p.Glu81Gly),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1273,NM_006912.6(RIT1):c.242A>G (p.Glu81Gly),RIT1,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1273,NM_006912.6(RIT1):c.242A>G (p.Glu81Gly),RIT1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1273,NM_006912.6(RIT1):c.242A>G (p.Glu81Gly),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1274,NM_006912.6(RIT1):c.235C>G (p.Gln79Glu),RIT1,noonan syndrome 8,C3809233,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1275,NM_006912.6(RIT1):c.233G>A (p.Gly78Glu),RIT1,noonan syndrome 8,C3809233,"likely pathogenic(last reviewed: jan 17, 2020)","criteria provided, single submitter"
1276,NM_006912.6(RIT1):c.230C>G (p.Ala77Gly),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: aug 17, 2022)","criteria provided, multiple submitters, no conflicts"
1277,NM_006912.6(RIT1):c.229G>T (p.Ala77Ser),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
1278,NM_006912.6(RIT1):c.229G>C (p.Ala77Pro),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: jan 21, 2023)","criteria provided, multiple submitters, no conflicts"
1278,NM_006912.6(RIT1):c.229G>C (p.Ala77Pro),RIT1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: jan 21, 2023)","criteria provided, multiple submitters, no conflicts"
1279,NM_006912.6(RIT1):c.229G>A (p.Ala77Thr),RIT1,noonan syndrome 8,C3809233,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1279,NM_006912.6(RIT1):c.229G>A (p.Ala77Thr),RIT1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1279,NM_006912.6(RIT1):c.229G>A (p.Ala77Thr),RIT1,noonan syndrome 1,C4551602,"pathogenic/likely pathogenic(last reviewed: jan 16, 2023)","criteria provided, multiple submitters, no conflicts"
1280,NM_006912.6(RIT1):c.170C>G (p.Ala57Gly),RIT1,noonan syndrome,C0028326,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1280,NM_006912.6(RIT1):c.170C>G (p.Ala57Gly),RIT1,noonan syndrome 1,C4551602,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1280,NM_006912.6(RIT1):c.170C>G (p.Ala57Gly),RIT1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1280,NM_006912.6(RIT1):c.170C>G (p.Ala57Gly),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1280,NM_006912.6(RIT1):c.170C>G (p.Ala57Gly),RIT1,rasopathy,CL1662414,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1280,NM_006912.6(RIT1):c.170C>G (p.Ala57Gly),RIT1,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1281,NM_006912.6(RIT1):c.116T>G (p.Met39Arg),RIT1,noonan syndrome 8,C3809233,"likely pathogenic(last reviewed: aug 10, 2021)","criteria provided, single submitter"
1282,NM_006912.6(RIT1):c.113C>A (p.Thr38Asn),RIT1,noonan syndrome 8,C3809233,"likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
1283,NM_006912.6(RIT1):c.111G>C (p.Met37Ile),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
1284,NM_006912.6(RIT1):c.104G>C (p.Ser35Thr),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
1284,NM_006912.6(RIT1):c.104G>C (p.Ser35Thr),RIT1,noonan syndrome,C0028326,"pathogenic(last reviewed: aug 6, 2022)","criteria provided, multiple submitters, no conflicts"
1285,NM_006912.6(RIT1):c.91G>C (p.Gly31Arg),RIT1,noonan syndrome 1,C4551602,pathogenic,"criteria provided, single submitter"
1286,NM_006912.6(RIT1):c.69A>C (p.Lys23Asn),RIT1,noonan syndrome 8,C3809233,"pathogenic(last reviewed: nov 30, 2021)","criteria provided, multiple submitters, no conflicts"
1286,NM_006912.6(RIT1):c.69A>C (p.Lys23Asn),RIT1,noonan syndrome 1,C4551602,"pathogenic(last reviewed: nov 30, 2021)","criteria provided, multiple submitters, no conflicts"
1287,NM_006912.6(RIT1):c.67A>G (p.Lys23Glu),RIT1,noonan syndrome 8,C3809233,pathogenic,"criteria provided, single submitter"
1288,NM_170707.4(LMNA):c.1A>T (p.Met1Leu),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
1289,NM_170707.4(LMNA):c.3G>A (p.Met1Ile),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
1289,NM_170707.4(LMNA):c.3G>A (p.Met1Ile),LMNA,see cases,Cumapped260,"pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
1290,NM_170707.4(LMNA):c.3G>T (p.Met1Ile),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
1291,NM_170707.4(LMNA):c.11C>A (p.Pro4Gln),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1292,NM_170707.4(LMNA):c.11C>G (p.Pro4Arg),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1293,NM_170707.4(LMNA):c.28A>C (p.Thr10Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1294,NM_170707.4(LMNA):c.29C>T (p.Thr10Ile),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic/likely pathogenic(last reviewed: mar 15, 2016)","criteria provided, multiple submitters, no conflicts"
1295,NM_170707.4(LMNA):c.59C>T (p.Pro20Leu),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"likely pathogenic(last reviewed: dec 18, 2017)","criteria provided, single submitter"
1296,NM_170707.4(LMNA):c.73C>T (p.Arg25Cys),LMNA,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1296,NM_170707.4(LMNA):c.73C>T (p.Arg25Cys),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1297,NM_170707.4(LMNA):c.73C>G (p.Arg25Gly),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, multiple submitters, no conflicts"
1297,NM_170707.4(LMNA):c.73C>G (p.Arg25Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, multiple submitters, no conflicts"
1298,NM_170707.4(LMNA):c.74G>C (p.Arg25Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1299,NM_170707.4(LMNA):c.80C>T (p.Thr27Ile),LMNA,dilated cardiomyopathy 1a,C1449563,"likely pathogenic(last reviewed: sep 12, 2019)","criteria provided, single submitter"
1299,NM_170707.4(LMNA):c.80C>T (p.Thr27Ile),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"likely pathogenic(last reviewed: sep 12, 2019)","criteria provided, single submitter"
1300,NM_170707.4(LMNA):c.82C>T (p.Arg28Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 24, 2022)","criteria provided, single submitter"
1301,NM_170707.4(LMNA):c.83G>A (p.Arg28Gln),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, multiple submitters, no conflicts"
1301,NM_170707.4(LMNA):c.83G>A (p.Arg28Gln),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, multiple submitters, no conflicts"
1302,NM_170707.4(LMNA):c.91G>A (p.Glu31Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1303,NM_170707.4(LMNA):c.92A>G (p.Glu31Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 26, 2019)","criteria provided, single submitter"
1304,NM_170707.4(LMNA):c.94A>G (p.Lys32Glu),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1304,NM_170707.4(LMNA):c.94A>G (p.Lys32Glu),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
1305,NM_170707.4(LMNA):c.98A>G (p.Glu33Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, single submitter"
1306,NM_170707.4(LMNA):c.112C>G (p.Leu38Val),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1307,NM_170707.4(LMNA):c.115A>G (p.Asn39Asp),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1308,NM_170707.4(LMNA):c.115A>C (p.Asn39His),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1309,NM_170707.4(LMNA):c.116A>T (p.Asn39Ile),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1310,NM_170707.4(LMNA):c.116A>G (p.Asn39Ser),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
1310,NM_170707.4(LMNA):c.116A>G (p.Asn39Ser),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
1311,NM_170707.4(LMNA):c.117T>A (p.Asn39Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 13, 2022)","criteria provided, single submitter"
1312,NM_170707.4(LMNA):c.122G>A (p.Arg41His),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: apr 29, 2022)","criteria provided, multiple submitters, no conflicts"
1313,NM_170707.4(LMNA):c.125T>C (p.Leu42Ser),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: mar 17, 2022)","criteria provided, single submitter"
1314,NM_170707.4(LMNA):c.128C>A (p.Ala43Glu),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
1315,NM_170707.4(LMNA):c.142C>G (p.Arg48Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1316,NM_170707.4(LMNA):c.143G>C (p.Arg48Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1317,NM_170707.4(LMNA):c.154C>G (p.Leu52Val),LMNA,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: aug 10, 2011)","criteria provided, single submitter"
1318,NM_170707.4(LMNA):c.158A>G (p.Glu53Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
1319,NM_170707.4(LMNA):c.164A>G (p.Glu55Gly),LMNA,hutchinson-gilford syndrome,C0033300,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,likely pathogenic,"criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,C0796083,likely pathogenic,"criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,dilated cardiomyopathy 1a,C1449563,likely pathogenic,"criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,likely pathogenic,"criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,"heart-hand syndrome, slovenian type",C1857829,likely pathogenic,"criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,likely pathogenic,"criteria provided, single submitter"
1320,NM_170707.4(LMNA):c.168C>G (p.Asn56Lys),LMNA,hutchinson-gilford syndrome,C0033300,likely pathogenic,"criteria provided, single submitter"
1321,NM_170707.4(LMNA):c.184C>T (p.Arg62Cys),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1322,NM_170707.4(LMNA):c.184C>G (p.Arg62Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1322,NM_170707.4(LMNA):c.184C>G (p.Arg62Gly),LMNA,cardiomyopathy,C0878544,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1322,NM_170707.4(LMNA):c.184C>G (p.Arg62Gly),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
1323,NM_170707.4(LMNA):c.185G>T (p.Arg62Leu),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1324,NM_170707.4(LMNA):c.193G>A (p.Glu65Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1325,NM_170707.4(LMNA):c.194A>T (p.Glu65Val),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1326,NM_170707.4(LMNA):c.194A>G (p.Glu65Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
1327,NM_170707.4(LMNA):c.203A>T (p.Glu68Val),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
1328,NM_170707.4(LMNA):c.234G>T (p.Lys78Asn),LMNA,arrhythmogenic right ventricular dysplasia 9,C1836906,likely pathogenic,"criteria provided, single submitter"
1329,NM_170707.4(LMNA):c.244G>A (p.Glu82Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: apr 24, 2022)","criteria provided, multiple submitters, no conflicts"
1329,NM_170707.4(LMNA):c.244G>A (p.Glu82Lys),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: apr 24, 2022)","criteria provided, multiple submitters, no conflicts"
1330,NM_170707.4(LMNA):c.245A>G (p.Glu82Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1331,NM_170707.4(LMNA):c.254T>A (p.Leu85His),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1332,NM_170707.4(LMNA):c.265C>G (p.Arg89Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1333,NM_170707.4(LMNA):c.266G>C (p.Arg89Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1334,NM_170707.4(LMNA):c.266G>T (p.Arg89Leu),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
1335,NM_170707.4(LMNA):c.274C>T (p.Leu92Phe),LMNA,primary familial dilated cardiomyopathy,C0340427,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
1335,NM_170707.4(LMNA):c.274C>T (p.Leu92Phe),LMNA,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
1336,NM_170707.4(LMNA):c.275T>C (p.Leu92Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1337,NM_170707.4(LMNA):c.280T>C (p.Ser94Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1338,NM_170707.4(LMNA):c.296G>C (p.Arg99Pro),LMNA,primary familial dilated cardiomyopathy,C0340427,likely pathogenic,"criteria provided, single submitter"
1339,NM_170707.4(LMNA):c.317T>C (p.Leu106Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1340,NM_170707.4(LMNA):c.397C>T (p.Arg133Trp),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1341,NM_170707.4(LMNA):c.398G>C (p.Arg133Pro),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
1342,NM_170707.4(LMNA):c.398G>T (p.Arg133Leu),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
1343,NM_170707.4(LMNA):c.419T>C (p.Leu140Pro),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
1344,NM_170707.4(LMNA):c.422T>C (p.Leu141Pro),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1345,NM_170707.4(LMNA):c.427T>C (p.Ser143Pro),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1345,NM_170707.4(LMNA):c.427T>C (p.Ser143Pro),LMNA|LOC126805877,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1346,NM_170707.4(LMNA):c.431A>C (p.Lys144Thr),LOC126805877|LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1347,NM_170707.4(LMNA):c.448A>C (p.Thr150Pro),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
1347,NM_170707.4(LMNA):c.448A>C (p.Thr150Pro),LMNA|LOC126805877,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
1348,NM_170707.4(LMNA):c.481G>A (p.Glu161Lys),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1348,NM_170707.4(LMNA):c.481G>A (p.Glu161Lys),LMNA|LOC126805877,cardiomyopathy,C0878544,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1348,NM_170707.4(LMNA):c.481G>A (p.Glu161Lys),LMNA|LOC126805877,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1349,NM_170707.4(LMNA):c.497G>C (p.Arg166Pro),LMNA|LOC126805877,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1349,NM_170707.4(LMNA):c.497G>C (p.Arg166Pro),LMNA|LOC126805877,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1349,NM_170707.4(LMNA):c.497G>C (p.Arg166Pro),LMNA|LOC126805877,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1350,NM_170707.4(LMNA):c.568C>T (p.Arg190Trp),LMNA,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1350,NM_170707.4(LMNA):c.568C>T (p.Arg190Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1351,NM_170707.4(LMNA):c.569G>A (p.Arg190Gln),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
1351,NM_170707.4(LMNA):c.569G>A (p.Arg190Gln),LMNA,cardiomyopathy,C0878544,"pathogenic/likely pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
1351,NM_170707.4(LMNA):c.569G>A (p.Arg190Gln),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
1351,NM_170707.4(LMNA):c.569G>A (p.Arg190Gln),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
1352,NM_170707.4(LMNA):c.575A>T (p.Asp192Val),LMNA,dilated cardiomyopathy 1a,C1449563,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
1353,NM_170707.4(LMNA):c.585C>G (p.Asn195Lys),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: oct 27, 2021)","criteria provided, multiple submitters, no conflicts"
1353,NM_170707.4(LMNA):c.585C>G (p.Asn195Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 27, 2021)","criteria provided, multiple submitters, no conflicts"
1354,NM_170707.4(LMNA):c.590T>C (p.Leu197Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 26, 2019)","criteria provided, single submitter"
1355,NM_170707.4(LMNA):c.593A>C (p.Gln198Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
1356,NM_170707.4(LMNA):c.607G>A (p.Glu203Lys),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1356,NM_170707.4(LMNA):c.607G>A (p.Glu203Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1356,NM_170707.4(LMNA):c.607G>A (p.Glu203Lys),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1357,NM_170707.4(LMNA):c.608A>T (p.Glu203Val),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 7, 2022)","criteria provided, single submitter"
1358,NM_170707.4(LMNA):c.608A>G (p.Glu203Gly),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: aug 21, 2015)","criteria provided, single submitter"
1359,NM_170707.4(LMNA):c.611T>G (p.Leu204Arg),LMNA,dilated cardiomyopathy 1a,C1449563,"likely pathogenic(last reviewed: nov 27, 2017)","criteria provided, single submitter"
1360,NM_170707.4(LMNA):c.618C>A (p.Phe206Leu),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, multiple submitters, no conflicts"
1361,NM_170707.4(LMNA):c.644T>C (p.Leu215Pro),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1361,NM_170707.4(LMNA):c.644T>C (p.Leu215Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1362,NM_170707.4(LMNA):c.674G>C (p.Arg225Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1363,NM_170707.4(LMNA):c.674G>T (p.Arg225Leu),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1364,NM_170707.4(LMNA):c.694G>C (p.Gly232Arg),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1365,NM_170707.4(LMNA):c.695G>A (p.Gly232Glu),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
1365,NM_170707.4(LMNA):c.695G>A (p.Gly232Glu),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
1366,NM_170707.4(LMNA):c.727G>T (p.Asp243Tyr),LMNA,dilated cardiomyopathy 1a,C1449563,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
1367,NM_170707.4(LMNA):c.745C>G (p.Arg249Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1367,NM_170707.4(LMNA):c.745C>G (p.Arg249Gly),LMNA,laminopathy,CL1638038,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1368,NM_170707.4(LMNA):c.745C>T (p.Arg249Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
1368,NM_170707.4(LMNA):c.745C>T (p.Arg249Trp),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
1368,NM_170707.4(LMNA):c.745C>T (p.Arg249Trp),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"pathogenic/likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
1369,NM_170707.4(LMNA):c.746G>A (p.Arg249Gln),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1369,NM_170707.4(LMNA):c.746G>A (p.Arg249Gln),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1369,NM_170707.4(LMNA):c.746G>A (p.Arg249Gln),LMNA,muscular dystrophy,C0026850,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1369,NM_170707.4(LMNA):c.746G>A (p.Arg249Gln),LMNA,charcot-marie-tooth disease type 2b1,C1854154,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1369,NM_170707.4(LMNA):c.746G>A (p.Arg249Gln),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1369,NM_170707.4(LMNA):c.746G>A (p.Arg249Gln),LMNA,abnormality of the musculature,C4021745,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1370,NM_170707.4(LMNA):c.776A>G (p.Tyr259Cys),LMNA,abnormality of the musculature,C4021745,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
1371,NM_170707.4(LMNA):c.784G>A (p.Glu262Lys),LMNA,hutchinson-gilford syndrome,C0033300,likely pathogenic,"criteria provided, single submitter"
1372,NM_170707.4(LMNA):c.799T>C (p.Tyr267His),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: mar 25, 2022)","criteria provided, multiple submitters, no conflicts"
1372,NM_170707.4(LMNA):c.799T>C (p.Tyr267His),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: mar 25, 2022)","criteria provided, multiple submitters, no conflicts"
1372,NM_170707.4(LMNA):c.799T>C (p.Tyr267His),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: mar 25, 2022)","criteria provided, multiple submitters, no conflicts"
1373,NM_170707.4(LMNA):c.810G>C (p.Lys270Asn),LMNA,abnormality of the musculature,C4021745,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
1374,NM_170707.4(LMNA):c.832G>A (p.Ala278Thr),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, multiple submitters, no conflicts"
1375,NM_170707.4(LMNA):c.832G>C (p.Ala278Pro),LMNA,muscular dystrophy,C0026850,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1375,NM_170707.4(LMNA):c.832G>C (p.Ala278Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1376,NM_170707.4(LMNA):c.863C>G (p.Ala288Gly),LMNA,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: aug 13, 2012)","criteria provided, single submitter"
1377,NM_170707.4(LMNA):c.869A>T (p.Glu290Val),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1378,NM_170707.4(LMNA):c.893G>A (p.Arg298His),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1379,NM_170707.4(LMNA):c.898G>A (p.Asp300Asn),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
1379,NM_170707.4(LMNA):c.898G>A (p.Asp300Asn),LMNA,lipodystrophy,C0023787,"likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
1380,NM_170707.4(LMNA):c.917T>C (p.Leu306Pro),LMNA,dilated cardiomyopathy 1a,C1449563,"likely pathogenic(last reviewed: may 12, 2017)","criteria provided, multiple submitters, no conflicts"
1381,NM_170707.4(LMNA):c.949G>A (p.Glu317Lys),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1381,NM_170707.4(LMNA):c.949G>A (p.Glu317Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1381,NM_170707.4(LMNA):c.949G>A (p.Glu317Lys),LMNA,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1381,NM_170707.4(LMNA):c.949G>A (p.Glu317Lys),LMNA,cardiomyopathy,C0878544,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1381,NM_170707.4(LMNA):c.949G>A (p.Glu317Lys),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1381,NM_170707.4(LMNA):c.949G>A (p.Glu317Lys),LMNA,primary familial dilated cardiomyopathy,C0340427,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,laminopathy,CL1638038,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,left ventricular noncompaction,C1960469,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,arrhythmogenic right ventricular cardiomyopathy,C0349788,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,cardiomyopathy,C0878544,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,restrictive dermopathy 2,Cumapped248,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,"emery-dreifuss muscular dystrophy 3, autosomal recessive",C2750035,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,C0796083,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,charcot-marie-tooth disease type 2b1,C1854154,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,"heart-hand syndrome, slovenian type",C1857829,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,hutchinson-gilford syndrome,C0033300,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1382,NM_170707.4(LMNA):c.1003C>T (p.Arg335Trp),LMNA,mandibuloacral dysplasia with type a lipodystrophy,C0432291,"pathogenic/likely pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,C0796083,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,charcot-marie-tooth disease type 2b1,C1854154,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,mandibuloacral dysplasia with type a lipodystrophy,C0432291,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,"emery-dreifuss muscular dystrophy 3, autosomal recessive",C2750035,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,"heart-hand syndrome, slovenian type",C1857829,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,hutchinson-gilford syndrome,C0033300,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,restrictive dermopathy 2,Cumapped248,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,monogenic diabetes,C3888631,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1383,NM_170707.4(LMNA):c.1045C>T (p.Arg349Trp),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
1384,NM_170707.4(LMNA):c.1046G>T (p.Arg349Leu),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 10, 2021)","criteria provided, multiple submitters, no conflicts"
1385,NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys),LMNA,muscular dystrophy,C0026850,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1385,NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1385,NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys),LMNA,emery-dreifuss muscular dystrophy,C0410189,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1385,NM_170707.4(LMNA):c.1072G>A (p.Glu358Lys),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1386,NM_170707.4(LMNA):c.1081G>A (p.Glu361Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: dec 23, 2021)","criteria provided, multiple submitters, no conflicts"
1386,NM_170707.4(LMNA):c.1081G>A (p.Glu361Lys),LMNA,muscular dystrophy,C0026850,"pathogenic(last reviewed: dec 23, 2021)","criteria provided, multiple submitters, no conflicts"
1387,NM_170707.4(LMNA):c.1110C>G (p.Asp370Glu),LMNA,laminopathy,CL1638038,"likely pathogenic(last reviewed: nov 11, 2015)","criteria provided, single submitter"
1388,NM_170707.4(LMNA):c.1115A>G (p.Glu372Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jan 17, 2022)","criteria provided, single submitter"
1389,NM_170707.4(LMNA):c.1116G>C (p.Glu372Asp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1389,NM_170707.4(LMNA):c.1116G>C (p.Glu372Asp),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1390,NM_170707.4(LMNA):c.1117A>T (p.Ile373Phe),LMNA,dilated cardiomyopathy 1a,C1449563,"likely pathogenic(last reviewed: feb 8, 2013)","criteria provided, single submitter"
1391,NM_170707.4(LMNA):c.1118T>G (p.Ile373Ser),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: jun 19, 2017)","criteria provided, single submitter"
1392,NM_170707.4(LMNA):c.1119C>G (p.Ile373Met),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: feb 25, 2022)","criteria provided, single submitter"
1393,NM_170707.4(LMNA):c.1129C>T (p.Arg377Cys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
1393,NM_170707.4(LMNA):c.1129C>T (p.Arg377Cys),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
1393,NM_170707.4(LMNA):c.1129C>T (p.Arg377Cys),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
1394,NM_170707.4(LMNA):c.1130G>A (p.Arg377His),LMNA,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
1394,NM_170707.4(LMNA):c.1130G>A (p.Arg377His),LMNA,muscular dystrophy,C0026850,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
1394,NM_170707.4(LMNA):c.1130G>A (p.Arg377His),LMNA,sudden unexplained death,C0520806,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
1394,NM_170707.4(LMNA):c.1130G>A (p.Arg377His),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
1395,NM_170707.4(LMNA):c.1147G>A (p.Glu383Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1396,NM_170707.4(LMNA):c.1149G>T (p.Glu383Asp),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1397,NM_170707.4(LMNA):c.1150G>A (p.Glu384Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1398,NM_170707.4(LMNA):c.1156A>G (p.Arg386Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1399,NM_170707.4(LMNA):c.1157G>C (p.Arg386Thr),LMNA,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: feb 16, 2016)","criteria provided, single submitter"
1400,NM_170707.4(LMNA):c.1163G>C (p.Arg388Pro),LMNA,muscular dystrophy,C0026850,"likely pathogenic(last reviewed: feb 8, 2013)","criteria provided, single submitter"
1401,NM_170707.4(LMNA):c.1163G>A (p.Arg388His),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1402,NM_170707.4(LMNA):c.1337A>T (p.Asp446Val),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1403,NM_170707.4(LMNA):c.1346G>A (p.Gly449Asp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: nov 30, 2021)","criteria provided, single submitter"
1404,NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp),LMNA,muscular dystrophy,C0026850,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
1404,NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
1404,NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
1404,NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
1404,NM_170707.4(LMNA):c.1357C>T (p.Arg453Trp),LMNA,abnormality of the musculature,C4021745,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
1405,NM_170707.4(LMNA):c.1358G>C (p.Arg453Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 28, 2022)","criteria provided, single submitter"
1406,NM_170707.4(LMNA):c.1364G>C (p.Arg455Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, single submitter"
1407,NM_170707.4(LMNA):c.1366A>G (p.Asn456Asp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: jan 19, 2022)","criteria provided, multiple submitters, no conflicts"
1408,NM_170707.4(LMNA):c.1367A>C (p.Asn456Thr),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1409,NM_170707.4(LMNA):c.1368C>G (p.Asn456Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
1410,NM_170707.4(LMNA):c.1385A>C (p.Gln462Pro),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"likely pathogenic(last reviewed: dec 7, 2017)","criteria provided, single submitter"
1411,NM_170707.4(LMNA):c.1394G>A (p.Gly465Asp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1411,NM_170707.4(LMNA):c.1394G>A (p.Gly465Asp),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1412,NM_170707.4(LMNA):c.1399T>A (p.Trp467Arg),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
1413,NM_170707.4(LMNA):c.1411C>G (p.Arg471Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: jul 8, 2022)","criteria provided, multiple submitters, no conflicts"
1413,NM_170707.4(LMNA):c.1411C>G (p.Arg471Gly),LMNA,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: jul 8, 2022)","criteria provided, multiple submitters, no conflicts"
1414,NM_170707.4(LMNA):c.1412G>A (p.Arg471His),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1414,NM_170707.4(LMNA):c.1412G>A (p.Arg471His),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1414,NM_170707.4(LMNA):c.1412G>A (p.Arg471His),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1414,NM_170707.4(LMNA):c.1412G>A (p.Arg471His),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1415,NM_170707.4(LMNA):c.1444C>G (p.Arg482Gly),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,familial partial lipodystrophy,C0271694,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,restrictive dermopathy 2,Cumapped248,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,mandibuloacral dysplasia with type a lipodystrophy,C0432291,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,charcot-marie-tooth disease type 2b1,C1854154,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,"emery-dreifuss muscular dystrophy 3, autosomal recessive",C2750035,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,congenital muscular dystrophy due to lmna mutation,C2750785,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,hutchinson-gilford syndrome,C0033300,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,"heart-hand syndrome, slovenian type",C1857829,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome,C0796083,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1416,NM_170707.4(LMNA):c.1444C>T (p.Arg482Trp),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1417,NM_170707.4(LMNA):c.1458G>T (p.Lys486Asn),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic(last reviewed: jan 29, 2015)","criteria provided, single submitter"
1418,NM_170707.4(LMNA):c.1494G>T (p.Trp498Cys),LMNA,primary familial dilated cardiomyopathy,C0340427,"likely pathogenic(last reviewed: feb 17, 2017)","criteria provided, single submitter"
1419,NM_170707.4(LMNA):c.1558T>A (p.Trp520Arg),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1420,NM_170707.4(LMNA):c.1558T>C (p.Trp520Arg),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1421,NM_170707.4(LMNA):c.1580G>C (p.Arg527Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
1421,NM_170707.4(LMNA):c.1580G>C (p.Arg527Pro),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
1422,NM_170707.4(LMNA):c.1583C>G (p.Thr528Arg),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
1422,NM_170707.4(LMNA):c.1583C>G (p.Thr528Arg),LMNA,"familial partial lipodystrophy, dunnigan type",C1720860,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
1422,NM_170707.4(LMNA):c.1583C>G (p.Thr528Arg),LMNA,abnormality of the musculature,C4021745,"pathogenic/likely pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
1423,NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys),LMNA,hutchinson-gilford syndrome,C0033300,"pathogenic/likely pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1423,NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys),LMNA,benign scapuloperoneal muscular dystrophy with cardiomyopathy,C0410190,"pathogenic/likely pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1423,NM_170707.4(LMNA):c.1583C>A (p.Thr528Lys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: jan 4, 2023)","criteria provided, multiple submitters, no conflicts"
1424,NM_170707.4(LMNA):c.1585G>C (p.Ala529Pro),LMNA,charcot-marie-tooth disease type 2,C0270914,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1425,NM_170707.4(LMNA):c.1588C>T (p.Leu530Phe),LMNA,muscular dystrophy,C0026850,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1425,NM_170707.4(LMNA):c.1588C>T (p.Leu530Phe),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1426,NM_170707.4(LMNA):c.1619T>C (p.Met540Thr),LMNA,hutchinson-gilford syndrome,C0033300,"pathogenic(last reviewed: feb 8, 2013)","criteria provided, single submitter"
1427,NM_170707.4(LMNA):c.1620G>A (p.Met540Ile),LMNA,mandibuloacral dysplasia with type a lipodystrophy,C0432291,"pathogenic(last reviewed: apr 30, 2016)","criteria provided, single submitter"
1428,NM_170707.4(LMNA):c.1621C>A (p.Arg541Ser),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1429,NM_170707.4(LMNA):c.1621C>T (p.Arg541Cys),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
1429,NM_170707.4(LMNA):c.1621C>T (p.Arg541Cys),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
1429,NM_170707.4(LMNA):c.1621C>T (p.Arg541Cys),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
1429,NM_170707.4(LMNA):c.1621C>T (p.Arg541Cys),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
1430,NM_170707.4(LMNA):c.1622G>A (p.Arg541His),LMNA,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1430,NM_170707.4(LMNA):c.1622G>A (p.Arg541His),LMNA,charcot-marie-tooth disease type 2,C0270914,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1430,NM_170707.4(LMNA):c.1622G>A (p.Arg541His),LMNA,hutchinson-gilford syndrome,C0033300,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1430,NM_170707.4(LMNA):c.1622G>A (p.Arg541His),LMNA,dilated cardiomyopathy 1a,C1449563,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1430,NM_170707.4(LMNA):c.1622G>A (p.Arg541His),LMNA,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1431,NM_144772.3(NAXE):c.565G>A (p.Gly189Ser),NAXE,"encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1",C4310675,pathogenic,"criteria provided, single submitter"
1432,NM_144772.3(NAXE):c.611T>C (p.Leu204Pro),NAXE,"encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy, 1",C4310675,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
1433,NM_002529.4(NTRK1):c.1A>C (p.Met1Leu),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: nov 28, 2018)","criteria provided, single submitter"
1434,NM_002529.4(NTRK1):c.3G>A (p.Met1Ile),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: dec 15, 2021)","criteria provided, single submitter"
1435,NM_002529.4(NTRK1):c.303T>A (p.Ser101Arg),NTRK1,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: sep 13, 2021)","criteria provided, single submitter"
1436,NM_002529.4(NTRK1):c.572G>T (p.Cys191Phe),NTRK1,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
1437,NM_002529.4(NTRK1):c.638T>C (p.Leu213Pro),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
1438,NM_002529.4(NTRK1):c.1040G>C (p.Arg347Pro),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: jun 10, 2014)","criteria provided, single submitter"
1439,NM_002529.4(NTRK1):c.1592A>G (p.Asn531Ser),NTRK1,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
1440,NM_002529.4(NTRK1):c.1729G>A (p.Gly577Ser),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, single submitter"
1441,NM_002529.4(NTRK1):c.1759A>G (p.Met587Val),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1442,NM_002529.4(NTRK1):c.1805G>A (p.Arg602Gln),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: jan 15, 2022)","criteria provided, single submitter"
1443,NM_002529.4(NTRK1):c.1945C>T (p.Arg649Trp),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: oct 1, 2022)","criteria provided, single submitter"
1444,NM_002529.4(NTRK1):c.1960C>T (p.Arg654Cys),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
1445,NM_002529.4(NTRK1):c.1961G>C (p.Arg654Pro),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: apr 12, 2022)","criteria provided, single submitter"
1446,NM_002529.4(NTRK1):c.1961G>A (p.Arg654His),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
1447,NM_002529.4(NTRK1):c.2020G>T (p.Asp674Tyr),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic/likely pathogenic(last reviewed: apr 10, 2022)","criteria provided, multiple submitters, no conflicts"
1448,NM_002529.4(NTRK1):c.2074C>T (p.Arg692Cys),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: sep 17, 2022)","criteria provided, single submitter"
1449,NM_002529.4(NTRK1):c.2075G>A (p.Arg692His),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
1450,NM_002529.4(NTRK1):c.2084C>T (p.Pro695Leu),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: aug 18, 2022)","criteria provided, single submitter"
1451,NM_002529.4(NTRK1):c.2143G>A (p.Val715Met),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, single submitter"
1452,NM_002529.4(NTRK1):c.2170G>A (p.Gly724Ser),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: oct 7, 2022)","criteria provided, single submitter"
1453,NM_002529.4(NTRK1):c.2303C>T (p.Pro768Leu),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: aug 7, 2022)","criteria provided, single submitter"
1454,NM_002529.4(NTRK1):c.2311C>T (p.Arg771Cys),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"pathogenic(last reviewed: dec 7, 2021)","criteria provided, single submitter"
1455,NM_002529.4(NTRK1):c.2312G>A (p.Arg771His),NTRK1,hereditary insensitivity to pain with anhidrosis,C0020074,"likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, single submitter"
1456,NM_003126.4(SPTA1):c.1700T>C (p.Leu567Pro),SPTA1,hereditary spherocytosis type 3,C2678338,"likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, single submitter"
1457,NM_003126.4(SPTA1):c.779T>C (p.Leu260Pro),SPTA1,elliptocytosis 2,C1420385,"pathogenic/likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
1458,NM_003126.4(SPTA1):c.137G>T (p.Gly46Val),SPTA1,elliptocytosis 2,C1420385,"likely pathogenic(last reviewed: jun 23, 2017)","criteria provided, single submitter"
1459,NM_003126.4(SPTA1):c.83G>A (p.Arg28His),SPTA1,prenatal anemia,Cumapped216,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1459,NM_003126.4(SPTA1):c.83G>A (p.Arg28His),SPTA1,elliptocytosis 2,C1420385,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1459,NM_003126.4(SPTA1):c.83G>A (p.Arg28His),SPTA1,"pyropoikilocytosis, hereditary",C0520739,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1460,NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys),KCNJ10,pendred syndrome,C0271829,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1460,NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys),KCNJ10,autosomal recessive nonsyndromic hearing loss 4,C3711374,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1460,NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys),KCNJ10,east syndrome,C2748572,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1460,NM_002241.5(KCNJ10):c.889C>T (p.Arg297Cys),KCNJ10,east syndrome,C2748572,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1461,NM_002241.5(KCNJ10):c.755C>G (p.Pro252Arg),KCNJ10,abnormality of the nervous system,C0497552,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
1462,NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val),KCNJ10,pendred syndrome,C0271829,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1462,NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val),KCNJ10,autosomal recessive nonsyndromic hearing loss 4,C3711374,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1462,NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val),KCNJ10,east syndrome,C2748572,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1462,NM_002241.5(KCNJ10):c.500C>T (p.Ala167Val),KCNJ10,east syndrome,C2748572,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1463,NM_002241.5(KCNJ10):c.400C>A (p.Arg134Ser),KCNJ10,east syndrome,C2748572,"likely pathogenic(last reviewed: oct 5, 2021)","criteria provided, single submitter"
1464,NM_002241.5(KCNJ10):c.229G>C (p.Gly77Arg),KCNJ10,east syndrome,C2748572,"likely pathogenic(last reviewed: jul 29, 2022)","criteria provided, single submitter"
1465,NM_002241.5(KCNJ10):c.193C>T (p.Arg65Cys),KCNJ10,east syndrome,C2748572,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
1466,NM_000702.4(ATP1A2):c.604C>T (p.Arg202Trp),ATP1A2|LOC126805890,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: aug 19, 2021)","criteria provided, single submitter"
1467,NM_000702.4(ATP1A2):c.659C>T (p.Ser220Leu),ATP1A2|LOC126805890,"migraine, familial hemiplegic, 2",C1865322,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, single submitter"
1468,NM_000702.4(ATP1A2):c.788C>T (p.Thr263Met),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
1468,NM_000702.4(ATP1A2):c.788C>T (p.Thr263Met),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
1469,NM_000702.4(ATP1A2):c.857T>C (p.Ile286Thr),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: dec 16, 2021)","criteria provided, single submitter"
1470,NM_000702.4(ATP1A2):c.901G>A (p.Gly301Arg),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, single submitter"
1471,NM_000702.4(ATP1A2):c.902G>A (p.Gly301Glu),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
1472,NM_000702.4(ATP1A2):c.991C>G (p.Pro331Ala),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: jul 28, 2022)","criteria provided, single submitter"
1473,NM_000702.4(ATP1A2):c.1022G>A (p.Cys341Tyr),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
1473,NM_000702.4(ATP1A2):c.1022G>A (p.Cys341Tyr),ATP1A2,developmental and epileptic encephalopathy 98,C2931919,"likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
1474,NM_000702.4(ATP1A2):c.1091C>T (p.Thr364Met),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"pathogenic/likely pathogenic(last reviewed: nov 13, 2022)","criteria provided, multiple submitters, no conflicts"
1475,NM_000702.4(ATP1A2):c.1097G>T (p.Gly366Val),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, single submitter"
1476,NM_000702.4(ATP1A2):c.1103C>T (p.Thr368Met),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
1477,NM_000702.4(ATP1A2):c.1127C>T (p.Thr376Met),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1478,NM_000702.4(ATP1A2):c.1130G>T (p.Gly377Val),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
1479,NM_000702.4(ATP1A2):c.1133C>A (p.Thr378Asn),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic/likely pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
1479,NM_000702.4(ATP1A2):c.1133C>A (p.Thr378Asn),ATP1A2,alternating hemiplegia of childhood 1,C3549447,"pathogenic/likely pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
1480,NM_000702.4(ATP1A2):c.1148G>A (p.Arg383His),ATP1A2,alternating hemiplegia of childhood 1,C3549447,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1481,NM_000702.4(ATP1A2):c.1643G>A (p.Arg548His),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: oct 20, 2021)","criteria provided, multiple submitters, no conflicts"
1482,NM_000702.4(ATP1A2):c.1778G>T (p.Arg593Leu),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
1483,NM_000702.4(ATP1A2):c.1811G>A (p.Arg604Gln),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
1484,NM_000702.4(ATP1A2):c.1816G>A (p.Ala606Thr),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: nov 16, 2022)","criteria provided, multiple submitters, no conflicts"
1485,NM_000702.4(ATP1A2):c.1843G>A (p.Gly615Arg),ATP1A2,alternating hemiplegia of childhood 1,C3549447,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1485,NM_000702.4(ATP1A2):c.1843G>A (p.Gly615Arg),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1486,NM_000702.4(ATP1A2):c.1882G>A (p.Val628Met),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: jan 13, 2023)","criteria provided, multiple submitters, no conflicts"
1487,NM_000702.4(ATP1A2):c.2143G>A (p.Gly715Arg),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1488,NM_000702.4(ATP1A2):c.2152G>A (p.Asp718Asn),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"likely pathogenic(last reviewed: oct 28, 2020)","criteria provided, single submitter"
1489,NM_000702.4(ATP1A2):c.2192T>C (p.Met731Thr),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, single submitter"
1490,NM_000702.4(ATP1A2):c.2336G>A (p.Ser779Asn),ATP1A2,alternating hemiplegia of childhood 1,C3549447,"likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, single submitter"
1491,NM_000702.4(ATP1A2):c.2357C>T (p.Pro786Leu),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1492,NM_000702.4(ATP1A2):c.2434G>C (p.Asp812His),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1493,NM_000702.4(ATP1A2):c.2485A>G (p.Met829Val),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: jun 20, 2022)","criteria provided, single submitter"
1494,NM_000702.4(ATP1A2):c.2501G>T (p.Arg834Leu),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: jun 8, 2022)","criteria provided, single submitter"
1495,NM_000702.4(ATP1A2):c.2501G>A (p.Arg834Gln),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: may 21, 2022)","criteria provided, multiple submitters, no conflicts"
1495,NM_000702.4(ATP1A2):c.2501G>A (p.Arg834Gln),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"pathogenic(last reviewed: may 21, 2022)","criteria provided, multiple submitters, no conflicts"
1496,NM_000702.4(ATP1A2):c.2552A>G (p.Tyr851Cys),ATP1A2,see cases,Cumapped260,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,alternating hemiplegia of childhood 1,C3549447,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,"fetal akinesia, respiratory insufficiency, microcephaly, polymicrogyria, and dysmorphic facies",CL1783729,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,developmental and epileptic encephalopathy 98,C2931919,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1497,NM_000702.4(ATP1A2):c.2563G>A (p.Gly855Arg),ATP1A2,alternating hemiplegia of childhood 1,C3549447,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
1498,NM_000702.4(ATP1A2):c.2564G>A (p.Gly855Glu),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
1499,NM_000702.4(ATP1A2):c.2723G>A (p.Arg908Gln),ATP1A2,developmental and epileptic encephalopathy 98,C2931919,"pathogenic/likely pathogenic(last reviewed: mar 20, 2023)","criteria provided, multiple submitters, no conflicts"
1500,NM_000702.4(ATP1A2):c.2810G>A (p.Arg937His),ATP1A2,familial hemiplegic migraine,C0338484,"likely pathogenic(last reviewed: oct 7, 2021)","criteria provided, multiple submitters, no conflicts"
1501,NM_000702.4(ATP1A2):c.2936C>T (p.Pro979Leu),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
1502,NM_000702.4(ATP1A2):c.3005G>A (p.Arg1002Gln),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic/likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, multiple submitters, no conflicts"
1502,NM_000702.4(ATP1A2):c.3005G>A (p.Arg1002Gln),ATP1A2,"migraine, familial hemiplegic, 2",C1865322,"pathogenic/likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, multiple submitters, no conflicts"
1503,NM_000702.4(ATP1A2):c.3019C>T (p.Arg1007Trp),ATP1A2,familial hemiplegic migraine,C0338484,"pathogenic(last reviewed: jun 8, 2022)","criteria provided, single submitter"
1504,NM_002857.4(PEX19):c.161C>T (p.Ser54Leu),PEX19,peroxisome biogenesis disorder 12a (zellweger),C3554002,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, single submitter"
1505,NM_004371.4(COPA):c.725T>C (p.Val242Ala),COPA,autoimmune interstitial lung disease-arthritis syndrome,Cumapped19,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
1506,NM_004371.4(COPA):c.721G>A (p.Glu241Lys),COPA,autoimmune interstitial lung disease-arthritis syndrome,Cumapped19,"pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
1507,NM_004371.4(COPA):c.715G>C (p.Ala239Pro),COPA,autoimmune interstitial lung disease-arthritis syndrome,Cumapped19,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
1508,NM_004371.4(COPA):c.698G>A (p.Arg233His),COPA,autoimmune interstitial lung disease-arthritis syndrome,Cumapped19,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
1508,NM_004371.4(COPA):c.698G>A (p.Arg233His),COPA,see cases,Cumapped260,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
1509,NM_004371.4(COPA):c.690G>T (p.Lys230Asn),COPA,autoimmune interstitial lung disease-arthritis syndrome,Cumapped19,"pathogenic(last reviewed: apr 20, 2015)","criteria provided, single submitter"
1510,NM_015331.3(NCSTN):c.944C>T (p.Ala315Val),NCSTN,"acne inversa, familial, 1",C4551962,"likely pathogenic(last reviewed: dec 19, 2017)","criteria provided, single submitter"
1511,NM_001122764.3(PPOX):c.175C>T (p.Arg59Trp),PPOX,variegate porphyria,C0162532,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
1512,NM_001122764.3(PPOX):c.503G>A (p.Arg168His),PPOX,variegate porphyria,C0162532,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1512,NM_001122764.3(PPOX):c.503G>A (p.Arg168His),PPOX,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1513,NM_001122764.3(PPOX):c.848T>C (p.Ile283Thr),PPOX,abnormality of metabolism/homeostasis,C4021768,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
1514,NM_001377299.1(NDUFS2):c.268G>A (p.Ala90Thr),NDUFS2,leber optic atrophy,C0917796,"likely pathogenic(last reviewed: may 3, 2020)","criteria provided, single submitter"
1515,NM_001377299.1(NDUFS2):c.683G>A (p.Arg228Gln),NDUFS2,"mitochondrial complex 1 deficiency, nuclear type 6",C4748759,"pathogenic(last reviewed: may 29, 2019)","criteria provided, single submitter"
1516,NM_000530.8(MPZ):c.699T>G (p.Ser233Arg),MPZ,sensorimotor neuropathy,C1112256,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
1516,NM_000530.8(MPZ):c.699T>G (p.Ser233Arg),MPZ,emg: neuropathic changes,C4021727,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
1516,NM_000530.8(MPZ):c.699T>G (p.Ser233Arg),MPZ,limb muscle weakness,C0587246,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
1516,NM_000530.8(MPZ):c.699T>G (p.Ser233Arg),MPZ,tremor,C0040822,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
1517,NM_000530.8(MPZ):c.681A>T (p.Arg227Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1517,NM_000530.8(MPZ):c.681A>T (p.Arg227Ser),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1518,NM_000530.8(MPZ):c.670G>T (p.Asp224Tyr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1519,NM_000530.8(MPZ):c.499G>A (p.Gly167Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: dec 24, 2021)","criteria provided, single submitter"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,charcot-marie-tooth disease type 4e,C4721437,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,dejerine-sottas disease,C0011195,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,charcot-marie-tooth disease type 2i,C3888087,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,charcot-marie-tooth disease type 2j,C1843153,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1520,NM_000530.8(MPZ):c.499G>C (p.Gly167Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1521,NM_000530.8(MPZ):c.487G>A (p.Gly163Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: sep 29, 2021)","criteria provided, single submitter"
1522,NM_000530.8(MPZ):c.487G>C (p.Gly163Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
1523,NM_000530.8(MPZ):c.437T>C (p.Val146Ala),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,charcot-marie-tooth disease type 2j,C1843153,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,dejerine-sottas disease,C0011195,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,charcot-marie-tooth disease type 4e,C4721437,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,charcot-marie-tooth disease type 2i,C3888087,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1524,NM_000530.8(MPZ):c.434A>C (p.Tyr145Ser),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1525,NM_000530.8(MPZ):c.419C>T (p.Ser140Phe),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, single submitter"
1526,NM_000530.8(MPZ):c.419C>G (p.Ser140Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: mar 30, 2015)","criteria provided, single submitter"
1527,NM_000530.8(MPZ):c.418T>A (p.Ser140Thr),MPZ,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
1527,NM_000530.8(MPZ):c.418T>A (p.Ser140Thr),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
1527,NM_000530.8(MPZ):c.418T>A (p.Ser140Thr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
1528,NM_000530.8(MPZ):c.410G>A (p.Gly137Asp),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: sep 3, 2015)","criteria provided, single submitter"
1529,NM_000530.8(MPZ):c.409G>A (p.Gly137Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
1530,NM_000530.8(MPZ):c.404T>C (p.Ile135Thr),MPZ,dejerine-sottas disease,C0011195,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
1531,NM_000530.8(MPZ):c.403A>T (p.Ile135Leu),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1531,NM_000530.8(MPZ):c.403A>T (p.Ile135Leu),MPZ,charcot-marie-tooth disease type 1b,C0270912,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1532,NM_000530.8(MPZ):c.403A>C (p.Ile135Leu),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: aug 18, 2015)","criteria provided, single submitter"
1533,NM_000530.8(MPZ):c.401A>T (p.Asp134Val),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1534,NM_000530.8(MPZ):c.398C>T (p.Pro133Leu),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"likely pathogenic(last reviewed: may 26, 2018)","criteria provided, single submitter"
1535,NM_000530.8(MPZ):c.398C>G (p.Pro133Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1535,NM_000530.8(MPZ):c.398C>G (p.Pro133Arg),MPZ,charcot-marie-tooth disease type 2j,C1843153,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1536,NM_000530.8(MPZ):c.397C>T (p.Pro133Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: feb 1, 2022)","criteria provided, multiple submitters, no conflicts"
1537,NM_000530.8(MPZ):c.397C>G (p.Pro133Ala),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,charcot-marie-tooth disease type 4e,C4721437,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,charcot-marie-tooth disease type 2i,C3888087,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,charcot-marie-tooth disease type 2j,C1843153,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1538,NM_000530.8(MPZ):c.397C>A (p.Pro133Thr),MPZ,dejerine-sottas disease,C0011195,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
1539,NM_000530.8(MPZ):c.394C>T (p.Pro132Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
1540,NM_000530.8(MPZ):c.394C>G (p.Pro132Ala),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1541,NM_000530.8(MPZ):c.393C>A (p.Asn131Lys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
1542,NM_000530.8(MPZ):c.392A>G (p.Asn131Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1543,NM_000530.8(MPZ):c.382G>A (p.Asp128Asn),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: nov 11, 2021)","criteria provided, single submitter"
1544,NM_000530.8(MPZ):c.380G>A (p.Cys127Tyr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: jun 18, 2022)","criteria provided, multiple submitters, no conflicts"
1544,NM_000530.8(MPZ):c.380G>A (p.Cys127Tyr),MPZ,dejerine-sottas disease,C0011195,"pathogenic/likely pathogenic(last reviewed: jun 18, 2022)","criteria provided, multiple submitters, no conflicts"
1545,NM_000530.8(MPZ):c.380G>C (p.Cys127Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,dejerine-sottas disease,C0011195,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,charcot-marie-tooth disease type 2i,C3888087,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,charcot-marie-tooth disease type 2j,C1843153,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,charcot-marie-tooth disease type 4e,C4721437,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1546,NM_000530.8(MPZ):c.371C>T (p.Thr124Met),MPZ,charcot-marie-tooth disease dominant intermediate d,C1843075,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
1547,NM_000530.8(MPZ):c.361G>A (p.Asp121Asn),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1548,NM_000530.8(MPZ):c.356A>G (p.Tyr119Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
1549,NM_000530.8(MPZ):c.335T>C (p.Ile112Thr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1550,NM_000530.8(MPZ):c.332C>G (p.Ser111Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1551,NM_000530.8(MPZ):c.325G>A (p.Asp109Asn),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, single submitter"
1552,NM_000530.8(MPZ):c.314C>T (p.Pro105Leu),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
1552,NM_000530.8(MPZ):c.314C>T (p.Pro105Leu),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
1553,NM_000530.8(MPZ):c.303G>T (p.Trp101Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1554,NM_000530.8(MPZ):c.301T>C (p.Trp101Arg),MPZ,charcot-marie-tooth disease type 1b,C0270912,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1554,NM_000530.8(MPZ):c.301T>C (p.Trp101Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1555,NM_000530.8(MPZ):c.296T>C (p.Ile99Thr),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1555,NM_000530.8(MPZ):c.296T>C (p.Ile99Thr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,decreased nerve conduction velocity,C1857640,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,sensory neuropathy,C0151313,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,pes cavus,C0728829,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,distal muscle weakness,C0427065,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1556,NM_000530.8(MPZ):c.293G>A (p.Arg98His),MPZ,distal lower limb amyotrophy,C1836451,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1557,NM_000530.8(MPZ):c.293G>C (p.Arg98Pro),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: jul 8, 2022)","criteria provided, multiple submitters, no conflicts"
1558,NM_000530.8(MPZ):c.292C>T (p.Arg98Cys),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1558,NM_000530.8(MPZ):c.292C>T (p.Arg98Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1559,NM_000530.8(MPZ):c.286A>G (p.Lys96Glu),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
1560,NM_000530.8(MPZ):c.277G>A (p.Gly93Arg),MPZ,charcot-marie-tooth disease type 1b,C0270912,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1560,NM_000530.8(MPZ):c.277G>A (p.Gly93Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1561,NM_000530.8(MPZ):c.277G>C (p.Gly93Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: feb 6, 2019)","criteria provided, single submitter"
1562,NM_000530.8(MPZ):c.270C>A (p.Asp90Glu),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
1562,NM_000530.8(MPZ):c.270C>A (p.Asp90Glu),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
1563,NM_000530.8(MPZ):c.245A>G (p.Tyr82Cys),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
1563,NM_000530.8(MPZ):c.245A>G (p.Tyr82Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
1563,NM_000530.8(MPZ):c.245A>G (p.Tyr82Cys),MPZ,peripheral neuropathy,C4721453,"pathogenic/likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
1564,NM_000530.8(MPZ):c.244T>C (p.Tyr82His),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
1565,NM_000530.8(MPZ):c.242A>G (p.His81Arg),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
1566,NM_000530.8(MPZ):c.233C>G (p.Ser78Trp),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: aug 4, 2022)","criteria provided, multiple submitters, no conflicts"
1567,NM_000530.8(MPZ):c.233C>T (p.Ser78Leu),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
1567,NM_000530.8(MPZ):c.233C>T (p.Ser78Leu),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
1567,NM_000530.8(MPZ):c.233C>T (p.Ser78Leu),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
1568,NM_000530.8(MPZ):c.224A>T (p.Asp75Val),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1569,NM_000530.8(MPZ):c.208C>T (p.Pro70Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: jul 31, 2021)","criteria provided, single submitter"
1570,NM_000530.8(MPZ):c.200G>C (p.Arg67Pro),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: sep 3, 2021)","criteria provided, single submitter"
1571,NM_000530.8(MPZ):c.194C>A (p.Thr65Asn),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1571,NM_000530.8(MPZ):c.194C>A (p.Thr65Asn),MPZ,charcot-marie-tooth disease type 1b,C0270912,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1572,NM_000530.8(MPZ):c.188C>T (p.Ser63Phe),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1572,NM_000530.8(MPZ):c.188C>T (p.Ser63Phe),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1573,NM_000530.8(MPZ):c.188C>G (p.Ser63Cys),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1574,NM_000530.8(MPZ):c.182A>G (p.Asp61Gly),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
1575,NM_000530.8(MPZ):c.181G>A (p.Asp61Asn),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
1576,NM_000530.8(MPZ):c.156C>G (p.Phe52Leu),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
1577,NM_000530.8(MPZ):c.152C>T (p.Ser51Phe),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
1578,NM_000530.8(MPZ):c.131C>T (p.Ser44Phe),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic(last reviewed: jul 22, 2022)","criteria provided, multiple submitters, no conflicts"
1578,NM_000530.8(MPZ):c.131C>T (p.Ser44Phe),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: jul 22, 2022)","criteria provided, multiple submitters, no conflicts"
1579,NM_000530.8(MPZ):c.130T>C (p.Ser44Pro),MPZ,motor neuron disease,C0085084,"likely pathogenic(last reviewed: mar 1, 2021)","criteria provided, single submitter"
1580,NM_000530.8(MPZ):c.116A>C (p.His39Pro),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: oct 11, 2022)","criteria provided, multiple submitters, no conflicts"
1580,NM_000530.8(MPZ):c.116A>C (p.His39Pro),MPZ,not specified,Cumapped182,"pathogenic(last reviewed: oct 11, 2022)","criteria provided, multiple submitters, no conflicts"
1581,NM_000530.8(MPZ):c.113T>A (p.Val38Asp),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1582,NM_000530.8(MPZ):c.106A>T (p.Arg36Trp),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
1583,NM_000530.8(MPZ):c.103G>A (p.Asp35Asn),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
1583,NM_000530.8(MPZ):c.103G>A (p.Asp35Asn),MPZ,charcot-marie-tooth disease type 2i,C3888087,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
1584,NM_000530.8(MPZ):c.103G>T (p.Asp35Tyr),MPZ,charcot-marie-tooth disease,C0007959,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1584,NM_000530.8(MPZ):c.103G>T (p.Asp35Tyr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1585,NM_000530.8(MPZ):c.101C>T (p.Thr34Ile),MPZ,charcot-marie-tooth disease type 1b,C0270912,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1586,NM_000530.8(MPZ):c.90C>G (p.Ile30Met),MPZ,"charcot-marie-tooth disease, type i",C0751036,"pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
1587,NM_000530.8(MPZ):c.89T>G (p.Ile30Ser),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1588,NM_000530.8(MPZ):c.89T>C (p.Ile30Thr),MPZ,"charcot-marie-tooth disease, type i",C0751036,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
1589,NM_003001.5(SDHC):c.1A>C (p.Met1Leu),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: dec 23, 2021)","criteria provided, single submitter"
1589,NM_003001.5(SDHC):c.1A>C (p.Met1Leu),SDHC,paragangliomas 3,C1854336,"pathogenic(last reviewed: dec 23, 2021)","criteria provided, single submitter"
1590,NM_003001.5(SDHC):c.1A>T (p.Met1Leu),SDHC,paragangliomas 3,C1854336,"pathogenic(last reviewed: aug 6, 2021)","criteria provided, single submitter"
1590,NM_003001.5(SDHC):c.1A>T (p.Met1Leu),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 6, 2021)","criteria provided, single submitter"
1591,NM_003001.5(SDHC):c.1A>G (p.Met1Val),SDHC,paragangliomas 3,C1854336,"pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
1591,NM_003001.5(SDHC):c.1A>G (p.Met1Val),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
1591,NM_003001.5(SDHC):c.1A>G (p.Met1Val),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
1591,NM_003001.5(SDHC):c.1A>G (p.Met1Val),SDHC,paragangliomas 3,C1854336,"pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
1592,NM_003001.5(SDHC):c.2T>G (p.Met1Arg),SDHC,gastrointestinal stromal tumor,C0238198,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1592,NM_003001.5(SDHC):c.2T>G (p.Met1Arg),SDHC,paragangliomas 3,C1854336,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1593,NM_003001.5(SDHC):c.3G>A (p.Met1Ile),SDHC,paragangliomas 3,C1854336,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1593,NM_003001.5(SDHC):c.3G>A (p.Met1Ile),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1594,NM_003001.5(SDHC):c.160C>T (p.Pro54Ser),SDHC,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 14, 2021)","criteria provided, single submitter"
1595,NM_003001.5(SDHC):c.202T>C (p.Ser68Pro),SDHC,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 3, 2020)","criteria provided, single submitter"
1596,NM_003001.5(SDHC):c.215G>T (p.Arg72Leu),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: dec 16, 2020)","criteria provided, single submitter"
1597,NM_003001.5(SDHC):c.223G>C (p.Gly75Arg),SDHC,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 20, 2017)","criteria provided, single submitter"
1598,NM_003001.5(SDHC):c.224G>A (p.Gly75Asp),SDHC,paragangliomas 3,C1854336,"pathogenic/likely pathogenic(last reviewed: oct 25, 2021)","criteria provided, multiple submitters, no conflicts"
1598,NM_003001.5(SDHC):c.224G>A (p.Gly75Asp),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 25, 2021)","criteria provided, multiple submitters, no conflicts"
1598,NM_003001.5(SDHC):c.224G>A (p.Gly75Asp),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 25, 2021)","criteria provided, multiple submitters, no conflicts"
1599,NM_003001.5(SDHC):c.374T>G (p.Met125Arg),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1599,NM_003001.5(SDHC):c.374T>G (p.Met125Arg),SDHC,paragangliomas 3,C1854336,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1599,NM_003001.5(SDHC):c.374T>G (p.Met125Arg),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1600,NM_003001.5(SDHC):c.377A>G (p.Tyr126Cys),SDHC,paragangliomas 3,C1854336,"pathogenic/likely pathogenic(last reviewed: mar 22, 2023)","criteria provided, multiple submitters, no conflicts"
1600,NM_003001.5(SDHC):c.377A>G (p.Tyr126Cys),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: mar 22, 2023)","criteria provided, multiple submitters, no conflicts"
1600,NM_003001.5(SDHC):c.377A>G (p.Tyr126Cys),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: mar 22, 2023)","criteria provided, multiple submitters, no conflicts"
1600,NM_003001.5(SDHC):c.377A>G (p.Tyr126Cys),SDHC,paragangliomas 3,C1854336,"pathogenic/likely pathogenic(last reviewed: mar 22, 2023)","criteria provided, multiple submitters, no conflicts"
1601,NM_003001.5(SDHC):c.379C>T (p.His127Tyr),SDHC,paragangliomas 3,C1854336,"pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
1601,NM_003001.5(SDHC):c.379C>T (p.His127Tyr),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
1601,NM_003001.5(SDHC):c.379C>T (p.His127Tyr),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
1602,NM_003001.5(SDHC):c.380A>G (p.His127Arg),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: dec 3, 2022)","criteria provided, multiple submitters, no conflicts"
1602,NM_003001.5(SDHC):c.380A>G (p.His127Arg),SDHC,paragangliomas 3,C1854336,"pathogenic/likely pathogenic(last reviewed: dec 3, 2022)","criteria provided, multiple submitters, no conflicts"
1602,NM_003001.5(SDHC):c.380A>G (p.His127Arg),SDHC,gastrointestinal stromal tumor,C0238198,"pathogenic/likely pathogenic(last reviewed: dec 3, 2022)","criteria provided, multiple submitters, no conflicts"
1602,NM_003001.5(SDHC):c.380A>G (p.His127Arg),SDHC,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: dec 3, 2022)","criteria provided, multiple submitters, no conflicts"
1603,NM_007348.4(ATF6):c.970C>T (p.Arg324Cys),ATF6,achromatopsia 7,C4225297,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
1604,NM_007348.4(ATF6):c.1699T>A (p.Tyr567Asn),ATF6,achromatopsia 7,C4225297,"pathogenic(last reviewed: jun 17, 2015)","criteria provided, single submitter"
1605,NM_175866.5(UHMK1):c.1214C>T (p.Pro405Leu),UHMK1,cerebral visual impairment and intellectual disability,Cumapped44,"likely pathogenic(last reviewed: sep 9, 2015)","criteria provided, single submitter"
1606,NM_145697.3(NUF2):c.371T>G (p.Ile124Ser),NUF2,microcephaly,C4551563,"pathogenic(last reviewed: dec 22, 2020)","criteria provided, single submitter"
1606,NM_145697.3(NUF2):c.371T>G (p.Ile124Ser),NUF2,short stature,C2919142,"pathogenic(last reviewed: dec 22, 2020)","criteria provided, single submitter"
1607,NM_002585.4(PBX1):c.320G>A (p.Arg107Gln),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,"likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, single submitter"
1608,NM_002585.4(PBX1):c.701G>A (p.Arg234Gln),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,"likely pathogenic(last reviewed: jan 4, 2018)","criteria provided, single submitter"
1609,NM_002585.4(PBX1):c.703C>T (p.Arg235Trp),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
1610,NM_002585.4(PBX1):c.758A>C (p.Tyr253Ser),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,"likely pathogenic(last reviewed: aug 21, 2020)","criteria provided, single submitter"
1611,NM_002585.4(PBX1):c.817T>C (p.Cys273Arg),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,"likely pathogenic(last reviewed: feb 20, 2020)","criteria provided, single submitter"
1612,NM_002585.4(PBX1):c.818G>A (p.Cys273Tyr),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,"likely pathogenic(last reviewed: aug 14, 2018)","criteria provided, single submitter"
1613,NM_002585.4(PBX1):c.836A>G (p.Gln279Arg),PBX1,"congenital anomalies of kidney and urinary tract syndrome with or without hearing loss, abnormal ears, or developmental delay",C4539968,likely pathogenic,"criteria provided, single submitter"
1614,NM_177398.4(LMX1A):c.595A>G (p.Arg199Gly),LMX1A,autosomal dominant nonsyndromic hearing loss 7,C3711374,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
1615,NM_019026.6(TMCO1):c.70G>A (p.Gly24Ser),TMCO1,"craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1",CL1899768,"likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, single submitter"
1616,NM_019026.6(TMCO1):c.70G>C (p.Gly24Arg),TMCO1,"craniofacial dysmorphism, skeletal anomalies, and impaired intellectual development 1",CL1899768,pathogenic,"criteria provided, single submitter"
1617,NM_001198956.2(DCAF6):c.2240G>A (p.Arg747Gln),DCAF6,cerebral visual impairment and intellectual disability,Cumapped44,"likely pathogenic(last reviewed: sep 9, 2015)","criteria provided, single submitter"
1618,NM_005149.3(TBX19):c.206G>A (p.Arg69Gln),TBX19,congenital isolated adrenocorticotropic hormone deficiency,C4055196,"likely pathogenic(last reviewed: sep 23, 2021)","criteria provided, single submitter"
1619,NM_005149.3(TBX19):c.608C>T (p.Thr203Met),TBX19,see cases,Cumapped260,"likely pathogenic(last reviewed: dec 17, 2021)","criteria provided, single submitter"
1620,NM_001937.5(DPT):c.544C>T (p.Arg182Cys),DPT,progressive sensorineural hearing impairment,C1843156,"pathogenic(last reviewed: mar 1, 2016)","criteria provided, single submitter"
1621,NM_006996.3(SLC19A2):c.1001G>A (p.Gly334Asp),SLC19A2,"megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",C0342287,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
1622,NM_006996.3(SLC19A2):c.515G>A (p.Gly172Asp),SLC19A2,"megaloblastic anemia, thiamine-responsive, with diabetes mellitus and sensorineural deafness",C0342287,"pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
1623,NM_000130.5(F5):c.1673A>G (p.Tyr558Cys),F5,factor v deficiency,C4317320,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1624,NM_000130.5(F5):c.1671G>C (p.Trp557Cys),F5,factor v deficiency,C4317320,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1625,NM_000130.4(F5):c.1601G>A (p.Arg534Gln),F5,thrombophilia due to activated protein c resistance,C1861171,"pathogenic/pathogenic, low penetrance; risk factor(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1625,NM_000130.4(F5):c.1601G>A (p.Arg534Gln),F5,factor v deficiency,C4317320,"pathogenic/pathogenic, low penetrance; risk factor(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1625,NM_000130.4(F5):c.1601G>A (p.Arg534Gln),F5,not specified,Cumapped182,"pathogenic/pathogenic, low penetrance; risk factor(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1625,NM_000130.4(F5):c.1601G>A (p.Arg534Gln),F5,thrombophilia due to activated protein c resistance,C1861171,"pathogenic/pathogenic, low penetrance; risk factor(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1625,NM_000130.4(F5):c.1601G>A (p.Arg534Gln),F5,factor v deficiency,C4317320,"pathogenic/pathogenic, low penetrance; risk factor(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
1626,NM_000130.5(F5):c.1498T>G (p.Cys500Gly),F5,factor v deficiency,C4317320,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1627,NM_001002294.3(FMO3):c.667C>T (p.Arg223Trp),FMO3,trimethylaminuria,C0342739,"likely pathogenic(last reviewed: jun 20, 2019)","criteria provided, single submitter"
1628,NM_001002294.3(FMO3):c.929C>T (p.Ser310Leu),FMO3,trimethylaminuria,C0342739,"likely pathogenic(last reviewed: mar 28, 2022)","criteria provided, multiple submitters, no conflicts"
1628,NM_001002294.3(FMO3):c.929C>T (p.Ser310Leu),FMO3,see cases,Cumapped260,"likely pathogenic(last reviewed: mar 28, 2022)","criteria provided, multiple submitters, no conflicts"
1629,NM_001002294.3(FMO3):c.1474C>T (p.Arg492Trp),FMO3,trimethylaminuria,C0342739,"likely pathogenic(last reviewed: sep 4, 2020)","criteria provided, multiple submitters, no conflicts"
1630,NM_000261.2(MYOC):c.1495A>T (p.Ile499Phe),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1631,NM_000261.2(MYOC):c.1442C>T (p.Pro481Leu),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1632,NM_000261.2(MYOC):c.1440C>G (p.Asn480Lys),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1633,NM_000261.2(MYOC):c.1440C>A (p.Asn480Lys),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1634,NM_000261.2(MYOC):c.1435T>C (p.Tyr479His),MYOC,"glaucoma 1, open angle, a",C1842028,"likely pathogenic(last reviewed: may 27, 2021)","criteria provided, single submitter"
1635,NM_000261.2(MYOC):c.1430T>A (p.Ile477Asn),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1636,NM_000261.2(MYOC):c.1313C>T (p.Thr438Ile),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 15, 2023)",reviewed by expert panel
1637,NM_000261.2(MYOC):c.1309T>C (p.Tyr437His),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1638,NM_000261.2(MYOC):c.1297T>C (p.Cys433Arg),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1639,NM_000261.2(MYOC):c.1276G>T (p.Val426Phe),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1640,NM_000261.2(MYOC):c.1267A>G (p.Lys423Glu),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1641,NM_000261.2(MYOC):c.1150G>A (p.Asp384Asn),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1642,NM_000261.2(MYOC):c.1139A>C (p.Asp380Ala),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1643,NM_000261.2(MYOC):c.1138G>T (p.Asp380Tyr),MYOC,"glaucoma 1, open angle, e",C1842026,"likely pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1644,NM_000261.2(MYOC):c.1138G>C (p.Asp380His),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1645,NM_000261.2(MYOC):c.1130C>T (p.Thr377Met),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1646,NM_000261.2(MYOC):c.1109C>T (p.Pro370Leu),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1647,NM_000261.2(MYOC):c.1099G>A (p.Gly367Arg),MYOC,glaucoma of childhood,C2981140,"pathogenic(last reviewed: may 9, 2022)",reviewed by expert panel
1648,NM_000261.2(MYOC):c.1091G>T (p.Gly364Val),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1649,NM_000261.2(MYOC):c.1087G>A (p.Ala363Thr),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1650,NM_000261.2(MYOC):c.1021T>C (p.Ser341Pro),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 15, 2023)",reviewed by expert panel
1651,NM_000261.2(MYOC):c.976G>C (p.Gly326Arg),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1652,NM_000261.2(MYOC):c.967G>A (p.Glu323Lys),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1653,NM_000261.2(MYOC):c.761C>T (p.Pro254Leu),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: mar 5, 2022)",reviewed by expert panel
1654,NM_000261.2(MYOC):c.754G>A (p.Gly252Arg),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1655,NM_000261.2(MYOC):c.752T>C (p.Val251Ala),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1656,NM_000261.2(MYOC):c.736G>A (p.Gly246Arg),MYOC,glaucoma of childhood,C2981140,"likely pathogenic(last reviewed: feb 20, 2022)",reviewed by expert panel
1657,NM_153747.2(PIGC):c.659T>C (p.Leu220Pro),PIGC|C1orf105,non-immune hydrops fetalis,C0455988,"likely pathogenic(last reviewed: mar 22, 2014)","criteria provided, single submitter"
1658,NM_153747.2(PIGC):c.635T>C (p.Leu212Pro),PIGC|C1orf105,glycosylphosphatidylinositol biosynthesis defect 16,C4540521,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
1659,NM_153747.2(PIGC):c.566T>G (p.Leu189Trp),C1orf105|PIGC,glycosylphosphatidylinositol biosynthesis defect 16,C4540521,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
1660,NM_014458.4(KLHL20):c.1069G>A (p.Gly357Arg),KLHL20,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: feb 4, 2022)","criteria provided, multiple submitters, no conflicts"
1660,NM_014458.4(KLHL20):c.1069G>A (p.Gly357Arg),KLHL20,intellectual disability,C3714756,"likely pathogenic(last reviewed: feb 4, 2022)","criteria provided, multiple submitters, no conflicts"
1661,NM_018122.5(DARS2):c.172C>G (p.Arg58Gly),DARS2,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,CL547123,"pathogenic(last reviewed: sep 2, 2022)","criteria provided, multiple submitters, no conflicts"
1662,NM_018122.5(DARS2):c.259G>A (p.Asp87Asn),DARS2,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,CL547123,"likely pathogenic(last reviewed: feb 17, 2016)","criteria provided, single submitter"
1663,NM_018122.5(DARS2):c.416T>C (p.Ile139Thr),DARS2,spastic ataxia,Cumapped289,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
1664,NM_018122.5(DARS2):c.455G>T (p.Cys152Phe),DARS2,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,CL547123,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
1664,NM_018122.5(DARS2):c.455G>T (p.Cys152Phe),DARS2,see cases,Cumapped260,"pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
1665,NM_018122.5(DARS2):c.563G>A (p.Arg188Gln),DARS2,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,CL547123,"likely pathogenic(last reviewed: nov 12, 2019)","criteria provided, single submitter"
1666,NM_018122.5(DARS2):c.1441G>A (p.Val481Met),DARS2,leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome,CL547123,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
1667,NM_000488.4(SERPINC1):c.1376C>A (p.Ala459Asp),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1668,NM_000488.4(SERPINC1):c.1366G>C (p.Gly456Arg),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic(last reviewed: may 19, 2022)","criteria provided, single submitter"
1669,NM_000488.4(SERPINC1):c.1315C>G (p.Pro439Ala),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1670,NM_000488.4(SERPINC1):c.1315C>A (p.Pro439Thr),SERPINC1,abnormal thrombosis,C4025731,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1671,NM_000488.4(SERPINC1):c.1306G>A (p.Ala436Thr),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1672,NM_000488.4(SERPINC1):c.1302C>A (p.Phe434Leu),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: jan 11, 2022)","criteria provided, single submitter"
1673,NM_000488.4(SERPINC1):c.1277C>T (p.Ser426Leu),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1674,NM_000488.4(SERPINC1):c.1274G>A (p.Arg425His),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
1675,NM_000488.4(SERPINC1):c.1273C>T (p.Arg425Cys),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1676,NM_000488.4(SERPINC1):c.1157T>C (p.Ile386Thr),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic/likely pathogenic(last reviewed: apr 24, 2022)","criteria provided, multiple submitters, no conflicts"
1677,NM_000488.4(SERPINC1):c.1057C>T (p.Pro353Ser),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: jun 29, 2020)","criteria provided, single submitter"
1678,NM_000488.4(SERPINC1):c.953C>T (p.Pro318Leu),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, multiple submitters, no conflicts"
1679,NM_000488.4(SERPINC1):c.819G>C (p.Lys273Asn),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: jul 22, 2021)","criteria provided, single submitter"
1680,NM_000488.4(SERPINC1):c.655A>G (p.Asn219Asp),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic/likely pathogenic(last reviewed: jun 10, 2020)","criteria provided, multiple submitters, no conflicts"
1681,NM_000488.4(SERPINC1):c.641C>A (p.Ser214Tyr),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: apr 25, 2022)","criteria provided, single submitter"
1682,NM_000488.4(SERPINC1):c.592T>C (p.Tyr198His),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
1683,NM_000488.4(SERPINC1):c.536T>C (p.Phe179Ser),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1684,NM_000488.4(SERPINC1):c.442T>C (p.Ser148Pro),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, single submitter"
1685,NM_000488.4(SERPINC1):c.436A>G (p.Lys146Glu),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic(last reviewed: dec 3, 2021)","criteria provided, single submitter"
1686,NM_000488.4(SERPINC1):c.391C>T (p.Leu131Phe),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1686,NM_000488.4(SERPINC1):c.391C>T (p.Leu131Phe),SERPINC1,deep venous thrombosis,C0149871,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1687,NM_000488.4(SERPINC1):c.341G>A (p.Ser114Asn),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic(last reviewed: aug 4, 2021)","criteria provided, single submitter"
1688,NM_000488.4(SERPINC1):c.235C>T (p.Arg79Cys),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic/likely pathogenic(last reviewed: mar 26, 2022)","criteria provided, multiple submitters, no conflicts"
1689,NM_000488.4(SERPINC1):c.218C>T (p.Pro73Leu),SERPINC1,hereditary antithrombin deficiency,C3658294,"pathogenic/likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, multiple submitters, no conflicts"
1690,NM_000488.4(SERPINC1):c.166C>T (p.Arg56Cys),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
1691,NM_000488.4(SERPINC1):c.133C>T (p.Arg45Trp),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: mar 10, 2021)","criteria provided, single submitter"
1692,NM_000488.4(SERPINC1):c.116T>C (p.Ile39Thr),SERPINC1,hereditary antithrombin deficiency,C3658294,"likely pathogenic(last reviewed: jan 24, 2022)","criteria provided, single submitter"
1693,NM_003285.3(TNR):c.1594G>A (p.Asp532Asn),TNR,non-progressive neurodevelopmental disorder with spasticity and transient opisthotonus,Cumapped177,"likely pathogenic(last reviewed: jul 25, 2019)","criteria provided, single submitter"
1694,NM_003285.3(TNR):c.1189G>A (p.Ala397Thr),TNR,non-progressive neurodevelopmental disorder with spasticity and transient opisthotonus,Cumapped177,"likely pathogenic(last reviewed: jul 25, 2019)","criteria provided, single submitter"
1695,NM_004319.3(ASTN1):c.2224G>C (p.Gly742Arg),ASTN1,abnormality of brain morphology,C4021085,likely pathogenic,"criteria provided, single submitter"
1696,NM_014625.4(NPHS2):c.928G>A (p.Glu310Lys),AXDND1|NPHS2,"nephrotic syndrome, type 2",C4014120,"likely pathogenic(last reviewed: apr 20, 2022)","criteria provided, multiple submitters, no conflicts"
1697,NM_014625.4(NPHS2):c.923C>T (p.Ala308Val),AXDND1|NPHS2,"nephrotic syndrome, type 2",C4014120,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
1698,NM_014625.4(NPHS2):c.890C>T (p.Ala297Val),AXDND1|NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
1698,NM_014625.4(NPHS2):c.890C>T (p.Ala297Val),AXDND1|NPHS2,idiopathic nephrotic syndrome,C3496337,"pathogenic/likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
1699,NM_014625.4(NPHS2):c.871C>T (p.Arg291Trp),NPHS2|AXDND1,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
1700,NM_014625.4(NPHS2):c.868G>A (p.Val290Met),AXDND1|NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
1701,NM_014625.4(NPHS2):c.851C>T (p.Ala284Val),AXDND1|NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
1701,NM_014625.4(NPHS2):c.851C>T (p.Ala284Val),AXDND1|NPHS2,idiopathic nephrotic syndrome,C3496337,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
1702,NM_014625.4(NPHS2):c.714G>C (p.Arg238Ser),NPHS2,idiopathic nephrotic syndrome,C3496337,"pathogenic/likely pathogenic(last reviewed: jan 6, 2023)","criteria provided, multiple submitters, no conflicts"
1703,NM_014625.4(NPHS2):c.714G>T (p.Arg238Ser),NPHS2,focal segmental glomerulosclerosis,C0017668,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
1703,NM_014625.4(NPHS2):c.714G>T (p.Arg238Ser),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
1704,NM_014625.4(NPHS2):c.538G>A (p.Val180Met),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic(last reviewed: sep 11, 2022)","criteria provided, multiple submitters, no conflicts"
1705,NM_014625.4(NPHS2):c.506T>C (p.Leu169Pro),NPHS2,idiopathic nephrotic syndrome,C3496337,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
1705,NM_014625.4(NPHS2):c.506T>C (p.Leu169Pro),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
1706,NM_014625.4(NPHS2):c.503G>A (p.Arg168His),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
1707,NM_014625.4(NPHS2):c.502C>T (p.Arg168Cys),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic/likely pathogenic(last reviewed: jun 23, 2022)","criteria provided, multiple submitters, no conflicts"
1708,NM_014625.4(NPHS2):c.379G>A (p.Val127Ile),NPHS2,"nephrotic syndrome, type 2",C4014120,"likely pathogenic(last reviewed: apr 26, 2019)","criteria provided, single submitter"
1709,NM_014625.4(NPHS2):c.353C>T (p.Pro118Leu),NPHS2,proteinuria,C1962972,"pathogenic(last reviewed: jun 11, 2019)","criteria provided, multiple submitters, no conflicts"
1709,NM_014625.4(NPHS2):c.353C>T (p.Pro118Leu),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic(last reviewed: jun 11, 2019)","criteria provided, multiple submitters, no conflicts"
1710,NM_014625.4(NPHS2):c.3G>A (p.Met1Ile),NPHS2,"nephrotic syndrome, type 2",C4014120,"likely pathogenic(last reviewed: mar 22, 2016)","criteria provided, single submitter"
1711,NM_014625.4(NPHS2):c.1A>T (p.Met1Leu),NPHS2,"nephrotic syndrome, type 2",C4014120,"pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
1712,NM_015602.4(TOR1AIP1):c.1427C>T (p.Ala476Val),TOR1AIP1,autosomal recessive limb-girdle muscular dystrophy type 2y,C4511482,"likely pathogenic(last reviewed: nov 14, 2016)","criteria provided, single submitter"
1713,NM_033343.4(LHX4):c.171T>G (p.Cys57Trp),LHX4,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
1714,NM_001205293.3(CACNA1E):c.1042G>C (p.Gly348Arg),CACNA1E,"developmental and epileptic encephalopathy, 69",C2931919,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
1715,NM_001205293.3(CACNA1E):c.1054G>A (p.Gly352Arg),CACNA1E,"developmental and epileptic encephalopathy, 69",C2931919,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1716,NM_001205293.3(CACNA1E):c.2104G>A (p.Ala702Thr),CACNA1E,van der woude syndrome 1,C4551864,"pathogenic/likely pathogenic(last reviewed: mar 6, 2023)","criteria provided, multiple submitters, no conflicts"
1716,NM_001205293.3(CACNA1E):c.2104G>A (p.Ala702Thr),CACNA1E,"developmental and epileptic encephalopathy, 69",C2931919,"pathogenic/likely pathogenic(last reviewed: mar 6, 2023)","criteria provided, multiple submitters, no conflicts"
1717,NM_001033044.4(GLUL):c.1075T>G (p.Cys359Gly),GLUL,congenital brain dysgenesis due to glutamine synthetase deficiency,Cumapped53,"likely pathogenic(last reviewed: mar 24, 2021)","criteria provided, single submitter"
1718,NM_021133.4(RNASEL):c.1469A>G (p.Asn490Ser),RNASEL,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
1719,NM_021133.4(RNASEL):c.1115C>A (p.Ala372Asp),RNASEL,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
1720,NM_005562.3(LAMC2):c.3G>T (p.Met1Ile),LAMC2|LOC126805948,junctional epidermolysis bullosa gravis of herlitz,C0079683,"likely pathogenic(last reviewed: jan 11, 2017)","criteria provided, single submitter"
1721,NM_005562.3(LAMC2):c.379G>T (p.Gly127Trp),LAMC2,junctional epidermolysis bullosa,C0079301,"pathogenic(last reviewed: dec 4, 2018)","criteria provided, single submitter"
1722,NM_000433.4(NCF2):c.605C>T (p.Ala202Val),NCF2,"granulomatous disease, chronic, autosomal recessive, cytochrome b-positive, type 2",C1856245,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1723,NM_052965.4(TSEN15):c.346C>T (p.His116Tyr),TSEN15,"pontocerebellar hypoplasia, type 2f",C4310757,"likely pathogenic(last reviewed: mar 1, 2020)","criteria provided, single submitter"
1724,NM_024529.5(CDC73):c.1A>G (p.Met1Val),CDC73,parathyroid carcinoma,C0687150,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
1725,NM_024529.5(CDC73):c.188T>C (p.Leu63Pro),CDC73,parathyroid carcinoma,C0687150,"likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
1726,NM_024529.5(CDC73):c.191T>C (p.Leu64Pro),CDC73,parathyroid carcinoma,C0687150,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
1727,NM_198503.5(KCNT2):c.1667C>T (p.Thr556Ile),KCNT2,"developmental and epileptic encephalopathy, 57",C2931919,"likely pathogenic(last reviewed: nov 29, 2022)","criteria provided, single submitter"
1728,NM_198503.5(KCNT2):c.1096A>G (p.Lys366Glu),KCNT2,"developmental and epileptic encephalopathy, 57",C2931919,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
1729,NM_198503.5(KCNT2):c.914G>C (p.Cys305Ser),KCNT2,"developmental and epileptic encephalopathy, 57",C2931919,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
1730,NM_198503.5(KCNT2):c.569G>C (p.Arg190Pro),KCNT2,"developmental and epileptic encephalopathy, 57",C2931919,"pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
1731,NM_000186.4(CFH):c.157C>T (p.Arg53Cys),CFH,age related macular degeneration 4,C4230251,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
1731,NM_000186.4(CFH):c.157C>T (p.Arg53Cys),CFH,basal laminar drusen,C0730295,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
1731,NM_000186.4(CFH):c.157C>T (p.Arg53Cys),CFH,factor h deficiency,C0398777,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
1731,NM_000186.4(CFH):c.157C>T (p.Arg53Cys),CFH,"hemolytic uremic syndrome, atypical, susceptibility to, 1",C2749604,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
1731,NM_000186.4(CFH):c.157C>T (p.Arg53Cys),CFH,"hemolytic uremic syndrome, atypical, susceptibility to, 1",C2749604,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
1732,NM_018136.5(ASPM):c.2T>C (p.Met1Thr),ASPM,"microcephaly 5, primary, autosomal recessive",C1837501,"likely pathogenic(last reviewed: mar 18, 2016)","criteria provided, single submitter"
1733,NM_201253.3(CRB1):c.455G>A (p.Cys152Tyr),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
1733,NM_201253.3(CRB1):c.455G>A (p.Cys152Tyr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
1733,NM_201253.3(CRB1):c.455G>A (p.Cys152Tyr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
1734,NM_201253.3(CRB1):c.488G>T (p.Cys163Phe),CRB1,leber congenital amaurosis 1,C2931258,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1735,NM_201253.3(CRB1):c.548G>A (p.Cys183Tyr),CRB1,abnormality of the eye,C4316870,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,macular dystrophy,C4231166,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1736,NM_201253.3(CRB1):c.584G>T (p.Cys195Phe),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
1737,NM_201253.3(CRB1):c.585C>G (p.Cys195Trp),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jun 12, 2022)","criteria provided, single submitter"
1737,NM_201253.3(CRB1):c.585C>G (p.Cys195Trp),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jun 12, 2022)","criteria provided, single submitter"
1738,NM_201253.3(CRB1):c.716G>A (p.Cys239Tyr),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: may 9, 2022)","criteria provided, single submitter"
1738,NM_201253.3(CRB1):c.716G>A (p.Cys239Tyr),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: may 9, 2022)","criteria provided, single submitter"
1739,NM_201253.3(CRB1):c.716G>C (p.Cys239Ser),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
1739,NM_201253.3(CRB1):c.716G>C (p.Cys239Ser),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
1740,NM_201253.3(CRB1):c.716G>T (p.Cys239Phe),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
1740,NM_201253.3(CRB1):c.716G>T (p.Cys239Phe),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
1741,NM_201253.3(CRB1):c.997G>C (p.Gly333Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
1741,NM_201253.3(CRB1):c.997G>C (p.Gly333Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
1741,NM_201253.3(CRB1):c.997G>C (p.Gly333Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
1742,NM_201253.3(CRB1):c.998G>C (p.Gly333Ala),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: aug 10, 2021)","criteria provided, single submitter"
1742,NM_201253.3(CRB1):c.998G>C (p.Gly333Ala),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: aug 10, 2021)","criteria provided, single submitter"
1743,NM_201253.3(CRB1):c.1147T>C (p.Cys383Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: dec 3, 2018)","criteria provided, single submitter"
1744,NM_201253.3(CRB1):c.1148G>A (p.Cys383Tyr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1744,NM_201253.3(CRB1):c.1148G>A (p.Cys383Tyr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1744,NM_201253.3(CRB1):c.1148G>A (p.Cys383Tyr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1744,NM_201253.3(CRB1):c.1148G>A (p.Cys383Tyr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1744,NM_201253.3(CRB1):c.1148G>A (p.Cys383Tyr),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
1745,NM_201253.3(CRB1):c.1181G>T (p.Cys394Phe),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
1745,NM_201253.3(CRB1):c.1181G>T (p.Cys394Phe),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
1746,NM_201253.3(CRB1):c.1229G>A (p.Gly410Asp),CRB1,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jun 7, 2021)","criteria provided, single submitter"
1747,NM_201253.3(CRB1):c.1312T>A (p.Cys438Ser),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: aug 28, 2022)","criteria provided, single submitter"
1747,NM_201253.3(CRB1):c.1312T>A (p.Cys438Ser),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: aug 28, 2022)","criteria provided, single submitter"
1748,NM_201253.3(CRB1):c.1348T>C (p.Cys450Arg),CRB1,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, multiple submitters, no conflicts"
1748,NM_201253.3(CRB1):c.1348T>C (p.Cys450Arg),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, multiple submitters, no conflicts"
1748,NM_201253.3(CRB1):c.1348T>C (p.Cys450Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, multiple submitters, no conflicts"
1749,NM_201253.3(CRB1):c.1349G>A (p.Cys450Tyr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, single submitter"
1749,NM_201253.3(CRB1):c.1349G>A (p.Cys450Tyr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, single submitter"
1750,NM_201253.3(CRB1):c.1405T>G (p.Cys469Gly),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: feb 14, 2022)","criteria provided, single submitter"
1750,NM_201253.3(CRB1):c.1405T>G (p.Cys469Gly),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: feb 14, 2022)","criteria provided, single submitter"
1751,NM_201253.3(CRB1):c.1429G>A (p.Gly477Arg),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1751,NM_201253.3(CRB1):c.1429G>A (p.Gly477Arg),CRB1,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1751,NM_201253.3(CRB1):c.1429G>A (p.Gly477Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1751,NM_201253.3(CRB1):c.1429G>A (p.Gly477Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
1752,NM_201253.3(CRB1):c.1430G>T (p.Gly477Val),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: sep 3, 2021)","criteria provided, single submitter"
1752,NM_201253.3(CRB1):c.1430G>T (p.Gly477Val),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: sep 3, 2021)","criteria provided, single submitter"
1753,NM_201253.3(CRB1):c.1436T>C (p.Leu479Pro),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: mar 21, 2022)","criteria provided, multiple submitters, no conflicts"
1753,NM_201253.3(CRB1):c.1436T>C (p.Leu479Pro),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: mar 21, 2022)","criteria provided, multiple submitters, no conflicts"
1753,NM_201253.3(CRB1):c.1436T>C (p.Leu479Pro),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: mar 21, 2022)","criteria provided, multiple submitters, no conflicts"
1754,NM_201253.3(CRB1):c.1438T>C (p.Cys480Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1754,NM_201253.3(CRB1):c.1438T>C (p.Cys480Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1754,NM_201253.3(CRB1):c.1438T>C (p.Cys480Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1755,NM_201253.3(CRB1):c.1439G>C (p.Cys480Ser),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
1755,NM_201253.3(CRB1):c.1439G>C (p.Cys480Ser),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
1756,NM_201253.3(CRB1):c.1522T>C (p.Cys508Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1756,NM_201253.3(CRB1):c.1522T>C (p.Cys508Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1757,NM_201253.3(CRB1):c.1562C>T (p.Ala521Val),CRB1,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: jun 24, 2020)","criteria provided, single submitter"
1758,NM_201253.3(CRB1):c.1690G>A (p.Asp564Asn),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, single submitter"
1758,NM_201253.3(CRB1):c.1690G>A (p.Asp564Asn),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, single submitter"
1759,NM_201253.3(CRB1):c.1760G>A (p.Cys587Tyr),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
1759,NM_201253.3(CRB1):c.1760G>A (p.Cys587Tyr),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
1760,NM_201253.3(CRB1):c.1831T>C (p.Ser611Pro),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
1760,NM_201253.3(CRB1):c.1831T>C (p.Ser611Pro),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
1760,NM_201253.3(CRB1):c.1831T>C (p.Ser611Pro),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
1760,NM_201253.3(CRB1):c.1831T>C (p.Ser611Pro),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
1760,NM_201253.3(CRB1):c.1831T>C (p.Ser611Pro),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
1761,NM_201253.3(CRB1):c.1840G>C (p.Gly614Arg),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, single submitter"
1761,NM_201253.3(CRB1):c.1840G>C (p.Gly614Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, single submitter"
1762,NM_201253.3(CRB1):c.1841G>T (p.Gly614Val),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: jun 7, 2022)","criteria provided, multiple submitters, no conflicts"
1762,NM_201253.3(CRB1):c.1841G>T (p.Gly614Val),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: jun 7, 2022)","criteria provided, multiple submitters, no conflicts"
1762,NM_201253.3(CRB1):c.1841G>T (p.Gly614Val),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: jun 7, 2022)","criteria provided, multiple submitters, no conflicts"
1763,NM_201253.3(CRB1):c.1843G>A (p.Gly615Ser),CRB1,leber congenital amaurosis 1,C2931258,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1764,NM_201253.3(CRB1):c.1844G>T (p.Gly615Val),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: aug 7, 2021)","criteria provided, multiple submitters, no conflicts"
1764,NM_201253.3(CRB1):c.1844G>T (p.Gly615Val),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: aug 7, 2021)","criteria provided, multiple submitters, no conflicts"
1765,NM_201253.3(CRB1):c.1913C>T (p.Ser638Leu),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
1765,NM_201253.3(CRB1):c.1913C>T (p.Ser638Leu),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
1766,NM_201253.3(CRB1):c.1997T>A (p.Val666Asp),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
1766,NM_201253.3(CRB1):c.1997T>A (p.Val666Asp),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
1767,NM_201253.3(CRB1):c.2042G>A (p.Cys681Tyr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1767,NM_201253.3(CRB1):c.2042G>A (p.Cys681Tyr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1768,NM_201253.3(CRB1):c.2053G>A (p.Gly685Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, single submitter"
1768,NM_201253.3(CRB1):c.2053G>A (p.Gly685Arg),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, single submitter"
1769,NM_201253.3(CRB1):c.2054G>C (p.Gly685Ala),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: may 29, 2022)","criteria provided, single submitter"
1769,NM_201253.3(CRB1):c.2054G>C (p.Gly685Ala),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: may 29, 2022)","criteria provided, single submitter"
1770,NM_201253.3(CRB1):c.2054G>T (p.Gly685Val),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, single submitter"
1770,NM_201253.3(CRB1):c.2054G>T (p.Gly685Val),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, single submitter"
1771,NM_201253.3(CRB1):c.2086T>C (p.Cys696Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
1771,NM_201253.3(CRB1):c.2086T>C (p.Cys696Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
1772,NM_201253.3(CRB1):c.2087G>A (p.Cys696Tyr),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
1772,NM_201253.3(CRB1):c.2087G>A (p.Cys696Tyr),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
1773,NM_201253.3(CRB1):c.2105A>G (p.Tyr702Cys),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1773,NM_201253.3(CRB1):c.2105A>G (p.Tyr702Cys),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1774,NM_201253.3(CRB1):c.2128G>A (p.Glu710Lys),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: nov 17, 2021)","criteria provided, single submitter"
1774,NM_201253.3(CRB1):c.2128G>A (p.Glu710Lys),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: nov 17, 2021)","criteria provided, single submitter"
1775,NM_201253.3(CRB1):c.2129A>T (p.Glu710Val),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1775,NM_201253.3(CRB1):c.2129A>T (p.Glu710Val),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1775,NM_201253.3(CRB1):c.2129A>T (p.Glu710Val),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1776,NM_201253.3(CRB1):c.2138C>T (p.Ala713Val),CRB1,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jun 26, 2019)","criteria provided, single submitter"
1777,NM_201253.3(CRB1):c.2159A>T (p.Asp720Val),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
1777,NM_201253.3(CRB1):c.2159A>T (p.Asp720Val),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
1778,NM_201253.3(CRB1):c.2171A>G (p.Tyr724Cys),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1778,NM_201253.3(CRB1):c.2171A>G (p.Tyr724Cys),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1779,NM_201253.3(CRB1):c.2222T>C (p.Met741Thr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
1779,NM_201253.3(CRB1):c.2222T>C (p.Met741Thr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
1780,NM_201253.3(CRB1):c.2223G>A (p.Met741Ile),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
1780,NM_201253.3(CRB1):c.2223G>A (p.Met741Ile),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
1781,NM_201253.3(CRB1):c.2227G>C (p.Val743Leu),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jul 22, 2021)","criteria provided, multiple submitters, no conflicts"
1781,NM_201253.3(CRB1):c.2227G>C (p.Val743Leu),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jul 22, 2021)","criteria provided, multiple submitters, no conflicts"
1782,NM_201253.3(CRB1):c.2234C>A (p.Thr745Lys),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, single submitter"
1782,NM_201253.3(CRB1):c.2234C>A (p.Thr745Lys),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, single submitter"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1783,NM_201253.3(CRB1):c.2234C>T (p.Thr745Met),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1784,NM_201253.3(CRB1):c.2248G>A (p.Gly750Ser),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
1784,NM_201253.3(CRB1):c.2248G>A (p.Gly750Ser),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
1785,NM_201253.3(CRB1):c.2249G>T (p.Gly750Val),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, single submitter"
1785,NM_201253.3(CRB1):c.2249G>T (p.Gly750Val),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, single submitter"
1786,NM_201253.3(CRB1):c.2264T>C (p.Leu755Ser),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
1786,NM_201253.3(CRB1):c.2264T>C (p.Leu755Ser),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,macular dystrophy,C4231166,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1787,NM_201253.3(CRB1):c.2290C>T (p.Arg764Cys),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1788,NM_201253.3(CRB1):c.2300T>C (p.Leu767Pro),CRB1,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1788,NM_201253.3(CRB1):c.2300T>C (p.Leu767Pro),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1788,NM_201253.3(CRB1):c.2300T>C (p.Leu767Pro),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1789,NM_201253.3(CRB1):c.2308G>A (p.Gly770Ser),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1789,NM_201253.3(CRB1):c.2308G>A (p.Gly770Ser),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1789,NM_201253.3(CRB1):c.2308G>A (p.Gly770Ser),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1789,NM_201253.3(CRB1):c.2308G>A (p.Gly770Ser),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1790,NM_201253.3(CRB1):c.2389T>C (p.Ser797Pro),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: dec 3, 2017)","criteria provided, single submitter"
1791,NM_201253.3(CRB1):c.2497G>T (p.Gly833Cys),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: nov 5, 2021)","criteria provided, single submitter"
1791,NM_201253.3(CRB1):c.2497G>T (p.Gly833Cys),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: nov 5, 2021)","criteria provided, single submitter"
1792,NM_201253.3(CRB1):c.2497G>C (p.Gly833Arg),CRB1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: mar 13, 2022)","criteria provided, multiple submitters, no conflicts"
1792,NM_201253.3(CRB1):c.2497G>C (p.Gly833Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: mar 13, 2022)","criteria provided, multiple submitters, no conflicts"
1792,NM_201253.3(CRB1):c.2497G>C (p.Gly833Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: mar 13, 2022)","criteria provided, multiple submitters, no conflicts"
1793,NM_201253.3(CRB1):c.2498G>A (p.Gly833Asp),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: oct 9, 2022)","criteria provided, single submitter"
1793,NM_201253.3(CRB1):c.2498G>A (p.Gly833Asp),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: oct 9, 2022)","criteria provided, single submitter"
1794,NM_201253.3(CRB1):c.2501G>A (p.Gly834Asp),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic/likely pathogenic(last reviewed: mar 17, 2022)","criteria provided, multiple submitters, no conflicts"
1794,NM_201253.3(CRB1):c.2501G>A (p.Gly834Asp),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic/likely pathogenic(last reviewed: mar 17, 2022)","criteria provided, multiple submitters, no conflicts"
1795,NM_201253.3(CRB1):c.2536G>A (p.Gly846Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1795,NM_201253.3(CRB1):c.2536G>A (p.Gly846Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1796,NM_201253.3(CRB1):c.2537G>A (p.Gly846Glu),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
1796,NM_201253.3(CRB1):c.2537G>A (p.Gly846Glu),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
1797,NM_201253.3(CRB1):c.2548G>A (p.Gly850Ser),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, single submitter"
1797,NM_201253.3(CRB1):c.2548G>A (p.Gly850Ser),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, single submitter"
1798,NM_201253.3(CRB1):c.2549G>A (p.Gly850Asp),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1798,NM_201253.3(CRB1):c.2549G>A (p.Gly850Asp),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
1799,NM_201253.3(CRB1):c.2549G>T (p.Gly850Val),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, single submitter"
1799,NM_201253.3(CRB1):c.2549G>T (p.Gly850Val),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, single submitter"
1800,NM_201253.3(CRB1):c.2555T>C (p.Ile852Thr),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
1800,NM_201253.3(CRB1):c.2555T>C (p.Ile852Thr),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
1801,NM_201253.3(CRB1):c.2640T>G (p.Asn880Lys),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, single submitter"
1801,NM_201253.3(CRB1):c.2640T>G (p.Asn880Lys),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, single submitter"
1802,NM_201253.3(CRB1):c.2687G>C (p.Cys896Ser),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: jan 30, 2021)","criteria provided, single submitter"
1803,NM_201253.3(CRB1):c.2687G>A (p.Cys896Tyr),CRB1,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: jan 9, 2020)","criteria provided, multiple submitters, no conflicts"
1804,NM_201253.3(CRB1):c.2694T>G (p.Asn898Lys),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: jun 7, 2021)","criteria provided, single submitter"
1805,NM_201253.3(CRB1):c.2695G>A (p.Gly899Arg),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, single submitter"
1805,NM_201253.3(CRB1):c.2695G>A (p.Gly899Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, single submitter"
1806,NM_201253.3(CRB1):c.2696G>C (p.Gly899Ala),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: may 24, 2022)","criteria provided, single submitter"
1806,NM_201253.3(CRB1):c.2696G>C (p.Gly899Ala),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: may 24, 2022)","criteria provided, single submitter"
1807,NM_201253.3(CRB1):c.2783G>A (p.Cys928Tyr),CRB1,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: jan 1, 2015)","criteria provided, single submitter"
1808,NM_201253.3(CRB1):c.2809G>C (p.Ala937Pro),CRB1,leber congenital amaurosis,C0339527,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
1809,NM_201253.3(CRB1):c.2815T>C (p.Cys939Arg),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, single submitter"
1809,NM_201253.3(CRB1):c.2815T>C (p.Cys939Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, single submitter"
1810,NM_201253.3(CRB1):c.2833G>C (p.Gly945Arg),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
1810,NM_201253.3(CRB1):c.2833G>C (p.Gly945Arg),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
1811,NM_201253.3(CRB1):c.2842T>C (p.Cys948Arg),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: jul 30, 2022)","criteria provided, multiple submitters, no conflicts"
1811,NM_201253.3(CRB1):c.2842T>C (p.Cys948Arg),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: jul 30, 2022)","criteria provided, multiple submitters, no conflicts"
1811,NM_201253.3(CRB1):c.2842T>C (p.Cys948Arg),CRB1,leber congenital amaurosis 1,C2931258,"pathogenic(last reviewed: jul 30, 2022)","criteria provided, multiple submitters, no conflicts"
1811,NM_201253.3(CRB1):c.2842T>C (p.Cys948Arg),CRB1,pigmented paravenous retinochoroidal atrophy,C1868310,"pathogenic(last reviewed: jul 30, 2022)","criteria provided, multiple submitters, no conflicts"
1812,NM_201253.3(CRB1):c.2927T>C (p.Ile976Thr),CRB1,retinitis pigmentosa 12,C1838647,"likely pathogenic(last reviewed: nov 8, 2021)","criteria provided, single submitter"
1812,NM_201253.3(CRB1):c.2927T>C (p.Ile976Thr),CRB1,leber congenital amaurosis 8,C3151202,"likely pathogenic(last reviewed: nov 8, 2021)","criteria provided, single submitter"
1813,NM_201253.3(CRB1):c.3014A>T (p.Asp1005Val),CRB1,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1813,NM_201253.3(CRB1):c.3014A>T (p.Asp1005Val),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1813,NM_201253.3(CRB1):c.3014A>T (p.Asp1005Val),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1814,NM_201253.3(CRB1):c.3017C>T (p.Ser1006Phe),CRB1,retinitis pigmentosa 12,C1838647,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
1814,NM_201253.3(CRB1):c.3017C>T (p.Ser1006Phe),CRB1,leber congenital amaurosis 8,C3151202,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
1815,NM_001031725.6(DDX59):c.1100T>G (p.Val367Gly),DDX59,orofaciodigital syndrome v,C1868118,"pathogenic/likely pathogenic(last reviewed: oct 28, 2019)","criteria provided, multiple submitters, no conflicts"
1816,NM_000069.3(CACNA1S):c.2700G>C (p.Arg900Ser),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
1816,NM_000069.3(CACNA1S):c.2700G>C (p.Arg900Ser),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
1817,NM_000069.3(CACNA1S):c.2700G>T (p.Arg900Ser),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1817,NM_000069.3(CACNA1S):c.2700G>T (p.Arg900Ser),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1818,NM_000069.3(CACNA1S):c.2690G>A (p.Arg897Lys),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
1818,NM_000069.3(CACNA1S):c.2690G>A (p.Arg897Lys),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
1819,NM_000069.3(CACNA1S):c.2627T>A (p.Val876Glu),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, single submitter"
1820,NM_000069.3(CACNA1S):c.1734G>A (p.Met578Ile),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1821,NM_000069.3(CACNA1S):c.1583G>T (p.Arg528Leu),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1821,NM_000069.3(CACNA1S):c.1583G>T (p.Arg528Leu),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1821,NM_000069.3(CACNA1S):c.1583G>T (p.Arg528Leu),CACNA1S,"thyrotoxic periodic paralysis, susceptibility to, 1",C2749982,"likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1821,NM_000069.3(CACNA1S):c.1583G>T (p.Arg528Leu),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1821,NM_000069.3(CACNA1S):c.1583G>T (p.Arg528Leu),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
1822,NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1822,NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1822,NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1822,NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His),CACNA1S,"thyrotoxic periodic paralysis, susceptibility to, 1",C2749982,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1822,NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1822,NM_000069.3(CACNA1S):c.1583G>A (p.Arg528His),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
1823,NM_000069.3(CACNA1S):c.1582C>T (p.Arg528Cys),CACNA1S,"malignant hyperthermia, susceptibility to, 5",C1866077,"likely pathogenic(last reviewed: feb 9, 2021)","criteria provided, multiple submitters, no conflicts"
1823,NM_000069.3(CACNA1S):c.1582C>T (p.Arg528Cys),CACNA1S,"hypokalemic periodic paralysis, type 1",C3714580,"likely pathogenic(last reviewed: feb 9, 2021)","criteria provided, multiple submitters, no conflicts"
1824,NM_001276345.2(TNNT2):c.837C>A (p.Asn279Lys),TNNT2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
1825,NM_001276345.2(TNNT2):c.662T>C (p.Ile221Thr),TNNT2,hypertrophic cardiomyopathy 2,C1861864,likely pathogenic,"criteria provided, single submitter"
1826,NM_001276345.2(TNNT2):c.638C>G (p.Thr213Ser),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1826,NM_001276345.2(TNNT2):c.638C>G (p.Thr213Ser),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1826,NM_001276345.2(TNNT2):c.638C>G (p.Thr213Ser),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1827,NM_001276345.2(TNNT2):c.617G>T (p.Arg206Leu),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1827,NM_001276345.2(TNNT2):c.617G>T (p.Arg206Leu),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1827,NM_001276345.2(TNNT2):c.617G>T (p.Arg206Leu),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1828,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1828,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1828,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1828,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1828,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1828,NM_001276345.2(TNNT2):c.566C>T (p.Ser189Phe),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
1829,NM_001276345.2(TNNT2):c.565T>G (p.Ser189Ala),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1829,NM_001276345.2(TNNT2):c.565T>G (p.Ser189Ala),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1829,NM_001276345.2(TNNT2):c.565T>G (p.Ser189Ala),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1830,NM_001276345.2(TNNT2):c.548G>T (p.Arg183Leu),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: jul 18, 2019)","criteria provided, single submitter"
1831,NM_001276345.2(TNNT2):c.548G>A (p.Arg183Gln),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1831,NM_001276345.2(TNNT2):c.548G>A (p.Arg183Gln),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1831,NM_001276345.2(TNNT2):c.548G>A (p.Arg183Gln),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1831,NM_001276345.2(TNNT2):c.548G>A (p.Arg183Gln),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1831,NM_001276345.2(TNNT2):c.548G>A (p.Arg183Gln),TNNT2,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
1832,NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp),TNNT2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1832,NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1832,NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1832,NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1832,NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1832,NM_001276345.2(TNNT2):c.547C>T (p.Arg183Trp),TNNT2,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
1833,NM_001276345.2(TNNT2):c.499G>C (p.Ala167Pro),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, single submitter"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,familial isolated dilated cardiomyopathy,C0340427,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,cardiomyopathy,C0878544,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1834,NM_001276345.2(TNNT2):c.451C>T (p.Arg151Trp),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
1835,NM_001276345.2(TNNT2):c.445C>G (p.Arg149Gly),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1835,NM_001276345.2(TNNT2):c.445C>G (p.Arg149Gly),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1835,NM_001276345.2(TNNT2):c.445C>G (p.Arg149Gly),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1836,NM_001276345.2(TNNT2):c.430C>G (p.Arg144Gly),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: apr 17, 2022)","criteria provided, multiple submitters, no conflicts"
1836,NM_001276345.2(TNNT2):c.430C>G (p.Arg144Gly),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: apr 17, 2022)","criteria provided, multiple submitters, no conflicts"
1836,NM_001276345.2(TNNT2):c.430C>G (p.Arg144Gly),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: apr 17, 2022)","criteria provided, multiple submitters, no conflicts"
1836,NM_001276345.2(TNNT2):c.430C>G (p.Arg144Gly),TNNT2,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: apr 17, 2022)","criteria provided, multiple submitters, no conflicts"
1837,NM_001276345.2(TNNT2):c.422G>C (p.Arg141Pro),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1837,NM_001276345.2(TNNT2):c.422G>C (p.Arg141Pro),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1837,NM_001276345.2(TNNT2):c.422G>C (p.Arg141Pro),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1837,NM_001276345.2(TNNT2):c.422G>C (p.Arg141Pro),TNNT2,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1838,NM_001276345.2(TNNT2):c.422G>A (p.Arg141Gln),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: mar 26, 2022)","criteria provided, multiple submitters, no conflicts"
1838,NM_001276345.2(TNNT2):c.422G>A (p.Arg141Gln),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: mar 26, 2022)","criteria provided, multiple submitters, no conflicts"
1838,NM_001276345.2(TNNT2):c.422G>A (p.Arg141Gln),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: mar 26, 2022)","criteria provided, multiple submitters, no conflicts"
1838,NM_001276345.2(TNNT2):c.422G>A (p.Arg141Gln),TNNT2,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: mar 26, 2022)","criteria provided, multiple submitters, no conflicts"
1839,NM_001276345.2(TNNT2):c.421C>T (p.Arg141Trp),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
1839,NM_001276345.2(TNNT2):c.421C>T (p.Arg141Trp),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
1839,NM_001276345.2(TNNT2):c.421C>T (p.Arg141Trp),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
1839,NM_001276345.2(TNNT2):c.421C>T (p.Arg141Trp),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
1839,NM_001276345.2(TNNT2):c.421C>T (p.Arg141Trp),TNNT2,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,cardiomyopathy,C0878544,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1840,NM_001276345.2(TNNT2):c.418C>T (p.Arg140Cys),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
1841,NM_001276345.2(TNNT2):c.385G>C (p.Glu129Gln),TNNT2,primary familial dilated cardiomyopathy,C0340427,likely pathogenic,"criteria provided, single submitter"
1842,NM_001276345.2(TNNT2):c.382G>A (p.Glu128Lys),TNNT2,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: jan 14, 2013)","criteria provided, single submitter"
1843,NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: nov 27, 2018)","criteria provided, multiple submitters, no conflicts"
1843,NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu),TNNT2,wolff-parkinson-white pattern,C0043202,"pathogenic/likely pathogenic(last reviewed: nov 27, 2018)","criteria provided, multiple submitters, no conflicts"
1843,NM_001276345.2(TNNT2):c.360T>G (p.Phe120Leu),TNNT2,primary familial hypertrophic cardiomyopathy,C0949658,"pathogenic/likely pathogenic(last reviewed: nov 27, 2018)","criteria provided, multiple submitters, no conflicts"
1844,NM_001276345.2(TNNT2):c.358T>A (p.Phe120Ile),TNNT2,cardiomyopathy,C0878544,"pathogenic(last reviewed: mar 4, 2021)","criteria provided, multiple submitters, no conflicts"
1844,NM_001276345.2(TNNT2):c.358T>A (p.Phe120Ile),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: mar 4, 2021)","criteria provided, multiple submitters, no conflicts"
1845,NM_001276345.2(TNNT2):c.321G>C (p.Lys107Asn),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: feb 21, 2022)","criteria provided, single submitter"
1845,NM_001276345.2(TNNT2):c.321G>C (p.Lys107Asn),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: feb 21, 2022)","criteria provided, single submitter"
1845,NM_001276345.2(TNNT2):c.321G>C (p.Lys107Asn),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: feb 21, 2022)","criteria provided, single submitter"
1846,NM_001276345.2(TNNT2):c.321G>T (p.Lys107Asn),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
1846,NM_001276345.2(TNNT2):c.321G>T (p.Lys107Asn),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
1846,NM_001276345.2(TNNT2):c.321G>T (p.Lys107Asn),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
1846,NM_001276345.2(TNNT2):c.321G>T (p.Lys107Asn),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1847,NM_001276345.2(TNNT2):c.311G>T (p.Arg104Leu),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1848,NM_001276345.2(TNNT2):c.311G>A (p.Arg104His),TNNT2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
1848,NM_001276345.2(TNNT2):c.311G>A (p.Arg104His),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
1848,NM_001276345.2(TNNT2):c.311G>A (p.Arg104His),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
1848,NM_001276345.2(TNNT2):c.311G>A (p.Arg104His),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
1848,NM_001276345.2(TNNT2):c.311G>A (p.Arg104His),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
1849,NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
1849,NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
1849,NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
1849,NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
1849,NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys),TNNT2,restrictive cardiomyopathy,C1963079,"pathogenic/likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
1849,NM_001276345.2(TNNT2):c.310C>T (p.Arg104Cys),TNNT2,primary familial hypertrophic cardiomyopathy,C0949658,"pathogenic/likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
1850,NM_001276345.2(TNNT2):c.307A>C (p.Lys103Gln),TNNT2,hypertrophic cardiomyopathy,C3278959,"likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, single submitter"
1851,NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1851,NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1851,NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1851,NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1851,NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1851,NM_001276345.2(TNNT2):c.305G>A (p.Arg102Gln),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,primary familial hypertrophic cardiomyopathy,C0949658,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1852,NM_001276345.2(TNNT2):c.304C>T (p.Arg102Trp),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
1853,NM_001276345.2(TNNT2):c.299T>A (p.Ile100Asn),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
1854,NM_001276345.2(TNNT2):c.294T>A (p.Asp98Glu),TNNT2,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: may 14, 2019)","criteria provided, single submitter"
1855,NM_001276345.2(TNNT2):c.294T>G (p.Asp98Glu),TNNT2,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: jun 4, 2015)","criteria provided, single submitter"
1856,NM_001276345.2(TNNT2):c.290T>A (p.Phe97Tyr),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1856,NM_001276345.2(TNNT2):c.290T>A (p.Phe97Tyr),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1856,NM_001276345.2(TNNT2):c.290T>A (p.Phe97Tyr),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1857,NM_001276345.2(TNNT2):c.290T>G (p.Phe97Cys),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1857,NM_001276345.2(TNNT2):c.290T>G (p.Phe97Cys),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1857,NM_001276345.2(TNNT2):c.290T>G (p.Phe97Cys),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1858,NM_001276345.2(TNNT2):c.287A>C (p.Asp96Ala),TNNT2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: mar 1, 2023)","criteria provided, multiple submitters, no conflicts"
1858,NM_001276345.2(TNNT2):c.287A>C (p.Asp96Ala),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic/likely pathogenic(last reviewed: mar 1, 2023)","criteria provided, multiple submitters, no conflicts"
1858,NM_001276345.2(TNNT2):c.287A>C (p.Asp96Ala),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic/likely pathogenic(last reviewed: mar 1, 2023)","criteria provided, multiple submitters, no conflicts"
1858,NM_001276345.2(TNNT2):c.287A>C (p.Asp96Ala),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic/likely pathogenic(last reviewed: mar 1, 2023)","criteria provided, multiple submitters, no conflicts"
1858,NM_001276345.2(TNNT2):c.287A>C (p.Asp96Ala),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: mar 1, 2023)","criteria provided, multiple submitters, no conflicts"
1859,NM_001276345.2(TNNT2):c.283G>A (p.Val95Met),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1859,NM_001276345.2(TNNT2):c.283G>A (p.Val95Met),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1859,NM_001276345.2(TNNT2):c.283G>A (p.Val95Met),TNNT2,dilated cardiomyopathy 1d,C1832243,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1860,NM_001276345.2(TNNT2):c.274G>A (p.Gly92Arg),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic/likely pathogenic(last reviewed: mar 30, 2016)","criteria provided, multiple submitters, no conflicts"
1861,NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn),TNNT2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1861,NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn),TNNT2,cardiomyopathy,C0878544,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1861,NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn),TNNT2,dilated cardiomyopathy 1d,C1832243,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1861,NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn),TNNT2,"cardiomyopathy, familial restrictive, 3",C2676271,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1861,NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn),TNNT2,hypertrophic cardiomyopathy 2,C1861864,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1861,NM_001276345.2(TNNT2):c.266T>A (p.Ile89Asn),TNNT2,hypertrophic cardiomyopathy,C3278959,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1862,NM_014176.4(UBE2T):c.4C>G (p.Gln2Glu),UBE2T,fanconi anemia complementation group t,Cumapped74,"pathogenic(last reviewed: mar 20, 2020)","criteria provided, single submitter"
1863,NM_000537.4(REN):c.58T>C (p.Cys20Arg),LOC107548112|REN,familial juvenile hyperuricemic nephropathy type 2,C4303080,"pathogenic/likely pathogenic(last reviewed: jul 14, 2022)","criteria provided, multiple submitters, no conflicts"
1864,NM_032833.5(PPP1R15B):c.1972C>T (p.Arg658Cys),PPP1R15B,"microcephaly, short stature, and impaired glucose metabolism 2",C4225195,"pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
1865,NM_001006658.3(CR2):c.1613A>G (p.His538Arg),CR2,"immunodeficiency, common variable, 7",C3542922,"likely pathogenic(last reviewed: aug 14, 2021)","criteria provided, single submitter"
1866,NM_001006658.3(CR2):c.2870G>A (p.Gly957Glu),CR2,"immunodeficiency, common variable, 7",C3542922,"likely pathogenic(last reviewed: aug 14, 2021)","criteria provided, single submitter"
1867,NM_025179.4(PLXNA2):c.2206G>A (p.Gly736Ser),PLXNA2,atypical cerebral palsy,C0007789,likely pathogenic,"criteria provided, single submitter"
1868,NM_000228.3(LAMB3):c.628G>A (p.Glu210Lys),LAMB3,junctional epidermolysis bullosa,C0079301,"pathogenic/likely pathogenic(last reviewed: feb 1, 2023)","criteria provided, multiple submitters, no conflicts"
1868,NM_000228.3(LAMB3):c.628G>A (p.Glu210Lys),LAMB3,"junctional epidermolysis bullosa, non-herlitz type",C0268374,"pathogenic/likely pathogenic(last reviewed: feb 1, 2023)","criteria provided, multiple submitters, no conflicts"
1869,NM_000228.3(LAMB3):c.323T>C (p.Leu108Pro),LAMB3,junctional epidermolysis bullosa,C0079301,"pathogenic(last reviewed: dec 18, 2015)","criteria provided, single submitter"
1870,NM_000228.3(LAMB3):c.1A>T (p.Met1Leu),LAMB3,junctional epidermolysis bullosa gravis of herlitz,C0079683,likely pathogenic,"criteria provided, single submitter"
1871,NM_006147.4(IRF6):c.1210G>A (p.Glu404Lys),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1871,NM_006147.4(IRF6):c.1210G>A (p.Glu404Lys),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1871,NM_006147.4(IRF6):c.1210G>A (p.Glu404Lys),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: sep 26, 2021)","criteria provided, multiple submitters, no conflicts"
1872,NM_006147.4(IRF6):c.1198C>T (p.Arg400Trp),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1872,NM_006147.4(IRF6):c.1198C>T (p.Arg400Trp),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1872,NM_006147.4(IRF6):c.1198C>T (p.Arg400Trp),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1873,NM_006147.4(IRF6):c.1138C>T (p.Pro380Ser),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1873,NM_006147.4(IRF6):c.1138C>T (p.Pro380Ser),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1873,NM_006147.4(IRF6):c.1138C>T (p.Pro380Ser),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
1874,NM_006147.4(IRF6):c.1121G>A (p.Cys374Tyr),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1874,NM_006147.4(IRF6):c.1121G>A (p.Cys374Tyr),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1874,NM_006147.4(IRF6):c.1121G>A (p.Cys374Tyr),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1875,NM_006147.4(IRF6):c.1052T>C (p.Phe351Ser),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1875,NM_006147.4(IRF6):c.1052T>C (p.Phe351Ser),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1875,NM_006147.4(IRF6):c.1052T>C (p.Phe351Ser),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1876,NM_006147.4(IRF6):c.950G>A (p.Cys317Tyr),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1876,NM_006147.4(IRF6):c.950G>A (p.Cys317Tyr),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1876,NM_006147.4(IRF6):c.950G>A (p.Cys317Tyr),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
1877,NM_006147.4(IRF6):c.749G>A (p.Arg250Gln),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, single submitter"
1877,NM_006147.4(IRF6):c.749G>A (p.Arg250Gln),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, single submitter"
1877,NM_006147.4(IRF6):c.749G>A (p.Arg250Gln),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: aug 19, 2022)","criteria provided, single submitter"
1878,NM_006147.4(IRF6):c.659C>T (p.Ser220Phe),IRF6,van der woude syndrome 1,C4551864,"likely pathogenic(last reviewed: may 16, 2017)","criteria provided, single submitter"
1879,NM_006147.4(IRF6):c.292G>C (p.Asp98His),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1879,NM_006147.4(IRF6):c.292G>C (p.Asp98His),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1879,NM_006147.4(IRF6):c.292G>C (p.Asp98His),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1880,NM_006147.4(IRF6):c.274G>A (p.Glu92Lys),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: dec 14, 2021)","criteria provided, single submitter"
1880,NM_006147.4(IRF6):c.274G>A (p.Glu92Lys),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: dec 14, 2021)","criteria provided, single submitter"
1880,NM_006147.4(IRF6):c.274G>A (p.Glu92Lys),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: dec 14, 2021)","criteria provided, single submitter"
1881,NM_006147.4(IRF6):c.269G>C (p.Ser90Thr),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1881,NM_006147.4(IRF6):c.269G>C (p.Ser90Thr),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1881,NM_006147.4(IRF6):c.269G>C (p.Ser90Thr),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
1882,NM_006147.4(IRF6):c.263A>G (p.Asn88Ser),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: oct 12, 2022)","criteria provided, single submitter"
1882,NM_006147.4(IRF6):c.263A>G (p.Asn88Ser),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: oct 12, 2022)","criteria provided, single submitter"
1882,NM_006147.4(IRF6):c.263A>G (p.Asn88Ser),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: oct 12, 2022)","criteria provided, single submitter"
1883,NM_006147.4(IRF6):c.251G>A (p.Arg84His),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1883,NM_006147.4(IRF6):c.251G>A (p.Arg84His),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1883,NM_006147.4(IRF6):c.251G>A (p.Arg84His),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1884,NM_006147.4(IRF6):c.250C>T (p.Arg84Cys),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: aug 26, 2022)","criteria provided, multiple submitters, no conflicts"
1884,NM_006147.4(IRF6):c.250C>T (p.Arg84Cys),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: aug 26, 2022)","criteria provided, multiple submitters, no conflicts"
1884,NM_006147.4(IRF6):c.250C>T (p.Arg84Cys),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: aug 26, 2022)","criteria provided, multiple submitters, no conflicts"
1885,NM_006147.4(IRF6):c.232A>G (p.Lys78Glu),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1885,NM_006147.4(IRF6):c.232A>G (p.Lys78Glu),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1885,NM_006147.4(IRF6):c.232A>G (p.Lys78Glu),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1885,NM_006147.4(IRF6):c.232A>G (p.Lys78Glu),IRF6,van der woude syndrome 1,C4551864,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
1886,NM_006147.4(IRF6):c.226C>T (p.Pro76Ser),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
1886,NM_006147.4(IRF6):c.226C>T (p.Pro76Ser),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
1886,NM_006147.4(IRF6):c.226C>T (p.Pro76Ser),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
1887,NM_006147.4(IRF6):c.176C>T (p.Ala59Val),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1887,NM_006147.4(IRF6):c.176C>T (p.Ala59Val),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1887,NM_006147.4(IRF6):c.176C>T (p.Ala59Val),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
1888,NM_006147.4(IRF6):c.169T>C (p.Phe57Leu),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1888,NM_006147.4(IRF6):c.169T>C (p.Phe57Leu),IRF6,popliteal pterygium syndrome,C0265259,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1888,NM_006147.4(IRF6):c.169T>C (p.Phe57Leu),IRF6,van der woude syndrome,Cumapped340,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
1889,NM_006147.4(IRF6):c.120G>T (p.Trp40Cys),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1889,NM_006147.4(IRF6):c.120G>T (p.Trp40Cys),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1889,NM_006147.4(IRF6):c.120G>T (p.Trp40Cys),IRF6,van der woude syndrome,Cumapped340,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1889,NM_006147.4(IRF6):c.120G>T (p.Trp40Cys),IRF6,van der woude syndrome 1,C4551864,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
1890,NM_006147.4(IRF6):c.113T>C (p.Ile38Thr),IRF6,van der woude syndrome 1,C4551864,pathogenic,"criteria provided, single submitter"
1891,NM_006147.4(IRF6):c.25C>T (p.Arg9Trp),IRF6,van der woude syndrome,Cumapped340,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1891,NM_006147.4(IRF6):c.25C>T (p.Arg9Trp),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1891,NM_006147.4(IRF6):c.25C>T (p.Arg9Trp),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1891,NM_006147.4(IRF6):c.25C>T (p.Arg9Trp),IRF6,van der woude syndrome 1,C4551864,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
1892,NM_006147.4(IRF6):c.16C>T (p.Arg6Cys),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
1892,NM_006147.4(IRF6):c.16C>T (p.Arg6Cys),IRF6,van der woude syndrome 1,C4551864,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
1892,NM_006147.4(IRF6):c.16C>T (p.Arg6Cys),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
1892,NM_006147.4(IRF6):c.16C>T (p.Arg6Cys),IRF6,cleft palate,C0008925,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
1893,NM_006147.4(IRF6):c.2T>A (p.Met1Lys),IRF6,"orofacial cleft 6, susceptibility to",C1837213,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
1893,NM_006147.4(IRF6):c.2T>A (p.Met1Lys),IRF6,popliteal pterygium syndrome,C0265259,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
1893,NM_006147.4(IRF6):c.2T>A (p.Met1Lys),IRF6,van der woude syndrome,Cumapped340,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
1894,NM_172362.3(KCNH1):c.1559G>A (p.Arg520Gln),KCNH1,zimmermann-laband syndrome 1,C4551773,"likely pathogenic(last reviewed: aug 6, 2018)","criteria provided, single submitter"
1895,NM_172362.3(KCNH1):c.1486G>A (p.Gly496Arg),KCNH1,zimmermann-laband syndrome 1,C4551773,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
1895,NM_172362.3(KCNH1):c.1486G>A (p.Gly496Arg),KCNH1,temple-baraitser syndrome,C2678486,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
1895,NM_172362.3(KCNH1):c.1486G>A (p.Gly496Arg),KCNH1,zimmermann-laband syndrome 1,C4551773,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
1895,NM_172362.3(KCNH1):c.1486G>A (p.Gly496Arg),KCNH1,temple-baraitser syndrome,C2678486,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
1895,NM_172362.3(KCNH1):c.1486G>A (p.Gly496Arg),KCNH1,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
1896,NM_172362.3(KCNH1):c.1481T>C (p.Ile494Thr),KCNH1,see cases,Cumapped260,"likely pathogenic(last reviewed: jan 29, 2020)","criteria provided, single submitter"
1897,NM_172362.3(KCNH1):c.1480A>G (p.Ile494Val),KCNH1,zimmermann-laband syndrome 1,C4551773,"pathogenic(last reviewed: apr 20, 2021)","criteria provided, multiple submitters, no conflicts"
1897,NM_172362.3(KCNH1):c.1480A>G (p.Ile494Val),KCNH1,temple-baraitser syndrome,C2678486,"pathogenic(last reviewed: apr 20, 2021)","criteria provided, multiple submitters, no conflicts"
1898,NM_172362.3(KCNH1):c.1136T>C (p.Leu379Pro),KCNH1,neurodevelopmental disorder,C1535926,"pathogenic/likely pathogenic(last reviewed: oct 27, 2020)","criteria provided, multiple submitters, no conflicts"
1899,NM_172362.3(KCNH1):c.1070G>A (p.Arg357Gln),KCNH1,zimmermann-laband syndrome 1,C4551773,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1899,NM_172362.3(KCNH1):c.1070G>A (p.Arg357Gln),KCNH1,temple-baraitser syndrome,C2678486,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
1900,NM_172362.3(KCNH1):c.1069C>T (p.Arg357Trp),KCNH1,temple-baraitser syndrome,C2678486,"likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
1901,NM_014053.4(FLVCR1):c.2T>C (p.Met1Thr),FLVCR1,posterior column ataxia-retinitis pigmentosa syndrome,Cumapped212,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
1902,NM_014053.4(FLVCR1):c.574T>C (p.Cys192Arg),FLVCR1,posterior column ataxia-retinitis pigmentosa syndrome,Cumapped212,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
1903,NM_014053.4(FLVCR1):c.730G>A (p.Gly244Ser),FLVCR1,hereditary sensory and autonomic neuropathy,C0027889,"likely pathogenic(last reviewed: apr 23, 2020)","criteria provided, single submitter"
1903,NM_014053.4(FLVCR1):c.730G>A (p.Gly244Ser),FLVCR1,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: apr 23, 2020)","criteria provided, single submitter"
1904,NM_206933.4(USH2A):c.2296T>C (p.Cys766Arg),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1904,NM_206933.4(USH2A):c.2296T>C (p.Cys766Arg),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1904,NM_206933.4(USH2A):c.2296T>C (p.Cys766Arg),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1904,NM_206933.4(USH2A):c.2296T>C (p.Cys766Arg),USH2A,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
1905,NM_206933.4(USH2A):c.2276G>T (p.Cys759Phe),USH2A,usher syndrome,C0271097,"pathogenic(last reviewed: jul 28, 2019)",reviewed by expert panel
1906,NM_206933.4(USH2A):c.2081G>A (p.Cys694Tyr),USH2A,usher syndrome,C0271097,"likely pathogenic(last reviewed: jan 21, 2020)",reviewed by expert panel
1907,NM_206933.4(USH2A):c.2080T>A (p.Cys694Ser),USH2A,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
1908,NM_206933.4(USH2A):c.1985G>C (p.Cys662Ser),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
1909,NM_206933.4(USH2A):c.1859G>T (p.Cys620Phe),USH2A,usher syndrome,C0271097,"likely pathogenic(last reviewed: feb 25, 2020)",reviewed by expert panel
1910,NM_206933.4(USH2A):c.1724G>A (p.Cys575Tyr),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1910,NM_206933.4(USH2A):c.1724G>A (p.Cys575Tyr),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1910,NM_206933.4(USH2A):c.1724G>A (p.Cys575Tyr),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1911,NM_206933.4(USH2A):c.1606T>C (p.Cys536Arg),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic(last reviewed: nov 10, 2022)","criteria provided, multiple submitters, no conflicts"
1911,NM_206933.4(USH2A):c.1606T>C (p.Cys536Arg),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic(last reviewed: nov 10, 2022)","criteria provided, multiple submitters, no conflicts"
1911,NM_206933.4(USH2A):c.1606T>C (p.Cys536Arg),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic(last reviewed: nov 10, 2022)","criteria provided, multiple submitters, no conflicts"
1911,NM_206933.4(USH2A):c.1606T>C (p.Cys536Arg),USH2A,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 10, 2022)","criteria provided, multiple submitters, no conflicts"
1912,NM_206933.4(USH2A):c.1547G>T (p.Gly516Val),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
1913,NM_206933.4(USH2A):c.1478A>G (p.Tyr493Cys),USH2A,retinitis pigmentosa 39,C3151138,"likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
1914,NM_206933.4(USH2A):c.1391G>A (p.Arg464His),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
1915,NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe),USH2A,rare genetic deafness,Cumapped240,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1915,NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe),USH2A,usher syndrome,C0271097,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1915,NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe),USH2A,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1915,NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1915,NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1915,NM_206933.4(USH2A):c.1256G>T (p.Cys419Phe),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
1916,NM_206933.4(USH2A):c.1227G>C (p.Trp409Cys),USH2A,rare genetic deafness,Cumapped240,"likely pathogenic(last reviewed: mar 5, 2013)","criteria provided, single submitter"
1917,NM_206933.4(USH2A):c.1055C>T (p.Thr352Ile),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1917,NM_206933.4(USH2A):c.1055C>T (p.Thr352Ile),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1917,NM_206933.4(USH2A):c.1055C>T (p.Thr352Ile),USH2A,rare genetic deafness,Cumapped240,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
1918,NM_206933.4(USH2A):c.1036A>C (p.Asn346His),USH2A,usher syndrome,C0271097,"pathogenic(last reviewed: sep 14, 2018)",reviewed by expert panel
1919,NM_206933.4(USH2A):c.1000C>T (p.Arg334Trp),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1919,NM_206933.4(USH2A):c.1000C>T (p.Arg334Trp),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1919,NM_206933.4(USH2A):c.1000C>T (p.Arg334Trp),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1919,NM_206933.4(USH2A):c.1000C>T (p.Arg334Trp),USH2A,rare genetic deafness,Cumapped240,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1920,NM_206933.4(USH2A):c.956G>A (p.Cys319Tyr),USH2A,usher syndrome,C0271097,"pathogenic(last reviewed: aug 3, 2022)",reviewed by expert panel
1921,NM_206933.4(USH2A):c.908G>A (p.Arg303His),USH2A,usher syndrome,C0271097,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
1921,NM_206933.4(USH2A):c.908G>A (p.Arg303His),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
1921,NM_206933.4(USH2A):c.908G>A (p.Arg303His),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
1922,NM_206933.4(USH2A):c.838C>T (p.Leu280Phe),USH2A,usher syndrome,C0271097,"pathogenic/likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
1923,NM_206933.4(USH2A):c.820C>G (p.Arg274Gly),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
1924,NM_206933.4(USH2A):c.802G>A (p.Gly268Arg),USH2A,usher syndrome,C0271097,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
1924,NM_206933.4(USH2A):c.802G>A (p.Gly268Arg),USH2A,usher syndrome type 2a,Cumapped336,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
1924,NM_206933.4(USH2A):c.802G>A (p.Gly268Arg),USH2A,retinitis pigmentosa 39,C3151138,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
1924,NM_206933.4(USH2A):c.802G>A (p.Gly268Arg),USH2A,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
1925,NM_206933.4(USH2A):c.685G>C (p.Gly229Arg),USH2A,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: nov 7, 2018)","criteria provided, single submitter"
1926,NM_206933.4(USH2A):c.668T>C (p.Ile223Thr),USH2A,usher syndrome type 2,C0339534,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
1927,NM_206933.4(USH2A):c.647T>G (p.Val216Gly),USH2A,usher syndrome type 2a,Cumapped336,"likely pathogenic(last reviewed: jul 15, 2019)","criteria provided, single submitter"
1928,NM_206933.4(USH2A):c.575A>C (p.Asn192Thr),USH2A,usher syndrome type 2,C0339534,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
1929,NM_206933.4(USH2A):c.490G>T (p.Val164Phe),USH2A,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
1930,NM_206933.4(USH2A):c.487T>C (p.Cys163Arg),USH2A,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: jun 24, 2020)","criteria provided, single submitter"
1931,NM_206933.4(USH2A):c.199T>G (p.Cys67Gly),USH2A,usher syndrome type 2a,Cumapped336,"likely pathogenic(last reviewed: dec 6, 2021)","criteria provided, single submitter"
1932,NM_003238.6(TGFB2):c.547C>T (p.Arg183Cys),TGFB2,loeys-dietz syndrome 4,C3553762,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
1933,NM_003238.6(TGFB2):c.895C>T (p.Arg299Trp),TGFB2,familial aortopathy,Cumapped70,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
1933,NM_003238.6(TGFB2):c.895C>T (p.Arg299Trp),TGFB2,loeys-dietz syndrome 4,C3553762,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
1933,NM_003238.6(TGFB2):c.895C>T (p.Arg299Trp),TGFB2,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
1934,NM_003238.6(TGFB2):c.896G>A (p.Arg299Gln),TGFB2,loeys-dietz syndrome 4,C3553762,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
1934,NM_003238.6(TGFB2):c.896G>A (p.Arg299Gln),TGFB2,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
1935,NM_003238.6(TGFB2):c.904C>A (p.Arg302Ser),TGFB2,loeys-dietz syndrome 4,C3553762,"pathogenic/likely pathogenic(last reviewed: jan 11, 2022)","criteria provided, multiple submitters, no conflicts"
1936,NM_003238.6(TGFB2):c.904C>T (p.Arg302Cys),TGFB2,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: sep 11, 2022)","criteria provided, multiple submitters, no conflicts"
1936,NM_003238.6(TGFB2):c.904C>T (p.Arg302Cys),TGFB2,loeys-dietz syndrome 4,C3553762,"pathogenic/likely pathogenic(last reviewed: sep 11, 2022)","criteria provided, multiple submitters, no conflicts"
1937,NM_003238.6(TGFB2):c.905G>A (p.Arg302His),TGFB2,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1937,NM_003238.6(TGFB2):c.905G>A (p.Arg302His),TGFB2,loeys-dietz syndrome 4,C3553762,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1938,NM_003238.6(TGFB2):c.958C>T (p.Arg320Cys),TGFB2,loeys-dietz syndrome 4,C3553762,"pathogenic/likely pathogenic(last reviewed: dec 23, 2022)","criteria provided, multiple submitters, no conflicts"
1939,NM_003238.6(TGFB2):c.1013C>A (p.Pro338His),TGFB2,loeys-dietz syndrome 4,C3553762,pathogenic,"criteria provided, single submitter"
1940,NM_003238.6(TGFB2):c.1049G>A (p.Cys350Tyr),TGFB2,loeys-dietz syndrome 4,C3553762,"likely pathogenic(last reviewed: mar 2, 2022)","criteria provided, single submitter"
1941,NM_003238.6(TGFB2):c.1139G>T (p.Cys380Phe),TGFB2,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: sep 8, 2020)","criteria provided, single submitter"
1942,NM_004446.3(EPRS1):c.1459A>G (p.Met487Val),EPRS1,intellectual disability,C3714756,"pathogenic(last reviewed: oct 26, 2021)","criteria provided, single submitter"
1943,NM_004446.3(EPRS1):c.635T>C (p.Ile212Thr),EPRS1,global developmental delay,C0557874,"pathogenic(last reviewed: oct 26, 2021)","criteria provided, single submitter"
1944,NM_012414.4(RAB3GAP2):c.1283C>A (p.Ala428Glu),RAB3GAP2,martsolf syndrome,C0796037,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
1945,NM_012414.4(RAB3GAP2):c.1276C>T (p.Arg426Cys),RAB3GAP2,warburg micro syndrome 2,C3280214,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1945,NM_012414.4(RAB3GAP2):c.1276C>T (p.Arg426Cys),RAB3GAP2,martsolf syndrome,C0796037,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1945,NM_012414.4(RAB3GAP2):c.1276C>T (p.Arg426Cys),RAB3GAP2,martsolf syndrome,C0796037,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
1946,NM_003676.4(DEGS1):c.337A>G (p.Asn113Asp),DEGS1,"leukodystrophy, hypomyelinating, 18",C5193078,"likely pathogenic(last reviewed: sep 25, 2019)","criteria provided, single submitter"
1947,NM_003676.4(DEGS1):c.397C>T (p.Arg133Trp),DEGS1,"leukodystrophy, hypomyelinating, 18",C5193078,"likely pathogenic(last reviewed: sep 25, 2019)","criteria provided, multiple submitters, no conflicts"
1948,NM_003676.4(DEGS1):c.764A>G (p.Asn255Ser),DEGS1,leukodystrophy,C0023520,"pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
1948,NM_003676.4(DEGS1):c.764A>G (p.Asn255Ser),DEGS1,"leukodystrophy, hypomyelinating, 18",C5193078,"pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
1949,NM_003676.4(DEGS1):c.839C>T (p.Ala280Val),DEGS1,"leukodystrophy, hypomyelinating, 18",C5193078,"likely pathogenic(last reviewed: sep 25, 2019)","criteria provided, single submitter"
1950,NM_001379403.1(WDR26):c.1829G>A (p.Arg610Gln),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: oct 10, 2020)","criteria provided, single submitter"
1951,NM_001379403.1(WDR26):c.1694G>T (p.Gly565Val),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
1952,NM_001379403.1(WDR26):c.1556G>A (p.Cys519Tyr),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: feb 15, 2021)","criteria provided, single submitter"
1953,NM_001379403.1(WDR26):c.1537G>A (p.Asp513Asn),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: sep 14, 2017)","criteria provided, single submitter"
1954,NM_001379403.1(WDR26):c.1525T>G (p.Trp509Gly),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: sep 14, 2017)","criteria provided, single submitter"
1955,NM_001379403.1(WDR26):c.1411G>C (p.Ala471Pro),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: mar 12, 2021)","criteria provided, single submitter"
1956,NM_001379403.1(WDR26):c.1082A>G (p.His361Arg),WDR26,skraban-deardorff syndrome,C4539927,"likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, single submitter"
1957,NM_002296.4(LBR):c.1639A>G (p.Asn547Asp),LBR,greenberg dysplasia,C2931048,"pathogenic/likely pathogenic(last reviewed: may 7, 2019)","criteria provided, multiple submitters, no conflicts"
1958,NM_014698.3(TMEM63A):c.1699G>A (p.Gly567Ser),TMEM63A,leukodystrophy,C0023520,"pathogenic(last reviewed: sep 4, 2019)","criteria provided, single submitter"
1959,NM_014698.3(TMEM63A):c.1385T>A (p.Ile462Asn),TMEM63A,leukodystrophy,C0023520,"pathogenic(last reviewed: sep 4, 2019)","criteria provided, single submitter"
1960,NM_014698.3(TMEM63A):c.503G>A (p.Gly168Glu),TMEM63A,leukodystrophy,C0023520,"pathogenic(last reviewed: sep 4, 2019)","criteria provided, single submitter"
1961,NM_013328.4(PYCR2):c.595C>T (p.Arg199Trp),PYCR2,hypomyelinating leukodystrophy 10,C4225332,"likely pathogenic(last reviewed: mar 19, 2020)","criteria provided, single submitter"
1962,NM_013328.4(PYCR2):c.400G>A (p.Val134Met),PYCR2,hypomyelinating leukodystrophy 10,C4225332,likely pathogenic,"criteria provided, single submitter"
1963,NM_013328.4(PYCR2):c.356G>A (p.Arg119His),PYCR2,hypomyelinating leukodystrophy 10,C4225332,"likely pathogenic(last reviewed: oct 15, 2020)","criteria provided, multiple submitters, no conflicts"
1964,NM_013328.4(PYCR2):c.257T>G (p.Val86Gly),PYCR2,hypomyelinating leukodystrophy 10,C4225332,likely pathogenic,"criteria provided, single submitter"
1965,NM_002107.7(H3-3A):c.250C>G (p.Arg84Gly),H3-3A,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
1966,NM_002221.4(ITPKB):c.1655C>A (p.Pro552Gln),ITPKB,"myeloproliferative neoplasm, unclassifiable",C1328061,"likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, single submitter"
1967,NM_002221.4(ITPKB):c.1222T>G (p.Ser408Ala),ITPKB,"myeloproliferative neoplasm, unclassifiable",C1328061,"likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, single submitter"
1968,NM_002221.4(ITPKB):c.964G>A (p.Ala322Thr),ITPKB,"myeloproliferative neoplasm, unclassifiable",C1328061,"pathogenic(last reviewed: aug 25, 2022)","criteria provided, single submitter"
1969,NM_000447.3(PSEN2):c.422A>T (p.Asn141Ile),PSEN2,alzheimer disease 4,C1847200,"pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
1970,NM_020247.5(COQ8A):c.638G>A (p.Arg213Gln),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"likely pathogenic(last reviewed: aug 17, 2020)","criteria provided, multiple submitters, no conflicts"
1971,NM_020247.5(COQ8A):c.814G>T (p.Gly272Cys),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,pathogenic,"criteria provided, single submitter"
1972,NM_020247.5(COQ8A):c.836A>C (p.Gln279Pro),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,likely pathogenic,"criteria provided, single submitter"
1973,NM_020247.5(COQ8A):c.895C>T (p.Arg299Trp),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1974,NM_020247.5(COQ8A):c.901C>T (p.Arg301Trp),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
1975,NM_020247.5(COQ8A):c.902G>A (p.Arg301Gln),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, single submitter"
1976,NM_020247.5(COQ8A):c.1000C>T (p.Arg334Trp),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
1977,NM_020247.5(COQ8A):c.1013C>T (p.Ala338Val),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"likely pathogenic(last reviewed: may 29, 2019)","criteria provided, single submitter"
1978,NM_020247.5(COQ8A):c.1015G>A (p.Ala339Thr),COQ8A,mitochondrial disease,C0751651,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1978,NM_020247.5(COQ8A):c.1015G>A (p.Ala339Thr),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
1979,NM_020247.5(COQ8A):c.1376T>C (p.Leu459Pro),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
1980,NM_020247.5(COQ8A):c.1532C>T (p.Thr511Met),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
1981,NM_020247.5(COQ8A):c.1651G>A (p.Glu551Lys),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"pathogenic/likely pathogenic(last reviewed: feb 9, 2023)","criteria provided, multiple submitters, no conflicts"
1981,NM_020247.5(COQ8A):c.1651G>A (p.Glu551Lys),COQ8A,abnormality of the nervous system,C0497552,"pathogenic/likely pathogenic(last reviewed: feb 9, 2023)","criteria provided, multiple submitters, no conflicts"
1981,NM_020247.5(COQ8A):c.1651G>A (p.Glu551Lys),COQ8A,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: feb 9, 2023)","criteria provided, multiple submitters, no conflicts"
1982,NM_020247.5(COQ8A):c.1844G>A (p.Gly615Asp),COQ8A,autosomal recessive ataxia due to ubiquinone deficiency,C4511089,"pathogenic(last reviewed: jan 4, 2021)","criteria provided, single submitter"
1983,NM_001658.4(ARF1):c.55C>T (p.Arg19Cys),ARF1,periventricular nodular heterotopia 8,C4748602,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, multiple submitters, no conflicts"
1984,NM_001658.4(ARF1):c.103T>G (p.Tyr35Asp),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1985,NM_001658.4(ARF1):c.143C>T (p.Thr48Ile),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"likely pathogenic(last reviewed: mar 22, 2019)","criteria provided, single submitter"
1986,NM_001658.4(ARF1):c.151T>C (p.Phe51Leu),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1987,NM_001658.4(ARF1):c.153C>A (p.Phe51Leu),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1988,NM_001658.4(ARF1):c.295C>T (p.Arg99Cys),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1989,NM_001658.4(ARF1):c.296G>A (p.Arg99His),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic/likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, multiple submitters, no conflicts"
1990,NM_001658.4(ARF1):c.379A>G (p.Lys127Glu),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1991,NM_001658.4(ARF1):c.392C>T (p.Pro131Leu),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1992,NM_001658.4(ARF1):c.392C>G (p.Pro131Arg),ARF1|LOC126806039,periventricular nodular heterotopia 8,C4748602,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
1993,NM_020435.4(GJC2):c.108C>G (p.Ile36Met),GJC2,hereditary spastic paraplegia 44,C0037773,"pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
1994,NM_020435.4(GJC2):c.118G>C (p.Ala40Pro),GJC2,hypomyelinating leukodystrophy 2,C1837355,"likely pathogenic(last reviewed: jul 5, 2019)","criteria provided, single submitter"
1995,NM_020435.4(GJC2):c.203A>G (p.Tyr68Cys),GJC2,spastic paraplegia,C0037772,"pathogenic(last reviewed: apr 26, 2022)","criteria provided, single submitter"
1996,NM_020435.4(GJC2):c.254T>C (p.Val85Ala),GJC2,hypomyelinating leukodystrophy 2,C1837355,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
1997,NM_020435.4(GJC2):c.733T>A (p.Cys245Ser),GJC2,hypomyelinating leukodystrophy 2,C1837355,"likely pathogenic(last reviewed: jul 5, 2019)","criteria provided, single submitter"
1998,NM_020435.4(GJC2):c.755A>G (p.His252Arg),GJC2,hypomyelinating leukodystrophy 2,C1837355,likely pathogenic,"criteria provided, single submitter"
1999,NM_020435.4(GJC2):c.760G>A (p.Val254Met),GJC2,abnormality of the nervous system,C0497552,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
2000,NM_020435.4(GJC2):c.857T>C (p.Met286Thr),GJC2,see cases,Cumapped260,"pathogenic(last reviewed: dec 16, 2021)","criteria provided, single submitter"
2001,NM_020435.4(GJC2):c.1175C>G (p.Ser392Cys),GJC2,hypomyelinating leukodystrophy 2,C1837355,"likely pathogenic(last reviewed: jan 6, 2017)","criteria provided, single submitter"
2002,NM_001010867.4(IBA57):c.286T>C (p.Tyr96His),IBA57,multiple mitochondrial dysfunctions syndrome 3,C3809165,"pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
2003,NM_001010867.4(IBA57):c.316A>G (p.Thr106Ala),IBA57,hereditary spastic paraplegia 74,C0037773,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
2003,NM_001010867.4(IBA57):c.316A>G (p.Thr106Ala),IBA57,multiple mitochondrial dysfunctions syndrome 3,C3809165,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
2004,NM_001010867.4(IBA57):c.323A>C (p.Tyr108Ser),IBA57,multiple mitochondrial dysfunctions syndrome 3,C3809165,"likely pathogenic(last reviewed: jun 16, 2019)","criteria provided, single submitter"
2005,NM_001100.4(ACTA1):c.1130T>C (p.Phe377Ser),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: mar 8, 2019)","criteria provided, single submitter"
2006,NM_001100.4(ACTA1):c.1127G>T (p.Cys376Phe),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
2007,NM_001100.4(ACTA1):c.1123A>G (p.Lys375Glu),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2008,NM_001100.4(ACTA1):c.1106C>T (p.Pro369Leu),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: sep 5, 2021)","criteria provided, multiple submitters, no conflicts"
2009,NM_001100.4(ACTA1):c.1075A>G (p.Ile359Val),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: jun 19, 2022)","criteria provided, single submitter"
2010,NM_001100.4(ACTA1):c.1074G>T (p.Trp358Cys),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: feb 23, 2022)","criteria provided, single submitter"
2011,NM_001100.4(ACTA1):c.1054T>C (p.Ser352Pro),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
2012,NM_001100.4(ACTA1):c.1049C>T (p.Ser350Leu),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
2013,NM_001100.4(ACTA1):c.1004C>G (p.Pro335Arg),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2014,NM_001100.4(ACTA1):c.1004C>T (p.Pro335Leu),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
2015,NM_001100.4(ACTA1):c.1003C>G (p.Pro335Ala),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: feb 23, 2022)","criteria provided, single submitter"
2016,NM_001100.4(ACTA1):c.1001C>G (p.Pro334Arg),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, multiple submitters, no conflicts"
2017,NM_001100.4(ACTA1):c.1000C>T (p.Pro334Ser),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
2018,NM_001100.4(ACTA1):c.980T>A (p.Met327Lys),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: oct 9, 2021)","criteria provided, single submitter"
2019,NM_001100.4(ACTA1):c.920T>G (p.Met307Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: mar 16, 2022)","criteria provided, single submitter"
2020,NM_001100.4(ACTA1):c.868G>C (p.Asp290His),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 4, 2018)","criteria provided, multiple submitters, no conflicts"
2021,NM_001100.4(ACTA1):c.846C>G (p.Asn282Lys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
2022,NM_001100.4(ACTA1):c.844A>C (p.Asn282His),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: apr 19, 2022)","criteria provided, single submitter"
2023,NM_001100.4(ACTA1):c.842A>G (p.Tyr281Cys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
2024,NM_001100.4(ACTA1):c.841T>C (p.Tyr281His),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
2025,NM_001100.4(ACTA1):c.821C>A (p.Ala274Glu),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2026,NM_001100.4(ACTA1):c.821C>T (p.Ala274Val),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jan 5, 2022)","criteria provided, multiple submitters, no conflicts"
2026,NM_001100.4(ACTA1):c.821C>T (p.Ala274Val),ACTA1,progressive scapulohumeroperoneal distal myopathy,Cumapped226,"pathogenic(last reviewed: jan 5, 2022)","criteria provided, multiple submitters, no conflicts"
2027,NM_001100.4(ACTA1):c.812T>G (p.Met271Arg),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
2028,NM_001100.4(ACTA1):c.809G>A (p.Gly270Asp),ACTA1,"nemaline myopathy 3, autosomal dominant or recessive",Cumapped144,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
2028,NM_001100.4(ACTA1):c.809G>A (p.Gly270Asp),ACTA1,neurodevelopmental delay,C4022738,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
2029,NM_001100.4(ACTA1):c.808G>C (p.Gly270Arg),ACTA1,neuromuscular disease,C0027868,"pathogenic(last reviewed: dec 21, 2018)","criteria provided, multiple submitters, no conflicts"
2029,NM_001100.4(ACTA1):c.808G>C (p.Gly270Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: dec 21, 2018)","criteria provided, multiple submitters, no conflicts"
2030,NM_001100.4(ACTA1):c.803T>C (p.Phe268Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
2031,NM_001100.4(ACTA1):c.794A>G (p.Gln265Arg),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: may 10, 2022)","criteria provided, single submitter"
2032,NM_001100.4(ACTA1):c.782A>T (p.Glu261Val),ACTA1,congenital myopathy with fiber type disproportion,C0546264,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
2032,NM_001100.4(ACTA1):c.782A>T (p.Glu261Val),ACTA1,progressive scapulohumeroperoneal distal myopathy,Cumapped226,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
2032,NM_001100.4(ACTA1):c.782A>T (p.Glu261Val),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
2032,NM_001100.4(ACTA1):c.782A>T (p.Glu261Val),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
2033,NM_001100.4(ACTA1):c.772C>T (p.Arg258Cys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
2034,NM_001100.4(ACTA1):c.767G>A (p.Arg256His),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
2035,NM_001100.4(ACTA1):c.766C>T (p.Arg256Cys),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: sep 4, 2018)","criteria provided, single submitter"
2036,NM_001100.4(ACTA1):c.762C>G (p.Asn254Lys),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2037,NM_001100.4(ACTA1):c.739G>A (p.Gly247Arg),ACTA1,arthrogryposis multiplex congenita,C0003886,"pathogenic(last reviewed: jun 28, 2019)","criteria provided, single submitter"
2037,NM_001100.4(ACTA1):c.739G>A (p.Gly247Arg),ACTA1,fetal akinesia deformation sequence 1,C1276035,"pathogenic(last reviewed: jun 28, 2019)","criteria provided, single submitter"
2038,NM_001100.4(ACTA1):c.739G>C (p.Gly247Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: feb 5, 2023)","criteria provided, multiple submitters, no conflicts"
2039,NM_001100.4(ACTA1):c.704C>A (p.Ser235Tyr),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
2040,NM_001100.4(ACTA1):c.685A>T (p.Met229Leu),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
2041,NM_001100.4(ACTA1):c.682G>C (p.Glu228Gln),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 21, 2022)","criteria provided, single submitter"
2042,NM_001100.4(ACTA1):c.676G>C (p.Glu226Gln),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, multiple submitters, no conflicts"
2043,NM_001100.4(ACTA1):c.617C>T (p.Ala206Val),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
2044,NM_001100.4(ACTA1):c.616G>A (p.Ala206Thr),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
2045,NM_001100.4(ACTA1):c.611C>T (p.Thr204Ile),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
2046,NM_001100.4(ACTA1):c.599A>G (p.Tyr200Cys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
2047,NM_001100.4(ACTA1):c.598T>A (p.Tyr200Asn),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
2048,NM_001100.4(ACTA1):c.592C>T (p.Arg198Cys),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
2049,NM_001100.4(ACTA1):c.591G>T (p.Glu197Asp),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: apr 6, 2022)","criteria provided, multiple submitters, no conflicts"
2050,NM_001100.4(ACTA1):c.557A>G (p.Asp186Gly),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2051,NM_001100.4(ACTA1):c.556G>A (p.Asp186Asn),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: sep 5, 2021)","criteria provided, single submitter"
2052,NM_001100.4(ACTA1):c.553C>T (p.Arg185Cys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
2053,NM_001100.4(ACTA1):c.553C>A (p.Arg185Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: dec 24, 2021)","criteria provided, multiple submitters, no conflicts"
2054,NM_001100.4(ACTA1):c.529A>G (p.Ile177Val),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: oct 8, 2018)","criteria provided, single submitter"
2055,NM_001100.4(ACTA1):c.515C>A (p.Ala172Glu),ACTA1,"nemaline myopathy 3, autosomal dominant or recessive",Cumapped144,"pathogenic(last reviewed: oct 8, 2013)","criteria provided, single submitter"
2056,NM_001100.4(ACTA1):c.509G>A (p.Gly170Asp),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
2057,NM_001100.4(ACTA1):c.493G>A (p.Val165Met),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
2058,NM_001100.4(ACTA1):c.489C>A (p.His163Gln),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: mar 19, 2019)","criteria provided, single submitter"
2059,NM_001100.4(ACTA1):c.478G>A (p.Gly160Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
2060,NM_001100.4(ACTA1):c.461T>C (p.Val154Ala),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
2061,NM_001100.4(ACTA1):c.460G>T (p.Val154Leu),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
2062,NM_001100.4(ACTA1):c.460G>C (p.Val154Leu),ACTA1,congenital muscular dystrophy with rigid spine,C0699743,"likely pathogenic(last reviewed: dec 1, 2015)","criteria provided, single submitter"
2063,NM_001100.4(ACTA1):c.449C>G (p.Thr150Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
2064,NM_001100.4(ACTA1):c.448A>T (p.Thr150Ser),ACTA1,progressive scapulohumeroperoneal distal myopathy,Cumapped226,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
2065,NM_001100.4(ACTA1):c.430C>T (p.Leu144Phe),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: feb 25, 2023)","criteria provided, multiple submitters, no conflicts"
2066,NM_001100.4(ACTA1):c.425T>C (p.Leu142Pro),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
2067,NM_001100.4(ACTA1):c.419C>A (p.Ala140Asp),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: aug 15, 2021)","criteria provided, multiple submitters, no conflicts"
2068,NM_001100.4(ACTA1):c.419C>G (p.Ala140Gly),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 27, 2018)","criteria provided, single submitter"
2069,NM_001100.4(ACTA1):c.413T>A (p.Ile138Asn),ACTA1,"nemaline myopathy 3, autosomal dominant or recessive",Cumapped144,"likely pathogenic(last reviewed: mar 31, 2014)","criteria provided, single submitter"
2070,NM_001100.4(ACTA1):c.402G>T (p.Met134Ile),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: apr 11, 2020)","criteria provided, single submitter"
2071,NM_001100.4(ACTA1):c.402G>A (p.Met134Ile),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2072,NM_001100.4(ACTA1):c.400A>G (p.Met134Val),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: dec 21, 2018)","criteria provided, single submitter"
2073,NM_001100.4(ACTA1):c.359A>T (p.Lys120Met),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2074,NM_001100.4(ACTA1):c.350A>G (p.Asn117Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
2075,NM_001100.4(ACTA1):c.347C>T (p.Ala116Val),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: jun 5, 2020)","criteria provided, single submitter"
2076,NM_001100.4(ACTA1):c.346G>A (p.Ala116Thr),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2077,NM_001100.4(ACTA1):c.287T>C (p.Leu96Pro),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2078,NM_001100.4(ACTA1):c.286C>G (p.Leu96Val),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: oct 3, 2021)","criteria provided, single submitter"
2079,NM_001100.4(ACTA1):c.282C>A (p.Asn94Lys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
2080,NM_001100.4(ACTA1):c.236C>T (p.Thr79Ile),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: jan 25, 2023)","criteria provided, multiple submitters, no conflicts"
2081,NM_001100.4(ACTA1):c.226G>C (p.Gly76Arg),ACTA1,non-immune hydrops fetalis,C0455988,"pathogenic/likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
2081,NM_001100.4(ACTA1):c.226G>C (p.Gly76Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
2082,NM_001100.4(ACTA1):c.215C>G (p.Pro72Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
2083,NM_001100.4(ACTA1):c.209A>G (p.Lys70Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2084,NM_001100.4(ACTA1):c.197T>G (p.Ile66Ser),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
2085,NM_001100.4(ACTA1):c.197T>A (p.Ile66Asn),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
2086,NM_001100.4(ACTA1):c.172G>A (p.Asp58Asn),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2087,NM_001100.4(ACTA1):c.169G>C (p.Gly57Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: nov 8, 2021)","criteria provided, single submitter"
2088,NM_001100.4(ACTA1):c.146T>G (p.Met49Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
2089,NM_001100.4(ACTA1):c.143G>T (p.Gly48Val),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2090,NM_001100.4(ACTA1):c.143G>A (p.Gly48Asp),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
2091,NM_001100.4(ACTA1):c.142G>C (p.Gly48Arg),ACTA1,actin accumulation myopathy,C3711389,"likely pathogenic(last reviewed: aug 7, 2021)","criteria provided, single submitter"
2092,NM_001100.4(ACTA1):c.142G>A (p.Gly48Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
2093,NM_001100.4(ACTA1):c.137T>C (p.Met46Thr),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: aug 26, 2022)","criteria provided, multiple submitters, no conflicts"
2094,NM_001100.4(ACTA1):c.133G>T (p.Val45Phe),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
2095,NM_001100.4(ACTA1):c.128A>G (p.Gln43Arg),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: mar 26, 2019)","criteria provided, single submitter"
2096,NM_001100.4(ACTA1):c.124C>T (p.His42Tyr),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
2097,NM_001100.4(ACTA1):c.109G>C (p.Val37Leu),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
2097,NM_001100.4(ACTA1):c.109G>C (p.Val37Leu),ACTA1,see cases,Cumapped260,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
2098,NM_001100.4(ACTA1):c.109G>T (p.Val37Leu),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
2099,NM_001100.4(ACTA1):c.60A>C (p.Lys20Asn),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
2100,NM_001100.4(ACTA1):c.50G>A (p.Gly17Asp),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: jun 16, 2022)","criteria provided, single submitter"
2101,NM_001100.4(ACTA1):c.49G>A (p.Gly17Ser),ACTA1,actin accumulation myopathy,C3711389,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2102,NM_001100.4(ACTA1):c.16G>A (p.Glu6Lys),ACTA1,progressive scapulohumeroperoneal distal myopathy,Cumapped226,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2102,NM_001100.4(ACTA1):c.16G>A (p.Glu6Lys),ACTA1,actin accumulation myopathy,C3711389,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2103,NM_018230.3(NUP133):c.2922T>G (p.Ser974Arg),NUP133,"nephrotic syndrome, type 18",C4748549,"likely pathogenic(last reviewed: jan 10, 2019)","criteria provided, single submitter"
2104,NM_018230.3(NUP133):c.691C>G (p.Arg231Gly),NUP133,"nephrotic syndrome, type 18",C4748549,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
2105,NM_004481.5(GALNT2):c.311T>C (p.Phe104Ser),GALNT2,"congenital disorder of glycosylation, type iit",CL1640190,"likely pathogenic(last reviewed: dec 18, 2020)","criteria provided, single submitter"
2106,NM_004481.5(GALNT2):c.623G>A (p.Arg208Gln),GALNT2,"congenital disorder of glycosylation, type iit",CL1640190,"likely pathogenic(last reviewed: dec 23, 2020)","criteria provided, single submitter"
2107,NM_004481.5(GALNT2):c.629G>C (p.Arg210Pro),GALNT2,"congenital disorder of glycosylation, type iit",CL1640190,"likely pathogenic(last reviewed: dec 18, 2020)","criteria provided, single submitter"
2108,NM_022786.3(ARV1):c.565G>A (p.Gly189Arg),ARV1,abnormality of the nervous system,C0497552,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, single submitter"
2109,NM_003193.5(TBCE):c.332T>G (p.Val111Gly),TBCE,"encephalopathy, progressive, with amyotrophy and optic atrophy",C4310667,"likely pathogenic(last reviewed: dec 3, 2017)","criteria provided, single submitter"
2110,NM_000081.4(LYST):c.2971C>A (p.His991Asn),LYST,recurrent infections,C0239998,"likely pathogenic(last reviewed: dec 15, 2015)","criteria provided, single submitter"
2111,NM_145861.4(EDARADD):c.85G>A (p.Glu29Lys),EDARADD,"ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive",C3539920,"pathogenic(last reviewed: feb 13, 2021)","criteria provided, single submitter"
2112,NM_145861.4(EDARADD):c.359A>C (p.Asp120Ala),EDARADD,"ectodermal dysplasia 11a, hypohidrotic/hair/tooth type, autosomal dominant",C3541517,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
2113,NM_145861.4(EDARADD):c.413A>T (p.Asn138Ile),EDARADD,tooth agenesis,C4083050,likely pathogenic,"criteria provided, single submitter"
2114,NM_145861.4(EDARADD):c.570C>A (p.Asp190Glu),EDARADD,"ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive",C3539920,"pathogenic(last reviewed: feb 13, 2021)","criteria provided, single submitter"
2115,NM_001103.4(ACTN2):c.355G>A (p.Ala119Thr),ACTN2,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
2115,NM_001103.4(ACTN2):c.355G>A (p.Ala119Thr),ACTN2,hypertrophic cardiomyopathy,C3278959,"pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
2115,NM_001103.4(ACTN2):c.355G>A (p.Ala119Thr),ACTN2,dilated cardiomyopathy 1aa,C2677338,"pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
2115,NM_001103.4(ACTN2):c.355G>A (p.Ala119Thr),ACTN2,primary familial hypertrophic cardiomyopathy,C0949658,"pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
2116,NM_001103.4(ACTN2):c.683T>C (p.Met228Thr),ACTN2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: jun 1, 2016)","criteria provided, single submitter"
2117,NM_001103.4(ACTN2):c.740C>T (p.Thr247Met),ACTN2,dilated cardiomyopathy 1aa,C2677338,"likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
2117,NM_001103.4(ACTN2):c.740C>T (p.Thr247Met),ACTN2,primary familial hypertrophic cardiomyopathy,C0949658,"likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
2118,NM_001103.4(ACTN2):c.1459T>C (p.Cys487Arg),ACTN2,"myopathy, distal, 6, adult-onset, autosomal dominant",C5203349,"likely pathogenic(last reviewed: jun 25, 2020)","criteria provided, single submitter"
2119,NM_001103.4(ACTN2):c.2180T>G (p.Leu727Arg),ACTN2,"myopathy, congenital, with structured cores and z-line abnormalities",C5231445,"likely pathogenic(last reviewed: jun 25, 2020)","criteria provided, single submitter"
2120,NM_000254.3(MTR):c.2482G>A (p.Gly828Ser),MTR,methylcobalamin deficiency type cblg,C1855128,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2121,NM_001035.3(RYR2):c.139T>C (p.Cys47Arg),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: mar 31, 2022)","criteria provided, single submitter"
2122,NM_001035.3(RYR2):c.230C>T (p.Ala77Val),RYR2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
2122,NM_001035.3(RYR2):c.230C>T (p.Ala77Val),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic/likely pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
2123,NM_001035.3(RYR2):c.239A>G (p.Glu80Gly),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, single submitter"
2124,NM_001035.3(RYR2):c.243G>A (p.Met81Ile),RYR2,conduction disorder of the heart,C0264886,likely pathogenic,"criteria provided, single submitter"
2125,NM_001035.3(RYR2):c.344A>G (p.Tyr115Cys),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
2126,NM_001035.3(RYR2):c.490C>T (p.Pro164Ser),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
2127,NM_001035.3(RYR2):c.505C>G (p.Arg169Gly),RYR2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: oct 13, 2017)","criteria provided, single submitter"
2128,NM_001035.3(RYR2):c.506G>T (p.Arg169Leu),RYR2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: mar 4, 2019)","criteria provided, multiple submitters, no conflicts"
2129,NM_001035.3(RYR2):c.506G>A (p.Arg169Gln),RYR2,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: apr 28, 2022)","criteria provided, multiple submitters, no conflicts"
2129,NM_001035.3(RYR2):c.506G>A (p.Arg169Gln),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic/likely pathogenic(last reviewed: apr 28, 2022)","criteria provided, multiple submitters, no conflicts"
2129,NM_001035.3(RYR2):c.506G>A (p.Arg169Gln),RYR2,catecholaminergic polymorphic ventricular tachycardia,C4025298,"pathogenic/likely pathogenic(last reviewed: apr 28, 2022)","criteria provided, multiple submitters, no conflicts"
2130,NM_001035.3(RYR2):c.514G>A (p.Gly172Arg),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
2131,NM_001035.3(RYR2):c.515G>A (p.Gly172Glu),RYR2,catecholaminergic polymorphic ventricular tachycardia,C4025298,"likely pathogenic(last reviewed: may 10, 2019)","criteria provided, single submitter"
2132,NM_001035.3(RYR2):c.527G>T (p.Arg176Leu),RYR2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
2133,NM_001035.3(RYR2):c.527G>A (p.Arg176Gln),RYR2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2133,NM_001035.3(RYR2):c.527G>A (p.Arg176Gln),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2133,NM_001035.3(RYR2):c.527G>A (p.Arg176Gln),RYR2,arrhythmogenic right ventricular dysplasia 2,C1832931,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2134,NM_001035.3(RYR2):c.537T>A (p.Asp179Glu),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
2135,NM_001035.3(RYR2):c.567A>T (p.Glu189Asp),RYR2,catecholaminergic polymorphic ventricular tachycardia,C4025298,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2136,NM_001035.3(RYR2):c.677G>A (p.Gly226Glu),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
2137,NM_001035.3(RYR2):c.854G>T (p.Ser285Ile),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2138,NM_001035.3(RYR2):c.1069G>A (p.Gly357Ser),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2138,NM_001035.3(RYR2):c.1069G>A (p.Gly357Ser),RYR2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2139,NM_001035.3(RYR2):c.1070G>A (p.Gly357Asp),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
2140,NM_001035.3(RYR2):c.1172C>A (p.Ala391Asp),RYR2,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
2140,NM_001035.3(RYR2):c.1172C>A (p.Ala391Asp),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
2141,NM_001035.3(RYR2):c.1198G>A (p.Asp400Asn),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
2142,NM_001035.3(RYR2):c.1199A>C (p.Asp400Ala),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
2143,NM_001035.3(RYR2):c.1244C>T (p.Thr415Ile),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: may 6, 2021)","criteria provided, single submitter"
2144,NM_001035.3(RYR2):c.1244C>A (p.Thr415Lys),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: sep 13, 2020)","criteria provided, single submitter"
2145,NM_001035.3(RYR2):c.1259G>A (p.Arg420Gln),RYR2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: feb 22, 2023)","criteria provided, multiple submitters, no conflicts"
2145,NM_001035.3(RYR2):c.1259G>A (p.Arg420Gln),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"pathogenic(last reviewed: feb 22, 2023)","criteria provided, multiple submitters, no conflicts"
2146,NM_001035.3(RYR2):c.1298T>C (p.Leu433Pro),RYR2,catecholaminergic polymorphic ventricular tachycardia,C4025298,"pathogenic(last reviewed: dec 26, 2017)","criteria provided, multiple submitters, no conflicts"
2146,NM_001035.3(RYR2):c.1298T>C (p.Leu433Pro),RYR2,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: dec 26, 2017)","criteria provided, multiple submitters, no conflicts"
2147,NM_001035.3(RYR2):c.1646C>T (p.Ala549Val),RYR2,arrhythmogenic right ventricular dysplasia 2,C1832931,likely pathogenic,"criteria provided, single submitter"
2147,NM_001035.3(RYR2):c.1646C>T (p.Ala549Val),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,likely pathogenic,"criteria provided, single submitter"
2148,NM_001035.3(RYR2):c.1847C>T (p.Ser616Leu),RYR2,catecholaminergic polymorphic ventricular tachycardia 1,C4053736,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
2149,NM_001035.3(RYR2):c.2238A>C (p.Gln746His),RYR2,childhood-onset schizophrenia,C0036346,"likely pathogenic(last reviewed: jan 1, 2014)","criteria provided, single submitter"
2150,NM_020066.5(FMN2):c.547A>T (p.Ile183Phe),FMN2,"intellectual disability, autosomal recessive 47",C4015444,"likely pathogenic(last reviewed: feb 23, 2018)","criteria provided, multiple submitters, no conflicts"
2151,NM_022469.4(GREM2):c.38C>T (p.Ala13Val),GREM2,"tooth agenesis, selective, 9",C4310638,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2152,NM_000143.4(FH):c.1394A>G (p.Tyr465Cys),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, multiple submitters, no conflicts"
2152,NM_000143.4(FH):c.1394A>G (p.Tyr465Cys),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, multiple submitters, no conflicts"
2153,NM_000143.4(FH):c.1256C>T (p.Ser419Leu),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2154,NM_000143.4(FH):c.1255T>C (p.Ser419Pro),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
2154,NM_000143.4(FH):c.1255T>C (p.Ser419Pro),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
2155,NM_000143.4(FH):c.1192G>A (p.Gly398Ser),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 8, 2020)","criteria provided, single submitter"
2156,NM_000143.4(FH):c.1189G>A (p.Gly397Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
2156,NM_000143.4(FH):c.1189G>A (p.Gly397Arg),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
2156,NM_000143.4(FH):c.1189G>A (p.Gly397Arg),FH,fumarase deficiency,C0342770,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
2157,NM_000143.4(FH):c.1165G>A (p.Gly389Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 30, 2020)","criteria provided, single submitter"
2158,NM_000143.4(FH):c.1157A>G (p.Gln386Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 13, 2022)","criteria provided, multiple submitters, no conflicts"
2159,NM_000143.4(FH):c.1144A>G (p.Met382Val),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: nov 16, 2021)","criteria provided, multiple submitters, no conflicts"
2160,NM_000143.4(FH):c.1120C>A (p.Pro374Thr),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 12, 2015)","criteria provided, single submitter"
2161,NM_000143.4(FH):c.1097G>A (p.Ser366Asn),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
2161,NM_000143.4(FH):c.1097G>A (p.Ser366Asn),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
2162,NM_000143.4(FH):c.1094G>A (p.Ser365Asn),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
2163,NM_000143.4(FH):c.1093A>G (p.Ser365Gly),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: dec 13, 2022)","criteria provided, multiple submitters, no conflicts"
2163,NM_000143.4(FH):c.1093A>G (p.Ser365Gly),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic(last reviewed: dec 13, 2022)","criteria provided, multiple submitters, no conflicts"
2164,NM_000143.4(FH):c.1084G>A (p.Glu362Lys),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: nov 1, 2021)","criteria provided, multiple submitters, no conflicts"
2165,NM_000143.4(FH):c.1084G>C (p.Glu362Gln),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 1, 2018)","criteria provided, single submitter"
2166,NM_000143.4(FH):c.1064A>T (p.Glu355Val),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"likely pathogenic(last reviewed: nov 10, 2021)","criteria provided, single submitter"
2167,NM_000143.4(FH):c.1023T>G (p.Asp341Glu),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
2168,NM_000143.4(FH):c.1020T>A (p.Asn340Lys),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2168,NM_000143.4(FH):c.1020T>A (p.Asn340Lys),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2169,NM_000143.4(FH):c.1007T>G (p.Met336Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 10, 2017)","criteria provided, single submitter"
2170,NM_000143.4(FH):c.1000A>C (p.Ser334Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
2171,NM_000143.4(FH):c.998G>A (p.Cys333Tyr),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 11, 2022)","criteria provided, multiple submitters, no conflicts"
2172,NM_000143.4(FH):c.994G>C (p.Ala332Pro),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"likely pathogenic(last reviewed: apr 7, 2022)","criteria provided, single submitter"
2173,NM_000143.4(FH):c.988A>C (p.Thr330Pro),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 13, 2022)","criteria provided, multiple submitters, no conflicts"
2174,NM_000143.4(FH):c.977G>A (p.Gly326Glu),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 11, 2022)","criteria provided, multiple submitters, no conflicts"
2175,NM_000143.4(FH):c.956A>T (p.Asp319Val),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 30, 2021)","criteria provided, single submitter"
2176,NM_000143.4(FH):c.955G>T (p.Asp319Tyr),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: apr 30, 2017)","criteria provided, single submitter"
2177,NM_000143.4(FH):c.952C>T (p.His318Tyr),FH,fumarase deficiency,C0342770,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2177,NM_000143.4(FH):c.952C>T (p.His318Tyr),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2177,NM_000143.4(FH):c.952C>T (p.His318Tyr),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2177,NM_000143.4(FH):c.952C>T (p.His318Tyr),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2178,NM_000143.4(FH):c.947C>A (p.Ala316Asp),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 2, 2022)","criteria provided, multiple submitters, no conflicts"
2179,NM_000143.4(FH):c.936T>G (p.Phe312Leu),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: mar 16, 2022)","criteria provided, multiple submitters, no conflicts"
2180,NM_000143.4(FH):c.935T>C (p.Phe312Ser),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2181,NM_000143.4(FH):c.934T>C (p.Phe312Leu),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
2182,NM_000143.4(FH):c.923C>G (p.Ala308Gly),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
2183,NM_000143.4(FH):c.914T>C (p.Phe305Ser),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
2184,NM_000143.4(FH):c.842C>G (p.Thr281Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 15, 2022)","criteria provided, single submitter"
2185,NM_000143.4(FH):c.827G>T (p.Gly276Val),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: feb 22, 2017)","criteria provided, single submitter"
2186,NM_000143.4(FH):c.827G>A (p.Gly276Asp),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
2187,NM_000143.4(FH):c.820G>C (p.Ala274Pro),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"likely pathogenic(last reviewed: jan 17, 2017)","criteria provided, single submitter"
2188,NM_000143.4(FH):c.731T>G (p.Leu244Arg),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"likely pathogenic(last reviewed: jan 17, 2017)","criteria provided, single submitter"
2189,NM_000143.4(FH):c.704A>G (p.His235Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
2190,NM_000143.4(FH):c.703C>G (p.His235Asp),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"likely pathogenic(last reviewed: jan 17, 2017)","criteria provided, single submitter"
2191,NM_000143.4(FH):c.703C>T (p.His235Tyr),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: may 1, 2021)","criteria provided, multiple submitters, no conflicts"
2192,NM_000143.4(FH):c.700A>G (p.Thr234Ala),FH,fumarase deficiency,C0342770,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
2192,NM_000143.4(FH):c.700A>G (p.Thr234Ala),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
2192,NM_000143.4(FH):c.700A>G (p.Thr234Ala),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
2193,NM_000143.4(FH):c.698G>T (p.Arg233Leu),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 12, 2022)","criteria provided, multiple submitters, no conflicts"
2193,NM_000143.4(FH):c.698G>T (p.Arg233Leu),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: oct 12, 2022)","criteria provided, multiple submitters, no conflicts"
2194,NM_000143.4(FH):c.698G>A (p.Arg233His),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2194,NM_000143.4(FH):c.698G>A (p.Arg233His),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2194,NM_000143.4(FH):c.698G>A (p.Arg233His),FH,see cases,Cumapped260,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2195,NM_000143.4(FH):c.697C>G (p.Arg233Gly),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
2196,NM_000143.4(FH):c.697C>T (p.Arg233Cys),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
2197,NM_000143.4(FH):c.689A>G (p.Lys230Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2198,NM_000143.4(FH):c.664T>C (p.Ser222Pro),FH,fumarase deficiency,C0342770,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
2199,NM_000143.4(FH):c.653T>G (p.Leu218Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: nov 20, 2019)","criteria provided, single submitter"
2200,NM_000143.4(FH):c.584T>C (p.Met195Thr),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
2200,NM_000143.4(FH):c.584T>C (p.Met195Thr),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
2201,NM_000143.4(FH):c.583A>G (p.Met195Val),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
2202,NM_000143.4(FH):c.575C>T (p.Pro192Leu),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
2203,NM_000143.4(FH):c.566A>T (p.Asp189Val),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
2204,NM_000143.4(FH):c.562A>G (p.Asn188Asp),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, single submitter"
2205,NM_000143.4(FH):c.557G>A (p.Ser186Asn),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
2206,NM_000143.4(FH):c.554A>G (p.Gln185Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
2206,NM_000143.4(FH):c.554A>G (p.Gln185Arg),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
2207,NM_000143.4(FH):c.539A>G (p.His180Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 14, 2022)","criteria provided, multiple submitters, no conflicts"
2208,NM_000143.4(FH):c.524T>G (p.Val175Gly),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 20, 2021)","criteria provided, single submitter"
2209,NM_000143.4(FH):c.478A>G (p.Arg160Gly),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2210,NM_000143.4(FH):c.470T>G (p.Ile157Ser),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 13, 2022)","criteria provided, single submitter"
2211,NM_000143.4(FH):c.450T>A (p.Asn150Lys),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 4, 2022)","criteria provided, multiple submitters, no conflicts"
2212,NM_000143.4(FH):c.439A>G (p.Thr147Ala),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
2213,NM_000143.4(FH):c.431G>C (p.Gly144Ala),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
2214,NM_000143.4(FH):c.431G>A (p.Gly144Glu),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
2215,NM_000143.4(FH):c.425A>G (p.Gln142Arg),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 4, 2022)","criteria provided, multiple submitters, no conflicts"
2216,NM_000143.4(FH):c.378G>C (p.Glu126Asp),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: nov 15, 2019)","criteria provided, single submitter"
2217,NM_000143.4(FH):c.349G>C (p.Ala117Pro),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
2218,NM_000143.4(FH):c.320A>C (p.Asn107Thr),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
2218,NM_000143.4(FH):c.320A>C (p.Asn107Thr),FH,hereditary leiomyomatosis and renal cell cancer,C1708350,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
2219,NM_000143.4(FH):c.302G>C (p.Arg101Pro),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 30, 2020)","criteria provided, multiple submitters, no conflicts"
2220,NM_000143.4(FH):c.284C>A (p.Ala95Asp),FH,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: dec 9, 2021)","criteria provided, single submitter"
2221,NM_000143.4(FH):c.152G>A (p.Arg51Gln),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
2222,NM_000143.4(FH):c.132G>A (p.Met44Ile),FH,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 16, 2021)","criteria provided, multiple submitters, no conflicts"
2223,NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp),AKT3,global developmental delay,C0557874,"pathogenic/likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
2223,NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp),AKT3,capillary hemangioma,C0206733,"pathogenic/likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
2223,NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp),AKT3,macrocephaly,C0221355,"pathogenic/likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
2223,NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp),AKT3,polymicrogyria,C0266464,"pathogenic/likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
2223,NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp),AKT3,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,C4014738,"pathogenic/likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
2223,NM_005465.7(AKT3):c.1393C>T (p.Arg465Trp),AKT3,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, multiple submitters, no conflicts"
2224,NM_005465.7(AKT3):c.964G>T (p.Asp322Tyr),AKT3,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,C4014738,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2225,NM_005465.7(AKT3):c.685A>C (p.Asn229His),AKT3,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,C4014738,"likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, single submitter"
2226,NM_005465.7(AKT3):c.548T>A (p.Val183Asp),AKT3,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,C4014738,likely pathogenic,"criteria provided, single submitter"
2227,NM_005465.7(AKT3):c.538A>G (p.Lys180Glu),AKT3,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,C4014738,"pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
2228,NM_005465.7(AKT3):c.237G>C (p.Trp79Cys),AKT3,megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2,C4014738,"likely pathogenic(last reviewed: sep 20, 2021)","criteria provided, single submitter"
2229,NM_005465.7(AKT3):c.49G>A (p.Glu17Lys),AKT3,overgrowth syndrome and/or cerebral malformations due to abnormalities in mtor pathway genes,Cumapped193,"pathogenic(last reviewed: feb 12, 2022)",reviewed by expert panel
2230,NM_205768.3(ZBTB18):c.160T>C (p.Cys54Arg),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
2231,NM_205768.3(ZBTB18):c.1210G>A (p.Glu404Lys),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2232,NM_205768.3(ZBTB18):c.1283T>G (p.Phe428Cys),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: jul 2, 2019)","criteria provided, single submitter"
2233,NM_205768.3(ZBTB18):c.1301T>C (p.Leu434Pro),ZBTB18,marfanoid habitus and intellectual disability,CL536965,"likely pathogenic(last reviewed: mar 3, 2016)","criteria provided, single submitter"
2233,NM_205768.3(ZBTB18):c.1301T>C (p.Leu434Pro),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: mar 3, 2016)","criteria provided, single submitter"
2234,NM_205768.3(ZBTB18):c.1306C>T (p.Arg436Cys),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, single submitter"
2235,NM_205768.3(ZBTB18):c.1309C>T (p.His437Tyr),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, single submitter"
2236,NM_205768.3(ZBTB18):c.1355G>A (p.Cys452Tyr),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: sep 25, 2018)","criteria provided, single submitter"
2237,NM_205768.3(ZBTB18):c.1378C>T (p.His460Tyr),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"pathogenic/likely pathogenic(last reviewed: may 19, 2020)","criteria provided, multiple submitters, no conflicts"
2238,NM_205768.3(ZBTB18):c.1382A>G (p.Asn461Ser),ZBTB18,intellectual disability,C3714756,"pathogenic(last reviewed: jul 20, 2020)","criteria provided, multiple submitters, no conflicts"
2239,NM_205768.3(ZBTB18):c.1391G>T (p.Arg464Leu),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
2240,NM_205768.3(ZBTB18):c.1391G>A (p.Arg464His),ZBTB18,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: feb 23, 2020)","criteria provided, multiple submitters, no conflicts"
2241,NM_205768.3(ZBTB18):c.1403T>C (p.Val468Ala),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
2242,NM_205768.3(ZBTB18):c.1406A>G (p.His469Arg),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
2243,NM_205768.3(ZBTB18):c.1444C>T (p.Arg482Cys),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"pathogenic(last reviewed: nov 21, 2017)","criteria provided, single submitter"
2244,NM_205768.3(ZBTB18):c.1465G>T (p.Asp489Tyr),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
2245,NM_205768.3(ZBTB18):c.1478A>G (p.His493Arg),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
2246,NM_205768.3(ZBTB18):c.1493A>C (p.His498Pro),ZBTB18,"intellectual disability, autosomal dominant 22",C3808184,"likely pathogenic(last reviewed: apr 16, 2018)","criteria provided, single submitter"
2247,NM_031844.3(HNRNPU):c.1807G>A (p.Ala603Thr),HNRNPU,"developmental and epileptic encephalopathy, 54",C2931919,"likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
2248,NM_031844.3(HNRNPU):c.1118G>A (p.Gly373Asp),HNRNPU,"developmental and epileptic encephalopathy, 54",C2931919,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
2249,NM_031844.3(HNRNPU):c.112C>A (p.Leu38Ile),HNRNPU,"developmental and epileptic encephalopathy, 54",C2931919,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2250,NM_031844.3(HNRNPU):c.61A>G (p.Lys21Glu),HNRNPU,"developmental and epileptic encephalopathy, 54",C2931919,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
2251,NM_001243133.2(NLRP3):c.55G>C (p.Asp19His),NLRP3,keratitis fugax hereditaria,C1835697,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
2252,NM_001243133.2(NLRP3):c.515T>C (p.Ile172Thr),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2253,NM_001243133.2(NLRP3):c.902G>A (p.Gly301Asp),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic/likely pathogenic(last reviewed: jan 20, 2022)","criteria provided, multiple submitters, no conflicts"
2254,NM_001243133.2(NLRP3):c.905T>G (p.Phe302Cys),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2255,NM_001243133.2(NLRP3):c.907G>A (p.Asp303Asn),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
2256,NM_001243133.2(NLRP3):c.908A>G (p.Asp303Gly),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
2257,NM_001243133.2(NLRP3):c.910G>A (p.Glu304Lys),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: nov 15, 2022)","criteria provided, multiple submitters, no conflicts"
2258,NM_001243133.2(NLRP3):c.914T>C (p.Leu305Pro),NLRP3,autoinflammatory syndrome,C3890737,"pathogenic/likely pathogenic(last reviewed: sep 28, 2021)","criteria provided, multiple submitters, no conflicts"
2258,NM_001243133.2(NLRP3):c.914T>C (p.Leu305Pro),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic/likely pathogenic(last reviewed: sep 28, 2021)","criteria provided, multiple submitters, no conflicts"
2259,NM_001243133.2(NLRP3):c.920G>T (p.Gly307Val),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
2260,NM_001243133.2(NLRP3):c.931G>A (p.Glu311Lys),NLRP3,familial amyloid nephropathy with urticaria and deafness,C0268390,"pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
2261,NM_001243133.2(NLRP3):c.977G>A (p.Gly326Glu),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
2262,NM_001243133.2(NLRP3):c.1000A>G (p.Ile334Val),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: sep 20, 2019)","criteria provided, single submitter"
2263,NM_001243133.2(NLRP3):c.1043C>T (p.Thr348Met),NLRP3,"chronic infantile neurological, cutaneous and articular syndrome",C0409818,"pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
2263,NM_001243133.2(NLRP3):c.1043C>T (p.Thr348Met),NLRP3,familial amyloid nephropathy with urticaria and deafness,C0268390,"pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
2263,NM_001243133.2(NLRP3):c.1043C>T (p.Thr348Met),NLRP3,autoinflammatory syndrome,C3890737,"pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
2263,NM_001243133.2(NLRP3):c.1043C>T (p.Thr348Met),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
2263,NM_001243133.2(NLRP3):c.1043C>T (p.Thr348Met),NLRP3,familial amyloid nephropathy with urticaria and deafness,C0268390,"pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
2264,NM_001243133.2(NLRP3):c.1051G>A (p.Val351Met),NLRP3,autoinflammatory syndrome,C3890737,"likely pathogenic(last reviewed: jan 14, 2022)","criteria provided, single submitter"
2265,NM_001243133.2(NLRP3):c.1054G>A (p.Ala352Thr),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
2265,NM_001243133.2(NLRP3):c.1054G>A (p.Ala352Thr),NLRP3,"chronic infantile neurological, cutaneous and articular syndrome",C0409818,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
2266,NM_001243133.2(NLRP3):c.1055C>T (p.Ala352Val),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,familial cold autoinflammatory syndrome 1,C4551895,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,"chronic infantile neurological, cutaneous and articular syndrome",C0409818,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,"hearing loss, autosomal dominant 34, with or without inflammation",C3887873,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,familial amyloid nephropathy with urticaria and deafness,C0268390,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,keratitis fugax hereditaria,C1835697,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2267,NM_001243133.2(NLRP3):c.1058T>C (p.Leu353Pro),NLRP3,not specified,Cumapped182,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2268,NM_001243133.2(NLRP3):c.1213A>C (p.Thr405Pro),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic/likely pathogenic(last reviewed: nov 22, 2021)","criteria provided, multiple submitters, no conflicts"
2269,NM_001243133.2(NLRP3):c.1217T>C (p.Met406Thr),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
2270,NM_001243133.2(NLRP3):c.1218G>A (p.Met406Ile),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
2271,NM_001243133.2(NLRP3):c.1307C>T (p.Thr436Ile),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic/likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, multiple submitters, no conflicts"
2272,NM_001243133.2(NLRP3):c.1315G>A (p.Ala439Thr),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: aug 8, 2022)","criteria provided, single submitter"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,familial amyloid nephropathy with urticaria and deafness,C0268390,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,keratitis fugax hereditaria,C1835697,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,"hearing loss, autosomal dominant 34, with or without inflammation",C3887873,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,familial cold autoinflammatory syndrome 1,C4551895,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,"chronic infantile neurological, cutaneous and articular syndrome",C0409818,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,autoinflammatory syndrome,C3890737,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2273,NM_001243133.2(NLRP3):c.1316C>T (p.Ala439Val),NLRP3,familial cold autoinflammatory syndrome 1,C4551895,"pathogenic(last reviewed: nov 23, 2022)","criteria provided, multiple submitters, no conflicts"
2274,NM_001243133.2(NLRP3):c.1562T>A (p.Met521Lys),NLRP3,autoinflammatory syndrome,C3890737,"likely pathogenic(last reviewed: jul 20, 2017)","criteria provided, single submitter"
2275,NM_001243133.2(NLRP3):c.1568T>G (p.Phe523Cys),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
2276,NM_001243133.2(NLRP3):c.1573G>A (p.Glu525Lys),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2277,NM_001243133.2(NLRP3):c.1699G>A (p.Glu567Lys),NLRP3,familial cold autoinflammatory syndrome 1,C4551895,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
2277,NM_001243133.2(NLRP3):c.1699G>A (p.Glu567Lys),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
2278,NM_001243133.2(NLRP3):c.1700A>G (p.Glu567Gly),NLRP3,inflammatory abnormality of the skin,C3875321,"likely pathogenic(last reviewed: aug 2, 2022)","criteria provided, single submitter"
2279,NM_001243133.2(NLRP3):c.1700A>C (p.Glu567Ala),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
2280,NM_001243133.2(NLRP3):c.1880A>G (p.Glu627Gly),NLRP3,autoinflammatory syndrome,C3890737,"likely pathogenic(last reviewed: jan 6, 2017)","criteria provided, single submitter"
2281,NM_001243133.2(NLRP3):c.1976T>G (p.Met659Arg),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
2282,NM_001243133.2(NLRP3):c.2263G>A (p.Gly755Arg),NLRP3,cryopyrin associated periodic syndrome,C2316212,"pathogenic(last reviewed: mar 13, 2022)","criteria provided, single submitter"
2283,NM_001243133.2(NLRP3):c.2264G>C (p.Gly755Ala),NLRP3,cryopyrin associated periodic syndrome,C2316212,"likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, single submitter"
2284,NM_001243133.2(NLRP3):c.2575T>C (p.Tyr859His),NLRP3,familial cold autoinflammatory syndrome 1,C4551895,"likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
2284,NM_001243133.2(NLRP3):c.2575T>C (p.Tyr859His),NLRP3,keratitis fugax hereditaria,C1835697,"likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
2284,NM_001243133.2(NLRP3):c.2575T>C (p.Tyr859His),NLRP3,familial amyloid nephropathy with urticaria and deafness,C0268390,"likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
2284,NM_001243133.2(NLRP3):c.2575T>C (p.Tyr859His),NLRP3,"hearing loss, autosomal dominant 34, with or without inflammation",C3887873,"likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
2284,NM_001243133.2(NLRP3):c.2575T>C (p.Tyr859His),NLRP3,"chronic infantile neurological, cutaneous and articular syndrome",C0409818,"likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
2285,NM_001206744.2(TPO):c.391T>C (p.Ser131Pro),TPO,deficiency of iodide peroxidase,C1291299,"likely pathogenic(last reviewed: dec 30, 2019)","criteria provided, single submitter"
2286,NM_001206744.2(TPO):c.1159G>A (p.Gly387Arg),TPO,deficiency of iodide peroxidase,C1291299,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
2287,NM_001206744.2(TPO):c.1357T>G (p.Tyr453Asp),TPO,deficiency of iodide peroxidase,C1291299,"pathogenic(last reviewed: oct 30, 2021)","criteria provided, multiple submitters, no conflicts"
2288,NM_001206744.2(TPO):c.1477G>A (p.Gly493Ser),TPO,neurodevelopmental disorder,C1535926,"pathogenic(last reviewed: feb 18, 2020)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,delayed speech and language development,C0454644,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,global developmental delay,C0557874,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,short stature,C2919142,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,congenital hypothyroidism,C0010308,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,protruding tongue,C0241442,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,"intellectual disability, severe",C0036857,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,delayed gross motor development,C1837658,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2289,NM_001206744.2(TPO):c.1558C>T (p.His520Tyr),TPO,deficiency of iodide peroxidase,C1291299,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2290,NM_001206744.2(TPO):c.1978C>G (p.Gln660Glu),TPO,deficiency of iodide peroxidase,C1291299,"pathogenic/likely pathogenic(last reviewed: jun 8, 2022)","criteria provided, multiple submitters, no conflicts"
2291,NM_001206744.2(TPO):c.1994G>A (p.Arg665Gln),TPO,deficiency of iodide peroxidase,C1291299,"likely pathogenic(last reviewed: apr 22, 2022)","criteria provided, single submitter"
2292,NM_001206744.2(TPO):c.2395G>A (p.Glu799Lys),TPO,deficiency of iodide peroxidase,C1291299,"pathogenic(last reviewed: nov 1, 2021)","criteria provided, multiple submitters, no conflicts"
2293,NM_001206744.2(TPO):c.2473T>C (p.Cys825Arg),TPO,deficiency of iodide peroxidase,C1291299,"likely pathogenic(last reviewed: may 22, 2022)","criteria provided, single submitter"
2294,NM_001206744.2(TPO):c.2578G>A (p.Gly860Arg),TPO,deficiency of iodide peroxidase,C1291299,"pathogenic/likely pathogenic(last reviewed: jun 15, 2022)","criteria provided, multiple submitters, no conflicts"
2295,NM_012293.3(PXDN):c.2276C>T (p.Ser759Leu),PXDN,anterior segment dysgenesis 7,C3151617,"pathogenic(last reviewed: jul 19, 2019)","criteria provided, single submitter"
2296,NM_012293.3(PXDN):c.1A>G (p.Met1Val),PXDN,anterior segment dysgenesis 7,C3151617,"pathogenic(last reviewed: jul 19, 2019)","criteria provided, single submitter"
2297,NM_001303052.2(MYT1L):c.2671A>G (p.Ser891Gly),MYT1L,intellectual disability,C3714756,"pathogenic(last reviewed: apr 20, 2020)","criteria provided, single submitter"
2298,NM_001303052.2(MYT1L):c.1733C>T (p.Ala578Val),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: oct 17, 2018)","criteria provided, single submitter"
2299,NM_001303052.2(MYT1L):c.1706G>A (p.Arg569Gln),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
2299,NM_001303052.2(MYT1L):c.1706G>A (p.Arg569Gln),MYT1L,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
2300,NM_001303052.2(MYT1L):c.1695G>T (p.Arg565Ser),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2301,NM_001303052.2(MYT1L):c.1682T>A (p.Val561Asp),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"pathogenic(last reviewed: mar 13, 2018)","criteria provided, single submitter"
2302,NM_001303052.2(MYT1L):c.1678C>T (p.His560Tyr),MYT1L,intellectual disability,C3714756,"likely pathogenic(last reviewed: aug 3, 2020)","criteria provided, single submitter"
2303,NM_001303052.2(MYT1L):c.1672C>T (p.Arg558Cys),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: aug 28, 2018)","criteria provided, single submitter"
2304,NM_001303052.2(MYT1L):c.1670G>T (p.Gly557Val),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: nov 29, 2022)","criteria provided, single submitter"
2305,NM_001303052.2(MYT1L):c.1585G>A (p.Gly529Arg),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"pathogenic(last reviewed: dec 13, 2022)","criteria provided, multiple submitters, no conflicts"
2306,NM_001303052.2(MYT1L):c.1574G>T (p.Arg525Leu),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2307,NM_001303052.2(MYT1L):c.1570C>A (p.His524Asn),MYT1L,intellectual disability,C3714756,"likely pathogenic(last reviewed: apr 20, 2020)","criteria provided, single submitter"
2308,NM_001303052.2(MYT1L):c.1559T>C (p.Leu520Pro),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: jan 12, 2017)","criteria provided, single submitter"
2309,NM_001303052.2(MYT1L):c.1543G>A (p.Gly515Ser),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: may 26, 2022)","criteria provided, single submitter"
2310,NM_001303052.2(MYT1L):c.1538G>T (p.Gly513Val),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, single submitter"
2311,NM_001303052.2(MYT1L):c.1516T>C (p.Cys506Arg),MYT1L,"intellectual disability, autosomal dominant 39",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 14, 2022)","criteria provided, multiple submitters, no conflicts"
2312,NM_001303052.2(MYT1L):c.682A>G (p.Asn228Asp),MYT1L,intellectual disability,C3714756,"likely pathogenic(last reviewed: jul 18, 2019)","criteria provided, single submitter"
2313,NM_016030.6(TRAPPC12):c.1880C>T (p.Ala627Val),TRAPPC12|TRAPPC12-AS1,progressive childhood encephalopathy,Cumapped222,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2314,NM_002936.6(RNASEH1):c.424G>A (p.Val142Ile),RNASEH1,"progressive external ophthalmoplegia with mitochondrial dna deletions, autosomal recessive 2",C4225312,"pathogenic/likely pathogenic(last reviewed: apr 6, 2022)","criteria provided, multiple submitters, no conflicts"
2315,NM_003108.4(SOX11):c.146T>A (p.Ile49Asn),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2316,NM_003108.4(SOX11):c.146T>G (p.Ile49Ser),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: aug 18, 2020)","criteria provided, single submitter"
2317,NM_003108.4(SOX11):c.148A>C (p.Lys50Gln),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2318,NM_003108.4(SOX11):c.150G>C (p.Lys50Asn),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2319,NM_003108.4(SOX11):c.151C>G (p.Arg51Gly),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2320,NM_003108.4(SOX11):c.152G>T (p.Arg51Leu),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2321,NM_003108.4(SOX11):c.152G>A (p.Arg51Gln),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
2322,NM_003108.4(SOX11):c.155C>T (p.Pro52Leu),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic/likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
2323,NM_003108.4(SOX11):c.157A>G (p.Met53Val),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2324,NM_003108.4(SOX11):c.158T>G (p.Met53Arg),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2325,NM_003108.4(SOX11):c.159G>A (p.Met53Ile),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2326,NM_003108.4(SOX11):c.159G>T (p.Met53Ile),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: nov 29, 2022)","criteria provided, single submitter"
2327,NM_003108.4(SOX11):c.167T>G (p.Phe56Cys),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2328,NM_003108.4(SOX11):c.168C>G (p.Phe56Leu),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
2329,NM_003108.4(SOX11):c.170T>C (p.Met57Thr),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic/likely pathogenic(last reviewed: mar 26, 2023)","criteria provided, multiple submitters, no conflicts"
2330,NM_003108.4(SOX11):c.190C>A (p.Arg64Ser),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2331,NM_003108.4(SOX11):c.191G>T (p.Arg64Leu),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2332,NM_003108.4(SOX11):c.191G>C (p.Arg64Pro),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
2333,NM_003108.4(SOX11):c.223C>G (p.His75Asp),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2334,NM_003108.4(SOX11):c.239C>T (p.Ser80Phe),SOX11,"intellectual disability, autosomal dominant 27",C3276355,likely pathogenic,"criteria provided, single submitter"
2335,NM_003108.4(SOX11):c.250G>A (p.Gly84Ser),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2336,NM_003108.4(SOX11):c.250G>C (p.Gly84Arg),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic(last reviewed: jun 5, 2020)","criteria provided, single submitter"
2337,NM_003108.4(SOX11):c.259T>C (p.Trp87Arg),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2338,NM_003108.4(SOX11):c.299G>C (p.Arg100Pro),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic/likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
2339,NM_003108.4(SOX11):c.305C>T (p.Ala102Val),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, multiple submitters, no conflicts"
2340,NM_003108.4(SOX11):c.317G>C (p.Arg106Pro),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2341,NM_003108.4(SOX11):c.322A>G (p.Lys108Glu),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: dec 28, 2017)","criteria provided, single submitter"
2342,NM_003108.4(SOX11):c.326A>C (p.His109Pro),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2343,NM_003108.4(SOX11):c.337T>C (p.Tyr113His),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2344,NM_003108.4(SOX11):c.353A>C (p.Tyr118Ser),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"pathogenic(last reviewed: jul 30, 2018)","criteria provided, single submitter"
2345,NM_003108.4(SOX11):c.359C>A (p.Pro120His),SOX11,"intellectual disability, autosomal dominant 27",C3276355,"likely pathogenic(last reviewed: mar 9, 2023)","criteria provided, single submitter"
2346,NM_003108.4(SOX11):c.359C>T (p.Pro120Leu),SOX11,"intellectual disability, autosomal dominant 27",C3276355,likely pathogenic,"criteria provided, single submitter"
2347,NM_015909.4(NBAS):c.2630G>T (p.Gly877Val),NBAS,infantile liver failure syndrome 2,C3809651,"likely pathogenic(last reviewed: mar 6, 2021)","criteria provided, single submitter"
2348,NM_015909.4(NBAS):c.409C>T (p.Arg137Trp),NBAS,infantile liver failure syndrome 2,C3809651,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2349,NM_015909.4(NBAS):c.406A>G (p.Arg136Gly),NBAS,infantile liver failure syndrome 2,C3809651,likely pathogenic,"criteria provided, single submitter"
2350,NM_015909.4(NBAS):c.1A>T (p.Met1Leu),NBAS,acute infantile liver failure due to synthesis defect of mtdna-encoded proteins,CL516813,"likely pathogenic(last reviewed: may 23, 2022)","criteria provided, single submitter"
2351,NM_005378.6(MYCN):c.77C>T (p.Pro26Leu),MYCNOS|MYCN,feingold syndrome type 1,CL1774253,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
2352,NM_005378.6(MYCN):c.179C>T (p.Pro60Leu),MYCN|MYCNOS,see cases,Cumapped260,"likely pathogenic(last reviewed: nov 12, 2020)","criteria provided, single submitter"
2353,NM_005378.6(MYCN):c.1181G>T (p.Arg394Leu),MYCN,feingold syndrome type 1,CL1774253,"likely pathogenic(last reviewed: jan 12, 2016)","criteria provided, single submitter"
2354,NM_020779.4(WDR35):c.1400G>A (p.Arg467Lys),WDR35,short-rib thoracic dysplasia 7 with or without polydactyly,C3279792,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
2355,NM_020779.4(WDR35):c.1382G>A (p.Arg461Gln),WDR35,cranioectodermal dysplasia 2,C3150874,"likely pathogenic(last reviewed: aug 27, 2017)","criteria provided, single submitter"
2356,NM_020779.4(WDR35):c.504T>A (p.Ser168Arg),WDR35,short-rib thoracic dysplasia 7 with or without polydactyly,C3279792,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
2356,NM_020779.4(WDR35):c.504T>A (p.Ser168Arg),WDR35,cranioectodermal dysplasia 2,C3150874,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
2357,NM_020779.4(WDR35):c.206G>A (p.Gly69Asp),WDR35,cranioectodermal dysplasia 2,C3150874,"pathogenic(last reviewed: dec 13, 2019)","criteria provided, single submitter"
2358,NM_002381.5(MATN3):c.368C>T (p.Ala123Val),MATN3,multiple epiphyseal dysplasia type 5,C4275060,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
2359,NM_002381.5(MATN3):c.361C>T (p.Arg121Trp),MATN3,multiple epiphyseal dysplasia type 5,C4275060,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
2360,NM_002381.5(MATN3):c.359C>T (p.Thr120Met),MATN3,multiple epiphyseal dysplasia type 5,C4275060,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
2361,NM_000384.3(APOB):c.1468C>T (p.Arg490Trp),APOB,"hypercholesterolemia, autosomal dominant, type b",C1704417,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2362,NM_001013663.2(PTRHD1):c.155G>A (p.Cys52Tyr),PTRHD1,parkinsonism,C0242422,"pathogenic(last reviewed: dec 14, 2021)","criteria provided, single submitter"
2363,NM_022552.5(DNMT3A):c.2722T>A (p.Tyr908Asn),DNMT3A,intellectual disability,C3714756,"likely pathogenic(last reviewed: sep 10, 2020)","criteria provided, single submitter"
2364,NM_022552.5(DNMT3A):c.2693T>C (p.Ile898Thr),DNMT3A,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: jun 7, 2021)","criteria provided, single submitter"
2365,NM_022552.5(DNMT3A):c.2644C>T (p.Arg882Cys),DNMT3A,neurodevelopmental disorder,C1535926,"pathogenic(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
2365,NM_022552.5(DNMT3A):c.2644C>T (p.Arg882Cys),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"pathogenic(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
2365,NM_022552.5(DNMT3A):c.2644C>T (p.Arg882Cys),DNMT3A,acute myeloid leukemia,C0023467,"pathogenic(last reviewed: dec 20, 2022)","criteria provided, multiple submitters, no conflicts"
2366,NM_022552.5(DNMT3A):c.2525A>G (p.Gln842Arg),DNMT3A,acute myeloid leukemia,C0023467,"likely pathogenic(last reviewed: sep 4, 2017)","criteria provided, single submitter"
2366,NM_022552.5(DNMT3A):c.2525A>G (p.Gln842Arg),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: sep 4, 2017)","criteria provided, single submitter"
2367,NM_022552.5(DNMT3A):c.2495C>T (p.Thr832Ile),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2368,NM_022552.5(DNMT3A):c.2311C>G (p.Arg771Gly),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, single submitter"
2369,NM_022552.5(DNMT3A):c.2245C>T (p.Arg749Cys),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
2370,NM_022552.5(DNMT3A):c.2186G>A (p.Arg729Gln),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,likely pathogenic,"criteria provided, single submitter"
2371,NM_022552.5(DNMT3A):c.1757G>T (p.Cys586Phe),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,pathogenic,"criteria provided, single submitter"
2372,NM_022552.5(DNMT3A):c.1676G>A (p.Cys559Tyr),DNMT3A,acute myeloid leukemia,C0023467,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2373,NM_022552.5(DNMT3A):c.1634A>G (p.Glu545Gly),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: aug 17, 2017)","criteria provided, single submitter"
2374,NM_022552.5(DNMT3A):c.1627G>A (p.Gly543Ser),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: dec 22, 2022)","criteria provided, single submitter"
2375,NM_022552.5(DNMT3A):c.1585G>A (p.Asp529Asn),DNMT3A,see cases,Cumapped260,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2376,NM_022552.5(DNMT3A):c.1490G>T (p.Cys497Phe),DNMT3A,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
2377,NM_022552.5(DNMT3A):c.1004A>G (p.Lys335Arg),DNMT3A,neonatal hypotonia,C2267233,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
2378,NM_022552.5(DNMT3A):c.920C>T (p.Pro307Leu),DNMT3A,acute myeloid leukemia,C0023467,"likely pathogenic(last reviewed: nov 7, 2017)","criteria provided, single submitter"
2378,NM_022552.5(DNMT3A):c.920C>T (p.Pro307Leu),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: nov 7, 2017)","criteria provided, single submitter"
2379,NM_022552.5(DNMT3A):c.905G>C (p.Gly302Ala),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, single submitter"
2380,NM_022552.5(DNMT3A):c.895A>C (p.Lys299Gln),DNMT3A,tall stature-intellectual disability-facial dysmorphism syndrome,Cumapped314,"likely pathogenic(last reviewed: sep 15, 2016)","criteria provided, single submitter"
2381,NM_018263.6(ASXL2):c.2326A>C (p.Thr776Pro),ASXL2,autism spectrum disorder,C1510586,"likely pathogenic(last reviewed: apr 12, 2022)","criteria provided, single submitter"
2382,NM_000182.5(HADHA):c.2198T>C (p.Leu733Pro),HADHA|GAREM2,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2382,NM_000182.5(HADHA):c.2198T>C (p.Leu733Pro),HADHA|GAREM2,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2383,NM_000182.5(HADHA):c.2027G>A (p.Arg676His),HADHA|GAREM2,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
2383,NM_000182.5(HADHA):c.2027G>A (p.Arg676His),HADHA|GAREM2,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
2384,NM_000182.5(HADHA):c.2026C>T (p.Arg676Cys),GAREM2|HADHA,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"likely pathogenic(last reviewed: oct 10, 2021)","criteria provided, multiple submitters, no conflicts"
2384,NM_000182.5(HADHA):c.2026C>T (p.Arg676Cys),GAREM2|HADHA,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: oct 10, 2021)","criteria provided, multiple submitters, no conflicts"
2385,NM_000182.5(HADHA):c.1645A>G (p.Arg549Gly),HADHA|GAREM2,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: aug 7, 2018)","criteria provided, single submitter"
2385,NM_000182.5(HADHA):c.1645A>G (p.Arg549Gly),HADHA|GAREM2,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"likely pathogenic(last reviewed: aug 7, 2018)","criteria provided, single submitter"
2386,NM_000182.5(HADHA):c.1528G>C (p.Glu510Gln),HADHA|GAREM2,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"pathogenic(last reviewed: nov 28, 2022)","criteria provided, multiple submitters, no conflicts"
2386,NM_000182.5(HADHA):c.1528G>C (p.Glu510Gln),HADHA|GAREM2,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic(last reviewed: nov 28, 2022)","criteria provided, multiple submitters, no conflicts"
2386,NM_000182.5(HADHA):c.1528G>C (p.Glu510Gln),HADHA|GAREM2,not specified,Cumapped182,"pathogenic(last reviewed: nov 28, 2022)","criteria provided, multiple submitters, no conflicts"
2386,NM_000182.5(HADHA):c.1528G>C (p.Glu510Gln),HADHA|GAREM2,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"pathogenic(last reviewed: nov 28, 2022)","criteria provided, multiple submitters, no conflicts"
2386,NM_000182.5(HADHA):c.1528G>C (p.Glu510Gln),HADHA|GAREM2,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic(last reviewed: nov 28, 2022)","criteria provided, multiple submitters, no conflicts"
2386,NM_000182.5(HADHA):c.1528G>C (p.Glu510Gln),HADHA|GAREM2,see cases,Cumapped260,"pathogenic(last reviewed: nov 28, 2022)","criteria provided, multiple submitters, no conflicts"
2387,NM_000182.5(HADHA):c.914T>A (p.Ile305Asn),HADHA,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2387,NM_000182.5(HADHA):c.914T>A (p.Ile305Asn),HADHA,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2388,NM_000182.5(HADHA):c.703C>T (p.Arg235Trp),HADHA,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
2388,NM_000182.5(HADHA):c.703C>T (p.Arg235Trp),HADHA,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
2388,NM_000182.5(HADHA):c.703C>T (p.Arg235Trp),HADHA,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"pathogenic/likely pathogenic(last reviewed: sep 8, 2022)","criteria provided, multiple submitters, no conflicts"
2389,NM_000182.5(HADHA):c.539C>T (p.Pro180Leu),HADHA,mitochondrial trifunctional protein deficiency,C1969443,likely pathogenic,"criteria provided, single submitter"
2390,NM_000182.5(HADHA):c.3G>A (p.Met1Ile),HADHA,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"likely pathogenic(last reviewed: aug 2, 2017)","criteria provided, single submitter"
2391,NM_000182.5(HADHA):c.1A>G (p.Met1Val),HADHA,long chain 3-hydroxyacyl-coa dehydrogenase deficiency,C3711645,"likely pathogenic(last reviewed: nov 4, 2016)","criteria provided, single submitter"
2392,NM_000183.3(HADHB):c.182G>A (p.Arg61His),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
2393,NM_000183.3(HADHB):c.392C>T (p.Ala131Val),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
2394,NM_000183.3(HADHB):c.407T>C (p.Met136Thr),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
2395,NM_000183.3(HADHB):c.427C>G (p.Gln143Glu),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
2396,NM_000183.3(HADHB):c.901G>C (p.Gly301Arg),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: aug 7, 2018)","criteria provided, single submitter"
2397,NM_000183.3(HADHB):c.1063C>A (p.Pro355Thr),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: jul 7, 2021)","criteria provided, single submitter"
2398,NM_000183.3(HADHB):c.1165A>G (p.Asn389Asp),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
2399,NM_000183.3(HADHB):c.1175C>T (p.Ala392Val),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2400,NM_000183.3(HADHB):c.1364T>G (p.Val455Gly),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2401,NM_000183.3(HADHB):c.1375G>A (p.Ala459Thr),HADHB,mitochondrial trifunctional protein deficiency,C1969443,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2402,NM_194248.3(OTOF):c.2891C>A (p.Ala964Glu),OTOF,bilateral sensorineural hearing impairment,C0452138,pathogenic,"criteria provided, single submitter"
2403,NM_194248.3(OTOF):c.1841G>A (p.Gly614Glu),OTOF,bilateral sensorineural hearing impairment,C0452138,likely pathogenic,"criteria provided, single submitter"
2404,NM_194248.3(OTOF):c.1621G>A (p.Gly541Ser),OTOF,autosomal recessive nonsyndromic hearing loss 9,C1832828,"pathogenic(last reviewed: jul 1, 2017)","criteria provided, single submitter"
2405,NM_194248.3(OTOF):c.1544T>C (p.Ile515Thr),OTOF,rare genetic deafness,Cumapped240,"likely pathogenic(last reviewed: feb 14, 2017)","criteria provided, single submitter"
2406,NM_002246.3(KCNK3):c.365T>C (p.Leu122Pro),KCNK3,"pulmonary hypertension, primary, 4",Cumapped231,"likely pathogenic(last reviewed: sep 21, 2017)","criteria provided, single submitter"
2407,NM_021095.4(SLC5A6):c.1285A>G (p.Ser429Gly),SLC5A6,"peripheral motor neuropathy, childhood-onset, biotin-responsive",CL1899800,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
2407,NM_021095.4(SLC5A6):c.1285A>G (p.Ser429Gly),SLC5A6,"neurodegeneration, infantile-onset, biotin-responsive",Cumapped152,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
2408,NM_004341.5(CAD):c.98T>G (p.Met33Arg),CAD,"developmental and epileptic encephalopathy, 50",C2931919,"pathogenic/likely pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
2409,NM_002437.5(MPV17):c.509C>T (p.Ser170Phe),MPV17,navajo neurohepatopathy,C1850406,"likely pathogenic(last reviewed: aug 13, 2019)","criteria provided, single submitter"
2410,NM_002437.5(MPV17):c.461G>T (p.Arg154Met),MPV17,navajo neurohepatopathy,C1850406,"likely pathogenic(last reviewed: aug 13, 2019)","criteria provided, multiple submitters, no conflicts"
2411,NM_002437.5(MPV17):c.293C>T (p.Pro98Leu),MPV17,navajo neurohepatopathy,C1850406,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
2411,NM_002437.5(MPV17):c.293C>T (p.Pro98Leu),MPV17,"charcot-marie-tooth disease, axonal, type 2ee",C5193076,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
2411,NM_002437.5(MPV17):c.293C>T (p.Pro98Leu),MPV17,navajo neurohepatopathy,C1850406,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
2412,NM_002437.5(MPV17):c.280G>C (p.Gly94Arg),MPV17,mitochondrial dna depletion syndrome,C3149750,"likely pathogenic(last reviewed: jan 21, 2023)","criteria provided, multiple submitters, no conflicts"
2413,NM_002437.5(MPV17):c.278A>C (p.Gln93Pro),MPV17,navajo neurohepatopathy,C1850406,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
2414,NM_002437.5(MPV17):c.275A>G (p.Asp92Gly),MPV17,navajo neurohepatopathy,C1850406,"likely pathogenic(last reviewed: aug 13, 2019)","criteria provided, multiple submitters, no conflicts"
2415,NM_002437.5(MPV17):c.191C>G (p.Pro64Arg),MPV17,navajo neurohepatopathy,C1850406,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
2416,NM_002437.5(MPV17):c.149G>A (p.Arg50Gln),MPV17,mitochondrial dna depletion syndrome,C3149750,"pathogenic(last reviewed: dec 14, 2022)","criteria provided, multiple submitters, no conflicts"
2417,NM_002437.5(MPV17):c.122G>A (p.Arg41Gln),MPV17,"charcot-marie-tooth disease, axonal, type 2ee",C5193076,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
2418,NM_002437.5(MPV17):c.67G>C (p.Ala23Pro),MPV17,navajo neurohepatopathy,C1850406,"likely pathogenic(last reviewed: aug 13, 2019)","criteria provided, single submitter"
2419,NM_001034116.2(EIF2B4):c.728C>T (p.Pro243Leu),GTF3C2-AS2|EIF2B4,vanishing white matter disease,C2960129,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
2420,NM_001034116.2(EIF2B4):c.631G>T (p.Gly211Cys),EIF2B4,vanishing white matter disease,C2960129,"likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, single submitter"
2421,NM_001034116.2(EIF2B4):c.551C>T (p.Pro184Leu),EIF2B4,vanishing white matter disease,C2960129,"likely pathogenic(last reviewed: jul 5, 2018)","criteria provided, single submitter"
2422,NM_002709.3(PPP1CB):c.146C>G (p.Pro49Arg),PPP1CB,noonan syndrome-like disorder with loose anagen hair 2,C4479577,"pathogenic(last reviewed: oct 12, 2022)","criteria provided, multiple submitters, no conflicts"
2422,NM_002709.3(PPP1CB):c.146C>G (p.Pro49Arg),PPP1CB,neurodevelopmental delay,C4022738,"pathogenic(last reviewed: oct 12, 2022)","criteria provided, multiple submitters, no conflicts"
2423,NM_002709.3(PPP1CB):c.493G>C (p.Asp165His),PPP1CB,noonan syndrome-like disorder with loose anagen hair 2,C4479577,"likely pathogenic(last reviewed: nov 18, 2022)","criteria provided, single submitter"
2424,NM_002709.3(PPP1CB):c.658C>T (p.Arg220Cys),PPP1CB,noonan syndrome-like disorder with loose anagen hair 2,C4479577,"pathogenic/likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, multiple submitters, no conflicts"
2425,NM_004304.5(ALK):c.402G>C (p.Lys134Asn),ALK,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
2426,NM_000348.4(SRD5A2):c.737G>A (p.Arg246Gln),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
2427,NM_000348.4(SRD5A2):c.736C>T (p.Arg246Trp),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
2428,NM_000348.4(SRD5A2):c.725A>G (p.Tyr242Cys),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"likely pathogenic(last reviewed: aug 10, 2017)","criteria provided, single submitter"
2429,NM_000348.4(SRD5A2):c.704A>T (p.Tyr235Phe),SRD5A2,hypergonadotropic hypogonadism,C4013694,"pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
2429,NM_000348.4(SRD5A2):c.704A>T (p.Tyr235Phe),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
2430,NM_000348.4(SRD5A2):c.695A>G (p.His232Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2431,NM_000348.4(SRD5A2):c.692A>G (p.His231Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
2432,NM_000348.4(SRD5A2):c.683C>T (p.Ala228Val),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2433,NM_000348.4(SRD5A2):c.682G>A (p.Ala228Thr),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2434,NM_000348.4(SRD5A2):c.680G>A (p.Arg227Gln),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
2435,NM_000348.4(SRD5A2):c.635C>G (p.Pro212Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2436,NM_000348.4(SRD5A2):c.623C>T (p.Thr208Ile),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
2437,NM_000348.4(SRD5A2):c.620C>A (p.Ala207Asp),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2438,NM_000348.4(SRD5A2):c.607G>A (p.Gly203Ser),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2439,NM_000348.4(SRD5A2):c.591G>T (p.Glu197Asp),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: jul 7, 2022)","criteria provided, single submitter"
2440,NM_000348.4(SRD5A2):c.589G>A (p.Glu197Lys),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,pathogenic,"criteria provided, single submitter"
2441,NM_000348.4(SRD5A2):c.586G>C (p.Gly196Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: feb 1, 2018)","criteria provided, single submitter"
2442,NM_000348.4(SRD5A2):c.578A>G (p.Asn193Ser),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: apr 4, 2022)","criteria provided, multiple submitters, no conflicts"
2443,NM_000348.4(SRD5A2):c.547G>A (p.Gly183Ser),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2444,NM_000348.4(SRD5A2):c.513G>C (p.Arg171Ser),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2445,NM_000348.4(SRD5A2):c.485A>C (p.His162Pro),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: nov 15, 2019)","criteria provided, single submitter"
2446,NM_000348.4(SRD5A2):c.377A>G (p.Gln126Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: apr 16, 2022)","criteria provided, multiple submitters, no conflicts"
2447,NM_000348.4(SRD5A2):c.358A>C (p.Thr120Pro),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"likely pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
2448,NM_000348.4(SRD5A2):c.344G>A (p.Gly115Asp),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2449,NM_000348.4(SRD5A2):c.271T>C (p.Tyr91His),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
2450,NM_000348.4(SRD5A2):c.169G>C (p.Glu57Gln),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2451,NM_000348.4(SRD5A2):c.164T>C (p.Leu55Pro),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
2452,NM_000348.4(SRD5A2):c.164T>A (p.Leu55Gln),SRD5A2,abnormality of the genitourinary system,C0042063,"pathogenic/likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, multiple submitters, no conflicts"
2452,NM_000348.4(SRD5A2):c.164T>A (p.Leu55Gln),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic/likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, multiple submitters, no conflicts"
2453,NM_000348.4(SRD5A2):c.100G>C (p.Gly34Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 21, 2019)","criteria provided, single submitter"
2454,NM_000348.4(SRD5A2):c.100G>A (p.Gly34Arg),SRD5A2,3-oxo-5 alpha-steroid delta 4-dehydrogenase deficiency,C0268297,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2455,NM_014946.4(SPAST):c.955A>T (p.Asn319Tyr),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2456,NM_014946.4(SPAST):c.983T>C (p.Ile328Thr),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2457,NM_014946.4(SPAST):c.1031T>G (p.Ile344Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: oct 18, 2021)","criteria provided, single submitter"
2458,NM_014946.4(SPAST):c.1037G>T (p.Gly346Val),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2459,NM_014946.4(SPAST):c.1040A>C (p.Gln347Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jun 20, 2022)","criteria provided, multiple submitters, no conflicts"
2460,NM_014946.4(SPAST):c.1047G>C (p.Leu349Phe),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2461,NM_014946.4(SPAST):c.1066G>A (p.Glu356Lys),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jul 1, 2016)","criteria provided, multiple submitters, no conflicts"
2462,NM_014946.4(SPAST):c.1067A>G (p.Glu356Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
2463,NM_014946.4(SPAST):c.1081C>T (p.Pro361Ser),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2464,NM_014946.4(SPAST):c.1085C>T (p.Ser362Phe),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2465,NM_014946.4(SPAST):c.1091G>C (p.Arg364Thr),SPAST,hereditary spastic paraplegia,C0037773,"likely pathogenic(last reviewed: oct 1, 2018)","criteria provided, single submitter"
2466,NM_014946.4(SPAST):c.1103T>C (p.Phe368Ser),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jul 27, 2022)","criteria provided, multiple submitters, no conflicts"
2467,NM_014946.4(SPAST):c.1105A>C (p.Thr369Pro),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2468,NM_014946.4(SPAST):c.1111C>T (p.Leu371Phe),SPAST,hereditary spastic paraplegia,C0037773,"likely pathogenic(last reviewed: dec 12, 2016)","criteria provided, multiple submitters, no conflicts"
2468,NM_014946.4(SPAST):c.1111C>T (p.Leu371Phe),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: dec 12, 2016)","criteria provided, multiple submitters, no conflicts"
2469,NM_014946.4(SPAST):c.1112T>C (p.Leu371Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: dec 18, 2021)","criteria provided, single submitter"
2470,NM_014946.4(SPAST):c.1112T>G (p.Leu371Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jun 15, 2017)","criteria provided, multiple submitters, no conflicts"
2471,NM_014946.4(SPAST):c.1121C>T (p.Pro374Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
2472,NM_014946.4(SPAST):c.1132C>G (p.Leu378Val),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: oct 4, 2021)","criteria provided, single submitter"
2473,NM_014946.4(SPAST):c.1133T>A (p.Leu378Gln),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic(last reviewed: mar 7, 2017)","criteria provided, single submitter"
2474,NM_014946.4(SPAST):c.1139T>C (p.Leu380Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
2475,NM_014946.4(SPAST):c.1148C>G (p.Pro383Arg),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2476,NM_014946.4(SPAST):c.1151C>G (p.Pro384Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
2476,NM_014946.4(SPAST):c.1151C>G (p.Pro384Arg),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
2477,NM_014946.4(SPAST):c.1151C>T (p.Pro384Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: sep 11, 2021)","criteria provided, single submitter"
2478,NM_014946.4(SPAST):c.1157A>G (p.Asn386Ser),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2478,NM_014946.4(SPAST):c.1157A>G (p.Asn386Ser),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2479,NM_014946.4(SPAST):c.1159G>A (p.Gly387Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
2480,NM_014946.4(SPAST):c.1163A>G (p.Lys388Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: nov 27, 2021)","criteria provided, single submitter"
2481,NM_014946.4(SPAST):c.1164G>C (p.Lys388Asn),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
2482,NM_014946.4(SPAST):c.1164G>T (p.Lys388Asn),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
2483,NM_014946.4(SPAST):c.1165A>G (p.Thr389Ala),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: jul 12, 2021)","criteria provided, multiple submitters, no conflicts"
2484,NM_014946.4(SPAST):c.1168A>G (p.Met390Val),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
2485,NM_014946.4(SPAST):c.1169T>A (p.Met390Lys),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: sep 8, 2017)","criteria provided, single submitter"
2486,NM_014946.4(SPAST):c.1170G>A (p.Met390Ile),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
2487,NM_014946.4(SPAST):c.1181C>A (p.Ala394Glu),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2488,NM_014946.4(SPAST):c.1196C>T (p.Ser399Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: feb 1, 2023)","criteria provided, multiple submitters, no conflicts"
2489,NM_014946.4(SPAST):c.1209C>A (p.Phe403Leu),SPAST,hereditary spastic paraplegia,C0037773,"likely pathogenic(last reviewed: feb 5, 2020)","criteria provided, single submitter"
2490,NM_014946.4(SPAST):c.1216A>G (p.Ile406Val),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
2490,NM_014946.4(SPAST):c.1216A>G (p.Ile406Val),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
2491,NM_014946.4(SPAST):c.1219A>C (p.Ser407Arg),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2492,NM_014946.4(SPAST):c.1220G>A (p.Ser407Asn),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
2493,NM_014946.4(SPAST):c.1225G>A (p.Ala409Thr),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: aug 29, 2022)","criteria provided, multiple submitters, no conflicts"
2494,NM_014946.4(SPAST):c.1226C>A (p.Ala409Glu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
2495,NM_014946.4(SPAST):c.1226C>T (p.Ala409Val),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2496,NM_014946.4(SPAST):c.1238C>T (p.Ser413Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
2497,NM_014946.4(SPAST):c.1250G>T (p.Gly417Val),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: jun 23, 2022)","criteria provided, multiple submitters, no conflicts"
2498,NM_014946.4(SPAST):c.1250G>A (p.Gly417Glu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
2499,NM_014946.4(SPAST):c.1253A>G (p.Glu418Gly),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2500,NM_014946.4(SPAST):c.1259A>G (p.Glu420Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2501,NM_014946.4(SPAST):c.1266G>C (p.Leu422Phe),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2502,NM_014946.4(SPAST):c.1271G>C (p.Arg424Thr),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2503,NM_014946.4(SPAST):c.1276C>G (p.Leu426Val),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: sep 14, 2022)","criteria provided, multiple submitters, no conflicts"
2504,NM_014946.4(SPAST):c.1303C>A (p.Pro435Thr),SPAST,hereditary spastic paraplegia 2,C0037773,"likely pathogenic(last reviewed: aug 11, 2021)","criteria provided, single submitter"
2505,NM_014946.4(SPAST):c.1304C>T (p.Pro435Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 21, 2021)","criteria provided, single submitter"
2506,NM_014946.4(SPAST):c.1306T>C (p.Ser436Pro),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2507,NM_014946.4(SPAST):c.1307C>A (p.Ser436Tyr),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2508,NM_014946.4(SPAST):c.1322A>T (p.Asp441Val),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
2509,NM_014946.4(SPAST):c.1322A>G (p.Asp441Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 15, 2022)","criteria provided, multiple submitters, no conflicts"
2510,NM_014946.4(SPAST):c.1324G>A (p.Glu442Lys),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2511,NM_014946.4(SPAST):c.1325A>T (p.Glu442Val),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
2512,NM_014946.4(SPAST):c.1343G>A (p.Cys448Tyr),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
2513,NM_014946.4(SPAST):c.1348A>G (p.Arg450Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jun 9, 2022)","criteria provided, multiple submitters, no conflicts"
2514,NM_014946.4(SPAST):c.1360G>A (p.Glu454Lys),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: feb 22, 2022)","criteria provided, multiple submitters, no conflicts"
2515,NM_014946.4(SPAST):c.1361A>G (p.Glu454Gly),SPAST,hereditary spastic paraplegia,C0037773,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
2516,NM_014946.4(SPAST):c.1372A>C (p.Ser458Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, single submitter"
2517,NM_014946.4(SPAST):c.1378C>T (p.Arg460Cys),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic(last reviewed: feb 3, 2023)","criteria provided, multiple submitters, no conflicts"
2517,NM_014946.4(SPAST):c.1378C>T (p.Arg460Cys),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: feb 3, 2023)","criteria provided, multiple submitters, no conflicts"
2518,NM_014946.4(SPAST):c.1379G>T (p.Arg460Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: jul 22, 2022)","criteria provided, single submitter"
2519,NM_014946.4(SPAST):c.1379G>A (p.Arg460His),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
2519,NM_014946.4(SPAST):c.1379G>A (p.Arg460His),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
2520,NM_014946.4(SPAST):c.1384A>C (p.Lys462Gln),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2521,NM_014946.4(SPAST):c.1396C>G (p.Leu466Val),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2522,NM_014946.4(SPAST):c.1405T>G (p.Phe469Val),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2523,NM_014946.4(SPAST):c.1412G>A (p.Gly471Asp),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: jun 19, 2017)","criteria provided, single submitter"
2524,NM_014946.4(SPAST):c.1456A>G (p.Thr486Ala),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: jul 6, 2022)","criteria provided, multiple submitters, no conflicts"
2525,NM_014946.4(SPAST):c.1462A>G (p.Arg488Gly),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2526,NM_014946.4(SPAST):c.1466C>T (p.Pro489Leu),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2527,NM_014946.4(SPAST):c.1472A>G (p.Glu491Gly),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2528,NM_014946.4(SPAST):c.1477G>T (p.Asp493Tyr),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: apr 12, 2017)","criteria provided, single submitter"
2529,NM_014946.4(SPAST):c.1484C>T (p.Ala495Val),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, multiple submitters, no conflicts"
2530,NM_014946.4(SPAST):c.1492A>G (p.Arg498Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, multiple submitters, no conflicts"
2531,NM_014946.4(SPAST):c.1494G>C (p.Arg498Ser),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
2532,NM_014946.4(SPAST):c.1495C>T (p.Arg499Cys),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: sep 14, 2022)","criteria provided, multiple submitters, no conflicts"
2532,NM_014946.4(SPAST):c.1495C>T (p.Arg499Cys),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: sep 14, 2022)","criteria provided, multiple submitters, no conflicts"
2532,NM_014946.4(SPAST):c.1495C>T (p.Arg499Cys),SPAST,spastic paraparesis,C0037771,"pathogenic/likely pathogenic(last reviewed: sep 14, 2022)","criteria provided, multiple submitters, no conflicts"
2533,NM_014946.4(SPAST):c.1496G>T (p.Arg499Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2534,NM_014946.4(SPAST):c.1507C>T (p.Arg503Trp),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
2534,NM_014946.4(SPAST):c.1507C>T (p.Arg503Trp),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
2535,NM_014946.4(SPAST):c.1508G>A (p.Arg503Gln),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, single submitter"
2536,NM_014946.4(SPAST):c.1536G>T (p.Glu512Asp),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: jul 23, 2021)","criteria provided, multiple submitters, no conflicts"
2536,NM_014946.4(SPAST):c.1536G>T (p.Glu512Asp),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: jul 23, 2021)","criteria provided, multiple submitters, no conflicts"
2537,NM_014946.4(SPAST):c.1550T>G (p.Leu517Trp),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
2538,NM_014946.4(SPAST):c.1550T>C (p.Leu517Ser),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2539,NM_014946.4(SPAST):c.1601T>C (p.Leu534Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2540,NM_014946.4(SPAST):c.1634C>T (p.Ser545Leu),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: jan 2, 2022)","criteria provided, single submitter"
2541,NM_014946.4(SPAST):c.1636G>C (p.Gly546Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: sep 20, 2021)","criteria provided, single submitter"
2542,NM_014946.4(SPAST):c.1637G>T (p.Gly546Val),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
2543,NM_014946.4(SPAST):c.1637G>A (p.Gly546Glu),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2544,NM_014946.4(SPAST):c.1642G>C (p.Asp548His),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: may 6, 2021)","criteria provided, single submitter"
2545,NM_014946.4(SPAST):c.1646T>A (p.Leu549Gln),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
2546,NM_014946.4(SPAST):c.1646T>C (p.Leu549Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
2547,NM_014946.4(SPAST):c.1666G>A (p.Ala556Thr),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: jun 14, 2016)","criteria provided, single submitter"
2548,NM_014946.4(SPAST):c.1666G>C (p.Ala556Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: feb 27, 2022)","criteria provided, single submitter"
2549,NM_014946.4(SPAST):c.1667C>T (p.Ala556Val),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2550,NM_014946.4(SPAST):c.1670C>G (p.Ala557Gly),SPAST,spastic paraparesis,C0037771,"likely pathogenic(last reviewed: may 22, 2015)","criteria provided, single submitter"
2551,NM_014946.4(SPAST):c.1675G>C (p.Gly559Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2552,NM_014946.4(SPAST):c.1684C>G (p.Arg562Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
2553,NM_014946.4(SPAST):c.1685G>A (p.Arg562Gln),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
2553,NM_014946.4(SPAST):c.1685G>A (p.Arg562Gln),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
2554,NM_014946.4(SPAST):c.1715T>C (p.Met572Thr),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2555,NM_014946.4(SPAST):c.1730T>G (p.Met577Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, multiple submitters, no conflicts"
2556,NM_014946.4(SPAST):c.1738A>G (p.Ile580Val),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: feb 11, 2021)","criteria provided, single submitter"
2557,NM_014946.4(SPAST):c.1742G>C (p.Arg581Pro),SPAST,hereditary spastic paraplegia 4,C3711371,pathogenic,"criteria provided, single submitter"
2558,NM_014946.4(SPAST):c.1754T>C (p.Phe585Ser),SPAST,hereditary spastic paraplegia 4,C3711371,likely pathogenic,"criteria provided, single submitter"
2559,NM_014946.4(SPAST):c.1762T>C (p.Ser588Pro),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: mar 2, 2022)","criteria provided, multiple submitters, no conflicts"
2560,NM_014946.4(SPAST):c.1775T>A (p.Ile592Lys),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
2561,NM_014946.4(SPAST):c.1785C>G (p.Ser595Arg),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2562,NM_014946.4(SPAST):c.1838A>G (p.Asp613Gly),SPAST,hereditary spastic paraplegia 4,C3711371,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2563,NM_014946.4(SPAST):c.1841C>T (p.Thr614Ile),SPAST,hereditary spastic paraplegia 4,C3711371,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2563,NM_014946.4(SPAST):c.1841C>T (p.Thr614Ile),SPAST,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2564,NM_001199138.2(NLRC4):c.1328A>C (p.His443Pro),NLRC4,familial cold autoinflammatory syndrome 4,C4016985,"pathogenic(last reviewed: aug 21, 2019)","criteria provided, single submitter"
2564,NM_001199138.2(NLRC4):c.1328A>C (p.His443Pro),NLRC4,periodic fever-infantile enterocolitis-autoinflammatory syndrome,Cumapped198,"pathogenic(last reviewed: aug 21, 2019)","criteria provided, single submitter"
2565,NM_001199138.2(NLRC4):c.1022T>C (p.Val341Ala),NLRC4,periodic fever-infantile enterocolitis-autoinflammatory syndrome,Cumapped198,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2565,NM_001199138.2(NLRC4):c.1022T>C (p.Val341Ala),NLRC4,familial cold autoinflammatory syndrome 4,C4016985,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2565,NM_001199138.2(NLRC4):c.1022T>C (p.Val341Ala),NLRC4,syndrome of entercolitis and autoinflmmation caused by mutation of nlrc4 (scan4),Cumapped307,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
2566,NM_001199138.2(NLRC4):c.1021G>T (p.Val341Leu),NLRC4,periodic fever-infantile enterocolitis-autoinflammatory syndrome,Cumapped198,"pathogenic(last reviewed: feb 3, 2023)","criteria provided, single submitter"
2567,NM_001199138.2(NLRC4):c.1021G>C (p.Val341Leu),NLRC4,periodic fever-infantile enterocolitis-autoinflammatory syndrome,Cumapped198,"pathogenic(last reviewed: apr 18, 2019)","criteria provided, multiple submitters, no conflicts"
2568,NM_001199138.2(NLRC4):c.1015C>G (p.Leu339Val),NLRC4,autoinflammatory syndrome,C3890737,"likely pathogenic(last reviewed: dec 12, 2016)","criteria provided, single submitter"
2569,NM_001199138.2(NLRC4):c.1009A>T (p.Thr337Ser),NLRC4,periodic fever-infantile enterocolitis-autoinflammatory syndrome,Cumapped198,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
2569,NM_001199138.2(NLRC4):c.1009A>T (p.Thr337Ser),NLRC4,familial cold autoinflammatory syndrome 4,C4016985,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
2570,NM_001135651.3(EIF2AK2):c.388G>C (p.Gly130Arg),EIF2AK2,dystonia 33,CL1784339,"likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, single submitter"
2571,NM_001135651.3(EIF2AK2):c.388G>A (p.Gly130Arg),EIF2AK2,dystonia 33,CL1784339,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2572,NM_000104.4(CYP1B1):c.1405C>T (p.Arg469Trp),CYP1B1|LOC128772254,congenital glaucoma,C0020302,"pathogenic(last reviewed: feb 3, 2023)","criteria provided, multiple submitters, no conflicts"
2572,NM_000104.4(CYP1B1):c.1405C>T (p.Arg469Trp),CYP1B1|LOC128772254,glaucoma 3a,C1856439,"pathogenic(last reviewed: feb 3, 2023)","criteria provided, multiple submitters, no conflicts"
2572,NM_000104.4(CYP1B1):c.1405C>T (p.Arg469Trp),CYP1B1|LOC128772254,primary congenital glaucoma,C1533041,"pathogenic(last reviewed: feb 3, 2023)","criteria provided, multiple submitters, no conflicts"
2573,NM_000104.4(CYP1B1):c.1331G>A (p.Arg444Gln),CYP1B1|LOC128772254,congenital glaucoma,C0020302,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2574,NM_000104.4(CYP1B1):c.1169G>A (p.Arg390His),CYP1B1,anterior segment dysgenesis 6,C4310623,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
2575,NM_000104.4(CYP1B1):c.1168C>A (p.Arg390Ser),CYP1B1,congenital glaucoma,C0020302,"pathogenic(last reviewed: may 20, 2022)","criteria provided, single submitter"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,congenital glaucoma,C0020302,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,anterior segment dysgenesis 6,C4310623,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,glaucoma 3a,C1856439,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,"glaucoma 3, primary infantile, b",C1415096,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,glaucoma of childhood,C2981140,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,glaucoma 3a,C1856439,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2576,NM_000104.4(CYP1B1):c.1159G>A (p.Glu387Lys),CYP1B1,primary congenital glaucoma,C1533041,"pathogenic/likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
2577,NM_000104.4(CYP1B1):c.1090G>A (p.Val364Met),CYP1B1,primary congenital glaucoma,C1533041,"pathogenic(last reviewed: jun 9, 2022)","criteria provided, multiple submitters, no conflicts"
2577,NM_000104.4(CYP1B1):c.1090G>A (p.Val364Met),CYP1B1,congenital glaucoma,C0020302,"pathogenic(last reviewed: jun 9, 2022)","criteria provided, multiple submitters, no conflicts"
2578,NM_000104.4(CYP1B1):c.717C>A (p.Ser239Arg),CYP1B1,anterior segment dysgenesis,C3552341,"likely pathogenic(last reviewed: jun 11, 2020)","criteria provided, single submitter"
2579,NM_000104.4(CYP1B1):c.710C>A (p.Ala237Glu),CYP1B1,glaucoma 3a,C1856439,"likely pathogenic(last reviewed: jan 19, 2022)","criteria provided, single submitter"
2580,NM_000104.4(CYP1B1):c.578C>T (p.Pro193Leu),CYP1B1,primary congenital glaucoma,C1533041,"likely pathogenic(last reviewed: jul 6, 2021)","criteria provided, multiple submitters, no conflicts"
2580,NM_000104.4(CYP1B1):c.578C>T (p.Pro193Leu),CYP1B1,glaucoma 3a,C1856439,"likely pathogenic(last reviewed: jul 6, 2021)","criteria provided, multiple submitters, no conflicts"
2580,NM_000104.4(CYP1B1):c.578C>T (p.Pro193Leu),CYP1B1,"glaucoma 3, primary infantile, b",C1415096,"likely pathogenic(last reviewed: jul 6, 2021)","criteria provided, multiple submitters, no conflicts"
2580,NM_000104.4(CYP1B1):c.578C>T (p.Pro193Leu),CYP1B1,anterior segment dysgenesis 6,C4310623,"likely pathogenic(last reviewed: jul 6, 2021)","criteria provided, multiple submitters, no conflicts"
2581,NM_000104.4(CYP1B1):c.517G>A (p.Glu173Lys),CYP1B1,primary congenital glaucoma,C1533041,"pathogenic(last reviewed: feb 21, 2020)","criteria provided, single submitter"
2582,NM_000104.4(CYP1B1):c.350G>T (p.Arg117Leu),CYP1B1,congenital glaucoma,C0020302,"pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
2583,NM_000104.4(CYP1B1):c.349C>T (p.Arg117Trp),CYP1B1,glaucoma 3a,C1856439,likely pathogenic,"criteria provided, single submitter"
2584,NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu),CYP1B1,anterior segment dysgenesis 6,C4310623,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
2584,NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu),CYP1B1,congenital glaucoma,C0020302,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
2584,NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu),CYP1B1,glaucoma 3a,C1856439,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
2584,NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu),CYP1B1,"glaucoma 3, primary infantile, b",C1415096,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
2584,NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu),CYP1B1,anterior segment dysgenesis 6,C4310623,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
2584,NM_000104.4(CYP1B1):c.182G>A (p.Gly61Glu),CYP1B1,glaucoma 3a,C1856439,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, multiple submitters, no conflicts"
2585,NM_000104.4(CYP1B1):c.181G>A (p.Gly61Arg),CYP1B1,anterior segment dysgenesis 6,C4310623,"pathogenic(last reviewed: jun 8, 2020)","criteria provided, single submitter"
2586,NM_000104.4(CYP1B1):c.2T>C (p.Met1Thr),CYP1B1,primary congenital glaucoma,C1533041,"likely pathogenic(last reviewed: feb 16, 2023)","criteria provided, single submitter"
2587,NM_000104.4(CYP1B1):c.1A>G (p.Met1Val),CYP1B1,primary congenital glaucoma,C1533041,"pathogenic/likely pathogenic(last reviewed: dec 28, 2022)","criteria provided, multiple submitters, no conflicts"
2588,NM_005633.4(SOS1):c.3022T>C (p.Tyr1008His),SOS1,noonan syndrome,C0028326,"likely pathogenic(last reviewed: mar 1, 2008)","criteria provided, single submitter"
2589,NM_005633.4(SOS1):c.2536G>A (p.Glu846Lys),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 3, 2017)",reviewed by expert panel
2590,NM_005633.4(SOS1):c.2207T>G (p.Ile736Arg),SOS1,"fibromatosis, gingival, 1",C4551558,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
2591,NM_005633.4(SOS1):c.2197A>T (p.Ile733Phe),SOS1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2591,NM_005633.4(SOS1):c.2197A>T (p.Ile733Phe),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2591,NM_005633.4(SOS1):c.2197A>T (p.Ile733Phe),SOS1,noonan syndrome 3,C1860991,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2592,NM_005633.4(SOS1):c.2183A>C (p.Lys728Thr),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: aug 14, 2021)","criteria provided, single submitter"
2593,NM_005633.4(SOS1):c.2183A>T (p.Lys728Ile),SOS1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
2593,NM_005633.4(SOS1):c.2183A>T (p.Lys728Ile),SOS1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
2593,NM_005633.4(SOS1):c.2183A>T (p.Lys728Ile),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
2594,NM_005633.4(SOS1):c.2104T>C (p.Tyr702His),SOS1,"fibromatosis, gingival, 1",C4551558,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
2594,NM_005633.4(SOS1):c.2104T>C (p.Tyr702His),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
2594,NM_005633.4(SOS1):c.2104T>C (p.Tyr702His),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
2594,NM_005633.4(SOS1):c.2104T>C (p.Tyr702His),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
2595,NM_005633.4(SOS1):c.1867T>A (p.Phe623Ile),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"likely pathogenic(last reviewed: feb 28, 2019)",reviewed by expert panel
2596,NM_005633.4(SOS1):c.1656G>T (p.Arg552Ser),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: may 10, 2019)",reviewed by expert panel
2597,NM_005633.4(SOS1):c.1656G>C (p.Arg552Ser),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: may 10, 2019)",reviewed by expert panel
2598,NM_005633.4(SOS1):c.1655G>A (p.Arg552Lys),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: may 10, 2019)",reviewed by expert panel
2599,NM_005633.4(SOS1):c.1655G>C (p.Arg552Thr),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: may 10, 2019)",reviewed by expert panel
2600,NM_005633.4(SOS1):c.1655G>T (p.Arg552Met),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"likely pathogenic(last reviewed: may 10, 2019)",reviewed by expert panel
2601,NM_005633.4(SOS1):c.1654A>T (p.Arg552Trp),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"likely pathogenic(last reviewed: may 10, 2019)",reviewed by expert panel
2602,NM_005633.4(SOS1):c.1654A>G (p.Arg552Gly),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 3, 2017)",reviewed by expert panel
2603,NM_005633.4(SOS1):c.1649T>C (p.Leu550Pro),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2603,NM_005633.4(SOS1):c.1649T>C (p.Leu550Pro),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2604,NM_005633.4(SOS1):c.1644T>A (p.Ser548Arg),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: jun 8, 2022)","criteria provided, multiple submitters, no conflicts"
2604,NM_005633.4(SOS1):c.1644T>A (p.Ser548Arg),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: jun 8, 2022)","criteria provided, multiple submitters, no conflicts"
2605,NM_005633.4(SOS1):c.1642A>C (p.Ser548Arg),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 3, 2017)",reviewed by expert panel
2606,NM_005633.4(SOS1):c.1322G>A (p.Cys441Tyr),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
2606,NM_005633.4(SOS1):c.1322G>A (p.Cys441Tyr),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
2606,NM_005633.4(SOS1):c.1322G>A (p.Cys441Tyr),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: jan 17, 2023)","criteria provided, multiple submitters, no conflicts"
2607,NM_005633.4(SOS1):c.1310T>A (p.Ile437Asn),SOS1,cardiovascular phenotype,C0007222,"likely pathogenic(last reviewed: oct 18, 2021)","criteria provided, multiple submitters, no conflicts"
2607,NM_005633.4(SOS1):c.1310T>A (p.Ile437Asn),SOS1,noonan syndrome 4,C1853120,"likely pathogenic(last reviewed: oct 18, 2021)","criteria provided, multiple submitters, no conflicts"
2607,NM_005633.4(SOS1):c.1310T>A (p.Ile437Asn),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: oct 18, 2021)","criteria provided, multiple submitters, no conflicts"
2608,NM_005633.4(SOS1):c.1310T>G (p.Ile437Ser),SOS1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
2608,NM_005633.4(SOS1):c.1310T>G (p.Ile437Ser),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
2609,NM_005633.4(SOS1):c.1310T>C (p.Ile437Thr),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2609,NM_005633.4(SOS1):c.1310T>C (p.Ile437Thr),SOS1,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2609,NM_005633.4(SOS1):c.1310T>C (p.Ile437Thr),SOS1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2609,NM_005633.4(SOS1):c.1310T>C (p.Ile437Thr),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2609,NM_005633.4(SOS1):c.1310T>C (p.Ile437Thr),SOS1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,pulmonic stenosis,C0034089,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,ptosis,C0033377,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,abnormal sternum morphology,C1860493,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,short stature,C2919142,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,fetal cystic hygroma,C0948242,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,"fibromatosis, gingival, 1",C4551558,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,noonan syndrome 1,C4551602,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2610,NM_005633.4(SOS1):c.1300G>A (p.Gly434Arg),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2611,NM_005633.4(SOS1):c.1300G>C (p.Gly434Arg),SOS1,not specified,Cumapped182,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2611,NM_005633.4(SOS1):c.1300G>C (p.Gly434Arg),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2611,NM_005633.4(SOS1):c.1300G>C (p.Gly434Arg),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2612,NM_005633.4(SOS1):c.1297G>A (p.Glu433Lys),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: mar 20, 2023)","criteria provided, multiple submitters, no conflicts"
2612,NM_005633.4(SOS1):c.1297G>A (p.Glu433Lys),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: mar 20, 2023)","criteria provided, multiple submitters, no conflicts"
2612,NM_005633.4(SOS1):c.1297G>A (p.Glu433Lys),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: mar 20, 2023)","criteria provided, multiple submitters, no conflicts"
2612,NM_005633.4(SOS1):c.1297G>A (p.Glu433Lys),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: mar 20, 2023)","criteria provided, multiple submitters, no conflicts"
2613,NM_005633.4(SOS1):c.1294T>C (p.Trp432Arg),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
2613,NM_005633.4(SOS1):c.1294T>C (p.Trp432Arg),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
2613,NM_005633.4(SOS1):c.1294T>C (p.Trp432Arg),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: apr 18, 2022)","criteria provided, multiple submitters, no conflicts"
2614,NM_005633.4(SOS1):c.1132A>G (p.Thr378Ala),SOS1,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2614,NM_005633.4(SOS1):c.1132A>G (p.Thr378Ala),SOS1,rasopathy,CL1662414,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2614,NM_005633.4(SOS1):c.1132A>G (p.Thr378Ala),SOS1,noonan syndrome,C0028326,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2614,NM_005633.4(SOS1):c.1132A>G (p.Thr378Ala),SOS1,noonan syndrome 4,C1853120,"pathogenic/likely pathogenic(last reviewed: jul 9, 2022)","criteria provided, multiple submitters, no conflicts"
2615,NM_005633.4(SOS1):c.1009T>C (p.Tyr337His),SOS1,noonan syndrome 4,C1853120,likely pathogenic,"criteria provided, single submitter"
2616,NM_005633.4(SOS1):c.925G>A (p.Asp309Asn),SOS1,noonan syndrome 4,C1853120,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
2617,NM_005633.4(SOS1):c.925G>T (p.Asp309Tyr),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2617,NM_005633.4(SOS1):c.925G>T (p.Asp309Tyr),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2617,NM_005633.4(SOS1):c.925G>T (p.Asp309Tyr),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2617,NM_005633.4(SOS1):c.925G>T (p.Asp309Tyr),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
2618,NM_005633.4(SOS1):c.844T>C (p.Cys282Arg),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: sep 24, 2019)",reviewed by expert panel
2619,NM_005633.4(SOS1):c.806T>C (p.Met269Thr),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 3, 2017)",reviewed by expert panel
2620,NM_005633.4(SOS1):c.806T>G (p.Met269Arg),SOS1,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: sep 24, 2022)","criteria provided, multiple submitters, no conflicts"
2620,NM_005633.4(SOS1):c.806T>G (p.Met269Arg),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: sep 24, 2022)","criteria provided, multiple submitters, no conflicts"
2620,NM_005633.4(SOS1):c.806T>G (p.Met269Arg),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: sep 24, 2022)","criteria provided, multiple submitters, no conflicts"
2620,NM_005633.4(SOS1):c.806T>G (p.Met269Arg),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: sep 24, 2022)","criteria provided, multiple submitters, no conflicts"
2620,NM_005633.4(SOS1):c.806T>G (p.Met269Arg),SOS1,noonan syndrome 1,C4551602,"pathogenic(last reviewed: sep 24, 2022)","criteria provided, multiple submitters, no conflicts"
2621,NM_005633.4(SOS1):c.805A>G (p.Met269Val),SOS1,noonan syndrome 4,C1853120,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
2622,NM_005633.4(SOS1):c.797C>G (p.Thr266Arg),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: nov 24, 2021)","criteria provided, single submitter"
2623,NM_005633.4(SOS1):c.797C>A (p.Thr266Lys),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
2623,NM_005633.4(SOS1):c.797C>A (p.Thr266Lys),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
2623,NM_005633.4(SOS1):c.797C>A (p.Thr266Lys),SOS1,"fibromatosis, gingival, 1",C4551558,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
2623,NM_005633.4(SOS1):c.797C>A (p.Thr266Lys),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
2623,NM_005633.4(SOS1):c.797C>A (p.Thr266Lys),SOS1,noonan syndrome 4,C1853120,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
2624,NM_005633.4(SOS1):c.796A>C (p.Thr266Pro),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, single submitter"
2625,NM_005633.4(SOS1):c.512T>C (p.Val171Ala),SOS1,noonan syndrome and noonan-related syndrome,Cumapped100,"likely pathogenic(last reviewed: feb 28, 2019)",reviewed by expert panel
2626,NM_005633.4(SOS1):c.508A>G (p.Lys170Glu),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 3, 2017)",reviewed by expert panel
2627,NM_005633.4(SOS1):c.445G>A (p.Val149Ile),SOS1,noonan syndrome 4,C1853120,"likely pathogenic(last reviewed: dec 2, 2022)","criteria provided, single submitter"
2628,NM_005633.4(SOS1):c.406T>C (p.Tyr136His),SOS1,"46,xy partial gonadal dysgenesis",C4510744,"likely pathogenic(last reviewed: aug 1, 2020)","criteria provided, single submitter"
2629,NM_005633.4(SOS1):c.335C>G (p.Pro112Arg),SOS1,noonan syndrome,C0028326,"likely pathogenic(last reviewed: mar 1, 2008)","criteria provided, single submitter"
2630,NM_005633.4(SOS1):c.322G>A (p.Glu108Lys),SOS1,noonan syndrome,C0028326,"pathogenic(last reviewed: apr 3, 2017)",reviewed by expert panel
2631,NM_005633.4(SOS1):c.305C>G (p.Pro102Arg),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
2631,NM_005633.4(SOS1):c.305C>G (p.Pro102Arg),SOS1,noonan syndrome 4,C1853120,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
2632,NM_005633.4(SOS1):c.255G>C (p.Trp85Cys),SOS1,rasopathy,CL1662414,"likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
2633,NM_005633.4(SOS1):c.253T>C (p.Trp85Arg),SOS1,rasopathy,CL1662414,"pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
2634,NM_022436.3(ABCG5):c.1311C>G (p.Asn437Lys),ABCG5|DYNC2LI1,sitosterolemia,C0342907,"likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, single submitter"
2635,NM_022436.3(ABCG5):c.1166G>A (p.Arg389His),ABCG5|DYNC2LI1,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
2635,NM_022436.3(ABCG5):c.1166G>A (p.Arg389His),ABCG5|DYNC2LI1,sitosterolemia 2,C5231453,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
2635,NM_022436.3(ABCG5):c.1166G>A (p.Arg389His),ABCG5|DYNC2LI1,sitosterolemia,C0342907,"pathogenic/likely pathogenic(last reviewed: sep 25, 2022)","criteria provided, multiple submitters, no conflicts"
2636,NM_022437.3(ABCG8):c.2T>C (p.Met1Thr),ABCG5|ABCG8,sitosterolemia 1,C5231390,"likely pathogenic(last reviewed: oct 12, 2021)","criteria provided, multiple submitters, no conflicts"
2637,NM_022437.3(ABCG8):c.3G>T (p.Met1Ile),ABCG5|ABCG8,early-onset coronary artery disease,C4229399,"likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, single submitter"
2638,NM_022437.3(ABCG8):c.1720G>A (p.Gly574Arg),ABCG8,cardiovascular phenotype,C0007222,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
2638,NM_022437.3(ABCG8):c.1720G>A (p.Gly574Arg),ABCG8,sitosterolemia 1,C5231390,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
2638,NM_022437.3(ABCG8):c.1720G>A (p.Gly574Arg),ABCG8,sitosterolemia,C0342907,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
2639,NM_133259.4(LRPPRC):c.1061C>T (p.Ala354Val),LRPPRC,"congenital lactic acidosis, saguenay-lac-saint-jean type",C1857355,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
2640,NM_133259.4(LRPPRC):c.3G>A (p.Met1Ile),LRPPRC,"congenital lactic acidosis, saguenay-lac-saint-jean type",C1857355,"likely pathogenic(last reviewed: apr 3, 2018)","criteria provided, single submitter"
2641,NM_133259.4(LRPPRC):c.2T>A (p.Met1Lys),LRPPRC,"congenital lactic acidosis, saguenay-lac-saint-jean type",C1857355,"likely pathogenic(last reviewed: feb 21, 2018)","criteria provided, single submitter"
2642,NM_000341.4(SLC3A1):c.266T>C (p.Leu89Pro),SLC3A1,cystinuria,C0010691,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
2643,NM_000341.4(SLC3A1):c.638C>G (p.Pro213Arg),SLC3A1,cystinuria,C0010691,"pathogenic(last reviewed: jan 11, 2022)","criteria provided, single submitter"
2644,NM_000341.4(SLC3A1):c.647C>T (p.Thr216Met),SLC3A1,cystinuria,C0010691,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
2645,NM_000341.4(SLC3A1):c.1093C>T (p.Arg365Trp),SLC3A1,cystinuria,C0010691,"pathogenic/likely pathogenic(last reviewed: may 22, 2022)","criteria provided, multiple submitters, no conflicts"
2646,NM_000341.4(SLC3A1):c.1094G>T (p.Arg365Leu),SLC3A1,cystinuria,C0010691,"pathogenic/likely pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
2647,NM_000341.4(SLC3A1):c.1094G>A (p.Arg365Gln),SLC3A1,cystinuria,C0010691,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
2648,NM_000341.4(SLC3A1):c.1230C>A (p.Asn410Lys),SLC3A1,cystinuria,C0010691,"likely pathogenic(last reviewed: aug 1, 2019)","criteria provided, single submitter"
2649,NM_000341.4(SLC3A1):c.1320G>T (p.Trp440Cys),SLC3A1,cystinuria,C0010691,"likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, single submitter"
2650,NM_000341.4(SLC3A1):c.1354C>T (p.Arg452Trp),SLC3A1,cystinuria,C0010691,"pathogenic(last reviewed: jan 17, 2022)","criteria provided, multiple submitters, no conflicts"
2651,NM_000341.4(SLC3A1):c.1400T>C (p.Met467Thr),SLC3A1,cystinuria,C0010691,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
2651,NM_000341.4(SLC3A1):c.1400T>C (p.Met467Thr),SLC3A1,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
2652,NM_000341.4(SLC3A1):c.1744T>C (p.Tyr582His),PREPL|SLC3A1,cystinuria,C0010691,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2653,NM_001171613.2(PREPL):c.1827G>T (p.Lys609Asn),SLC3A1|PREPL,"myasthenic syndrome, congenital, 22",C4479088,"likely pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
2654,NM_005413.4(SIX3):c.339G>T (p.Trp113Cys),SIX3,not specified,Cumapped182,"pathogenic(last reviewed: jan 6, 2017)","criteria provided, single submitter"
2655,NM_005413.4(SIX3):c.581G>C (p.Arg194Pro),SIX3,holoprosencephaly 2,C1834877,"likely pathogenic(last reviewed: feb 22, 2019)","criteria provided, single submitter"
2656,NM_005413.4(SIX3):c.749T>C (p.Val250Ala),SIX3,holoprosencephaly 2,C1834877,"pathogenic(last reviewed: may 20, 2021)","criteria provided, single submitter"
2657,NM_005413.4(SIX3):c.770G>C (p.Arg257Pro),SIX3,holoprosencephaly 2,C1834877,"likely pathogenic(last reviewed: aug 2, 2019)","criteria provided, single submitter"
2658,NM_001430.5(EPAS1):c.1604T>C (p.Met535Thr),EPAS1,"erythrocytosis, familial, 4",C2673187,"pathogenic(last reviewed: may 6, 2021)","criteria provided, single submitter"
2659,NM_001430.5(EPAS1):c.1609G>A (p.Gly537Arg),EPAS1,"erythrocytosis, familial, 4",C2673187,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2660,NM_014171.6(CRIPT):c.8G>A (p.Cys3Tyr),CRIPT,short stature with microcephaly and distinctive facies,C4014339,"likely pathogenic(last reviewed: dec 23, 2015)","criteria provided, single submitter"
2661,NM_001743.6(CALM2):c.434T>G (p.Met145Arg),CALM2,long qt syndrome 1,C4551647,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2662,NM_001743.6(CALM2):c.423G>C (p.Glu141Asp),CALM2,long qt syndrome 1,C4551647,"likely pathogenic(last reviewed: oct 3, 2022)","criteria provided, single submitter"
2663,NM_001743.6(CALM2):c.414C>G (p.Asn138Lys),CALM2,long qt syndrome 15,C4015695,"pathogenic(last reviewed: oct 30, 2017)","criteria provided, single submitter"
2664,NM_001743.6(CALM2):c.397G>A (p.Gly133Ser),CALM2,long qt syndrome 1,C4551647,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
2665,NM_001743.6(CALM2):c.396T>G (p.Asp132Glu),CALM2,long qt syndrome 15,C4015695,"pathogenic(last reviewed: aug 20, 2018)","criteria provided, single submitter"
2666,NM_001743.6(CALM2):c.395A>G (p.Asp132Gly),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
2667,NM_001743.6(CALM2):c.394G>T (p.Asp132Tyr),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
2668,NM_001743.6(CALM2):c.389A>G (p.Asp130Gly),CALM2,long qt syndrome 1,C4551647,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2669,NM_001743.6(CALM2):c.388G>A (p.Asp130Asn),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
2670,NM_001743.6(CALM2):c.293A>T (p.Asn98Ile),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
2671,NM_001743.6(CALM2):c.293A>G (p.Asn98Ser),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
2672,NM_001743.6(CALM2):c.287A>T (p.Asp96Val),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: nov 26, 2021)","criteria provided, multiple submitters, no conflicts"
2673,NM_001743.6(CALM2):c.286G>T (p.Asp96Tyr),CALM2,long qt syndrome 1,C4551647,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2674,NM_000251.3(MSH2):c.211G>T (p.Gly71Ter),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: mar 24, 2020)","criteria provided, single submitter"
2675,NM_000251.3(MSH2):c.211G>C (p.Gly71Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: jan 5, 2022)","criteria provided, multiple submitters, no conflicts"
2675,NM_000251.3(MSH2):c.211G>C (p.Gly71Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 5, 2022)","criteria provided, multiple submitters, no conflicts"
2675,NM_000251.3(MSH2):c.211G>C (p.Gly71Arg),MSH2,lynch syndrome,C4552100,"pathogenic/likely pathogenic(last reviewed: jan 5, 2022)","criteria provided, multiple submitters, no conflicts"
2676,NM_000251.3(MSH2):c.277C>T (p.Leu93Phe),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2677,NM_000251.3(MSH2):c.445G>C (p.Gly149Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 21, 2022)","criteria provided, single submitter"
2678,NM_000251.3(MSH2):c.482T>A (p.Val161Asp),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2679,NM_000251.3(MSH2):c.484G>A (p.Gly162Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2680,NM_000251.3(MSH2):c.488T>G (p.Val163Gly),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: mar 18, 2015)",reviewed by expert panel
2681,NM_000251.3(MSH2):c.488T>A (p.Val163Asp),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2682,NM_000251.3(MSH2):c.490G>C (p.Gly164Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 19, 2018)","criteria provided, single submitter"
2683,NM_000251.3(MSH2):c.490G>T (p.Gly164Trp),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
2683,NM_000251.3(MSH2):c.490G>T (p.Gly164Trp),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
2684,NM_000251.3(MSH2):c.490G>A (p.Gly164Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2685,NM_000251.3(MSH2):c.491G>A (p.Gly164Glu),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: nov 22, 2018)",reviewed by expert panel
2686,NM_000251.3(MSH2):c.493T>G (p.Tyr165Asp),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2687,NM_000251.3(MSH2):c.518T>G (p.Leu173Arg),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2688,NM_000251.3(MSH2):c.518T>C (p.Leu173Pro),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
2688,NM_000251.3(MSH2):c.518T>C (p.Leu173Pro),MSH2,hereditary nonpolyposis colon cancer,C1333990,"likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
2688,NM_000251.3(MSH2):c.518T>C (p.Leu173Pro),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
2689,NM_000251.3(MSH2):c.560T>G (p.Leu187Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2690,NM_000251.3(MSH2):c.560T>C (p.Leu187Pro),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2691,NM_000251.3(MSH2):c.572T>G (p.Leu191Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 1, 2022)","criteria provided, single submitter"
2692,NM_000251.3(MSH2):c.595T>C (p.Cys199Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2693,NM_000251.3(MSH2):c.597T>G (p.Cys199Trp),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: may 30, 2019)","criteria provided, single submitter"
2694,NM_000251.3(MSH2):c.599T>A (p.Val200Asp),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: oct 10, 2014)",reviewed by expert panel
2695,NM_000251.3(MSH2):c.929T>G (p.Leu310Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
2695,NM_000251.3(MSH2):c.929T>G (p.Leu310Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
2695,NM_000251.3(MSH2):c.929T>G (p.Leu310Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
2696,NM_000251.3(MSH2):c.929T>C (p.Leu310Pro),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2697,NM_000251.3(MSH2):c.942G>T (p.Gln314His),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 12, 2018)","criteria provided, single submitter"
2698,NM_000251.3(MSH2):c.989T>C (p.Leu330Pro),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2699,NM_000251.3(MSH2):c.997T>C (p.Cys333Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
2699,NM_000251.3(MSH2):c.997T>C (p.Cys333Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
2700,NM_000251.3(MSH2):c.998G>T (p.Cys333Phe),MSH2,lynch syndrome 1,C2936783,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
2700,NM_000251.3(MSH2):c.998G>T (p.Cys333Phe),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
2700,NM_000251.3(MSH2):c.998G>T (p.Cys333Phe),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
2701,NM_000251.3(MSH2):c.998G>A (p.Cys333Tyr),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: nov 3, 2016)",reviewed by expert panel
2702,NM_000251.3(MSH2):c.999T>G (p.Cys333Trp),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: mar 11, 2020)","criteria provided, multiple submitters, no conflicts"
2703,NM_000251.3(MSH2):c.1012G>C (p.Gly338Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, multiple submitters, no conflicts"
2703,NM_000251.3(MSH2):c.1012G>C (p.Gly338Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, multiple submitters, no conflicts"
2704,NM_000251.3(MSH2):c.1012G>A (p.Gly338Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
2704,NM_000251.3(MSH2):c.1012G>A (p.Gly338Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
2705,NM_000251.3(MSH2):c.1013G>A (p.Gly338Glu),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2706,NM_000251.3(MSH2):c.1022T>C (p.Leu341Pro),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2707,NM_000251.3(MSH2):c.1046C>T (p.Pro349Leu),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2708,NM_000251.3(MSH2):c.1046C>G (p.Pro349Arg),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: oct 10, 2014)",reviewed by expert panel
2709,NM_000251.3(MSH2):c.1067T>G (p.Ile356Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: apr 29, 2022)","criteria provided, single submitter"
2710,NM_000251.3(MSH2):c.1075A>G (p.Arg359Gly),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 4, 2020)","criteria provided, single submitter"
2711,NM_000251.3(MSH2):c.1076G>T (p.Arg359Ile),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 10, 2022)","criteria provided, multiple submitters, no conflicts"
2711,NM_000251.3(MSH2):c.1076G>T (p.Arg359Ile),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: jul 10, 2022)","criteria provided, multiple submitters, no conflicts"
2712,NM_000251.3(MSH2):c.1077A>T (p.Arg359Ser),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2713,NM_000251.3(MSH2):c.1241T>C (p.Leu414Pro),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
2714,NM_000251.3(MSH2):c.1276G>C (p.Gly426Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 24, 2019)","criteria provided, single submitter"
2715,NM_000251.3(MSH2):c.1319T>G (p.Leu440Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
2716,NM_000251.3(MSH2):c.1319T>C (p.Leu440Pro),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2717,NM_000251.3(MSH2):c.1355A>T (p.Glu452Val),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: feb 19, 2021)","criteria provided, single submitter"
2718,NM_000251.3(MSH2):c.1358T>A (p.Met453Lys),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2719,NM_000251.3(MSH2):c.1361T>A (p.Ile454Lys),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, single submitter"
2720,NM_000251.3(MSH2):c.1433T>G (p.Leu478Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 1, 2022)","criteria provided, single submitter"
2721,NM_000251.3(MSH2):c.1568T>C (p.Phe523Ser),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 2, 2021)","criteria provided, single submitter"
2722,NM_000251.3(MSH2):c.1571G>C (p.Arg524Pro),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2723,NM_000251.3(MSH2):c.1660A>T (p.Ser554Cys),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2724,NM_000251.3(MSH2):c.1660A>G (p.Ser554Gly),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2725,NM_000251.3(MSH2):c.1661G>T (p.Ser554Ile),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 19, 2018)","criteria provided, single submitter"
2726,NM_000251.3(MSH2):c.1661G>A (p.Ser554Asn),MSH2,lynch syndrome 1,C2936783,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
2726,NM_000251.3(MSH2):c.1661G>A (p.Ser554Asn),MSH2,mismatch repair cancer syndrome 2,CL1660719,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
2726,NM_000251.3(MSH2):c.1661G>A (p.Ser554Asn),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
2726,NM_000251.3(MSH2):c.1661G>A (p.Ser554Asn),MSH2,lynch syndrome 1,C2936783,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
2726,NM_000251.3(MSH2):c.1661G>A (p.Ser554Asn),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
2727,NM_000251.3(MSH2):c.1661G>C (p.Ser554Thr),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2728,NM_000251.3(MSH2):c.1667T>G (p.Leu556Trp),MSH2,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2729,NM_000251.3(MSH2):c.1667T>C (p.Leu556Ser),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: oct 25, 2021)","criteria provided, multiple submitters, no conflicts"
2729,NM_000251.3(MSH2):c.1667T>C (p.Leu556Ser),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 25, 2021)","criteria provided, multiple submitters, no conflicts"
2730,NM_000251.3(MSH2):c.1759G>A (p.Gly587Ser),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
2730,NM_000251.3(MSH2):c.1759G>A (p.Gly587Ser),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
2731,NM_000251.3(MSH2):c.1759G>T (p.Gly587Cys),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 24, 2019)","criteria provided, single submitter"
2732,NM_000251.3(MSH2):c.1759G>C (p.Gly587Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2733,NM_000251.3(MSH2):c.1784T>G (p.Leu595Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic(last reviewed: feb 18, 2022)","criteria provided, multiple submitters, no conflicts"
2733,NM_000251.3(MSH2):c.1784T>G (p.Leu595Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: feb 18, 2022)","criteria provided, multiple submitters, no conflicts"
2734,NM_000251.3(MSH2):c.1799C>A (p.Ala600Asp),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: apr 12, 2021)","criteria provided, single submitter"
2735,NM_000251.3(MSH2):c.1799C>T (p.Ala600Val),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
2735,NM_000251.3(MSH2):c.1799C>T (p.Ala600Val),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
2736,NM_000251.3(MSH2):c.1807G>T (p.Asp603Tyr),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jul 26, 2018)","criteria provided, single submitter"
2737,NM_000251.3(MSH2):c.1808A>G (p.Asp603Gly),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2738,NM_000251.3(MSH2):c.1829A>C (p.His610Pro),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: feb 3, 2021)","criteria provided, single submitter"
2739,NM_000251.3(MSH2):c.1832T>A (p.Val611Glu),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: feb 7, 2018)","criteria provided, single submitter"
2740,NM_000251.3(MSH2):c.1864C>A (p.Pro622Thr),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, multiple submitters, no conflicts"
2740,NM_000251.3(MSH2):c.1864C>A (p.Pro622Thr),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, multiple submitters, no conflicts"
2741,NM_000251.3(MSH2):c.1865C>T (p.Pro622Leu),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2742,NM_000251.3(MSH2):c.1906G>C (p.Ala636Pro),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2743,NM_000251.3(MSH2):c.1915C>T (p.His639Tyr),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2744,NM_000251.3(MSH2):c.1955C>A (p.Pro652His),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2745,NM_000251.3(MSH2):c.1979A>G (p.Asp660Gly),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2746,NM_000251.3(MSH2):c.2006G>T (p.Gly669Val),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2747,NM_000251.3(MSH2):c.2011A>T (p.Asn671Tyr),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 10, 2021)","criteria provided, single submitter"
2748,NM_000251.3(MSH2):c.2020G>A (p.Gly674Ser),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2748,NM_000251.3(MSH2):c.2020G>A (p.Gly674Ser),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
2749,NM_000251.3(MSH2):c.2020G>C (p.Gly674Arg),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2750,NM_000251.3(MSH2):c.2021G>T (p.Gly674Val),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 24, 2021)","criteria provided, single submitter"
2751,NM_000251.3(MSH2):c.2021G>A (p.Gly674Asp),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2752,NM_000251.3(MSH2):c.2026T>C (p.Ser676Pro),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 25, 2018)","criteria provided, single submitter"
2753,NM_000251.3(MSH2):c.2039G>C (p.Arg680Pro),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: may 23, 2022)","criteria provided, multiple submitters, no conflicts"
2753,NM_000251.3(MSH2):c.2039G>C (p.Arg680Pro),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: may 23, 2022)","criteria provided, multiple submitters, no conflicts"
2754,NM_000251.3(MSH2):c.2047G>A (p.Gly683Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2755,NM_000251.3(MSH2):c.2054T>G (p.Ile685Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
2755,NM_000251.3(MSH2):c.2054T>G (p.Ile685Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
2756,NM_000251.3(MSH2):c.2063T>G (p.Met688Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2757,NM_000251.3(MSH2):c.2074G>A (p.Gly692Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: jan 7, 2022)","criteria provided, multiple submitters, no conflicts"
2757,NM_000251.3(MSH2):c.2074G>A (p.Gly692Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jan 7, 2022)","criteria provided, multiple submitters, no conflicts"
2758,NM_000251.3(MSH2):c.2074G>C (p.Gly692Arg),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2759,NM_000251.3(MSH2):c.2075G>T (p.Gly692Val),MSH2,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2760,NM_000251.3(MSH2):c.2081T>C (p.Phe694Ser),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: sep 21, 2021)","criteria provided, single submitter"
2761,NM_000251.3(MSH2):c.2083G>A (p.Val695Met),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: oct 18, 2018)",reviewed by expert panel
2762,NM_000251.3(MSH2):c.2087C>T (p.Pro696Leu),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2763,NM_000251.3(MSH2):c.2089T>C (p.Cys697Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2764,NM_000251.3(MSH2):c.2090G>C (p.Cys697Ser),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: jul 17, 2022)","criteria provided, single submitter"
2765,NM_000251.3(MSH2):c.2090G>A (p.Cys697Tyr),MSH2,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2766,NM_000251.3(MSH2):c.2090G>T (p.Cys697Phe),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2767,NM_000251.3(MSH2):c.2099C>A (p.Ala700Glu),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
2768,NM_000251.3(MSH2):c.2210G>A (p.Arg737Lys),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
2769,NM_000251.3(MSH2):c.2242G>T (p.Asp748Tyr),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
2770,NM_000251.3(MSH2):c.2245G>A (p.Glu749Lys),MSH2,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2771,NM_000251.3(MSH2):c.2251G>C (p.Gly751Arg),MSH2,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: jun 13, 2018)",reviewed by expert panel
2772,NM_000251.3(MSH2):c.2251G>A (p.Gly751Arg),MSH2,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2773,NM_000251.3(MSH2):c.2281G>A (p.Gly761Arg),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
2773,NM_000251.3(MSH2):c.2281G>A (p.Gly761Arg),MSH2,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
2774,NM_000251.3(MSH2):c.2287G>C (p.Ala763Pro),MSH2,lynch syndrome 1,C2936783,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2775,NM_000251.3(MSH2):c.2320A>G (p.Ile774Val),MSH2,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2775,NM_000251.3(MSH2):c.2320A>G (p.Ile774Val),MSH2,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2776,NM_000179.3(MSH6):c.1A>G (p.Met1Val),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, multiple submitters, no conflicts"
2776,NM_000179.3(MSH6):c.1A>G (p.Met1Val),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, multiple submitters, no conflicts"
2777,NM_000179.3(MSH6):c.2T>C (p.Met1Thr),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: apr 2, 2022)","criteria provided, single submitter"
2778,NM_000179.3(MSH6):c.3G>C (p.Met1Ile),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 27, 2017)","criteria provided, single submitter"
2779,NM_000179.3(MSH6):c.3G>T (p.Met1Ile),MSH6,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2780,NM_000179.3(MSH6):c.150G>A (p.Trp50Ter),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: dec 15, 2021)","criteria provided, single submitter"
2781,NM_000179.3(MSH6):c.179T>A (p.Leu60Ter),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 20, 2021)","criteria provided, single submitter"
2782,NM_000179.3(MSH6):c.194C>A (p.Ser65Ter),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
2782,NM_000179.3(MSH6):c.194C>A (p.Ser65Ter),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
2783,NM_000179.3(MSH6):c.1100A>G (p.His367Arg),MSH6,lynch syndrome 1,C2936783,"pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2784,NM_000179.3(MSH6):c.1109T>C (p.Leu370Ser),MSH6,hereditary nonpolyposis colon cancer,C1333990,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2784,NM_000179.3(MSH6):c.1109T>C (p.Leu370Ser),MSH6,lynch syndrome,C4552100,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2784,NM_000179.3(MSH6):c.1109T>C (p.Leu370Ser),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2784,NM_000179.3(MSH6):c.1109T>C (p.Leu370Ser),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2784,NM_000179.3(MSH6):c.1109T>C (p.Leu370Ser),MSH6,not specified,Cumapped182,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
2785,NM_000179.3(MSH6):c.1193T>A (p.Val398Glu),MSH6,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2786,NM_000179.3(MSH6):c.1252T>C (p.Ser418Pro),MSH6,lynch syndrome,C4552100,"likely pathogenic(last reviewed: oct 18, 2018)",reviewed by expert panel
2787,NM_000179.3(MSH6):c.1304T>C (p.Leu435Pro),MSH6,lynch syndrome 5,Cumapped122,"pathogenic/likely pathogenic(last reviewed: jul 13, 2022)","criteria provided, multiple submitters, no conflicts"
2787,NM_000179.3(MSH6):c.1304T>C (p.Leu435Pro),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: jul 13, 2022)","criteria provided, multiple submitters, no conflicts"
2787,NM_000179.3(MSH6):c.1304T>C (p.Leu435Pro),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 13, 2022)","criteria provided, multiple submitters, no conflicts"
2788,NM_000179.3(MSH6):c.1346T>C (p.Leu449Pro),MSH6,lynch syndrome,C4552100,"pathogenic(last reviewed: sep 5, 2013)",reviewed by expert panel
2789,NM_000179.3(MSH6):c.1439T>A (p.Val480Glu),MSH6,lynch syndrome,C4552100,"pathogenic(last reviewed: dec 19, 2018)",reviewed by expert panel
2790,NM_000179.3(MSH6):c.1445G>C (p.Arg482Pro),MSH6,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: jun 13, 2018)",reviewed by expert panel
2791,NM_000179.3(MSH6):c.1621A>C (p.Ser541Arg),MSH6,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2792,NM_000179.3(MSH6):c.2057G>A (p.Gly686Asp),MSH6,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2793,NM_000179.3(MSH6):c.2117T>C (p.Phe706Ser),MSH6,lynch syndrome,C4552100,"likely pathogenic(last reviewed: jun 21, 2019)",reviewed by expert panel
2794,NM_000179.3(MSH6):c.2118T>A (p.Phe706Leu),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
2795,NM_000179.3(MSH6):c.2234T>A (p.Ile745Asn),MSH6,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: jun 13, 2018)",reviewed by expert panel
2796,NM_000179.3(MSH6):c.2299A>C (p.Thr767Pro),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: jul 22, 2022)","criteria provided, single submitter"
2797,NM_000179.3(MSH6):c.2300C>T (p.Thr767Ile),MSH6,lynch syndrome 1,C2936783,"pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2798,NM_000179.3(MSH6):c.2314C>T (p.Arg772Trp),MSH6,lynch syndrome,C4552100,"pathogenic(last reviewed: oct 18, 2018)",reviewed by expert panel
2799,NM_000179.3(MSH6):c.2341C>T (p.Pro781Ser),MSH6,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jan 14, 2022)","criteria provided, single submitter"
2800,NM_000179.3(MSH6):c.2393T>C (p.Leu798Pro),MSH6,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: nov 9, 2021)","criteria provided, single submitter"
2801,NM_000179.3(MSH6):c.2559G>T (p.Lys853Asn),MSH6,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: feb 25, 2021)","criteria provided, single submitter"
2802,NM_000179.3(MSH6):c.2559G>C (p.Lys853Asn),MSH6,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
2802,NM_000179.3(MSH6):c.2559G>C (p.Lys853Asn),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
2803,NM_000179.3(MSH6):c.2905T>C (p.Tyr969His),MSH6,hereditary nonpolyposis colorectal neoplasms,C0009405,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
2804,NM_000179.3(MSH6):c.2906A>G (p.Tyr969Cys),MSH6,lynch syndrome 1,C2936783,"likely pathogenic(last reviewed: mar 9, 2018)",reviewed by expert panel
2805,NM_001190274.2(FBXO11):c.2747C>T (p.Ala916Val),FBXO11|MSH6,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
2806,NM_001190274.2(FBXO11):c.2729A>T (p.Asp910Val),FBXO11|MSH6,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2807,NM_001190274.2(FBXO11):c.2729A>G (p.Asp910Gly),FBXO11|MSH6,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
2808,NM_001190274.2(FBXO11):c.2666A>T (p.Asp889Val),FBXO11|MSH6,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: may 24, 2022)","criteria provided, single submitter"
2809,NM_001190274.2(FBXO11):c.2603G>A (p.Cys868Tyr),FBXO11|MSH6,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,likely pathogenic,"criteria provided, single submitter"
2810,NM_001190274.2(FBXO11):c.2188G>A (p.Gly730Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 16, 2019)","criteria provided, single submitter"
2811,NM_001190274.2(FBXO11):c.2145G>C (p.Lys715Asn),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2812,NM_001190274.2(FBXO11):c.2125A>G (p.Met709Val),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2813,NM_001190274.2(FBXO11):c.2075A>T (p.Tyr692Phe),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2814,NM_001190274.2(FBXO11):c.2074T>A (p.Tyr692Asn),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2815,NM_001190274.2(FBXO11):c.2060G>A (p.Gly687Asp),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
2816,NM_001190274.2(FBXO11):c.2036A>G (p.Asn679Ser),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2817,NM_001190274.2(FBXO11):c.1993G>A (p.Gly665Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,likely pathogenic,"criteria provided, single submitter"
2818,NM_001190274.2(FBXO11):c.1967A>G (p.Asn656Ser),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2819,NM_001190274.2(FBXO11):c.1949A>C (p.His650Pro),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2820,NM_001190274.2(FBXO11):c.1921G>A (p.Val641Ile),FBXO11,developmental disorder,C0008073,"likely pathogenic(last reviewed: nov 18, 2021)","criteria provided, single submitter"
2821,NM_001190274.2(FBXO11):c.1830T>G (p.Asn610Lys),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2822,NM_001190274.2(FBXO11):c.1784G>A (p.Gly595Asp),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, single submitter"
2823,NM_001190274.2(FBXO11):c.1783G>A (p.Gly595Ser),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
2824,NM_001190274.2(FBXO11):c.1781A>G (p.His594Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2825,NM_001190274.2(FBXO11):c.1733C>G (p.Thr578Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2826,NM_001190274.2(FBXO11):c.1669G>A (p.Gly557Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: aug 23, 2021)","criteria provided, single submitter"
2827,NM_001190274.2(FBXO11):c.1648G>C (p.Gly550Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, multiple submitters, no conflicts"
2828,NM_001190274.2(FBXO11):c.1645G>A (p.Gly549Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2829,NM_001190274.2(FBXO11):c.1637G>A (p.Gly546Glu),FBXO11,intellectual disability,C3714756,"likely pathogenic(last reviewed: mar 11, 2021)","criteria provided, single submitter"
2830,NM_001190274.2(FBXO11):c.1576G>A (p.Ala526Thr),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: mar 22, 2019)","criteria provided, single submitter"
2831,NM_001190274.2(FBXO11):c.1523A>G (p.His508Arg),FBXO11,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
2832,NM_001190274.2(FBXO11):c.1517A>G (p.Tyr506Cys),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2833,NM_001190274.2(FBXO11):c.1504A>C (p.Thr502Pro),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2834,NM_001190274.2(FBXO11):c.1340G>C (p.Arg447Thr),FBXO11,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
2835,NM_001190274.2(FBXO11):c.1276A>T (p.Asn426Tyr),FBXO11,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: nov 25, 2020)","criteria provided, single submitter"
2836,NM_001190274.2(FBXO11):c.1261G>A (p.Gly421Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2837,NM_001190274.2(FBXO11):c.617A>G (p.Tyr206Cys),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2838,NM_001190274.2(FBXO11):c.606A>C (p.Glu202Asp),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2839,NM_001190274.2(FBXO11):c.554G>A (p.Arg185His),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2840,NM_001190274.2(FBXO11):c.412A>G (p.Arg138Gly),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2841,NM_001190274.2(FBXO11):c.404A>G (p.Lys135Arg),FBXO11,intellectual developmental disorder with dysmorphic facies and behavioral abnormalities,C4748135,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
2842,NM_000233.4(LHCGR):c.1847C>A (p.Ser616Tyr),STON1-GTF2A1L|LHCGR,leydig cell agenesis,C0266432,"pathogenic/likely pathogenic(last reviewed: jul 15, 2022)","criteria provided, multiple submitters, no conflicts"
2843,NM_000233.4(LHCGR):c.1733A>G (p.Asp578Gly),LHCGR|STON1-GTF2A1L,gonadotropin-independent familial sexual precocity,C4055017,"pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2843,NM_000233.4(LHCGR):c.1733A>G (p.Asp578Gly),LHCGR|STON1-GTF2A1L,leydig cell agenesis,C0266432,"pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
2844,NM_000233.4(LHCGR):c.1732G>T (p.Asp578Tyr),LHCGR|STON1-GTF2A1L,gonadotropin-independent familial sexual precocity,C4055017,"likely pathogenic(last reviewed: aug 18, 2011)","criteria provided, single submitter"
2845,NM_000233.4(LHCGR):c.1691A>G (p.Asp564Gly),LHCGR|STON1-GTF2A1L,gonadotropin-independent familial sexual precocity,C4055017,"pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
2846,NM_000145.4(FSHR):c.1862C>T (p.Ala621Val),FSHR,ovarian dysgenesis 1,C0949595,"likely pathogenic(last reviewed: oct 1, 2020)","criteria provided, single submitter"
2847,NM_000145.4(FSHR):c.1384G>C (p.Ala462Pro),FSHR,ovarian dysgenesis 1,C0949595,"likely pathogenic(last reviewed: oct 1, 2020)","criteria provided, single submitter"
2848,NM_000145.4(FSHR):c.2T>C (p.Met1Thr),FSHR,amenorrhea,C0002453,"pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
2849,NM_003128.3(SPTBN1):c.176C>G (p.Thr59Ser),SPTBN1,"developmental delay, impaired speech, and behavioral abnormalities",CL1783776,"pathogenic(last reviewed: mar 24, 2022)","criteria provided, single submitter"
2850,NM_003128.3(SPTBN1):c.586C>T (p.His196Tyr),SPTBN1,"developmental delay, impaired speech, and behavioral abnormalities",CL1783776,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2851,NM_003128.3(SPTBN1):c.748C>G (p.Leu250Val),SPTBN1,neurodevelopmental delay,C4022738,likely pathogenic,"criteria provided, single submitter"
2852,NM_003128.3(SPTBN1):c.811G>A (p.Val271Met),SPTBN1,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: jun 17, 2021)","criteria provided, single submitter"
2853,NM_003128.3(SPTBN1):c.1043G>C (p.Arg348Pro),SPTBN1,"developmental delay, impaired speech, and behavioral abnormalities",CL1783776,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2854,NM_003128.3(SPTBN1):c.1429C>T (p.Arg477Cys),SPTBN1,"developmental delay, impaired speech, and behavioral abnormalities",CL1783776,"likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
2855,NM_033109.5(PNPT1):c.1528G>C (p.Ala510Pro),PNPT1,combined oxidative phosphorylation defect type 13,C4706283,"pathogenic/likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2856,NM_033109.5(PNPT1):c.1400C>A (p.Pro467His),PNPT1,combined oxidative phosphorylation defect type 13,C4706283,"likely pathogenic(last reviewed: may 6, 2021)","criteria provided, single submitter"
2857,NM_033109.5(PNPT1):c.760C>A (p.Gln254Lys),PNPT1,combined oxidative phosphorylation defect type 13,C4706283,pathogenic,"criteria provided, single submitter"
2858,NM_033109.5(PNPT1):c.526G>A (p.Ala176Thr),PNPT1,combined oxidative phosphorylation defect type 13,C4706283,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2859,NM_033109.5(PNPT1):c.406C>T (p.Arg136Cys),PNPT1,combined oxidative phosphorylation defect type 13,C4706283,"pathogenic(last reviewed: may 6, 2021)","criteria provided, single submitter"
2860,NM_001039348.3(EFEMP1):c.1189T>C (p.Tyr397His),EFEMP1,optic disc drusen,C0029128,"likely pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
2860,NM_001039348.3(EFEMP1):c.1189T>C (p.Tyr397His),EFEMP1,night blindness,C4553660,"likely pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
2860,NM_001039348.3(EFEMP1):c.1189T>C (p.Tyr397His),EFEMP1,retinal pigment epithelial atrophy,C1840457,"likely pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
2860,NM_001039348.3(EFEMP1):c.1189T>C (p.Tyr397His),EFEMP1,macular dystrophy,C4231166,"likely pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
2860,NM_001039348.3(EFEMP1):c.1189T>C (p.Tyr397His),EFEMP1,blindness,C3665346,"likely pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
2861,NM_001039348.3(EFEMP1):c.1033C>T (p.Arg345Trp),EFEMP1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
2861,NM_001039348.3(EFEMP1):c.1033C>T (p.Arg345Trp),EFEMP1,doyne honeycomb retinal dystrophy,C1832174,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
2862,NM_018062.4(FANCL):c.3G>A (p.Met1Ile),FANCL,fanconi anemia,C3469521,"likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
2863,NM_018062.4(FANCL):c.2T>G (p.Met1Arg),FANCL,fanconi anemia,C3469521,"likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, single submitter"
2864,NM_018062.4(FANCL):c.1A>C (p.Met1Leu),FANCL,fanconi anemia,C3469521,"likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, single submitter"
2865,NM_018062.4(FANCL):c.1A>G (p.Met1Val),FANCL,fanconi anemia,C3469521,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
2866,NM_022893.4(BCL11A):c.1663A>T (p.Met555Leu),BCL11A,dias-logan syndrome,C4310833,"pathogenic(last reviewed: aug 28, 2018)","criteria provided, single submitter"
2867,NM_022893.4(BCL11A):c.977C>A (p.Thr326Lys),BCL11A,intellectual disability,C3714756,"likely pathogenic(last reviewed: oct 16, 2020)","criteria provided, single submitter"
2868,NM_022893.4(BCL11A):c.152G>C (p.Cys51Ser),BCL11A,microcephaly,C4551563,likely pathogenic,"criteria provided, single submitter"
2868,NM_022893.4(BCL11A):c.152G>C (p.Cys51Ser),BCL11A,intellectual disability,C3714756,likely pathogenic,"criteria provided, single submitter"
2868,NM_022893.4(BCL11A):c.152G>C (p.Cys51Ser),BCL11A,profound global developmental delay,C3553450,likely pathogenic,"criteria provided, single submitter"
2868,NM_022893.4(BCL11A):c.152G>C (p.Cys51Ser),BCL11A,global developmental delay,C0557874,likely pathogenic,"criteria provided, single submitter"
2869,NM_022893.4(BCL11A):c.143G>T (p.Cys48Phe),BCL11A,dias-logan syndrome,C4310833,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
2870,NM_022893.4(BCL11A):c.3G>A (p.Met1Ile),BCL11A,dias-logan syndrome,C4310833,"pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
2871,NM_022893.4(BCL11A):c.1A>G (p.Met1Val),BCL11A,dias-logan syndrome,C4310833,"pathogenic/likely pathogenic(last reviewed: nov 11, 2021)","criteria provided, multiple submitters, no conflicts"
2871,NM_022893.4(BCL11A):c.1A>G (p.Met1Val),BCL11A,neurodevelopmental delay,C4022738,"pathogenic/likely pathogenic(last reviewed: nov 11, 2021)","criteria provided, multiple submitters, no conflicts"
2872,NM_006759.4(UGP2):c.34A>G (p.Met12Val),UGP2,d-6618,Cumapped59,"pathogenic/likely pathogenic(last reviewed: aug 18, 2022)","criteria provided, multiple submitters, no conflicts"
2872,NM_006759.4(UGP2):c.34A>G (p.Met12Val),UGP2,"developmental and epileptic encephalopathy, 83",C2931919,"pathogenic/likely pathogenic(last reviewed: aug 18, 2022)","criteria provided, multiple submitters, no conflicts"
2873,NM_003038.5(SLC1A4):c.766G>A (p.Glu256Lys),SLC1A4,spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome,Cumapped294,"pathogenic(last reviewed: jan 5, 2023)","criteria provided, multiple submitters, no conflicts"
2874,NM_181784.3(SPRED2):c.299T>C (p.Leu100Pro),SPRED2,noonan syndrome,C0028326,"pathogenic(last reviewed: aug 1, 2021)","criteria provided, single submitter"
2875,NM_032208.3(ANTXR1):c.1150G>A (p.Gly384Ser),ANTXR1,gapo syndrome,C0406723,"likely pathogenic(last reviewed: sep 1, 2014)","criteria provided, single submitter"
2876,NM_001244710.2(GFPT1):c.398A>G (p.Lys133Arg),GFPT1,congenital myasthenic syndrome 12,C3552335,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
2877,NM_001244710.2(GFPT1):c.332G>A (p.Arg111His),GFPT1,congenital myasthenic syndrome 12,C3552335,"pathogenic(last reviewed: oct 19, 2021)","criteria provided, single submitter"
2878,NM_001244710.2(GFPT1):c.331C>T (p.Arg111Cys),GFPT1,congenital myasthenic syndrome 12,C3552335,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
2879,NM_001244710.2(GFPT1):c.209A>G (p.Asp70Gly),GFPT1,congenital myasthenic syndrome 12,C3552335,"likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
2880,NM_001244710.2(GFPT1):c.44C>T (p.Thr15Met),GFPT1,congenital myasthenic syndrome 12,C3552335,"likely pathogenic(last reviewed: may 14, 2022)","criteria provided, single submitter"
2881,NM_001244710.2(GFPT1):c.41G>A (p.Arg14Gln),GFPT1,congenital myasthenic syndrome 4c,C1837091,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
2882,NM_001002755.4(NFU1):c.622G>T (p.Gly208Cys),NFU1,multiple mitochondrial dysfunctions syndrome 1,C3276432,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
2883,NM_001002755.4(NFU1):c.565G>A (p.Gly189Arg),NFU1,multiple mitochondrial dysfunctions syndrome 1,C3276432,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
2884,NM_001002755.4(NFU1):c.545G>A (p.Arg182Gln),NFU1,multiple mitochondrial dysfunctions syndrome 1,C3276432,"likely pathogenic(last reviewed: jan 29, 2018)","criteria provided, single submitter"
2885,NM_001002755.4(NFU1):c.544C>T (p.Arg182Trp),NFU1,multiple mitochondrial dysfunctions syndrome 1,C3276432,"pathogenic(last reviewed: dec 7, 2017)","criteria provided, single submitter"
2886,NM_022173.4(TIA1):c.1150G>A (p.Glu384Lys),TIA1,welander distal myopathy,C0221054,"pathogenic(last reviewed: sep 2, 2022)","criteria provided, multiple submitters, no conflicts"
2887,NM_001692.4(ATP6V1B1):c.232G>A (p.Gly78Arg),ATP6V1B1,renal tubular acidosis with progressive nerve deafness,C0403554,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2888,NM_001692.4(ATP6V1B1):c.242T>C (p.Leu81Pro),ATP6V1B1,renal tubular acidosis with progressive nerve deafness,C0403554,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
2889,NM_001692.4(ATP6V1B1):c.1037C>G (p.Pro346Arg),ATP6V1B1,renal tubular acidosis with progressive nerve deafness,C0403554,"pathogenic(last reviewed: apr 1, 2023)","criteria provided, multiple submitters, no conflicts"
2890,NM_001692.4(ATP6V1B1):c.1060G>A (p.Asp354Asn),ATP6V1B1,renal tubular acidosis with progressive nerve deafness,C0403554,"likely pathogenic(last reviewed: mar 7, 2022)","criteria provided, single submitter"
2891,NM_001692.4(ATP6V1B1):c.1449G>T (p.Lys483Asn),ATP6V1B1,renal tubular acidosis with progressive nerve deafness,C0403554,"likely pathogenic(last reviewed: feb 7, 2022)","criteria provided, single submitter"
2892,NM_003494.4(DYSF):c.1A>G (p.Met1Val),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"likely pathogenic(last reviewed: dec 7, 2017)","criteria provided, single submitter"
2893,NM_003494.4(DYSF):c.2T>C (p.Met1Thr),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, multiple submitters, no conflicts"
2893,NM_003494.4(DYSF):c.2T>C (p.Met1Thr),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, multiple submitters, no conflicts"
2894,NM_001130987.2(DYSF):c.139T>C (p.Trp47Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
2895,NM_001130987.2(DYSF):c.157T>A (p.Trp53Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
2896,NM_001130987.2(DYSF):c.247G>C (p.Gly83Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, single submitter"
2897,NM_001130987.2(DYSF):c.359T>C (p.Leu120Pro),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: feb 15, 2022)","criteria provided, single submitter"
2898,NM_001130987.2(DYSF):c.796G>T (p.Gly266Trp),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
2899,NM_001130987.2(DYSF):c.797G>A (p.Gly266Glu),DYSF,autosomal recessive limb-girdle muscular dystrophy,C0686353,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
2899,NM_001130987.2(DYSF):c.797G>A (p.Gly266Glu),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
2900,NM_001130987.2(DYSF):c.851C>T (p.Thr284Met),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2900,NM_001130987.2(DYSF):c.851C>T (p.Thr284Met),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2900,NM_001130987.2(DYSF):c.851C>T (p.Thr284Met),DYSF,abnormality of the musculature,C4021745,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
2901,NM_001130987.2(DYSF):c.853C>T (p.Arg285Trp),DYSF,miyoshi muscular dystrophy 1,C4551973,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
2901,NM_001130987.2(DYSF):c.853C>T (p.Arg285Trp),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
2901,NM_001130987.2(DYSF):c.853C>T (p.Arg285Trp),DYSF,distal myopathy with anterior tibial onset,C1847532,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
2901,NM_001130987.2(DYSF):c.853C>T (p.Arg285Trp),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
2901,NM_001130987.2(DYSF):c.853C>T (p.Arg285Trp),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, multiple submitters, no conflicts"
2902,NM_001130987.2(DYSF):c.959A>T (p.Asp320Val),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: may 31, 2022)","criteria provided, multiple submitters, no conflicts"
2902,NM_001130987.2(DYSF):c.959A>T (p.Asp320Val),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: may 31, 2022)","criteria provided, multiple submitters, no conflicts"
2903,NM_001130987.2(DYSF):c.991G>C (p.Gly331Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2904,NM_001130987.2(DYSF):c.991G>T (p.Gly331Trp),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: mar 31, 2023)","criteria provided, multiple submitters, no conflicts"
2905,NM_001130987.2(DYSF):c.991G>A (p.Gly331Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: jul 17, 2022)","criteria provided, multiple submitters, no conflicts"
2906,NM_001130987.2(DYSF):c.1061T>C (p.Leu354Pro),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: apr 9, 2022)","criteria provided, multiple submitters, no conflicts"
2906,NM_001130987.2(DYSF):c.1061T>C (p.Leu354Pro),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: apr 9, 2022)","criteria provided, multiple submitters, no conflicts"
2907,NM_001130987.2(DYSF):c.1116C>A (p.Ser372Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
2907,NM_001130987.2(DYSF):c.1116C>A (p.Ser372Arg),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
2908,NM_001130987.2(DYSF):c.1127T>C (p.Leu376Pro),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"likely pathogenic(last reviewed: dec 29, 2021)","criteria provided, single submitter"
2909,NM_001130987.2(DYSF):c.1264G>A (p.Asp422Asn),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: apr 16, 2022)","criteria provided, multiple submitters, no conflicts"
2910,NM_001130987.2(DYSF):c.1372G>A (p.Gly458Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
2911,NM_001130987.2(DYSF):c.1717C>T (p.Arg573Trp),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
2912,NM_001130987.2(DYSF):c.1721T>C (p.Leu574Pro),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
2913,NM_001130987.2(DYSF):c.1906G>C (p.Gly636Arg),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: jun 2, 2016)","criteria provided, multiple submitters, no conflicts"
2914,NM_001130987.2(DYSF):c.1915G>A (p.Gly639Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic/likely pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
2914,NM_001130987.2(DYSF):c.1915G>A (p.Gly639Arg),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
2915,NM_001130987.2(DYSF):c.2426C>G (p.Pro809Arg),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: apr 20, 2022)","criteria provided, multiple submitters, no conflicts"
2916,NM_001130987.2(DYSF):c.2929C>T (p.Arg977Trp),DYSF,miyoshi muscular dystrophy 1,C4551973,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
2916,NM_001130987.2(DYSF):c.2929C>T (p.Arg977Trp),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
2916,NM_001130987.2(DYSF):c.2929C>T (p.Arg977Trp),DYSF,distal myopathy with anterior tibial onset,C1847532,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
2916,NM_001130987.2(DYSF):c.2929C>T (p.Arg977Trp),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
2917,NM_001130987.2(DYSF):c.2930G>A (p.Arg977Gln),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"likely pathogenic(last reviewed: may 20, 2022)","criteria provided, single submitter"
2918,NM_001130987.2(DYSF):c.3028T>C (p.Trp1010Arg),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
2918,NM_001130987.2(DYSF):c.3028T>C (p.Trp1010Arg),DYSF,distal myopathy with anterior tibial onset,C1847532,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
2918,NM_001130987.2(DYSF):c.3028T>C (p.Trp1010Arg),DYSF,miyoshi muscular dystrophy 1,C4551973,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
2918,NM_001130987.2(DYSF):c.3028T>C (p.Trp1010Arg),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
2919,NM_001130987.2(DYSF):c.3051G>T (p.Trp1017Cys),DYSF,qualitative or quantitative defects of dysferlin,Cumapped235,"pathogenic(last reviewed: aug 30, 2022)","criteria provided, multiple submitters, no conflicts"
2919,NM_001130987.2(DYSF):c.3051G>T (p.Trp1017Cys),DYSF,autosomal recessive limb-girdle muscular dystrophy type 2b,C4273680,"pathogenic(last reviewed: aug 30, 2022)","criteria provided, multiple submitters, no conflicts"
2920,NM_003124.5(SPR):c.1A>C (p.Met1Leu),SPR,dopa-responsive dystonia due to sepiapterin reductase deficiency,C0268468,"likely pathogenic(last reviewed: mar 1, 2022)","criteria provided, single submitter"
2921,NM_003124.5(SPR):c.448A>G (p.Arg150Gly),SPR,dystonic disorder,C0393593,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
2921,NM_003124.5(SPR):c.448A>G (p.Arg150Gly),SPR,dopa-responsive dystonia due to sepiapterin reductase deficiency,C0268468,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, multiple submitters, no conflicts"
2922,NM_003124.5(SPR):c.512G>A (p.Cys171Tyr),SPR,dopa-responsive dystonia due to sepiapterin reductase deficiency,C0268468,"likely pathogenic(last reviewed: may 27, 2021)","criteria provided, single submitter"
2923,NM_001378454.1(ALMS1):c.2T>G (p.Met1Arg),ALMS1,alstrom syndrome,C0268425,"likely pathogenic(last reviewed: apr 28, 2017)","criteria provided, single submitter"
2924,NM_001378454.1(ALMS1):c.3G>A (p.Met1Ile),ALMS1,hearing impairment,C1550444,"likely pathogenic(last reviewed: apr 12, 2021)","criteria provided, single submitter"
2925,NM_213622.4(STAMBP):c.112C>T (p.Arg38Cys),LOC126806253|STAMBP,microcephaly-capillary malformation syndrome,C3280296,"pathogenic/likely pathogenic(last reviewed: aug 7, 2022)","criteria provided, multiple submitters, no conflicts"
2926,NM_213622.4(STAMBP):c.125A>G (p.Glu42Gly),LOC126806253|STAMBP,microcephaly-capillary malformation syndrome,C3280296,"likely pathogenic(last reviewed: apr 19, 2017)","criteria provided, single submitter"
2927,NM_213622.4(STAMBP):c.299T>A (p.Phe100Tyr),STAMBP,microcephaly-capillary malformation syndrome,C3280296,"pathogenic(last reviewed: sep 1, 2017)","criteria provided, single submitter"
2928,NM_001615.4(ACTG2):c.116C>G (p.Pro39Arg),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"likely pathogenic(last reviewed: aug 29, 2022)","criteria provided, single submitter"
2929,NM_001615.4(ACTG2):c.116C>T (p.Pro39Leu),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: oct 4, 2019)","criteria provided, single submitter"
2930,NM_001615.4(ACTG2):c.118C>T (p.Arg40Cys),ACTG2,visceral myopathy,C0042781,"pathogenic/likely pathogenic(last reviewed: apr 22, 2021)","criteria provided, multiple submitters, no conflicts"
2931,NM_001615.4(ACTG2):c.119G>A (p.Arg40His),ACTG2,"visceral neuropathy, familial, 3, autosomal dominant",C1864996,"pathogenic/likely pathogenic(last reviewed: jul 14, 2022)","criteria provided, multiple submitters, no conflicts"
2931,NM_001615.4(ACTG2):c.119G>A (p.Arg40His),ACTG2,visceral myopathy,C0042781,"pathogenic/likely pathogenic(last reviewed: jul 14, 2022)","criteria provided, multiple submitters, no conflicts"
2931,NM_001615.4(ACTG2):c.119G>A (p.Arg40His),ACTG2,visceral myopathy,C0042781,"pathogenic/likely pathogenic(last reviewed: jul 14, 2022)","criteria provided, multiple submitters, no conflicts"
2931,NM_001615.4(ACTG2):c.119G>A (p.Arg40His),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"pathogenic/likely pathogenic(last reviewed: jul 14, 2022)","criteria provided, multiple submitters, no conflicts"
2932,NM_001615.4(ACTG2):c.134T>C (p.Met45Thr),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: mar 27, 2014)","criteria provided, single submitter"
2933,NM_001615.4(ACTG2):c.187C>G (p.Arg63Gly),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: dec 20, 2016)","criteria provided, multiple submitters, no conflicts"
2934,NM_001615.4(ACTG2):c.188G>T (p.Arg63Leu),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"likely pathogenic(last reviewed: mar 4, 2022)","criteria provided, single submitter"
2935,NM_001615.4(ACTG2):c.188G>A (p.Arg63Gln),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: sep 30, 2019)","criteria provided, single submitter"
2936,NM_001615.4(ACTG2):c.337C>G (p.Pro113Ala),ACTG2,visceral myopathy,C0042781,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
2937,NM_001615.4(ACTG2):c.348C>A (p.Asn116Lys),ACTG2,visceral myopathy,C0042781,"likely pathogenic(last reviewed: jan 16, 2020)","criteria provided, single submitter"
2938,NM_001615.4(ACTG2):c.400T>A (p.Tyr134Asn),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: mar 27, 2014)","criteria provided, single submitter"
2939,NM_001615.4(ACTG2):c.439G>C (p.Gly147Arg),ACTG2,"megacystis, microcolon, hypoperistalsis syndrome",C1608393,"likely pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
2940,NM_001615.4(ACTG2):c.442C>T (p.Arg148Cys),ACTG2,intestinal obstruction,C0021843,"likely pathogenic(last reviewed: jul 6, 2021)","criteria provided, single submitter"
2941,NM_001615.4(ACTG2):c.532C>T (p.Arg178Cys),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
2941,NM_001615.4(ACTG2):c.532C>T (p.Arg178Cys),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
2942,NM_001615.4(ACTG2):c.533G>A (p.Arg178His),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: nov 26, 2022)","criteria provided, multiple submitters, no conflicts"
2943,NM_001615.4(ACTG2):c.590G>C (p.Arg197Thr),ACTG2,visceral myopathy,C0042781,"likely pathogenic(last reviewed: dec 28, 2021)","criteria provided, single submitter"
2944,NM_001615.4(ACTG2):c.593G>T (p.Gly198Val),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
2945,NM_001615.4(ACTG2):c.593G>A (p.Gly198Asp),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: feb 17, 2017)","criteria provided, multiple submitters, no conflicts"
2946,NM_001615.4(ACTG2):c.613G>A (p.Ala205Thr),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: aug 21, 2015)","criteria provided, single submitter"
2947,NM_001615.4(ACTG2):c.632G>T (p.Arg211Leu),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: jun 24, 2022)","criteria provided, single submitter"
2948,NM_001615.4(ACTG2):c.632G>A (p.Arg211Gln),ACTG2,visceral myopathy,C0042781,"likely pathogenic(last reviewed: oct 17, 2016)","criteria provided, single submitter"
2949,NM_001615.4(ACTG2):c.769C>T (p.Arg257Cys),ACTG2,"visceral neuropathy, familial, 3, autosomal dominant",C1864996,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2949,NM_001615.4(ACTG2):c.769C>T (p.Arg257Cys),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2949,NM_001615.4(ACTG2):c.769C>T (p.Arg257Cys),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2949,NM_001615.4(ACTG2):c.769C>T (p.Arg257Cys),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2949,NM_001615.4(ACTG2):c.769C>T (p.Arg257Cys),ACTG2,hyperinsulinemia,C0020459,"pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
2950,NM_001615.4(ACTG2):c.770G>A (p.Arg257His),ACTG2,visceral myopathy,C0042781,"pathogenic(last reviewed: apr 12, 2022)","criteria provided, multiple submitters, no conflicts"
2950,NM_001615.4(ACTG2):c.770G>A (p.Arg257His),ACTG2,megacystis-microcolon-intestinal hypoperistalsis syndrome 5,CL1767457,"pathogenic(last reviewed: apr 12, 2022)","criteria provided, multiple submitters, no conflicts"
2951,NM_001615.4(ACTG2):c.968C>T (p.Pro323Leu),ACTG2,chronic intestinal pseudoobstruction,C1864223,"likely pathogenic(last reviewed: mar 18, 2021)","criteria provided, single submitter"
2952,NM_001287491.2(TET3):c.2617G>A (p.Glu873Lys),TET3,beck-fahrner syndrome,CL1639710,"likely pathogenic(last reviewed: jan 12, 2021)","criteria provided, single submitter"
2953,NM_212552.3(BOLA3):c.200T>A (p.Ile67Asn),BOLA3,multiple mitochondrial dysfunctions syndrome 2,CL1795935,"likely pathogenic(last reviewed: feb 7, 2023)","criteria provided, multiple submitters, no conflicts"
2954,NM_212552.3(BOLA3):c.176G>A (p.Cys59Tyr),BOLA3,multiple mitochondrial dysfunctions syndrome 2,CL1795935,"pathogenic/likely pathogenic(last reviewed: mar 20, 2023)","criteria provided, multiple submitters, no conflicts"
2955,NM_004082.5(DCTN1):c.1864A>T (p.Ile622Phe),DCTN1,amyotrophic lateral sclerosis,C0002736,"likely pathogenic(last reviewed: jul 31, 2020)","criteria provided, single submitter"
2956,NM_004082.5(DCTN1):c.212G>A (p.Gly71Glu),DCTN1,perry syndrome,C1868594,"pathogenic(last reviewed: mar 1, 2021)","criteria provided, multiple submitters, no conflicts"
2957,NM_004082.5(DCTN1):c.175G>C (p.Gly59Arg),DCTN1,amyotrophic lateral sclerosis type 1,C1862939,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2957,NM_004082.5(DCTN1):c.175G>C (p.Gly59Arg),DCTN1,"neuronopathy, distal hereditary motor, type 7b",C1843315,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2957,NM_004082.5(DCTN1):c.175G>C (p.Gly59Arg),DCTN1,perry syndrome,C1868594,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2958,NM_004082.5(DCTN1):c.175G>A (p.Gly59Ser),DCTN1,"neuronopathy, distal hereditary motor, type 7b",C1843315,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2958,NM_004082.5(DCTN1):c.175G>A (p.Gly59Ser),DCTN1,amyotrophic lateral sclerosis type 1,C1862939,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2958,NM_004082.5(DCTN1):c.175G>A (p.Gly59Ser),DCTN1,perry syndrome,C1868594,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
2959,NM_006302.3(MOGS):c.1880T>C (p.Leu627Pro),MOGS,mogs-congenital disorder of glycosylation,C1853736,"likely pathogenic(last reviewed: nov 21, 2018)","criteria provided, single submitter"
2960,NM_003849.4(SUCLG1):c.626C>A (p.Ala209Glu),SUCLG1,mitochondrial dna depletion syndrome 9,C3149750,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
2961,NM_003849.4(SUCLG1):c.458T>A (p.Val153Glu),SUCLG1,mitochondrial dna depletion syndrome 9,C3149750,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
2962,NM_003849.4(SUCLG1):c.41T>C (p.Met14Thr),SUCLG1,mitochondrial dna depletion syndrome 9,C3149750,"likely pathogenic(last reviewed: nov 1, 2018)","criteria provided, single submitter"
2963,NM_001135022.2(ELMOD3):c.512A>G (p.His171Arg),ELMOD3,"hearing loss, autosomal dominant 81",C3887873,"likely pathogenic(last reviewed: feb 22, 2022)","criteria provided, single submitter"
2964,NM_000821.7(GGCX):c.1538G>A (p.Arg513Lys),GGCX,body skin hyperlaxity due to vitamin k-dependent coagulation factor deficiency,C4049241,pathogenic,"criteria provided, single submitter"
2965,NM_000542.5(SFTPB):c.904T>G (p.Cys302Gly),SFTPB,hereditary pulmonary alveolar proteinosis,C3808435,"likely pathogenic(last reviewed: may 13, 2020)","criteria provided, single submitter"
2966,NM_000542.5(SFTPB):c.754C>T (p.Arg252Cys),SFTPB,hereditary pulmonary alveolar proteinosis,C3808435,"pathogenic(last reviewed: jun 8, 2018)","criteria provided, single submitter"
2967,NM_000542.5(SFTPB):c.730G>A (p.Gly244Ser),SFTPB,hereditary pulmonary alveolar proteinosis,C3808435,"likely pathogenic(last reviewed: jun 13, 2017)","criteria provided, single submitter"
2968,NM_003896.4(ST3GAL5):c.1024G>A (p.Gly342Ser),ST3GAL5,gm3 synthase deficiency,C1836824,"likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, multiple submitters, no conflicts"
2969,NM_003896.4(ST3GAL5):c.740G>A (p.Gly247Asp),ST3GAL5,gm3 synthase deficiency,C1836824,"likely pathogenic(last reviewed: sep 10, 2020)","criteria provided, multiple submitters, no conflicts"
2969,NM_003896.4(ST3GAL5):c.740G>A (p.Gly247Asp),ST3GAL5,intellectual disability,C3714756,"likely pathogenic(last reviewed: sep 10, 2020)","criteria provided, multiple submitters, no conflicts"
2970,NM_003896.4(ST3GAL5):c.601G>A (p.Gly201Arg),ST3GAL5,gm3 synthase deficiency,C1836824,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
2971,NM_001371279.1(REEP1):c.260T>G (p.Leu87Arg),REEP1,hereditary spastic paraplegia 31,C0037773,pathogenic,"criteria provided, single submitter"
2972,NM_001371279.1(REEP1):c.166G>C (p.Asp56His),REEP1,hereditary spastic paraplegia 31,C0037773,pathogenic,"criteria provided, single submitter"
2973,NM_001371279.1(REEP1):c.59C>T (p.Ala20Val),REEP1,hereditary spastic paraplegia 31,C0037773,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
2974,NM_001371279.1(REEP1):c.59C>A (p.Ala20Glu),REEP1,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 19, 2023)","criteria provided, multiple submitters, no conflicts"
2974,NM_001371279.1(REEP1):c.59C>A (p.Ala20Glu),REEP1,hereditary spastic paraplegia 31,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 19, 2023)","criteria provided, multiple submitters, no conflicts"
2975,NM_001371279.1(REEP1):c.58G>C (p.Ala20Pro),REEP1,hereditary spastic paraplegia,C0037773,"likely pathogenic(last reviewed: mar 7, 2017)","criteria provided, single submitter"
2976,NM_001371279.1(REEP1):c.56C>T (p.Pro19Leu),REEP1,hereditary spastic paraplegia 31,C0037773,pathogenic,"criteria provided, single submitter"
2977,NM_001371279.1(REEP1):c.56C>G (p.Pro19Arg),REEP1,hereditary spastic paraplegia 31,C0037773,"likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, single submitter"
2978,NM_001371279.1(REEP1):c.2T>C (p.Met1Thr),REEP1,hereditary spastic paraplegia 31,C0037773,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
2979,NM_001768.7(CD8A):c.331G>A (p.Gly111Ser),CD8A,susceptibility to respiratory infections associated with cd8alpha chain mutation,Cumapped107,"pathogenic(last reviewed: aug 14, 2021)","criteria provided, single submitter"
2980,NM_004836.7(EIF2AK3):c.641A>G (p.Tyr214Cys),EIF2AK3,wolcott-rallison dysplasia,C0432217,"likely pathogenic(last reviewed: feb 28, 2020)","criteria provided, single submitter"
2981,NM_144563.3(RPIA):c.253G>A (p.Ala85Thr),RPIA,deficiency of ribose-5-phosphate isomerase,C1291609,"likely pathogenic(last reviewed: mar 19, 2019)","criteria provided, single submitter"
2982,NM_144563.3(RPIA):c.770T>C (p.Ile257Thr),RPIA,deficiency of ribose-5-phosphate isomerase,C1291609,likely pathogenic,"criteria provided, single submitter"
2983,NM_017849.4(TMEM127):c.239T>C (p.Leu80Pro),TMEM127,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
2984,NM_017849.4(TMEM127):c.3G>A (p.Met1Ile),TMEM127,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic(last reviewed: feb 25, 2022)","criteria provided, single submitter"
2985,NM_017849.4(TMEM127):c.3G>T (p.Met1Ile),TMEM127,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: nov 6, 2017)","criteria provided, single submitter"
2986,NM_017849.4(TMEM127):c.2T>A (p.Met1Lys),TMEM127,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic(last reviewed: jul 1, 2021)","criteria provided, single submitter"
2987,NM_017849.4(TMEM127):c.2T>G (p.Met1Arg),TMEM127,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
2987,NM_017849.4(TMEM127):c.2T>G (p.Met1Arg),TMEM127,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
2988,NM_017849.4(TMEM127):c.1A>T (p.Met1Leu),TMEM127,hereditary pheochromocytoma-paraganglioma,Cumapped85,"pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
2989,NM_014014.5(SNRNP200):c.2438C>T (p.Ala813Val),SNRNP200,retinitis pigmentosa 33,C1835895,"likely pathogenic(last reviewed: dec 3, 2018)","criteria provided, single submitter"
2990,NM_014014.5(SNRNP200):c.2359G>A (p.Ala787Thr),SNRNP200,retinitis pigmentosa 33,C1835895,"pathogenic(last reviewed: feb 14, 2023)","criteria provided, multiple submitters, no conflicts"
2991,NM_014014.5(SNRNP200):c.2183G>T (p.Arg728Leu),SNRNP200,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
2992,NM_014014.5(SNRNP200):c.2066A>G (p.Tyr689Cys),SNRNP200,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 14, 2021)","criteria provided, multiple submitters, no conflicts"
2993,NM_014014.5(SNRNP200):c.2042G>A (p.Arg681His),SNRNP200,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 29, 2022)","criteria provided, multiple submitters, no conflicts"
2993,NM_014014.5(SNRNP200):c.2042G>A (p.Arg681His),SNRNP200,retinitis pigmentosa 33,C1835895,"pathogenic/likely pathogenic(last reviewed: aug 29, 2022)","criteria provided, multiple submitters, no conflicts"
2994,NM_014014.5(SNRNP200):c.2041C>T (p.Arg681Cys),SNRNP200,retinitis pigmentosa,C0035334,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
2994,NM_014014.5(SNRNP200):c.2041C>T (p.Arg681Cys),SNRNP200,retinitis pigmentosa 33,C1835895,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
2995,NM_014014.5(SNRNP200):c.1704A>C (p.Glu568Asp),SNRNP200,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: apr 1, 2021)","criteria provided, single submitter"
2996,NM_014014.5(SNRNP200):c.1625C>T (p.Ala542Val),SNRNP200,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: mar 29, 2022)","criteria provided, multiple submitters, no conflicts"
2997,NM_030805.4(LMAN2L):c.740G>A (p.Arg247His),LMAN2L,"intellectual disability, autosomal recessive 52",C3276355,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
2998,NM_020184.4(CNNM4):c.1475G>A (p.Gly492Asp),CNNM4,jalili syndrome,C3495589,pathogenic,"criteria provided, single submitter"
2999,NM_001079.4(ZAP70):c.283C>T (p.Pro95Ser),ZAP70,combined immunodeficiency,C0494261,"pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3000,NM_001079.4(ZAP70):c.1079G>C (p.Arg360Pro),ZAP70,combined immunodeficiency,C0494261,"pathogenic(last reviewed: oct 1, 2015)","criteria provided, single submitter"
3001,NM_001298.3(CNGA3):c.545A>G (p.Asn182Ser),CNGA3,achromatopsia 2,C1857618,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3002,NM_001298.3(CNGA3):c.560T>C (p.Ile187Thr),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3003,NM_001298.3(CNGA3):c.572G>A (p.Cys191Tyr),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
3004,NM_001298.3(CNGA3):c.625T>C (p.Ser209Pro),CNGA3,cone dystrophy,C3665342,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
3005,NM_001298.3(CNGA3):c.667C>T (p.Arg223Trp),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
3005,NM_001298.3(CNGA3):c.667C>T (p.Arg223Trp),CNGA3,achromatopsia,C0302129,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
3005,NM_001298.3(CNGA3):c.667C>T (p.Arg223Trp),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
3006,NM_001298.3(CNGA3):c.668G>A (p.Arg223Gln),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: sep 6, 2022)","criteria provided, multiple submitters, no conflicts"
3007,NM_001298.3(CNGA3):c.704A>T (p.Asp235Val),CNGA3,achromatopsia,C0302129,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
3008,NM_001298.3(CNGA3):c.778G>A (p.Asp260Asn),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3008,NM_001298.3(CNGA3):c.778G>A (p.Asp260Asn),CNGA3,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3009,NM_001298.3(CNGA3):c.787T>G (p.Tyr263Asp),CNGA3,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: nov 28, 2018)","criteria provided, single submitter"
3010,NM_001298.3(CNGA3):c.829C>T (p.Arg277Cys),CNGA3,achromatopsia,C0302129,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3010,NM_001298.3(CNGA3):c.829C>T (p.Arg277Cys),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3010,NM_001298.3(CNGA3):c.829C>T (p.Arg277Cys),CNGA3,macular degeneration,C0024437,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3010,NM_001298.3(CNGA3):c.829C>T (p.Arg277Cys),CNGA3,color vision defect,C0009398,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3010,NM_001298.3(CNGA3):c.829C>T (p.Arg277Cys),CNGA3,photophobia,C4554342,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3011,NM_001298.3(CNGA3):c.830G>A (p.Arg277His),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
3011,NM_001298.3(CNGA3):c.830G>A (p.Arg277His),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
3012,NM_001298.3(CNGA3):c.847C>T (p.Arg283Trp),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
3012,NM_001298.3(CNGA3):c.847C>T (p.Arg283Trp),CNGA3,monochromacy,C5201048,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
3013,NM_001298.3(CNGA3):c.848G>A (p.Arg283Gln),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
3013,NM_001298.3(CNGA3):c.848G>A (p.Arg283Gln),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: dec 27, 2022)","criteria provided, multiple submitters, no conflicts"
3014,NM_001298.3(CNGA3):c.872C>G (p.Thr291Arg),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: nov 28, 2018)","criteria provided, single submitter"
3015,NM_001298.3(CNGA3):c.955T>C (p.Cys319Arg),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: may 15, 2022)","criteria provided, multiple submitters, no conflicts"
3016,NM_001298.3(CNGA3):c.1021T>C (p.Ser341Pro),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: sep 15, 2021)","criteria provided, multiple submitters, no conflicts"
3017,NM_001298.3(CNGA3):c.1228C>T (p.Arg410Trp),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3017,NM_001298.3(CNGA3):c.1228C>T (p.Arg410Trp),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3018,NM_001298.3(CNGA3):c.1255T>C (p.Ser419Pro),CNGA3,achromatopsia,C0302129,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
3019,NM_001298.3(CNGA3):c.1271T>C (p.Met424Thr),CNGA3,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: may 19, 2017)","criteria provided, single submitter"
3020,NM_001298.3(CNGA3):c.1279C>T (p.Arg427Cys),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
3020,NM_001298.3(CNGA3):c.1279C>T (p.Arg427Cys),CNGA3,achromatopsia,C0302129,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
3020,NM_001298.3(CNGA3):c.1279C>T (p.Arg427Cys),CNGA3,abnormality of the eye,C4316870,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
3020,NM_001298.3(CNGA3):c.1279C>T (p.Arg427Cys),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
3021,NM_001298.3(CNGA3):c.1280G>T (p.Arg427Leu),CNGA3,achromatopsia 2,C1857618,"likely pathogenic(last reviewed: jun 5, 2020)","criteria provided, single submitter"
3022,NM_001298.3(CNGA3):c.1306C>T (p.Arg436Trp),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3022,NM_001298.3(CNGA3):c.1306C>T (p.Arg436Trp),CNGA3,achromatopsia,C0302129,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3022,NM_001298.3(CNGA3):c.1306C>T (p.Arg436Trp),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3023,NM_001298.3(CNGA3):c.1315C>T (p.Arg439Trp),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3023,NM_001298.3(CNGA3):c.1315C>T (p.Arg439Trp),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3024,NM_001298.3(CNGA3):c.1580T>C (p.Leu527Pro),CNGA3,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jan 30, 2019)","criteria provided, single submitter"
3025,NM_001298.3(CNGA3):c.1585G>A (p.Val529Met),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
3026,NM_001298.3(CNGA3):c.1641C>A (p.Phe547Leu),CNGA3,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
3026,NM_001298.3(CNGA3):c.1641C>A (p.Phe547Leu),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
3026,NM_001298.3(CNGA3):c.1641C>A (p.Phe547Leu),CNGA3,monochromacy,C5201048,"pathogenic/likely pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
3027,NM_001298.3(CNGA3):c.1686C>A (p.Asn562Lys),CNGA3,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: oct 26, 2018)","criteria provided, single submitter"
3028,NM_001298.3(CNGA3):c.1688G>A (p.Arg563His),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
3028,NM_001298.3(CNGA3):c.1688G>A (p.Arg563His),CNGA3,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
3029,NM_001298.3(CNGA3):c.1694C>T (p.Thr565Met),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: jan 26, 2023)","criteria provided, multiple submitters, no conflicts"
3029,NM_001298.3(CNGA3):c.1694C>T (p.Thr565Met),CNGA3,achromatopsia 2,C1857618,"pathogenic(last reviewed: jan 26, 2023)","criteria provided, multiple submitters, no conflicts"
3030,NM_001298.3(CNGA3):c.1706G>A (p.Arg569His),CNGA3,retinal dystrophy,C4229674,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
3031,NM_001298.3(CNGA3):c.1717T>C (p.Tyr573His),CNGA3,achromatopsia 2,C1857618,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
3032,NM_001298.3(CNGA3):c.1777G>A (p.Glu593Lys),CNGA3,achromatopsia,C0302129,"pathogenic(last reviewed: mar 20, 2018)","criteria provided, single submitter"
3033,NM_001298.3(CNGA3):c.1981C>A (p.Arg661Ser),CNGA3,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
3034,NM_145199.3(LIPT1):c.212C>T (p.Ser71Phe),LIPT1|MITD1,lipoyl transferase 1 deficiency,C5190588,"likely pathogenic(last reviewed: apr 1, 2020)","criteria provided, multiple submitters, no conflicts"
3035,NM_001386135.1(AFF3):c.698C>T (p.Ala233Val),AFF3,kinsship syndrome,CL1767195,"pathogenic/likely pathogenic(last reviewed: may 29, 2022)","criteria provided, multiple submitters, no conflicts"
3036,NM_002518.4(NPAS2):c.1363C>G (p.Pro455Ala),NPAS2|NPAS2-AS1,non-obstructive azoospermia,C4021107,"likely pathogenic(last reviewed: aug 1, 2015)","criteria provided, single submitter"
3037,NM_001395002.1(MAP4K4):c.1694G>A (p.Arg565Gln),MAP4K4,cerebral arteriovenous malformation,C0917804,"likely pathogenic(last reviewed: feb 14, 2018)","criteria provided, single submitter"
3038,NM_006236.3(POU3F3):c.983A>C (p.Gln328Pro),POU3F3,snijders blok-fisher syndrome,C5231424,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3039,NM_006236.3(POU3F3):c.998G>C (p.Arg333Pro),POU3F3,snijders blok-fisher syndrome,C5231424,"likely pathogenic(last reviewed: jul 2, 2021)","criteria provided, single submitter"
3040,NM_006236.3(POU3F3):c.1009G>A (p.Gly337Ser),POU3F3,snijders blok-fisher syndrome,C5231424,"likely pathogenic(last reviewed: sep 29, 2021)","criteria provided, single submitter"
3041,NM_006236.3(POU3F3):c.1019A>C (p.Gln340Pro),POU3F3,snijders blok-fisher syndrome,C5231424,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, single submitter"
3042,NM_006236.3(POU3F3):c.1085G>T (p.Arg362Leu),POU3F3,snijders blok-fisher syndrome,C5231424,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3043,NM_006236.3(POU3F3):c.1165T>G (p.Ser389Ala),POU3F3,snijders blok-fisher syndrome,C5231424,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
3044,NM_006236.3(POU3F3):c.1217A>G (p.Lys406Arg),POU3F3,snijders blok-fisher syndrome,C5231424,"likely pathogenic(last reviewed: may 25, 2020)","criteria provided, single submitter"
3045,NM_006236.3(POU3F3):c.1220G>T (p.Arg407Leu),POU3F3,snijders blok-fisher syndrome,C5231424,"likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
3046,NM_022336.4(EDAR):c.1259G>A (p.Arg420Gln),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3046,NM_022336.4(EDAR):c.1259G>A (p.Arg420Gln),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3046,NM_022336.4(EDAR):c.1259G>A (p.Arg420Gln),EDAR|RANBP2,"ectodermal dysplasia 11b, hypohidrotic/hair/tooth type, autosomal recessive",C3539920,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3046,NM_022336.4(EDAR):c.1259G>A (p.Arg420Gln),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3047,NM_022336.4(EDAR):c.1214G>A (p.Gly405Asp),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: oct 18, 2021)","criteria provided, single submitter"
3047,NM_022336.4(EDAR):c.1214G>A (p.Gly405Asp),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: oct 18, 2021)","criteria provided, single submitter"
3048,NM_022336.4(EDAR):c.1214G>C (p.Gly405Ala),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: nov 8, 2021)","criteria provided, single submitter"
3048,NM_022336.4(EDAR):c.1214G>C (p.Gly405Ala),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: nov 8, 2021)","criteria provided, single submitter"
3049,NM_022336.4(EDAR):c.1213G>C (p.Gly405Arg),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"likely pathogenic(last reviewed: oct 18, 2021)","criteria provided, single submitter"
3049,NM_022336.4(EDAR):c.1213G>C (p.Gly405Arg),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"likely pathogenic(last reviewed: oct 18, 2021)","criteria provided, single submitter"
3050,NM_022336.4(EDAR):c.1208C>G (p.Thr403Arg),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, single submitter"
3050,NM_022336.4(EDAR):c.1208C>G (p.Thr403Arg),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, single submitter"
3051,NM_022336.4(EDAR):c.1208C>T (p.Thr403Met),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3051,NM_022336.4(EDAR):c.1208C>T (p.Thr403Met),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3052,NM_022336.4(EDAR):c.1144G>A (p.Gly382Ser),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3052,NM_022336.4(EDAR):c.1144G>A (p.Gly382Ser),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3053,NM_022336.4(EDAR):c.1132G>A (p.Ala378Thr),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, single submitter"
3053,NM_022336.4(EDAR):c.1132G>A (p.Ala378Thr),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: oct 28, 2022)","criteria provided, single submitter"
3054,NM_022336.4(EDAR):c.1073G>A (p.Arg358Gln),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3054,NM_022336.4(EDAR):c.1073G>A (p.Arg358Gln),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3054,NM_022336.4(EDAR):c.1073G>A (p.Arg358Gln),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3055,NM_022336.4(EDAR):c.986T>G (p.Ile329Ser),RANBP2|EDAR,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
3055,NM_022336.4(EDAR):c.986T>G (p.Ile329Ser),RANBP2|EDAR,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
3056,NM_022336.4(EDAR):c.973C>T (p.Arg325Trp),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3056,NM_022336.4(EDAR):c.973C>T (p.Arg325Trp),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3057,NM_022336.4(EDAR):c.442T>C (p.Cys148Arg),EDAR|RANBP2,"ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive",C3887494,"likely pathogenic(last reviewed: mar 3, 2021)","criteria provided, single submitter"
3058,NM_022336.4(EDAR):c.293G>A (p.Arg98Gln),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: may 16, 2022)","criteria provided, single submitter"
3058,NM_022336.4(EDAR):c.293G>A (p.Arg98Gln),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: may 16, 2022)","criteria provided, single submitter"
3059,NM_022336.4(EDAR):c.292C>T (p.Arg98Trp),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
3059,NM_022336.4(EDAR):c.292C>T (p.Arg98Trp),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
3059,NM_022336.4(EDAR):c.292C>T (p.Arg98Trp),EDAR|RANBP2,"ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive",C3887494,"pathogenic/likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, multiple submitters, no conflicts"
3060,NM_022336.4(EDAR):c.287T>C (p.Phe96Ser),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"likely pathogenic(last reviewed: jun 1, 2020)","criteria provided, single submitter"
3061,NM_022336.4(EDAR):c.278G>C (p.Cys93Ser),EDAR|RANBP2,"ectodermal dysplasia 10b, hypohidrotic/hair/tooth type, autosomal recessive",C3887494,"pathogenic(last reviewed: dec 18, 2017)","criteria provided, single submitter"
3062,NM_022336.4(EDAR):c.266G>A (p.Arg89His),RANBP2|EDAR,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
3062,NM_022336.4(EDAR):c.266G>A (p.Arg89His),RANBP2|EDAR,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
3062,NM_022336.4(EDAR):c.266G>A (p.Arg89His),RANBP2|EDAR,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
3063,NM_022336.4(EDAR):c.265C>T (p.Arg89Cys),EDAR|RANBP2,autosomal recessive hypohidrotic ectodermal dysplasia syndrome,C0406702,"pathogenic(last reviewed: jun 28, 2022)","criteria provided, single submitter"
3063,NM_022336.4(EDAR):c.265C>T (p.Arg89Cys),EDAR|RANBP2,"ectodermal dysplasia 10a, hypohidrotic/hair/nail type, autosomal dominant",C3888065,"pathogenic(last reviewed: jun 28, 2022)","criteria provided, single submitter"
3064,NM_001128178.3(NPHP1):c.859G>A (p.Gly287Arg),NPHP1,nephronophthisis,C0687120,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
3065,NM_006343.3(MERTK):c.345C>G (p.Cys115Trp),MERTK,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
3065,NM_006343.3(MERTK):c.345C>G (p.Cys115Trp),MERTK,retinitis pigmentosa 38,C3151228,"pathogenic/likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, multiple submitters, no conflicts"
3066,NM_006343.3(MERTK):c.2162A>C (p.His721Pro),MERTK,retinitis pigmentosa 38,C3151228,"likely pathogenic(last reviewed: feb 15, 2019)","criteria provided, single submitter"
3067,NM_006343.3(MERTK):c.2192T>C (p.Leu731Ser),MERTK,retinitis pigmentosa 38,C3151228,"likely pathogenic(last reviewed: sep 10, 2013)","criteria provided, single submitter"
3068,NM_006343.3(MERTK):c.2302G>A (p.Ala768Thr),MERTK,retinitis pigmentosa,C0035334,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
3069,NM_006343.3(MERTK):c.2303C>T (p.Ala768Val),MERTK,retinitis pigmentosa 38,C3151228,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3070,NM_006343.3(MERTK):c.2418C>A (p.Asn806Lys),MERTK,retinal dystrophy,C4229674,"likely pathogenic(last reviewed: jul 9, 2019)","criteria provided, single submitter"
3071,NM_006343.3(MERTK):c.2507G>A (p.Cys836Tyr),MERTK,retinitis pigmentosa,C0035334,"pathogenic(last reviewed: jan 9, 2020)","criteria provided, single submitter"
3072,NM_006343.3(MERTK):c.2530C>T (p.Arg844Cys),MERTK,retinitis pigmentosa 38,C3151228,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
3073,NM_012275.3(IL36RN):c.80T>C (p.Leu27Pro),IL36RN,generalized pustular psoriasis,C0343055,"pathogenic(last reviewed: may 19, 2022)","criteria provided, multiple submitters, no conflicts"
3074,NM_003466.4(PAX8):c.203C>T (p.Thr68Ile),PAX8|PAX8-AS1,"hypothyroidism, congenital, nongoitrous, 2",C1869118,"likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, single submitter"
3075,NM_003466.4(PAX8):c.160A>T (p.Ser54Cys),PAX8|PAX8-AS1,"hypothyroidism, congenital, nongoitrous, 2",C1869118,"likely pathogenic(last reviewed: nov 7, 2016)","criteria provided, single submitter"
3076,NM_139343.3(BIN1):c.700C>T (p.Arg234Cys),BIN1,"myopathy, centronuclear, 2",C0410204,"pathogenic/likely pathogenic(last reviewed: dec 15, 2021)","criteria provided, multiple submitters, no conflicts"
3077,NM_139343.3(BIN1):c.433C>T (p.Arg145Cys),BIN1,"myopathy, centronuclear, 2",C0410204,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3078,NM_000122.2(ERCC3):c.466A>G (p.Ile156Val),ERCC3,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
3079,NM_000312.4(PROC):c.41G>A (p.Trp14Ter),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: feb 22, 2022)","criteria provided, single submitter"
3080,NM_000312.4(PROC):c.76G>A (p.Val26Met),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3081,NM_000312.4(PROC):c.94C>T (p.Arg32Cys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
3082,NM_000312.4(PROC):c.124C>T (p.Arg42Cys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: oct 12, 2021)","criteria provided, multiple submitters, no conflicts"
3082,NM_000312.4(PROC):c.124C>T (p.Arg42Cys),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"pathogenic/likely pathogenic(last reviewed: oct 12, 2021)","criteria provided, multiple submitters, no conflicts"
3082,NM_000312.4(PROC):c.124C>T (p.Arg42Cys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: oct 12, 2021)","criteria provided, multiple submitters, no conflicts"
3083,NM_000312.4(PROC):c.125G>A (p.Arg42His),PROC,deep venous thrombosis,C0149871,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, multiple submitters, no conflicts"
3083,NM_000312.4(PROC):c.125G>A (p.Arg42His),PROC,thromboembolism,C0040038,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, multiple submitters, no conflicts"
3083,NM_000312.4(PROC):c.125G>A (p.Arg42His),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, multiple submitters, no conflicts"
3084,NM_000312.4(PROC):c.127G>A (p.Ala43Thr),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: dec 10, 2021)","criteria provided, single submitter"
3085,NM_000312.4(PROC):c.169C>T (p.Arg57Trp),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
3085,NM_000312.4(PROC):c.169C>T (p.Arg57Trp),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
3085,NM_000312.4(PROC):c.169C>T (p.Arg57Trp),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
3086,NM_000312.4(PROC):c.199G>A (p.Glu67Lys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: dec 27, 2018)","criteria provided, single submitter"
3087,NM_000312.4(PROC):c.226G>A (p.Val76Met),PROC,cerebral palsy,C0007789,"pathogenic/likely pathogenic(last reviewed: jun 10, 2021)","criteria provided, multiple submitters, no conflicts"
3087,NM_000312.4(PROC):c.226G>A (p.Val76Met),PROC,abnormal thrombosis,C4025731,"pathogenic/likely pathogenic(last reviewed: jun 10, 2021)","criteria provided, multiple submitters, no conflicts"
3088,NM_000312.4(PROC):c.303C>A (p.Cys101Ter),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"pathogenic/likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
3088,NM_000312.4(PROC):c.303C>A (p.Cys101Ter),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
3088,NM_000312.4(PROC):c.303C>A (p.Cys101Ter),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, multiple submitters, no conflicts"
3089,NM_000312.4(PROC):c.352T>C (p.Phe118Leu),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
3089,NM_000312.4(PROC):c.352T>C (p.Phe118Leu),PROC,thromboembolism,C0040038,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
3089,NM_000312.4(PROC):c.352T>C (p.Phe118Leu),PROC,deep venous thrombosis,C0149871,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
3090,NM_000312.4(PROC):c.400G>T (p.Glu134Ter),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3091,NM_000312.4(PROC):c.421T>C (p.Ser141Pro),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3092,NM_000312.4(PROC):c.433G>A (p.Gly145Ser),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jul 22, 2021)","criteria provided, single submitter"
3093,NM_000312.4(PROC):c.440G>A (p.Cys147Tyr),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, multiple submitters, no conflicts"
3093,NM_000312.4(PROC):c.440G>A (p.Cys147Tyr),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, multiple submitters, no conflicts"
3094,NM_000312.4(PROC):c.472C>T (p.Arg158Trp),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jan 1, 2020)","criteria provided, single submitter"
3095,NM_000312.4(PROC):c.479G>C (p.Cys160Ser),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: feb 23, 2021)","criteria provided, single submitter"
3096,NM_000312.4(PROC):c.497A>G (p.Tyr166Cys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,likely pathogenic,"criteria provided, single submitter"
3097,NM_000312.4(PROC):c.524G>A (p.Cys175Tyr),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3098,NM_000312.4(PROC):c.532G>C (p.Ala178Pro),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3099,NM_000312.4(PROC):c.541T>G (p.Phe181Val),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
3099,NM_000312.4(PROC):c.541T>G (p.Phe181Val),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
3099,NM_000312.4(PROC):c.541T>G (p.Phe181Val),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
3100,NM_000312.4(PROC):c.631C>T (p.Arg211Trp),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: may 29, 2022)","criteria provided, multiple submitters, no conflicts"
3100,NM_000312.4(PROC):c.631C>T (p.Arg211Trp),PROC,reduced protein c activity,C0398625,"pathogenic/likely pathogenic(last reviewed: may 29, 2022)","criteria provided, multiple submitters, no conflicts"
3101,NM_000312.4(PROC):c.632G>A (p.Arg211Gln),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jan 11, 2021)","criteria provided, single submitter"
3102,NM_000312.4(PROC):c.658C>T (p.Arg220Trp),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: sep 21, 2021)","criteria provided, single submitter"
3103,NM_000312.4(PROC):c.659G>A (p.Arg220Gln),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3103,NM_000312.4(PROC):c.659G>A (p.Arg220Gln),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3103,NM_000312.4(PROC):c.659G>A (p.Arg220Gln),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3103,NM_000312.4(PROC):c.659G>A (p.Arg220Gln),PROC,reduced protein c activity,C0398625,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3104,NM_000312.4(PROC):c.673T>C (p.Trp225Arg),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: apr 21, 2021)","criteria provided, single submitter"
3105,NM_000312.4(PROC):c.715G>A (p.Gly239Arg),PROC,deep venous thrombosis,C0149871,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3106,NM_000312.4(PROC):c.752C>T (p.Ala251Val),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"likely pathogenic(last reviewed: jan 8, 2020)","criteria provided, single submitter"
3107,NM_000312.4(PROC):c.790A>G (p.Arg264Gly),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: apr 11, 2022)","criteria provided, single submitter"
3108,NM_000312.4(PROC):c.814C>T (p.Arg272Cys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
3108,NM_000312.4(PROC):c.814C>T (p.Arg272Cys),PROC,thromboembolism,C0040038,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
3109,NM_000312.4(PROC):c.862C>T (p.His288Tyr),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jun 12, 2020)","criteria provided, single submitter"
3110,NM_000312.4(PROC):c.889G>C (p.Asp297His),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
3110,NM_000312.4(PROC):c.889G>C (p.Asp297His),PROC,"thrombophilia due to protein c deficiency, autosomal recessive",C2676759,"pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
3110,NM_000312.4(PROC):c.889G>C (p.Asp297His),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: aug 24, 2022)","criteria provided, multiple submitters, no conflicts"
3111,NM_000312.4(PROC):c.925G>A (p.Ala309Thr),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
3112,NM_000312.4(PROC):c.935C>T (p.Ser312Leu),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3113,NM_000312.4(PROC):c.962C>T (p.Pro321Leu),PROC,deep venous thrombosis,C0149871,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3113,NM_000312.4(PROC):c.962C>T (p.Pro321Leu),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3114,NM_000312.4(PROC):c.970G>A (p.Gly324Ser),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: feb 17, 2022)","criteria provided, single submitter"
3115,NM_000312.4(PROC):c.982C>T (p.Arg328Cys),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic/likely pathogenic(last reviewed: jan 21, 2022)","criteria provided, multiple submitters, no conflicts"
3115,NM_000312.4(PROC):c.982C>T (p.Arg328Cys),PROC,reduced protein c activity,C0398625,"pathogenic/likely pathogenic(last reviewed: jan 21, 2022)","criteria provided, multiple submitters, no conflicts"
3116,NM_000312.4(PROC):c.983G>A (p.Arg328His),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: oct 27, 2021)","criteria provided, single submitter"
3117,NM_000312.4(PROC):c.1019C>A (p.Thr340Lys),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3118,NM_000312.4(PROC):c.1019C>T (p.Thr340Met),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, single submitter"
3119,NM_000312.4(PROC):c.1099G>A (p.Val367Met),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
3120,NM_000312.4(PROC):c.1154T>C (p.Met385Thr),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: aug 4, 2021)","criteria provided, single submitter"
3121,NM_000312.4(PROC):c.1163C>T (p.Ala388Val),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jan 1, 2020)","criteria provided, multiple submitters, no conflicts"
3121,NM_000312.4(PROC):c.1163C>T (p.Ala388Val),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: jan 1, 2020)","criteria provided, multiple submitters, no conflicts"
3122,NM_000312.4(PROC):c.1166G>C (p.Gly389Ala),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: dec 27, 2018)","criteria provided, single submitter"
3123,NM_000312.4(PROC):c.1201G>A (p.Asp401Asn),PROC,reduced protein c activity,C0398625,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3124,NM_000312.4(PROC):c.1218G>A (p.Met406Ile),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"pathogenic(last reviewed: may 1, 2022)","criteria provided, single submitter"
3125,NM_000312.4(PROC):c.1267G>A (p.Gly423Ser),PROC,"thrombophilia due to protein c deficiency, autosomal dominant",C2674321,"likely pathogenic(last reviewed: jul 1, 2021)","criteria provided, single submitter"
3126,NM_017951.5(SMPD4):c.575T>C (p.Leu192Pro),SMPD4,"neurodevelopmental disorder with microcephaly, arthrogryposis, and structural brain anomalies",C5231431,"likely pathogenic(last reviewed: feb 14, 2020)","criteria provided, single submitter"
3127,NM_032357.4(CCDC115):c.92T>C (p.Leu31Ser),CCDC115,ccdc115-cdg,Cumapped39,"pathogenic(last reviewed: mar 10, 2021)","criteria provided, multiple submitters, no conflicts"
3128,NM_001349.4(DARS1):c.1481G>A (p.Arg494His),DARS1,hypomyelination with brain stem and spinal cord involvement and leg spasticity,C4755254,"likely pathogenic(last reviewed: may 3, 2020)","criteria provided, single submitter"
3129,NM_001349.4(DARS1):c.389G>C (p.Cys130Ser),DARS1,abnormality of brain morphology,C4021085,likely pathogenic,"criteria provided, single submitter"
3130,NM_003937.3(KYNU):c.326G>C (p.Trp109Ser),KYNU,catel-manzke syndrome,C1844887,"pathogenic(last reviewed: jan 7, 2012)","criteria provided, single submitter"
3131,NM_003937.3(KYNU):c.773T>C (p.Val258Ala),KYNU,hydroxykynureninuria,C0268474,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3132,NM_003937.3(KYNU):c.989G>A (p.Arg330Gln),KYNU,catel-manzke syndrome,C1844887,"pathogenic(last reviewed: jan 7, 2012)","criteria provided, single submitter"
3133,NM_003937.3(KYNU):c.1282C>T (p.Arg428Trp),KYNU,catel-manzke syndrome,C1844887,"pathogenic(last reviewed: jan 7, 2012)","criteria provided, single submitter"
3134,NM_014795.4(ZEB2):c.3067G>A (p.Gly1023Arg),ZEB2,marfanoid habitus and intellectual disability,CL536965,likely pathogenic,"criteria provided, single submitter"
3135,NM_014795.4(ZEB2):c.3023T>G (p.Phe1008Cys),ZEB2,mowat-wilson syndrome,C1856113,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
3136,NM_014795.4(ZEB2):c.2932G>T (p.Asp978Tyr),ZEB2,mowat-wilson syndrome,C1856113,"likely pathogenic(last reviewed: jul 17, 2012)","criteria provided, single submitter"
3137,NM_014795.4(ZEB2):c.1001G>C (p.Cys334Ser),ZEB2,see cases,Cumapped260,"likely pathogenic(last reviewed: may 4, 2021)","criteria provided, single submitter"
3138,NM_014795.4(ZEB2):c.982C>T (p.His328Tyr),ZEB2,see cases,Cumapped260,"likely pathogenic(last reviewed: apr 26, 2021)","criteria provided, single submitter"
3139,NM_014795.4(ZEB2):c.899A>G (p.His300Arg),ZEB2,mowat-wilson syndrome,C1856113,"likely pathogenic(last reviewed: oct 18, 2019)","criteria provided, single submitter"
3140,NM_014795.4(ZEB2):c.851G>A (p.Cys284Tyr),ZEB2,mowat-wilson syndrome,C1856113,"likely pathogenic(last reviewed: jun 19, 2020)","criteria provided, single submitter"
3141,NM_181741.4(ORC4):c.956A>G (p.His319Arg),ORC4,meier-gorlin syndrome 2,C3151097,"likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, single submitter"
3142,NM_181741.4(ORC4):c.521A>G (p.Tyr174Cys),ORC4,meier-gorlin syndrome 2,C3151097,"pathogenic/likely pathogenic(last reviewed: dec 30, 2022)","criteria provided, multiple submitters, no conflicts"
3143,NM_181741.4(ORC4):c.1A>G (p.Met1Val),ORC4,meier-gorlin syndrome 2,C3151097,"pathogenic(last reviewed: mar 18, 2016)","criteria provided, single submitter"
3144,NM_001378120.1(MBD5):c.1A>G (p.Met1Val),MBD5,"intellectual disability, autosomal dominant 1",C3276355,"likely pathogenic(last reviewed: oct 25, 2018)","criteria provided, single submitter"
3145,NM_001378120.1(MBD5):c.1250T>G (p.Met417Arg),MBD5,"intellectual disability, autosomal dominant 1",C3276355,"likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, single submitter"
3146,NM_001378120.1(MBD5):c.1756G>A (p.Ala586Thr),MBD5,"intellectual disability, autosomal dominant 1",C3276355,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
3147,NM_004522.3(KIF5C):c.265T>C (p.Ser89Pro),KIF5C,complex cortical dysplasia with other brain malformations 2,C3809013,pathogenic,"criteria provided, single submitter"
3148,NM_004522.3(KIF5C):c.709G>A (p.Glu237Lys),KIF5C,complex cortical dysplasia with other brain malformations 2,C3809013,"pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
3149,NM_015702.3(MMADHC):c.776T>C (p.Leu259Pro),MMADHC,methylmalonic aciduria and homocystinuria type cbld,C2678262,"likely pathogenic(last reviewed: may 3, 2022)","criteria provided, single submitter"
3150,NM_000726.5(CACNB4):c.615A>T (p.Lys205Asn),CACNB4,spastic ataxia,Cumapped289,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
3151,NM_006186.4(NR4A2):c.943T>C (p.Cys315Arg),NR4A2,neurodevelopmental delay,C4022738,likely pathogenic,"criteria provided, single submitter"
3152,NM_006186.4(NR4A2):c.896G>T (p.Cys299Phe),NR4A2,"parkinson disease, late-onset",C3160718,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3153,NM_006186.4(NR4A2):c.854G>A (p.Gly285Asp),NR4A2,complex neurodevelopmental disorder,CL1777523,"likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, single submitter"
3154,NM_001111067.4(ACVR1):c.1067G>A (p.Gly356Asp),ACVR1,progressive myositis ossificans,Cumapped225,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3155,NM_001111067.4(ACVR1):c.983G>A (p.Gly328Glu),ACVR1,progressive myositis ossificans,Cumapped225,"pathogenic/likely pathogenic(last reviewed: oct 12, 2018)","criteria provided, multiple submitters, no conflicts"
3156,NM_001111067.4(ACVR1):c.772A>G (p.Arg258Gly),ACVR1,progressive myositis ossificans,Cumapped225,"likely pathogenic(last reviewed: nov 27, 2012)","criteria provided, single submitter"
3157,NM_001111067.4(ACVR1):c.617G>A (p.Arg206His),ACVR1,progressive myositis ossificans,Cumapped225,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3157,NM_001111067.4(ACVR1):c.617G>A (p.Arg206His),ACVR1,epicanthal fold,C0678230,"pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3158,NM_006593.4(TBR1):c.673A>T (p.Ile225Phe),TBR1,autistic behavior,C0856975,"likely pathogenic(last reviewed: mar 1, 2016)","criteria provided, single submitter"
3158,NM_006593.4(TBR1):c.673A>T (p.Ile225Phe),TBR1,severe global developmental delay,C1837397,"likely pathogenic(last reviewed: mar 1, 2016)","criteria provided, single submitter"
3159,NM_006593.4(TBR1):c.811T>C (p.Trp271Arg),TBR1,autistic behavior,C0856975,"likely pathogenic(last reviewed: may 28, 2016)","criteria provided, single submitter"
3159,NM_006593.4(TBR1):c.811T>C (p.Trp271Arg),TBR1,severe global developmental delay,C1837397,"likely pathogenic(last reviewed: may 28, 2016)","criteria provided, single submitter"
3160,NM_006593.4(TBR1):c.812G>C (p.Trp271Ser),TBR1,moderate global developmental delay,C2237142,"likely pathogenic(last reviewed: jun 22, 2017)","criteria provided, single submitter"
3161,NM_006593.4(TBR1):c.1118A>G (p.Gln373Arg),TBR1,moderate global developmental delay,C2237142,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
3161,NM_006593.4(TBR1):c.1118A>G (p.Gln373Arg),TBR1,behavioral abnormality,C0233514,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
3161,NM_006593.4(TBR1):c.1118A>G (p.Gln373Arg),TBR1,aplasia/hypoplasia of the corpus callosum,C1861866,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
3161,NM_006593.4(TBR1):c.1118A>G (p.Gln373Arg),TBR1,seizure,C0036572,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
3161,NM_006593.4(TBR1):c.1118A>G (p.Gln373Arg),TBR1,moderate global developmental delay,C2237142,"pathogenic/likely pathogenic(last reviewed: nov 8, 2022)","criteria provided, multiple submitters, no conflicts"
3162,NM_006593.4(TBR1):c.1126G>C (p.Asp376His),TBR1,"autism, susceptibility to, 5",C3275438,"pathogenic(last reviewed: feb 18, 2022)","criteria provided, single submitter"
3163,NM_006593.4(TBR1):c.1155C>G (p.Asn385Lys),TBR1,autistic behavior,C0856975,"likely pathogenic(last reviewed: jul 11, 2016)","criteria provided, single submitter"
3163,NM_006593.4(TBR1):c.1155C>G (p.Asn385Lys),TBR1,moderate global developmental delay,C2237142,"likely pathogenic(last reviewed: jul 11, 2016)","criteria provided, single submitter"
3164,NM_006593.4(TBR1):c.1162G>C (p.Ala388Pro),TBR1,"autism, susceptibility to, 5",C3275438,"likely pathogenic(last reviewed: may 25, 2022)","criteria provided, single submitter"
3165,NM_006593.4(TBR1):c.1168G>C (p.Gly390Arg),TBR1,"autism, susceptibility to, 5",C3275438,"likely pathogenic(last reviewed: mar 10, 2022)","criteria provided, single submitter"
3166,NM_006593.4(TBR1):c.1174C>T (p.Arg392Trp),TBR1,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: nov 16, 2020)","criteria provided, single submitter"
3167,NM_006593.4(TBR1):c.1237G>C (p.Asp413His),TBR1,see cases,Cumapped260,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3168,NM_022168.4(IFIH1):c.2936T>G (p.Leu979Trp),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3168,NM_022168.4(IFIH1):c.2936T>G (p.Leu979Trp),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3169,NM_022168.4(IFIH1):c.2465G>A (p.Arg822Gln),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
3169,NM_022168.4(IFIH1):c.2465G>A (p.Arg822Gln),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
3169,NM_022168.4(IFIH1):c.2465G>A (p.Arg822Gln),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
3170,NM_022168.4(IFIH1):c.2336G>T (p.Arg779Leu),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic/likely pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
3170,NM_022168.4(IFIH1):c.2336G>T (p.Arg779Leu),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic/likely pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
3170,NM_022168.4(IFIH1):c.2336G>T (p.Arg779Leu),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic/likely pathogenic(last reviewed: jul 21, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,hyperreflexia,C0151889,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,abnormal cerebral white matter morphology,Cumapped3,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,neonatal hypotonia,C2267233,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,abnormal upper motor neuron morphology,C4025723,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,abnormal basal ganglia morphology,C4520981,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,developmental regression,C1836830,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3171,NM_022168.4(IFIH1):c.2336G>A (p.Arg779His),IFIH1,clonus,C0009024,"pathogenic/likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, multiple submitters, no conflicts"
3172,NM_022168.4(IFIH1):c.2335C>T (p.Arg779Cys),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
3172,NM_022168.4(IFIH1):c.2335C>T (p.Arg779Cys),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
3173,NM_022168.4(IFIH1):c.2159G>A (p.Arg720Gln),IFIH1,singleton-merten syndrome 1,C4225427,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
3173,NM_022168.4(IFIH1):c.2159G>A (p.Arg720Gln),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
3173,NM_022168.4(IFIH1):c.2159G>A (p.Arg720Gln),IFIH1,aicardi-goutieres syndrome 7,C3888244,"pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
3174,NM_022168.4(IFIH1):c.1850T>C (p.Ile617Thr),IFIH1,neurodevelopmental delay,C4022738,pathogenic,"criteria provided, single submitter"
3175,NM_022168.4(IFIH1):c.1246A>C (p.Ile416Leu),IFIH1,aicardi-goutieres syndrome 7,C3888244,"likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, single submitter"
3176,NM_022168.4(IFIH1):c.1178A>T (p.Asp393Val),IFIH1,aicardi-goutieres syndrome 7,C3888244,"likely pathogenic(last reviewed: dec 13, 2018)","criteria provided, single submitter"
3177,NM_022168.4(IFIH1):c.986T>C (p.Leu329Pro),IFIH1,singleton-merten syndrome 1,C4225427,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3177,NM_022168.4(IFIH1):c.986T>C (p.Leu329Pro),IFIH1,aicardi-goutieres syndrome 7,C3888244,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3178,NM_006922.4(SCN3A):c.2653C>T (p.Leu885Phe),SCN3A,"developmental and epileptic encephalopathy, 62",C2931919,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3179,NM_006922.4(SCN3A):c.2624T>C (p.Ile875Thr),SCN3A,"developmental and epileptic encephalopathy, 62",C2931919,"pathogenic/likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
3179,NM_006922.4(SCN3A):c.2624T>C (p.Ile875Thr),SCN3A,"epilepsy, familial focal, with variable foci 4",C4693694,"pathogenic/likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
3180,NM_006922.4(SCN3A):c.2564T>C (p.Leu855Pro),SCN3A,"developmental and epileptic encephalopathy, 62",C2931919,"likely pathogenic(last reviewed: dec 21, 2021)","criteria provided, single submitter"
3181,NM_006922.4(SCN3A):c.626T>C (p.Leu209Pro),SCN3A,"developmental and epileptic encephalopathy, 62",C2931919,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3181,NM_006922.4(SCN3A):c.626T>C (p.Leu209Pro),SCN3A,atypical cerebral palsy,C0007789,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3182,NM_001040142.2(SCN2A):c.1A>T (p.Met1Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 7, 2017)","criteria provided, single submitter"
3183,NM_001040142.2(SCN2A):c.164A>C (p.Asp55Ala),SCN2A,epileptic encephalopathy,C0543888,"likely pathogenic(last reviewed: feb 18, 2020)","criteria provided, single submitter"
3184,NM_001040142.2(SCN2A):c.304C>G (p.Arg102Gly),SCN2A,neurodevelopmental disorder,C1535926,"likely pathogenic(last reviewed: may 6, 2020)","criteria provided, single submitter"
3185,NM_001040142.2(SCN2A):c.407T>G (p.Met136Arg),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: may 7, 2022)","criteria provided, single submitter"
3185,NM_001040142.2(SCN2A):c.407T>G (p.Met136Arg),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: may 7, 2022)","criteria provided, single submitter"
3186,NM_001040142.2(SCN2A):c.408G>A (p.Met136Ile),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
3186,NM_001040142.2(SCN2A):c.408G>A (p.Met136Ile),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, multiple submitters, no conflicts"
3187,NM_001040142.2(SCN2A):c.571T>G (p.Trp191Gly),SCN2A,focal epilepsy,C0014547,"likely pathogenic(last reviewed: nov 16, 2016)","criteria provided, single submitter"
3188,NM_001040142.2(SCN2A):c.573G>T (p.Trp191Cys),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3188,NM_001040142.2(SCN2A):c.573G>T (p.Trp191Cys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3189,NM_001040142.2(SCN2A):c.586T>G (p.Phe196Val),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3189,NM_001040142.2(SCN2A):c.586T>G (p.Phe196Val),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3190,NM_001371246.1(SCN2A):c.634A>G (p.Asn212Asp),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: aug 28, 2018)","criteria provided, multiple submitters, no conflicts"
3191,NM_001040142.2(SCN2A):c.620T>C (p.Phe207Ser),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 8, 2019)","criteria provided, single submitter"
3192,NM_001040142.2(SCN2A):c.629T>A (p.Leu210Gln),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3192,NM_001040142.2(SCN2A):c.629T>A (p.Leu210Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3193,NM_001040142.2(SCN2A):c.634A>G (p.Asn212Asp),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3194,NM_001040142.2(SCN2A):c.635A>G (p.Asn212Ser),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3194,NM_001040142.2(SCN2A):c.635A>G (p.Asn212Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3195,NM_001040142.2(SCN2A):c.638T>C (p.Val213Ala),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3195,NM_001040142.2(SCN2A):c.638T>C (p.Val213Ala),SCN2A,malignant migrating partial seizures of infancy,C3494976,"pathogenic/likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3196,NM_001040142.2(SCN2A):c.644C>A (p.Ala215Glu),SCN2A,see cases,Cumapped260,"likely pathogenic(last reviewed: may 24, 2021)","criteria provided, single submitter"
3197,NM_001040142.2(SCN2A):c.647T>C (p.Leu216Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
3198,NM_001040142.2(SCN2A):c.647T>G (p.Leu216Trp),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: feb 14, 2022)","criteria provided, multiple submitters, no conflicts"
3198,NM_001040142.2(SCN2A):c.647T>G (p.Leu216Trp),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: feb 14, 2022)","criteria provided, multiple submitters, no conflicts"
3199,NM_001040142.2(SCN2A):c.658A>G (p.Arg220Gly),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: sep 30, 2021)","criteria provided, single submitter"
3199,NM_001040142.2(SCN2A):c.658A>G (p.Arg220Gly),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: sep 30, 2021)","criteria provided, single submitter"
3200,NM_001040142.2(SCN2A):c.664C>A (p.Leu222Ile),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3200,NM_001040142.2(SCN2A):c.664C>A (p.Leu222Ile),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3201,NM_001040142.2(SCN2A):c.668G>A (p.Arg223Gln),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: apr 4, 2022)","criteria provided, multiple submitters, no conflicts"
3201,NM_001040142.2(SCN2A):c.668G>A (p.Arg223Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: apr 4, 2022)","criteria provided, multiple submitters, no conflicts"
3201,NM_001040142.2(SCN2A):c.668G>A (p.Arg223Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: apr 4, 2022)","criteria provided, multiple submitters, no conflicts"
3202,NM_001040142.2(SCN2A):c.685T>A (p.Ser229Thr),SCN2A,infantile spasms,C3887898,likely pathogenic,"criteria provided, single submitter"
3203,NM_001040142.2(SCN2A):c.685T>G (p.Ser229Ala),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3203,NM_001040142.2(SCN2A):c.685T>G (p.Ser229Ala),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3204,NM_001040142.2(SCN2A):c.710T>C (p.Ile237Thr),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
3205,NM_001040142.2(SCN2A):c.718G>T (p.Ala240Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: jan 26, 2022)","criteria provided, multiple submitters, no conflicts"
3205,NM_001040142.2(SCN2A):c.718G>T (p.Ala240Ser),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: jan 26, 2022)","criteria provided, multiple submitters, no conflicts"
3205,NM_001040142.2(SCN2A):c.718G>T (p.Ala240Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: jan 26, 2022)","criteria provided, multiple submitters, no conflicts"
3206,NM_001040142.2(SCN2A):c.718G>A (p.Ala240Thr),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3206,NM_001040142.2(SCN2A):c.718G>A (p.Ala240Thr),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3207,NM_001040142.2(SCN2A):c.719C>T (p.Ala240Val),SCN2A,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: apr 20, 2020)","criteria provided, multiple submitters, no conflicts"
3208,NM_001040142.2(SCN2A):c.722T>G (p.Leu241Arg),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
3208,NM_001040142.2(SCN2A):c.722T>G (p.Leu241Arg),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, multiple submitters, no conflicts"
3209,NM_001040142.2(SCN2A):c.751G>T (p.Val251Phe),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3209,NM_001040142.2(SCN2A):c.751G>T (p.Val251Phe),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3210,NM_001040142.2(SCN2A):c.751G>A (p.Val251Ile),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: apr 9, 2020)","criteria provided, multiple submitters, no conflicts"
3210,NM_001040142.2(SCN2A):c.751G>A (p.Val251Ile),SCN2A,epileptic encephalopathy,C0543888,"pathogenic/likely pathogenic(last reviewed: apr 9, 2020)","criteria provided, multiple submitters, no conflicts"
3211,NM_001040142.2(SCN2A):c.781G>T (p.Val261Leu),SCN2A,seizure,C0036572,pathogenic,"criteria provided, single submitter"
3212,NM_001040142.2(SCN2A):c.781G>A (p.Val261Met),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
3212,NM_001040142.2(SCN2A):c.781G>A (p.Val261Met),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
3212,NM_001040142.2(SCN2A):c.781G>A (p.Val261Met),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
3213,NM_001040142.2(SCN2A):c.785T>C (p.Phe262Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,likely pathogenic,"criteria provided, single submitter"
3214,NM_001040142.2(SCN2A):c.787G>A (p.Ala263Thr),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
3214,NM_001040142.2(SCN2A):c.787G>A (p.Ala263Thr),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
3215,NM_001040142.2(SCN2A):c.788C>A (p.Ala263Glu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: nov 15, 2017)","criteria provided, single submitter"
3216,NM_001040142.2(SCN2A):c.788C>T (p.Ala263Val),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: mar 24, 2023)","criteria provided, multiple submitters, no conflicts"
3216,NM_001040142.2(SCN2A):c.788C>T (p.Ala263Val),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: mar 24, 2023)","criteria provided, multiple submitters, no conflicts"
3216,NM_001040142.2(SCN2A):c.788C>T (p.Ala263Val),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: mar 24, 2023)","criteria provided, multiple submitters, no conflicts"
3216,NM_001040142.2(SCN2A):c.788C>T (p.Ala263Val),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: mar 24, 2023)","criteria provided, multiple submitters, no conflicts"
3216,NM_001040142.2(SCN2A):c.788C>T (p.Ala263Val),SCN2A,infantile spasms,C3887898,"pathogenic(last reviewed: mar 24, 2023)","criteria provided, multiple submitters, no conflicts"
3216,NM_001040142.2(SCN2A):c.788C>T (p.Ala263Val),SCN2A,epileptic encephalopathy,C0543888,"pathogenic(last reviewed: mar 24, 2023)","criteria provided, multiple submitters, no conflicts"
3217,NM_001040142.2(SCN2A):c.819C>A (p.Asn273Lys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
3218,NM_001040142.2(SCN2A):c.1058G>C (p.Cys353Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 14, 2020)","criteria provided, single submitter"
3219,NM_001040142.2(SCN2A):c.1120T>C (p.Phe374Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3219,NM_001040142.2(SCN2A):c.1120T>C (p.Phe374Leu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3220,NM_001040142.2(SCN2A):c.1136G>A (p.Arg379His),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: jan 20, 2021)","criteria provided, single submitter"
3221,NM_001040142.2(SCN2A):c.1141A>G (p.Met381Val),SCN2A,hemiplegia/hemiparesis,C0375206,likely pathogenic,"criteria provided, single submitter"
3222,NM_001040142.2(SCN2A):c.1147C>G (p.Gln383Glu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3222,NM_001040142.2(SCN2A):c.1147C>G (p.Gln383Glu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3223,NM_001040142.2(SCN2A):c.1148A>T (p.Gln383Leu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3223,NM_001040142.2(SCN2A):c.1148A>T (p.Gln383Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3224,NM_001040142.2(SCN2A):c.1242C>G (p.Phe414Leu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3224,NM_001040142.2(SCN2A):c.1242C>G (p.Phe414Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3225,NM_001040142.2(SCN2A):c.1255T>A (p.Leu419Met),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 14, 2020)","criteria provided, single submitter"
3226,NM_001040142.2(SCN2A):c.1267G>T (p.Val423Leu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3226,NM_001040142.2(SCN2A):c.1267G>T (p.Val423Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3227,NM_001040142.2(SCN2A):c.1267G>C (p.Val423Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3228,NM_001040142.2(SCN2A):c.1270G>A (p.Val424Met),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3228,NM_001040142.2(SCN2A):c.1270G>A (p.Val424Met),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3228,NM_001040142.2(SCN2A):c.1270G>A (p.Val424Met),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3229,NM_001040142.2(SCN2A):c.1271T>G (p.Val424Gly),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3230,NM_001040142.2(SCN2A):c.1271T>C (p.Val424Ala),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3230,NM_001040142.2(SCN2A):c.1271T>C (p.Val424Ala),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3231,NM_001040142.2(SCN2A):c.1283A>T (p.Tyr428Phe),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
3232,NM_001040142.2(SCN2A):c.1289A>G (p.Glu430Gly),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3232,NM_001040142.2(SCN2A):c.1289A>G (p.Glu430Gly),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3233,NM_001040142.2(SCN2A):c.1312G>C (p.Glu438Gln),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: feb 11, 2022)","criteria provided, single submitter"
3233,NM_001040142.2(SCN2A):c.1312G>C (p.Glu438Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: feb 11, 2022)","criteria provided, single submitter"
3234,NM_001040142.2(SCN2A):c.1312G>A (p.Glu438Lys),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3234,NM_001040142.2(SCN2A):c.1312G>A (p.Glu438Lys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3235,NM_001040142.2(SCN2A):c.2305A>G (p.Ile769Val),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3235,NM_001040142.2(SCN2A):c.2305A>G (p.Ile769Val),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3236,NM_001040142.2(SCN2A):c.2317A>G (p.Thr773Ala),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: dec 13, 2018)","criteria provided, single submitter"
3237,NM_001040142.2(SCN2A):c.2501G>A (p.Ser834Asn),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 14, 2020)","criteria provided, multiple submitters, no conflicts"
3238,NM_001040142.2(SCN2A):c.2528T>A (p.Val843Glu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3238,NM_001040142.2(SCN2A):c.2528T>A (p.Val843Glu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3239,NM_001040142.2(SCN2A):c.2558G>C (p.Arg853Pro),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
3239,NM_001040142.2(SCN2A):c.2558G>C (p.Arg853Pro),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
3240,NM_001040142.2(SCN2A):c.2558G>A (p.Arg853Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
3240,NM_001040142.2(SCN2A):c.2558G>A (p.Arg853Gln),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
3240,NM_001040142.2(SCN2A):c.2558G>A (p.Arg853Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
3241,NM_001040142.2(SCN2A):c.2567G>A (p.Arg856Gln),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
3241,NM_001040142.2(SCN2A):c.2567G>A (p.Arg856Gln),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
3241,NM_001040142.2(SCN2A):c.2567G>A (p.Arg856Gln),SCN2A,seizure,C0036572,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
3242,NM_001040142.2(SCN2A):c.2588C>A (p.Ser863Tyr),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,pathogenic,"criteria provided, single submitter"
3243,NM_001040142.2(SCN2A):c.2627A>G (p.Asn876Ser),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3243,NM_001040142.2(SCN2A):c.2627A>G (p.Asn876Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3244,NM_001040142.2(SCN2A):c.2635G>A (p.Gly879Arg),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: dec 11, 2017)","criteria provided, single submitter"
3245,NM_001040142.2(SCN2A):c.2638G>T (p.Ala880Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
3245,NM_001040142.2(SCN2A):c.2638G>T (p.Ala880Ser),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
3245,NM_001040142.2(SCN2A):c.2638G>T (p.Ala880Ser),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
3246,NM_001040142.2(SCN2A):c.2638G>A (p.Ala880Thr),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3246,NM_001040142.2(SCN2A):c.2638G>A (p.Ala880Thr),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3246,NM_001040142.2(SCN2A):c.2638G>A (p.Ala880Thr),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3247,NM_001040142.2(SCN2A):c.2659G>C (p.Val887Leu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3248,NM_001040142.2(SCN2A):c.2674G>A (p.Val892Ile),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
3248,NM_001040142.2(SCN2A):c.2674G>A (p.Val892Ile),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: oct 29, 2022)","criteria provided, multiple submitters, no conflicts"
3249,NM_001040142.2(SCN2A):c.2687C>T (p.Ala896Val),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: oct 25, 2017)","criteria provided, multiple submitters, no conflicts"
3249,NM_001040142.2(SCN2A):c.2687C>T (p.Ala896Val),SCN2A,epileptic encephalopathy,C0543888,"pathogenic/likely pathogenic(last reviewed: oct 25, 2017)","criteria provided, multiple submitters, no conflicts"
3250,NM_001040142.2(SCN2A):c.2809C>T (p.Arg937Cys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
3250,NM_001040142.2(SCN2A):c.2809C>T (p.Arg937Cys),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
3251,NM_001040142.2(SCN2A):c.2872A>G (p.Met958Val),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: feb 28, 2022)","criteria provided, single submitter"
3251,NM_001040142.2(SCN2A):c.2872A>G (p.Met958Val),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: feb 28, 2022)","criteria provided, single submitter"
3252,NM_001040142.2(SCN2A):c.2928C>A (p.Asn976Lys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3252,NM_001040142.2(SCN2A):c.2928C>A (p.Asn976Lys),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3253,NM_001040142.2(SCN2A):c.2934C>A (p.Phe978Leu),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, single submitter"
3253,NM_001040142.2(SCN2A):c.2934C>A (p.Phe978Leu),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, single submitter"
3254,NM_001040142.2(SCN2A):c.2948T>G (p.Leu983Trp),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3254,NM_001040142.2(SCN2A):c.2948T>G (p.Leu983Trp),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3255,NM_001040142.2(SCN2A):c.2950A>G (p.Ser984Gly),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3255,NM_001040142.2(SCN2A):c.2950A>G (p.Ser984Gly),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3256,NM_001040142.2(SCN2A):c.2959A>T (p.Ser987Cys),SCN2A,"seizures, benign familial infantile, 3",C1843140,"likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, single submitter"
3256,NM_001040142.2(SCN2A):c.2959A>T (p.Ser987Cys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: nov 2, 2022)","criteria provided, single submitter"
3257,NM_001040142.2(SCN2A):c.2960G>T (p.Ser987Ile),SCN2A,hereditary episodic ataxia,C1720189,"pathogenic/likely pathogenic(last reviewed: feb 5, 2018)","criteria provided, multiple submitters, no conflicts"
3257,NM_001040142.2(SCN2A):c.2960G>T (p.Ser987Ile),SCN2A,seizure,C0036572,"pathogenic/likely pathogenic(last reviewed: feb 5, 2018)","criteria provided, multiple submitters, no conflicts"
3257,NM_001040142.2(SCN2A):c.2960G>T (p.Ser987Ile),SCN2A,vertigo,C1069915,"pathogenic/likely pathogenic(last reviewed: feb 5, 2018)","criteria provided, multiple submitters, no conflicts"
3257,NM_001040142.2(SCN2A):c.2960G>T (p.Ser987Ile),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: feb 5, 2018)","criteria provided, multiple submitters, no conflicts"
3258,NM_001040142.2(SCN2A):c.2986G>A (p.Asp996Asn),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"likely pathogenic(last reviewed: oct 5, 2021)","criteria provided, single submitter"
3259,NM_001040142.2(SCN2A):c.2995G>A (p.Glu999Lys),SCN2A,"seizures, benign familial infantile, 3",C1843140,"pathogenic/likely pathogenic(last reviewed: feb 24, 2022)","criteria provided, multiple submitters, no conflicts"
3259,NM_001040142.2(SCN2A):c.2995G>A (p.Glu999Lys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: feb 24, 2022)","criteria provided, multiple submitters, no conflicts"
3259,NM_001040142.2(SCN2A):c.2995G>A (p.Glu999Lys),SCN2A,"developmental and epileptic encephalopathy, 11",C4016378,"pathogenic/likely pathogenic(last reviewed: feb 24, 2022)","criteria provided, multiple submitters, no conflicts"
3260,NM_004482.4(GALNT3):c.1312C>T (p.Arg438Cys),GALNT3,"tumoral calcinosis, hyperphosphatemic, familial, 1",C4692564,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
3261,NM_024753.5(TTC21B):c.992G>A (p.Gly331Glu),TTC21B,nephronophthisis 12,C3151186,"likely pathogenic(last reviewed: may 17, 2022)","criteria provided, single submitter"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,jeune thoracic dystrophy,C0265275,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,nephronophthisis,C0687120,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,nephronophthisis 12,C3151186,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,asphyxiating thoracic dystrophy 4,C3151185,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,nephronophthisis 12,C3151186,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,infantile nephronophthisis,C1865872,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3262,NM_024753.5(TTC21B):c.626C>T (p.Pro209Leu),TTC21B|TTC21B-AS1,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3263,NM_001165963.4(SCN1A):c.2997C>G (p.Asn999Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
3264,NM_001165963.4(SCN1A):c.2983T>C (p.Phe995Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3265,NM_001165963.4(SCN1A):c.2981C>T (p.Ser994Leu),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
3266,NM_001165963.4(SCN1A):c.2975T>C (p.Leu992Pro),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: oct 17, 2019)","criteria provided, single submitter"
3267,NM_001165963.4(SCN1A):c.2974C>A (p.Leu992Met),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 24, 2022)","criteria provided, single submitter"
3268,NM_001165963.4(SCN1A):c.2971C>T (p.Leu991Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: apr 6, 2022)","criteria provided, multiple submitters, no conflicts"
3268,NM_001165963.4(SCN1A):c.2971C>T (p.Leu991Phe),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: apr 6, 2022)","criteria provided, multiple submitters, no conflicts"
3269,NM_001165963.4(SCN1A):c.2970G>C (p.Leu990Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3270,NM_001165963.4(SCN1A):c.2963T>G (p.Leu988Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: may 10, 2019)","criteria provided, single submitter"
3271,NM_001165963.4(SCN1A):c.2956C>T (p.Leu986Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
3272,NM_001165963.4(SCN1A):c.2951T>G (p.Leu984Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
3273,NM_001165963.4(SCN1A):c.2951T>C (p.Leu984Pro),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3274,NM_001165963.4(SCN1A):c.2950C>G (p.Leu984Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 5, 2022)","criteria provided, single submitter"
3275,NM_001165963.4(SCN1A):c.2948T>G (p.Val983Gly),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3276,NM_001165963.4(SCN1A):c.2948T>A (p.Val983Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
3277,NM_001165963.4(SCN1A):c.2947G>T (p.Val983Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3278,NM_001165963.4(SCN1A):c.2947G>A (p.Val983Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3279,NM_001165963.4(SCN1A):c.2942T>C (p.Leu981Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 5, 2022)","criteria provided, single submitter"
3280,NM_001165963.4(SCN1A):c.2940C>A (p.Asn980Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 10, 2021)","criteria provided, single submitter"
3281,NM_001165963.4(SCN1A):c.2936G>A (p.Gly979Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3281,NM_001165963.4(SCN1A):c.2936G>A (p.Gly979Glu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3282,NM_001165963.4(SCN1A):c.2929G>A (p.Val977Met),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3283,NM_001165963.4(SCN1A):c.2928G>C (p.Met976Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: feb 4, 2022)","criteria provided, single submitter"
3284,NM_001165963.4(SCN1A):c.2928G>A (p.Met976Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
3285,NM_001165963.4(SCN1A):c.2927T>C (p.Met976Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 10, 2022)","criteria provided, multiple submitters, no conflicts"
3285,NM_001165963.4(SCN1A):c.2927T>C (p.Met976Thr),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: sep 10, 2022)","criteria provided, multiple submitters, no conflicts"
3286,NM_001165963.4(SCN1A):c.2921T>G (p.Met974Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 22, 2022)","criteria provided, single submitter"
3287,NM_001165963.4(SCN1A):c.2911G>A (p.Val971Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jun 8, 2022)","criteria provided, multiple submitters, no conflicts"
3288,NM_001165963.4(SCN1A):c.2904C>G (p.Cys968Trp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3289,NM_001165963.4(SCN1A):c.2903G>A (p.Cys968Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3290,NM_001165963.4(SCN1A):c.2903G>T (p.Cys968Phe),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3291,NM_001165963.4(SCN1A):c.2879T>A (p.Met960Lys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: jun 20, 2022)","criteria provided, single submitter"
3292,NM_001165963.4(SCN1A):c.2879T>C (p.Met960Thr),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: aug 16, 2018)","criteria provided, single submitter"
3293,NM_001165963.4(SCN1A):c.2879T>G (p.Met960Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3294,NM_001165963.4(SCN1A):c.2876G>A (p.Cys959Tyr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
3295,NM_001165963.4(SCN1A):c.2875T>G (p.Cys959Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
3296,NM_001165963.4(SCN1A):c.2875T>C (p.Cys959Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3296,NM_001165963.4(SCN1A):c.2875T>C (p.Cys959Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3297,NM_001165963.4(SCN1A):c.2869T>G (p.Trp957Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 23, 2019)","criteria provided, single submitter"
3298,NM_001165963.4(SCN1A):c.2868G>A (p.Met956Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3299,NM_001165963.4(SCN1A):c.2867T>C (p.Met956Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 4, 2021)","criteria provided, multiple submitters, no conflicts"
3299,NM_001165963.4(SCN1A):c.2867T>C (p.Met956Thr),SCN1A,"generalized epilepsy with febrile seizures plus, type 1",C1858672,"pathogenic/likely pathogenic(last reviewed: sep 4, 2021)","criteria provided, multiple submitters, no conflicts"
3300,NM_001165963.4(SCN1A):c.2862G>C (p.Glu954Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3301,NM_001165963.4(SCN1A):c.2862G>T (p.Glu954Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
3302,NM_001165963.4(SCN1A):c.2861A>G (p.Glu954Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
3303,NM_001165963.4(SCN1A):c.2861A>T (p.Glu954Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3304,NM_001165963.4(SCN1A):c.2860G>C (p.Glu954Gln),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: mar 13, 2022)","criteria provided, single submitter"
3305,NM_001165963.4(SCN1A):c.2860G>A (p.Glu954Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
3306,NM_001165963.4(SCN1A):c.2856G>C (p.Trp952Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: apr 7, 2022)","criteria provided, single submitter"
3307,NM_001165963.4(SCN1A):c.2854T>G (p.Trp952Gly),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3308,NM_001165963.4(SCN1A):c.2851G>A (p.Glu951Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: may 3, 2022)","criteria provided, single submitter"
3309,NM_001165963.4(SCN1A):c.2848G>A (p.Gly950Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3310,NM_001165963.4(SCN1A):c.2846G>T (p.Cys949Phe),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: oct 31, 2018)","criteria provided, single submitter"
3311,NM_001165963.4(SCN1A):c.2837G>C (p.Arg946Pro),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3312,NM_001165963.4(SCN1A):c.2837G>A (p.Arg946His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3312,NM_001165963.4(SCN1A):c.2837G>A (p.Arg946His),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3312,NM_001165963.4(SCN1A):c.2837G>A (p.Arg946His),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3312,NM_001165963.4(SCN1A):c.2837G>A (p.Arg946His),SCN1A,seizure,C0036572,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3313,NM_001165963.4(SCN1A):c.2836C>T (p.Arg946Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: nov 30, 2022)","criteria provided, multiple submitters, no conflicts"
3313,NM_001165963.4(SCN1A):c.2836C>T (p.Arg946Cys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: nov 30, 2022)","criteria provided, multiple submitters, no conflicts"
3313,NM_001165963.4(SCN1A):c.2836C>T (p.Arg946Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: nov 30, 2022)","criteria provided, multiple submitters, no conflicts"
3314,NM_001165963.4(SCN1A):c.2835C>G (p.Phe945Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3314,NM_001165963.4(SCN1A):c.2835C>G (p.Phe945Leu),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3315,NM_001165963.4(SCN1A):c.2831T>C (p.Val944Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3316,NM_001165963.4(SCN1A):c.2819C>T (p.Ser940Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3317,NM_001165963.4(SCN1A):c.2815C>G (p.His939Asp),SCN1A,seizure,C0036572,"likely pathogenic(last reviewed: dec 15, 2015)","criteria provided, single submitter"
3318,NM_001165963.4(SCN1A):c.2815C>T (p.His939Tyr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: mar 14, 2019)","criteria provided, multiple submitters, no conflicts"
3319,NM_001165963.4(SCN1A):c.2807A>C (p.Asp936Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: may 5, 2022)","criteria provided, single submitter"
3320,NM_001165963.4(SCN1A):c.2806G>C (p.Asp936His),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
3321,NM_001165963.4(SCN1A):c.2806G>T (p.Asp936Tyr),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3322,NM_001165963.4(SCN1A):c.2802G>A (p.Met934Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
3323,NM_001165963.4(SCN1A):c.2801T>G (p.Met934Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, multiple submitters, no conflicts"
3323,NM_001165963.4(SCN1A):c.2801T>G (p.Met934Arg),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: jun 4, 2022)","criteria provided, multiple submitters, no conflicts"
3324,NM_001165963.4(SCN1A):c.2800A>G (p.Met934Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
3325,NM_001165963.4(SCN1A):c.2797C>T (p.His933Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: mar 29, 2022)","criteria provided, multiple submitters, no conflicts"
3326,NM_001165963.4(SCN1A):c.2796G>T (p.Trp932Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3327,NM_001165963.4(SCN1A):c.2792G>T (p.Arg931Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
3327,NM_001165963.4(SCN1A):c.2792G>T (p.Arg931Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
3328,NM_001165963.4(SCN1A):c.2792G>C (p.Arg931Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
3328,NM_001165963.4(SCN1A):c.2792G>C (p.Arg931Pro),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
3329,NM_001165963.4(SCN1A):c.2792G>A (p.Arg931His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3329,NM_001165963.4(SCN1A):c.2792G>A (p.Arg931His),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3329,NM_001165963.4(SCN1A):c.2792G>A (p.Arg931His),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3329,NM_001165963.4(SCN1A):c.2792G>A (p.Arg931His),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3329,NM_001165963.4(SCN1A):c.2792G>A (p.Arg931His),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3330,NM_001165963.4(SCN1A):c.2791C>A (p.Arg931Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: apr 24, 2022)","criteria provided, multiple submitters, no conflicts"
3330,NM_001165963.4(SCN1A):c.2791C>A (p.Arg931Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: apr 24, 2022)","criteria provided, multiple submitters, no conflicts"
3331,NM_001165963.4(SCN1A):c.2791C>G (p.Arg931Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3332,NM_001165963.4(SCN1A):c.2791C>T (p.Arg931Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jun 2, 2022)","criteria provided, multiple submitters, no conflicts"
3332,NM_001165963.4(SCN1A):c.2791C>T (p.Arg931Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: jun 2, 2022)","criteria provided, multiple submitters, no conflicts"
3333,NM_001165963.4(SCN1A):c.2780G>T (p.Cys927Phe),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3334,NM_001165963.4(SCN1A):c.2779T>C (p.Cys927Arg),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3335,NM_001165963.4(SCN1A):c.2729A>T (p.Gln910Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: feb 4, 2022)","criteria provided, single submitter"
3336,NM_001165963.4(SCN1A):c.2729A>G (p.Gln910Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3337,NM_001165963.4(SCN1A):c.2728C>A (p.Gln910Lys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3338,NM_001165963.4(SCN1A):c.2720T>G (p.Val907Gly),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, single submitter"
3339,NM_001165963.4(SCN1A):c.2691G>T (p.Leu897Phe),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3340,NM_001165963.4(SCN1A):c.2684T>C (p.Leu895Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jun 15, 2022)","criteria provided, single submitter"
3341,NM_001165963.4(SCN1A):c.2671G>A (p.Gly891Arg),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
3342,NM_001165963.4(SCN1A):c.2669T>C (p.Leu890Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3343,NM_001165963.4(SCN1A):c.2665G>A (p.Ala889Thr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: jun 22, 2020)","criteria provided, multiple submitters, no conflicts"
3343,NM_001165963.4(SCN1A):c.2665G>A (p.Ala889Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jun 22, 2020)","criteria provided, multiple submitters, no conflicts"
3344,NM_001165963.4(SCN1A):c.2624C>A (p.Thr875Lys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3345,NM_001165963.4(SCN1A):c.2624C>T (p.Thr875Met),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
3345,NM_001165963.4(SCN1A):c.2624C>T (p.Thr875Met),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
3345,NM_001165963.4(SCN1A):c.2624C>T (p.Thr875Met),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
3346,NM_001165963.4(SCN1A):c.2619G>T (p.Trp873Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3347,NM_001165963.4(SCN1A):c.2618G>C (p.Trp873Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
3348,NM_001165963.4(SCN1A):c.2615C>A (p.Ser872Tyr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: feb 1, 2021)","criteria provided, multiple submitters, no conflicts"
3349,NM_001165963.4(SCN1A):c.2596G>C (p.Val866Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 22, 2021)","criteria provided, single submitter"
3350,NM_001165963.4(SCN1A):c.2588T>G (p.Leu863Trp),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3351,NM_001165963.4(SCN1A):c.2585G>T (p.Arg862Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3351,NM_001165963.4(SCN1A):c.2585G>T (p.Arg862Leu),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3352,NM_001165963.4(SCN1A):c.2576G>A (p.Arg859His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
3352,NM_001165963.4(SCN1A):c.2576G>A (p.Arg859His),SCN1A,autosomal dominant epilepsy,C3810329,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
3352,NM_001165963.4(SCN1A):c.2576G>A (p.Arg859His),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
3353,NM_001165963.4(SCN1A):c.2575C>T (p.Arg859Cys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3353,NM_001165963.4(SCN1A):c.2575C>T (p.Arg859Cys),SCN1A,seizure,C0036572,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3353,NM_001165963.4(SCN1A):c.2575C>T (p.Arg859Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3354,NM_001165963.4(SCN1A):c.2537A>G (p.Glu846Gly),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3355,NM_001165963.4(SCN1A):c.2522C>G (p.Thr841Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: nov 30, 2021)","criteria provided, single submitter"
3356,NM_001165963.4(SCN1A):c.2479T>G (p.Tyr827Asp),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3357,NM_001165963.4(SCN1A):c.2435C>G (p.Thr812Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3358,NM_001165963.4(SCN1A):c.2429T>A (p.Ile810Asn),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3359,NM_001165963.4(SCN1A):c.2369A>T (p.Tyr790Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 2, 2022)","criteria provided, single submitter"
3360,NM_001165963.4(SCN1A):c.2369A>G (p.Tyr790Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: mar 26, 2022)","criteria provided, single submitter"
3361,NM_001165963.4(SCN1A):c.2368T>A (p.Tyr790Asn),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
3362,NM_001165963.4(SCN1A):c.2363A>T (p.Glu788Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 23, 2022)","criteria provided, single submitter"
3363,NM_001165963.4(SCN1A):c.2355G>A (p.Met785Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3364,NM_001165963.4(SCN1A):c.2354T>G (p.Met785Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
3365,NM_001165963.4(SCN1A):c.2353A>G (p.Met785Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3365,NM_001165963.4(SCN1A):c.2353A>G (p.Met785Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3366,NM_001165963.4(SCN1A):c.2273A>C (p.Lys758Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 20, 2022)","criteria provided, single submitter"
3367,NM_001165963.4(SCN1A):c.2272A>C (p.Lys758Gln),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 23, 2022)","criteria provided, single submitter"
3368,NM_001165963.4(SCN1A):c.2261G>T (p.Trp754Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3369,NM_001165963.4(SCN1A):c.2213G>T (p.Trp738Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3370,NM_001165963.4(SCN1A):c.1970C>T (p.Pro657Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3371,NM_001165963.4(SCN1A):c.1876A>G (p.Ser626Gly),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3372,NM_001165963.4(SCN1A):c.1848G>C (p.Glu616Asp),SCN1A,epileptic encephalopathy,C0543888,"pathogenic(last reviewed: nov 16, 2016)","criteria provided, single submitter"
3373,NM_001165963.4(SCN1A):c.1574C>T (p.Ser525Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: feb 24, 2022)","criteria provided, single submitter"
3374,NM_001165963.4(SCN1A):c.1294G>C (p.Ala432Pro),SCN1A,epilepsy,C0014544,"pathogenic/likely pathogenic(last reviewed: dec 7, 2022)","criteria provided, multiple submitters, no conflicts"
3375,NM_001165963.4(SCN1A):c.1277A>G (p.Tyr426Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3375,NM_001165963.4(SCN1A):c.1277A>G (p.Tyr426Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 7, 2022)","criteria provided, multiple submitters, no conflicts"
3376,NM_001165963.4(SCN1A):c.1265T>C (p.Val422Ala),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3377,NM_001165963.4(SCN1A):c.1264G>A (p.Val422Met),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: feb 3, 2020)","criteria provided, multiple submitters, no conflicts"
3378,NM_001165963.4(SCN1A):c.1261G>A (p.Val421Met),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, multiple submitters, no conflicts"
3379,NM_001165963.4(SCN1A):c.1248T>A (p.Asn416Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: feb 4, 2022)","criteria provided, single submitter"
3380,NM_001165963.4(SCN1A):c.1247A>G (p.Asn416Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: feb 11, 2022)","criteria provided, single submitter"
3381,NM_001165963.4(SCN1A):c.1232C>T (p.Ser411Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 28, 2022)","criteria provided, single submitter"
3382,NM_001165963.4(SCN1A):c.1229G>T (p.Gly410Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3383,NM_001165963.4(SCN1A):c.1220T>A (p.Ile407Asn),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
3384,NM_001165963.4(SCN1A):c.1217T>C (p.Val406Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
3385,NM_001165963.4(SCN1A):c.1207T>C (p.Phe403Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
3386,NM_001165963.4(SCN1A):c.1204T>A (p.Phe402Ile),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3387,NM_001165963.4(SCN1A):c.1199T>C (p.Met400Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3388,NM_001165963.4(SCN1A):c.1199T>A (p.Met400Lys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3389,NM_001165963.4(SCN1A):c.1184C>G (p.Ala395Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: mar 28, 2023)","criteria provided, multiple submitters, no conflicts"
3390,NM_001165963.4(SCN1A):c.1184C>A (p.Ala395Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, single submitter"
3391,NM_001165963.4(SCN1A):c.1184C>T (p.Ala395Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3392,NM_001165963.4(SCN1A):c.1181C>T (p.Ala394Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: mar 3, 2022)","criteria provided, single submitter"
3393,NM_001165963.4(SCN1A):c.1178G>C (p.Arg393Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3394,NM_001165963.4(SCN1A):c.1178G>A (p.Arg393His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3394,NM_001165963.4(SCN1A):c.1178G>A (p.Arg393His),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3394,NM_001165963.4(SCN1A):c.1178G>A (p.Arg393His),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,"intellectual disability, mild",C0026106,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,seizure,C0036572,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3395,NM_001165963.4(SCN1A):c.1177C>T (p.Arg393Cys),SCN1A,developmental and epileptic encephalopathy 6b,C2931919,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3396,NM_001165963.4(SCN1A):c.1177C>A (p.Arg393Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3397,NM_001165963.4(SCN1A):c.1169T>C (p.Leu390Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: mar 11, 2022)","criteria provided, single submitter"
3398,NM_001165963.4(SCN1A):c.1163A>G (p.Tyr388Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 5, 2022)","criteria provided, single submitter"
3399,NM_001165963.4(SCN1A):c.1162T>C (p.Tyr388His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3400,NM_001165963.4(SCN1A):c.1160T>C (p.Leu387Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: nov 8, 2019)","criteria provided, single submitter"
3401,NM_001165963.4(SCN1A):c.1154A>C (p.Glu385Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jan 13, 2022)","criteria provided, single submitter"
3402,NM_001165963.4(SCN1A):c.1153G>A (p.Glu385Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 19, 2022)","criteria provided, single submitter"
3403,NM_001165963.4(SCN1A):c.1153G>C (p.Glu385Gln),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3404,NM_001165963.4(SCN1A):c.1151G>C (p.Trp384Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
3405,NM_001165963.4(SCN1A):c.1150T>A (p.Trp384Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
3406,NM_001165963.4(SCN1A):c.1149C>A (p.Phe383Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3407,NM_001165963.4(SCN1A):c.1146C>A (p.Asp382Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
3407,NM_001165963.4(SCN1A):c.1146C>A (p.Asp382Glu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
3408,NM_001165963.4(SCN1A):c.1144G>A (p.Asp382Asn),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3409,NM_001165963.4(SCN1A):c.1136T>A (p.Met379Lys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3410,NM_001165963.4(SCN1A):c.1133T>A (p.Leu378Gln),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
3411,NM_001165963.4(SCN1A):c.1133T>C (p.Leu378Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
3412,NM_001165963.4(SCN1A):c.1130G>A (p.Arg377Gln),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
3412,NM_001165963.4(SCN1A):c.1130G>A (p.Arg377Gln),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
3412,NM_001165963.4(SCN1A):c.1130G>A (p.Arg377Gln),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
3413,NM_001165963.4(SCN1A):c.1121C>A (p.Ser374Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3414,NM_001165963.4(SCN1A):c.1118T>C (p.Leu373Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: apr 25, 2021)","criteria provided, single submitter"
3415,NM_001165963.4(SCN1A):c.1111G>C (p.Ala371Pro),SCN1A,severe myoclonic epilepsy in infancy,C0751122,likely pathogenic,"criteria provided, single submitter"
3416,NM_001165963.4(SCN1A):c.1096G>C (p.Asp366His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3417,NM_001165963.4(SCN1A):c.1087A>C (p.Thr363Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
3418,NM_001165963.4(SCN1A):c.1077T>A (p.Asn359Lys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3419,NM_001165963.4(SCN1A):c.1072C>G (p.Pro358Ala),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: nov 17, 2017)","criteria provided, single submitter"
3420,NM_001165963.4(SCN1A):c.1072C>T (p.Pro358Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3421,NM_001165963.4(SCN1A):c.1064G>A (p.Gly355Asp),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: nov 20, 2022)","criteria provided, single submitter"
3422,NM_001165963.4(SCN1A):c.1052G>C (p.Cys351Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
3423,NM_001165963.4(SCN1A):c.1051T>G (p.Cys351Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
3424,NM_001165963.4(SCN1A):c.1048A>G (p.Met350Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3425,NM_001165963.4(SCN1A):c.1046A>G (p.Tyr349Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3426,NM_001165963.4(SCN1A):c.1037C>T (p.Pro346Leu),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: dec 30, 2020)","criteria provided, single submitter"
3426,NM_001165963.4(SCN1A):c.1037C>T (p.Pro346Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: dec 30, 2020)","criteria provided, single submitter"
3427,NM_001165963.4(SCN1A):c.1033T>C (p.Cys345Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3427,NM_001165963.4(SCN1A):c.1033T>C (p.Cys345Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3428,NM_001165963.4(SCN1A):c.1028G>C (p.Gly343Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 1, 2022)","criteria provided, single submitter"
3429,NM_001165963.4(SCN1A):c.1028G>A (p.Gly343Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: apr 25, 2022)","criteria provided, multiple submitters, no conflicts"
3430,NM_001165963.4(SCN1A):c.1025C>A (p.Ala342Glu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: sep 19, 2016)","criteria provided, single submitter"
3431,NM_001165963.4(SCN1A):c.1025C>T (p.Ala342Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3432,NM_001165963.4(SCN1A):c.1024G>T (p.Ala342Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3433,NM_001165963.4(SCN1A):c.1019C>A (p.Ser340Tyr),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3434,NM_001165963.4(SCN1A):c.1018T>C (p.Ser340Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jan 12, 2022)","criteria provided, single submitter"
3435,NM_001165963.4(SCN1A):c.1008T>G (p.Cys336Trp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 16, 2021)","criteria provided, single submitter"
3436,NM_001165963.4(SCN1A):c.1007G>A (p.Cys336Tyr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3437,NM_001165963.4(SCN1A):c.1006T>C (p.Cys336Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
3438,NM_001165963.4(SCN1A):c.997G>A (p.Ala333Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3439,NM_001165963.4(SCN1A):c.986G>A (p.Gly329Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 4, 2021)","criteria provided, single submitter"
3440,NM_001165963.4(SCN1A):c.986G>C (p.Gly329Ala),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3440,NM_001165963.4(SCN1A):c.986G>C (p.Gly329Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3441,NM_001165963.4(SCN1A):c.985G>T (p.Gly329Cys),SCN1A,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
3441,NM_001165963.4(SCN1A):c.985G>T (p.Gly329Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
3441,NM_001165963.4(SCN1A):c.985G>T (p.Gly329Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 21, 2021)","criteria provided, multiple submitters, no conflicts"
3442,NM_001165963.4(SCN1A):c.974A>G (p.Tyr325Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3443,NM_001165963.4(SCN1A):c.965G>T (p.Arg322Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
3444,NM_001165963.4(SCN1A):c.942G>T (p.Trp314Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3445,NM_001165963.4(SCN1A):c.942G>C (p.Trp314Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3446,NM_001165963.4(SCN1A):c.940T>C (p.Trp314Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3447,NM_001165963.4(SCN1A):c.935T>C (p.Phe312Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: nov 11, 2021)","criteria provided, single submitter"
3448,NM_001165963.4(SCN1A):c.842C>G (p.Pro281Arg),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: may 15, 2019)","criteria provided, single submitter"
3449,NM_001165963.4(SCN1A):c.838T>C (p.Trp280Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3450,NM_001165963.4(SCN1A):c.833T>A (p.Ile278Lys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: aug 20, 2018)","criteria provided, single submitter"
3451,NM_001165963.4(SCN1A):c.830G>A (p.Cys277Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3451,NM_001165963.4(SCN1A):c.830G>A (p.Cys277Tyr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3452,NM_001165963.4(SCN1A):c.829T>C (p.Cys277Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
3453,NM_001165963.4(SCN1A):c.826A>C (p.Lys276Gln),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3454,NM_001165963.4(SCN1A):c.812G>T (p.Gly271Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3454,NM_001165963.4(SCN1A):c.812G>T (p.Gly271Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3455,NM_001165963.4(SCN1A):c.811G>A (p.Gly271Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3455,NM_001165963.4(SCN1A):c.811G>A (p.Gly271Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3455,NM_001165963.4(SCN1A):c.811G>A (p.Gly271Ser),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3455,NM_001165963.4(SCN1A):c.811G>A (p.Gly271Ser),SCN1A,developmental and epileptic encephalopathy 6b,C2931919,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3455,NM_001165963.4(SCN1A):c.811G>A (p.Gly271Ser),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic/likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
3456,NM_001165963.4(SCN1A):c.797T>C (p.Leu266Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3457,NM_001165963.4(SCN1A):c.788T>C (p.Leu263Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
3458,NM_001165963.4(SCN1A):c.787C>G (p.Leu263Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, single submitter"
3459,NM_001165963.4(SCN1A):c.777C>A (p.Ser259Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: jun 10, 2022)","criteria provided, multiple submitters, no conflicts"
3460,NM_001165963.4(SCN1A):c.769T>C (p.Cys257Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: aug 21, 2018)","criteria provided, multiple submitters, no conflicts"
3461,NM_001165963.4(SCN1A):c.755T>C (p.Ile252Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3462,NM_001165963.4(SCN1A):c.754A>C (p.Ile252Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, single submitter"
3463,NM_001165963.4(SCN1A):c.752T>G (p.Met251Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: apr 4, 2018)","criteria provided, single submitter"
3464,NM_001165963.4(SCN1A):c.751A>T (p.Met251Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3465,NM_001165963.4(SCN1A):c.747T>G (p.Asp249Glu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3466,NM_001165963.4(SCN1A):c.746A>G (p.Asp249Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: nov 17, 2021)","criteria provided, single submitter"
3467,NM_001165963.4(SCN1A):c.740T>C (p.Leu247Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3468,NM_001165963.4(SCN1A):c.728C>A (p.Ser243Tyr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3469,NM_001165963.4(SCN1A):c.727T>C (p.Ser243Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
3470,NM_001165963.4(SCN1A):c.725A>G (p.Gln242Arg),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,likely pathogenic,"criteria provided, single submitter"
3471,NM_001165963.4(SCN1A):c.719T>C (p.Leu240Pro),SCN1A,seizure,C0036572,"likely pathogenic(last reviewed: oct 21, 2014)","criteria provided, single submitter"
3472,NM_001165963.4(SCN1A):c.716C>A (p.Ala239Asp),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3473,NM_001165963.4(SCN1A):c.716C>G (p.Ala239Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3474,NM_001165963.4(SCN1A):c.716C>T (p.Ala239Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: jun 17, 2016)","criteria provided, single submitter"
3475,NM_001165963.4(SCN1A):c.715G>A (p.Ala239Thr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3476,NM_001165963.4(SCN1A):c.703A>G (p.Thr235Ala),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
3477,NM_001165963.4(SCN1A):c.683C>T (p.Ser228Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3478,NM_001165963.4(SCN1A):c.682T>C (p.Ser228Pro),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: nov 16, 2016)","criteria provided, single submitter"
3479,NM_001165963.4(SCN1A):c.680T>C (p.Ile227Thr),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic/likely pathogenic(last reviewed: feb 27, 2022)","criteria provided, multiple submitters, no conflicts"
3480,NM_001165963.4(SCN1A):c.680T>G (p.Ile227Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
3480,NM_001165963.4(SCN1A):c.680T>G (p.Ile227Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: feb 20, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,"developmental and epileptic encephalopathy, 6",C2931919,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,developmental and epileptic encephalopathy 6b,C2931919,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3481,NM_001165963.4(SCN1A):c.677C>T (p.Thr226Met),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: nov 9, 2022)","criteria provided, multiple submitters, no conflicts"
3482,NM_001165963.4(SCN1A):c.675G>C (p.Lys225Asn),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: jun 24, 2015)","criteria provided, multiple submitters, no conflicts"
3483,NM_001165963.4(SCN1A):c.673A>G (p.Lys225Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3484,NM_001165963.4(SCN1A):c.656G>C (p.Arg219Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, multiple submitters, no conflicts"
3485,NM_001165963.4(SCN1A):c.655A>G (p.Arg219Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3486,NM_001165963.4(SCN1A):c.652T>C (p.Phe218Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, multiple submitters, no conflicts"
3487,NM_001165963.4(SCN1A):c.650C>A (p.Thr217Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: apr 10, 2022)","criteria provided, single submitter"
3488,NM_001165963.4(SCN1A):c.629G>A (p.Gly210Asp),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, multiple submitters, no conflicts"
3488,NM_001165963.4(SCN1A):c.629G>A (p.Gly210Asp),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, multiple submitters, no conflicts"
3489,NM_001165963.4(SCN1A):c.602C>A (p.Ala201Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3490,NM_001165963.4(SCN1A):c.602C>T (p.Ala201Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 22, 2022)","criteria provided, single submitter"
3491,NM_001165963.4(SCN1A):c.580G>T (p.Asp194Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
3492,NM_001165963.4(SCN1A):c.580G>A (p.Asp194Asn),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, multiple submitters, no conflicts"
3492,NM_001165963.4(SCN1A):c.580G>A (p.Asp194Asn),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 29, 2022)","criteria provided, multiple submitters, no conflicts"
3493,NM_001165963.4(SCN1A):c.573C>G (p.Asn191Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 20, 2022)","criteria provided, single submitter"
3494,NM_001165963.4(SCN1A):c.568T>C (p.Trp190Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: jul 18, 2022)","criteria provided, multiple submitters, no conflicts"
3494,NM_001165963.4(SCN1A):c.568T>C (p.Trp190Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: jul 18, 2022)","criteria provided, multiple submitters, no conflicts"
3495,NM_001165963.4(SCN1A):c.563A>T (p.Asp188Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3496,NM_001165963.4(SCN1A):c.557T>C (p.Leu186Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3497,NM_001165963.4(SCN1A):c.530G>T (p.Gly177Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3498,NM_001165963.4(SCN1A):c.530G>A (p.Gly177Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
3499,NM_001165963.4(SCN1A):c.523G>A (p.Ala175Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3500,NM_001165963.4(SCN1A):c.519T>G (p.Ile173Met),SCN1A,seizure,C0036572,"likely pathogenic(last reviewed: apr 1, 2021)","criteria provided, single submitter"
3501,NM_001165963.4(SCN1A):c.493T>C (p.Tyr165His),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
3501,NM_001165963.4(SCN1A):c.493T>C (p.Tyr165His),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 23, 2021)","criteria provided, multiple submitters, no conflicts"
3502,NM_001165963.4(SCN1A):c.488G>A (p.Gly163Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3503,NM_001165963.4(SCN1A):c.485C>T (p.Thr162Ile),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, multiple submitters, no conflicts"
3503,NM_001165963.4(SCN1A):c.485C>T (p.Thr162Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, multiple submitters, no conflicts"
3504,NM_001165963.4(SCN1A):c.479C>A (p.Thr160Asn),SCN1A|SCN1A-AS1,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: dec 13, 2022)","criteria provided, multiple submitters, no conflicts"
3504,NM_001165963.4(SCN1A):c.479C>A (p.Thr160Asn),SCN1A|SCN1A-AS1,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: dec 13, 2022)","criteria provided, multiple submitters, no conflicts"
3505,NM_001165963.4(SCN1A):c.434T>G (p.Met145Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: apr 25, 2021)","criteria provided, single submitter"
3506,NM_001165963.4(SCN1A):c.433A>G (p.Met145Val),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3507,NM_001165963.4(SCN1A):c.423C>A (p.Asn141Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
3508,NM_001165963.4(SCN1A):c.417G>C (p.Leu139Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: nov 9, 2021)","criteria provided, single submitter"
3509,NM_001165963.4(SCN1A):c.413T>G (p.Ile138Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
3510,NM_001165963.4(SCN1A):c.409A>C (p.Thr137Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, single submitter"
3511,NM_001165963.4(SCN1A):c.380A>T (p.His127Leu),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3512,NM_001165963.4(SCN1A):c.379C>T (p.His127Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3512,NM_001165963.4(SCN1A):c.379C>T (p.His127Tyr),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3513,NM_001165963.4(SCN1A):c.361G>C (p.Ala121Pro),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: dec 11, 2019)","criteria provided, single submitter"
3514,NM_001165963.4(SCN1A):c.354G>T (p.Arg118Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3515,NM_001165963.4(SCN1A):c.350T>C (p.Leu117Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: oct 15, 2021)","criteria provided, multiple submitters, no conflicts"
3515,NM_001165963.4(SCN1A):c.350T>C (p.Leu117Pro),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: oct 15, 2021)","criteria provided, multiple submitters, no conflicts"
3516,NM_001165963.4(SCN1A):c.345T>A (p.Asn115Lys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,pathogenic,"criteria provided, single submitter"
3517,NM_001165963.4(SCN1A):c.338C>T (p.Pro113Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3518,NM_001165963.4(SCN1A):c.338C>G (p.Pro113Arg),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"likely pathogenic(last reviewed: jan 1, 2018)","criteria provided, single submitter"
3519,NM_001165963.4(SCN1A):c.337C>T (p.Pro113Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3520,NM_001165963.4(SCN1A):c.337C>A (p.Pro113Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
3520,NM_001165963.4(SCN1A):c.337C>A (p.Pro113Thr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
3521,NM_001165963.4(SCN1A):c.335C>T (p.Thr112Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: jan 26, 2022)","criteria provided, multiple submitters, no conflicts"
3522,NM_001165963.4(SCN1A):c.323T>A (p.Leu108Gln),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"likely pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3523,NM_001165963.4(SCN1A):c.323T>C (p.Leu108Pro),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3524,NM_001165963.4(SCN1A):c.311C>A (p.Ala104Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 4, 2022)","criteria provided, multiple submitters, no conflicts"
3524,NM_001165963.4(SCN1A):c.311C>A (p.Ala104Asp),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: aug 4, 2022)","criteria provided, multiple submitters, no conflicts"
3525,NM_001165963.4(SCN1A):c.308G>T (p.Ser103Ile),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3526,NM_001165963.4(SCN1A):c.305T>C (p.Phe102Ser),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: dec 8, 2021)","criteria provided, single submitter"
3527,NM_001165963.4(SCN1A):c.302G>A (p.Arg101Gln),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
3527,NM_001165963.4(SCN1A):c.302G>A (p.Arg101Gln),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
3527,NM_001165963.4(SCN1A):c.302G>A (p.Arg101Gln),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
3528,NM_001165963.4(SCN1A):c.301C>T (p.Arg101Trp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
3528,NM_001165963.4(SCN1A):c.301C>T (p.Arg101Trp),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
3528,NM_001165963.4(SCN1A):c.301C>T (p.Arg101Trp),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, multiple submitters, no conflicts"
3529,NM_001165963.4(SCN1A):c.300C>G (p.Phe100Leu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 15, 2022)","criteria provided, single submitter"
3530,NM_001165963.4(SCN1A):c.298T>G (p.Phe100Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: mar 29, 2022)","criteria provided, single submitter"
3531,NM_001165963.4(SCN1A):c.280A>T (p.Asn94Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: nov 29, 2021)","criteria provided, single submitter"
3532,NM_001165963.4(SCN1A):c.272T>C (p.Ile91Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
3532,NM_001165963.4(SCN1A):c.272T>C (p.Ile91Thr),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
3532,NM_001165963.4(SCN1A):c.272T>C (p.Ile91Thr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
3533,NM_001165963.4(SCN1A):c.269T>C (p.Phe90Ser),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: jul 15, 2015)","criteria provided, multiple submitters, no conflicts"
3534,NM_001165963.4(SCN1A):c.251A>G (p.Tyr84Cys),SCN1A,"generalized epilepsy with febrile seizures plus, type 2",C1858673,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3534,NM_001165963.4(SCN1A):c.251A>G (p.Tyr84Cys),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3534,NM_001165963.4(SCN1A):c.251A>G (p.Tyr84Cys),SCN1A,"migraine, familial hemiplegic, 3",C1864987,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3534,NM_001165963.4(SCN1A):c.251A>G (p.Tyr84Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3535,NM_001165963.4(SCN1A):c.248A>G (p.Tyr83Cys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3536,NM_001165963.4(SCN1A):c.247T>G (p.Tyr83Asp),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3537,NM_001165963.4(SCN1A):c.243C>A (p.Asp81Glu),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3538,NM_001165963.4(SCN1A):c.242A>T (p.Asp81Val),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 27, 2022)","criteria provided, single submitter"
3539,NM_001165963.4(SCN1A):c.241G>T (p.Asp81Tyr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: oct 12, 2022)","criteria provided, single submitter"
3540,NM_001165963.4(SCN1A):c.236A>G (p.Asp79Gly),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: sep 28, 2022)","criteria provided, single submitter"
3541,NM_001165963.4(SCN1A):c.232G>A (p.Glu78Lys),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, single submitter"
3542,NM_001165963.4(SCN1A):c.230T>C (p.Leu77Pro),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, multiple submitters, no conflicts"
3543,NM_001165963.4(SCN1A):c.182T>C (p.Leu61Pro),SCN1A,sudden unexplained death in childhood,C3827273,"likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, single submitter"
3544,NM_001165963.4(SCN1A):c.181C>T (p.Leu61Phe),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
3545,NM_001165963.4(SCN1A):c.172G>A (p.Gly58Arg),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3546,NM_001165963.4(SCN1A):c.70G>A (p.Ala24Thr),SCN1A,severe myoclonic epilepsy in infancy,C0751122,"pathogenic(last reviewed: dec 20, 2014)","criteria provided, single submitter"
3547,NM_001165963.4(SCN1A):c.3G>A (p.Met1Ile),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
3548,NM_001165963.4(SCN1A):c.2T>C (p.Met1Thr),SCN1A,early infantile epileptic encephalopathy with suppression bursts,C0393706,"pathogenic/likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
3549,NM_001365536.1(SCN9A):c.2720G>A (p.Arg907Gln),SCN1A-AS1|SCN9A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
3549,NM_001365536.1(SCN9A):c.2720G>A (p.Arg907Gln),SCN1A-AS1|SCN9A,"generalized epilepsy with febrile seizures plus, type 7",C2751778,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, single submitter"
3550,NM_001365536.1(SCN9A):c.2719C>T (p.Arg907Trp),SCN9A|SCN1A-AS1,"generalized epilepsy with febrile seizures plus, type 7",C2751778,"pathogenic/likely pathogenic(last reviewed: mar 8, 2023)","criteria provided, multiple submitters, no conflicts"
3550,NM_001365536.1(SCN9A):c.2719C>T (p.Arg907Trp),SCN9A|SCN1A-AS1,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic/likely pathogenic(last reviewed: mar 8, 2023)","criteria provided, multiple submitters, no conflicts"
3551,NM_001365536.1(SCN9A):c.2656C>G (p.Gln886Glu),SCN1A-AS1|SCN9A,primary erythromelalgia,C0014805,"likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, single submitter"
3552,NM_001365536.1(SCN9A):c.2606T>A (p.Leu869His),SCN1A-AS1|SCN9A,"generalized epilepsy with febrile seizures plus, type 7",C2751778,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
3552,NM_001365536.1(SCN9A):c.2606T>A (p.Leu869His),SCN1A-AS1|SCN9A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic(last reviewed: sep 12, 2022)","criteria provided, single submitter"
3553,NM_001365536.1(SCN9A):c.2576T>C (p.Ile859Thr),SCN1A-AS1|SCN9A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
3553,NM_001365536.1(SCN9A):c.2576T>C (p.Ile859Thr),SCN1A-AS1|SCN9A,"generalized epilepsy with febrile seizures plus, type 7",C2751778,"pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
3554,NM_001365536.1(SCN9A):c.1198G>A (p.Val400Met),SCN1A-AS1|SCN9A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic(last reviewed: jun 20, 2022)","criteria provided, multiple submitters, no conflicts"
3554,NM_001365536.1(SCN9A):c.1198G>A (p.Val400Met),SCN1A-AS1|SCN9A,"generalized epilepsy with febrile seizures plus, type 7",C2751778,"pathogenic(last reviewed: jun 20, 2022)","criteria provided, multiple submitters, no conflicts"
3555,NM_001365536.1(SCN9A):c.701T>C (p.Ile234Thr),SCN9A,"generalized epilepsy with febrile seizures plus, type 7",C2751778,"pathogenic(last reviewed: dec 20, 2021)","criteria provided, single submitter"
3555,NM_001365536.1(SCN9A):c.701T>C (p.Ile234Thr),SCN9A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic(last reviewed: dec 20, 2021)","criteria provided, single submitter"
3556,NM_003742.4(ABCB11):c.2944G>A (p.Gly982Arg),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3556,NM_003742.4(ABCB11):c.2944G>A (p.Gly982Arg),ABCB11,benign recurrent intrahepatic cholestasis type 2,C2608083,"pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3557,NM_003742.4(ABCB11):c.2842C>T (p.Arg948Cys),ABCB11|LOC126806400,progressive familial intrahepatic cholestasis,C0268312,"pathogenic/likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
3557,NM_003742.4(ABCB11):c.2842C>T (p.Arg948Cys),ABCB11|LOC126806400,benign recurrent intrahepatic cholestasis type 2,C2608083,"pathogenic/likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
3557,NM_003742.4(ABCB11):c.2842C>T (p.Arg948Cys),ABCB11|LOC126806400,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic/likely pathogenic(last reviewed: feb 28, 2023)","criteria provided, multiple submitters, no conflicts"
3558,NM_003742.4(ABCB11):c.2494C>T (p.Arg832Cys),ABCB11,progressive familial intrahepatic cholestasis,C0268312,"pathogenic/likely pathogenic(last reviewed: dec 26, 2022)","criteria provided, multiple submitters, no conflicts"
3558,NM_003742.4(ABCB11):c.2494C>T (p.Arg832Cys),ABCB11,progressive familial intrahepatic cholestasis type 3,C4272381,"pathogenic/likely pathogenic(last reviewed: dec 26, 2022)","criteria provided, multiple submitters, no conflicts"
3558,NM_003742.4(ABCB11):c.2494C>T (p.Arg832Cys),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic/likely pathogenic(last reviewed: dec 26, 2022)","criteria provided, multiple submitters, no conflicts"
3559,NM_003742.4(ABCB11):c.1763C>T (p.Ala588Val),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3559,NM_003742.4(ABCB11):c.1763C>T (p.Ala588Val),ABCB11,benign recurrent intrahepatic cholestasis type 2,C2608083,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3559,NM_003742.4(ABCB11):c.1763C>T (p.Ala588Val),ABCB11,progressive familial intrahepatic cholestasis,C0268312,"pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3560,NM_003742.4(ABCB11):c.1493T>C (p.Ile498Thr),ABCB11,progressive familial intrahepatic cholestasis,C0268312,"pathogenic/likely pathogenic(last reviewed: oct 6, 2022)","criteria provided, multiple submitters, no conflicts"
3561,NM_003742.4(ABCB11):c.1445A>G (p.Asp482Gly),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
3561,NM_003742.4(ABCB11):c.1445A>G (p.Asp482Gly),ABCB11,benign recurrent intrahepatic cholestasis type 2,C2608083,"pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
3561,NM_003742.4(ABCB11):c.1445A>G (p.Asp482Gly),ABCB11,benign recurrent intrahepatic cholestasis type 2,C2608083,"pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
3561,NM_003742.4(ABCB11):c.1445A>G (p.Asp482Gly),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
3562,NM_003742.4(ABCB11):c.890A>G (p.Glu297Gly),ABCB11,progressive familial intrahepatic cholestasis,C0268312,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
3562,NM_003742.4(ABCB11):c.890A>G (p.Glu297Gly),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
3563,NM_003742.4(ABCB11):c.257T>A (p.Met86Lys),ABCB11,progressive familial intrahepatic cholestasis type 2,C4272382,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3564,NM_152384.3(BBS5):c.2T>A (p.Met1Lys),BBS5,bardet-biedl syndrome 5,C1412750,"pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3565,NM_152384.3(BBS5):c.214G>A (p.Gly72Ser),BBS5,bardet-biedl syndrome,C0752166,"pathogenic(last reviewed: jul 31, 2022)","criteria provided, multiple submitters, no conflicts"
3566,NM_152384.3(BBS5):c.413G>A (p.Arg138His),BBS5,bardet-biedl syndrome,C0752166,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3567,NM_006063.3(KLHL41):c.667C>T (p.Arg223Cys),KLHL41,nemaline myopathy 9,C3810384,"likely pathogenic(last reviewed: sep 17, 2021)","criteria provided, single submitter"
3568,NM_000817.3(GAD1):c.1370G>A (p.Arg457His),GAD1,developmental and epileptic encephalopathy 89,C2931919,"likely pathogenic(last reviewed: apr 26, 2022)","criteria provided, single submitter"
3569,NM_001378.3(DYNC1I2):c.740A>G (p.Tyr247Cys),DYNC1I2,"neurodevelopmental disorder with microcephaly, hypotonia, and variable brain anomalies",C4479566,"pathogenic(last reviewed: may 28, 2020)","criteria provided, single submitter"
3570,NM_003705.5(SLC25A12):c.1618G>A (p.Asp540Asn),SLC25A12,"developmental and epileptic encephalopathy, 39",C2931919,"likely pathogenic(last reviewed: nov 28, 2017)","criteria provided, single submitter"
3571,NM_003705.5(SLC25A12):c.1490T>A (p.Ile497Asn),SLC25A12,"developmental and epileptic encephalopathy, 1",C3463992,likely pathogenic,"criteria provided, single submitter"
3572,NM_000079.4(CHRNA1):c.1321G>A (p.Gly441Arg),CHRNA1,lethal multiple pterygium syndrome,C1854678,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
3573,NM_000079.4(CHRNA1):c.997C>T (p.Arg333Trp),CHRNA1,lethal multiple pterygium syndrome,C1854678,"pathogenic/likely pathogenic(last reviewed: jun 17, 2022)","criteria provided, multiple submitters, no conflicts"
3574,NM_000079.4(CHRNA1):c.711C>A (p.Asn237Lys),CHRNA1,lethal multiple pterygium syndrome,C1854678,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3575,NM_000079.4(CHRNA1):c.517G>A (p.Gly173Ser),CHRNA1,congenital myasthenic syndrome 1a,C0393929,"pathogenic/likely pathogenic(last reviewed: jun 15, 2022)","criteria provided, multiple submitters, no conflicts"
3575,NM_000079.4(CHRNA1):c.517G>A (p.Gly173Ser),CHRNA1,lethal multiple pterygium syndrome,C1854678,"pathogenic/likely pathogenic(last reviewed: jun 15, 2022)","criteria provided, multiple submitters, no conflicts"
3576,NM_000079.4(CHRNA1):c.1A>G (p.Met1Val),CHRNA1,lethal multiple pterygium syndrome,C1854678,"likely pathogenic(last reviewed: may 9, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,diaphragmatic eventration,C0011981,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,abnormality of the vertebral column,C4021789,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,cerebellar vermis hypoplasia,C1840379,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,dandy-walker syndrome,C1414203,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,global developmental delay,C0557874,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,micrognathia,C0025990,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,small hand,C0575802,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,abnormality of the cervical spine,C1852464,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,congenital laryngomalacia,C0345160,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,cleft palate,C0008925,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,duane retraction syndrome,C0013261,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,hydronephrosis,C0020295,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,sensorineural hearing loss disorder,C0018784,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,night blindness,C4553660,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,feeding difficulties,C0232466,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,hydroureter,C0521620,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,arachnodactyly,C0003706,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,microglossia,C0025988,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,abnormality of the diaphragm,C1848873,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3577,NM_001822.7(CHN1):c.667G>A (p.Ala223Thr),CHN1,see cases,Cumapped260,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3578,NM_001822.7(CHN1):c.661T>C (p.Tyr221His),CHN1,duane retraction syndrome 2,C0751083,"pathogenic/likely pathogenic(last reviewed: apr 10, 2017)","criteria provided, multiple submitters, no conflicts"
3579,NM_001822.7(CHN1):c.643G>A (p.Gly215Arg),CHN1,duane retraction syndrome 2,C0751083,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, single submitter"
3580,NM_000523.4(HOXD13):c.916C>T (p.Arg306Trp),HOXD13,synpolydactyly type 1,C2699746,"likely pathogenic(last reviewed: jul 21, 2021)","criteria provided, single submitter"
3581,NM_003690.5(PRKRA):c.665C>T (p.Pro222Leu),CHROMR|PRKRA,dystonia 16,C2677567,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3582,NM_003690.5(PRKRA):c.638G>T (p.Cys213Phe),CHROMR|PRKRA,dystonia 16,C2677567,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3583,NM_001042702.5(PJVK):c.547C>T (p.Arg183Trp),PJVK,ear malformation,C0266589,"pathogenic(last reviewed: may 20, 2022)","criteria provided, multiple submitters, no conflicts"
3584,NM_001042702.5(PJVK):c.671T>G (p.Leu224Arg),PJVK,autosomal recessive nonsyndromic hearing loss 59,C3711374,"pathogenic(last reviewed: dec 23, 2021)","criteria provided, single submitter"
3585,NM_001042702.5(PJVK):c.880C>G (p.His294Asp),PJVK,autosomal recessive nonsyndromic hearing loss 59,C3711374,"pathogenic(last reviewed: dec 23, 2021)","criteria provided, single submitter"
3586,NM_001267550.2(TTN):c.2926T>C (p.Trp976Arg),TTN,primary dilated cardiomyopathy,C0007193,"likely pathogenic(last reviewed: jun 19, 2018)","criteria provided, single submitter"
3587,NM_201548.5(CERKL):c.375C>G (p.Cys125Trp),CERKL,retinal dystrophy,C4229674,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
3587,NM_201548.5(CERKL):c.375C>G (p.Cys125Trp),CERKL,retinitis pigmentosa 26,C1842127,"pathogenic/likely pathogenic(last reviewed: oct 28, 2022)","criteria provided, multiple submitters, no conflicts"
3588,NM_201548.5(CERKL):c.356G>A (p.Gly119Asp),CERKL,retinitis pigmentosa 26,C1842127,"pathogenic/likely pathogenic(last reviewed: nov 21, 2022)","criteria provided, multiple submitters, no conflicts"
3589,NM_000090.4(COL3A1):c.145C>G (p.Pro49Ala),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"likely pathogenic(last reviewed: jul 8, 2019)","criteria provided, multiple submitters, no conflicts"
3589,NM_000090.4(COL3A1):c.145C>G (p.Pro49Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jul 8, 2019)","criteria provided, multiple submitters, no conflicts"
3590,NM_000090.4(COL3A1):c.530G>C (p.Gly177Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 6, 2021)","criteria provided, single submitter"
3591,NM_000090.4(COL3A1):c.530G>T (p.Gly177Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3592,NM_000090.4(COL3A1):c.547G>A (p.Gly183Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: aug 10, 2021)","criteria provided, multiple submitters, no conflicts"
3592,NM_000090.4(COL3A1):c.547G>A (p.Gly183Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: aug 10, 2021)","criteria provided, multiple submitters, no conflicts"
3593,NM_000090.4(COL3A1):c.548G>T (p.Gly183Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
3594,NM_000090.4(COL3A1):c.583G>A (p.Gly195Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3595,NM_000090.4(COL3A1):c.593G>A (p.Gly198Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3596,NM_000090.4(COL3A1):c.611G>A (p.Gly204Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: dec 3, 2021)","criteria provided, multiple submitters, no conflicts"
3596,NM_000090.4(COL3A1):c.611G>A (p.Gly204Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: dec 3, 2021)","criteria provided, multiple submitters, no conflicts"
3597,NM_000090.4(COL3A1):c.619G>T (p.Gly207Trp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: may 14, 2018)","criteria provided, single submitter"
3598,NM_000090.4(COL3A1):c.638G>A (p.Gly213Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: dec 18, 2021)","criteria provided, multiple submitters, no conflicts"
3598,NM_000090.4(COL3A1):c.638G>A (p.Gly213Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: dec 18, 2021)","criteria provided, multiple submitters, no conflicts"
3599,NM_000090.4(COL3A1):c.647G>A (p.Gly216Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3600,NM_000090.4(COL3A1):c.665G>A (p.Gly222Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: jul 24, 2018)","criteria provided, single submitter"
3601,NM_000090.4(COL3A1):c.665G>T (p.Gly222Val),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: jul 3, 2019)","criteria provided, single submitter"
3602,NM_000090.4(COL3A1):c.674G>A (p.Gly225Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
3603,NM_000090.4(COL3A1):c.674G>C (p.Gly225Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
3603,NM_000090.4(COL3A1):c.674G>C (p.Gly225Ala),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
3604,NM_000090.4(COL3A1):c.701G>A (p.Gly234Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3605,NM_000090.4(COL3A1):c.721G>A (p.Glu241Lys),COL3A1,ehlers-danlos syndrome,C0013720,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
3605,NM_000090.4(COL3A1):c.721G>A (p.Glu241Lys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
3606,NM_000090.4(COL3A1):c.727G>C (p.Gly243Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: apr 23, 2022)","criteria provided, single submitter"
3607,NM_000090.4(COL3A1):c.745G>A (p.Gly249Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 8, 2021)","criteria provided, single submitter"
3608,NM_000090.4(COL3A1):c.746G>T (p.Gly249Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
3609,NM_000090.4(COL3A1):c.746G>A (p.Gly249Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: dec 29, 2017)","criteria provided, single submitter"
3610,NM_000090.4(COL3A1):c.754G>A (p.Gly252Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: apr 2, 2022)","criteria provided, single submitter"
3611,NM_000090.4(COL3A1):c.754G>T (p.Gly252Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
3612,NM_000090.4(COL3A1):c.755G>T (p.Gly252Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: mar 10, 2022)","criteria provided, multiple submitters, no conflicts"
3613,NM_000090.4(COL3A1):c.773G>C (p.Gly258Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
3614,NM_000090.4(COL3A1):c.781G>C (p.Gly261Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, single submitter"
3615,NM_000090.4(COL3A1):c.791G>A (p.Gly264Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, multiple submitters, no conflicts"
3615,NM_000090.4(COL3A1):c.791G>A (p.Gly264Glu),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, multiple submitters, no conflicts"
3616,NM_000090.4(COL3A1):c.800G>T (p.Gly267Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3617,NM_000090.4(COL3A1):c.809G>A (p.Gly270Glu),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, single submitter"
3618,NM_000090.4(COL3A1):c.826G>A (p.Gly276Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: jun 5, 2019)","criteria provided, single submitter"
3619,NM_000090.4(COL3A1):c.827G>T (p.Gly276Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3620,NM_000090.4(COL3A1):c.836G>A (p.Gly279Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3621,NM_000090.4(COL3A1):c.845G>T (p.Gly282Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
3622,NM_000090.4(COL3A1):c.862G>A (p.Gly288Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, single submitter"
3623,NM_000090.4(COL3A1):c.862G>T (p.Gly288Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: dec 17, 2018)","criteria provided, single submitter"
3624,NM_000090.4(COL3A1):c.880G>A (p.Gly294Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: dec 15, 2021)","criteria provided, single submitter"
3625,NM_000090.4(COL3A1):c.889G>A (p.Gly297Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3626,NM_000090.4(COL3A1):c.926G>A (p.Gly309Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3627,NM_000090.4(COL3A1):c.944G>T (p.Gly315Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3628,NM_000090.4(COL3A1):c.944G>C (p.Gly315Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: feb 17, 2022)","criteria provided, single submitter"
3629,NM_000090.4(COL3A1):c.953G>A (p.Gly318Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
3630,NM_000090.4(COL3A1):c.961G>A (p.Gly321Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: dec 27, 2021)","criteria provided, single submitter"
3631,NM_000090.4(COL3A1):c.962G>A (p.Gly321Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, multiple submitters, no conflicts"
3632,NM_000090.4(COL3A1):c.970G>A (p.Gly324Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
3632,NM_000090.4(COL3A1):c.970G>A (p.Gly324Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: oct 18, 2022)","criteria provided, multiple submitters, no conflicts"
3633,NM_000090.4(COL3A1):c.971G>T (p.Gly324Val),COL3A1,ehlers-danlos syndrome,C0013720,"likely pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
3634,NM_000090.4(COL3A1):c.998G>A (p.Gly333Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: may 2, 2016)","criteria provided, single submitter"
3635,NM_000090.4(COL3A1):c.1024G>A (p.Gly342Arg),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: sep 21, 2022)","criteria provided, multiple submitters, no conflicts"
3635,NM_000090.4(COL3A1):c.1024G>A (p.Gly342Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: sep 21, 2022)","criteria provided, multiple submitters, no conflicts"
3636,NM_000090.4(COL3A1):c.1051G>A (p.Gly351Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3637,NM_000090.4(COL3A1):c.1052G>T (p.Gly351Val),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"likely pathogenic(last reviewed: jan 31, 2022)","criteria provided, multiple submitters, no conflicts"
3637,NM_000090.4(COL3A1):c.1052G>T (p.Gly351Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jan 31, 2022)","criteria provided, multiple submitters, no conflicts"
3638,NM_000090.4(COL3A1):c.1070G>A (p.Gly357Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 8, 2021)","criteria provided, single submitter"
3639,NM_000090.4(COL3A1):c.1079G>T (p.Gly360Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, single submitter"
3640,NM_000090.4(COL3A1):c.1079G>A (p.Gly360Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: jun 17, 2020)","criteria provided, single submitter"
3641,NM_000090.4(COL3A1):c.1096G>A (p.Gly366Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jul 20, 2021)","criteria provided, single submitter"
3641,NM_000090.4(COL3A1):c.1096G>A (p.Gly366Arg),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"likely pathogenic(last reviewed: jul 20, 2021)","criteria provided, single submitter"
3642,NM_000090.4(COL3A1):c.1105G>C (p.Gly369Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jan 5, 2022)","criteria provided, single submitter"
3643,NM_000090.4(COL3A1):c.1106G>T (p.Gly369Val),COL3A1,familial aortopathy,Cumapped70,"likely pathogenic(last reviewed: nov 13, 2017)","criteria provided, single submitter"
3644,NM_000090.4(COL3A1):c.1133G>A (p.Gly378Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3645,NM_000090.4(COL3A1):c.1186G>A (p.Gly396Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
3646,NM_000090.4(COL3A1):c.1187G>A (p.Gly396Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
3647,NM_000090.4(COL3A1):c.1196G>C (p.Gly399Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3648,NM_000090.4(COL3A1):c.1213G>A (p.Gly405Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
3649,NM_000090.4(COL3A1):c.1223G>T (p.Gly408Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, single submitter"
3650,NM_000090.4(COL3A1):c.1231G>C (p.Gly411Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jan 14, 2022)","criteria provided, multiple submitters, no conflicts"
3650,NM_000090.4(COL3A1):c.1231G>C (p.Gly411Arg),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: jan 14, 2022)","criteria provided, multiple submitters, no conflicts"
3651,NM_000090.4(COL3A1):c.1241G>A (p.Gly414Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 20, 2020)","criteria provided, single submitter"
3652,NM_000090.4(COL3A1):c.1241G>T (p.Gly414Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3653,NM_000090.4(COL3A1):c.1249G>C (p.Gly417Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3654,NM_000090.4(COL3A1):c.1258G>A (p.Gly420Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
3654,NM_000090.4(COL3A1):c.1258G>A (p.Gly420Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: jul 26, 2022)","criteria provided, multiple submitters, no conflicts"
3655,NM_000090.4(COL3A1):c.1277G>A (p.Gly426Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, single submitter"
3656,NM_000090.4(COL3A1):c.1295G>A (p.Gly432Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3656,NM_000090.4(COL3A1):c.1295G>A (p.Gly432Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3657,NM_000090.4(COL3A1):c.1303G>T (p.Gly435Cys),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: jul 21, 2020)","criteria provided, single submitter"
3658,NM_000090.4(COL3A1):c.1303G>A (p.Gly435Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3658,NM_000090.4(COL3A1):c.1303G>A (p.Gly435Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, multiple submitters, no conflicts"
3659,NM_000090.4(COL3A1):c.1304G>A (p.Gly435Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: feb 24, 2021)","criteria provided, single submitter"
3660,NM_000090.4(COL3A1):c.1313G>A (p.Gly438Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: apr 11, 2022)","criteria provided, single submitter"
3661,NM_000090.4(COL3A1):c.1321G>A (p.Gly441Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, single submitter"
3662,NM_000090.4(COL3A1):c.1322G>A (p.Gly441Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3663,NM_000090.4(COL3A1):c.1330G>C (p.Gly444Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
3664,NM_000090.4(COL3A1):c.1330G>A (p.Gly444Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: dec 19, 2022)","criteria provided, multiple submitters, no conflicts"
3665,NM_000090.4(COL3A1):c.1357G>T (p.Gly453Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, single submitter"
3666,NM_000090.4(COL3A1):c.1366G>A (p.Gly456Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, single submitter"
3667,NM_000090.4(COL3A1):c.1384G>A (p.Gly462Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 15, 2021)","criteria provided, multiple submitters, no conflicts"
3668,NM_000090.4(COL3A1):c.1421G>T (p.Gly474Val),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: dec 28, 2016)","criteria provided, single submitter"
3669,NM_000090.4(COL3A1):c.1429G>T (p.Gly477Trp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3670,NM_000090.4(COL3A1):c.1430G>A (p.Gly477Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
3671,NM_000090.4(COL3A1):c.1438G>A (p.Gly480Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, single submitter"
3672,NM_000090.4(COL3A1):c.1457G>A (p.Gly486Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 29, 2021)","criteria provided, single submitter"
3673,NM_000090.4(COL3A1):c.1457G>T (p.Gly486Val),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: aug 19, 2020)","criteria provided, multiple submitters, no conflicts"
3674,NM_000090.4(COL3A1):c.1465G>T (p.Gly489Trp),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"likely pathogenic(last reviewed: jan 1, 2016)","criteria provided, single submitter"
3675,NM_000090.4(COL3A1):c.1484G>A (p.Gly495Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3676,NM_000090.4(COL3A1):c.1502G>A (p.Gly501Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3677,NM_000090.4(COL3A1):c.1618G>A (p.Gly540Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: apr 4, 2022)","criteria provided, multiple submitters, no conflicts"
3678,NM_000090.4(COL3A1):c.1654G>A (p.Gly552Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3679,NM_000090.4(COL3A1):c.1691G>C (p.Gly564Ala),COL3A1,familial aortopathy,Cumapped70,"likely pathogenic(last reviewed: aug 18, 2011)","criteria provided, single submitter"
3680,NM_000090.4(COL3A1):c.1708G>A (p.Gly570Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3681,NM_000090.4(COL3A1):c.1709G>A (p.Gly570Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 28, 2021)","criteria provided, multiple submitters, no conflicts"
3681,NM_000090.4(COL3A1):c.1709G>A (p.Gly570Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 28, 2021)","criteria provided, multiple submitters, no conflicts"
3682,NM_000090.4(COL3A1):c.1727G>A (p.Gly576Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 20, 2020)","criteria provided, single submitter"
3683,NM_000090.4(COL3A1):c.1744G>T (p.Gly582Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
3684,NM_000090.4(COL3A1):c.1744G>A (p.Gly582Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: jan 1, 2022)","criteria provided, multiple submitters, no conflicts"
3685,NM_000090.4(COL3A1):c.1745G>A (p.Gly582Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3686,NM_000090.4(COL3A1):c.1762G>A (p.Gly588Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: dec 10, 2021)","criteria provided, multiple submitters, no conflicts"
3686,NM_000090.4(COL3A1):c.1762G>A (p.Gly588Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: dec 10, 2021)","criteria provided, multiple submitters, no conflicts"
3687,NM_000090.4(COL3A1):c.1763G>T (p.Gly588Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: jan 17, 2022)","criteria provided, multiple submitters, no conflicts"
3688,NM_000090.4(COL3A1):c.1763G>A (p.Gly588Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, multiple submitters, no conflicts"
3688,NM_000090.4(COL3A1):c.1763G>A (p.Gly588Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, multiple submitters, no conflicts"
3689,NM_000090.4(COL3A1):c.1789G>A (p.Gly597Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 4, 2022)","criteria provided, single submitter"
3690,NM_000090.4(COL3A1):c.1808G>A (p.Gly603Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3691,NM_000090.4(COL3A1):c.1808G>T (p.Gly603Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: mar 23, 2022)","criteria provided, single submitter"
3692,NM_000090.4(COL3A1):c.1816G>T (p.Gly606Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, single submitter"
3693,NM_000090.4(COL3A1):c.1834G>A (p.Gly612Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 10, 2021)","criteria provided, single submitter"
3694,NM_000090.4(COL3A1):c.1844G>A (p.Gly615Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: jun 14, 2019)","criteria provided, single submitter"
3695,NM_000090.4(COL3A1):c.1853G>A (p.Gly618Glu),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
3695,NM_000090.4(COL3A1):c.1853G>A (p.Gly618Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
3696,NM_000090.4(COL3A1):c.1871G>A (p.Gly624Glu),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
3696,NM_000090.4(COL3A1):c.1871G>A (p.Gly624Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
3697,NM_000090.4(COL3A1):c.1897G>A (p.Gly633Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3698,NM_000090.4(COL3A1):c.1961G>A (p.Gly654Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 25, 2021)","criteria provided, single submitter"
3698,NM_000090.4(COL3A1):c.1961G>A (p.Gly654Glu),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"likely pathogenic(last reviewed: aug 25, 2021)","criteria provided, single submitter"
3699,NM_000090.4(COL3A1):c.1978G>A (p.Gly660Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3700,NM_000090.4(COL3A1):c.1987G>A (p.Gly663Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: jun 17, 2022)","criteria provided, single submitter"
3701,NM_000090.4(COL3A1):c.1988G>T (p.Gly663Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3702,NM_000090.4(COL3A1):c.1996G>A (p.Gly666Ser),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
3702,NM_000090.4(COL3A1):c.1996G>A (p.Gly666Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
3702,NM_000090.4(COL3A1):c.1996G>A (p.Gly666Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
3702,NM_000090.4(COL3A1):c.1996G>A (p.Gly666Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 9, 2022)","criteria provided, multiple submitters, no conflicts"
3703,NM_000090.4(COL3A1):c.1997G>A (p.Gly666Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, single submitter"
3704,NM_000090.4(COL3A1):c.2023G>A (p.Gly675Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 14, 2021)","criteria provided, single submitter"
3705,NM_000090.4(COL3A1):c.2042G>A (p.Gly681Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
3706,NM_000090.4(COL3A1):c.2044G>A (p.Glu682Lys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
3706,NM_000090.4(COL3A1):c.2044G>A (p.Glu682Lys),COL3A1,ehlers-danlos syndrome,C0013720,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
3707,NM_000090.4(COL3A1):c.2051G>A (p.Gly684Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3708,NM_000090.4(COL3A1):c.2069G>A (p.Gly690Glu),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: nov 13, 2017)","criteria provided, single submitter"
3709,NM_000090.4(COL3A1):c.2078G>T (p.Gly693Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3710,NM_000090.4(COL3A1):c.2078G>C (p.Gly693Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3711,NM_000090.4(COL3A1):c.2096G>A (p.Gly699Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: apr 1, 2018)","criteria provided, single submitter"
3712,NM_000090.4(COL3A1):c.2104G>A (p.Gly702Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: oct 8, 2022)","criteria provided, single submitter"
3713,NM_000090.4(COL3A1):c.2105G>C (p.Gly702Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 6, 2021)","criteria provided, single submitter"
3714,NM_000090.4(COL3A1):c.2113G>A (p.Gly705Arg),COL3A1,ehlers-danlos syndrome,C0013720,"likely pathogenic(last reviewed: feb 1, 2019)","criteria provided, single submitter"
3715,NM_000090.4(COL3A1):c.2122G>A (p.Gly708Ser),COL3A1,ehlers-danlos syndrome,C0013720,"likely pathogenic(last reviewed: jan 1, 2020)","criteria provided, single submitter"
3716,NM_000090.4(COL3A1):c.2123G>A (p.Gly708Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
3717,NM_000090.4(COL3A1):c.2123G>T (p.Gly708Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: apr 29, 2015)","criteria provided, single submitter"
3718,NM_000090.4(COL3A1):c.2131G>A (p.Gly711Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3718,NM_000090.4(COL3A1):c.2131G>A (p.Gly711Ser),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3718,NM_000090.4(COL3A1):c.2131G>A (p.Gly711Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3718,NM_000090.4(COL3A1):c.2131G>A (p.Gly711Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
3719,NM_000090.4(COL3A1):c.2140G>A (p.Gly714Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3720,NM_000090.4(COL3A1):c.2149G>C (p.Gly717Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 23, 2022)","criteria provided, single submitter"
3721,NM_000090.4(COL3A1):c.2159G>A (p.Gly720Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 20, 2018)","criteria provided, single submitter"
3722,NM_000090.4(COL3A1):c.2168G>A (p.Gly723Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3723,NM_000090.4(COL3A1):c.2176G>A (p.Gly726Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: dec 1, 2021)","criteria provided, single submitter"
3724,NM_000090.4(COL3A1):c.2194G>A (p.Gly732Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
3725,NM_000090.4(COL3A1):c.2203G>A (p.Gly735Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, single submitter"
3726,NM_000090.4(COL3A1):c.2212G>C (p.Gly738Arg),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: mar 2, 2022)","criteria provided, single submitter"
3727,NM_000090.4(COL3A1):c.2212G>A (p.Gly738Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3728,NM_000090.4(COL3A1):c.2221G>T (p.Gly741Cys),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: aug 30, 2017)","criteria provided, multiple submitters, no conflicts"
3729,NM_000090.4(COL3A1):c.2230G>T (p.Gly744Cys),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, single submitter"
3730,NM_000090.4(COL3A1):c.2230G>C (p.Gly744Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3731,NM_000090.4(COL3A1):c.2240G>A (p.Gly747Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3732,NM_000090.4(COL3A1):c.2257G>T (p.Gly753Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3733,NM_000090.4(COL3A1):c.2267G>A (p.Gly756Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, multiple submitters, no conflicts"
3734,NM_000090.4(COL3A1):c.2284G>T (p.Gly762Cys),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: oct 12, 2022)","criteria provided, single submitter"
3735,NM_000090.4(COL3A1):c.2284G>A (p.Gly762Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3736,NM_000090.4(COL3A1):c.2285G>A (p.Gly762Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: jan 17, 2020)","criteria provided, single submitter"
3737,NM_000090.4(COL3A1):c.2285G>T (p.Gly762Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3738,NM_000090.4(COL3A1):c.2294G>T (p.Gly765Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
3739,NM_000090.4(COL3A1):c.2312G>A (p.Gly771Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3740,NM_000090.4(COL3A1):c.2321G>A (p.Gly774Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
3741,NM_000090.4(COL3A1):c.2337G>C (p.Lys779Asn),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: feb 7, 2022)","criteria provided, single submitter"
3742,NM_000090.4(COL3A1):c.2356G>A (p.Gly786Arg),COL3A1|LOC126806446,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
3742,NM_000090.4(COL3A1):c.2356G>A (p.Gly786Arg),COL3A1|LOC126806446,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
3743,NM_000090.4(COL3A1):c.2393G>A (p.Gly798Asp),COL3A1|LOC126806446,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3744,NM_000090.4(COL3A1):c.2456G>A (p.Gly819Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jan 11, 2022)","criteria provided, single submitter"
3745,NM_000090.4(COL3A1):c.2501G>C (p.Gly834Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 23, 2020)","criteria provided, single submitter"
3746,NM_000090.4(COL3A1):c.2563G>T (p.Gly855Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, multiple submitters, no conflicts"
3746,NM_000090.4(COL3A1):c.2563G>T (p.Gly855Cys),COL3A1,polymicrogyria with or without vascular-type ehlers-danlos syndrome,C5193040,"pathogenic/likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, multiple submitters, no conflicts"
3746,NM_000090.4(COL3A1):c.2563G>T (p.Gly855Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: dec 2, 2021)","criteria provided, multiple submitters, no conflicts"
3747,NM_000090.4(COL3A1):c.2627G>C (p.Gly876Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
3748,NM_000090.4(COL3A1):c.2672G>A (p.Gly891Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,pathogenic,"criteria provided, single submitter"
3749,NM_000090.4(COL3A1):c.2690G>A (p.Gly897Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3750,NM_000090.4(COL3A1):c.2717G>A (p.Gly906Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: aug 25, 2021)","criteria provided, single submitter"
3751,NM_000090.4(COL3A1):c.2726G>A (p.Gly909Asp),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 23, 2019)","criteria provided, single submitter"
3752,NM_000090.4(COL3A1):c.2734G>A (p.Gly912Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 23, 2021)","criteria provided, single submitter"
3753,NM_000090.4(COL3A1):c.2743G>A (p.Gly915Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: feb 8, 2022)","criteria provided, single submitter"
3754,NM_000090.4(COL3A1):c.2752G>A (p.Gly918Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, multiple submitters, no conflicts"
3755,NM_000090.4(COL3A1):c.2753G>A (p.Gly918Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: jun 22, 2022)","criteria provided, single submitter"
3756,NM_000090.4(COL3A1):c.2762G>A (p.Gly921Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3757,NM_000090.4(COL3A1):c.2770G>A (p.Gly924Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: jul 3, 2021)","criteria provided, single submitter"
3758,NM_000090.4(COL3A1):c.2770G>T (p.Gly924Cys),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: sep 17, 2018)","criteria provided, single submitter"
3759,NM_000090.4(COL3A1):c.2771G>A (p.Gly924Asp),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: sep 17, 2018)","criteria provided, single submitter"
3760,NM_000090.4(COL3A1):c.2797G>A (p.Gly933Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3761,NM_000090.4(COL3A1):c.2815G>C (p.Gly939Arg),COL3A1,ehlers-danlos syndrome,C0013720,"likely pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
3762,NM_000090.4(COL3A1):c.2815G>T (p.Gly939Cys),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3763,NM_000090.4(COL3A1):c.2824G>A (p.Gly942Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3764,NM_000090.4(COL3A1):c.2833G>A (p.Gly945Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jul 29, 2022)","criteria provided, single submitter"
3765,NM_000090.4(COL3A1):c.2843G>A (p.Gly948Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: jun 26, 2022)","criteria provided, single submitter"
3766,NM_000090.4(COL3A1):c.2860G>A (p.Gly954Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 20, 2022)","criteria provided, single submitter"
3767,NM_000090.4(COL3A1):c.2869G>A (p.Gly957Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: mar 14, 2022)","criteria provided, single submitter"
3768,NM_000090.4(COL3A1):c.2870G>T (p.Gly957Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
3769,NM_000090.4(COL3A1):c.2887G>C (p.Gly963Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
3770,NM_000090.4(COL3A1):c.2888G>T (p.Gly963Val),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3771,NM_000090.4(COL3A1):c.2914G>A (p.Gly972Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: oct 24, 2016)","criteria provided, single submitter"
3772,NM_000090.4(COL3A1):c.2915G>C (p.Gly972Ala),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3773,NM_000090.4(COL3A1):c.2924G>C (p.Gly975Ala),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, single submitter"
3774,NM_000090.4(COL3A1):c.2932G>A (p.Gly978Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
3775,NM_000090.4(COL3A1):c.2933G>A (p.Gly978Asp),COL3A1,seizure,C0036572,"pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
3775,NM_000090.4(COL3A1):c.2933G>A (p.Gly978Asp),COL3A1,connective tissue nevi,C0334083,"pathogenic(last reviewed: jan 1, 2017)","criteria provided, single submitter"
3776,NM_000090.4(COL3A1):c.2959G>A (p.Gly987Ser),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic(last reviewed: apr 8, 2022)","criteria provided, multiple submitters, no conflicts"
3776,NM_000090.4(COL3A1):c.2959G>A (p.Gly987Ser),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic(last reviewed: apr 8, 2022)","criteria provided, multiple submitters, no conflicts"
3777,NM_000090.4(COL3A1):c.2986G>A (p.Gly996Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: apr 3, 2022)","criteria provided, multiple submitters, no conflicts"
3777,NM_000090.4(COL3A1):c.2986G>A (p.Gly996Arg),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: apr 3, 2022)","criteria provided, multiple submitters, no conflicts"
3778,NM_000090.4(COL3A1):c.3032G>A (p.Gly1011Glu),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, single submitter"
3779,NM_000090.4(COL3A1):c.3040G>A (p.Gly1014Arg),COL3A1,familial thoracic aortic aneurysm and aortic dissection,C4707243,"pathogenic/likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
3779,NM_000090.4(COL3A1):c.3040G>A (p.Gly1014Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"pathogenic/likely pathogenic(last reviewed: sep 27, 2021)","criteria provided, multiple submitters, no conflicts"
3780,NM_000090.4(COL3A1):c.3049G>A (p.Gly1017Arg),COL3A1,"ehlers-danlos syndrome, type 4",C0268338,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
3781,NM_000393.5(COL5A2):c.2833G>A (p.Gly945Arg),COL5A2,"ehlers-danlos syndrome, classic type, 2",C4538407,"likely pathogenic(last reviewed: apr 12, 2020)","criteria provided, single submitter"
3782,NM_000393.5(COL5A2):c.2285G>A (p.Gly762Asp),COL5A2,"ehlers-danlos syndrome, classic type, 2",C4538407,"likely pathogenic(last reviewed: jan 23, 2023)","criteria provided, single submitter"
3783,NM_000393.5(COL5A2):c.1933G>A (p.Gly645Arg),COL5A2,"ehlers-danlos syndrome, classic type, 1",C4552122,"likely pathogenic(last reviewed: aug 9, 2021)","criteria provided, single submitter"
3784,NM_000393.5(COL5A2):c.1907G>C (p.Gly636Ala),COL5A2,"ehlers-danlos syndrome, classic type, 2",C4538407,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
3785,NM_000393.5(COL5A2):c.1186G>C (p.Gly396Arg),COL5A2,"ehlers-danlos syndrome, classic type",C4225429,"likely pathogenic(last reviewed: nov 27, 2019)","criteria provided, single submitter"
3786,NM_000393.5(COL5A2):c.1105G>A (p.Gly369Ser),COL5A2,"ehlers-danlos syndrome, classic type, 2",C4538407,pathogenic,"criteria provided, single submitter"
3787,NM_000393.5(COL5A2):c.971G>A (p.Gly324Asp),COL5A2,"ehlers-danlos syndrome, classic type, 1",C4552122,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3788,NM_000393.5(COL5A2):c.754G>T (p.Gly252Cys),COL5A2,"ehlers-danlos syndrome, classic type, 2",C4538407,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3788,NM_000393.5(COL5A2):c.754G>T (p.Gly252Cys),COL5A2,joint hypermobility,C0086437,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3788,NM_000393.5(COL5A2):c.754G>T (p.Gly252Cys),COL5A2,telecanthus,C0423113,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3788,NM_000393.5(COL5A2):c.754G>T (p.Gly252Cys),COL5A2,hyperextensible skin,C4230250,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3788,NM_000393.5(COL5A2):c.754G>T (p.Gly252Cys),COL5A2,neuropathic spinal arthropathy,Cumapped173,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3788,NM_000393.5(COL5A2):c.754G>T (p.Gly252Cys),COL5A2,"ehlers-danlos syndrome, classic type, 1",C4552122,"likely pathogenic(last reviewed: may 28, 2022)","criteria provided, multiple submitters, no conflicts"
3789,NM_014585.6(SLC40A1):c.1469G>A (p.Gly490Asp),SLC40A1,hemochromatosis type 4,C1853733,"pathogenic(last reviewed: mar 12, 2022)","criteria provided, multiple submitters, no conflicts"
3790,NM_014585.6(SLC40A1):c.1468G>A (p.Gly490Ser),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: jul 1, 2020)","criteria provided, single submitter"
3791,NM_014585.6(SLC40A1):c.977G>T (p.Cys326Phe),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: feb 12, 2022)","criteria provided, single submitter"
3792,NM_014585.6(SLC40A1):c.698T>C (p.Leu233Pro),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: jul 1, 2020)","criteria provided, single submitter"
3793,NM_014585.6(SLC40A1):c.626C>T (p.Ser209Leu),SLC40A1,hemochromatosis type 4,C1853733,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
3794,NM_014585.6(SLC40A1):c.610G>A (p.Gly204Ser),SLC40A1,hemochromatosis type 4,C1853733,"pathogenic/likely pathogenic(last reviewed: jul 23, 2022)","criteria provided, multiple submitters, no conflicts"
3795,NM_014585.6(SLC40A1):c.554A>C (p.Asn185Thr),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: jul 1, 2020)","criteria provided, single submitter"
3796,NM_014585.6(SLC40A1):c.533G>A (p.Arg178Gln),SLC40A1,hemochromatosis type 4,C1853733,"pathogenic/likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, multiple submitters, no conflicts"
3797,NM_014585.6(SLC40A1):c.524C>A (p.Ala175Asp),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: nov 11, 2021)","criteria provided, single submitter"
3798,NM_014585.6(SLC40A1):c.474G>T (p.Trp158Cys),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3799,NM_014585.6(SLC40A1):c.470A>G (p.Asp157Gly),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: may 20, 2022)","criteria provided, multiple submitters, no conflicts"
3800,NM_014585.6(SLC40A1):c.430A>G (p.Asn144Asp),SLC40A1,hemochromatosis type 4,C1853733,"pathogenic/likely pathogenic(last reviewed: mar 14, 2023)","criteria provided, multiple submitters, no conflicts"
3801,NM_014585.6(SLC40A1):c.430A>T (p.Asn144Tyr),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3802,NM_014585.6(SLC40A1):c.262A>G (p.Arg88Gly),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: jul 1, 2020)","criteria provided, single submitter"
3803,NM_014585.6(SLC40A1):c.238G>A (p.Gly80Ser),SLC40A1,hemochromatosis type 4,C1853733,"pathogenic/likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
3804,NM_014585.6(SLC40A1):c.212C>T (p.Ser71Phe),SLC40A1,hemochromatosis type 4,C1853733,"likely pathogenic(last reviewed: jul 1, 2020)","criteria provided, single submitter"
3805,NM_000534.5(PMS1):c.287C>G (p.Ala96Gly),PMS1,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
3806,NM_000534.5(PMS1):c.2780A>G (p.Tyr927Cys),PMS1,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
3807,NM_014362.4(HIBCH):c.860A>G (p.Asp287Gly),HIBCH,beta-hydroxyisobutyryl-coa deacylase deficiency,C0342738,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3808,NM_014362.4(HIBCH):c.777T>A (p.Phe259Leu),HIBCH,beta-hydroxyisobutyryl-coa deacylase deficiency,C0342738,likely pathogenic,"criteria provided, single submitter"
3809,NM_014362.4(HIBCH):c.488G>T (p.Cys163Phe),HIBCH,beta-hydroxyisobutyryl-coa deacylase deficiency,C0342738,"pathogenic/likely pathogenic(last reviewed: may 27, 2022)","criteria provided, multiple submitters, no conflicts"
3810,NM_014362.4(HIBCH):c.458A>G (p.His153Arg),HIBCH,see cases,Cumapped260,"likely pathogenic(last reviewed: dec 21, 2022)","criteria provided, single submitter"
3811,NM_014362.4(HIBCH):c.457C>T (p.His153Tyr),HIBCH,beta-hydroxyisobutyryl-coa deacylase deficiency,C0342738,"likely pathogenic(last reviewed: dec 1, 2019)","criteria provided, single submitter"
3812,NM_014362.4(HIBCH):c.452C>T (p.Ser151Leu),HIBCH,neurodegeneration due to 3-hydroxyisobutyryl coenzyme a hydrolase deficiency,C4283745,"likely pathogenic(last reviewed: dec 3, 2017)","criteria provided, single submitter"
3813,NM_014362.4(HIBCH):c.212A>C (p.Gln71Pro),HIBCH,beta-hydroxyisobutyryl-coa deacylase deficiency,C0342738,"likely pathogenic(last reviewed: dec 9, 2017)","criteria provided, single submitter"
3814,NM_014905.5(GLS):c.815G>A (p.Arg272Lys),GLS,"developmental and epileptic encephalopathy, 71",C2931919,"pathogenic(last reviewed: mar 1, 2019)","criteria provided, single submitter"
3815,NM_014905.5(GLS):c.866A>T (p.Lys289Ile),GLS,"infantile cataract, skin abnormalities, glutamate excess, and impaired intellectual development",CL1371083,likely pathogenic,"criteria provided, single submitter"
3816,NM_007315.4(STAT1):c.2159C>T (p.Thr720Ile),STAT1,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3817,NM_007315.4(STAT1):c.2102A>G (p.Tyr701Cys),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: aug 17, 2021)","criteria provided, single submitter"
3817,NM_007315.4(STAT1):c.2102A>G (p.Tyr701Cys),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: aug 17, 2021)","criteria provided, single submitter"
3817,NM_007315.4(STAT1):c.2102A>G (p.Tyr701Cys),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: aug 17, 2021)","criteria provided, single submitter"
3818,NM_007315.4(STAT1):c.1398C>A (p.Ser466Arg),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: aug 4, 2021)","criteria provided, single submitter"
3818,NM_007315.4(STAT1):c.1398C>A (p.Ser466Arg),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: aug 4, 2021)","criteria provided, single submitter"
3818,NM_007315.4(STAT1):c.1398C>A (p.Ser466Arg),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: aug 4, 2021)","criteria provided, single submitter"
3819,NM_007315.4(STAT1):c.1310C>T (p.Thr437Ile),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, single submitter"
3819,NM_007315.4(STAT1):c.1310C>T (p.Thr437Ile),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, single submitter"
3819,NM_007315.4(STAT1):c.1310C>T (p.Thr437Ile),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: oct 29, 2022)","criteria provided, single submitter"
3820,NM_007315.4(STAT1):c.1210T>G (p.Phe404Val),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: dec 7, 2022)","criteria provided, single submitter"
3821,NM_007315.4(STAT1):c.1198C>G (p.Leu400Val),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: may 25, 2022)","criteria provided, single submitter"
3821,NM_007315.4(STAT1):c.1198C>G (p.Leu400Val),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: may 25, 2022)","criteria provided, single submitter"
3821,NM_007315.4(STAT1):c.1198C>G (p.Leu400Val),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: may 25, 2022)","criteria provided, single submitter"
3822,NM_007315.4(STAT1):c.1166T>G (p.Val389Gly),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3822,NM_007315.4(STAT1):c.1166T>G (p.Val389Gly),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3822,NM_007315.4(STAT1):c.1166T>G (p.Val389Gly),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
3823,NM_007315.4(STAT1):c.1162A>G (p.Lys388Glu),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
3823,NM_007315.4(STAT1):c.1162A>G (p.Lys388Glu),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
3823,NM_007315.4(STAT1):c.1162A>G (p.Lys388Glu),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
3824,NM_007315.4(STAT1):c.1162A>C (p.Lys388Gln),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3824,NM_007315.4(STAT1):c.1162A>C (p.Lys388Gln),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3824,NM_007315.4(STAT1):c.1162A>C (p.Lys388Gln),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3825,NM_007315.4(STAT1):c.1159A>G (p.Thr387Ala),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: jun 12, 2022)","criteria provided, single submitter"
3825,NM_007315.4(STAT1):c.1159A>G (p.Thr387Ala),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: jun 12, 2022)","criteria provided, single submitter"
3825,NM_007315.4(STAT1):c.1159A>G (p.Thr387Ala),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: jun 12, 2022)","criteria provided, single submitter"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,inherited immunodeficiency diseases,C5197805,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,combined immunodeficiency,C0494261,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,chronic diarrhea,C0401151,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,hypothyroidism,C4553310,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,failure to thrive,C0015544,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,cognitive impairment,C0338656,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,bronchiectasis,C0006267,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,liver abscess,C0023885,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,chronic oral candidiasis,C4024599,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,severe t-cell immunodeficiency,C4025208,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,primary hypothyroidism,C0700502,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,delayed speech and language development,C0454644,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,hypothyroidism,C4553310,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,short stature,C2919142,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3826,NM_007315.4(STAT1):c.1154C>T (p.Thr385Met),STAT1,see cases,Cumapped260,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3827,NM_007315.4(STAT1):c.1015G>T (p.Val339Phe),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: dec 28, 2021)","criteria provided, single submitter"
3828,NM_007315.4(STAT1):c.974T>A (p.Met325Lys),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, single submitter"
3828,NM_007315.4(STAT1):c.974T>A (p.Met325Lys),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, single submitter"
3828,NM_007315.4(STAT1):c.974T>A (p.Met325Lys),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: dec 7, 2021)","criteria provided, single submitter"
3829,NM_007315.4(STAT1):c.970T>C (p.Cys324Arg),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3829,NM_007315.4(STAT1):c.970T>C (p.Cys324Arg),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3829,NM_007315.4(STAT1):c.970T>C (p.Cys324Arg),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3829,NM_007315.4(STAT1):c.970T>C (p.Cys324Arg),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: jul 13, 2021)","criteria provided, multiple submitters, no conflicts"
3830,NM_007315.4(STAT1):c.876C>A (p.Asp292Glu),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3830,NM_007315.4(STAT1):c.876C>A (p.Asp292Glu),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3830,NM_007315.4(STAT1):c.876C>A (p.Asp292Glu),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3830,NM_007315.4(STAT1):c.876C>A (p.Asp292Glu),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, multiple submitters, no conflicts"
3831,NM_007315.4(STAT1):c.866A>G (p.Tyr289Cys),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, single submitter"
3831,NM_007315.4(STAT1):c.866A>G (p.Tyr289Cys),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, single submitter"
3831,NM_007315.4(STAT1):c.866A>G (p.Tyr289Cys),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: oct 26, 2022)","criteria provided, single submitter"
3832,NM_007315.4(STAT1):c.865T>C (p.Tyr289His),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: nov 27, 2021)","criteria provided, single submitter"
3832,NM_007315.4(STAT1):c.865T>C (p.Tyr289His),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: nov 27, 2021)","criteria provided, single submitter"
3832,NM_007315.4(STAT1):c.865T>C (p.Tyr289His),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: nov 27, 2021)","criteria provided, single submitter"
3833,NM_007315.4(STAT1):c.863C>T (p.Thr288Ile),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3833,NM_007315.4(STAT1):c.863C>T (p.Thr288Ile),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3833,NM_007315.4(STAT1):c.863C>T (p.Thr288Ile),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
3834,NM_007315.4(STAT1):c.862A>G (p.Thr288Ala),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
3834,NM_007315.4(STAT1):c.862A>G (p.Thr288Ala),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
3834,NM_007315.4(STAT1):c.862A>G (p.Thr288Ala),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
3835,NM_007315.4(STAT1):c.859T>G (p.Tyr287Asp),STAT1,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3836,NM_007315.4(STAT1):c.856A>C (p.Lys286Gln),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: nov 21, 2019)","criteria provided, single submitter"
3836,NM_007315.4(STAT1):c.856A>C (p.Lys286Gln),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: nov 21, 2019)","criteria provided, single submitter"
3836,NM_007315.4(STAT1):c.856A>C (p.Lys286Gln),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: nov 21, 2019)","criteria provided, single submitter"
3837,NM_007315.4(STAT1):c.851A>G (p.Glu284Gly),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3837,NM_007315.4(STAT1):c.851A>G (p.Glu284Gly),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3837,NM_007315.4(STAT1):c.851A>G (p.Glu284Gly),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3838,NM_007315.4(STAT1):c.839T>G (p.Leu280Trp),STAT1,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3839,NM_007315.4(STAT1):c.821G>A (p.Arg274Gln),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3839,NM_007315.4(STAT1):c.821G>A (p.Arg274Gln),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3839,NM_007315.4(STAT1):c.821G>A (p.Arg274Gln),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3839,NM_007315.4(STAT1):c.821G>A (p.Arg274Gln),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3839,NM_007315.4(STAT1):c.821G>A (p.Arg274Gln),STAT1,see cases,Cumapped260,"pathogenic(last reviewed: dec 21, 2022)","criteria provided, multiple submitters, no conflicts"
3840,NM_007315.4(STAT1):c.820C>G (p.Arg274Gly),STAT1,immunodeficiency 31b,C3151088,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3840,NM_007315.4(STAT1):c.820C>G (p.Arg274Gly),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3840,NM_007315.4(STAT1):c.820C>G (p.Arg274Gly),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3840,NM_007315.4(STAT1):c.820C>G (p.Arg274Gly),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic/likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, multiple submitters, no conflicts"
3841,NM_007315.4(STAT1):c.820C>T (p.Arg274Trp),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, multiple submitters, no conflicts"
3841,NM_007315.4(STAT1):c.820C>T (p.Arg274Trp),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, multiple submitters, no conflicts"
3841,NM_007315.4(STAT1):c.820C>T (p.Arg274Trp),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, multiple submitters, no conflicts"
3841,NM_007315.4(STAT1):c.820C>T (p.Arg274Trp),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: aug 17, 2022)","criteria provided, multiple submitters, no conflicts"
3842,NM_007315.4(STAT1):c.800C>T (p.Ala267Val),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
3842,NM_007315.4(STAT1):c.800C>T (p.Ala267Val),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
3842,NM_007315.4(STAT1):c.800C>T (p.Ala267Val),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
3842,NM_007315.4(STAT1):c.800C>T (p.Ala267Val),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
3842,NM_007315.4(STAT1):c.800C>T (p.Ala267Val),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
3842,NM_007315.4(STAT1):c.800C>T (p.Ala267Val),STAT1,chronic mucocutaneous candidiasis,C0006845,"pathogenic(last reviewed: aug 13, 2022)","criteria provided, multiple submitters, no conflicts"
3843,NM_007315.4(STAT1):c.604A>G (p.Met202Val),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3843,NM_007315.4(STAT1):c.604A>G (p.Met202Val),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3843,NM_007315.4(STAT1):c.604A>G (p.Met202Val),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: jun 27, 2022)","criteria provided, single submitter"
3844,NM_007315.4(STAT1):c.520T>C (p.Cys174Arg),STAT1,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3845,NM_007315.4(STAT1):c.514T>C (p.Phe172Leu),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
3846,NM_007315.4(STAT1):c.511G>A (p.Asp171Asn),STAT1,immunodeficiency 31b,C3151088,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
3846,NM_007315.4(STAT1):c.511G>A (p.Asp171Asn),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
3846,NM_007315.4(STAT1):c.511G>A (p.Asp171Asn),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, single submitter"
3847,NM_007315.4(STAT1):c.209G>C (p.Arg70Pro),STAT1,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3848,NM_007315.4(STAT1):c.200A>C (p.Gln67Pro),STAT1,autoimmune enteropathy and endocrinopathy - susceptibility to chronic infections syndrome,C4302671,"pathogenic(last reviewed: jul 8, 2022)","criteria provided, single submitter"
3848,NM_007315.4(STAT1):c.200A>C (p.Gln67Pro),STAT1,mendelian susceptibility to mycobacterial diseases due to partial stat1 deficiency,C4509855,"pathogenic(last reviewed: jul 8, 2022)","criteria provided, single submitter"
3848,NM_007315.4(STAT1):c.200A>C (p.Gln67Pro),STAT1,immunodeficiency 31b,C3151088,"pathogenic(last reviewed: jul 8, 2022)","criteria provided, single submitter"
3849,NM_001348768.2(HECW2):c.2587T>C (p.Tyr863His),HECW2,"neurodevelopmental disorder with hypotonia, seizures, and absent language",C4310643,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, multiple submitters, no conflicts"
3849,NM_001348768.2(HECW2):c.2587T>C (p.Tyr863His),HECW2,abnormality of the nervous system,C0497552,"likely pathogenic(last reviewed: jul 10, 2021)","criteria provided, multiple submitters, no conflicts"
3850,NM_001348768.2(HECW2):c.811C>T (p.Arg271Cys),HECW2,"neurodevelopmental disorder with hypotonia, seizures, and absent language",C4310643,"likely pathogenic(last reviewed: dec 16, 2022)","criteria provided, single submitter"
3851,NM_001348768.2(HECW2):c.412A>G (p.Ile138Val),HECW2,"neurodevelopmental disorder with hypotonia, seizures, and absent language",C4310643,"likely pathogenic(last reviewed: mar 17, 2021)","criteria provided, single submitter"
3852,NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn),SF3B1,myelodysplastic syndrome progressed to acute myeloid leukemia,Cumapped140,"pathogenic/likely pathogenic(last reviewed: oct 10, 2021)","criteria provided, multiple submitters, no conflicts"
3852,NM_012433.4(SF3B1):c.1998G>T (p.Lys666Asn),SF3B1,myelodysplastic syndrome,C4552879,"pathogenic/likely pathogenic(last reviewed: oct 10, 2021)","criteria provided, multiple submitters, no conflicts"
3853,NM_012433.4(SF3B1):c.1874G>A (p.Arg625His),SF3B1,uveal melanoma,C0220633,"likely pathogenic(last reviewed: dec 5, 2021)","criteria provided, single submitter"
3854,NM_002156.5(HSPD1):c.292G>A (p.Val98Ile),HSPD1,hereditary spastic paraplegia 13,C0037773,pathogenic,"criteria provided, single submitter"
3855,NM_001172509.2(SATB2):c.1964C>T (p.Pro655Leu),LOC126806462|SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic/likely pathogenic(last reviewed: jun 21, 2022)","criteria provided, multiple submitters, no conflicts"
3856,NM_001172509.2(SATB2):c.1696G>A (p.Glu566Lys),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic/likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
3857,NM_001172509.2(SATB2):c.1564C>T (p.Arg522Cys),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic/likely pathogenic(last reviewed: dec 16, 2022)","criteria provided, multiple submitters, no conflicts"
3858,NM_001172509.2(SATB2):c.1538G>A (p.Ser513Asn),SATB2,intellectual disability,C3714756,"pathogenic(last reviewed: apr 20, 2020)","criteria provided, single submitter"
3859,NM_001172509.2(SATB2):c.1307A>T (p.Glu436Val),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"likely pathogenic(last reviewed: dec 14, 2018)","criteria provided, single submitter"
3860,NM_001172509.2(SATB2):c.1298A>C (p.Tyr433Ser),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"likely pathogenic(last reviewed: sep 22, 2017)","criteria provided, single submitter"
3861,NM_001172509.2(SATB2):c.1226A>G (p.Gln409Arg),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, single submitter"
3862,NM_001172509.2(SATB2):c.1204G>A (p.Glu402Lys),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
3863,NM_001172509.2(SATB2):c.1196G>A (p.Arg399His),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
3864,NM_001172509.2(SATB2):c.1195C>T (p.Arg399Cys),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
3864,NM_001172509.2(SATB2):c.1195C>T (p.Arg399Cys),SATB2,intellectual disability,C3714756,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
3865,NM_001172509.2(SATB2):c.1187A>G (p.Glu396Gly),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3866,NM_001172509.2(SATB2):c.1174G>C (p.Gly392Arg),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic/likely pathogenic(last reviewed: dec 13, 2021)","criteria provided, multiple submitters, no conflicts"
3867,NM_001172509.2(SATB2):c.1174G>A (p.Gly392Arg),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3868,NM_001172509.2(SATB2):c.1172A>C (p.Gln391Pro),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"likely pathogenic(last reviewed: jun 4, 2020)","criteria provided, single submitter"
3869,NM_001172509.2(SATB2):c.1169C>T (p.Thr390Ile),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"likely pathogenic(last reviewed: jul 22, 2014)","criteria provided, single submitter"
3870,NM_001172509.2(SATB2):c.1166G>C (p.Arg389Pro),SATB2,developmental disorder,C0008073,"pathogenic(last reviewed: oct 10, 2019)","criteria provided, single submitter"
3871,NM_001172509.2(SATB2):c.1166G>T (p.Arg389Leu),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
3872,NM_001172509.2(SATB2):c.1165C>T (p.Arg389Cys),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"pathogenic/likely pathogenic(last reviewed: jan 18, 2022)","criteria provided, multiple submitters, no conflicts"
3873,NM_001172509.2(SATB2):c.700G>A (p.Val234Met),SATB2,chromosome 2q32-q33 deletion syndrome,C2676739,"likely pathogenic(last reviewed: nov 16, 2021)","criteria provided, single submitter"
3874,NM_002491.3(NDUFB3):c.64T>C (p.Trp22Arg),NDUFB3,"mitochondrial complex 1 deficiency, nuclear type 25",C4748806,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3874,NM_002491.3(NDUFB3):c.64T>C (p.Trp22Arg),NDUFB3,mitochondrial complex i deficiency,C1838979,"pathogenic/likely pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
3875,NM_001372051.1(CASP8):c.679C>T (p.Gln227Ter),CASP8,autoimmune lymphoproliferative syndrome type 2b,C1846545,"pathogenic(last reviewed: dec 8, 2021)","criteria provided, single submitter"
3876,NM_001372051.1(CASP8):c.742C>T (p.Arg248Trp),CASP8,autoimmune lymphoproliferative syndrome type 2b,C1846545,"likely pathogenic(last reviewed: mar 7, 2022)","criteria provided, single submitter"
3877,NM_001044385.3(TMEM237):c.676A>G (p.Arg226Gly),TMEM237,joubert syndrome 14,C3280766,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3878,NM_020919.4(ALS2):c.1718C>A (p.Ala573Glu),ALS2,"amyotrophic lateral sclerosis type 2, juvenile",C1859807,"likely pathogenic(last reviewed: mar 31, 2020)","criteria provided, multiple submitters, no conflicts"
3878,NM_020919.4(ALS2):c.1718C>A (p.Ala573Glu),ALS2,infantile-onset ascending hereditary spastic paralysis,C2931441,"likely pathogenic(last reviewed: mar 31, 2020)","criteria provided, multiple submitters, no conflicts"
3879,NM_020919.4(ALS2):c.1649C>T (p.Pro550Leu),ALS2,"amyotrophic lateral sclerosis type 2, juvenile",C1859807,likely pathogenic,"criteria provided, single submitter"
3880,NM_020919.4(ALS2):c.470G>A (p.Cys157Tyr),ALS2,infantile-onset ascending hereditary spastic paralysis,C2931441,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
3881,NM_020919.4(ALS2):c.347G>A (p.Gly116Glu),ALS2,infantile-onset ascending hereditary spastic paralysis,C2931441,pathogenic,"criteria provided, single submitter"
3882,NM_001204.7(BMPR2):c.200A>G (p.Tyr67Cys),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3883,NM_001204.7(BMPR2):c.296G>A (p.Cys99Tyr),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
3884,NM_001204.7(BMPR2):c.350G>A (p.Cys117Tyr),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
3884,NM_001204.7(BMPR2):c.350G>A (p.Cys117Tyr),BMPR2,not specified,Cumapped182,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
3885,NM_001204.7(BMPR2):c.354T>G (p.Cys118Trp),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: sep 17, 2022)","criteria provided, single submitter"
3886,NM_001204.7(BMPR2):c.377A>G (p.Asn126Ser),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic/likely pathogenic(last reviewed: aug 28, 2021)","criteria provided, multiple submitters, no conflicts"
3887,NM_001204.7(BMPR2):c.901T>C (p.Ser301Pro),BMPR2,idiopathic and/or familial pulmonary arterial hypertension,C3809621,"likely pathogenic(last reviewed: jun 1, 2020)","criteria provided, single submitter"
3888,NM_001204.7(BMPR2):c.1039T>C (p.Cys347Arg),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
3889,NM_001204.7(BMPR2):c.1259G>A (p.Cys420Tyr),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: feb 28, 2022)","criteria provided, single submitter"
3890,NM_001204.7(BMPR2):c.1276G>C (p.Gly426Arg),BMPR2,"pulmonary hypertension, primary, 1",C4552070,"likely pathogenic(last reviewed: sep 8, 2015)","criteria provided, single submitter"
3891,NM_001204.7(BMPR2):c.1429A>G (p.Lys477Glu),BMPR2,"tooth agenesis, selective, 1",C3489529,likely pathogenic,"criteria provided, single submitter"
3892,NM_001204.7(BMPR2):c.1461T>G (p.Asp487Glu),BMPR2,primary pulmonary hypertension,C0152171,"likely pathogenic(last reviewed: oct 15, 2021)","criteria provided, single submitter"
3893,NM_001204.7(BMPR2):c.1471C>T (p.Arg491Trp),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
3893,NM_001204.7(BMPR2):c.1471C>T (p.Arg491Trp),BMPR2,pulmonary arterial hypertension,C2973725,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
3894,NM_001204.7(BMPR2):c.1472G>T (p.Arg491Leu),BMPR2,primary pulmonary hypertension,C0152171,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
3895,NM_001204.7(BMPR2):c.1472G>A (p.Arg491Gln),BMPR2,primary pulmonary hypertension,C0152171,"pathogenic(last reviewed: oct 14, 2021)","criteria provided, multiple submitters, no conflicts"
3896,NM_001204.7(BMPR2):c.1488T>G (p.Cys496Trp),BMPR2,primary pulmonary hypertension,C0152171,"likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, single submitter"
3897,NM_005214.5(CTLA4):c.127C>G (p.Pro43Ala),CTLA4,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3898,NM_005214.5(CTLA4):c.223C>T (p.Arg75Trp),CTLA4,autoimmune lymphoproliferative syndrome due to ctla4 haploinsuffiency,C4015214,"pathogenic(last reviewed: oct 16, 2022)","criteria provided, single submitter"
3899,NM_005214.5(CTLA4):c.410C>G (p.Pro137Arg),CTLA4,inherited immunodeficiency diseases,C5197805,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
3900,NM_005214.5(CTLA4):c.412C>A (p.Pro138Thr),CTLA4,autoimmune lymphoproliferative syndrome due to ctla4 haploinsuffiency,C4015214,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
3901,NM_005214.5(CTLA4):c.436G>A (p.Gly146Arg),CTLA4,autoimmune lymphoproliferative syndrome due to ctla4 haploinsuffiency,C4015214,"pathogenic/likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
3902,NM_005006.7(NDUFS1):c.1285G>A (p.Val429Met),NDUFS1,"mitochondrial complex 1 deficiency, nuclear type 5",CL968046,"likely pathogenic(last reviewed: jul 5, 2019)","criteria provided, single submitter"
3903,NM_005006.7(NDUFS1):c.1223G>A (p.Arg408His),NDUFS1,"mitochondrial complex 1 deficiency, nuclear type 5",CL968046,"likely pathogenic(last reviewed: feb 20, 2019)","criteria provided, multiple submitters, no conflicts"
3904,NM_005006.7(NDUFS1):c.758T>G (p.Val253Gly),NDUFS1,"juvenile myopathy, encephalopathy, lactic acidosis and stroke",C0162671,"likely pathogenic(last reviewed: aug 12, 2011)","criteria provided, single submitter"
3905,NM_005006.7(NDUFS1):c.683T>C (p.Val228Ala),NDUFS1,"mitochondrial complex 1 deficiency, nuclear type 5",CL968046,"pathogenic/likely pathogenic(last reviewed: jan 10, 2023)","criteria provided, multiple submitters, no conflicts"
3906,NM_005006.7(NDUFS1):c.518T>G (p.Met173Arg),NDUFS1,leigh syndrome,C0023264,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3907,NM_001136193.2(FASTKD2):c.1898G>T (p.Arg633Ile),FASTKD2,cytochrome-c oxidase deficiency disease,C0268237,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3908,NM_003709.4(KLF7):c.790G>A (p.Asp264Asn),KLF7,neurodevelopmental disorder,C1535926,"pathogenic/likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, multiple submitters, no conflicts"
3909,NM_006891.4(CRYGD):c.176G>A (p.Arg59His),LOC100507443|CRYGD,aculeiform cataract,C1861832,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
3910,NM_006891.4(CRYGD):c.154T>C (p.Ser52Pro),LOC100507443|CRYGD,aculeiform cataract,C1861832,"likely pathogenic(last reviewed: jul 21, 2022)","criteria provided, single submitter"
3911,NM_006891.4(CRYGD):c.70C>A (p.Pro24Thr),CRYGD|LOC100507443,aculeiform cataract,C1861832,"pathogenic/likely pathogenic(last reviewed: feb 1, 2022)","criteria provided, multiple submitters, no conflicts"
3912,NM_006891.4(CRYGD):c.43C>T (p.Arg15Cys),CRYGD|LOC100507443,aculeiform cataract,C1861832,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3913,NM_005896.4(IDH1):c.890G>T (p.Cys297Phe),IDH1,paroxysmal extreme pain disorder,C1833661,"likely pathogenic(last reviewed: mar 6, 2021)","criteria provided, single submitter"
3914,NM_005896.4(IDH1):c.565A>G (p.Ile189Val),IDH1,enchondromatosis,C0014084,likely pathogenic,"criteria provided, single submitter"
3915,NM_005896.4(IDH1):c.395G>A (p.Arg132His),IDH1,metaphyseal chondromatosis with d-2-hydroxyglutaric aciduria,C3553958,"pathogenic/likely pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
3915,NM_005896.4(IDH1):c.395G>A (p.Arg132His),IDH1,enchondromatosis,C0014084,"pathogenic/likely pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
3916,NM_005896.4(IDH1):c.394C>T (p.Arg132Cys),IDH1,acute myeloid leukemia,C0023467,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
3916,NM_005896.4(IDH1):c.394C>T (p.Arg132Cys),IDH1,maffucci syndrome,C0024454,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
3916,NM_005896.4(IDH1):c.394C>T (p.Arg132Cys),IDH1,enchondromatosis,C0014084,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
3916,NM_005896.4(IDH1):c.394C>T (p.Arg132Cys),IDH1,enchondromatosis,C0014084,"pathogenic/likely pathogenic(last reviewed: aug 11, 2022)","criteria provided, multiple submitters, no conflicts"
3917,NM_001371986.1(UNC80):c.565G>A (p.Val189Met),UNC80,encephalopathy,C0085584,"likely pathogenic(last reviewed: aug 30, 2015)","criteria provided, single submitter"
3918,NM_079420.3(MYL1):c.488T>G (p.Met163Arg),MYL1,congenital myopathy with reduced type 2 muscle fibers,C4229492,"likely pathogenic(last reviewed: aug 21, 2019)","criteria provided, single submitter"
3919,NM_001875.5(CPS1):c.3G>T (p.Met1Ile),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: sep 26, 2017)","criteria provided, single submitter"
3920,NM_001875.5(CPS1):c.149T>C (p.Leu50Pro),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, single submitter"
3921,NM_001875.5(CPS1):c.794C>T (p.Pro265Leu),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: feb 5, 2023)","criteria provided, single submitter"
3922,NM_001875.5(CPS1):c.840G>C (p.Lys280Asn),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: jan 4, 2022)","criteria provided, single submitter"
3923,NM_001875.5(CPS1):c.1291G>A (p.Gly431Arg),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3924,NM_001875.5(CPS1):c.1312G>C (p.Ala438Pro),CPS1,"pulmonary hypertension, neonatal, susceptibility to",C3714958,"likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
3924,NM_001875.5(CPS1):c.1312G>C (p.Ala438Pro),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
3924,NM_001875.5(CPS1):c.1312G>C (p.Ala438Pro),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: feb 17, 2023)","criteria provided, multiple submitters, no conflicts"
3925,NM_001875.5(CPS1):c.1370T>G (p.Val457Gly),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic(last reviewed: dec 18, 2021)","criteria provided, single submitter"
3926,NM_001875.5(CPS1):c.1631C>T (p.Thr544Met),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: jul 18, 2022)","criteria provided, single submitter"
3927,NM_001875.5(CPS1):c.1760G>A (p.Arg587His),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic/likely pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
3928,NM_001875.5(CPS1):c.2339G>A (p.Arg780His),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic/likely pathogenic(last reviewed: oct 23, 2021)","criteria provided, multiple submitters, no conflicts"
3929,NM_001875.5(CPS1):c.2376G>C (p.Met792Ile),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: sep 16, 2022)","criteria provided, single submitter"
3930,NM_001875.5(CPS1):c.2407C>G (p.Arg803Gly),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3930,NM_001875.5(CPS1):c.2407C>G (p.Arg803Gly),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3930,NM_001875.5(CPS1):c.2407C>G (p.Arg803Gly),CPS1,"pulmonary hypertension, neonatal, susceptibility to",C3714958,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3931,NM_001875.5(CPS1):c.2429A>G (p.Gln810Arg),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
3932,NM_001875.5(CPS1):c.2548C>T (p.Arg850Cys),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: oct 31, 2021)","criteria provided, single submitter"
3933,NM_001875.5(CPS1):c.2548C>G (p.Arg850Gly),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3934,NM_001875.5(CPS1):c.2549G>A (p.Arg850His),CPS1,"congenital hyperammonemia, type i",C4082171,"pathogenic(last reviewed: sep 5, 2022)","criteria provided, single submitter"
3935,NM_001875.5(CPS1):c.2945G>A (p.Gly982Asp),CPS1,"congenital hyperammonemia, type i",C4082171,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3936,NM_005235.3(ERBB4):c.2207T>A (p.Ile736Asn),ERBB4,amyotrophic lateral sclerosis type 19,C3715155,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3937,NM_000465.4(BARD1):c.1904G>A (p.Trp635Ter),BARD1,familial cancer of breast,C0346153,"pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
3937,NM_000465.4(BARD1):c.1904G>A (p.Trp635Ter),BARD1,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 14, 2021)","criteria provided, multiple submitters, no conflicts"
3938,NM_000465.4(BARD1):c.1736C>T (p.Ser579Leu),BARD1,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
3939,NM_000465.4(BARD1):c.212G>A (p.Cys71Tyr),BARD1,familial cancer of breast,C0346153,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
3940,NM_173076.3(ABCA12):c.130C>T (p.Arg44Trp),ABCA12,autosomal recessive congenital ichthyosis 4a,C0020758,"likely pathogenic(last reviewed: mar 9, 2022)","criteria provided, multiple submitters, no conflicts"
3940,NM_173076.3(ABCA12):c.130C>T (p.Arg44Trp),ABCA12,autosomal recessive congenital ichthyosis 4b,C0020758,"likely pathogenic(last reviewed: mar 9, 2022)","criteria provided, multiple submitters, no conflicts"
3941,NM_004044.7(ATIC):c.1085A>G (p.Tyr362Cys),ATIC,aica-ribosiduria,C4510943,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
3942,NM_212482.4(FN1):c.2918A>G (p.Tyr973Cys),FN1,glomerulopathy with fibronectin deposits 2,C1866075,"pathogenic(last reviewed: apr 11, 2022)","criteria provided, multiple submitters, no conflicts"
3942,NM_212482.4(FN1):c.2918A>G (p.Tyr973Cys),FN1,glomerulopathy with fibronectin deposits 2,C1866075,"pathogenic(last reviewed: apr 11, 2022)","criteria provided, multiple submitters, no conflicts"
3942,NM_212482.4(FN1):c.2918A>G (p.Tyr973Cys),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"pathogenic(last reviewed: apr 11, 2022)","criteria provided, multiple submitters, no conflicts"
3943,NM_212482.4(FN1):c.778T>G (p.Cys260Gly),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
3944,NM_212482.4(FN1):c.718T>G (p.Tyr240Asp),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
3945,NM_212482.4(FN1):c.675C>G (p.Cys225Trp),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
3946,NM_212482.4(FN1):c.367T>C (p.Cys123Arg),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"pathogenic/likely pathogenic(last reviewed: jul 1, 2022)","criteria provided, multiple submitters, no conflicts"
3947,NM_212482.4(FN1):c.261C>G (p.Cys87Trp),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
3948,NM_212482.4(FN1):c.260G>T (p.Cys87Phe),FN1,spondylometaphyseal dysplasia - sutcliffe type,C0432221,"likely pathogenic(last reviewed: oct 15, 2018)","criteria provided, single submitter"
3949,NM_014140.4(SMARCAL1):c.836T>C (p.Phe279Ser),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"likely pathogenic(last reviewed: oct 15, 2022)","criteria provided, multiple submitters, no conflicts"
3950,NM_014140.4(SMARCAL1):c.1402G>C (p.Ala468Pro),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
3951,NM_014140.4(SMARCAL1):c.1682G>A (p.Arg561His),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic(last reviewed: oct 1, 2022)","criteria provided, single submitter"
3952,NM_014140.4(SMARCAL1):c.1736C>T (p.Ser579Leu),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic/likely pathogenic(last reviewed: sep 15, 2022)","criteria provided, multiple submitters, no conflicts"
3953,NM_014140.4(SMARCAL1):c.1930C>T (p.Arg644Trp),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3954,NM_014140.4(SMARCAL1):c.1931G>A (p.Arg644Gln),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic(last reviewed: sep 3, 2022)","criteria provided, single submitter"
3955,NM_014140.4(SMARCAL1):c.1933C>T (p.Arg645Cys),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
3956,NM_014140.4(SMARCAL1):c.1934G>A (p.Arg645His),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
3957,NM_014140.4(SMARCAL1):c.2291G>A (p.Arg764Gln),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic(last reviewed: nov 4, 2022)","criteria provided, single submitter"
3958,NM_014140.4(SMARCAL1):c.2459G>A (p.Arg820His),SMARCAL1,inherited immunodeficiency diseases,C5197805,"pathogenic/likely pathogenic(last reviewed: oct 6, 2022)","criteria provided, multiple submitters, no conflicts"
3958,NM_014140.4(SMARCAL1):c.2459G>A (p.Arg820His),SMARCAL1,schimke immuno-osseous dysplasia,Cumapped257,"pathogenic/likely pathogenic(last reviewed: oct 6, 2022)","criteria provided, multiple submitters, no conflicts"
3959,NM_001557.4(CXCR2):c.623G>A (p.Arg208Gln),CXCR2,whim syndrome 2,Cumapped349,"likely pathogenic(last reviewed: dec 28, 2021)","criteria provided, single submitter"
3960,NM_015488.5(PNKD):c.20C>T (p.Ala7Val),PNKD,paroxysmal nonkinesigenic dyskinesia,C1869117,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
3960,NM_015488.5(PNKD):c.20C>T (p.Ala7Val),PNKD,paroxysmal nonkinesigenic dyskinesia 1,C4551506,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
3961,NM_015488.5(PNKD):c.26C>T (p.Ala9Val),PNKD,paroxysmal nonkinesigenic dyskinesia,C1869117,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3962,NM_005444.3(CNOT9):c.874C>T (p.Arg292Trp),CNOT9,neurodevelopmental delay,C4022738,"pathogenic(last reviewed: sep 28, 2022)","criteria provided, multiple submitters, no conflicts"
3963,NM_001079866.2(BCS1L):c.170A>G (p.Asp57Gly),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"likely pathogenic(last reviewed: feb 2, 2022)","criteria provided, single submitter"
3964,NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"pathogenic(last reviewed: dec 9, 2022)","criteria provided, multiple submitters, no conflicts"
3964,NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly),BCS1L,pili torti-deafness syndrome,C0266006,"pathogenic(last reviewed: dec 9, 2022)","criteria provided, multiple submitters, no conflicts"
3964,NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly),BCS1L,gracile syndrome,C1412777,"pathogenic(last reviewed: dec 9, 2022)","criteria provided, multiple submitters, no conflicts"
3964,NM_001079866.2(BCS1L):c.232A>G (p.Ser78Gly),BCS1L,gracile syndrome,C1412777,"pathogenic(last reviewed: dec 9, 2022)","criteria provided, multiple submitters, no conflicts"
3965,NM_001079866.2(BCS1L):c.269G>A (p.Arg90His),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"likely pathogenic(last reviewed: dec 12, 2019)","criteria provided, multiple submitters, no conflicts"
3966,NM_001079866.2(BCS1L):c.296C>T (p.Pro99Leu),BCS1L,gracile syndrome,C1412777,"pathogenic/likely pathogenic(last reviewed: jan 18, 2022)","criteria provided, multiple submitters, no conflicts"
3967,NM_001079866.2(BCS1L):c.340C>T (p.Arg114Trp),BCS1L,pili torti-deafness syndrome,C0266006,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3968,NM_001079866.2(BCS1L):c.385G>A (p.Gly129Arg),BCS1L,leigh syndrome,C0023264,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3968,NM_001079866.2(BCS1L):c.385G>A (p.Gly129Arg),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"pathogenic/likely pathogenic(last reviewed: oct 19, 2022)","criteria provided, multiple submitters, no conflicts"
3969,NM_001079866.2(BCS1L):c.548G>A (p.Arg183His),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
3969,NM_001079866.2(BCS1L):c.548G>A (p.Arg183His),BCS1L,gracile syndrome,C1412777,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
3969,NM_001079866.2(BCS1L):c.548G>A (p.Arg183His),BCS1L,pili torti-deafness syndrome,C0266006,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
3969,NM_001079866.2(BCS1L):c.548G>A (p.Arg183His),BCS1L,leigh syndrome,C0023264,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
3969,NM_001079866.2(BCS1L):c.548G>A (p.Arg183His),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
3970,NM_001079866.2(BCS1L):c.916C>T (p.Arg306Cys),BCS1L,gracile syndrome,C1412777,"pathogenic/likely pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
3970,NM_001079866.2(BCS1L):c.916C>T (p.Arg306Cys),BCS1L,pili torti-deafness syndrome,C0266006,"pathogenic/likely pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
3970,NM_001079866.2(BCS1L):c.916C>T (p.Arg306Cys),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"pathogenic/likely pathogenic(last reviewed: apr 15, 2022)","criteria provided, multiple submitters, no conflicts"
3971,NM_001079866.2(BCS1L):c.917G>A (p.Arg306His),BCS1L,gracile syndrome,C1412777,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
3971,NM_001079866.2(BCS1L):c.917G>A (p.Arg306His),BCS1L,pili torti-deafness syndrome,C0266006,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
3971,NM_001079866.2(BCS1L):c.917G>A (p.Arg306His),BCS1L,mitochondrial complex iii deficiency nuclear type 1,C3541471,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
3972,NM_000784.4(CYP27A1):c.379C>G (p.Arg127Gly),CYP27A1,cholestanol storage disease,Cumapped47,"likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, single submitter"
3973,NM_000784.4(CYP27A1):c.379C>T (p.Arg127Trp),CYP27A1,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3973,NM_000784.4(CYP27A1):c.379C>T (p.Arg127Trp),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
3974,NM_000784.4(CYP27A1):c.380G>A (p.Arg127Gln),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3975,NM_000784.4(CYP27A1):c.410G>C (p.Arg137Pro),CYP27A1,cholestanol storage disease,Cumapped47,"likely pathogenic(last reviewed: jun 25, 2022)","criteria provided, single submitter"
3976,NM_000784.4(CYP27A1):c.433G>A (p.Gly145Arg),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic(last reviewed: oct 2, 2022)","criteria provided, multiple submitters, no conflicts"
3977,NM_000784.4(CYP27A1):c.646G>C (p.Ala216Pro),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
3978,NM_000784.4(CYP27A1):c.776A>G (p.Lys259Arg),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
3979,NM_000784.4(CYP27A1):c.804G>T (p.Trp268Cys),CYP27A1,cholestanol storage disease,Cumapped47,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
3980,NM_000784.4(CYP27A1):c.1016C>T (p.Thr339Met),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3981,NM_000784.4(CYP27A1):c.1183C>T (p.Arg395Cys),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: nov 11, 2022)","criteria provided, multiple submitters, no conflicts"
3982,NM_000784.4(CYP27A1):c.1184G>A (p.Arg395His),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
3983,NM_000784.4(CYP27A1):c.1213C>T (p.Arg405Trp),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
3984,NM_000784.4(CYP27A1):c.1214G>A (p.Arg405Gln),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, multiple submitters, no conflicts"
3985,NM_000784.4(CYP27A1):c.1420C>T (p.Arg474Trp),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic/likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, multiple submitters, no conflicts"
3986,NM_000784.4(CYP27A1):c.1421G>C (p.Arg474Pro),CYP27A1,cholestanol storage disease,Cumapped47,"likely pathogenic(last reviewed: oct 5, 2022)","criteria provided, single submitter"
3987,NM_000784.4(CYP27A1):c.1421G>A (p.Arg474Gln),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic(last reviewed: oct 20, 2022)","criteria provided, multiple submitters, no conflicts"
3988,NM_000784.4(CYP27A1):c.1435C>A (p.Arg479Ser),CYP27A1,cholestanol storage disease,Cumapped47,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
3989,NM_000784.4(CYP27A1):c.1436G>C (p.Arg479Pro),CYP27A1,cholestanol storage disease,Cumapped47,"likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, single submitter"
3990,NM_000784.4(CYP27A1):c.1436G>T (p.Arg479Leu),CYP27A1,cholestanol storage disease,Cumapped47,"likely pathogenic(last reviewed: oct 26, 2022)","criteria provided, single submitter"
3991,NM_025216.3(WNT10A):c.1A>T (p.Met1Leu),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
3991,NM_025216.3(WNT10A):c.1A>T (p.Met1Leu),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
3992,NM_025216.3(WNT10A):c.3G>A (p.Met1Ile),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"likely pathogenic(last reviewed: may 16, 2022)","criteria provided, single submitter"
3992,NM_025216.3(WNT10A):c.3G>A (p.Met1Ile),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: may 16, 2022)","criteria provided, single submitter"
3993,NM_025216.3(WNT10A):c.283G>A (p.Glu95Lys),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
3993,NM_025216.3(WNT10A):c.283G>A (p.Glu95Lys),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: jun 13, 2022)","criteria provided, multiple submitters, no conflicts"
3994,NM_025216.3(WNT10A):c.322T>C (p.Ser108Pro),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
3994,NM_025216.3(WNT10A):c.322T>C (p.Ser108Pro),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"likely pathogenic(last reviewed: aug 9, 2022)","criteria provided, single submitter"
3995,NM_025216.3(WNT10A):c.353A>G (p.Tyr118Cys),WNT10A,"tooth agenesis, selective, 4",C1835492,likely pathogenic,"criteria provided, single submitter"
3996,NM_025216.3(WNT10A):c.383G>A (p.Arg128Gln),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3996,NM_025216.3(WNT10A):c.383G>A (p.Arg128Gln),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3996,NM_025216.3(WNT10A):c.383G>A (p.Arg128Gln),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,schc6pf-schulz-passarge syndrome,Cumapped256,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,schc6pf-schulz-passarge syndrome,Cumapped256,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3997,NM_025216.3(WNT10A):c.391G>A (p.Ala131Thr),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: oct 27, 2022)","criteria provided, multiple submitters, no conflicts"
3998,NM_025216.3(WNT10A):c.433G>A (p.Val145Met),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
3998,NM_025216.3(WNT10A):c.433G>A (p.Val145Met),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
3998,NM_025216.3(WNT10A):c.433G>A (p.Val145Met),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
3999,NM_025216.3(WNT10A):c.661G>A (p.Gly221Arg),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: dec 2, 2022)","criteria provided, multiple submitters, no conflicts"
3999,NM_025216.3(WNT10A):c.661G>A (p.Gly221Arg),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: dec 2, 2022)","criteria provided, multiple submitters, no conflicts"
4000,NM_025216.3(WNT10A):c.662G>T (p.Gly221Val),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: aug 21, 2022)","criteria provided, single submitter"
4000,NM_025216.3(WNT10A):c.662G>T (p.Gly221Val),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"likely pathogenic(last reviewed: aug 21, 2022)","criteria provided, single submitter"
4001,NM_025216.3(WNT10A):c.812G>A (p.Cys271Tyr),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, single submitter"
4002,NM_025216.3(WNT10A):c.910A>C (p.Asn304His),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, single submitter"
4002,NM_025216.3(WNT10A):c.910A>C (p.Asn304His),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, single submitter"
4003,NM_025216.3(WNT10A):c.1028C>T (p.Pro343Leu),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
4003,NM_025216.3(WNT10A):c.1028C>T (p.Pro343Leu),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"likely pathogenic(last reviewed: jul 11, 2022)","criteria provided, single submitter"
4004,NM_025216.3(WNT10A):c.1079G>C (p.Arg360Pro),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4004,NM_025216.3(WNT10A):c.1079G>C (p.Arg360Pro),WNT10A,"tooth agenesis, selective, 4",C1835492,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4005,NM_025216.3(WNT10A):c.1079G>T (p.Arg360Leu),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
4005,NM_025216.3(WNT10A):c.1079G>T (p.Arg360Leu),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
4006,NM_025216.3(WNT10A):c.1084T>C (p.Cys362Arg),WNT10A,"tooth agenesis, selective, 4",C1835492,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4006,NM_025216.3(WNT10A):c.1084T>C (p.Cys362Arg),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4007,NM_025216.3(WNT10A):c.1199G>A (p.Cys400Tyr),WNT10A,odonto-onycho-dermal dysplasia,C1275074,"pathogenic(last reviewed: jun 11, 2019)","criteria provided, single submitter"
4008,NM_002181.4(IHH):c.484A>G (p.Lys162Glu),IHH,brachydactyly type a1,C1862151,"likely pathogenic(last reviewed: mar 23, 2020)","criteria provided, single submitter"
4009,NM_002181.4(IHH):c.478C>A (p.Arg160Ser),IHH,brachydactyly type a1,C1862151,"likely pathogenic(last reviewed: mar 23, 2020)","criteria provided, single submitter"
4010,NM_002181.4(IHH):c.448G>A (p.Ala150Thr),IHH,brachydactyly type a1,C1862151,"likely pathogenic(last reviewed: mar 23, 2020)","criteria provided, single submitter"
4011,NM_002181.4(IHH):c.298G>A (p.Asp100Asn),IHH,brachydactyly type a1a,Cumapped34,pathogenic,"criteria provided, single submitter"
4012,NM_005689.4(ABCB6):c.1123C>T (p.Arg375Trp),ABCB6,dyschromatosis universalis hereditaria 3,C3809394,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4012,NM_005689.4(ABCB6):c.1123C>T (p.Arg375Trp),ABCB6,familial pseudohyperkalemia,C4273970,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4012,NM_005689.4(ABCB6):c.1123C>T (p.Arg375Trp),ABCB6,langereis blood group,C3276339,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4012,NM_005689.4(ABCB6):c.1123C>T (p.Arg375Trp),ABCB6,"microphthalmia, isolated, with coloboma 7",C3281027,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4013,NM_006736.6(DNAJB2):c.14A>G (p.Tyr5Cys),DNAJB2,young adult-onset distal hereditary motor neuropathy,C4749918,"likely pathogenic(last reviewed: mar 31, 2020)","criteria provided, single submitter"
4014,NM_006736.6(DNAJB2):c.757G>A (p.Glu253Lys),DNAJB2,young adult-onset distal hereditary motor neuropathy,C4749918,"likely pathogenic(last reviewed: mar 31, 2020)","criteria provided, single submitter"
4015,NM_001927.4(DES):c.1A>G (p.Met1Val),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, multiple submitters, no conflicts"
4016,NM_001927.4(DES):c.2T>C (p.Met1Thr),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
4017,NM_001927.4(DES):c.35C>T (p.Ser12Phe),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: may 5, 2022)","criteria provided, multiple submitters, no conflicts"
4017,NM_001927.4(DES):c.35C>T (p.Ser12Phe),DES,primary dilated cardiomyopathy,C0007193,"pathogenic/likely pathogenic(last reviewed: may 5, 2022)","criteria provided, multiple submitters, no conflicts"
4017,NM_001927.4(DES):c.35C>T (p.Ser12Phe),DES,neuromuscular disease,C0027868,"pathogenic/likely pathogenic(last reviewed: may 5, 2022)","criteria provided, multiple submitters, no conflicts"
4018,NM_001927.4(DES):c.38C>T (p.Ser13Phe),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic(last reviewed: mar 16, 2022)","criteria provided, multiple submitters, no conflicts"
4018,NM_001927.4(DES):c.38C>T (p.Ser13Phe),DES,primary dilated cardiomyopathy,C0007193,"pathogenic(last reviewed: mar 16, 2022)","criteria provided, multiple submitters, no conflicts"
4019,NM_001927.4(DES):c.343C>A (p.Leu115Ile),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic(last reviewed: aug 18, 2022)","criteria provided, single submitter"
4020,NM_001927.4(DES):c.347A>G (p.Asn116Ser),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4021,NM_001927.4(DES):c.735G>C (p.Glu245Asp),DES,dilated cardiomyopathy 1i,C4016015,"pathogenic/likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, multiple submitters, no conflicts"
4021,NM_001927.4(DES):c.735G>C (p.Glu245Asp),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, multiple submitters, no conflicts"
4022,NM_001927.4(DES):c.1009G>C (p.Ala337Pro),DES,dilated cardiomyopathy 1i,C4016015,"pathogenic(last reviewed: nov 18, 2019)","criteria provided, single submitter"
4023,NM_001927.4(DES):c.1013T>C (p.Leu338Pro),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4024,NM_001927.4(DES):c.1013T>G (p.Leu338Arg),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: jan 29, 2022)","criteria provided, multiple submitters, no conflicts"
4025,NM_001927.4(DES):c.1024A>G (p.Asn342Asp),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic(last reviewed: jul 14, 2021)","criteria provided, single submitter"
4026,NM_001927.4(DES):c.1034T>C (p.Leu345Pro),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4027,NM_001927.4(DES):c.1049G>C (p.Arg350Pro),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic(last reviewed: apr 25, 2022)","criteria provided, multiple submitters, no conflicts"
4028,NM_001927.4(DES):c.1055T>C (p.Leu352Ser),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: may 6, 2022)","criteria provided, single submitter"
4029,NM_001927.4(DES):c.1109T>C (p.Leu370Pro),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic(last reviewed: dec 14, 2021)","criteria provided, multiple submitters, no conflicts"
4030,NM_001927.4(DES):c.1130T>C (p.Leu377Pro),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: jun 19, 2022)","criteria provided, single submitter"
4031,NM_001927.4(DES):c.1151A>G (p.His384Arg),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: dec 3, 2017)","criteria provided, single submitter"
4032,NM_001927.4(DES):c.1195G>T (p.Asp399Tyr),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: mar 16, 2015)","criteria provided, single submitter"
4033,NM_001927.4(DES):c.1201G>A (p.Glu401Lys),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
4034,NM_001927.4(DES):c.1202A>G (p.Glu401Gly),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4035,NM_001927.4(DES):c.1214A>C (p.Tyr405Ser),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: sep 15, 2021)","criteria provided, single submitter"
4036,NM_001927.4(DES):c.1216C>T (p.Arg406Trp),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4036,NM_001927.4(DES):c.1216C>T (p.Arg406Trp),DES,arrhythmogenic right ventricular cardiomyopathy,C0349788,"pathogenic/likely pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4036,NM_001927.4(DES):c.1216C>T (p.Arg406Trp),DES,cardiomyopathy,C0878544,"pathogenic/likely pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4037,NM_001927.4(DES):c.1217G>C (p.Arg406Pro),DES,desmin-related myofibrillar myopathy,C1832370,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4038,NM_001927.4(DES):c.1237G>A (p.Glu413Lys),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: dec 17, 2021)","criteria provided, multiple submitters, no conflicts"
4039,NM_001927.4(DES):c.1255C>T (p.Pro419Ser),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
4040,NM_001927.4(DES):c.1325C>T (p.Thr442Ile),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, multiple submitters, no conflicts"
4041,NM_001927.4(DES):c.1346A>C (p.Lys449Thr),DES,desmin-related myofibrillar myopathy,C1832370,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
4042,NM_004438.5(EPHA4):c.2242G>A (p.Ala748Thr),EPHA4,atypical cerebral palsy,C0007789,likely pathogenic,"criteria provided, single submitter"
4043,NM_181458.4(PAX3):c.812G>A (p.Arg271His),PAX3,craniofacial-deafness-hand syndrome,C1852510,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
4043,NM_181458.4(PAX3):c.812G>A (p.Arg271His),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
4043,NM_181458.4(PAX3):c.812G>A (p.Arg271His),PAX3,alveolar rhabdomyosarcoma,C0206655,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
4043,NM_181458.4(PAX3):c.812G>A (p.Arg271His),PAX3,waardenburg syndrome type 3,C0079661,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
4043,NM_181458.4(PAX3):c.812G>A (p.Arg271His),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
4044,NM_181458.4(PAX3):c.811C>T (p.Arg271Cys),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: aug 31, 2021)","criteria provided, multiple submitters, no conflicts"
4045,NM_181458.4(PAX3):c.808C>T (p.Arg270Cys),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic/likely pathogenic(last reviewed: jan 24, 2023)","criteria provided, multiple submitters, no conflicts"
4046,NM_181458.4(PAX3):c.791A>C (p.Gln264Pro),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
4047,NM_181458.4(PAX3):c.755T>C (p.Leu252Pro),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
4048,NM_181458.4(PAX3):c.706C>A (p.Arg236Ser),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
4049,NM_181458.4(PAX3):c.692T>C (p.Leu231Pro),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
4050,NM_181458.4(PAX3):c.688C>A (p.Gln230Lys),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
4051,NM_181458.4(PAX3):c.671C>T (p.Thr224Ile),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
4052,NM_181458.4(PAX3):c.668G>A (p.Arg223Gln),PAX3,waardenburg syndrome,C3266898,"pathogenic(last reviewed: oct 1, 2019)","criteria provided, multiple submitters, no conflicts"
4052,NM_181458.4(PAX3):c.668G>A (p.Arg223Gln),PAX3,rare genetic deafness,Cumapped240,"pathogenic(last reviewed: oct 1, 2019)","criteria provided, multiple submitters, no conflicts"
4053,NM_181458.4(PAX3):c.281G>T (p.Gly94Val),PAX3,waardenburg syndrome type 1,C1847800,likely pathogenic,"criteria provided, single submitter"
4054,NM_181458.4(PAX3):c.269A>G (p.Tyr90Cys),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
4055,NM_181458.4(PAX3):c.251C>T (p.Ser84Phe),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: aug 1, 2020)","criteria provided, single submitter"
4056,NM_181458.4(PAX3):c.246C>G (p.Cys82Trp),PAX3,waardenburg syndrome type 3,C0079661,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, multiple submitters, no conflicts"
4056,NM_181458.4(PAX3):c.246C>G (p.Cys82Trp),PAX3,rare genetic deafness,Cumapped240,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, multiple submitters, no conflicts"
4057,NM_181458.4(PAX3):c.241G>C (p.Gly81Arg),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: jan 1, 2019)","criteria provided, single submitter"
4058,NM_181458.4(PAX3):c.239A>G (p.His80Arg),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
4059,NM_181458.4(PAX3):c.232G>T (p.Val78Leu),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
4060,NM_181458.4(PAX3):c.218C>T (p.Ser73Leu),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
4061,NM_181458.4(PAX3):c.202C>T (p.Arg68Trp),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: aug 1, 2020)","criteria provided, single submitter"
4062,NM_181458.4(PAX3):c.167G>T (p.Arg56Leu),PAX3,waardenburg syndrome,C3266898,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4063,NM_181458.4(PAX3):c.166C>T (p.Arg56Cys),PAX3,waardenburg syndrome type 1,C1847800,likely pathogenic,"criteria provided, single submitter"
4064,NM_181458.4(PAX3):c.142G>C (p.Gly48Arg),PAX3,waardenburg syndrome type 1,C1847800,"pathogenic/likely pathogenic(last reviewed: jul 11, 2022)","criteria provided, multiple submitters, no conflicts"
4065,NM_181458.4(PAX3):c.124G>C (p.Gly42Arg),PAX3,waardenburg syndrome type 1,C1847800,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4065,NM_181458.4(PAX3):c.124G>C (p.Gly42Arg),PAX3,intellectual disability,C3714756,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4066,NM_005687.5(FARSB):c.1381A>C (p.Thr461Pro),FARSB,cirrhosis of liver,C0023890,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4066,NM_005687.5(FARSB):c.1381A>C (p.Thr461Pro),FARSB,interstitial pneumonitis,C0206061,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4066,NM_005687.5(FARSB):c.1381A>C (p.Thr461Pro),FARSB,cerebral calcification,C0270685,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4066,NM_005687.5(FARSB):c.1381A>C (p.Thr461Pro),FARSB,vascular dilatation,C0042401,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4067,NM_005687.5(FARSB):c.1202G>A (p.Arg401Gln),FARSB,cirrhosis of liver,C0023890,"pathogenic(last reviewed: jun 21, 2018)","criteria provided, single submitter"
4067,NM_005687.5(FARSB):c.1202G>A (p.Arg401Gln),FARSB,interstitial pneumonitis,C0206061,"pathogenic(last reviewed: jun 21, 2018)","criteria provided, single submitter"
4067,NM_005687.5(FARSB):c.1202G>A (p.Arg401Gln),FARSB,cerebral calcification,C0270685,"pathogenic(last reviewed: jun 21, 2018)","criteria provided, single submitter"
4067,NM_005687.5(FARSB):c.1202G>A (p.Arg401Gln),FARSB,vascular dilatation,C0042401,"pathogenic(last reviewed: jun 21, 2018)","criteria provided, single submitter"
4068,NM_005687.5(FARSB):c.784A>G (p.Lys262Glu),FARSB,cirrhosis of liver,C0023890,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4068,NM_005687.5(FARSB):c.784A>G (p.Lys262Glu),FARSB,interstitial pneumonitis,C0206061,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4068,NM_005687.5(FARSB):c.784A>G (p.Lys262Glu),FARSB,cerebral calcification,C0270685,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4068,NM_005687.5(FARSB):c.784A>G (p.Lys262Glu),FARSB,vascular dilatation,C0042401,"pathogenic(last reviewed: may 28, 2018)","criteria provided, single submitter"
4069,NM_005687.5(FARSB):c.460A>G (p.Arg154Gly),FARSB,rajab interstitial lung disease with brain calcifications 1,Cumapped238,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
4070,NM_005687.5(FARSB):c.226T>C (p.Cys76Arg),FARSB,cirrhosis of liver,C0023890,pathogenic,"criteria provided, single submitter"
4070,NM_005687.5(FARSB):c.226T>C (p.Cys76Arg),FARSB,interstitial pneumonitis,C0206061,pathogenic,"criteria provided, single submitter"
4070,NM_005687.5(FARSB):c.226T>C (p.Cys76Arg),FARSB,cerebral calcification,C0270685,pathogenic,"criteria provided, single submitter"
4070,NM_005687.5(FARSB):c.226T>C (p.Cys76Arg),FARSB,vascular dilatation,C0042401,pathogenic,"criteria provided, single submitter"
4071,NM_022915.5(MRPL44):c.467T>G (p.Leu156Arg),MRPL44,infantile hypertrophic cardiomyopathy due to mrpl44 deficiency,C4749946,"pathogenic/likely pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
4072,NM_003590.5(CUL3):c.641C>G (p.Ala214Gly),CUL3,pseudohypoaldosteronism type 2e,Cumapped229,"pathogenic(last reviewed: sep 22, 2017)","criteria provided, single submitter"
4073,NM_000092.5(COL4A4):c.2878G>A (p.Gly960Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
4074,NM_000092.5(COL4A4):c.2734G>C (p.Gly912Arg),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
4075,NM_000092.5(COL4A4):c.2726G>A (p.Gly909Glu),COL4A4,autosomal recessive alport syndrome,C1567741,likely pathogenic,"criteria provided, single submitter"
4076,NM_000092.5(COL4A4):c.2690G>A (p.Gly897Glu),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
4076,NM_000092.5(COL4A4):c.2690G>A (p.Gly897Glu),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
4076,NM_000092.5(COL4A4):c.2690G>A (p.Gly897Glu),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
4076,NM_000092.5(COL4A4):c.2690G>A (p.Gly897Glu),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
4077,NM_000092.5(COL4A4):c.2654G>A (p.Gly885Asp),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: feb 19, 2020)","criteria provided, single submitter"
4078,NM_000092.5(COL4A4):c.2617G>A (p.Gly873Arg),COL4A4,benign familial hematuria,C0241908,"pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
4079,NM_000092.5(COL4A4):c.2590G>A (p.Gly864Arg),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
4079,NM_000092.5(COL4A4):c.2590G>A (p.Gly864Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
4079,NM_000092.5(COL4A4):c.2590G>A (p.Gly864Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
4080,NM_000092.5(COL4A4):c.2510G>C (p.Gly837Ala),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: feb 23, 2022)","criteria provided, multiple submitters, no conflicts"
4081,NM_000092.5(COL4A4):c.2374G>A (p.Gly792Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: jan 31, 2018)","criteria provided, single submitter"
4082,NM_000092.5(COL4A4):c.2155G>C (p.Gly719Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 18, 2022)","criteria provided, single submitter"
4083,NM_000092.5(COL4A4):c.2084G>A (p.Gly695Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 11, 2018)","criteria provided, single submitter"
4084,NM_000092.5(COL4A4):c.1970G>A (p.Gly657Asp),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: aug 14, 2018)","criteria provided, single submitter"
4085,NM_000092.5(COL4A4):c.1952G>T (p.Gly651Val),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4086,NM_000092.5(COL4A4):c.1856G>A (p.Gly619Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
4086,NM_000092.5(COL4A4):c.1856G>A (p.Gly619Asp),COL4A4,benign familial hematuria,C0241908,"pathogenic(last reviewed: may 9, 2022)","criteria provided, multiple submitters, no conflicts"
4087,NM_000092.5(COL4A4):c.1828G>A (p.Gly610Ser),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: oct 23, 2021)","criteria provided, single submitter"
4087,NM_000092.5(COL4A4):c.1828G>A (p.Gly610Ser),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: oct 23, 2021)","criteria provided, single submitter"
4088,NM_000092.5(COL4A4):c.1751G>A (p.Gly584Glu),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: jun 30, 2022)","criteria provided, single submitter"
4089,NM_000092.5(COL4A4):c.1715G>C (p.Gly572Ala),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: jul 23, 2022)","criteria provided, multiple submitters, no conflicts"
4090,NM_000092.5(COL4A4):c.1652G>A (p.Gly551Asp),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 16, 2022)","criteria provided, single submitter"
4090,NM_000092.5(COL4A4):c.1652G>A (p.Gly551Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 16, 2022)","criteria provided, single submitter"
4091,NM_000092.5(COL4A4):c.1598G>A (p.Gly533Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic(last reviewed: jan 31, 2018)","criteria provided, single submitter"
4092,NM_000092.5(COL4A4):c.1544G>T (p.Gly515Val),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: jun 30, 2021)","criteria provided, single submitter"
4092,NM_000092.5(COL4A4):c.1544G>T (p.Gly515Val),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: jun 30, 2021)","criteria provided, single submitter"
4093,NM_000092.5(COL4A4):c.1424G>C (p.Gly475Ala),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
4093,NM_000092.5(COL4A4):c.1424G>C (p.Gly475Ala),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: feb 10, 2022)","criteria provided, single submitter"
4094,NM_000092.5(COL4A4):c.1405G>A (p.Gly469Arg),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: jan 18, 2022)","criteria provided, single submitter"
4095,NM_000092.5(COL4A4):c.1396G>A (p.Gly466Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
4095,NM_000092.5(COL4A4):c.1396G>A (p.Gly466Arg),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: sep 20, 2022)","criteria provided, multiple submitters, no conflicts"
4096,NM_000092.5(COL4A4):c.1324G>T (p.Gly442Cys),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4097,NM_000092.5(COL4A4):c.1240G>T (p.Gly414Cys),COL4A4,alport syndrome,C1567741,"likely pathogenic(last reviewed: nov 13, 2020)","criteria provided, single submitter"
4098,NM_000092.5(COL4A4):c.1223G>A (p.Gly408Glu),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
4098,NM_000092.5(COL4A4):c.1223G>A (p.Gly408Glu),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
4098,NM_000092.5(COL4A4):c.1223G>A (p.Gly408Glu),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
4099,NM_000092.5(COL4A4):c.1118G>A (p.Gly373Glu),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jun 30, 2021)","criteria provided, multiple submitters, no conflicts"
4099,NM_000092.5(COL4A4):c.1118G>A (p.Gly373Glu),COL4A4,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: jun 30, 2021)","criteria provided, multiple submitters, no conflicts"
4100,NM_000092.5(COL4A4):c.1108G>A (p.Gly370Arg),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 25, 2019)","criteria provided, single submitter"
4101,NM_000092.5(COL4A4):c.994G>A (p.Gly332Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: sep 30, 2022)","criteria provided, single submitter"
4102,NM_000092.5(COL4A4):c.941G>A (p.Gly314Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, single submitter"
4102,NM_000092.5(COL4A4):c.941G>A (p.Gly314Asp),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, single submitter"
4103,NM_000092.5(COL4A4):c.836G>A (p.Gly279Glu),COL4A4,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 11, 2020)","criteria provided, single submitter"
4103,NM_000092.5(COL4A4):c.836G>A (p.Gly279Glu),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 11, 2020)","criteria provided, single submitter"
4104,NM_000092.5(COL4A4):c.755G>A (p.Gly252Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 9, 2022)","criteria provided, multiple submitters, no conflicts"
4104,NM_000092.5(COL4A4):c.755G>A (p.Gly252Asp),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 9, 2022)","criteria provided, multiple submitters, no conflicts"
4105,NM_000092.5(COL4A4):c.755G>T (p.Gly252Val),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
4105,NM_000092.5(COL4A4):c.755G>T (p.Gly252Val),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
4105,NM_000092.5(COL4A4):c.755G>T (p.Gly252Val),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, multiple submitters, no conflicts"
4106,NM_000092.5(COL4A4):c.731A>C (p.Asp244Ala),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4107,NM_000092.5(COL4A4):c.719G>A (p.Gly240Glu),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: jun 12, 2019)","criteria provided, single submitter"
4108,NM_000092.5(COL4A4):c.718G>C (p.Gly240Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 15, 2022)","criteria provided, single submitter"
4108,NM_000092.5(COL4A4):c.718G>C (p.Gly240Arg),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: feb 15, 2022)","criteria provided, single submitter"
4109,NM_000092.5(COL4A4):c.614G>T (p.Gly205Val),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 16, 2022)","criteria provided, single submitter"
4109,NM_000092.5(COL4A4):c.614G>T (p.Gly205Val),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 16, 2022)","criteria provided, single submitter"
4110,NM_000092.5(COL4A4):c.596G>T (p.Gly199Val),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
4110,NM_000092.5(COL4A4):c.596G>T (p.Gly199Val),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
4111,NM_000092.5(COL4A4):c.491G>A (p.Gly164Asp),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4112,NM_000092.5(COL4A4):c.481G>C (p.Gly161Arg),COL4A4,autosomal recessive alport syndrome,C1567741,"pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
4112,NM_000092.5(COL4A4):c.481G>C (p.Gly161Arg),COL4A4,benign familial hematuria,C0241908,"pathogenic(last reviewed: sep 30, 2022)","criteria provided, multiple submitters, no conflicts"
4113,NM_000092.5(COL4A4):c.446G>T (p.Gly149Val),COL4A4,benign familial hematuria,C0241908,"pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
4114,NM_000092.5(COL4A4):c.230G>C (p.Gly77Ala),COL4A4,benign familial hematuria,C0241908,"pathogenic(last reviewed: oct 2, 2018)","criteria provided, single submitter"
4115,NM_000092.5(COL4A4):c.193G>A (p.Gly65Ser),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: may 11, 2022)","criteria provided, multiple submitters, no conflicts"
4115,NM_000092.5(COL4A4):c.193G>A (p.Gly65Ser),COL4A4,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: may 11, 2022)","criteria provided, multiple submitters, no conflicts"
4115,NM_000092.5(COL4A4):c.193G>A (p.Gly65Ser),COL4A4,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: may 11, 2022)","criteria provided, multiple submitters, no conflicts"
4116,NM_000091.5(COL4A3):c.1A>C (p.Met1Leu),COL4A3,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4117,NM_000091.5(COL4A3):c.2T>C (p.Met1Thr),COL4A3,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 7, 2018)","criteria provided, single submitter"
4118,NM_000091.5(COL4A3):c.370G>C (p.Gly124Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 11, 2022)","criteria provided, single submitter"
4119,NM_000091.5(COL4A3):c.547G>T (p.Gly183Cys),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4120,NM_000091.5(COL4A3):c.647G>T (p.Gly216Val),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: feb 19, 2020)","criteria provided, single submitter"
4121,NM_000091.5(COL4A3):c.656G>T (p.Gly219Val),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: jul 29, 2021)","criteria provided, single submitter"
4121,NM_000091.5(COL4A3):c.656G>T (p.Gly219Val),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: jul 29, 2021)","criteria provided, single submitter"
4121,NM_000091.5(COL4A3):c.656G>T (p.Gly219Val),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: jul 29, 2021)","criteria provided, single submitter"
4122,NM_000091.5(COL4A3):c.680G>A (p.Gly227Glu),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: aug 20, 2019)","criteria provided, single submitter"
4123,NM_000091.5(COL4A3):c.688G>A (p.Gly230Ser),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
4123,NM_000091.5(COL4A3):c.688G>A (p.Gly230Ser),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
4123,NM_000091.5(COL4A3):c.688G>A (p.Gly230Ser),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
4124,NM_000091.5(COL4A3):c.697G>A (p.Gly233Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,likely pathogenic,"criteria provided, single submitter"
4125,NM_000091.5(COL4A3):c.725G>A (p.Gly242Glu),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4126,NM_000091.5(COL4A3):c.838G>A (p.Gly280Arg),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: nov 29, 2019)","criteria provided, single submitter"
4127,NM_000091.5(COL4A3):c.872G>A (p.Gly291Glu),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: dec 4, 2021)","criteria provided, multiple submitters, no conflicts"
4127,NM_000091.5(COL4A3):c.872G>A (p.Gly291Glu),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: dec 4, 2021)","criteria provided, multiple submitters, no conflicts"
4127,NM_000091.5(COL4A3):c.872G>A (p.Gly291Glu),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: dec 4, 2021)","criteria provided, multiple submitters, no conflicts"
4128,NM_000091.5(COL4A3):c.880G>C (p.Gly294Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: aug 2, 2021)","criteria provided, single submitter"
4129,NM_000091.5(COL4A3):c.890G>A (p.Gly297Glu),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: nov 13, 2017)","criteria provided, single submitter"
4130,NM_000091.5(COL4A3):c.953G>A (p.Gly318Asp),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, single submitter"
4130,NM_000091.5(COL4A3):c.953G>A (p.Gly318Asp),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, single submitter"
4130,NM_000091.5(COL4A3):c.953G>A (p.Gly318Asp),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 9, 2022)","criteria provided, single submitter"
4131,NM_000091.5(COL4A3):c.998G>C (p.Gly333Ala),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic(last reviewed: mar 18, 2016)","criteria provided, single submitter"
4132,NM_000091.5(COL4A3):c.1006G>T (p.Gly336Cys),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
4132,NM_000091.5(COL4A3):c.1006G>T (p.Gly336Cys),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
4132,NM_000091.5(COL4A3):c.1006G>T (p.Gly336Cys),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
4132,NM_000091.5(COL4A3):c.1006G>T (p.Gly336Cys),COL4A3|MFF-DT,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: sep 17, 2022)","criteria provided, multiple submitters, no conflicts"
4133,NM_000091.5(COL4A3):c.1175G>A (p.Gly392Glu),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: jul 22, 2021)","criteria provided, single submitter"
4134,NM_000091.5(COL4A3):c.1184G>A (p.Gly395Glu),MFF-DT|COL4A3,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
4134,NM_000091.5(COL4A3):c.1184G>A (p.Gly395Glu),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
4134,NM_000091.5(COL4A3):c.1184G>A (p.Gly395Glu),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: sep 23, 2022)","criteria provided, multiple submitters, no conflicts"
4135,NM_000091.5(COL4A3):c.1219G>C (p.Gly407Arg),COL4A3|MFF-DT,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
4135,NM_000091.5(COL4A3):c.1219G>C (p.Gly407Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
4135,NM_000091.5(COL4A3):c.1219G>C (p.Gly407Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: aug 19, 2022)","criteria provided, multiple submitters, no conflicts"
4136,NM_000091.5(COL4A3):c.1288G>A (p.Gly430Arg),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: jan 17, 2020)","criteria provided, single submitter"
4137,NM_000091.5(COL4A3):c.1315G>A (p.Gly439Ser),COL4A3|MFF-DT,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
4137,NM_000091.5(COL4A3):c.1315G>A (p.Gly439Ser),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
4137,NM_000091.5(COL4A3):c.1315G>A (p.Gly439Ser),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
4137,NM_000091.5(COL4A3):c.1315G>A (p.Gly439Ser),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: may 6, 2022)","criteria provided, multiple submitters, no conflicts"
4138,NM_000091.5(COL4A3):c.1372G>A (p.Gly458Arg),COL4A3|MFF-DT,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: oct 4, 2021)","criteria provided, multiple submitters, no conflicts"
4138,NM_000091.5(COL4A3):c.1372G>A (p.Gly458Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: oct 4, 2021)","criteria provided, multiple submitters, no conflicts"
4138,NM_000091.5(COL4A3):c.1372G>A (p.Gly458Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: oct 4, 2021)","criteria provided, multiple submitters, no conflicts"
4139,NM_000091.5(COL4A3):c.1391G>A (p.Gly464Glu),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: sep 29, 2021)","criteria provided, multiple submitters, no conflicts"
4139,NM_000091.5(COL4A3):c.1391G>A (p.Gly464Glu),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: sep 29, 2021)","criteria provided, multiple submitters, no conflicts"
4139,NM_000091.5(COL4A3):c.1391G>A (p.Gly464Glu),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: sep 29, 2021)","criteria provided, multiple submitters, no conflicts"
4140,NM_000091.5(COL4A3):c.1468G>C (p.Gly490Arg),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4140,NM_000091.5(COL4A3):c.1468G>C (p.Gly490Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4140,NM_000091.5(COL4A3):c.1468G>C (p.Gly490Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 1, 2022)","criteria provided, single submitter"
4141,NM_000091.5(COL4A3):c.1594G>A (p.Gly532Ser),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, multiple submitters, no conflicts"
4141,NM_000091.5(COL4A3):c.1594G>A (p.Gly532Ser),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, multiple submitters, no conflicts"
4141,NM_000091.5(COL4A3):c.1594G>A (p.Gly532Ser),MFF-DT|COL4A3,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 12, 2022)","criteria provided, multiple submitters, no conflicts"
4142,NM_000091.5(COL4A3):c.1594G>T (p.Gly532Cys),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, multiple submitters, no conflicts"
4142,NM_000091.5(COL4A3):c.1594G>T (p.Gly532Cys),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: apr 29, 2022)","criteria provided, multiple submitters, no conflicts"
4143,NM_000091.5(COL4A3):c.1814G>T (p.Gly605Val),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: jul 29, 2022)","criteria provided, single submitter"
4144,NM_000091.5(COL4A3):c.1855G>A (p.Gly619Arg),COL4A3|MFF-DT,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4144,NM_000091.5(COL4A3):c.1855G>A (p.Gly619Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4144,NM_000091.5(COL4A3):c.1855G>A (p.Gly619Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4144,NM_000091.5(COL4A3):c.1855G>A (p.Gly619Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4145,NM_000091.5(COL4A3):c.1918G>A (p.Gly640Arg),MFF-DT|COL4A3,microscopic hematuria,C0239937,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
4145,NM_000091.5(COL4A3):c.1918G>A (p.Gly640Arg),MFF-DT|COL4A3,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jul 12, 2022)","criteria provided, multiple submitters, no conflicts"
4146,NM_000091.5(COL4A3):c.2021G>A (p.Gly674Asp),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: sep 11, 2017)","criteria provided, single submitter"
4147,NM_000091.5(COL4A3):c.2065G>A (p.Gly689Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: sep 10, 2021)","criteria provided, multiple submitters, no conflicts"
4148,NM_000091.5(COL4A3):c.2074G>A (p.Gly692Ser),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4149,NM_000091.5(COL4A3):c.2126G>A (p.Gly709Glu),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, multiple submitters, no conflicts"
4150,NM_000091.5(COL4A3):c.2135G>T (p.Gly712Val),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 25, 2021)","criteria provided, single submitter"
4151,NM_000091.5(COL4A3):c.2153G>C (p.Gly718Ala),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4152,NM_000091.5(COL4A3):c.2215G>A (p.Gly739Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
4152,NM_000091.5(COL4A3):c.2215G>A (p.Gly739Arg),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
4152,NM_000091.5(COL4A3):c.2215G>A (p.Gly739Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
4152,NM_000091.5(COL4A3):c.2215G>A (p.Gly739Arg),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: apr 5, 2022)","criteria provided, multiple submitters, no conflicts"
4153,NM_000091.5(COL4A3):c.2267G>A (p.Gly756Asp),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,likely pathogenic,"criteria provided, single submitter"
4154,NM_000091.5(COL4A3):c.2330G>A (p.Gly777Asp),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, single submitter"
4155,NM_000091.5(COL4A3):c.2330G>T (p.Gly777Val),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jan 25, 2022)","criteria provided, multiple submitters, no conflicts"
4155,NM_000091.5(COL4A3):c.2330G>T (p.Gly777Val),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"pathogenic/likely pathogenic(last reviewed: jan 25, 2022)","criteria provided, multiple submitters, no conflicts"
4155,NM_000091.5(COL4A3):c.2330G>T (p.Gly777Val),COL4A3|MFF-DT,benign familial hematuria,C0241908,"pathogenic/likely pathogenic(last reviewed: jan 25, 2022)","criteria provided, multiple submitters, no conflicts"
4156,NM_000091.5(COL4A3):c.2390C>T (p.Pro797Leu),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 1, 2020)","criteria provided, single submitter"
4157,NM_000091.5(COL4A3):c.2558G>C (p.Gly853Ala),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, single submitter"
4158,NM_000091.5(COL4A3):c.2584G>C (p.Gly862Arg),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
4159,NM_000091.5(COL4A3):c.2711G>A (p.Gly904Glu),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: jul 28, 2022)","criteria provided, single submitter"
4160,NM_000091.5(COL4A3):c.2863G>A (p.Gly955Arg),MFF-DT|COL4A3,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
4161,NM_000091.5(COL4A3):c.2864G>T (p.Gly955Val),COL4A3|MFF-DT,autosomal recessive alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 14, 2022)","criteria provided, single submitter"
4162,NM_000091.5(COL4A3):c.3044G>A (p.Gly1015Glu),COL4A3|MFF-DT,autosomal dominant alport syndrome,C1567741,"likely pathogenic(last reviewed: mar 4, 2022)","criteria provided, multiple submitters, no conflicts"
4162,NM_000091.5(COL4A3):c.3044G>A (p.Gly1015Glu),COL4A3|MFF-DT,benign familial hematuria,C0241908,"likely pathogenic(last reviewed: mar 4, 2022)","criteria provided, multiple submitters, no conflicts"
4163,NM_025243.4(SLC19A3):c.1264A>G (p.Thr422Ala),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"pathogenic(last reviewed: aug 24, 2021)","criteria provided, multiple submitters, no conflicts"
4164,NM_025243.4(SLC19A3):c.541T>C (p.Ser181Pro),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"pathogenic(last reviewed: dec 11, 2017)","criteria provided, single submitter"
4165,NM_025243.4(SLC19A3):c.416T>A (p.Val139Glu),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"likely pathogenic(last reviewed: nov 14, 2019)","criteria provided, single submitter"
4166,NM_025243.4(SLC19A3):c.337T>C (p.Tyr113His),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"pathogenic/likely pathogenic(last reviewed: oct 21, 2022)","criteria provided, multiple submitters, no conflicts"
4167,NM_025243.4(SLC19A3):c.280T>C (p.Trp94Arg),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"pathogenic/likely pathogenic(last reviewed: aug 23, 2022)","criteria provided, multiple submitters, no conflicts"
4168,NM_025243.4(SLC19A3):c.68G>T (p.Gly23Val),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"pathogenic/likely pathogenic(last reviewed: nov 4, 2022)","criteria provided, multiple submitters, no conflicts"
4169,NM_025243.4(SLC19A3):c.67G>C (p.Gly23Arg),SLC19A3,biotin-responsive basal ganglia disease,C1843807,"likely pathogenic(last reviewed: aug 7, 2022)","criteria provided, single submitter"
4170,NM_001352754.2(ARMC9):c.1027C>T (p.Arg343Cys),ARMC9,joubert syndrome 30,C4539937,"pathogenic/likely pathogenic(last reviewed: mar 12, 2023)","criteria provided, multiple submitters, no conflicts"
4171,NM_004826.4(ECEL1):c.2023G>A (p.Ala675Thr),ECEL1,distal arthrogryposis type 5d,C3554415,"pathogenic/likely pathogenic(last reviewed: mar 3, 2020)","criteria provided, multiple submitters, no conflicts"
4172,NM_004826.4(ECEL1):c.1907C>T (p.Thr636Met),ECEL1,distal arthrogryposis type 5d,C3554415,"likely pathogenic(last reviewed: may 21, 2020)","criteria provided, single submitter"
4173,NM_004826.4(ECEL1):c.1531G>A (p.Gly511Ser),ECEL1,distal arthrogryposis type 5d,C3554415,"likely pathogenic(last reviewed: may 26, 2020)","criteria provided, single submitter"
4174,NM_004826.4(ECEL1):c.1369T>G (p.Phe457Val),ECEL1,distal arthrogryposis type 5d,C3554415,"likely pathogenic(last reviewed: apr 22, 2021)","criteria provided, single submitter"
4175,NM_004826.4(ECEL1):c.1209G>T (p.Trp403Cys),ECEL1,distal arthrogryposis type 5d,C3554415,"likely pathogenic(last reviewed: sep 13, 2016)","criteria provided, multiple submitters, no conflicts"
4176,NM_004826.4(ECEL1):c.1184G>A (p.Arg395Gln),ECEL1,distal arthrogryposis type 5d,C3554415,"pathogenic(last reviewed: jan 8, 2013)","criteria provided, single submitter"
4177,NM_004826.4(ECEL1):c.557C>G (p.Ser186Trp),ECEL1,distal arthrogryposis type 5d,C3554415,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
4178,NM_001195129.2(PRSS56):c.958G>A (p.Gly320Arg),PRSS56,isolated microphthalmia 6,C3150757,"likely pathogenic(last reviewed: nov 11, 2021)","criteria provided, single submitter"
4179,NM_000751.3(CHRND):c.2T>C (p.Met1Thr),CHRND,lethal multiple pterygium syndrome,C1854678,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
4180,NM_000751.3(CHRND):c.423G>C (p.Trp141Cys),CHRND,lethal multiple pterygium syndrome,C1854678,"likely pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
4181,NM_000751.3(CHRND):c.452G>C (p.Cys151Ser),CHRND,arthrogryposis multiplex congenita,C0003886,"likely pathogenic(last reviewed: jun 28, 2019)","criteria provided, single submitter"
4181,NM_000751.3(CHRND):c.452G>C (p.Cys151Ser),CHRND,fetal akinesia deformation sequence 1,C1276035,"likely pathogenic(last reviewed: jun 28, 2019)","criteria provided, single submitter"
4182,NM_000751.3(CHRND):c.769T>C (p.Cys257Arg),CHRND,lethal multiple pterygium syndrome,C1854678,"pathogenic(last reviewed: apr 25, 2022)","criteria provided, single submitter"
4183,NM_000751.3(CHRND):c.866C>T (p.Ser289Phe),CHRND,lethal multiple pterygium syndrome,C1854678,"likely pathogenic(last reviewed: jul 6, 2022)","criteria provided, single submitter"
4184,NM_000751.3(CHRND):c.1007G>A (p.Arg336Gln),CHRND,lethal multiple pterygium syndrome,C1854678,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
4185,NM_000751.3(CHRND):c.1385G>T (p.Trp462Leu),CHRND,ptosis,C0033377,"likely pathogenic(last reviewed: jun 3, 2014)","criteria provided, single submitter"
4185,NM_000751.3(CHRND):c.1385G>T (p.Trp462Leu),CHRND,breathing dysregulation,C3808046,"likely pathogenic(last reviewed: jun 3, 2014)","criteria provided, single submitter"
4185,NM_000751.3(CHRND):c.1385G>T (p.Trp462Leu),CHRND,muscle weakness,C0151786,"likely pathogenic(last reviewed: jun 3, 2014)","criteria provided, single submitter"
4185,NM_000751.3(CHRND):c.1385G>T (p.Trp462Leu),CHRND,dyspnea,C0013404,"likely pathogenic(last reviewed: jun 3, 2014)","criteria provided, single submitter"
4186,NM_005199.5(CHRNG):c.256C>T (p.Arg86Cys),CHRNG,peripheral neuropathy,C4721453,"pathogenic/likely pathogenic(last reviewed: feb 8, 2023)","criteria provided, multiple submitters, no conflicts"
4187,NM_005199.5(CHRNG):c.428C>G (p.Pro143Arg),CHRNG,lethal multiple pterygium syndrome,C1854678,"pathogenic(last reviewed: nov 17, 2022)","criteria provided, multiple submitters, no conflicts"
4188,NM_005199.5(CHRNG):c.715C>T (p.Arg239Cys),CHRNG,lethal multiple pterygium syndrome,C1854678,"pathogenic(last reviewed: feb 15, 2023)","criteria provided, multiple submitters, no conflicts"
4188,NM_005199.5(CHRNG):c.715C>T (p.Arg239Cys),CHRNG,autosomal recessive multiple pterygium syndrome,Cumapped27,"pathogenic(last reviewed: feb 15, 2023)","criteria provided, multiple submitters, no conflicts"
4189,NM_005199.5(CHRNG):c.895T>A (p.Ser299Thr),CHRNG,autosomal recessive multiple pterygium syndrome,Cumapped27,"likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, single submitter"
4190,NM_002242.4(KCNJ13):c.484C>T (p.Arg162Trp),GIGYF2|KCNJ13,snowflake vitreoretinal degeneration,C1860405,"pathogenic/likely pathogenic(last reviewed: oct 24, 2022)","criteria provided, multiple submitters, no conflicts"
4191,NM_002242.4(KCNJ13):c.458C>T (p.Thr153Ile),GIGYF2|KCNJ13,leber congenital amaurosis 16,C3280062,"likely pathogenic(last reviewed: nov 20, 2012)","criteria provided, single submitter"
4192,NM_000541.5(SAG):c.440G>T (p.Cys147Phe),SAG,retinal dystrophy,C4229674,"pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
4193,NM_000463.3(UGT1A1):c.44T>G (p.Leu15Arg),UGT1A3|UGT1A4|UGT1A9|UGT1A5|UGT1A|UGT1A1|UGT1A10|UGT1A7|UGT1A8|UGT1A6,gilbert syndrome,C0017551,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
4193,NM_000463.3(UGT1A1):c.44T>G (p.Leu15Arg),UGT1A3|UGT1A4|UGT1A9|UGT1A5|UGT1A|UGT1A1|UGT1A10|UGT1A7|UGT1A8|UGT1A6,lucey-driscoll syndrome,C0270210,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
4193,NM_000463.3(UGT1A1):c.44T>G (p.Leu15Arg),UGT1A3|UGT1A4|UGT1A9|UGT1A5|UGT1A|UGT1A1|UGT1A10|UGT1A7|UGT1A8|UGT1A6,crigler-najjar syndrome type 1,C0010324,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
4193,NM_000463.3(UGT1A1):c.44T>G (p.Leu15Arg),UGT1A3|UGT1A4|UGT1A9|UGT1A5|UGT1A|UGT1A1|UGT1A10|UGT1A7|UGT1A8|UGT1A6,"crigler-najjar syndrome, type ii",C2931132,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
4193,NM_000463.3(UGT1A1):c.44T>G (p.Leu15Arg),UGT1A3|UGT1A4|UGT1A9|UGT1A5|UGT1A|UGT1A1|UGT1A10|UGT1A7|UGT1A8|UGT1A6,"bilirubin, serum level of, quantitative trait locus 1",C1866173,"likely pathogenic(last reviewed: jul 28, 2021)","criteria provided, single submitter"
4194,NM_000463.3(UGT1A1):c.625C>T (p.Arg209Trp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,"crigler-najjar syndrome, type ii",C2931132,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
4194,NM_000463.3(UGT1A1):c.625C>T (p.Arg209Trp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,crigler-najjar syndrome,C0010324,"pathogenic/likely pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
4195,NM_000463.3(UGT1A1):c.826G>C (p.Gly276Arg),UGT1A8|UGT1A3|UGT1A7|UGT1A9|UGT1A6|UGT1A5|UGT1A|UGT1A10|UGT1A1|UGT1A4,"crigler-najjar syndrome, type ii",C2931132,"pathogenic(last reviewed: jan 3, 2022)","criteria provided, single submitter"
4196,NM_000463.3(UGT1A1):c.923G>A (p.Gly308Glu),UGT1A8|UGT1A7|UGT1A5|UGT1A1|UGT1A6|UGT1A3|UGT1A9|UGT1A|UGT1A4|UGT1A10,gilbert syndrome,C0017551,"likely pathogenic(last reviewed: aug 18, 2022)","criteria provided, multiple submitters, no conflicts"
4197,NM_000463.3(UGT1A1):c.1006C>T (p.Arg336Trp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,crigler-najjar syndrome,C0010324,"pathogenic(last reviewed: sep 10, 2022)","criteria provided, multiple submitters, no conflicts"
4198,NM_000463.3(UGT1A1):c.1349G>T (p.Arg450Leu),UGT1A3|UGT1A8|UGT1A1|UGT1A4|UGT1A9|UGT1A7|UGT1A|UGT1A10|UGT1A6|UGT1A5,"crigler-najjar syndrome, type ii",C2931132,"likely pathogenic(last reviewed: jan 31, 2023)","criteria provided, single submitter"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,lucey-driscoll syndrome,C0270210,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,"crigler-najjar syndrome, type ii",C2931132,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,"bilirubin, serum level of, quantitative trait locus 1",C1866173,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,gilbert syndrome,C0017551,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,crigler-najjar syndrome type 1,C0010324,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,"crigler-najjar syndrome, type ii",C2931132,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4199,NM_000463.3(UGT1A1):c.1456T>G (p.Tyr486Asp),UGT1A|UGT1A1|UGT1A10|UGT1A3|UGT1A4|UGT1A5|UGT1A6|UGT1A7|UGT1A8|UGT1A9,hyperbilirubinemia,C0311468,"pathogenic/likely pathogenic(last reviewed: sep 18, 2022)","criteria provided, multiple submitters, no conflicts"
4200,NM_001271893.4(TWIST2):c.223G>C (p.Glu75Gln),TWIST2,barber-say syndrome,C1319466,"pathogenic(last reviewed: aug 6, 2018)","criteria provided, single submitter"
4201,NM_001271893.4(TWIST2):c.223G>A (p.Glu75Lys),TWIST2,ablepharon macrostomia syndrome,C1860224,"pathogenic(last reviewed: jun 7, 2020)","criteria provided, multiple submitters, no conflicts"
4202,NM_001378414.1(HDAC4):c.731C>A (p.Thr244Lys),HDAC4,"intellectual disability, severe",C0036857,"pathogenic(last reviewed: aug 3, 2020)","criteria provided, single submitter"
4203,NM_004544.4(NDUFA10):c.1A>G (p.Met1Val),NDUFA10,"mitochondrial complex 1 deficiency, nuclear type 22",C4748796,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
4204,NM_001244008.2(KIF1A):c.1048C>T (p.Arg350Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4204,NM_001244008.2(KIF1A):c.1048C>T (p.Arg350Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4204,NM_001244008.2(KIF1A):c.1048C>T (p.Arg350Trp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4204,NM_001244008.2(KIF1A):c.1048C>T (p.Arg350Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4205,NM_001244008.2(KIF1A):c.1048C>G (p.Arg350Gly),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4206,NM_001244008.2(KIF1A):c.1040A>G (p.Tyr347Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: nov 6, 2018)","criteria provided, multiple submitters, no conflicts"
4207,NM_001244008.2(KIF1A):c.1031C>T (p.Thr344Met),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
4207,NM_001244008.2(KIF1A):c.1031C>T (p.Thr344Met),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
4207,NM_001244008.2(KIF1A):c.1031C>T (p.Thr344Met),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
4207,NM_001244008.2(KIF1A):c.1031C>T (p.Thr344Met),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: aug 9, 2022)","criteria provided, multiple submitters, no conflicts"
4208,NM_001244008.2(KIF1A):c.1013A>G (p.Tyr338Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4209,NM_001244008.2(KIF1A):c.1001C>T (p.Ala334Val),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4210,NM_001244008.2(KIF1A):c.967T>C (p.Ser323Pro),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4211,NM_001244008.2(KIF1A):c.946C>T (p.Arg316Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4212,NM_001244008.2(KIF1A):c.934A>C (p.Thr312Pro),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4212,NM_001244008.2(KIF1A):c.934A>C (p.Thr312Pro),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4212,NM_001244008.2(KIF1A):c.934A>C (p.Thr312Pro),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4213,NM_001244008.2(KIF1A):c.920G>C (p.Arg307Pro),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4214,NM_001244008.2(KIF1A):c.920G>A (p.Arg307Gln),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
4214,NM_001244008.2(KIF1A):c.920G>A (p.Arg307Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
4214,NM_001244008.2(KIF1A):c.920G>A (p.Arg307Gln),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
4214,NM_001244008.2(KIF1A):c.920G>A (p.Arg307Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: nov 12, 2021)","criteria provided, multiple submitters, no conflicts"
4215,NM_001244008.2(KIF1A):c.919C>G (p.Arg307Gly),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: mar 16, 2016)","criteria provided, single submitter"
4216,NM_001244008.2(KIF1A):c.914C>T (p.Pro305Leu),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, multiple submitters, no conflicts"
4216,NM_001244008.2(KIF1A):c.914C>T (p.Pro305Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, multiple submitters, no conflicts"
4216,NM_001244008.2(KIF1A):c.914C>T (p.Pro305Leu),KIF1A,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, multiple submitters, no conflicts"
4216,NM_001244008.2(KIF1A):c.914C>T (p.Pro305Leu),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, multiple submitters, no conflicts"
4216,NM_001244008.2(KIF1A):c.914C>T (p.Pro305Leu),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, multiple submitters, no conflicts"
4216,NM_001244008.2(KIF1A):c.914C>T (p.Pro305Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: mar 6, 2022)","criteria provided, multiple submitters, no conflicts"
4217,NM_001244008.2(KIF1A):c.841G>C (p.Val281Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4218,NM_001244008.2(KIF1A):c.839A>G (p.Lys280Arg),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: nov 5, 2018)","criteria provided, single submitter"
4219,NM_001244008.2(KIF1A):c.815A>G (p.Asn272Ser),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4219,NM_001244008.2(KIF1A):c.815A>G (p.Asn272Ser),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4219,NM_001244008.2(KIF1A):c.815A>G (p.Asn272Ser),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4220,NM_001244008.2(KIF1A):c.812T>G (p.Ile271Ser),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: oct 2, 2021)","criteria provided, single submitter"
4221,NM_001244008.2(KIF1A):c.806C>A (p.Ala269Asp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: feb 3, 2022)","criteria provided, single submitter"
4222,NM_001244008.2(KIF1A):c.802G>A (p.Gly268Arg),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
4223,NM_001244008.2(KIF1A):c.799G>C (p.Glu267Gln),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
4223,NM_001244008.2(KIF1A):c.799G>C (p.Glu267Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
4223,NM_001244008.2(KIF1A):c.799G>C (p.Glu267Gln),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: jun 4, 2022)","criteria provided, single submitter"
4224,NM_001244008.2(KIF1A):c.773C>A (p.Thr258Lys),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4224,NM_001244008.2(KIF1A):c.773C>A (p.Thr258Lys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4224,NM_001244008.2(KIF1A):c.773C>A (p.Thr258Lys),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4225,NM_001244008.2(KIF1A):c.773C>T (p.Thr258Met),KIF1A,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, multiple submitters, no conflicts"
4225,NM_001244008.2(KIF1A):c.773C>T (p.Thr258Met),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, multiple submitters, no conflicts"
4225,NM_001244008.2(KIF1A):c.773C>T (p.Thr258Met),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, multiple submitters, no conflicts"
4225,NM_001244008.2(KIF1A):c.773C>T (p.Thr258Met),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, multiple submitters, no conflicts"
4225,NM_001244008.2(KIF1A):c.773C>T (p.Thr258Met),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, multiple submitters, no conflicts"
4225,NM_001244008.2(KIF1A):c.773C>T (p.Thr258Met),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: nov 2, 2021)","criteria provided, multiple submitters, no conflicts"
4226,NM_001244008.2(KIF1A):c.764C>A (p.Ala255Asp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
4226,NM_001244008.2(KIF1A):c.764C>A (p.Ala255Asp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
4226,NM_001244008.2(KIF1A):c.764C>A (p.Ala255Asp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, single submitter"
4227,NM_001244008.2(KIF1A):c.761G>A (p.Arg254Gln),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4227,NM_001244008.2(KIF1A):c.761G>A (p.Arg254Gln),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4227,NM_001244008.2(KIF1A):c.761G>A (p.Arg254Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4227,NM_001244008.2(KIF1A):c.761G>A (p.Arg254Gln),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4227,NM_001244008.2(KIF1A):c.761G>A (p.Arg254Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 14, 2022)","criteria provided, multiple submitters, no conflicts"
4228,NM_001244008.2(KIF1A):c.760C>G (p.Arg254Gly),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
4228,NM_001244008.2(KIF1A):c.760C>G (p.Arg254Gly),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
4228,NM_001244008.2(KIF1A):c.760C>G (p.Arg254Gly),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4229,NM_001244008.2(KIF1A):c.760C>T (p.Arg254Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 3, 2022)","criteria provided, multiple submitters, no conflicts"
4230,NM_001244008.2(KIF1A):c.759G>C (p.Glu253Asp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
4230,NM_001244008.2(KIF1A):c.759G>C (p.Glu253Asp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
4230,NM_001244008.2(KIF1A):c.759G>C (p.Glu253Asp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jul 19, 2022)","criteria provided, single submitter"
4231,NM_001244008.2(KIF1A):c.757G>A (p.Glu253Lys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4231,NM_001244008.2(KIF1A):c.757G>A (p.Glu253Lys),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4231,NM_001244008.2(KIF1A):c.757G>A (p.Glu253Lys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4231,NM_001244008.2(KIF1A):c.757G>A (p.Glu253Lys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4232,NM_001244008.2(KIF1A):c.756C>G (p.Ser252Arg),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4233,NM_001244008.2(KIF1A):c.751G>A (p.Gly251Arg),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
4233,NM_001244008.2(KIF1A):c.751G>A (p.Gly251Arg),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
4233,NM_001244008.2(KIF1A):c.751G>A (p.Gly251Arg),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: aug 23, 2022)","criteria provided, single submitter"
4234,NM_001244008.2(KIF1A):c.749C>A (p.Ala250Asp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
4234,NM_001244008.2(KIF1A):c.749C>A (p.Ala250Asp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
4234,NM_001244008.2(KIF1A):c.749C>A (p.Ala250Asp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: aug 27, 2021)","criteria provided, single submitter"
4235,NM_001244008.2(KIF1A):c.748G>T (p.Ala250Ser),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
4235,NM_001244008.2(KIF1A):c.748G>T (p.Ala250Ser),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
4235,NM_001244008.2(KIF1A):c.748G>T (p.Ala250Ser),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: mar 8, 2022)","criteria provided, single submitter"
4236,NM_001244008.2(KIF1A):c.746T>A (p.Leu249Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4237,NM_001244008.2(KIF1A):c.737T>G (p.Leu246Arg),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4237,NM_001244008.2(KIF1A):c.737T>G (p.Leu246Arg),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4237,NM_001244008.2(KIF1A):c.737T>G (p.Leu246Arg),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4238,NM_001244008.2(KIF1A):c.658G>T (p.Val220Phe),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4239,NM_001244008.2(KIF1A):c.653A>G (p.His218Arg),KIF1A,"neuropathy, hereditary sensory and autonomic, type 2a",C2752089,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
4240,NM_001244008.2(KIF1A):c.647G>A (p.Arg216His),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: may 16, 2022)","criteria provided, multiple submitters, no conflicts"
4240,NM_001244008.2(KIF1A):c.647G>A (p.Arg216His),KIF1A,peho syndrome,C1850055,"pathogenic/likely pathogenic(last reviewed: may 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,syndromic intellectual disability,Cumapped309,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,peho syndrome,C1850055,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4241,NM_001244008.2(KIF1A):c.646C>T (p.Arg216Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 16, 2022)","criteria provided, multiple submitters, no conflicts"
4242,NM_001244008.2(KIF1A):c.644G>A (p.Ser215Asn),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4243,NM_001244008.2(KIF1A):c.643A>C (p.Ser215Arg),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: sep 1, 2019)","criteria provided, multiple submitters, no conflicts"
4244,NM_001244008.2(KIF1A):c.630G>A (p.Met210Ile),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
4245,NM_001244008.2(KIF1A):c.604G>C (p.Ala202Pro),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4246,NM_001244008.2(KIF1A):c.595G>A (p.Gly199Arg),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, multiple submitters, no conflicts"
4247,NM_001244008.2(KIF1A):c.556G>T (p.Val186Phe),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4248,NM_001244008.2(KIF1A):c.521T>C (p.Leu174Pro),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4249,NM_001244008.2(KIF1A):c.518T>C (p.Leu173Pro),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4250,NM_001244008.2(KIF1A):c.506G>C (p.Arg169Thr),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jul 10, 2019)","criteria provided, single submitter"
4251,NM_001244008.2(KIF1A):c.500G>A (p.Arg167His),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
4251,NM_001244008.2(KIF1A):c.500G>A (p.Arg167His),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
4251,NM_001244008.2(KIF1A):c.500G>A (p.Arg167His),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
4251,NM_001244008.2(KIF1A):c.500G>A (p.Arg167His),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: dec 1, 2022)","criteria provided, multiple submitters, no conflicts"
4252,NM_001244008.2(KIF1A):c.499C>T (p.Arg167Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4252,NM_001244008.2(KIF1A):c.499C>T (p.Arg167Cys),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4252,NM_001244008.2(KIF1A):c.499C>T (p.Arg167Cys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4252,NM_001244008.2(KIF1A):c.499C>T (p.Arg167Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4252,NM_001244008.2(KIF1A):c.499C>T (p.Arg167Cys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4253,NM_001244008.2(KIF1A):c.470T>C (p.Leu157Pro),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
4254,NM_001244008.2(KIF1A):c.467A>T (p.Asp156Val),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4254,NM_001244008.2(KIF1A):c.467A>T (p.Asp156Val),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4254,NM_001244008.2(KIF1A):c.467A>T (p.Asp156Val),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4255,NM_001244008.2(KIF1A):c.444G>T (p.Glu148Asp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4256,NM_001244008.2(KIF1A):c.442G>A (p.Glu148Lys),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: nov 3, 2021)","criteria provided, single submitter"
4257,NM_001244008.2(KIF1A):c.430G>T (p.Val144Phe),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4258,NM_001244008.2(KIF1A):c.317C>A (p.Thr106Asn),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4259,NM_001244008.2(KIF1A):c.305G>A (p.Gly102Asp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 15, 2020)","criteria provided, single submitter"
4260,NM_001244008.2(KIF1A):c.304G>A (p.Gly102Ser),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: feb 24, 2023)","criteria provided, multiple submitters, no conflicts"
4260,NM_001244008.2(KIF1A):c.304G>A (p.Gly102Ser),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 24, 2023)","criteria provided, multiple submitters, no conflicts"
4260,NM_001244008.2(KIF1A):c.304G>A (p.Gly102Ser),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 24, 2023)","criteria provided, multiple submitters, no conflicts"
4260,NM_001244008.2(KIF1A):c.304G>A (p.Gly102Ser),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 24, 2023)","criteria provided, multiple submitters, no conflicts"
4261,NM_001244008.2(KIF1A):c.302C>T (p.Ala101Val),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: feb 23, 2023)","criteria provided, single submitter"
4262,NM_001244008.2(KIF1A):c.296C>T (p.Thr99Met),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic(last reviewed: dec 31, 2022)","criteria provided, multiple submitters, no conflicts"
4262,NM_001244008.2(KIF1A):c.296C>T (p.Thr99Met),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: dec 31, 2022)","criteria provided, multiple submitters, no conflicts"
4262,NM_001244008.2(KIF1A):c.296C>T (p.Thr99Met),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic(last reviewed: dec 31, 2022)","criteria provided, multiple submitters, no conflicts"
4262,NM_001244008.2(KIF1A):c.296C>T (p.Thr99Met),KIF1A,peho syndrome,C1850055,"pathogenic(last reviewed: dec 31, 2022)","criteria provided, multiple submitters, no conflicts"
4262,NM_001244008.2(KIF1A):c.296C>T (p.Thr99Met),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: dec 31, 2022)","criteria provided, multiple submitters, no conflicts"
4263,NM_001244008.2(KIF1A):c.266A>T (p.Tyr89Phe),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, single submitter"
4263,NM_001244008.2(KIF1A):c.266A>T (p.Tyr89Phe),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, single submitter"
4263,NM_001244008.2(KIF1A):c.266A>T (p.Tyr89Phe),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jun 29, 2022)","criteria provided, single submitter"
4264,NM_001244008.2(KIF1A):c.265T>G (p.Tyr89Asp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic(last reviewed: jan 14, 2016)","criteria provided, single submitter"
4265,NM_001244008.2(KIF1A):c.233G>A (p.Gly78Asp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: may 28, 2019)","criteria provided, single submitter"
4266,NM_001244008.2(KIF1A):c.232G>C (p.Gly78Arg),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4267,NM_001244008.2(KIF1A):c.232G>A (p.Gly78Ser),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
4267,NM_001244008.2(KIF1A):c.232G>A (p.Gly78Ser),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
4267,NM_001244008.2(KIF1A):c.232G>A (p.Gly78Ser),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
4267,NM_001244008.2(KIF1A):c.232G>A (p.Gly78Ser),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: aug 16, 2022)","criteria provided, multiple submitters, no conflicts"
4268,NM_001244008.2(KIF1A):c.206C>G (p.Ser69Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4269,NM_001244008.2(KIF1A):c.206C>T (p.Ser69Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
4269,NM_001244008.2(KIF1A):c.206C>T (p.Ser69Leu),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
4269,NM_001244008.2(KIF1A):c.206C>T (p.Ser69Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
4269,NM_001244008.2(KIF1A):c.206C>T (p.Ser69Leu),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: jun 22, 2022)","criteria provided, multiple submitters, no conflicts"
4270,NM_001244008.2(KIF1A):c.173C>G (p.Ser58Trp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4270,NM_001244008.2(KIF1A):c.173C>G (p.Ser58Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4270,NM_001244008.2(KIF1A):c.173C>G (p.Ser58Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4271,NM_001244008.2(KIF1A):c.173C>T (p.Ser58Leu),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, multiple submitters, no conflicts"
4271,NM_001244008.2(KIF1A):c.173C>T (p.Ser58Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, multiple submitters, no conflicts"
4271,NM_001244008.2(KIF1A):c.173C>T (p.Ser58Leu),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, multiple submitters, no conflicts"
4271,NM_001244008.2(KIF1A):c.173C>T (p.Ser58Leu),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, multiple submitters, no conflicts"
4271,NM_001244008.2(KIF1A):c.173C>T (p.Ser58Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, multiple submitters, no conflicts"
4271,NM_001244008.2(KIF1A):c.173C>T (p.Ser58Leu),KIF1A,neurodevelopmental delay,C4022738,"pathogenic/likely pathogenic(last reviewed: jul 7, 2022)","criteria provided, multiple submitters, no conflicts"
4272,NM_001244008.2(KIF1A):c.104C>A (p.Thr35Asn),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4272,NM_001244008.2(KIF1A):c.104C>A (p.Thr35Asn),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4272,NM_001244008.2(KIF1A):c.104C>A (p.Thr35Asn),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, single submitter"
4273,NM_001244008.2(KIF1A):c.79A>G (p.Ile27Val),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
4273,NM_001244008.2(KIF1A):c.79A>G (p.Ile27Val),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
4273,NM_001244008.2(KIF1A):c.79A>G (p.Ile27Val),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: jul 30, 2022)","criteria provided, single submitter"
4274,NM_001244008.2(KIF1A):c.79A>T (p.Ile27Phe),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
4274,NM_001244008.2(KIF1A):c.79A>T (p.Ile27Phe),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
4274,NM_001244008.2(KIF1A):c.79A>T (p.Ile27Phe),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, single submitter"
4275,NM_001244008.2(KIF1A):c.76T>C (p.Cys26Arg),KIF1A,hereditary spastic paraplegia 30,C0037773,pathogenic,"criteria provided, single submitter"
4276,NM_001244008.2(KIF1A):c.40C>A (p.Pro14Thr),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,likely pathogenic,"criteria provided, single submitter"
4277,NM_001244008.2(KIF1A):c.38G>T (p.Arg13Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: sep 15, 2015)","criteria provided, single submitter"
4278,NM_001244008.2(KIF1A):c.38G>A (p.Arg13His),KIF1A,spastic paraplegia,C0037772,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
4278,NM_001244008.2(KIF1A):c.38G>A (p.Arg13His),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
4278,NM_001244008.2(KIF1A):c.38G>A (p.Arg13His),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
4278,NM_001244008.2(KIF1A):c.38G>A (p.Arg13His),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jan 9, 2023)","criteria provided, multiple submitters, no conflicts"
4279,NM_001244008.2(KIF1A):c.37C>T (p.Arg13Cys),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: feb 5, 2023)","criteria provided, multiple submitters, no conflicts"
4279,NM_001244008.2(KIF1A):c.37C>T (p.Arg13Cys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 5, 2023)","criteria provided, multiple submitters, no conflicts"
4279,NM_001244008.2(KIF1A):c.37C>T (p.Arg13Cys),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: feb 5, 2023)","criteria provided, multiple submitters, no conflicts"
4279,NM_001244008.2(KIF1A):c.37C>T (p.Arg13Cys),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: feb 5, 2023)","criteria provided, multiple submitters, no conflicts"
4280,NM_001244008.2(KIF1A):c.32G>T (p.Arg11Leu),KIF1A,hereditary spastic paraplegia 30,C0037773,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4280,NM_001244008.2(KIF1A):c.32G>T (p.Arg11Leu),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4280,NM_001244008.2(KIF1A):c.32G>T (p.Arg11Leu),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4281,NM_001244008.2(KIF1A):c.32G>A (p.Arg11Gln),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
4281,NM_001244008.2(KIF1A):c.32G>A (p.Arg11Gln),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
4281,NM_001244008.2(KIF1A):c.32G>A (p.Arg11Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
4281,NM_001244008.2(KIF1A):c.32G>A (p.Arg11Gln),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
4281,NM_001244008.2(KIF1A):c.32G>A (p.Arg11Gln),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: jun 24, 2022)","criteria provided, multiple submitters, no conflicts"
4282,NM_001244008.2(KIF1A):c.31C>T (p.Arg11Trp),KIF1A,"neuropathy, hereditary sensory, type 2c",C3280168,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
4282,NM_001244008.2(KIF1A):c.31C>T (p.Arg11Trp),KIF1A,"intellectual disability, autosomal dominant 9",C3276355,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
4282,NM_001244008.2(KIF1A):c.31C>T (p.Arg11Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
4282,NM_001244008.2(KIF1A):c.31C>T (p.Arg11Trp),KIF1A,hereditary spastic paraplegia,C0037773,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
4282,NM_001244008.2(KIF1A):c.31C>T (p.Arg11Trp),KIF1A,hereditary spastic paraplegia 30,C0037773,"pathogenic/likely pathogenic(last reviewed: apr 13, 2022)","criteria provided, multiple submitters, no conflicts"
4283,NM_000030.3(AGXT):c.2T>C (p.Met1Thr),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: nov 1, 2022)","criteria provided, multiple submitters, no conflicts"
4284,NM_000030.3(AGXT):c.32C>G (p.Pro11Arg),AGXT,primary hyperoxaluria,C0020501,"pathogenic/likely pathogenic(last reviewed: jan 10, 2023)","criteria provided, multiple submitters, no conflicts"
4284,NM_000030.3(AGXT):c.32C>G (p.Pro11Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: jan 10, 2023)","criteria provided, multiple submitters, no conflicts"
4285,NM_000030.3(AGXT):c.106C>T (p.Arg36Cys),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: feb 15, 2022)","criteria provided, multiple submitters, no conflicts"
4286,NM_000030.3(AGXT):c.107G>A (p.Arg36His),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: aug 20, 2022)","criteria provided, multiple submitters, no conflicts"
4287,NM_000030.3(AGXT):c.121G>A (p.Gly41Arg),AGXT,primary hyperoxaluria,C0020501,"pathogenic(last reviewed: feb 10, 2023)","criteria provided, multiple submitters, no conflicts"
4287,NM_000030.3(AGXT):c.121G>A (p.Gly41Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: feb 10, 2023)","criteria provided, multiple submitters, no conflicts"
4288,NM_000030.3(AGXT):c.122G>T (p.Gly41Val),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: dec 18, 2021)","criteria provided, multiple submitters, no conflicts"
4289,NM_000030.3(AGXT):c.242C>T (p.Ser81Leu),AGXT,primary hyperoxaluria,C0020501,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
4289,NM_000030.3(AGXT):c.242C>T (p.Ser81Leu),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: jun 3, 2022)","criteria provided, multiple submitters, no conflicts"
4290,NM_000030.3(AGXT):c.245G>A (p.Gly82Glu),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: jan 28, 2022)","criteria provided, multiple submitters, no conflicts"
4291,NM_000030.3(AGXT):c.302T>C (p.Leu101Pro),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: sep 1, 2022)","criteria provided, multiple submitters, no conflicts"
4292,NM_000030.3(AGXT):c.305T>A (p.Val102Asp),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: oct 12, 2021)","criteria provided, single submitter"
4293,NM_000030.3(AGXT):c.322T>C (p.Trp108Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
4294,NM_000030.3(AGXT):c.332G>A (p.Arg111Gln),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: sep 2, 2022)","criteria provided, multiple submitters, no conflicts"
4295,NM_000030.3(AGXT):c.335C>A (p.Ala112Asp),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: apr 16, 2021)","criteria provided, single submitter"
4296,NM_000030.3(AGXT):c.346G>A (p.Gly116Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
4296,NM_000030.3(AGXT):c.346G>A (p.Gly116Arg),AGXT,abnormality of metabolism/homeostasis,C4021768,"pathogenic/likely pathogenic(last reviewed: oct 1, 2022)","criteria provided, multiple submitters, no conflicts"
4297,NM_000030.3(AGXT):c.353G>A (p.Arg118His),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: mar 23, 2022)","criteria provided, single submitter"
4298,NM_000030.3(AGXT):c.454T>A (p.Phe152Ile),AGXT,primary hyperoxaluria,C0020501,"pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
4298,NM_000030.3(AGXT):c.454T>A (p.Phe152Ile),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: oct 16, 2022)","criteria provided, multiple submitters, no conflicts"
4299,NM_000030.3(AGXT):c.466G>C (p.Gly156Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: dec 2, 2021)","criteria provided, multiple submitters, no conflicts"
4300,NM_000030.3(AGXT):c.466G>A (p.Gly156Arg),AGXT,primary hyperoxaluria,C0020501,"pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
4300,NM_000030.3(AGXT):c.466G>A (p.Gly156Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: dec 17, 2022)","criteria provided, multiple submitters, no conflicts"
4301,NM_000030.3(AGXT):c.473C>T (p.Ser158Leu),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4302,NM_000030.3(AGXT):c.481G>T (p.Gly161Cys),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: apr 14, 2022)","criteria provided, multiple submitters, no conflicts"
4303,NM_000030.3(AGXT):c.508G>A (p.Gly170Arg),AGXT,primary hyperoxaluria,C0020501,"pathogenic/likely pathogenic(last reviewed: dec 12, 2022)","criteria provided, multiple submitters, no conflicts"
4303,NM_000030.3(AGXT):c.508G>A (p.Gly170Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: dec 12, 2022)","criteria provided, multiple submitters, no conflicts"
4304,NM_000030.3(AGXT):c.533G>A (p.Cys178Tyr),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: aug 21, 2022)","criteria provided, multiple submitters, no conflicts"
4305,NM_000030.3(AGXT):c.534C>G (p.Cys178Trp),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: jul 2, 2020)","criteria provided, single submitter"
4306,NM_000030.3(AGXT):c.547G>A (p.Asp183Asn),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: apr 21, 2022)","criteria provided, single submitter"
4307,NM_000030.3(AGXT):c.560C>T (p.Ser187Phe),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: feb 8, 2018)","criteria provided, single submitter"
4308,NM_000030.3(AGXT):c.568G>A (p.Gly190Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: oct 4, 2022)","criteria provided, multiple submitters, no conflicts"
4309,NM_000030.3(AGXT):c.584T>G (p.Met195Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: aug 5, 2022)","criteria provided, multiple submitters, no conflicts"
4310,NM_000030.3(AGXT):c.603C>A (p.Asp201Glu),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
4311,NM_000030.3(AGXT):c.613T>C (p.Ser205Pro),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4312,NM_000030.3(AGXT):c.614C>T (p.Ser205Leu),AGXT,primary hyperoxaluria,C0020501,"pathogenic(last reviewed: oct 11, 2022)","criteria provided, multiple submitters, no conflicts"
4313,NM_000030.3(AGXT):c.646G>A (p.Gly216Arg),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: sep 6, 2021)","criteria provided, single submitter"
4314,NM_000030.3(AGXT):c.653C>T (p.Ser218Leu),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4315,NM_000030.3(AGXT):c.697C>T (p.Arg233Cys),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: sep 14, 2022)","criteria provided, multiple submitters, no conflicts"
4316,NM_000030.3(AGXT):c.698G>A (p.Arg233His),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: may 12, 2022)","criteria provided, multiple submitters, no conflicts"
4317,NM_000030.3(AGXT):c.731T>C (p.Ile244Thr),AGXT,primary hyperoxaluria,C0020501,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4317,NM_000030.3(AGXT):c.731T>C (p.Ile244Thr),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4318,NM_000030.3(AGXT):c.1007T>A (p.Val336Asp),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: dec 8, 2022)","criteria provided, single submitter"
4319,NM_000030.3(AGXT):c.1049G>A (p.Gly350Asp),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: sep 22, 2022)","criteria provided, multiple submitters, no conflicts"
4320,NM_000030.3(AGXT):c.1076T>C (p.Leu359Pro),AGXT,"primary hyperoxaluria, type i",C0268164,"likely pathogenic(last reviewed: feb 5, 2022)","criteria provided, single submitter"
4321,NM_000030.3(AGXT):c.1079G>A (p.Arg360Gln),AGXT,"primary hyperoxaluria, type i",C0268164,"pathogenic/likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, multiple submitters, no conflicts"
4322,NM_152783.5(D2HGDH):c.1421C>T (p.Ala474Val),D2HGDH,d-2-hydroxyglutaric aciduria 1,C3152055,"likely pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
4323,NM_182916.3(TRNT1):c.443C>T (p.Ala148Val),TRNT1,congenital sideroblastic anemia-b-cell immunodeficiency-periodic fever-developmental delay syndrome,Cumapped57,"pathogenic/likely pathogenic(last reviewed: jan 13, 2022)","criteria provided, multiple submitters, no conflicts"
4324,NM_182916.3(TRNT1):c.608G>A (p.Arg203Lys),TRNT1,congenital sideroblastic anemia-b-cell immunodeficiency-periodic fever-developmental delay syndrome,Cumapped57,"likely pathogenic(last reviewed: jan 19, 2020)","criteria provided, single submitter"
4325,NM_182916.3(TRNT1):c.668T>C (p.Ile223Thr),TRNT1,congenital sideroblastic anemia-b-cell immunodeficiency-periodic fever-developmental delay syndrome,Cumapped57,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4326,NM_182916.3(TRNT1):c.1246A>G (p.Lys416Glu),TRNT1,congenital sideroblastic anemia-b-cell immunodeficiency-periodic fever-developmental delay syndrome,Cumapped57,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
4326,NM_182916.3(TRNT1):c.1246A>G (p.Lys416Glu),TRNT1,retinitis pigmentosa and erythrocytic microcytosis,C4310776,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
4326,NM_182916.3(TRNT1):c.1246A>G (p.Lys416Glu),TRNT1,congenital sideroblastic anemia-b-cell immunodeficiency-periodic fever-developmental delay syndrome,Cumapped57,"pathogenic/likely pathogenic(last reviewed: sep 3, 2022)","criteria provided, multiple submitters, no conflicts"
4327,NM_016302.4(CRBN):c.1171T>C (p.Cys391Arg),TRNT1|CRBN,"intellectual disability, autosomal recessive 2",C3276355,"likely pathogenic(last reviewed: sep 20, 2016)","criteria provided, multiple submitters, no conflicts"
4328,NM_182760.4(SUMF1):c.1046G>A (p.Arg349Gln),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: oct 10, 2022)","criteria provided, multiple submitters, no conflicts"
4329,NM_182760.4(SUMF1):c.1045C>T (p.Arg349Trp),SUMF1,multiple sulfatase deficiency,C0268263,"pathogenic/likely pathogenic(last reviewed: sep 19, 2022)","criteria provided, multiple submitters, no conflicts"
4330,NM_182760.4(SUMF1):c.1042G>C (p.Ala348Pro),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: jan 15, 2022)","criteria provided, single submitter"
4331,NM_182760.4(SUMF1):c.1033C>T (p.Arg345Cys),SUMF1,multiple sulfatase deficiency,C0268263,"pathogenic(last reviewed: nov 11, 2021)","criteria provided, multiple submitters, no conflicts"
4332,NM_182760.4(SUMF1):c.860A>T (p.Asn287Ile),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: dec 28, 2020)","criteria provided, single submitter"
4333,NM_182760.4(SUMF1):c.836C>T (p.Ala279Val),SUMF1,multiple sulfatase deficiency,C0268263,"pathogenic/likely pathogenic(last reviewed: dec 28, 2022)","criteria provided, multiple submitters, no conflicts"
4334,NM_182760.4(SUMF1):c.818A>G (p.Asp273Gly),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: aug 12, 2022)","criteria provided, multiple submitters, no conflicts"
4335,NM_182760.4(SUMF1):c.739G>C (p.Gly247Arg),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: oct 18, 2016)","criteria provided, single submitter"
4336,NM_182760.4(SUMF1):c.529G>C (p.Ala177Pro),SUMF1,multiple sulfatase deficiency,C0268263,"pathogenic(last reviewed: jun 15, 2022)","criteria provided, multiple submitters, no conflicts"
4337,NM_182760.4(SUMF1):c.463T>C (p.Ser155Pro),SUMF1,multiple sulfatase deficiency,C0268263,"pathogenic/likely pathogenic(last reviewed: oct 14, 2022)","criteria provided, multiple submitters, no conflicts"
4338,NM_182760.4(SUMF1):c.451A>G (p.Lys151Glu),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: aug 31, 2021)","criteria provided, single submitter"
4339,NM_182760.4(SUMF1):c.392T>G (p.Val131Gly),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: may 3, 2020)","criteria provided, single submitter"
4340,NM_182760.4(SUMF1):c.337G>A (p.Glu113Lys),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: jun 9, 2022)","criteria provided, single submitter"
4341,NM_182760.4(SUMF1):c.2T>G (p.Met1Arg),SUMF1,multiple sulfatase deficiency,C0268263,"likely pathogenic(last reviewed: may 25, 2022)","criteria provided, multiple submitters, no conflicts"
4342,NM_182760.4(SUMF1):c.1A>G (p.Met1Val),SUMF1,multiple sulfatase deficiency,C0268263,"pathogenic(last reviewed: sep 1, 2022)","criteria provided, single submitter"
4343,NM_001378452.1(ITPR1):c.722G>A (p.Arg241Lys),ITPR1,spinocerebellar ataxia type 29,C1861732,"pathogenic/likely pathogenic(last reviewed: mar 2, 2022)","criteria provided, multiple submitters, no conflicts"
4344,NM_001378452.1(ITPR1):c.731A>G (p.His244Arg),ITPR1,not specified,Cumapped182,"likely pathogenic(last reviewed: aug 15, 2017)","criteria provided, multiple submitters, no conflicts"
4345,NM_001378452.1(ITPR1):c.748T>C (p.Phe250Leu),ITPR1,spinocerebellar ataxia type 15/16,C4274322,"pathogenic/likely pathogenic(last reviewed: oct 1, 2021)","criteria provided, multiple submitters, no conflicts"
4346,NM_001378452.1(ITPR1):c.755C>T (p.Thr252Ile),ITPR1,spinocerebellar ataxia type 29,C1861732,"likely pathogenic(last reviewed: apr 7, 2021)","criteria provided, single submitter"
4347,NM_001378452.1(ITPR1):c.800C>G (p.Thr267Arg),ITPR1,spinocerebellar ataxia type 29,C1861732,"pathogenic/likely pathogenic(last reviewed: may 4, 2022)","criteria provided, multiple submitters, no conflicts"
4348,NM_001378452.1(ITPR1):c.830G>T (p.Ser277Ile),ITPR1,spinocerebellar ataxia type 29,C1861732,"likely pathogenic(last reviewed: oct 1, 2013)","criteria provided, single submitter"
4349,NM_001378452.1(ITPR1):c.1516C>T (p.Arg506Trp),ITPR1,spinocerebellar ataxia type 15/16,C4274322,"likely pathogenic(last reviewed: oct 28, 2021)","criteria provided, single submitter"
4350,NM_001378452.1(ITPR1):c.1531A>G (p.Arg511Gly),ITPR1,intellectual disability,C3714756,"likely pathogenic(last reviewed: sep 10, 2020)","criteria provided, single submitter"
4351,NM_001378452.1(ITPR1):c.1534G>A (p.Glu512Lys),ITPR1,spinocerebellar ataxia type 29,C1861732,"likely pathogenic(last reviewed: dec 18, 2020)","criteria provided, single submitter"
4352,NM_001378452.1(ITPR1):c.1702A>G (p.Arg568Gly),ITPR1,spinocerebellar ataxia type 29,C1861732,"pathogenic(last reviewed: feb 9, 2018)","criteria provided, single submitter"
4353,NM_001378452.1(ITPR1):c.2843G>A (p.Gly948Glu),ITPR1,spinocerebellar ataxia type 29,C1861732,"likely pathogenic(last reviewed: jul 12, 2021)","criteria provided, single submitter"
4354,NM_000844.4(GRM7):c.1180G>A (p.Glu394Lys),GRM7,bilateral multifocal epileptiform discharges,C4023485,pathogenic,"criteria provided, single submitter"
4354,NM_000844.4(GRM7):c.1180G>A (p.Glu394Lys),GRM7,microcephaly,C4551563,pathogenic,"criteria provided, single submitter"
4354,NM_000844.4(GRM7):c.1180G>A (p.Glu394Lys),GRM7,global developmental delay,C0557874,pathogenic,"criteria provided, single submitter"
4355,NM_000844.4(GRM7):c.2496T>G (p.Ser832Arg),GRM7,"neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities",Cumapped165,"likely pathogenic(last reviewed: mar 22, 2022)","criteria provided, single submitter"
4356,NM_033337.3(CAV3):c.79C>G (p.Arg27Gly),CAV3,long qt syndrome,C0023976,"pathogenic(last reviewed: aug 21, 2022)","criteria provided, single submitter"
4357,NM_033337.3(CAV3):c.80G>C (p.Arg27Pro),CAV3,long qt syndrome,C0023976,"likely pathogenic(last reviewed: sep 6, 2022)","criteria provided, single submitter"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,hypertrophic cardiomyopathy 1,C3495498,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,rippling muscle disease 2,C1832560,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,long qt syndrome 9,C2678485,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,"distal myopathy, tateyama type",C4041172,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,elevated circulating creatine kinase concentration,CL1898968,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,long qt syndrome,C0023976,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,rippling muscle disease 2,C1832560,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4358,NM_033337.3(CAV3):c.80G>A (p.Arg27Gln),CAV3|SSUH2,"distal myopathy, tateyama type",C4041172,"pathogenic(last reviewed: sep 9, 2022)","criteria provided, multiple submitters, no conflicts"
4359,NM_033337.3(CAV3):c.99C>A (p.Asn33Lys),CAV3,long qt syndrome,C0023976,"pathogenic(last reviewed: may 27, 2022)","criteria provided, single submitter"
4360,NM_033337.3(CAV3):c.99C>G (p.Asn33Lys),CAV3,long qt syndrome,C0023976,"pathogenic(last reviewed: jul 25, 2022)","criteria provided, single submitter"
4361,NM_033337.3(CAV3):c.136G>A (p.Ala46Thr),CAV3|OXTR,cardiovascular phenotype,C0007222,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
4361,NM_033337.3(CAV3):c.136G>A (p.Ala46Thr),CAV3|OXTR,long qt syndrome,C0023976,"pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
4362,NM_033337.3(CAV3):c.299T>A (p.Ile100Asn),CAV3|OXTR,hypertrophic cardiomyopathy 1,C3495498,"likely pathogenic(last reviewed: jan 28, 2019)","criteria provided, single submitter"
4362,NM_033337.3(CAV3):c.299T>A (p.Ile100Asn),CAV3|OXTR,long qt syndrome 9,C2678485,"likely pathogenic(last reviewed: jan 28, 2019)","criteria provided, single submitter"
4362,NM_033337.3(CAV3):c.299T>A (p.Ile100Asn),CAV3|OXTR,"distal myopathy, tateyama type",C4041172,"likely pathogenic(last reviewed: jan 28, 2019)","criteria provided, single submitter"
4362,NM_033337.3(CAV3):c.299T>A (p.Ile100Asn),CAV3|OXTR,elevated circulating creatine kinase concentration,CL1898968,"likely pathogenic(last reviewed: jan 28, 2019)","criteria provided, single submitter"
4362,NM_033337.3(CAV3):c.299T>A (p.Ile100Asn),CAV3|OXTR,rippling muscle disease 2,C1832560,"likely pathogenic(last reviewed: jan 28, 2019)","criteria provided, single submitter"
4363,NM_001080517.3(SETD5):c.875T>C (p.Leu292Ser),SETD5,intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency,C5190582,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
4364,NM_001080517.3(SETD5):c.914T>G (p.Val305Gly),SETD5,neurodevelopmental delay,C4022738,likely pathogenic,"criteria provided, single submitter"
4365,NM_001080517.3(SETD5):c.941A>G (p.Asn314Ser),SETD5,intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency,C5190582,"pathogenic/likely pathogenic(last reviewed: feb 21, 2023)","criteria provided, multiple submitters, no conflicts"
4366,NM_001080517.3(SETD5):c.972T>G (p.Phe324Leu),SETD5,global developmental delay,C0557874,"likely pathogenic(last reviewed: feb 20, 2020)","criteria provided, single submitter"
4367,NM_001080517.3(SETD5):c.988A>G (p.Lys330Glu),SETD5,intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency,C5190582,"likely pathogenic(last reviewed: sep 27, 2020)","criteria provided, multiple submitters, no conflicts"
4368,NM_001080517.3(SETD5):c.1060T>C (p.Cys354Arg),SETD5,intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency,C5190582,"likely pathogenic(last reviewed: sep 27, 2022)","criteria provided, single submitter"
4369,NM_001080517.3(SETD5):c.1082G>C (p.Arg361Pro),SETD5,intellectual disability-facial dysmorphism syndrome due to setd5 haploinsufficiency,C5190582,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
4370,NM_001003694.2(BRPF1):c.2T>G (p.Met1Arg),BRPF1,intellectual developmental disorder with dysmorphic facies and ptosis,C4310617,"likely pathogenic(last reviewed: may 1, 2020)","criteria provided, single submitter"
4371,NM_001003694.2(BRPF1):c.898G>A (p.Val300Met),BRPF1,intellectual developmental disorder with dysmorphic facies and ptosis,C4310617,"likely pathogenic(last reviewed: jan 18, 2022)","criteria provided, single submitter"
4372,NM_001003694.2(BRPF1):c.2027A>G (p.Lys676Arg),BRPF1,intellectual developmental disorder with dysmorphic facies and ptosis,C4310617,"pathogenic(last reviewed: may 4, 2022)","criteria provided, single submitter"
4373,NM_032492.4(JAGN1):c.40G>A (p.Gly14Ser),JAGN1,severe congenital neutropenia,C0340970,"pathogenic(last reviewed: jan 1, 2013)","criteria provided, single submitter"
4374,NM_032492.4(JAGN1):c.485A>G (p.Gln162Arg),JAGN1,severe congenital neutropenia,C0340970,"pathogenic(last reviewed: jan 1, 2013)","criteria provided, single submitter"
4375,NM_001018115.3(FANCD2):c.904C>T (p.Arg302Trp),FANCD2|LOC107303338,fanconi anemia,C3469521,"pathogenic/likely pathogenic(last reviewed: jul 29, 2022)","criteria provided, multiple submitters, no conflicts"
4375,NM_001018115.3(FANCD2):c.904C>T (p.Arg302Trp),FANCD2|LOC107303338,fanconi anemia complementation group d2,C3160738,"pathogenic/likely pathogenic(last reviewed: jul 29, 2022)","criteria provided, multiple submitters, no conflicts"
4376,NM_001018115.3(FANCD2):c.2273G>A (p.Cys758Tyr),FANCD2|LOC107303338,ovarian cancer,C1140680,"likely pathogenic(last reviewed: jan 1, 2022)","criteria provided, single submitter"
4377,NM_001018115.3(FANCD2):c.2444G>A (p.Arg815Gln),LOC107303338|FANCD2,fanconi anemia,C3469521,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
4377,NM_001018115.3(FANCD2):c.2444G>A (p.Arg815Gln),LOC107303338|FANCD2,fanconi anemia complementation group d2,C3160738,"pathogenic(last reviewed: oct 25, 2022)","criteria provided, multiple submitters, no conflicts"
4378,NM_000551.4(VHL):c.160A>T (p.Met54Leu),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
4378,NM_000551.4(VHL):c.160A>T (p.Met54Leu),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, single submitter"
4379,NM_000551.4(VHL):c.161T>G (p.Met54Arg),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: dec 15, 2021)","criteria provided, single submitter"
4379,NM_000551.4(VHL):c.161T>G (p.Met54Arg),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: dec 15, 2021)","criteria provided, single submitter"
4380,NM_000551.4(VHL):c.190C>A (p.Arg64Ser),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4380,NM_000551.4(VHL):c.190C>A (p.Arg64Ser),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4381,NM_000551.4(VHL):c.191G>C (p.Arg64Pro),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4381,NM_000551.4(VHL):c.191G>C (p.Arg64Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4381,NM_000551.4(VHL):c.191G>C (p.Arg64Pro),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4381,NM_000551.4(VHL):c.191G>C (p.Arg64Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4382,NM_000551.4(VHL):c.193T>A (p.Ser65Thr),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
4382,NM_000551.4(VHL):c.193T>A (p.Ser65Thr),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 24, 2021)","criteria provided, single submitter"
4383,NM_000551.4(VHL):c.193T>C (p.Ser65Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: nov 1, 2016)","criteria provided, single submitter"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,pancreatic cysts,C0030283,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,retinal capillary hemangioma,C0730303,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,spinal hemangioblastoma,C4024223,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,cerebellar hemangioblastoma,C1332900,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4384,NM_000551.4(VHL):c.194C>T (p.Ser65Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4385,NM_000551.4(VHL):c.194C>G (p.Ser65Trp),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4385,NM_000551.4(VHL):c.194C>G (p.Ser65Trp),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4385,NM_000551.4(VHL):c.194C>G (p.Ser65Trp),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: sep 26, 2022)","criteria provided, multiple submitters, no conflicts"
4386,NM_000551.4(VHL):c.208G>C (p.Glu70Gln),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4386,NM_000551.4(VHL):c.208G>C (p.Glu70Gln),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: oct 13, 2022)","criteria provided, single submitter"
4387,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4387,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4387,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4387,NM_000551.4(VHL):c.208G>A (p.Glu70Lys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4388,NM_000551.4(VHL):c.214T>C (p.Ser72Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, multiple submitters, no conflicts"
4388,NM_000551.4(VHL):c.214T>C (p.Ser72Pro),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, multiple submitters, no conflicts"
4388,NM_000551.4(VHL):c.214T>C (p.Ser72Pro),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 20, 2021)","criteria provided, multiple submitters, no conflicts"
4389,NM_000551.4(VHL):c.226T>A (p.Phe76Ile),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 25, 2019)","criteria provided, single submitter"
4390,NM_000551.4(VHL):c.232A>G (p.Asn78Asp),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: jun 30, 2022)","criteria provided, multiple submitters, no conflicts"
4390,NM_000551.4(VHL):c.232A>G (p.Asn78Asp),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: jun 30, 2022)","criteria provided, multiple submitters, no conflicts"
4390,NM_000551.4(VHL):c.232A>G (p.Asn78Asp),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: jun 30, 2022)","criteria provided, multiple submitters, no conflicts"
4391,NM_000551.4(VHL):c.232A>C (p.Asn78His),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 1, 2018)","criteria provided, single submitter"
4392,NM_000551.4(VHL):c.232A>T (p.Asn78Tyr),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: dec 19, 2016)","criteria provided, single submitter"
4393,NM_000551.4(VHL):c.233A>T (p.Asn78Ile),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: nov 27, 2018)","criteria provided, single submitter"
4393,NM_000551.4(VHL):c.233A>T (p.Asn78Ile),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: nov 27, 2018)","criteria provided, single submitter"
4394,NM_000551.4(VHL):c.233A>C (p.Asn78Thr),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: feb 5, 2022)","criteria provided, multiple submitters, no conflicts"
4394,NM_000551.4(VHL):c.233A>C (p.Asn78Thr),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: feb 5, 2022)","criteria provided, multiple submitters, no conflicts"
4395,NM_000551.4(VHL):c.233A>G (p.Asn78Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
4395,NM_000551.4(VHL):c.233A>G (p.Asn78Ser),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
4395,NM_000551.4(VHL):c.233A>G (p.Asn78Ser),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
4395,NM_000551.4(VHL):c.233A>G (p.Asn78Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 13, 2022)","criteria provided, multiple submitters, no conflicts"
4396,NM_000551.4(VHL):c.238A>C (p.Ser80Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: feb 5, 2016)","criteria provided, single submitter"
4397,NM_000551.4(VHL):c.238A>G (p.Ser80Gly),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, multiple submitters, no conflicts"
4397,NM_000551.4(VHL):c.238A>G (p.Ser80Gly),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, multiple submitters, no conflicts"
4397,NM_000551.4(VHL):c.238A>G (p.Ser80Gly),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: apr 8, 2022)","criteria provided, multiple submitters, no conflicts"
4398,NM_000551.4(VHL):c.239G>A (p.Ser80Asn),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
4398,NM_000551.4(VHL):c.239G>A (p.Ser80Asn),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 26, 2021)","criteria provided, single submitter"
4399,NM_000551.4(VHL):c.239G>T (p.Ser80Ile),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: dec 8, 2021)","criteria provided, multiple submitters, no conflicts"
4399,NM_000551.4(VHL):c.239G>T (p.Ser80Ile),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: dec 8, 2021)","criteria provided, multiple submitters, no conflicts"
4399,NM_000551.4(VHL):c.239G>T (p.Ser80Ile),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: dec 8, 2021)","criteria provided, multiple submitters, no conflicts"
4400,NM_000551.4(VHL):c.242C>T (p.Pro81Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
4400,NM_000551.4(VHL):c.242C>T (p.Pro81Leu),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
4400,NM_000551.4(VHL):c.242C>T (p.Pro81Leu),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
4400,NM_000551.4(VHL):c.242C>T (p.Pro81Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
4400,NM_000551.4(VHL):c.242C>T (p.Pro81Leu),VHL,see cases,Cumapped260,"pathogenic/likely pathogenic(last reviewed: oct 8, 2022)","criteria provided, multiple submitters, no conflicts"
4401,NM_000551.4(VHL):c.245G>T (p.Arg82Leu),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4401,NM_000551.4(VHL):c.245G>T (p.Arg82Leu),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4401,NM_000551.4(VHL):c.245G>T (p.Arg82Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4401,NM_000551.4(VHL):c.245G>T (p.Arg82Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 12, 2021)","criteria provided, multiple submitters, no conflicts"
4402,NM_000551.4(VHL):c.245G>C (p.Arg82Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: feb 14, 2019)","criteria provided, multiple submitters, no conflicts"
4403,NM_000551.4(VHL):c.250G>C (p.Val84Leu),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4403,NM_000551.4(VHL):c.250G>C (p.Val84Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4403,NM_000551.4(VHL):c.250G>C (p.Val84Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4403,NM_000551.4(VHL):c.250G>C (p.Val84Leu),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: mar 31, 2022)","criteria provided, multiple submitters, no conflicts"
4404,NM_000551.4(VHL):c.250G>T (p.Val84Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
4404,NM_000551.4(VHL):c.250G>T (p.Val84Leu),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
4404,NM_000551.4(VHL):c.250G>T (p.Val84Leu),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
4404,NM_000551.4(VHL):c.250G>T (p.Val84Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: oct 3, 2022)","criteria provided, multiple submitters, no conflicts"
4405,NM_000551.4(VHL):c.251T>A (p.Val84Glu),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 30, 2021)","criteria provided, single submitter"
4406,NM_000551.4(VHL):c.256C>T (p.Pro86Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
4406,NM_000551.4(VHL):c.256C>T (p.Pro86Ser),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
4406,NM_000551.4(VHL):c.256C>T (p.Pro86Ser),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
4406,NM_000551.4(VHL):c.256C>T (p.Pro86Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: nov 3, 2022)","criteria provided, multiple submitters, no conflicts"
4407,NM_000551.4(VHL):c.256C>G (p.Pro86Ala),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: nov 12, 2019)","criteria provided, multiple submitters, no conflicts"
4407,NM_000551.4(VHL):c.256C>G (p.Pro86Ala),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: nov 12, 2019)","criteria provided, multiple submitters, no conflicts"
4407,NM_000551.4(VHL):c.256C>G (p.Pro86Ala),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: nov 12, 2019)","criteria provided, multiple submitters, no conflicts"
4408,NM_000551.4(VHL):c.257C>G (p.Pro86Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
4408,NM_000551.4(VHL):c.257C>G (p.Pro86Arg),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
4408,NM_000551.4(VHL):c.257C>G (p.Pro86Arg),VHL,nonpapillary renal cell carcinoma,C0279702,"pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
4408,NM_000551.4(VHL):c.257C>G (p.Pro86Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
4408,NM_000551.4(VHL):c.257C>G (p.Pro86Arg),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: nov 3, 2021)","criteria provided, multiple submitters, no conflicts"
4409,NM_000551.4(VHL):c.257C>T (p.Pro86Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
4409,NM_000551.4(VHL):c.257C>T (p.Pro86Leu),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
4409,NM_000551.4(VHL):c.257C>T (p.Pro86Leu),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
4409,NM_000551.4(VHL):c.257C>T (p.Pro86Leu),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: oct 31, 2022)","criteria provided, multiple submitters, no conflicts"
4410,NM_000551.4(VHL):c.262T>C (p.Trp88Arg),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4410,NM_000551.4(VHL):c.262T>C (p.Trp88Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4410,NM_000551.4(VHL):c.262T>C (p.Trp88Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4411,NM_000551.4(VHL):c.262T>A (p.Trp88Arg),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4411,NM_000551.4(VHL):c.262T>A (p.Trp88Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4411,NM_000551.4(VHL):c.262T>A (p.Trp88Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4411,NM_000551.4(VHL):c.262T>A (p.Trp88Arg),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 13, 2021)","criteria provided, multiple submitters, no conflicts"
4412,NM_000551.4(VHL):c.264G>C (p.Trp88Cys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
4412,NM_000551.4(VHL):c.264G>C (p.Trp88Cys),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 12, 2021)","criteria provided, single submitter"
4413,NM_000551.4(VHL):c.264G>T (p.Trp88Cys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: may 2, 2022)","criteria provided, multiple submitters, no conflicts"
4413,NM_000551.4(VHL):c.264G>T (p.Trp88Cys),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: may 2, 2022)","criteria provided, multiple submitters, no conflicts"
4413,NM_000551.4(VHL):c.264G>T (p.Trp88Cys),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: may 2, 2022)","criteria provided, multiple submitters, no conflicts"
4413,NM_000551.4(VHL):c.264G>T (p.Trp88Cys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: may 2, 2022)","criteria provided, multiple submitters, no conflicts"
4414,NM_000551.4(VHL):c.265C>T (p.Leu89Phe),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
4414,NM_000551.4(VHL):c.265C>T (p.Leu89Phe),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: oct 31, 2022)","criteria provided, single submitter"
4415,NM_000551.4(VHL):c.266T>C (p.Leu89Pro),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
4415,NM_000551.4(VHL):c.266T>C (p.Leu89Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
4415,NM_000551.4(VHL):c.266T>C (p.Leu89Pro),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
4415,NM_000551.4(VHL):c.266T>C (p.Leu89Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 25, 2022)","criteria provided, multiple submitters, no conflicts"
4416,NM_000551.4(VHL):c.269A>T (p.Asn90Ile),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 9, 2020)","criteria provided, single submitter"
4417,NM_000551.4(VHL):c.277G>C (p.Gly93Arg),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: mar 11, 2022)","criteria provided, multiple submitters, no conflicts"
4417,NM_000551.4(VHL):c.277G>C (p.Gly93Arg),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: mar 11, 2022)","criteria provided, multiple submitters, no conflicts"
4417,NM_000551.4(VHL):c.277G>C (p.Gly93Arg),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: mar 11, 2022)","criteria provided, multiple submitters, no conflicts"
4418,NM_000551.4(VHL):c.277G>A (p.Gly93Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: mar 5, 2022)","criteria provided, multiple submitters, no conflicts"
4418,NM_000551.4(VHL):c.277G>A (p.Gly93Ser),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: mar 5, 2022)","criteria provided, multiple submitters, no conflicts"
4418,NM_000551.4(VHL):c.277G>A (p.Gly93Ser),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: mar 5, 2022)","criteria provided, multiple submitters, no conflicts"
4419,NM_000551.4(VHL):c.278G>A (p.Gly93Asp),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4419,NM_000551.4(VHL):c.278G>A (p.Gly93Asp),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4419,NM_000551.4(VHL):c.278G>A (p.Gly93Asp),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: nov 23, 2021)","criteria provided, multiple submitters, no conflicts"
4420,NM_000551.4(VHL):c.292T>C (p.Tyr98His),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4420,NM_000551.4(VHL):c.292T>C (p.Tyr98His),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4420,NM_000551.4(VHL):c.292T>C (p.Tyr98His),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4420,NM_000551.4(VHL):c.292T>C (p.Tyr98His),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jan 31, 2023)","criteria provided, multiple submitters, no conflicts"
4421,NM_000551.4(VHL):c.293A>G (p.Tyr98Cys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 27, 2022)","criteria provided, single submitter"
4421,NM_000551.4(VHL):c.293A>G (p.Tyr98Cys),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 27, 2022)","criteria provided, single submitter"
4422,NM_000551.4(VHL):c.293A>C (p.Tyr98Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
4422,NM_000551.4(VHL):c.293A>C (p.Tyr98Ser),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
4422,NM_000551.4(VHL):c.293A>C (p.Tyr98Ser),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 17, 2022)","criteria provided, multiple submitters, no conflicts"
4423,NM_000551.4(VHL):c.302T>G (p.Leu101Arg),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: apr 9, 2015)","criteria provided, single submitter"
4424,NM_000551.4(VHL):c.302T>A (p.Leu101Gln),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: jun 6, 2022)","criteria provided, single submitter"
4425,NM_000551.4(VHL):c.302T>C (p.Leu101Pro),VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4425,NM_000551.4(VHL):c.302T>C (p.Leu101Pro),VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4425,NM_000551.4(VHL):c.302T>C (p.Leu101Pro),VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 30, 2021)","criteria provided, multiple submitters, no conflicts"
4426,NM_000551.4(VHL):c.313A>C (p.Thr105Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: feb 5, 2016)","criteria provided, single submitter"
4427,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
4427,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),VHL,pheochromocytoma,C4551683,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
4427,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),VHL,nonpapillary renal cell carcinoma,C0279702,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
4427,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
4427,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
4427,NM_000551.4(VHL):c.319C>G (p.Arg107Gly),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: oct 31, 2018)","criteria provided, multiple submitters, no conflicts"
4428,NM_000551.4(VHL):c.320G>A (p.Arg107His),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
4428,NM_000551.4(VHL):c.320G>A (p.Arg107His),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
4428,NM_000551.4(VHL):c.320G>A (p.Arg107His),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: aug 31, 2022)","criteria provided, multiple submitters, no conflicts"
4429,NM_000551.4(VHL):c.320G>C (p.Arg107Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4429,NM_000551.4(VHL):c.320G>C (p.Arg107Pro),VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4429,NM_000551.4(VHL):c.320G>C (p.Arg107Pro),VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4429,NM_000551.4(VHL):c.320G>C (p.Arg107Pro),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic/likely pathogenic(last reviewed: aug 10, 2022)","criteria provided, multiple submitters, no conflicts"
4430,NM_000551.4(VHL):c.331A>G (p.Ser111Gly),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4430,NM_000551.4(VHL):c.331A>G (p.Ser111Gly),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4430,NM_000551.4(VHL):c.331A>G (p.Ser111Gly),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4431,NM_000551.4(VHL):c.331A>T (p.Ser111Cys),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
4431,NM_000551.4(VHL):c.331A>T (p.Ser111Cys),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: jul 13, 2021)","criteria provided, single submitter"
4432,NM_000551.4(VHL):c.332G>A (p.Ser111Asn),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
4432,NM_000551.4(VHL):c.332G>A (p.Ser111Asn),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
4432,NM_000551.4(VHL):c.332G>A (p.Ser111Asn),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
4432,NM_000551.4(VHL):c.332G>A (p.Ser111Asn),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: apr 2, 2022)","criteria provided, multiple submitters, no conflicts"
4433,NM_000551.4(VHL):c.333C>G (p.Ser111Arg),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4433,NM_000551.4(VHL):c.333C>G (p.Ser111Arg),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4433,NM_000551.4(VHL):c.333C>G (p.Ser111Arg),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4434,NM_000551.4(VHL):c.334T>A (p.Tyr112Asn),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 1, 2018)","criteria provided, multiple submitters, no conflicts"
4435,NM_000551.4(VHL):c.334T>C (p.Tyr112His),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
4435,NM_000551.4(VHL):c.334T>C (p.Tyr112His),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
4435,NM_000551.4(VHL):c.334T>C (p.Tyr112His),VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
4435,NM_000551.4(VHL):c.334T>C (p.Tyr112His),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: dec 1, 2021)","criteria provided, multiple submitters, no conflicts"
4436,NM_000551.4(VHL):c.340G>A (p.Gly114Ser),VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4436,NM_000551.4(VHL):c.340G>A (p.Gly114Ser),VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: aug 28, 2021)","criteria provided, single submitter"
4437,NM_000551.4(VHL):c.344A>G (p.His115Arg),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
4437,NM_000551.4(VHL):c.344A>G (p.His115Arg),LOC107303340|VHL,chuvash polycythemia,C4749274,"likely pathogenic(last reviewed: aug 13, 2021)","criteria provided, single submitter"
4438,NM_000551.4(VHL):c.344A>C (p.His115Pro),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: oct 16, 2018)","criteria provided, multiple submitters, no conflicts"
4439,NM_000551.4(VHL):c.345C>A (p.His115Gln),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4439,NM_000551.4(VHL):c.345C>A (p.His115Gln),LOC107303340|VHL,chuvash polycythemia,C4749274,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4439,NM_000551.4(VHL):c.345C>A (p.His115Gln),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic/likely pathogenic(last reviewed: sep 1, 2021)","criteria provided, multiple submitters, no conflicts"
4440,NM_000551.4(VHL):c.349T>C (p.Trp117Arg),VHL|LOC107303340,chuvash polycythemia,C4749274,"pathogenic(last reviewed: jan 20, 2022)","criteria provided, single submitter"
4440,NM_000551.4(VHL):c.349T>C (p.Trp117Arg),VHL|LOC107303340,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jan 20, 2022)","criteria provided, single submitter"
4441,NM_000551.4(VHL):c.349T>G (p.Trp117Gly),LOC107303340|VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4441,NM_000551.4(VHL):c.349T>G (p.Trp117Gly),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: sep 2, 2021)","criteria provided, single submitter"
4442,NM_000551.4(VHL):c.351G>T (p.Trp117Cys),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: mar 30, 2022)","criteria provided, multiple submitters, no conflicts"
4442,NM_000551.4(VHL):c.351G>T (p.Trp117Cys),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: mar 30, 2022)","criteria provided, multiple submitters, no conflicts"
4443,NM_000551.4(VHL):c.353T>C (p.Leu118Pro),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jan 18, 2022)","criteria provided, multiple submitters, no conflicts"
4443,NM_000551.4(VHL):c.353T>C (p.Leu118Pro),LOC107303340|VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: jan 18, 2022)","criteria provided, multiple submitters, no conflicts"
4443,NM_000551.4(VHL):c.353T>C (p.Leu118Pro),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jan 18, 2022)","criteria provided, multiple submitters, no conflicts"
4444,NM_000551.4(VHL):c.353T>G (p.Leu118Arg),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 26, 2017)","criteria provided, single submitter"
4445,NM_000551.4(VHL):c.355T>C (p.Phe119Leu),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
4445,NM_000551.4(VHL):c.355T>C (p.Phe119Leu),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
4445,NM_000551.4(VHL):c.355T>C (p.Phe119Leu),LOC107303340|VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
4445,NM_000551.4(VHL):c.355T>C (p.Phe119Leu),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: jul 19, 2022)","criteria provided, multiple submitters, no conflicts"
4446,NM_000551.4(VHL):c.357C>A (p.Phe119Leu),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"likely pathogenic(last reviewed: aug 3, 2017)","criteria provided, single submitter"
4447,NM_000551.4(VHL):c.357C>G (p.Phe119Leu),LOC107303340|VHL,hereditary cancer-predisposing syndrome,C0027672,"pathogenic(last reviewed: feb 17, 2022)","criteria provided, multiple submitters, no conflicts"
4447,NM_000551.4(VHL):c.357C>G (p.Phe119Leu),LOC107303340|VHL,chuvash polycythemia,C4749274,"pathogenic(last reviewed: feb 17, 2022)","criteria provided, multiple submitters, no conflicts"
4447,NM_000551.4(VHL):c.357C>G (p.Phe119Leu),LOC107303340|VHL,von hippel-lindau syndrome,C0019562,"pathogenic(last reviewed: feb 17, 2022)","criteria provided, multiple submitters, no conflicts"
